{
  "graph": {
    "directed": false,
    "type": "BEL-V1.0",
    "label": "NFE2L2 Signaling-2.0-Hs",
    "metadata": {
      "description": "The NFE2L2 Signaling network depicts the causal mechanisms that are involved in transcriptional activation of NFE2L2 (central mediator of the cellular oxidative stress response), its interaction with MAF proteins, and its downstream target genes such as ATF4, GCLC, NQO1, and PRDX1.\\u003c/p\\u003e\\n\\u003ch2\\u003eJamboree Review Focus\\u003c/h2\\u003e\\n\\u003cp\\u003eInteraction of NFE2L2 with MAF proteins. Reviewed during Jamboree2014",
      "species_common_name": "Human",
      "version": "2.0",
      "boundary_conditions": "The human model sets were built to represent healthy processes and were then enhanced with COPD data to represent early COPD (GOLD stage I and II) processes. If supporting literature from early COPD studies were not available, stage-independent COPD studies were used. For a mechanism predicted from COPD data it was incorporated into a network with an edge based on COPD studies if available, and if not healthy context was used to incorporate these COPD mechanisms. Literature describing processes active in acute exacerbation in COPD patients was excluded from supporting edges of the network models. We prioritized data collected from studies of lung and COPD-relevant cell types, but excluded literature related to asthma or bronchitis. We excluded cancer, idiopathic pulmonary fibrosis, cystic fibrosis, all virus infections, all bacterial infections, septic pneumonitis, acute respiratory distress syndrome (ARDS), allergic responses/asthma, pneumoconiosis, and COPD exacerbations. We also excluded animal inhalation studies with solid particles (titanium dioxide, quartz, asbestos, carbon black, diesel exhaust etc). For the in vitro-specific exclusion criteria we excluded tumor-derived cell lines, immortalized cell lines, neuronal cells, and cell types that cannot be found in the respiratory/vascular system. There were some exceptions where we included immortalized cell lines and non-lung cell types for canonical mechanisms where there was evidence that the relationship was not tissue-specific but could also take place in the lung. Human-specific connections were preferred, but rat and mouse were also included where human data was not available."
    },
    "nodes": [
      {
        "id": "kin(p(HGNC:EIF2AK3))",
        "label": "kin(p(HGNC:EIF2AK3))",
        "metadata": {
          "coordinate": [
            0.516320837689,
            0.156702843287662
          ],
          "bel_function_type": "kinaseActivity",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d06"
        }
      },
      {
        "id": "p(HGNC:FYN,pmod(P,T))",
        "label": "p(HGNC:FYN,pmod(P,T))",
        "metadata": {
          "coordinate": [
            0.439538340371795,
            0.843155541844586
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d07"
        }
      },
      {
        "id": "p(HGNC:GCLC)",
        "label": "p(HGNC:GCLC)",
        "metadata": {
          "coordinate": [
            0.400435949880323,
            0.400890399072154
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d08"
        }
      },
      {
        "id": "p(HGNC:MAPK11)",
        "label": "p(HGNC:MAPK11)",
        "metadata": {
          "coordinate": [
            0.548642012443638,
            0.92836026649498
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d09"
        }
      },
      {
        "id": "kin(p(SFAM:\"PRKC Family\"))",
        "label": "kin(p(SFAM:\"PRKC Family\"))",
        "metadata": {
          "coordinate": [
            0.621956122660132,
            0.199588506510079
          ],
          "bel_function_type": "kinaseActivity",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d0a"
        }
      },
      {
        "id": "kin(p(SFAM:\"PIK3C Class IA Family\"))",
        "label": "kin(p(SFAM:\"PIK3C Class IA Family\"))",
        "metadata": {
          "coordinate": [
            0.853757104213797,
            0.615265573284199
          ],
          "bel_function_type": "kinaseActivity",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d0b"
        }
      },
      {
        "id": "p(HGNC:ATF4)",
        "label": "p(HGNC:ATF4)",
        "metadata": {
          "coordinate": [
            0.277929091915703,
            0.356825302258461
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d0c"
        }
      },
      {
        "id": "p(HGNC:IKBKB)",
        "label": "p(HGNC:IKBKB)",
        "metadata": {
          "coordinate": [
            0.679527548565074,
            0.26209528582118
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d0d"
        }
      },
      {
        "id": "tloc(p(MGI:Keap1),GOCC:cytoplasm,GOCC:nucleus)",
        "label": "tloc(p(MGI:Keap1),GOCC:cytoplasm,GOCC:nucleus)",
        "metadata": {
          "coordinate": [
            0.768780702905768,
            0.347105092980158
          ],
          "bel_function_type": "translocation",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d0e"
        }
      },
      {
        "id": "tloc(p(HGNC:NFE2L2),GOCC:cytoplasm,GOCC:nucleus)",
        "label": "tloc(p(HGNC:NFE2L2),GOCC:cytoplasm,GOCC:nucleus)",
        "metadata": {
          "coordinate": [
            0.638628275134179,
            0.580724119758681
          ],
          "bel_function_type": "translocation",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d0f"
        }
      },
      {
        "id": "tloc(p(HGNC:NFE2L2),GOCC:nucleus,GOCC:cytoplasm)",
        "label": "tloc(p(HGNC:NFE2L2),GOCC:nucleus,GOCC:cytoplasm)",
        "metadata": {
          "coordinate": [
            0.531955806723639,
            0.748852239796874
          ],
          "bel_function_type": "translocation",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d10"
        }
      },
      {
        "id": "p(HGNC:SQSTM1)",
        "label": "p(HGNC:SQSTM1)",
        "metadata": {
          "coordinate": [
            0.461205435414734,
            0.359490215125967
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d11"
        }
      },
      {
        "id": "kin(p(HGNC:FYN))",
        "label": "kin(p(HGNC:FYN))",
        "metadata": {
          "coordinate": [
            0.451800159255324,
            0.735472529763375
          ],
          "bel_function_type": "kinaseActivity",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d12"
        }
      },
      {
        "id": "p(SFAM:\"PRKC Family\")",
        "label": "p(SFAM:\"PRKC Family\")",
        "metadata": {
          "coordinate": [
            0.640501826716325,
            0.138235567070314
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d13"
        }
      },
      {
        "id": "p(HGNC:MAPK1)",
        "label": "p(HGNC:MAPK1)",
        "metadata": {
          "coordinate": [
            0.244528378246274,
            0.245329260104972
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d14"
        }
      },
      {
        "id": "composite(p(HGNC:KEAP1),a(SCHEM:\"15-deoxy-D12,14-prostaglandin J2\"))",
        "label": "composite(p(HGNC:KEAP1),a(SCHEM:\"15-deoxy-D12,14-prostaglandin J2\"))",
        "metadata": {
          "coordinate": [
            0.862217531802001,
            0.36694212535421
          ],
          "bel_function_type": "compositeAbundance",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d15"
        }
      },
      {
        "id": "p(HGNC:HMMR)",
        "label": "p(HGNC:HMMR)",
        "metadata": {
          "coordinate": [
            0.0533896734736169,
            0.483710230651445
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d16"
        }
      },
      {
        "id": "p(HGNC:MAFG)",
        "label": "p(HGNC:MAFG)",
        "metadata": {
          "coordinate": [
            0.192692699134046,
            0.52759154913676
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d17"
        }
      },
      {
        "id": "p(HGNC:TXNRD1)",
        "label": "p(HGNC:TXNRD1)",
        "metadata": {
          "coordinate": [
            0.377745289295841,
            0.35652582980948
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d18"
        }
      },
      {
        "id": "complex(p(HGNC:NFE2L1),p(HGNC:MAFF))",
        "label": "complex(p(HGNC:NFE2L1),p(HGNC:MAFF))",
        "metadata": {
          "coordinate": [
            0.0848603872292999,
            0.377235452676272
          ],
          "bel_function_type": "complexAbundance",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d19"
        }
      },
      {
        "id": "kin(p(SFAM:\"MAPK p38 Family\"))",
        "label": "kin(p(SFAM:\"MAPK p38 Family\"))",
        "metadata": {
          "coordinate": [
            0.622044933669569,
            0.67527921066622
          ],
          "bel_function_type": "kinaseActivity",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d1a"
        }
      },
      {
        "id": "complex(p(HGNC:NFE2L2),p(HGNC:MAFF))",
        "label": "complex(p(HGNC:NFE2L2),p(HGNC:MAFF))",
        "metadata": {
          "coordinate": [
            0.339936539990285,
            0.57321510166456
          ],
          "bel_function_type": "complexAbundance",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d1b"
        }
      },
      {
        "id": "p(HGNC:HMOX1)",
        "label": "p(HGNC:HMOX1)",
        "metadata": {
          "coordinate": [
            0.210804435002711,
            0.586941123756141
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d1c"
        }
      },
      {
        "id": "cat(p(HGNC:PTGS2))",
        "label": "cat(p(HGNC:PTGS2))",
        "metadata": {
          "coordinate": [
            0.828610199311404,
            0.531148130612872
          ],
          "bel_function_type": "catalyticActivity",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d1d"
        }
      },
      {
        "id": "complex(p(HGNC:NFE2L2),p(HGNC:KEAP1),p(HGNC:RBX1),p(HGNC:CUL3))",
        "label": "complex(p(HGNC:NFE2L2),p(HGNC:KEAP1),p(HGNC:RBX1),p(HGNC:CUL3))",
        "metadata": {
          "coordinate": [
            0.546096127936054,
            0.329502531228747
          ],
          "bel_function_type": "complexAbundance",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d1e"
        }
      },
      {
        "id": "p(HGNC:NFE2L1)",
        "label": "p(HGNC:NFE2L1)",
        "metadata": {
          "coordinate": [
            0.193233708532091,
            0.334717682245832
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d1f"
        }
      },
      {
        "id": "complex(p(HGNC:NFE2L2),p(HGNC:EIF2AK3))",
        "label": "complex(p(HGNC:NFE2L2),p(HGNC:EIF2AK3))",
        "metadata": {
          "coordinate": [
            0.480469346833251,
            0.24686293474383
          ],
          "bel_function_type": "complexAbundance",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d20"
        }
      },
      {
        "id": "p(HGNC:NFE2L2,pmod(P))",
        "label": "p(HGNC:NFE2L2,pmod(P))",
        "metadata": {
          "coordinate": [
            0.543971184596698,
            0.212098197811879
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d21"
        }
      },
      {
        "id": "complex(p(HGNC:SQSTM1),p(HGNC:KEAP1))",
        "label": "complex(p(HGNC:SQSTM1),p(HGNC:KEAP1))",
        "metadata": {
          "coordinate": [
            0.592406187239896,
            0.367220323753485
          ],
          "bel_function_type": "complexAbundance",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d22"
        }
      },
      {
        "id": "kin(p(HGNC:GSK3B))",
        "label": "kin(p(HGNC:GSK3B))",
        "metadata": {
          "coordinate": [
            0.433654455515101,
            0.894756884047022
          ],
          "bel_function_type": "kinaseActivity",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d23"
        }
      },
      {
        "id": "p(HGNC:AKT1)",
        "label": "p(HGNC:AKT1)",
        "metadata": {
          "coordinate": [
            0.954545454545454,
            0.514427250377326
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d24"
        }
      },
      {
        "id": "a(CHEBI:curcumin)",
        "label": "a(CHEBI:curcumin)",
        "metadata": {
          "coordinate": [
            0.415282877422904,
            0.647134029751366
          ],
          "bel_function_type": "abundance",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d25"
        }
      },
      {
        "id": "p(HGNC:KEAP1)",
        "label": "p(HGNC:KEAP1)",
        "metadata": {
          "coordinate": [
            0.594025308962372,
            0.437392340763894
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d26"
        }
      },
      {
        "id": "p(HGNC:FYN)",
        "label": "p(HGNC:FYN)",
        "metadata": {
          "coordinate": [
            0.486331897516568,
            0.813653958213846
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d27"
        }
      },
      {
        "id": "p(HGNC:CUL3)",
        "label": "p(HGNC:CUL3)",
        "metadata": {
          "coordinate": [
            0.567887305325048,
            0.27686694983914
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d28"
        }
      },
      {
        "id": "p(HGNC:HSPA1B)",
        "label": "p(HGNC:HSPA1B)",
        "metadata": {
          "coordinate": [
            0.409771539412407,
            0.28523814026675
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d29"
        }
      },
      {
        "id": "p(HGNC:MAPK14)",
        "label": "p(HGNC:MAPK14)",
        "metadata": {
          "coordinate": [
            0.607232401638933,
            0.929307338908784
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d2a"
        }
      },
      {
        "id": "kin(p(HGNC:MAPK14))",
        "label": "kin(p(HGNC:MAPK14))",
        "metadata": {
          "coordinate": [
            0.589007660236709,
            0.84465828249318
          ],
          "bel_function_type": "kinaseActivity",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d2b"
        }
      },
      {
        "id": "a(CHEBI:heme)",
        "label": "a(CHEBI:heme)",
        "metadata": {
          "coordinate": [
            0.149023488525969,
            0.435382970979538
          ],
          "bel_function_type": "abundance",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d2c"
        }
      },
      {
        "id": "p(HGNC:NFE2L2,pmod(P,S))",
        "label": "p(HGNC:NFE2L2,pmod(P,S))",
        "metadata": {
          "coordinate": [
            0.571188316635039,
            0.673386470089598
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d2d"
        }
      },
      {
        "id": "kin(p(HGNC:MAPK13))",
        "label": "kin(p(HGNC:MAPK13))",
        "metadata": {
          "coordinate": [
            0.645990570992864,
            0.766198162391457
          ],
          "bel_function_type": "kinaseActivity",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d2e"
        }
      },
      {
        "id": "p(HGNC:MAFF)",
        "label": "p(HGNC:MAFF)",
        "metadata": {
          "coordinate": [
            0.203187325992469,
            0.648315339354157
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d2f"
        }
      },
      {
        "id": "p(HGNC:GSK3B)",
        "label": "p(HGNC:GSK3B)",
        "metadata": {
          "coordinate": [
            0.442096445722063,
            0.954545454545454
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d30"
        }
      },
      {
        "id": "path(SDIS:\"laminar shear stress\")",
        "label": "path(SDIS:\"laminar shear stress\")",
        "metadata": {
          "coordinate": [
            0.713662818791899,
            0.543375792721132
          ],
          "bel_function_type": "pathology",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d31"
        }
      },
      {
        "id": "kin(p(HGNC:MAPK1))",
        "label": "kin(p(HGNC:MAPK1))",
        "metadata": {
          "coordinate": [
            0.232531430013009,
            0.3078343190425
          ],
          "bel_function_type": "kinaseActivity",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d32"
        }
      },
      {
        "id": "kin(p(HGNC:PRKCI))",
        "label": "kin(p(HGNC:PRKCI))",
        "metadata": {
          "coordinate": [
            0.700605782353866,
            0.66494361241591
          ],
          "bel_function_type": "kinaseActivity",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d33"
        }
      },
      {
        "id": "p(HGNC:CSNK2A1)",
        "label": "p(HGNC:CSNK2A1)",
        "metadata": {
          "coordinate": [
            0.431785359579619,
            0.207996086371105
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d34"
        }
      },
      {
        "id": "p(HGNC:MAFK)",
        "label": "p(HGNC:MAFK)",
        "metadata": {
          "coordinate": [
            0.22280825558495,
            0.713890215380285
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d35"
        }
      },
      {
        "id": "p(SFAM:\"MAPK p38 Family\")",
        "label": "p(SFAM:\"MAPK p38 Family\")",
        "metadata": {
          "coordinate": [
            0.703561996897806,
            0.758621583081021
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d36"
        }
      },
      {
        "id": "p(HGNC:GSTP1)",
        "label": "p(HGNC:GSTP1)",
        "metadata": {
          "coordinate": [
            0.286831306798287,
            0.449224806091534
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d37"
        }
      },
      {
        "id": "complex(p(HGNC:NFE2L2),p(HGNC:MAFG))",
        "label": "complex(p(HGNC:NFE2L2),p(HGNC:MAFG))",
        "metadata": {
          "coordinate": [
            0.317678680468748,
            0.512366651576971
          ],
          "bel_function_type": "complexAbundance",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d38"
        }
      },
      {
        "id": "complex(p(HGNC:NFE2L2),p(HGNC:ATF4))",
        "label": "complex(p(HGNC:NFE2L2),p(HGNC:ATF4))",
        "metadata": {
          "coordinate": [
            0.504609445552682,
            0.41259186488019
          ],
          "bel_function_type": "complexAbundance",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d39"
        }
      },
      {
        "id": "a(CHEBI:quercetin)",
        "label": "a(CHEBI:quercetin)",
        "metadata": {
          "coordinate": [
            0.400818176119345,
            0.561000880274616
          ],
          "bel_function_type": "abundance",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d3a"
        }
      },
      {
        "id": "p(HGNC:GPX2)",
        "label": "p(HGNC:GPX2)",
        "metadata": {
          "coordinate": [
            0.40606348725467,
            0.334321217424473
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d3b"
        }
      },
      {
        "id": "p(HGNC:NFE2L2,pmod(P,S,40))",
        "label": "p(HGNC:NFE2L2,pmod(P,S,40))",
        "metadata": {
          "coordinate": [
            0.642313884939542,
            0.490944924809645
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d3c"
        }
      },
      {
        "id": "complex(p(HGNC:NFE2L2),p(HGNC:MAFK))",
        "label": "complex(p(HGNC:NFE2L2),p(HGNC:MAFK))",
        "metadata": {
          "coordinate": [
            0.331617480804332,
            0.678250257292485
          ],
          "bel_function_type": "complexAbundance",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d3d"
        }
      },
      {
        "id": "p(HGNC:EIF2AK3,pmod(P))",
        "label": "p(HGNC:EIF2AK3,pmod(P))",
        "metadata": {
          "coordinate": [
            0.517074860573048,
            0.0932473730308004
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d3e"
        }
      },
      {
        "id": "p(HGNC:RBX1)",
        "label": "p(HGNC:RBX1)",
        "metadata": {
          "coordinate": [
            0.514144214240325,
            0.283430658471374
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d3f"
        }
      },
      {
        "id": "p(HGNC:PRDX1)",
        "label": "p(HGNC:PRDX1)",
        "metadata": {
          "coordinate": [
            0.314890689293129,
            0.399197428412748
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d40"
        }
      },
      {
        "id": "p(HGNC:GCLM)",
        "label": "p(HGNC:GCLM)",
        "metadata": {
          "coordinate": [
            0.355577598740734,
            0.391750447268312
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d41"
        }
      },
      {
        "id": "p(HGNC:MAPK3)",
        "label": "p(HGNC:MAPK3)",
        "metadata": {
          "coordinate": [
            0.267435680072626,
            0.796719166336381
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d42"
        }
      },
      {
        "id": "kin(p(HGNC:AKT1))",
        "label": "kin(p(HGNC:AKT1))",
        "metadata": {
          "coordinate": [
            0.920624748732187,
            0.569993128804175
          ],
          "bel_function_type": "kinaseActivity",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d43"
        }
      },
      {
        "id": "tscript(p(HGNC:NFE2L1))",
        "label": "tscript(p(HGNC:NFE2L1))",
        "metadata": {
          "coordinate": [
            0.220743126536112,
            0.449404578748207
          ],
          "bel_function_type": "transcriptionalActivity",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d44"
        }
      },
      {
        "id": "p(HGNC:NFE2L2,pmod(U,K))",
        "label": "p(HGNC:NFE2L2,pmod(U,K))",
        "metadata": {
          "coordinate": [
            0.559639589201231,
            0.628544375385556
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d45"
        }
      },
      {
        "id": "p(HGNC:CAND1)",
        "label": "p(HGNC:CAND1)",
        "metadata": {
          "coordinate": [
            0.232508057929657,
            0.364284919034998
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d46"
        }
      },
      {
        "id": "a(SCHEM:\"Epigallocatechin gallate\")",
        "label": "a(SCHEM:\"Epigallocatechin gallate\")",
        "metadata": {
          "coordinate": [
            0.320033282344846,
            0.237411286160995
          ],
          "bel_function_type": "abundance",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d47"
        }
      },
      {
        "id": "p(HGNC:PARK7)",
        "label": "p(HGNC:PARK7)",
        "metadata": {
          "coordinate": [
            0.415734502139198,
            0.710963793992268
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d48"
        }
      },
      {
        "id": "p(HGNC:MAPK12)",
        "label": "p(HGNC:MAPK12)",
        "metadata": {
          "coordinate": [
            0.657161602866228,
            0.886689080287579
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d49"
        }
      },
      {
        "id": "complex(p(HGNC:NFE2L1),p(HGNC:MAFG))",
        "label": "complex(p(HGNC:NFE2L1),p(HGNC:MAFG))",
        "metadata": {
          "coordinate": [
            0.109540668679132,
            0.301328003820935
          ],
          "bel_function_type": "complexAbundance",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d4a"
        }
      },
      {
        "id": "bp(GOBP:\"response to oxidative stress\")",
        "label": "bp(GOBP:\"response to oxidative stress\")",
        "metadata": {
          "coordinate": [
            0.726399859921311,
            0.214741665130952
          ],
          "bel_function_type": "biologicalProcess",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d4b"
        }
      },
      {
        "id": "complex(p(HGNC:BACH1),p(HGNC:MAFG))",
        "label": "complex(p(HGNC:BACH1),p(HGNC:MAFG))",
        "metadata": {
          "coordinate": [
            0.0592400814605068,
            0.559022684993652
          ],
          "bel_function_type": "complexAbundance",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d4c"
        }
      },
      {
        "id": "tscript(p(HGNC:BACH1))",
        "label": "tscript(p(HGNC:BACH1))",
        "metadata": {
          "coordinate": [
            0.15312753183002,
            0.486528645192244
          ],
          "bel_function_type": "transcriptionalActivity",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d4d"
        }
      },
      {
        "id": "p(HGNC:NFE2L2,pmod(P,Y,576))",
        "label": "p(HGNC:NFE2L2,pmod(P,Y,576))",
        "metadata": {
          "coordinate": [
            0.466643036710874,
            0.657750740788752
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d4e"
        }
      },
      {
        "id": "kin(p(HGNC:CSNK2A1))",
        "label": "kin(p(HGNC:CSNK2A1))",
        "metadata": {
          "coordinate": [
            0.403743438831187,
            0.255608267541493
          ],
          "bel_function_type": "kinaseActivity",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d4f"
        }
      },
      {
        "id": "p(HGNC:NQO1)",
        "label": "p(HGNC:NQO1)",
        "metadata": {
          "coordinate": [
            0.318115557434815,
            0.349445374580823
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d50"
        }
      },
      {
        "id": "complex(p(HGNC:BACH1),p(HGNC:MAFK))",
        "label": "complex(p(HGNC:BACH1),p(HGNC:MAFK))",
        "metadata": {
          "coordinate": [
            0.133648956017957,
            0.750503088612447
          ],
          "bel_function_type": "complexAbundance",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d51"
        }
      },
      {
        "id": "p(HGNC:NFE2L2)",
        "label": "p(HGNC:NFE2L2)",
        "metadata": {
          "coordinate": [
            0.448222881654952,
            0.460980492720136
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d52"
        }
      },
      {
        "id": "tscript(p(HGNC:NFE2L2))",
        "label": "tscript(p(HGNC:NFE2L2))",
        "metadata": {
          "coordinate": [
            0.316581713355327,
            0.289253649603425
          ],
          "bel_function_type": "transcriptionalActivity",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d53"
        }
      },
      {
        "id": "p(HGNC:BACH1)",
        "label": "p(HGNC:BACH1)",
        "metadata": {
          "coordinate": [
            0.0691685376436489,
            0.641871323756805
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d54"
        }
      },
      {
        "id": "p(HGNC:GSS)",
        "label": "p(HGNC:GSS)",
        "metadata": {
          "coordinate": [
            0.267163812599698,
            0.396490838347345
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d55"
        }
      },
      {
        "id": "p(HGNC:MAPK13)",
        "label": "p(HGNC:MAPK13)",
        "metadata": {
          "coordinate": [
            0.701995987641758,
            0.812817432010824
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d56"
        }
      },
      {
        "id": "p(HGNC:PRKCI)",
        "label": "p(HGNC:PRKCI)",
        "metadata": {
          "coordinate": [
            0.751435780962599,
            0.627612288432852
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d57"
        }
      },
      {
        "id": "p(HGNC:EIF2AK3)",
        "label": "p(HGNC:EIF2AK3)",
        "metadata": {
          "coordinate": [
            0.500097439394934,
            0.0454545454545454
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d58"
        }
      },
      {
        "id": "deg(p(HGNC:NFE2L2))",
        "label": "deg(p(HGNC:NFE2L2))",
        "metadata": {
          "coordinate": [
            0.45286187282646,
            0.57926078392073
          ],
          "bel_function_type": "degradation",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d59"
        }
      },
      {
        "id": "p(HGNC:GADD45GIP1)",
        "label": "p(HGNC:GADD45GIP1)",
        "metadata": {
          "coordinate": [
            0.502800854124148,
            0.691704535405441
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d5a"
        }
      },
      {
        "id": "p(HGNC:SRXN1)",
        "label": "p(HGNC:SRXN1)",
        "metadata": {
          "coordinate": [
            0.338773737187442,
            0.462595903222832
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d5b"
        }
      },
      {
        "id": "p(HGNC:PTGS2)",
        "label": "p(HGNC:PTGS2)",
        "metadata": {
          "coordinate": [
            0.787017789535844,
            0.574940518559589
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d5c"
        }
      },
      {
        "id": "kin(p(HGNC:MAPK12))",
        "label": "kin(p(HGNC:MAPK12))",
        "metadata": {
          "coordinate": [
            0.63782810535307,
            0.82860005081679
          ],
          "bel_function_type": "kinaseActivity",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d5d"
        }
      },
      {
        "id": "complex(SCOMP:\"p85/p110 PI3Kinase Complex\")",
        "label": "complex(SCOMP:\"p85/p110 PI3Kinase Complex\")",
        "metadata": {
          "coordinate": [
            0.889381309259442,
            0.489601744780313
          ],
          "bel_function_type": "complexAbundance",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d5e"
        }
      },
      {
        "id": "kin(p(HGNC:MAPK11))",
        "label": "kin(p(HGNC:MAPK11))",
        "metadata": {
          "coordinate": [
            0.536111375229131,
            0.831104415329085
          ],
          "bel_function_type": "kinaseActivity",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d5f"
        }
      },
      {
        "id": "complex(p(HGNC:KEAP1),p(HGNC:IKBKB))",
        "label": "complex(p(HGNC:KEAP1),p(HGNC:IKBKB))",
        "metadata": {
          "coordinate": [
            0.702454222598016,
            0.301872327200971
          ],
          "bel_function_type": "complexAbundance",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d60"
        }
      },
      {
        "id": "complex(p(MGI:Bach1),p(MGI:Maff))",
        "label": "complex(p(MGI:Bach1),p(MGI:Maff))",
        "metadata": {
          "coordinate": [
            0.0454545454545454,
            0.712769035171657
          ],
          "bel_function_type": "complexAbundance",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d61"
        }
      },
      {
        "id": "p(HGNC:GSK3B,pmod(P,Y,216))",
        "label": "p(HGNC:GSK3B,pmod(P,Y,216))",
        "metadata": {
          "coordinate": [
            0.396739754362151,
            0.934722327557092
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d62"
        }
      },
      {
        "id": "kin(p(HGNC:MAPK3))",
        "label": "kin(p(HGNC:MAPK3))",
        "metadata": {
          "coordinate": [
            0.284169791908124,
            0.734684420309651
          ],
          "bel_function_type": "kinaseActivity",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d63"
        }
      },
      {
        "id": "complex(p(HGNC:KEAP1),p(HGNC:NFE2L2))",
        "label": "complex(p(HGNC:KEAP1),p(HGNC:NFE2L2))",
        "metadata": {
          "coordinate": [
            0.537734912628265,
            0.504510794099214
          ],
          "bel_function_type": "complexAbundance",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d64"
        }
      },
      {
        "id": "p(HGNC:GSTA5)",
        "label": "p(HGNC:GSTA5)",
        "metadata": {
          "coordinate": [
            0.380793552151643,
            0.439058864673164
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d65"
        }
      },
      {
        "id": "a(SCHEM:\"15-deoxy-D12,14-prostaglandin J2\")",
        "label": "a(SCHEM:\"15-deoxy-D12,14-prostaglandin J2\")",
        "metadata": {
          "coordinate": [
            0.801327707645894,
            0.486228988537216
          ],
          "bel_function_type": "abundance",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d66"
        }
      },
      {
        "id": "tscript(p(HGNC:AHR))",
        "label": "tscript(p(HGNC:AHR))",
        "metadata": {
          "coordinate": [
            0.675179293693592,
            0.14252793097055
          ],
          "bel_function_type": "transcriptionalActivity",
          "createdBy": "alejandroferreiromorales.cr",
          "nodeId": "55775dd92f9e241f18ad8d67"
        }
      },
      {
        "id": "cat(p(HGNC:TXNRD1))",
        "label": "cat(p(HGNC:TXNRD1))",
        "metadata": {
          "coordinate": [
            0.714771973767677,
            0.232004999756815
          ],
          "bel_function_type": "catalyticActivity",
          "createdBy": "alejandroferreiromorales.cr",
          "nodeId": "55775dd92f9e241f18ad8d68"
        }
      },
      {
        "id": "gtp(p(HGNC:KRAS))",
        "label": "gtp(p(HGNC:KRAS))",
        "metadata": {
          "coordinate": [
            0.860327808121372,
            0.619150022333092
          ],
          "bel_function_type": "gtpBoundActivity",
          "createdBy": "alejandroferreiromorales.cr",
          "nodeId": "55775dd92f9e241f18ad8d69"
        }
      },
      {
        "id": "complex(SCOMP:\"AP-1 Complex\")",
        "label": "complex(SCOMP:\"AP-1 Complex\")",
        "metadata": {
          "coordinate": [
            0.290268852510615,
            0.613334551273535
          ],
          "bel_function_type": "complexAbundance",
          "createdBy": "alejandroferreiromorales.cr",
          "nodeId": "55775dd92f9e241f18ad8d6a"
        }
      },
      {
        "id": "p(HGNC:SOD1)",
        "label": "p(HGNC:SOD1)",
        "metadata": {
          "coordinate": [
            0.224401046160795,
            0.159397129509317
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "alejandroferreiromorales.cr",
          "nodeId": "55775dd92f9e241f18ad8d6b"
        }
      },
      {
        "id": "p(HGNC:JUN)",
        "label": "p(HGNC:JUN)",
        "metadata": {
          "coordinate": [
            0.2682468285483361,
            0.7709569550536013
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775dd92f9e241f18ad8d6c"
        }
      }
    ],
    "edges": [
      {
        "source": "complex(p(HGNC:NFE2L1),p(HGNC:MAFG))",
        "relation": "hasComponent",
        "target": "p(HGNC:NFE2L1)",
        "directed": false,
        "label": "complex(p(HGNC:NFE2L1),p(HGNC:MAFG)) hasComponent p(HGNC:NFE2L1)",
        "metadata": {
          "casual": false,
          "createdBy": "",
          "edgeId": "55775dd92f9e241f18ad8d6d",
          "evidences": [

          ]
        }
      },
      {
        "source": "complex(p(HGNC:NFE2L1),p(HGNC:MAFG))",
        "relation": "directlyIncreases",
        "target": "tscript(p(HGNC:NFE2L1))",
        "directed": false,
        "label": "complex(p(HGNC:NFE2L1),p(HGNC:MAFG)) directlyIncreases tscript(p(HGNC:NFE2L1))",
        "metadata": {
          "casual": true,
          "createdBy": "Jamboree",
          "edgeId": "55775dd92f9e241f18ad8d6e",
          "evidences": [

          ]
        }
      },
      {
        "source": "complex(p(HGNC:NFE2L1),p(HGNC:MAFF))",
        "relation": "hasComponent",
        "target": "p(HGNC:NFE2L1)",
        "directed": false,
        "label": "complex(p(HGNC:NFE2L1),p(HGNC:MAFF)) hasComponent p(HGNC:NFE2L1)",
        "metadata": {
          "casual": false,
          "createdBy": "",
          "edgeId": "55775dd92f9e241f18ad8d6f",
          "evidences": [

          ]
        }
      },
      {
        "source": "complex(p(HGNC:NFE2L1),p(HGNC:MAFF))",
        "relation": "directlyIncreases",
        "target": "tscript(p(HGNC:NFE2L1))",
        "directed": false,
        "label": "complex(p(HGNC:NFE2L1),p(HGNC:MAFF)) directlyIncreases tscript(p(HGNC:NFE2L1))",
        "metadata": {
          "casual": true,
          "createdBy": "Jamboree",
          "edgeId": "55775dd92f9e241f18ad8d70",
          "evidences": [

          ]
        }
      },
      {
        "source": "tloc(p(HGNC:NFE2L2),GOCC:nucleus,GOCC:cytoplasm)",
        "relation": "increases",
        "target": "p(HGNC:NFE2L2,pmod(U,K))",
        "directed": false,
        "label": "tloc(p(HGNC:NFE2L2),GOCC:nucleus,GOCC:cytoplasm) increases p(HGNC:NFE2L2,pmod(U,K))",
        "metadata": {
          "casual": true,
          "createdBy": "",
          "edgeId": "55775dd92f9e241f18ad8d71",
          "evidences": [

          ]
        }
      },
      {
        "source": "tloc(p(HGNC:NFE2L2),GOCC:nucleus,GOCC:cytoplasm)",
        "relation": "translocates",
        "target": "p(HGNC:NFE2L2)",
        "directed": false,
        "label": "tloc(p(HGNC:NFE2L2),GOCC:nucleus,GOCC:cytoplasm) translocates p(HGNC:NFE2L2)",
        "metadata": {
          "casual": false,
          "createdBy": "Jamboree2014",
          "edgeId": "55775dd92f9e241f18ad8d72",
          "evidences": [
            {
              "bel_statement": "tloc(p(HGNC:NFE2L2),GOCC:nucleus,GOCC:cytoplasm) translocates p(HGNC:NFE2L2)",
              "summary_text": "This is a non-causal connector edge that does not require literature evidence.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7bbb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:HMMR)",
        "relation": "directlyDecreases",
        "target": "tscript(p(HGNC:BACH1))",
        "directed": false,
        "label": "p(HGNC:HMMR) directlyDecreases tscript(p(HGNC:BACH1))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8d73",
          "evidences": [
            {
              "bel_statement": "p(HGNC:HMMR) directlyDecreases tscript(p(HGNC:BACH1))",
              "summary_text": "The repression of HO-1 reporter activity by Bach1 was attenuated by co-transfecting IHABP in a dose-dependent manner. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biochem (Tokyo) 2005 Mar 137(3) 287-96",
                "id": "15809329"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7bbc"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "composite(p(HGNC:KEAP1),a(SCHEM:\"15-deoxy-D12,14-prostaglandin J2\"))",
        "relation": "directlyDecreases",
        "target": "complex(p(HGNC:KEAP1),p(HGNC:NFE2L2))",
        "directed": false,
        "label": "composite(p(HGNC:KEAP1),a(SCHEM:\"15-deoxy-D12,14-prostaglandin J2\")) directlyDecreases complex(p(HGNC:KEAP1),p(HGNC:NFE2L2))",
        "metadata": {
          "casual": true,
          "createdBy": "Jamboree2014",
          "edgeId": "55775dd92f9e241f18ad8d74",
          "evidences": [
            {
              "bel_statement": "composite(p(HGNC:KEAP1),a(SCHEM:\"15-deoxy-D12,14-prostaglandin J2\")) directlyDecreases complex(p(HGNC:KEAP1),p(HGNC:NFE2L2))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7bbf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "composite(p(HGNC:KEAP1),a(SCHEM:\"15-deoxy-D12,14-prostaglandin J2\")) directlyDecreases complex(p(HGNC:KEAP1),p(HGNC:NFE2L2))",
              "summary_text": "A downstream product of COX-2, 15-deoxy-Delta(12,14)-prostaglandin J2 (15d-PGJ2), activated the Nrf2 regulatory pathway in HAECs through binding to the cysteines of Keap1.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "15917255"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7bbe"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "endothelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "composite(p(HGNC:KEAP1),a(SCHEM:\"15-deoxy-D12,14-prostaglandin J2\")) directlyDecreases complex(p(HGNC:KEAP1),p(HGNC:NFE2L2))",
              "summary_text": "",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7bbd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "composite(p(HGNC:KEAP1),a(SCHEM:\"15-deoxy-D12,14-prostaglandin J2\"))",
        "relation": "hasComponent",
        "target": "p(HGNC:KEAP1)",
        "directed": false,
        "label": "composite(p(HGNC:KEAP1),a(SCHEM:\"15-deoxy-D12,14-prostaglandin J2\")) hasComponent p(HGNC:KEAP1)",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8d75",
          "evidences": [
            {
              "bel_statement": "composite(p(HGNC:KEAP1),a(SCHEM:\"15-deoxy-D12,14-prostaglandin J2\")) hasComponent p(HGNC:KEAP1)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7bc0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "composite(p(HGNC:KEAP1),a(SCHEM:\"15-deoxy-D12,14-prostaglandin J2\"))",
        "relation": "hasComponent",
        "target": "a(SCHEM:\"15-deoxy-D12,14-prostaglandin J2\")",
        "directed": false,
        "label": "composite(p(HGNC:KEAP1),a(SCHEM:\"15-deoxy-D12,14-prostaglandin J2\")) hasComponent a(SCHEM:\"15-deoxy-D12,14-prostaglandin J2\")",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8d76",
          "evidences": [
            {
              "bel_statement": "composite(p(HGNC:KEAP1),a(SCHEM:\"15-deoxy-D12,14-prostaglandin J2\")) hasComponent a(SCHEM:\"15-deoxy-D12,14-prostaglandin J2\")",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7bc1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:MAPK1)",
        "relation": "actsIn",
        "target": "kin(p(HGNC:MAPK1))",
        "directed": false,
        "label": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8d77",
          "evidences": [
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "In brief, p210BCR/ABL activates signal transduction pathways such as RAS/MAPK, PI-3 kinase, c-CBL and CRKL pathways, JAK-STAT and the Src pathway. Of these, the ras, Jun-kinase, and PI-3 kinase pathways have been demonstrated to play a major role in transformation and proliferation (Raitano et al., 1995; Sawyers et al., 1995; Skorski et al., 1995, 1997a). Inhibition of apoptosis is thought to result from activation of the PI-3 kinase and RAS pathways, with induction through AKT of c-myc and BCL-2 (Raitano et al., 1995; Sawyers et al., 1995; Skorski et al., 1995, 1997a; Warmuth et al., 1999)",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2002 Dec 9 21(56) 8547-59",
                "id": "12476301"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b82"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "CL100, the product of an immediate early gene, is synthesized within one hour of stimulating cells with growth factors or exposure to oxidative stress or heat shock. Incubation of NIH 3T3 fibroblasts with cycloheximide prevents both synthesis of CL100 and inactivation of p42mapk after stimulation with serum. Depleting cells of CL100 and preventing its induction using cycloheximide stopped the inactivation of p42mapk in Swiss 3T3 fibroblasts following stimulation with epidermal growth factor (EGF) rapid inactivation of p42mapk in response to EGF in adipose (3T3-L1) or chromaffin (PC12) cells or in response to platelet-derived growth factor (PDGF) in endothelial (PAE) cells",
              "citation": {
                "type": "PubMed",
                "name": "Curr Biol 1995 Mar 1 5(3) 283-95",
                "id": "7780739"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b81"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "To see the phosphorylation of MAPK by ETS, the control and ETS-exposed brain tissues were extracted and 100 mg proteins were analyzed by 10% SDS-PAGE and phosphorylated form of MAPK was detected by Western blot using anti-phospho-MAPK antibody. The result shown in Fig. 4B indicates that phosphorylated MAPK was increased in all the regions of the brain exposed to ETS as compared to control brain tissue. The same extracts were probed with anti- ERK antibody and the level of ERK was unchanged in all the lanes indicating equal loading of proteins as well as specificity of the phosphorylation of the MAPK because ERK also undergoes phoshorylation but through different signaling pathway [31]. These results therefore strongly suggest that ETS induces MAPK phosphorylation and that the level of phosphorylation was similar across all the regions of the brain. We next examined the effect of ETS on p38MAP kinase in various regions of the brain. We found that ETS induced the phosphorylation of the p38MAP kinase in all the regions of the brain examined without altering the levels of the p38 MAP kinase protein expression (Fig. 4C).",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Pharmacol 2006 May 28 71(11) 1602-9",
                "id": "16569398"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b80"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": "striatum"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "MafB/Kreisler is induced in response to ERK and synergizes with GATA and Ets to enhance transcription from the proximal promoter. The requirement for MafB in promoter regulation is demonstrated by inhibition of transactivation following dominant-negative or antisense suppression of MafB function. Thus, ERK promotes megakaryocyte differentiation by coordinate regulation of nuclear factors that synergize in GPIIb promoter regulation. These results establish a novel role for MafB as a regulator of ERK-induced gene expression.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 May 24(10) 4534-45",
                "id": "15121870"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b7f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "We further demonstrate that these events are Src family tyrosine kinase-dependent and specifically identify the role of hematopoietic cell kinase (Hck) as a new Gab family adapter protein kinase. Conversely, inhibition of Src family tyrosine kinases by the pyrazolopyrimidine PP2, as in kinase-inactive Hck mutants, significantly reduces IL-6-triggered activation of extracellular signal-regulated kinase and AKT-1, leading to significant reduction of multiple myeloma cell proliferation and survival. Taken together, these results delineate a key role for Hck-mediated phosphorylation of Gab1 and Gab2 docking proteins in IL-6-induced proliferation and survival of multiple myeloma cells and identify tyrosine kinases and downstream adapter proteins as potential new therapeutic targets in multiple myeloma.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 May 14 279(20) 21658-65",
                "id": "15010462"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b7e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Multiple Myeloma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "To investigate the biological significance of Ras/ERK1/2-induced STAT3 Ser(727) phosphorylation for cell proliferation and transformation, N-Ras-transformed NIH-3T3 cells were employed. These cells displayed elevated levels of activated ERK1/2 and Ser(727)-phosphorylated STAT3, which were inhibited by treatment with U0126. Importantly, overexpression of STAT3, in which the Ser(727) was mutated into Ala (STAT3(S727A)), rescued the transformed phenotype of N-Ras-transformed cells",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 Mar 2 282(9) 6415-24",
                "id": "17209045"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b7d"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Our previous study with rat pulmonary epithelial cells showed that the transcription of the Gclc and Gclm  mRNAs is regulated by different upstream kinases [60]  R.M. Liu, Z. Borok and H.J. Forman, 4-Hydroxy-2-nonenal increases gamma-glutamylcysteine synthetase gene expression in alveolar epithelial cells, Am. J. Respir. Cell. Mol. Biol. 24 (2001), pp. 499505. View Record in Scopus | Cited By in Scopus (40)[60]. In cells stimulated with HNE, the ERK  pathway inhibitor PD98059 completely blocked the increase in Gclc  mRNA but had no effect on the increase in Gclm  mRNA",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2005 Mar 1 38(5) 547-56",
                "id": "15683710"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b7c"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "we examined the requirement for PKCs in the PMA-induced activation of ERKs by using different PKC inhibitors. Treatment with GF109203X resulted in a total inhibition of ERKs activation, whereas rottlerin had no effect (Figure 8). Because rottlerin is unable to block the activation of ERKs by PMA, PKC-d is not implicated in this process. Given that atypical PKCs were not activated by PMA on the XG-6 cells, these results suggest that PKC-z was not involved...Finally, because XG-6 cells express PKC-nu and PKC-d as novel PKC isoforms, we can assume that the novel PKC, namely PCK-nu, is involved in the activation of ERKs by PMA.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2001 Aug 15 358(Pt 1) 193-200",
                "id": "11485567"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b7b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Multiple Myeloma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "The ability of CXCL12 to stimulate proliferation and survival is mediated by activation of the Erk 1/2 and phosphatidylinositol 3-kinase pathways in many cell types Taken together these data indicate that the ability of AMD 3100 to decrease tumor growth in animal models reflects direct inactivation of CXCR4 in tumor cells and consequent inhibition of Erk 1/2 and phosphatidylinositol 3-kinase pathways, resulting in increased tumor cell apoptosis and decreased proliferation.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2003 Nov 11 100(23) 13513-8",
                "id": "14595012"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b7a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Etienne-Manneville and Hall (2003) used primary rat astrocytes in a cell migration assay to demonstrate that PAR6-PKC-zeta interacts directly with and regulates glycogen synthase kinase-3-beta (GSK3-beta; 605004) to promote polarization of the centrosome and to control the direction of cell protrusion. CDC42-dependent phosphorylation of GSK3-beta occurs specifically at the leading edge of migrating cells, and induces the interaction of APC (175100) protein with the plus ends of microtubules. Erk1/2 activates p90RSK",
              "citation": {
                "type": "PubMed",
                "name": "Science 1998 Jan 30 279(5351) 707-10",
                "id": "9445476"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b79"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "The treatment of rat lung epithelial cells with nicotine for various periods differentially mobilizes multiple intracellular pathways [64]. Protein kinase C and PI3-OH-kinase are transiently activated after the treatment. Also, Ras and its downstream effector ERK1/2 are activated after long-term exposure to nicotine. The activation of Ras by nicotine treatment is responsible for the subsequent perturbation of the methotrexate (MTX)-mediated G1 cell cycle restriction, as well as an increase in production of reactive oxygen species [64].",
              "citation": {
                "type": "PubMed",
                "name": "Mutat Res 659(3) 221-31",
                "id": "18495523"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b78"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Treatment of glEND.2 cells with vascular endothelial growth factor (VEGF, 10 ng/ml) induced a time dependent phosphorylation of ERK1/2, which was significant at 2 minutes of VEGF exposure (3.7 fold), peaking at 10 minutes, and thereafter tapering off. VEGF also induced activation of VEGFR-2. VEGF induced ERK1/2 activation was totally blocked by pretreatment with specific ERK1/2 inhibitor U0126. Inhibition of ERK1/2 activation also inhibited VEGF induced proliferation, where as inhibition of PKC or PI3K had no effect, suggesting that VEGF induces receptor mediated activation of ERK1/2 leading to proliferation in glEND.2 cells.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2005 Sep 9 334(4) 1049-60",
                "id": "16039615"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b77"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Treatment of human umbilical vein endothelial cells (HUVECs) with betacellulin (BTC, 10 ng/ml) increased phosphorylation of two MAPKs, ERK1 (p44MAPK) and ERK2 (p42MAPK) and AKT as early as 1 minute and produced a maximal effect at 5 minutes, which declined and returned to control levels at 60 minutes. BTC treatment also phosphorylated all three Erb receptors ErbB2, ErbB3, and ErbB4 but not ErbB1. BTC induced phosphorylation of MAPK and AKT was not suppressed by a selectilvely inhibitory concentration of ErbB1 receptor inhibitor, AG1478), suggesting that BTC induced MAPK and AKT activation was mediated through ErbB4 homodimer, ErbB2/ErbB3, or ErbB2/ErbB4.",
              "citation": {
                "type": "PubMed",
                "name": "FASEB J 2003 Feb 17(2) 318-20",
                "id": "12475887"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b76"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "However, using an inhibitor of ERK activation, U0126, we show that Alb-AGE stimulates VEGF expression through an ERK-dependent pathway. Accordingly, we found that Alb-AGE activated mitogen-activate protein kinase, ERK1/2, JNK1/2, but not p38, and that Alb-AGE did not activate PI3K and PKB. Moreover, Alb-AGE activated the transcription factor, hypoxia inducible factor-1 (HIF-1) DNA binding activity. This activation is mediated by an increase in accumulation of the HIF-1alpha protein through an ERK-dependent pathway.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Nov 23 276(47) 43836-41",
                "id": "11571295"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b75"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "in fetal rat brown adipocyte primary cultures the PPARgamma agonist rosiglitazone (Rosi), as well as retinoic acids 9-cis-retinoic acid and all-trans-retinoic acid also have  extragenic  effects and induce p44/p42 and p38 mitogen-activated protein kinase (p38MAPK) activation. The latter is involved in UCP-1 gene expression, because inhibition of p38MAPK activity with PD169316 impairs the ability of Rosi and retinoids for UCP-1 induction.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Jan 3 278(1) 263-9",
                "id": "12414803"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b74"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "brown adipocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "The ERK2 MAP kinase pathway controls cell growth and survival and modulates integrin function. Here, we report that PEA15, a protein variably expressed in multiple cell types, blocks ERK-dependent transcription and proliferation by binding ERKs and preventing their localization in the nucleus. PEA-15 contains a nuclear export sequence required for its capacity to anchor ERK in the cytoplasm. Genetic deletion of PEA-15 results in increased ERK nuclear localization with consequent increased cFos transcription and cell proliferation. Thus, PEA-15 can redirect the biological outcome of MAP kinase signaling by regulating the subcellular localization of ERK MAP kinase.",
              "citation": {
                "type": "PubMed",
                "name": "Dev Cell 2001 Aug 1(2) 239-50",
                "id": "11702783"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b73"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "The major radioactive fraction of the cPLA2/p42mapk sample (retention time 130?140 min) co-eluted with a prominent OD210 peptide peak (133.2 min) and represented 85% of the total counts/min eluting from the mbHPLC column. Its retention time was the same as that of the Ser-505-containing phosphopeptide seen in the platelet and Sf9 cell experiments.....However, this peak was not seen in experiments where the mutated S505A cPLA2 was used as substrate for p42mapk (Fig. 5).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1998 Feb 20 273(8) 4449-58",
                "id": "9468497"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b72"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "we tested whether ERK1 and ERK2 (ERK1/2) were activated by conjugation of NK92 cells with Raji target cells. ERK1/2 activation peaked at 2 min, dropping back to basal levels by 10 min. PD98059, a specific MEK inhibitor, effectively suppressed this activation as well as NK lytic function against tumor cells (data not shown). More significantly, PD98059 blocked perforin and granzyme B movement in NK92 cells towards target cells (Fig. 1a,b). These results confirm that ERK1/2 are responsible for the mobilization and redistribution of perforin and granzyme B to effect lysis6.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Immunol 2000 Nov 1(5) 419-25",
                "id": "11062502"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b71"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "natural killer cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Furthermore, we identified three tyrosines (Tyr-1175, Tyr-1265, and Tyr-1294) within the kinase domain that play critical but overlapping roles in controlling constitutive Erk activation by mRon. Phenylalanine mutations at these three tyrosines results in a receptor that fails to constitutively activate the Erk pathway but retains the ability to induce Erk phosphorylation in response to ligand stimulation. The ability of mRon to activate the MAP kinase pathway is dependent on c-Src activity, and we have shown that c-Src co-immunoprecipitates with mRon. c-Src fails to interact with mRon when the three tyrosines required for MAP kinase activation are mutated, whereas the presence of any one of these tyrosines alone restores Erk phosphorylation and recruitment of c-Src.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Oct 21 280(42) 35098-107",
                "id": "16103119"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b70"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "control and Sod2-overexpressing cells were treated with the specific inhibitors of ERK1/2 (PD98059) and p38 (SB203580) (Fig. 4B, inset). Northern blotting demonstrated that the ERK1/2 inhibitor blocked basal MMP-1 expression and dramatically decreased MMP-1 mRNA levels in the HT15 cell lines. The p38 inhibitor increased MMP-1 expression in both control and HT15 cell lines......the inductive properties of SB203580 could be blocked by PD98059.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Apr 27 276(17) 14264-70",
                "id": "11297530"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b6f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "fibrosarcoma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "ERK5 is also induced in C10 cells by asbestos fibers through an oxidant-dependent process that is not dependent on EGFR activation (28). ERK1/2 and ERK5 activation by asbestos is Src-dependent, and activation of all three signaling events is essential for the initiation of asbestos-induced epithelial cell proliferation (28). [From primary paper: To confirm the involvement of Src in ERK1/2 and ERK5 activation, a dominant-negative Src construct was used. These experiments showed that Src was essential for ERK1/2 and also ERK5 phosphorylation by asbestos. ]",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2006 Jun 34(6) 666-9",
                "id": "16484683"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b6e"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Using isolated human platelets, we report that PKCdelta, but not PKCalpha or PKCbeta, is required for collagen-induced phospholipase C-dependent signaling, activation of alpha(IIb)beta(3), and platelet aggregation. Analysis of PKCdelta phosphorylation and translocation to the membrane following activation by both collagen and thrombin indicates that it is positively regulated by alpha(IIb)beta(3) outside-in signaling. Moreover, PKCdelta triggers activation of the mitogen-activated protein kinase-kinase (MEK)/extracellular-signal regulated kinase (ERK) and the p38 MAPK signaling. This leads to the subsequent release of thromboxane A(2), ##Phospho-specific antibodies for PKC?, MEK1/2, ERK1/2, and p38 MAPK came from Cell Signaling Technologies (Beverly, MA) and Santa Cruz Biotechnologies (Santa Cruz, CA).##",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Oct 6 281(40) 30024-35",
                "id": "16895913"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b6d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Blood Platelets",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "The phosphorylation of the human estrogen receptor (ER) serine residue at position 118 is required for full activity of the ER activation function 1 (AF-1). This Ser118 is phosphorylated by mitogen-activated protein kinase (MAPK) in vitro and in cells treated with epidermal growth factor (EGF) and insulin-like growth factor (IGF) in vivo. Overexpression of MAPK kinase (MAPKK) or of the guanine nucleotide binding protein Ras, both of which activate MAPK, enhanced estrogen-induced and antiestrogen (tamoxifen)-induced transcriptional activity of wild-type ER, but not that of a mutant ER with an alanine in place of Ser118.",
              "citation": {
                "type": "PubMed",
                "name": "Science 1995 Dec 1 270(5241) 1491-4",
                "id": "7491495"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b6c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "ERK phosphorylation that was constitutive in mutant ras MM cells was completely abolished by the MEK inhibitor PD98059 (Figure 2C, left panels), as was the ERK phosphorylation reinduced in wild-type cells by readdition of IL-6 (Figure 2C, right panel).......In addition, re-exposure to IL-6 could reinduce AKT phosphorylation in wild-type cells in a wortmannin-sensitive fashion. Moreover, the constitutively maintained AKT phosphorylation in the mutation-containing cells was also sensitive to wortmannin. These data indicate the PI3-K/AKT cascade is a ras effector in these mutant rascontaining MM cells.",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2003 Apr 15 101(8) 3126-35",
                "id": "12515720"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b6b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "We show that in the human breast carcinoma T47D cells, upon estrogen treatment, p130Cas rapidly and transiently associates with the estrogen receptor alpha in a multi-molecular complex containing the c-Src kinase and the p85 subunit of PI 3-kinase. Association of p130Cas with the estrogen receptor alpha occurs within 3 minutes of estrogen treatment and is dependent on c-Src kinase activation. Transient overexpression of p130Cas in T47D cells increases estrogen-dependent Src kinase and Erk1/2 MAPKs activities and accelerates their kinetics of stimulation.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 2004 Mar 15 117(Pt 8) 1603-11",
                "id": "15020686"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b6a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "The proliferative effect of C-peptide on VSMCs was inhibited by Src short interference RNA transfection, PP2, an inhibitor of Src-kinase, LY294002, an inhibitor of PI-3 kinase, and the ERK1/2 inhibitor PD98059. Moreover, C-peptide induced phosphorylation of Src, as well as activation of PI-3 kinase and ERK1/2, suggesting that these signaling molecules are involved in C-peptide-induced VSMC proliferation. Finally, C-peptide induced cyclin D1 expression as well as phosphorylation of Rb in VSMCs. Our results demonstrate that C-peptide induces VSMC proliferation through activation of Src- and PI-3 kinase as well as ERK1/2.",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 2006 Nov 24 99(11) 1181-7",
                "id": "17068290"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b69"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": "vascular smooth muscle"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Two classes of differentiation factors, the neurotrophins and fibroblast growth factors, induce rapid tyrosine phosphorylation of SNT1(FRS2alpha), which in turn enables SNT1 to recruit Shp2 tyrosine phosphatase and Grb2 adaptor protein in complex with the Ras GDP/GTP exchange factor Sos. Mutagenesis of SNT1(IRS)CX identified three classes of effector motifs within SNT critical for both sustained ERK activation and neuronal differentiation: 1) four phosphotyrosine motifs that mediate recruitment of Grb2, 2) two phosphotyrosine motifs that mediate recruitment of Shp2, and 3) a C-terminal motif that functions by helping to recruit Sos.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Apr 20 276(16) 13049-56",
                "id": "11278583"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b68"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "The results showed that transcriptional activation of the SRE by E2 was due to ERalpha activation of the MAPK pathway...The role of ERalpha  expression in mediating increased reporter gene activity was further investigated and shown to be related to enhanced ERK1/2 activation...in cells transfected with pSS and ERalpha  or HE11 (DNA binding domain deletion), E2 induced CAT activity; similar results were observed for CHO cells using pSRE (Fig. 3E), suggesting that this kinase-dependent response is not associated with nuclear ERalpha  action. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Apr 13 276(15) 11590-8",
                "id": "11145955"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b67"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "MyD88 also interacts directly with AKT, and a dominant-negative mutant of AKT causes a defect in MyD88-dependent NF-kB transcriptional activity. However, the binding of NF-kB to DNA is not affected by inhibiting AKT, indicating that AKT might be involved in the phosphorylation of the p65 transactivation domain. A dominant-negative mutant of MyD88 was shown to block the kinase activity of AKT generated in response to LPS and IL-1, and a dominant-negative mutant of p85 inhibited the NF-kB activity elicited by LPS and IL-1 but not that elicited by TNF85. These findings indicate that PI3K is a positive mediator of the signalling induced by LPS and IL-1 that leads to NF-kB activation. However, recent studies using mice that lack the p85 regulatory subunit showed an increased production of IL-12 by DCs, possibly because of enhanced activation of the p38 MAPK, indicating that PI3K might have a negative role in TLR signalling in DCs86.  ECSIT. ECSIT has no homology with any known protein and was cloned as a TRAF6-interacting protein by yeast two-hybrid screening87. ECSIT interacts with the conserved TRAF domain of TRAF6. A Drosophila homologue of ECSIT has been identified, and the interaction between TRAF6 and ECSIT is also conserved in Drosophila. ECSIT also interacts with MEKK1 (MAPK/ERK (extracellular signal-regulated kinase) kinase kinase 1), which can phosphorylate and activate the IKK complex. Expression of a dominant-negative mutant of ECSIT blocks signalling through TLR4, indicating that ECSIT might transduce TLR signals by bridging TRAF6 and the IKK complex. Furthermore, the inhibition of ECSIT expression, using siRNA in a macrophage cell line, resulted in impaired LPS-induced, but not TNF-induced, NF-kB activation88. The physiological function of ECSIT was studied by generating ECSIT-deficient mice, which were found to die on about embryonic day 7.5 (Ref. 88). Further characterization showed that ECSIT is an obligatory intermediate in bone morphogenetic protein (BMP) signalling, and therefore ECSIT is an essential component in both the TLR- and BMP-signalling pathways.  SRC family of tyrosine kinases. Bruton's tyrosine kinase (BTK) is a member of the SRC-related TEC-family of protein tyrosine kinases and has an essential role in B-cell development and B-cell receptor (BCR)-mediated signalling. Macrophages from X-linked-immunodeficient mice that lack BTK show reduced responses to LPS, and BTK has also been found to associate with the TIR domain of TLR4,TLR6, TLR8 and TLR9 (Ref. 89). It has also been shown to associate with MyD88, TIRAP and IRAK1, and to be tyrosine phosphorylated in response to LPS, whereas a dominant-negative form of BTK inhibits LPS-induced activation of NF-kB, indicating that BTK is involved in the TLR-mediated signalling pathway. During BCR-mediated signalling, BTK interacts with and is activated by the SRC family of tyrosine kinases, such as FYN, LYN and haematopoietic-cell kinase, HCK; however, SRC-family kinases have only a minor role in LPS signalling90. Therefore, the involvement of BTK in TLR signalling needs to be further investigated.  MAPKKK. Members of the MAPKKK family - such as TAK1, MEKK1, MEKK2, MEKK3, TPL2 (tumour-progression locus 2; also known as cancer Osaka thyroid, COT) and NIK - are implicated in IKK-NF-kB and MAPK activation. Among these members, MEKK3 has been shown to be involved in signalling through TLR4 but not through TLR9 (Ref. 91): in response to stimulation with a TLR4 ligand but not a TLR9 ligand, embryonic fibroblasts from MEKK3-deficient mice were shown to have impaired IL-6 production and defective activation of NF-kB, JNK and the p38 MAPK. Stimulation of TLR4 also induced association of MEKK3 with TRAF6. So, MEKK3 is involved in the TLR4-mediated signalling pathway. Another member of the MKKK family, TPL2 has been shown to be involved in the TLR4-mediated activation of ERK92. In response to TLR4 ligand, TPL2-deficient...",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Immunol 2004 Jul 4(7) 499-511",
                "id": "15229469"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b66"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Hyperoxia was associated with a significant increase in pJNKs and pERKs in WT mice as seen by Western blot. NOX1, but not NOX2, deficiency decreased ERK and JNK phosphorylation without modification of JNK and ERK protein levels (Figures 7A?7F).NOX1, but not NOX2, deficiency decreased ERK and JNK phosphorylation without modification of JNK and ERK protein levels (Figures 7A?7F). pERK staining was associated with type II pneumocytes and endothelial cell markers during hyperoxia (Figure 8A), whereas pJNK staining was detected mainly in endothelial cells (Figure 8B). ",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Crit Care Med 2009 Nov 15 180(10) 972-81",
                "id": "19661248"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b65"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Alveolar type II cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Moreover, IL-22 (100 ng/ml) induced a transient activation of ERK1/2 (Fig. 3A). During the observed time interval, total ERK1 and ERK2 levels remained unchanged (Fig. 3A). To identify upstream signaling events, we investigated the effect of the MEK-1 inhibitor PD98059 on the IL-22-mediated ERK regulation. PD98059 downregulated ERK1/2 phosphorylation after IL-22 stimulation significantly (Fig. 3B), suggesting MEK-1 as an upstream signal transducer of the IL-22-induced ERK activation. Cross talk between the PI3-kinase and the MEK-ERK pathway has been proposed (43). However, ERK activation after IL-22 stimulation was not significantly affected by pretreatment with wortmannin (Fig. 3C), suggesting a PI3-kinase-independent activation of ERK-MAP kinases by IL-22.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Gastrointest Liver Physiol 2006 Apr 290(4) G827-38",
                "id": "16537974"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b64"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Hyperoxia was associated with a significant increase in pJNKs and pERKs in WT mice as seen by Western blot. NOX1, but not NOX2, deficiency decreased ERK and JNK phosphorylation without modification of JNK and ERK protein levels (Figures 7A?7F).NOX1, but not NOX2, deficiency decreased ERK and JNK phosphorylation without modification of JNK and ERK protein levels (Figures 7A?7F). pERK staining was associated with type II pneumocytes and endothelial cell markers during hyperoxia (Figure 8A), whereas pJNK staining was detected mainly in endothelial cells (Figure 8B). ",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Crit Care Med 2009 Nov 15 180(10) 972-81",
                "id": "19661248"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b63"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "To see the phosphorylation of MAPK by ETS, the control and ETS-exposed brain tissues were extracted and 100 mg proteins were analyzed by 10% SDS-PAGE and phosphorylated form of MAPK was detected by Western blot using anti-phospho-MAPK antibody. The result shown in Fig. 4B indicates that phosphorylated MAPK was increased in all the regions of the brain exposed to ETS as compared to control brain tissue. The same extracts were probed with anti- ERK antibody and the level of ERK was unchanged in all the lanes indicating equal loading of proteins as well as specificity of the phosphorylation of the MAPK because ERK also undergoes phoshorylation but through different signaling pathway [31]. These results therefore strongly suggest that ETS induces MAPK phosphorylation and that the level of phosphorylation was similar across all the regions of the brain. We next examined the effect of ETS on p38MAP kinase in various regions of the brain. We found that ETS induced the phosphorylation of the p38MAP kinase in all the regions of the brain examined without altering the levels of the p38 MAP kinase protein expression (Fig. 4C).",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Pharmacol 2006 May 28 71(11) 1602-9",
                "id": "16569398"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b62"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Despite remarkable progress in dissecting the signaling pathways that are crucial for the metabolic effects of insulin, the molecular basis for the specificity of its cellular actions is not fully understood. One clue might lie in the spatial and temporal aspects of signaling. Recent evidence suggests that signaling molecules and pathways are localized to discrete compartments in cells by specific protein interactions. Also, the rapid termination of tyrosine or lipid phosphorylation by phosphatases or serine kinases might tightly control the strength of a signaling pathway, thus determining its effect on growth, differentiation and metabolism. Insulin is the most potent anabolic hormone known, promoting the synthesis and storage of carbohydrates, lipids and proteins and inhibiting their degradation and release back into the circulation. Decreased secretion of insulin, coupled with resistance to its actions, results in type 2 diabetes, a devastating disease that is reaching epidemic proportions [1]. Even in the absence of diabetes, insulin resistance is often associated with central obesity, hypertension, polycystic ovarian syndrome, dyslipidemia and atherosclerosis. At the cellular level, insulin action is characterized by diverse effects, including changes in vesicle trafficking, stimulation of protein kinases and phosphatases, promotion of cellular growth and differentiation and activation or repression of transcription. This complexity suggests that insulin action must involve multiple signaling pathways that diverge at or near the activation of its tyrosine kinase receptor. In fact, it is likely that even individual effects of the hormone require multiple signaling inputs. Evidence is emerging that the coordination of these pathways might be governed by their intracellular compartmentalization or duration of action. Here, we consider how temporal and spatial aspects of signal transduction play a crucial role in determining the specificity of insulin action, focusing on signal initiation from the receptor that is spatially segregated into discrete domains of the plasma membrane, as well as the mechanisms that determine the duration of individual signaling pathways. Together, these factors help to differentiate insulin from other hormones that share some of the same overall signaling properties. Divergent signaling pathways are initiated by insulin receptor substrates. The insulin receptor is a tyrosine kinase that catalyzes the phosphorylation of several intracellular substrates, including the insulin receptor substrate (IRS) proteins [2], GAB-1 [3], Shc [4], APS [5], p60DOK [6], SIRPS [7] and c-Cbl [8] (Fig. 1). Each of these substrates recruits a distinct subset of signaling proteins containing Src homology 2 (SH2) domains, which interact specifically with sequences surrounding the phosphotyrosine residue. Moreover, each of these substrates can be confined to distinct locations in the cell by specific sequences that direct interactions with other proteins or lipids. Most attention in the field of insulin receptor substrates has focused on the IRS family of proteins. Mice lacking the IRS-1 protein are insulin resistant but do not develop overt diabetes [9,10]. By contrast, animals lacking IRS-2 exhibit both impaired glucose tolerance and diabetes [11], which appears to result from a defect in insulin secretion as well as insulin resistance, presumably owing to decreased b-cell proliferation in the pancreas in the face of increased demand for insulin. Despite the similarity in structure and function, the apparent differences in phenotype between IRS1 and IRS2 knockout mice underscore a specific signaling specificity that probably results from their tissue distribution, subcellular location, activation&ndash;inactivation kinetics and combinatorial interactions with downstream effectors [12]. The tyrosine phosphorylation of IRS family members generates docking sites for sev...",
              "citation": {
                "type": "PubMed",
                "name": "Trends Cell Biol 2002 Feb 12(2) 65-71",
                "id": "11849969"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b61"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "High-level expression of MEK-DD alone was sufficient to induce clear cellular transformation of chicken embryo fibroblasts, which caused constitutive activation of endogenous MAPK, hyperphosphorylation of Fra-2, and elevation of fra-2 and c-jun gene expression. These results indicate that phosphorylation of Fra-2 by MAPK plays an important role in stimulating endogenous AP-1 activity in a positive autoregulation mechanism, in which phosphorylated Fra-2 induces fra-2 expression through AP-1 binding sites present in its promoter.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Growth Differ 1999 May 10(5) 333-42",
                "id": "10359014"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b60"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": " As might be expected from the wide array of hormones, cytokines, and growth factors that can affect adipogenesis, several different signal transduction pathways have been implicated in the process as well. There has been quite a bit of interest in the MAP kinase family of intracellular protein kinases. As just described, many growth factors that exert their influence through tyrosine kinase receptors inhibit fat cell differentiation. It is now clear that much of this inhibition occurs through activation of the \\\"classic\\\" MAP kinases, Erk 1 and 2. These kinases directly phosphorylate PPARg (see subsequent text), and inhibit its adipogenic activity.33",
              "citation": {
                "type": "PubMed",
                "name": "Ann N Y Acad Sci 2002 Dec 979 143-58; discussion 188-96",
                "id": "12543724"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b5f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Simultaneous overexpression of selenophosphate synthetase and phospholipid-hydroperoxide GSH peroxidase (PHGPx) [250] blocks activation of NF-kB by IL-1. Overexpression of SOD [84] or GSH peroxidase [81, 211] abolished NF-kB activation by preventing degradation of IkB after stimulation with TNF-a. The precise mechanism(s) through which oxidants and reductants influence activation of NF-kB is presently unknown; however, there is evidence that antioxidant enzyme (AOE372), a redox-sensitive thioredoxin peroxidase, regulates IkB phosphorylation [246]. Phosphatases The phosphatases are an important component of most signal transduction pathways, because failure to reverse kinase actions can disrupt normal cellular functions. For example, transfection of human fibroblasts with constitutively active ras (hRasV12) inhibits cell growth and ultimately results in a senescentlike phenotype [441]. Similarly, constitutive ERK activation has an inhibitory effect on cell cycle progression [442,443]. Both the serine/threonine phosphatases and the PTPs are known to be redox-sensitive [82,144,153,156,271,281, 444-449]. The mechanism of redox effects on activity is probably best understood for the PTPs. Without exception, the PTPs contain a highly conserved region of 11 amino acid residues in their catalytic domain; specifi- cally, (Ile/Val)-His-Cys-X-Ala-Gly-X-X-Arg-(Ser/Thr)- Gly, where X is a nonconserved amino acid [17]. Either oxidation or mutation of the cysteine renders these molecules inactive [17,281]. H2O2 is a potent inhibitor of PTPs. As in the case of other oxidants, H2O2 probably oxidizes the thiolate anion at the catalytic site [280]. Because formation of a phosphorylcysteine intermediate seems to be critical to PTP activity [450-452], blocking it through oxidation of the cysteine inactivates the molecules. In many cases, treatment of cells with H2O2 stimulates increases in protein phosphorylation by inhibiting phosphatase-catalyzed removal of phosphate groups. Furthermore, mitogens that increase cellular ox- idant production may stimulate phosphorylation indirectly by decreasing phosphatase activity. Additional mechanisms are involved in stimulation of pathways activated by growth factors that increase oxidant production, however, because there are known instances in which the oxidants they produce have no effect on protein phosphorylation. For example, TGF-b1 stimulates phosphorylation of numerous proteins and has been shown to cause a large increase in H2O2 production; however, its effects on protein phosphorylation are not blocked by catalase [453]. Furthermore, H2O2 is effective in promoting phosphorylation of phospholipase D, the PDGF receptor, and PKC-a even after pretreatment of Swiss 3T3 fibroblasts with orthovanadate to inhibit phosphatases [454]. Thus, although diminished phosphatase activity may partially account for increased phosphorylation in some cases, it cannot totally account for oxidation effects on phosphorylation in every case. SPECIFICITY In general, there is good agreement between studies on redox effects on any given gene; albeit, not all oxidizing or reducing treatments exert equivalent effects. This is clearly demonstrated in studies of pag , which encodes a protein associated with cellular proliferation. Pag protein inhibits the tyrosine kinase activity of the Abelson (abl ) protein by binding to its SH3-binding domain [455]. BSO, menadione, sodium arsenate, and diethyl maleate all stimulate pag expression, but H2O2 does not [269]. Conversely, H2O2 stimulates c-fos expression (Table 1), although 4-hydroynonenal (a product of v-6-polyunsaturated fatty acid peroxidation) not only fails to induce c-fos expression but is actually inhibitory to c-fos induction by EGF and PDGF [185]. Similarly, some oxidants such as diamide decrease hypoxia-induced signals [201], although others such as H2O2 increase them [124]. As might be expected, the effects of any stimu...",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2000 Feb 1 28(3) 463-99",
                "id": "10699758"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b5e"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": "mesothelium"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Simultaneous overexpression of selenophosphate synthetase and phospholipid-hydroperoxide GSH peroxidase (PHGPx) [250] blocks activation of NF-kB by IL-1. Overexpression of SOD [84] or GSH peroxidase [81, 211] abolished NF-kB activation by preventing degradation of IkB after stimulation with TNF-a. The precise mechanism(s) through which oxidants and reductants influence activation of NF-kB is presently unknown; however, there is evidence that antioxidant enzyme (AOE372), a redox-sensitive thioredoxin peroxidase, regulates IkB phosphorylation [246]. Phosphatases The phosphatases are an important component of most signal transduction pathways, because failure to reverse kinase actions can disrupt normal cellular functions. For example, transfection of human fibroblasts with constitutively active ras (hRasV12) inhibits cell growth and ultimately results in a senescentlike phenotype [441]. Similarly, constitutive ERK activation has an inhibitory effect on cell cycle progression [442,443]. Both the serine/threonine phosphatases and the PTPs are known to be redox-sensitive [82,144,153,156,271,281, 444-449]. The mechanism of redox effects on activity is probably best understood for the PTPs. Without exception, the PTPs contain a highly conserved region of 11 amino acid residues in their catalytic domain; specifi- cally, (Ile/Val)-His-Cys-X-Ala-Gly-X-X-Arg-(Ser/Thr)- Gly, where X is a nonconserved amino acid [17]. Either oxidation or mutation of the cysteine renders these molecules inactive [17,281]. H2O2 is a potent inhibitor of PTPs. As in the case of other oxidants, H2O2 probably oxidizes the thiolate anion at the catalytic site [280]. Because formation of a phosphorylcysteine intermediate seems to be critical to PTP activity [450-452], blocking it through oxidation of the cysteine inactivates the molecules. In many cases, treatment of cells with H2O2 stimulates increases in protein phosphorylation by inhibiting phosphatase-catalyzed removal of phosphate groups. Furthermore, mitogens that increase cellular ox- idant production may stimulate phosphorylation indirectly by decreasing phosphatase activity. Additional mechanisms are involved in stimulation of pathways activated by growth factors that increase oxidant production, however, because there are known instances in which the oxidants they produce have no effect on protein phosphorylation. For example, TGF-b1 stimulates phosphorylation of numerous proteins and has been shown to cause a large increase in H2O2 production; however, its effects on protein phosphorylation are not blocked by catalase [453]. Furthermore, H2O2 is effective in promoting phosphorylation of phospholipase D, the PDGF receptor, and PKC-a even after pretreatment of Swiss 3T3 fibroblasts with orthovanadate to inhibit phosphatases [454]. Thus, although diminished phosphatase activity may partially account for increased phosphorylation in some cases, it cannot totally account for oxidation effects on phosphorylation in every case. SPECIFICITY In general, there is good agreement between studies on redox effects on any given gene; albeit, not all oxidizing or reducing treatments exert equivalent effects. This is clearly demonstrated in studies of pag , which encodes a protein associated with cellular proliferation. Pag protein inhibits the tyrosine kinase activity of the Abelson (abl ) protein by binding to its SH3-binding domain [455]. BSO, menadione, sodium arsenate, and diethyl maleate all stimulate pag expression, but H2O2 does not [269]. Conversely, H2O2 stimulates c-fos expression (Table 1), although 4-hydroynonenal (a product of v-6-polyunsaturated fatty acid peroxidation) not only fails to induce c-fos expression but is actually inhibitory to c-fos induction by EGF and PDGF [185]. Similarly, some oxidants such as diamide decrease hypoxia-induced signals [201], although others such as H2O2 increase them [124]. As might be expected, the effects of any stimu...",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2000 Feb 1 28(3) 463-99",
                "id": "10699758"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b5d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Simultaneous overexpression of selenophosphate synthetase and phospholipid-hydroperoxide GSH peroxidase (PHGPx) [250] blocks activation of NF-kB by IL-1. Overexpression of SOD [84] or GSH peroxidase [81, 211] abolished NF-kB activation by preventing degradation of IkB after stimulation with TNF-a. The precise mechanism(s) through which oxidants and reductants influence activation of NF-kB is presently unknown; however, there is evidence that antioxidant enzyme (AOE372), a redox-sensitive thioredoxin peroxidase, regulates IkB phosphorylation [246]. Phosphatases The phosphatases are an important component of most signal transduction pathways, because failure to reverse kinase actions can disrupt normal cellular functions. For example, transfection of human fibroblasts with constitutively active ras (hRasV12) inhibits cell growth and ultimately results in a senescentlike phenotype [441]. Similarly, constitutive ERK activation has an inhibitory effect on cell cycle progression [442,443]. Both the serine/threonine phosphatases and the PTPs are known to be redox-sensitive [82,144,153,156,271,281, 444-449]. The mechanism of redox effects on activity is probably best understood for the PTPs. Without exception, the PTPs contain a highly conserved region of 11 amino acid residues in their catalytic domain; specifi- cally, (Ile/Val)-His-Cys-X-Ala-Gly-X-X-Arg-(Ser/Thr)- Gly, where X is a nonconserved amino acid [17]. Either oxidation or mutation of the cysteine renders these molecules inactive [17,281]. H2O2 is a potent inhibitor of PTPs. As in the case of other oxidants, H2O2 probably oxidizes the thiolate anion at the catalytic site [280]. Because formation of a phosphorylcysteine intermediate seems to be critical to PTP activity [450-452], blocking it through oxidation of the cysteine inactivates the molecules. In many cases, treatment of cells with H2O2 stimulates increases in protein phosphorylation by inhibiting phosphatase-catalyzed removal of phosphate groups. Furthermore, mitogens that increase cellular ox- idant production may stimulate phosphorylation indirectly by decreasing phosphatase activity. Additional mechanisms are involved in stimulation of pathways activated by growth factors that increase oxidant production, however, because there are known instances in which the oxidants they produce have no effect on protein phosphorylation. For example, TGF-b1 stimulates phosphorylation of numerous proteins and has been shown to cause a large increase in H2O2 production; however, its effects on protein phosphorylation are not blocked by catalase [453]. Furthermore, H2O2 is effective in promoting phosphorylation of phospholipase D, the PDGF receptor, and PKC-a even after pretreatment of Swiss 3T3 fibroblasts with orthovanadate to inhibit phosphatases [454]. Thus, although diminished phosphatase activity may partially account for increased phosphorylation in some cases, it cannot totally account for oxidation effects on phosphorylation in every case. SPECIFICITY In general, there is good agreement between studies on redox effects on any given gene; albeit, not all oxidizing or reducing treatments exert equivalent effects. This is clearly demonstrated in studies of pag , which encodes a protein associated with cellular proliferation. Pag protein inhibits the tyrosine kinase activity of the Abelson (abl ) protein by binding to its SH3-binding domain [455]. BSO, menadione, sodium arsenate, and diethyl maleate all stimulate pag expression, but H2O2 does not [269]. Conversely, H2O2 stimulates c-fos expression (Table 1), although 4-hydroynonenal (a product of v-6-polyunsaturated fatty acid peroxidation) not only fails to induce c-fos expression but is actually inhibitory to c-fos induction by EGF and PDGF [185]. Similarly, some oxidants such as diamide decrease hypoxia-induced signals [201], although others such as H2O2 increase them [124]. As might be expected, the effects of any stimu...",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2000 Feb 1 28(3) 463-99",
                "id": "10699758"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b5c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Simultaneous overexpression of selenophosphate synthetase and phospholipid-hydroperoxide GSH peroxidase (PHGPx) [250] blocks activation of NF-kB by IL-1. Overexpression of SOD [84] or GSH peroxidase [81, 211] abolished NF-kB activation by preventing degradation of IkB after stimulation with TNF-a. The precise mechanism(s) through which oxidants and reductants influence activation of NF-kB is presently unknown; however, there is evidence that antioxidant enzyme (AOE372), a redox-sensitive thioredoxin peroxidase, regulates IkB phosphorylation [246]. Phosphatases The phosphatases are an important component of most signal transduction pathways, because failure to reverse kinase actions can disrupt normal cellular functions. For example, transfection of human fibroblasts with constitutively active ras (hRasV12) inhibits cell growth and ultimately results in a senescentlike phenotype [441]. Similarly, constitutive ERK activation has an inhibitory effect on cell cycle progression [442,443]. Both the serine/threonine phosphatases and the PTPs are known to be redox-sensitive [82,144,153,156,271,281, 444-449]. The mechanism of redox effects on activity is probably best understood for the PTPs. Without exception, the PTPs contain a highly conserved region of 11 amino acid residues in their catalytic domain; specifi- cally, (Ile/Val)-His-Cys-X-Ala-Gly-X-X-Arg-(Ser/Thr)- Gly, where X is a nonconserved amino acid [17]. Either oxidation or mutation of the cysteine renders these molecules inactive [17,281]. H2O2 is a potent inhibitor of PTPs. As in the case of other oxidants, H2O2 probably oxidizes the thiolate anion at the catalytic site [280]. Because formation of a phosphorylcysteine intermediate seems to be critical to PTP activity [450-452], blocking it through oxidation of the cysteine inactivates the molecules. In many cases, treatment of cells with H2O2 stimulates increases in protein phosphorylation by inhibiting phosphatase-catalyzed removal of phosphate groups. Furthermore, mitogens that increase cellular ox- idant production may stimulate phosphorylation indirectly by decreasing phosphatase activity. Additional mechanisms are involved in stimulation of pathways activated by growth factors that increase oxidant production, however, because there are known instances in which the oxidants they produce have no effect on protein phosphorylation. For example, TGF-b1 stimulates phosphorylation of numerous proteins and has been shown to cause a large increase in H2O2 production; however, its effects on protein phosphorylation are not blocked by catalase [453]. Furthermore, H2O2 is effective in promoting phosphorylation of phospholipase D, the PDGF receptor, and PKC-a even after pretreatment of Swiss 3T3 fibroblasts with orthovanadate to inhibit phosphatases [454]. Thus, although diminished phosphatase activity may partially account for increased phosphorylation in some cases, it cannot totally account for oxidation effects on phosphorylation in every case. SPECIFICITY In general, there is good agreement between studies on redox effects on any given gene; albeit, not all oxidizing or reducing treatments exert equivalent effects. This is clearly demonstrated in studies of pag , which encodes a protein associated with cellular proliferation. Pag protein inhibits the tyrosine kinase activity of the Abelson (abl ) protein by binding to its SH3-binding domain [455]. BSO, menadione, sodium arsenate, and diethyl maleate all stimulate pag expression, but H2O2 does not [269]. Conversely, H2O2 stimulates c-fos expression (Table 1), although 4-hydroynonenal (a product of v-6-polyunsaturated fatty acid peroxidation) not only fails to induce c-fos expression but is actually inhibitory to c-fos induction by EGF and PDGF [185]. Similarly, some oxidants such as diamide decrease hypoxia-induced signals [201], although others such as H2O2 increase them [124]. As might be expected, the effects of any stimu...",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2000 Feb 1 28(3) 463-99",
                "id": "10699758"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b5b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "TLR4 and Syk were required for mmLDL activation of guanine nucleotide exchanging factor Vav1, small GTPase Ras, kinases Raf, MEK1 and ERK1/2; in turn, ERK1/2 phosphorylated paxillin at Ser126 and activated small GTPases Cdc42, Rac and Rho (Figure 3 and Online Figure III). These signaling events lead to actin polymerization, a necessary step in membrane ruffling. Our results agree with the reports of Syk-dependent ERK1/2 activation in phagocytosis45, ERK1/2 activation in TLR4-dependent antigen uptake by dendritic cells46, and the role of paxillin and small GTPases in actin reorganization and pinocytic vesicle formation9,26,27,47. ",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 2009 Jun 19 104(12) 1355-63",
                "id": "19461045"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b5a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "TOPK was shown to promote transformation in vitro and in vivo, and knockdown of TOPK in HCT116 colorectal cancer cells reduced this cell lines' tumorigenic properties in vitro and in vivo. Furthermore, a positive feedback loop between TOPK and ERK2 was identified. With epidermal growth factor treatment, knockdown of either TOPK or ERK2 in HCT116 cells resulted in a decreased phosphorylation of ERK2 or TOPK, respectively, and knockdown of TOPK in HCT116 colorectal cancer cells blocked the phosphorylation of downstream substrates of ERK2. CONCLUSIONS: The positive feedback loop between TOPK and ERK2 increases tumorigenesis properties of HCT116 colorectal cancer cells, and TOPK-regulated signaling may serve as a potential therapeutic target in colorectal cancer.",
              "citation": {
                "type": "PubMed",
                "name": "Gastroenterology 2007 Jul 133(1) 219-31",
                "id": "17631144"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b59"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "We further demonstrated that DDR1 activated the MAPK cascade in a Ras-dependent manner. When DDR1 and either a DN mutant form of Ras (N17Ras) or Raf1 (DN-Raf-Flag), a direct downstream effector of Ras, were transiently transfected into 293T cells stimulated with collagen IV, activation levels of ERK were substantially decreased (Figure 4B). These findings demonstrated that DDR1 activates MAPK through Ras and Raf, as has been demonstrated for p53-induced MAPK activation (Lee et al., 2000).",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2003 Mar 17 22(6) 1289-301",
                "id": "12628922"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b58"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Subsequently, to understand the mechanism of nanoparticles-induced oxidative stress, the involvement of oxidative stress-responding transcription factors, such as, nuclear factor-kappaB (NF-kappaB) and nuclear factor-E2-related factor-2 (Nrf-2), as well as the mitogen-activated protein (MAP) kinase signal transduction pathway were investigated. From the overall results, silica nanoparticles exerted toxicity via oxidative stress, which lead to the induction of HO-1 via the Nrf-2-ERK MAP kinase signaling pathway",
              "citation": {
                "type": "PubMed",
                "name": "Toxicol In Vitro 2009 Oct 23(7) 1326-32",
                "id": "19602432"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b57"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Furthermore, in mast cells lacking group V secretory PLA(2), the time course of phosphorylation of ERK1/2 and of cPLA(2)alpha was markedly truncated, leading to attenuation of eicosanoid generation in response to stimulation through TLR2, but not through c-kit or FcepsilonRI. These findings provide the first dissection of the mechanisms of TLR-dependent rapid eicosanoid generation, which is MyD88-dependent, requires cPLA(2)alpha, and is amplified by group V sPLA(2) through its regulation of the sequential phosphorylation and activation of ERK1/2 and cPLA(2)alpha.",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2007 Jul 15 110(2) 561-7",
                "id": "17369491"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b56"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "mast cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "The ability of CXCL12 to stimulate proliferation and survival is mediated by activation of the Erk 1/2 and phosphatidylinositol 3-kinase pathways in many cell types Taken together these data indicate that the ability of AMD 3100 to decrease tumor growth in animal models reflects direct inactivation of CXCR4 in tumor cells and consequent inhibition of Erk 1/2 and phosphatidylinositol 3-kinase pathways, resulting in increased tumor cell apoptosis and decreased proliferation.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2003 Nov 11 100(23) 13513-8",
                "id": "14595012"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b55"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Cholinergic differentiation factors (CDFs) suppress noradrenergic properties and induce cholinergic properties in sympathetic neurons. The CDFs leukemia inhibitory factor (LIF) and ciliary neurotrophic factor (CNTF) bind to a LIFR.gp130 receptor complex to activate Jak/signal transducers and activators of transcription and Ras/mitogen-activated protein kinases signaling pathways. Little is known about how these differentiation factors suppress noradrenergic properties. We used sympathetic neurons and SK-N-BE(2)M17 neuroblastoma cells to investigate CDF down-regulation of the norepinephrine synthetic enzyme dopamine-beta-hydroxylase (DBH). LIF and CNTF activated extracellular signal-regulated kinases (ERKs) 1 and 2 but not p38 or Jun N-terminal kinases in both cell types. Preventing ERK activation with PD98059 blocked CNTF suppression of DBH protein in sympathetic neurons but did not prevent the loss of DBH mRNA. CNTF decreased transcription of a DBH promoter-luciferase reporter construct in SK-N-BE(2)M17 cells, and this was also ERK-independent. Cytokine inhibition of DBH promoter activity did not require a silencer element but was prevented by overexpression of the transcriptional activator Phox2a. Inhibiting ERK activation increased basal DBH transcription in SK-N-BE(2)M17 cells, and DBH mRNA in sympathetic neurons. Transfection of Phox2a into PD98059-treated M17 cells resulted in a synergistic increase in DBH promoter activity compared with Phox2a or PD98059 alone. These data suggest that CDFs down-regulate DBH protein via an ERK-dependent pathway but inhibit DBH gene expression through an ERK-independent pathway. They further suggest that ERK activity inhibits basal DBH gene expression.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 May 2 278(18) 15897-904",
                "id": "12609984"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b54"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "LPS-induced IL-8 production also depends on CS-induced phosphorylation and activation of ERK-1, ERK-2 and P38MAPK. CS has been found to have a profound modulatory effect on ERK-1 and ERK-2. Both basal and LPS induced phosphorylation of ERK-2 was higher in AM from healthy smokers than those from non-smokers. CS has been shown to enhance mitogenactivated protein-kinase activation more than NF-kB activation to increase LPS-induced IL-8 production in AM [76].",
              "citation": {
                "type": "PubMed",
                "name": "Exp Lung Res 2009 Aug 35(6) 439-85",
                "id": "19842832"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b53"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Experiments with exogenous [(3)H]S1P showed a multi-exponential influx kinetic of intracellular uptake of [(3)H]S1P up to a steady state level over 2h. This process could be inhibited or enhanced by various synthetic modulators targeting both, S1P(1) receptor-dependent (Akt, ERK1/2) as well as independent DMS-sensitive pathways. The S1P(1) receptor signalling was shown to drive the sphingosine kinase - the rate limiting enzyme for the formation of S1P - to a higher or lower activity. Furthermore, S1P as an intracellular messenger induced the phosphorylation and nuclear translocation of the p65 subunit of NF-kappaB and in turn the expression of E-selectin and monocyte adhesion.",
              "citation": {
                "type": "PubMed",
                "name": "Eur J Cell Biol 2010 Oct 89(10) 733-41",
                "id": "20656374"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b52"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": "vascular tissue"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "IGFs induced the expression of VEGF ligands and up-regulated in vitro vascular vessel formation. IGF-IR/dn reduced VEGF expression, reduced the activation of both protein kinase B (Akt) and mitogen-activated protein kinase (MAPK), and reduced vascular formation, indicating that IGF-IR/dn inhibited tumor growth in mice by inhibiting both angiogenesis and lymphangiogenesis. However, IGF-IR/dn did not affect either blood sugar or body weight in these mice. The combination of IGF-IR/dn and bevacizumab was highly effective against these xenograft tumors, and only this combination resulted in the complete regression of 43% of tumors, reduced the expression of VEGF, and induced apoptosis.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer 2011 Jul 15 117(14) 3135-47",
                "id": "21264842"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b51"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Carcinoma of gastrointestinal tract",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "With ERK2/pTpY as a substrate, initial rate analysis indicated that theK  m for the PP2A-catalyzed reaction was greater than 20 ?m. Thus, we were only able to obtain ak  cat/K  m value of 5.55  104  m  ?1s?1 for the PP2A-catalyzed dephosphorylation of pThr in ERK2/pTpY (Table III). Interestingly, when the monophosphorylated ERK2/pT was used as a substrate, the k  cat/K  m value for the PP2A-catalyzed reaction was 1.21  106  m  ?1s?1, which is 22-fold higher than that for ERK2/pTpY (Fig. 4  and TableIII). PP2A was purified form human red blood cells by a modification of the method of Usui et al.(22) with a final step of Mono Q chromatography to obtain the purified AC dimer. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Aug 30 277(35) 31818-25",
                "id": "12082107"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b50"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "The extracellular signal-regulated kinases 1 and 2 (ERK1/2), also known as p44(MAPK) and p42(MAPK), respectively, are two of the kinases associated with HDAC4. ERK1/2 are components of the Ras-mitogen-activated protein kinase (MAPK) signal transduction pathway. Activation of the Ras-MAPK pathway by expression of oncogenic Ras or constitutively active MAPK/ERK kinase 1 results in an increased percentage of cells (from approximately 10% to approximately 70%) that express HDAC4 in the nucleus in C2C12 myoblast cells.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2000 Dec 19 97(26) 14329-33",
                "id": "11114188"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b4f"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Simultaneous overexpression of selenophosphate synthetase and phospholipid-hydroperoxide GSH peroxidase (PHGPx) [250] blocks activation of NF-kB by IL-1. Overexpression of SOD [84] or GSH peroxidase [81, 211] abolished NF-kB activation by preventing degradation of IkB after stimulation with TNF-a. The precise mechanism(s) through which oxidants and reductants influence activation of NF-kB is presently unknown; however, there is evidence that antioxidant enzyme (AOE372), a redox-sensitive thioredoxin peroxidase, regulates IkB phosphorylation [246]. Phosphatases The phosphatases are an important component of most signal transduction pathways, because failure to reverse kinase actions can disrupt normal cellular functions. For example, transfection of human fibroblasts with constitutively active ras (hRasV12) inhibits cell growth and ultimately results in a senescentlike phenotype [441]. Similarly, constitutive ERK activation has an inhibitory effect on cell cycle progression [442,443]. Both the serine/threonine phosphatases and the PTPs are known to be redox-sensitive [82,144,153,156,271,281, 444-449]. The mechanism of redox effects on activity is probably best understood for the PTPs. Without exception, the PTPs contain a highly conserved region of 11 amino acid residues in their catalytic domain; specifi- cally, (Ile/Val)-His-Cys-X-Ala-Gly-X-X-Arg-(Ser/Thr)- Gly, where X is a nonconserved amino acid [17]. Either oxidation or mutation of the cysteine renders these molecules inactive [17,281]. H2O2 is a potent inhibitor of PTPs. As in the case of other oxidants, H2O2 probably oxidizes the thiolate anion at the catalytic site [280]. Because formation of a phosphorylcysteine intermediate seems to be critical to PTP activity [450-452], blocking it through oxidation of the cysteine inactivates the molecules. In many cases, treatment of cells with H2O2 stimulates increases in protein phosphorylation by inhibiting phosphatase-catalyzed removal of phosphate groups. Furthermore, mitogens that increase cellular ox- idant production may stimulate phosphorylation indirectly by decreasing phosphatase activity. Additional mechanisms are involved in stimulation of pathways activated by growth factors that increase oxidant production, however, because there are known instances in which the oxidants they produce have no effect on protein phosphorylation. For example, TGF-b1 stimulates phosphorylation of numerous proteins and has been shown to cause a large increase in H2O2 production; however, its effects on protein phosphorylation are not blocked by catalase [453]. Furthermore, H2O2 is effective in promoting phosphorylation of phospholipase D, the PDGF receptor, and PKC-a even after pretreatment of Swiss 3T3 fibroblasts with orthovanadate to inhibit phosphatases [454]. Thus, although diminished phosphatase activity may partially account for increased phosphorylation in some cases, it cannot totally account for oxidation effects on phosphorylation in every case. SPECIFICITY In general, there is good agreement between studies on redox effects on any given gene; albeit, not all oxidizing or reducing treatments exert equivalent effects. This is clearly demonstrated in studies of pag , which encodes a protein associated with cellular proliferation. Pag protein inhibits the tyrosine kinase activity of the Abelson (abl ) protein by binding to its SH3-binding domain [455]. BSO, menadione, sodium arsenate, and diethyl maleate all stimulate pag expression, but H2O2 does not [269]. Conversely, H2O2 stimulates c-fos expression (Table 1), although 4-hydroynonenal (a product of v-6-polyunsaturated fatty acid peroxidation) not only fails to induce c-fos expression but is actually inhibitory to c-fos induction by EGF and PDGF [185]. Similarly, some oxidants such as diamide decrease hypoxia-induced signals [201], although others such as H2O2 increase them [124]. As might be expected, the effects of any stimu...",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2000 Feb 1 28(3) 463-99",
                "id": "10699758"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b4e"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Both ERK2 and JNK1 were isolated by immunoprecipitation from activated and nonactivated mast cells from LAT+/+, LAT+/?, and LAT?/? cell lines. In vitro kinase assays were performed using myelin basic protein and a c-Jun-GST chimeric protein as exogenous substrates for the ERK2 (Figure 5B) and JNK1 assays (Figure 5C), respectively. Enzyme activation was prominent in the wild-type cells, intermediate in the heterozygous, and barely detectable in the LAT?/? cells.",
              "citation": {
                "type": "PubMed",
                "name": "Immunity 2000 May 12(5) 525-35",
                "id": "10843385"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b4d"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "mast cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "To elucidate the role of MAPKs in keratinocyte differentiation, activation of ERK, JNK, and p38 in response to stimulation with extracellular calcium was analyzed. We provide evidence that calcium-induced differentiation of keratinocytes is associated with rapid and transient activation of the Raf/MEK/ERK pathway. Stimulation of keratinocytes with extracellular calcium resulted in activation of Raf isozymes and their downstream effector ERK within 10-15 min, but did not increase JNK or p38 activity",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Dec 29 275(52) 41011-7",
                "id": "11018025"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b4c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "active forms of ERK- 1 (p44mapk) and ERK-2 (p42mapk) were detected by Western blotting using an antibody that recognizes the dually phosphorylated forms of these enzymes. As illustrated by Figure 5A, addition of CCK-8 to quiescent cultures of Swiss 3T3 CCKBRGFP cells induced a striking ERK activation, comparable to that promoted by bombesin or EGF in parallel cultures of these cells. ERK activation in response to CCKB/gastrin receptor activation was virtually abolished by treatment with the selective MEK inhibitor PD 98059.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Physiol 2001 Dec 189(3) 291-305",
                "id": "11748587"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b4b"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Treating TMK-1 cells with IL-1beta increased VEGF mRNA levels and activated extracellular signal-regulated kinases 1 and 2 (Erk 1/2) and p38, but not Akt. Inhibitors of the Erk and p38 pathways blocked IL-1beta induction of VEGF mRNA. Treating TMK-1 cells with IL-1beta also increased VEGF promoter activity. VEGF transcriptional activity was found to depend on a 120-bp region just proximal to the transcription start site.",
              "citation": {
                "type": "PubMed",
                "name": "Surgery 2004 Sep 136(3) 686-92",
                "id": "15349119"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b4a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Carcinoma of gastrointestinal tract",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "CL100, the product of an immediate early gene, is synthesized within one hour of stimulating cells with growth factors or exposure to oxidative stress or heat shock. Incubation of NIH 3T3 fibroblasts with cycloheximide prevents both synthesis of CL100 and inactivation of p42mapk after stimulation with serum. Depleting cells of CL100 and preventing its induction using cycloheximide stopped the inactivation of p42mapk in Swiss 3T3 fibroblasts following stimulation with epidermal growth factor (EGF) rapid inactivation of p42mapk in response to EGF in adipose (3T3-L1) or chromaffin (PC12) cells or in response to platelet-derived growth factor (PDGF) in endothelial (PAE) cells",
              "citation": {
                "type": "PubMed",
                "name": "Curr Biol 1995 Mar 1 5(3) 283-95",
                "id": "7780739"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b49"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Studies with the recently described specific MEK inhibitor, PD184352, at concentrations that inhibited ERK1 and ERK2 but not ERK5 activity demonstrate that the ERK1 and ERK2 modules were involved in regulating fMLP-stimulated chemotaxis and chemokinesis. Our data suggest that the MEK5-ERK5 module is likely to regulate neutrophil responses at very low chemoattractant concentrations whereas at higher concentrations, a shift to the ERK1/ERK2 and p38 modules is apparent.  ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Nov 26 279(48) 49825-34",
                "id": "15381709"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b48"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "NF-IL6, a member of the basic leucine zipper (bZIP) family transcription factors, is involved in expression of inducible genes involved in immune and inflammatory responses. We observed that coexpression of oncogenic p21ras stimulated the transactivating activity of NF-IL6 and induced phosphorylation of Thr-235 located just N-terminal to the DNA binding domain of NF-IL6. Recently, mitogen-activated protein (MAP) kinases have been shown to be implicated in the cellular response to activated ras. Purified MAP kinases specifically phosphorylated Thr-235 of NF-IL6 in vitro. Mutation of Thr-235 abolished the ras-dependent activation of NF-IL6. From these results, we conclude that NF-IL6 is regulated through phosphorylation by MAP kinases in response to activated ras.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 1993 Mar 15 90(6) 2207-11",
                "id": "8384717"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b47"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Activation of PKC-a mediated the sustained decrease in mitochondrial membrane hyperpolarisation and oxidative phosphorylation but not the decrease in electron transfer rate. Sustained mitochondrial dysfunction was also affected by ERK1/2, through a PKC-independent pathway. These findings suggest that activation of PKC-a and/or ERK1/2 lead to decreased activity of ATP synthase, rather than affecting OXPHOS system complexes [40]. Indeed, the a, b, and e subunits of F(1)F(0)- ATPase have PKC consensus motifs [41]. PKC-a phosphorylated the b subunit of F(1)F(0)-ATPase on a serine residue and decreased F(0)F(1)-ATPase activity, oxidative phosphorylation and ATP production [41].",
              "citation": {
                "type": "PubMed",
                "name": "Cell Mol Life Sci 2006 Jun 63(11) 1236-48",
                "id": "16568236"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b46"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "As determined by decreased electrophoretic mobility due to phosphorylation, ERK1/2 were activated following stimulation with ET-1, LPA and thrombin, as with control RTK ligands EGF and PDGF (Fig. 4a, b). In HERCD533 transfectants, however, ERK activation by ET-1 and thrombin was blocked and the LPA response was attenuated whereas activation by PDGF or EGF remained unaltered (Fig. 4a). Unpon preincubation with AG1478, GPCR-ligand-triggered ERK activation was blocked at even lower concentrations than those necessary to block the EGF response (Fig. 4b).",
              "citation": {
                "type": "PubMed",
                "name": "Nature 1996 Feb 8 379(6565) 557-60",
                "id": "8596637"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b45"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": " In this study we show that the extracellular signal-regulated kinases 1 and 2 (ERK1/2) interact directly with CIITA, targeting serine residues in the amino terminus of the protein, including serine 288. Inhibition of this phosphorylation by dominant-negative forms of ERK or by treatment of cells with the ERK inhibitor PD98059 resulted in the increase in CIITA-mediated gene expression from a class II promoter, enhanced the nuclear concentration of CIITA, and impaired its ability to bind to the nuclear export factor, CRM1",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2008 Apr 4 283(14) 9031-9",
                "id": "18245089"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b44"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "When serum-deprived MRC-5 lung fibroblasts were incubated in the presence of HABP the phosphorylation of intracellular proteins, many of which act as kinases in signalling pathways was observed (Fig. 1). This included the time-dependent phosphorylation of the MAP kinase ERK1/2 (extracellular signal-related kinase), the MAPK kinase MEK1/2 and c-Raf, a kinase that phosphorylates and thus activates MEK1/2. A transient activation of the p90RSK was detectable as well (Fig. 1A).",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2005 Dec 17(12) 1486-94",
                "id": "16153533"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b43"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "The extracellular signal-regulated kinase (ERK) cascade is a central pathway that transmits signals from many extracellular agents to regulate cellular processes such as proliferation, differentiation and cell cycle progression. The signaling via the ERK cascade is mediated by sequential phosphorylation and activation of protein kinases in the different tiers of the cascade. Although the main core phosphorylation chain of the cascade includes Raf kinases, MEK1/2, ERK1/2 (ERKs) and RSKs, other alternatively spliced forms and distinct components exist in the different tiers, and participate in ERK signaling under specific conditions. These components enhance the complexity of the ERK cascade and thereby, enable the wide variety of functions that are regulated by it. Another factor that is important for the dissemination of ERKs' signals is the multiplicity of the cascade's substrates, which include transcription factors, protein kinases and phosphatases, cytoskeletal elements, regulators of apoptosis, and a variety of other signaling-related molecules. About 160 substrates have already been discovered for ERKs, and the list of these substrates, as well as the function and mechanism of activation of representative substrates, are described in the current review. Many of these substrates are localized in the nucleus, and seem to participate in the regulation of transcription upon stimulation. However, other substrates are found in the cytosol as well as in other cellular organelles, and those are responsible for processes such as translation, mitosis and apoptosis. Understanding of these processes may provide a full picture of the distinct, and even opposing cellular processes that are regulated by the ERK cascade.",
              "citation": {
                "type": "PubMed",
                "name": "Growth Factors 2006 Mar 24(1) 21-44",
                "id": "16393692"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b42"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "After binding of leptin to its receptor, the ObRb associated JAK2 becomes activated by auto or cross phosphorylation and it phosphorylates tyrosine residues in the cytoplasmic domain of the receptor, followed by phosphorylation and activation of the signal transducer and activator of transcription (STAT3).....Other adaptor proteins are recruited to activate phosphatidylinositol-3-phosphate kinase (PI3K) and extracellular signal-regulated kinase 1 ? 2 (ERK1 ? 2).......PI3K enhances the activity of phosphodiesterase 3B (PDE3B) which increases AMP formation from cAMP and thereby induces adenosine monophosphate kinase (AMPK).",
              "citation": {
                "type": "PubMed",
                "name": "Exp Dermatol 2010 Jan 19(1) 12-8",
                "id": "19601981"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b41"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "ecause smoke exposure in vivo affects a variety of cell types in the lung, and because cell culture studies cannot mimic the complexity of animal physiology, we performed in vivo studies to examine the signaling pathways activated in murine lung after exposure to cigarette smoke. Western blotting of normal mouse lung homogenates showed increased p-ERK at 10 days of smoke exposure compared with lungs from control (unexposed) mice (Fig. 4A). Immunohistochemistry of lung tissue sections revealed nominal p-ERK staining in airway lining cells and red blood cells in control mice, with no staining in alveolar cells (Figs. 4, B and C). Robust expression of p-ERK is observed in airway lining cells, as well as in macrophages in the alveolar spaces at 10 days of smoke exposure (Figs. 4, D and E).Strong airway and alveolar p-ERK staining was still present at 6 months of exposure (Fig. 4, F and G).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Apr 23 279(17) 17690-6",
                "id": "14764579"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b40"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "The growth-stimulating effects of thrombin are mediated primarily via activation of a G protein-coupled receptor, PAR-1. Because PAR-1 has no intrinsic tyrosine kinase activity, yet requires tyrosine phosphorylation events to induce mitogenesis, we investigated the role of the Janus tyrosine kinases (JAKs) in thrombin-mediated signaling. JAK2 was activated rapidly in rat vascular smooth muscle cells (VSMC) treated with thrombin, and signal transducers and activators of transcription (STAT1 and STAT3) were phosphorylated and translocated to the nucleus in a JAK2-dependent manner. AG-490, a JAK2-specific inhibitor, and a dominant negative JAK2 mutant inhibited thrombin-induced ERK2 activity and VSMC proliferation suggesting that JAK2 is upstream of the Ras/Raf/MEK/ERK pathway. To elucidate the functional significance of JAK-STAT activation, we studied the effect of thrombin on heat shock protein (Hsp) expression, based upon the following: 1) reports that thrombin stimulates reactive oxygen species production in VSMC; 2) the putative role of Hsps in modulating cellular responses to reactive oxygen species; and 3) the presence of functional STAT1/3-binding sites in Hsp70 and Hsp90beta promoters. Indeed, thrombin up-regulated Hsp70 and Hsp90 protein expression via enhanced binding of STATs to cognate binding sites in the Hsp70 and Hsp90 promoters. Together, these results suggest that JAK-STAT pathway activation is necessary for thrombin-induced VSMC growth and Hsp gene expression.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Jun 1 276(22) 18915-24",
                "id": "11278437"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b3f"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Platelet-derived growth factor (PDGF) has multiple functions including inhibition of apoptosis and promotion of cell proliferation. In this study, we show that Na(+)/H(+) exchanger regulatory factor 2 (NHERF2) binds to the carboxyl-terminal PDZ domain-binding motif of the PDGF receptor through a PDZ domain-mediated interaction, and evaluate the consequence on PDGF-induced proliferation. Stable transfection with NHERF2 increased the PDGF-induced phosphorylation of ERK and Akt in Rat1 embryonic fibroblasts.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2004 Jul 16(7) 791-800",
                "id": "15115658"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b3e"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": "embryonic tissue"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": " As might be expected from the wide array of hormones, cytokines, and growth factors that can affect adipogenesis, several different signal transduction pathways have been implicated in the process as well. There has been quite a bit of interest in the MAP kinase family of intracellular protein kinases. As just described, many growth factors that exert their influence through tyrosine kinase receptors inhibit fat cell differentiation. It is now clear that much of this inhibition occurs through activation of the \\\"classic\\\" MAP kinases, Erk 1 and 2. These kinases directly phosphorylate PPARg (see subsequent text), and inhibit its adipogenic activity.33",
              "citation": {
                "type": "PubMed",
                "name": "Ann N Y Acad Sci 2002 Dec 979 143-58; discussion 188-96",
                "id": "12543724"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b3d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Adipocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "PD98059, an inhibitor of MEK 1 and 2 is able to block ERK1 and ERK2 activation under normal tissue culture conditions (68, 69). PD98059 must be dissolved in dimethyl sulfoxide (DMSO) and crystallizes when added to tissue culture medium at concentrations higher than 100 mM. When studies are done with this compound, an equal amount of DMSO must be added to a control culture dish to exclude a toxic effect from the solvent. PD98059 at 2050 mM can completely inhibit TPO-induced ERK phosphorylation in murine megakaryocytes.",
              "citation": {
                "type": "PubMed",
                "name": "Methods 1999 Mar 17(3) 238-49",
                "id": "10080909"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b3c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "megakaryocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "We thus investigated the effect of OA, an inhibitor of serine/threonine phosphatases PP1 and PP2A, on ERK2 phosphorylation. In conditions of platelet aggregation, a dose-dependent increase in ERK2 activity was observed in the presence of various concentrations of OA (0?200 nM), with activity reaching 534%144% (P<0.05) at a concentration of 200 nM (Fig. 2A,E). Moreover, using an anti-T183P antibody, we showed that OA increased ERK2 phosphorylation by 400133% (P<0.05) at OA concentrations of 200 nM (Fig. 2B,E). In contrast, in the presence of RGDS peptide, in conditions in which ?llb?3 was not engaged, no statistically significant variation in ERK2 activity or in levels of the phosphothreonine form of ERK2 (even at 200 nM OA) was observed ( Fig. 2A,B,F). Surprisingly, increasing the concentration of OA decreased the level of phosphorylation of the Y185 residue of ERK2 (halved at 200 nM OA) in the presence or absence of RGDS peptide (Fig. 2C,E,F). ",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 2002 Jun 19 521(1-3) 145-51",
                "id": "12096712"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b3b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Blood Platelets",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Stromal vascular cultures containing newly differentiated human adipocytes were pretreated with a vehicle (dimethyl sulfoxide) for 1 hour, then with 1 microM BRL49653 (PPARgamma agonist) for 24hours and subsequently treated with 30microM trans-10, cis-12 conjugated linoleic acid for an additional 24hours. CLA treatment conferred the ability of ERK1/2 to phosphorylate its nuclear substrate ELK1 in vitro. Pretreatment with BRL49653 blocked the CLA mediated ability of ERK1/2 to phosphorylate ELK-1",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jun 18 279(25) 26735-47",
                "id": "15067015"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b3a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "from full text - In BE cells transfected with b-arrestin1 siRNA no pERK signals were detected (Fig. 1, C and D). These data provide further evidence that b-arrestin1 is necessary for IGF-1-induced ERK activation. We also investigated whether b-arrestin2 played a similar role. However, no significant reduction in IGF-1-stimulated pERK was observed in BE cells transfected with b-arrestin2 siRNA (Fig. 1, C and D). In contrast, down-regulation of b-arrestin2 levels led to an increase in both basal and IGF-1-stimulated ERK activity that was sustained up to 60 min (Fig. 1, C and D).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 Apr 13 282(15) 11329-38",
                "id": "17303558"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b39"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "melanoma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Cyclindependent kinases (CDKs), mainly CDK1 associated with cyclin B, have been identified as the kinase system that phosphorylates Ser-25 and Ser-38, but the protein kinase involved in phosphorylation of Ser-16 and Ser-63 during mitosis remains to be identified (5, 21). Besides cell cycle-regulated phosphorylation, Op18 is phosphorylated by members of the mitogen-activated protein kinase family on Ser-25 (22-24), by the Ca21/calmodulin-dependent kinase IV/Gr (CaMK IV/Gr) on Ser-16 (25), and by the cyclic AMP-dependent protein kinase (PKA) on Ser-16 and Ser-63 (4).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1997 Sep 17(9) 5530-9",
                "id": "9271428"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b38"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Studies to date suggest that, in these cancers, several (if not all) of the critical downstream signaling pathways, including the phosphoinositide 3-kinase (PI3K)/Akt, signal transducers and activators of transcription, and extracellular signal-regulated kinase 1 and 2 pathways, are solely controlled by EGFR. Thus, when the tumors are exposed to EGFR inhibitors, these intracellular pathways are turned off and the cancer cells undergo apoptosis (21, 22, 24, 25).",
              "citation": {
                "type": "PubMed",
                "name": "Clin Cancer Res 2008 May 15 14(10) 2895-9",
                "id": "18483355"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b37"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Carcinoma, Non-Small-Cell Lung",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "From full text...Phosphorylation of the T286 cyclin D1 residue allows it to be recognized by the nuclear exporter CRM1, which transports it to the cytoplasm where it is rapidly degraded. Glycogen synthase kinase-3 (GSK-3) phosphorylates T286 of cyclin D1, and activation of GSK-3 has been shown to result in cyclin D1 nuclear export and degradation [Diehl et al., [1998]]. Other kinases also phosphorylate cyclin D1 at the T286 position, including p38SAPK2 and ERK2, as reviewed [Alao, [2007]]. Varying forms of cellular stress can trigger cyclin D1 degradation, including ionizing radiation and a variety of genotoxic, osmotic, viral, and oxidative stimuli, as reviewed",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biochem 2007 Sep 14",
                "id": "17868090"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b36"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "we identified differentially regulated genes that by inspection revealed functionally significant classes of genes regulated by MKK5 and MKK1. These were not identifiable by applying any of the three filters alone, which individually yielded larger sets of genes that were significantly difficult to cluster. The results showed 36 genes that were induced by ERK5 activation, of which 17 were selectively up-regulated by ERK5 and not ERK1/2 (Table 1), and 19 genes were up-regulated by both ERK5 and ERK1/2 (Table 3). ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Jul 28 281(30) 20993-1003",
                "id": "16735500"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b35"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "retinal epithelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Simultaneous overexpression of selenophosphate synthetase and phospholipid-hydroperoxide GSH peroxidase (PHGPx) [250] blocks activation of NF-kB by IL-1. Overexpression of SOD [84] or GSH peroxidase [81, 211] abolished NF-kB activation by preventing degradation of IkB after stimulation with TNF-a. The precise mechanism(s) through which oxidants and reductants influence activation of NF-kB is presently unknown; however, there is evidence that antioxidant enzyme (AOE372), a redox-sensitive thioredoxin peroxidase, regulates IkB phosphorylation [246]. Phosphatases The phosphatases are an important component of most signal transduction pathways, because failure to reverse kinase actions can disrupt normal cellular functions. For example, transfection of human fibroblasts with constitutively active ras (hRasV12) inhibits cell growth and ultimately results in a senescentlike phenotype [441]. Similarly, constitutive ERK activation has an inhibitory effect on cell cycle progression [442,443]. Both the serine/threonine phosphatases and the PTPs are known to be redox-sensitive [82,144,153,156,271,281, 444-449]. The mechanism of redox effects on activity is probably best understood for the PTPs. Without exception, the PTPs contain a highly conserved region of 11 amino acid residues in their catalytic domain; specifi- cally, (Ile/Val)-His-Cys-X-Ala-Gly-X-X-Arg-(Ser/Thr)- Gly, where X is a nonconserved amino acid [17]. Either oxidation or mutation of the cysteine renders these molecules inactive [17,281]. H2O2 is a potent inhibitor of PTPs. As in the case of other oxidants, H2O2 probably oxidizes the thiolate anion at the catalytic site [280]. Because formation of a phosphorylcysteine intermediate seems to be critical to PTP activity [450-452], blocking it through oxidation of the cysteine inactivates the molecules. In many cases, treatment of cells with H2O2 stimulates increases in protein phosphorylation by inhibiting phosphatase-catalyzed removal of phosphate groups. Furthermore, mitogens that increase cellular ox- idant production may stimulate phosphorylation indirectly by decreasing phosphatase activity. Additional mechanisms are involved in stimulation of pathways activated by growth factors that increase oxidant production, however, because there are known instances in which the oxidants they produce have no effect on protein phosphorylation. For example, TGF-b1 stimulates phosphorylation of numerous proteins and has been shown to cause a large increase in H2O2 production; however, its effects on protein phosphorylation are not blocked by catalase [453]. Furthermore, H2O2 is effective in promoting phosphorylation of phospholipase D, the PDGF receptor, and PKC-a even after pretreatment of Swiss 3T3 fibroblasts with orthovanadate to inhibit phosphatases [454]. Thus, although diminished phosphatase activity may partially account for increased phosphorylation in some cases, it cannot totally account for oxidation effects on phosphorylation in every case. SPECIFICITY In general, there is good agreement between studies on redox effects on any given gene; albeit, not all oxidizing or reducing treatments exert equivalent effects. This is clearly demonstrated in studies of pag , which encodes a protein associated with cellular proliferation. Pag protein inhibits the tyrosine kinase activity of the Abelson (abl ) protein by binding to its SH3-binding domain [455]. BSO, menadione, sodium arsenate, and diethyl maleate all stimulate pag expression, but H2O2 does not [269]. Conversely, H2O2 stimulates c-fos expression (Table 1), although 4-hydroynonenal (a product of v-6-polyunsaturated fatty acid peroxidation) not only fails to induce c-fos expression but is actually inhibitory to c-fos induction by EGF and PDGF [185]. Similarly, some oxidants such as diamide decrease hypoxia-induced signals [201], although others such as H2O2 increase them [124]. As might be expected, the effects of any stimu...",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2000 Feb 1 28(3) 463-99",
                "id": "10699758"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b34"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "The chondrocyte cell lines C28/I2, C20/A4, and T/C28a2/a4 expressed functionally active VEGFR-2. VEGF stimulation induced receptor phosphorylation, activation of the mitogen-activated protein kinases ERK 1/2, and long-lasting activation of the transcription factor AP-1 (activator protein-1). VEGF increased secreted MMP-1, MMP-3, and especially MMP-13, which could be effectively reduced by an inhibitor of VEGFR-2 kinase activity. Interestingly, VEGF diminished the expression of TIMP-1 and especially TIMP-2.",
              "citation": {
                "type": "PubMed",
                "name": "J Pathol 2004 Mar 202(3) 367-74",
                "id": "14991903"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b33"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "chondrocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "\\\"Dependence of peroxisome proliferator-activated receptor ligand-induced mitogen-activated protein kinase signaling on epidermal growth factor receptor transactivation.\\\" In the current study, we demonstrate that various PPARalpha (nafenopin) and gamma (ciglitazone and troglitazone) agonists rapidly induced extracellular signal-regulated kinase (Erk) and/or p38 phosphorylation in rat liver epithelial cells (GN4). The selective epidermal growth factor receptor (EGFR) kinase inhibitors, PD153035 and ZD1839 (Iressa), abolished PPARalpha and gamma agonist-dependent Erk activation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Nov 21 278(47) 46261-9",
                "id": "12966092"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b32"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Briefly, 1) the phosphorylation of C-terminal serine residues (Ser-2279, Ser-2315, and Ser-2366) on p300 was the major action caused by EGF in vivo (Fig. 3). 2) The phosphorylation was mediated by the activation of ERK2 (Fig. 1). 3) The C-terminal serine phosphorylation of p300 stimulated the HAT activity of p300 (Fig. 4) and also enhanced its interaction with Sp1 (Fig. 5). 4) This C-terminal serine phosphorylation controlled the recruitment of p300 to the keratin 16 promoter (Fig. 6). ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 Sep 14 282(37) 27215-28",
                "id": "17623675"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b31"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Stromal vascular cultures containing newly differentiated human adipocytes were pretreated with a vehicle (dimethyl sulfoxide) for 1 hour, then with 1 microM BRL49653 (PPARgamma agonist) for 24hours and subsequently treated with 30microM trans-10, cis-12 conjugated linoleic acid for an additional 24hours. CLA treatment conferred the ability of ERK1/2 to phosphorylate its nuclear substrate ELK1 in vitro. Pretreatment with BRL49653 blocked the CLA mediated ability of ERK1/2 to phosphorylate ELK-1",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jun 18 279(25) 26735-47",
                "id": "15067015"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b30"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Adipocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": " PD0325901 is a selective inhibitor of MEK1 and MEK2 kinases that rapidly abrogates ERK signaling",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2009 Mar 17 106(11) 4519-24",
                "id": "19251651"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f2b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Here we show that phosphorylation of the nuclear ERK substrate, Elk-1 at serine 383, is anchorage dependent in response to growth factor treatment of NIH 3T3 fibroblasts.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2001 Apr 16 153(2) 273-82",
                "id": "11309409"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f2a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Addition of PD98059 or overexpressionof dominant-negative mutant of ERK2 indeed reversed ras-mediated inhibition of RECK promoter activity.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2004 Jun 16(6) 675-9",
                "id": "15093608"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f29"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "In addition, NHERF2 increases LPA-induced ERK activation, which is followed by cyclooxygenase-2 induction via a PLC-dependent pathway.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Jun 24(11) 5069-79",
                "id": "15143197"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f28"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "ndeed, p75/p85 S6 kinase (S6K), a downstream target of cytosolic P-ERK, is phosphorylated in response to both catecholamine and EGF stimulation in an AG 1478-sensitive (sp) manner (Fig. 1E).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2009 Jul 24 284(30) 20375-86",
                "id": "19509284"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f27"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "The activity of p70 S6K and phosphorylation of the S6 protein was completely blocked by rapamycin and significantly decreased upon treatment of the cells with wortmannin",
              "citation": {
                "type": "PubMed",
                "name": "Int J Mol Med 2004 Apr 13(4) 601-5",
                "id": "15010863"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f26"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "The redox-dependent enhancement of Grb2 recruitment to LMW-PTP ultimately leads to an improvement of ERK activation, likely triggering a prosurvival signal against the oxidant environment.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2006 Sep 22 348(2) 367-73",
                "id": "16890200"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f25"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2002 Jun 15 62(12) 3530-7",
                "id": "12068000"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f24"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1998 Feb 27 273(9) 4904-8",
                "id": "9478933"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f23"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "stimulation with the PAR-2 peptide produced a rapid increase in ERK1/2 activation that did not significantly decline even after 4 h of exposure. SLIGKV also activated p38MAPK with similar levels of activation evident at both early and late time points (Fig. 4B).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Apr 28 281(17) 11792-804",
                "id": "16467309"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f22"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "umbilical vein endothelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "IGF1 induced MAPK activity was increased in cells expressing wild type SHC and decreased in cells expressing mutated 3F-SHC.",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 2001 Dec 142(12) 5226-35",
                "id": "11713219"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f21"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Loss of b-catenin expression leads to a dramatic reduction in ERK1/2 activity (Figs. 6C and D).",
              "citation": {
                "type": "PubMed",
                "name": "Dev Biol 2005 Jul 1 283(1) 226-39",
                "id": "15907834"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f20"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": "Epithelium"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "IGF-1 stimulation of MEK, Erk, p90Rsk, and Akt were accordingly augmented.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Nov 14 278(46) 45492-8",
                "id": "12970367"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f1f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "We report that inhibition of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase (MEK)-1/2 blocked BCR-induced activation of extracellular signal-regulated kinase (ERK).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Apr 5 277(14) 12144-50",
                "id": "11823472"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f1e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "b-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "We first concentrated on T47D cells and their SR derivatives, in which ErbB-2 has been shown to enhance activation of the ERK2 isoform of MAP kinase (Graus-Porta et al., 1995).",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1996 Jan 15 15(2) 254-64",
                "id": "8617201"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f1d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "The phosphorylation of MAPKs including ERK1/2, p38, and JNK was measured by immunoblot analysis using specific Abs. LPS-induced phosphorylation of ERK1/2, p38, and JNK was inhibited by EGCG (Fig. 4A?C). However, in 67LR-ablated cells, the inhibitory effect of EGCG on LPSinduced upregulation of phosphorylation was attenuated (Fig. 4A?C).",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2010 Jul 1 185(1) 33-45",
                "id": "20511545"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f1c"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "leukemia",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "M-CSF triggers the activation of extracellular signal-regulated protein kinases (ERK)-1/2.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 1999 Sep 1 163(5) 2452-62",
                "id": "10452980"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f1b"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2001 Feb 5 152(3) 633-43",
                "id": "11157988"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f1a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Furthermore, BMP4 stimulated phosphorylation of Smad1 and ERK1/2 in HSCs.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Physiol 2006 May 207(2) 499-505",
                "id": "16447265"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f19"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "hepatic stellate cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Nucleic Acids Res 1994 Dec 11 22(24) 5173-6",
                "id": "7816602"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f18"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Second, 1 uM apelin (65-77) promoted a time-dependent phosphorylation of ERKs in HUVECs, which peaked at 40 s (Fig. 6B).",
              "citation": {
                "type": "PubMed",
                "name": "FASEB J 2004 Dec 18(15) 1909-11",
                "id": "15385434"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f17"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "umbilical vein endothelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "UA strikingly induced both Raf-1 and MEK1/2 activation within 2 min and that of ERK1/2 within 5 min, as compared with the nontreated cells (Fig. 2). Similarly, both MKK3/6 and p38 MAPK were activated within 2 min, whereas phosphorylation of JNK1/2 was not observed.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2007 Apr 15 178(8) 4854-64",
                "id": "17404266"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f16"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "S1P greatly enhances the activity of ERK1/2 via a S1P1/Gi-dependent pathway (Lee et al., 1998).",
              "citation": {
                "type": "PubMed",
                "name": "Microvasc Res 2009 Jan 77(1) 39-45",
                "id": "18973762"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f15"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Clin Cancer Res 2003 Apr 9(4) 1274-83",
                "id": "12684395"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f14"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "The activation of ERK1/2 was considerably higher in alpha-synuclein overexpressing cells, 5 min after adding serum, compared with the non-induced (Dox+) condition.",
              "citation": {
                "type": "PubMed",
                "name": "Neurobiol Aging 2003 Sep 24(5) 687-96",
                "id": "12885576"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f13"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Stimulation of VSMCs with MCP-1 induced proliferation and resulted in a concentration- and time-dependent release of the proinflammatory cytokine interleukin-6 (IL-6). MCP-1 also induced extracellular signal-regulated kinase, which, along with IL-6 release, was inhibited by pertussis toxin.",
              "citation": {
                "type": "PubMed",
                "name": "Arterioscler Thromb Vasc Biol 2002 Jun 1 22(6) 914-20",
                "id": "12067898"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f12"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "\\\"Phosphorylation of p53 on Thr55 by ERK2 is necessary for doxorubicin-induced p53 activation and cell death.\\\"",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2004 Apr 29 23(20) 3580-8",
                "id": "15116093"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f11"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Aug 18 275(33) 25146-54",
                "id": "10831586"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f10"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "hKSR-2 also regulates the activity of MEKK3 (another MAP3K family member) in HEK-293T cells. We demonstrate that hKSR-2 is a negative regulator of MEKK3-mediated activation of MAP kinase (specifically ERK and JNK) and NF-kappaB pathways, and concurrently inhibits MEKK3-mediated interleukin-8 production.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2005 Sep 9 334(4) 1214-8",
                "id": "16039990"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f0f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Downstream of EGF-R activation, Srcasm was shown to block ERK1/2 and STAT3 in addition to PDK- 1, the latter being a crucial activator of the PI3K/Akt axis (Vivanco and Sawyers, 2002).",
              "citation": {
                "type": "PubMed",
                "name": "J Invest Dermatol 2008 Mar 128(3) 501-16",
                "id": "18268536"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f0e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Additionally, Syk and Vav1 cooperatively induced activation of Jun N-terminal kinase (JNK), extracellular-signal-regulated kinase 2 (ERK2) and the kinase Akt, and phosphorylation of the oncoprotein Cbl in fibrinogen-adherent cells.",
              "citation": {
                "type": "PubMed",
                "name": "Curr Biol 1998 Dec 3 8(24) 1289-99",
                "id": "9843681"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f0d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Dec 6 277(49) 47373-9",
                "id": "12239221"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f0c"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Treatment of cells with selective mitogen-activated protein kinase kinase (MEK) inhibitors PD098059 and U0126 showed that integrin alpha2 expression, cell adhesion, and activation of ERK are inhibited in a parallel concentration-dependent fashion.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 May 30 278(22) 19861-9",
                "id": "12657625"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f0b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Neurofibromin expression was significantly decreased within 2 days after infection (Figure 3A). Concomitant with this decrease was an increase in ERK and AKT activity as assessed by their phosphorylation status....Ras-GTP levels were elevated 2 days after infection",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Cell 2006 Dec 10(6) 459-72",
                "id": "17157787"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f0a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "In addition, we have shown that the EP(4) receptor, but not the EP(2), can activate the extracellular signal-regulated kinases (ERKs) 1 and 2 by way of PI3K leading to the induction of early growth response factor-1 (EGR-1), a transcription factor traditionally associated with wound healing",
              "citation": {
                "type": "PubMed",
                "name": "Life Sci 2003 Dec 5 74(2-3) 143-53",
                "id": "14607241"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f09"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "In parental Fr3T3 cells only the phosphorylated inactive forms of ERK1 and ERK2 were detected as determined by shift in EMSA. In contrast, Met-transformed cells (Met activated) a significant portion of ERK1 and ERK2 was seen to have a retarded mobility in SDS-PAGE indicative of phosphorylation. There was increase in the MAP kinase activity.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1997 May 15 16(10) 2634-45",
                "id": "9184210"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f08"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Bone Miner Res 2000 Jan 15(1) 95-102",
                "id": "10646118"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f07"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Mig-6 overexpression results in reduced activation of the mitogenactivated protein kinase ERK2 in response to EGF,",
              "citation": {
                "type": "PubMed",
                "name": "Biol Chem 2001 Dec 382(12) 1649-62",
                "id": "11843178"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f06"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "In parallel, stimulation of the wild-type angiotensin type 1A receptor with Ang II robustly stimulates ERK1/2 activation with approximately 60% of the response blocked by the PKC inhibitor (G protein dependent)",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2003 Sep 16 100(19) 10782-7",
                "id": "12949261"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f05"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "PD-98059, a selective inhibitor of the mitogen-activated protein kinase kinase-1 (MEK-1)-ERK-1/2 pathway, abolished ERK-1/2 and NF-kappaB activation and ET(B) upregulation. NF-kappaB inhibition also prevented RLX-mediated ET(B) stimulation",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 2003 Jan 10 92(1) 32-40",
                "id": "12522118"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f04"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Gal-9 induced phosphorylation of the MAPK p38 and ERK1/2 in DCs, and an inhibitor of p38 signaling, but not inhibitors of signaling by either ERK1/2 or PI3K, blocked Gal-9-induced up-regulation of costimulatory molecule expression and IL-12 production.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2005 Sep 1 175(5) 2974-81",
                "id": "16116184"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f03"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "dendritic cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "In this study, we have attempted to identify the critical tyrosine residues in LAT that mediate TCR activation-induced mobilization of intracellular Ca(2+) and activation of the MAP kinase Erk2.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Aug 3 276(31) 29588-95",
                "id": "11395491"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f02"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "As shown in Fig. 3A, upon NGF treatment, TrkA phosphorylation was increased within 10 minutes. Concomitantly, the levels of phospho Akt (pAkt) and phospho ERK (pERK) were increased within 10 minutes and remained high even after 2 h of treatment with NGF. Furthermore, pharmacological inhibition of TrkA (K252a), PI3K (LY294002) and MEK 1/2 (PD98059) (Fig. 3B) totally abolished NGF stimulated invasion (Fig. 3C).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cancer 2010 9 157",
                "id": "20569463"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f01"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Hypertension 2003 Mar 41(3) 546-52",
                "id": "12623957"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f00"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Administration of PD98059, an inhibitor of MAPK3/MAPK1 (10 mg/kg) 1 h after carrageenan caused a reduction in all the parameters of inflammation measured. ",
              "citation": {
                "type": "PubMed",
                "name": "Int J Immunopathol Pharmacol 22(4) 937-50",
                "id": "20074457"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7eff"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Whereas overexpression of wild-type Epac1 enhanced the phosphorylation of ERK1/2 induced by the beta2-AR, the receptor response was almost fully blunted (n = 4; p < 0.003) by expression of R279K Epac1 (Fig. 5A).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Nov 5 279(45) 46497-508",
                "id": "15319437"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7efe"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "In addition, immune-complex kinase assays (Fig. lb, lower panels) revealed the stimulation of both epitope-tagged ERK1 and epitope-tagged ERK2 by TPA but not by anisomycin.",
              "citation": {
                "type": "PubMed",
                "name": "Curr Biol 1995 Oct 1 5(10) 1191-200",
                "id": "8548291"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7efd"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "HCA furthermore activated ERK pathway, and ERK inhibitor reversed inhibitory effect of HCA on cell growth and transcriptional activation of NF-kappaB. ",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Pharmacol 2005 Oct 15 70(8) 1147-57",
                "id": "16143316"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7efc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Recombinant galectin-1 and galectin-3 stimulated the proliferation of cultured HSCs via the MEK1/2-ERK1/2 signaling pathway.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 May 23 278(21) 18938-44",
                "id": "12646584"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7efb"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "On the other hand, transfection of the dominant  negative forms of raf-1 , MEK1 , or ERK1 / 2 markedly stimulated basal cystatin  A promoter activity.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Sep 28 276(39) 36632-8",
                "id": "11451947"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7efa"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2005 Jan 25(2) 854-64",
                "id": "15632084"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ef9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "HGF induced activation of ERK1 and ERK2 was shown to be dependent on the presence of HS moieties.",
              "citation": {
                "type": "PubMed",
                "name": "Arterioscler Thromb Vasc Biol 2003 Jan 1 23(1) 69-75",
                "id": "12524227"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ef8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "In macrophages, CD74 demonstrates high-affinity binding to MIF. MIF binds to the extracellular domain of CD74; this complex is required for MIF-mediated MAPK activation and cell proliferation [16] .",
              "citation": {
                "type": "PubMed",
                "name": "Oncology 2008 75(3-4) 127-33",
                "id": "18791328"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ef7"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "MEK specific inhibitors U0126 and PD98059...which inhibit the activation of ERK1/2 and ERK5",
              "citation": {
                "type": "PubMed",
                "name": "Development 2005 Apr 132(8) 1773-83",
                "id": "15772134"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ef6"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Pretreatment of the cells with PD 98059 and U-126 (MEK1/MEK2 inhibitor) reduced IL1B-induced increases in Erk activity.",
              "citation": {
                "type": "PubMed",
                "name": "J Pharmacol Exp Ther 2003 Jun 305(3) 981-8",
                "id": "12626640"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ef5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "VEGF-A expression is regulated at all steps of its synthesis including transcription, mRNA stability, an under estimated way of VEGF regulation and translation. In this chapter, we present the link between VEGF mRNA stability through AU-rich sequences present in its 3'-untranslated region (3'-UTR) and the ERK pathway. We present several methods that have been used to demonstrate that ERKs increase VEGF mRNA half-life.",
              "citation": {
                "type": "PubMed",
                "name": "Methods Mol Biol 2010 661 451-69",
                "id": "20812001"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ef4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Cardiomyocyte-derived cell lines deficient in p38alpha are more resistant to apoptosis owing to lower expression of the pro-apoptotic proteins Bax and Fas and upregulation of the ERK survival pathway",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2007 Jan 19(1) 62-74",
                "id": "16844343"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ef3"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "cardiomyocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Activated ERK can translocate into the nucleus, where it catalyses the phosphorylation of transcription factors such as p62TCF, initiating a transcriptional programme that leads to cellular proliferation or differentiation.",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2001 Dec 13 414(6865) 799-806",
                "id": "11742412"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ef2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "The NFIL3 (E4BP4) transcription factor, Bcl-xL, and constitutively active mutants of components in Ras signal transduction pathways have been identified as key regulation proteins affecting murine interleukin-3 (IL-3)-dependent cell survival. expression of Nfil3 is regulated by oncogenic Ras mutants through both the Raf-mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1999 Apr 19(4) 2754-62",
                "id": "10082541"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ef1"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Therefore, PDGF beta receptor, ERK1/2, PLC and PKC are involved in the signal transduction of PDGF-induced growth response of rat cardiac myocytes.",
              "citation": {
                "type": "PubMed",
                "name": "Regul Pept 2005 Apr 15 127(1-3) 11-8",
                "id": "15680465"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ef0"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "cardiomyocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "simultaneously western blotting showed that the expression of p-ERK1/2 was increased significantly in CCR7-BE1 cells, while exhibiting no effect on the total protein levels of ERK1/2 (Fig. 7C).",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Biol Ther 2009 Feb 8(4) 322-30",
                "id": "19305150"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7eef"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Carcinoma, Non-Small-Cell Lung",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Fig.3  A shows that an increase in phosphorylation of ERK2 at Tyr204 was detected after 5 min of exposure to 10 ng/ml IL-6; this effect peaked at 30 min and was followed by a decline to basal levels by 2 h. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 May 2 278(18) 16304-9",
                "id": "12595539"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7eee"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "myocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2003 Feb 23(3) 1095-111",
                "id": "12529413"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7eed"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "We propose that the FGF-1-induced signaling pathway that leads to promatrilysin expression is ERK-dependent and leads to phosphorylation of Ser-727 on STAT3, phosphorylated STAT3, then binds and transactivates the matrilysin promoter",
              "citation": {
                "type": "PubMed",
                "name": "Neoplasia 4(1) 60-7",
                "id": "11922392"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7eec"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Whereas both HSF1 and ERK are required to protect cells against apoptosis, ERK activation is paradoxically antagonistic to trans-activation of hsp promoters by HSF1 and HSP accumulation during heat shock.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Nov 19 279(47) 49460-9",
                "id": "15364926"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7eeb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "the Mek1/2-specific inhibitors, PD98059 and U0126, both completely abolished forskolin, PMA, and GIP-mediated ERK1/2 phosphorylation, supporting a role for Mek1/2 in the cascade (Fig. 4  C).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Oct 4 277(40) 37088-97",
                "id": "12138104"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7eea"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Investigation into the downstream targets and mechanisms involved in ALK7-induced apoptosis revealed that the TGF-beta signaling intermediates, Smad2 and -3, were activated, as well as the MAPKs JNK and p38. In addition, caspase-3 and -9 were also activated, and cytochrome c release from the mitochondria was observed",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jul 2 279(27) 28458-65",
                "id": "15107418"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ee9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "NNK has been found to promote Ca2+ influx, to release serotonin and to activate both protein kinase C (PKC) and the MAP kinase pathway to stimulate the proliferation of SCLC cells [42,45].",
              "citation": {
                "type": "PubMed",
                "name": "Trends Pharmacol Sci 2008 Mar 29(3) 151-8",
                "id": "18262664"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ee8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Carcinoma, Small Cell",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Aug 10 276(32) 29805-14",
                "id": "11390395"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ee7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Here, we demonstrate that extracellular signal-regulated kinases (ERKs) can phosphorylate 5-LO in vitro",
              "citation": {
                "type": "PubMed",
                "name": "FASEB J 2002 Sep 16(11) 1441-3",
                "id": "12205041"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ee6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "ANGPTL3 bound to alpha(v)beta(3) and induced integrin alpha(v)beta(3)-dependent haptotactic endothelial cell adhesion and migration and stimulated signal transduction pathways characteristic for integrin activation, including phosphorylation of Akt, mitogen-activated protein kinase, and focal adhesion kinase",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 May 10 277(19) 17281-90",
                "id": "11877390"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ee5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Treatment with a specific inhibitor of mitogen-activated protein (MAP) kinase, but not with other inhibitors, abolished the stimulation of apoA-I gene expression by E2 and genistein.",
              "citation": {
                "type": "PubMed",
                "name": "J Lipid Res 2004 Jan 45(1) 106-12",
                "id": "14563824"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ee4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Nat Med 2002 Mar 8(3) 289-93",
                "id": "11875501"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ee3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "After bFGF was added to pulmonary fibroblasts, the kinase activities of p44/p42 ERK1/2 were determined by an in-gel assay at various times after exposure (Fig. 1). The data demonstrate that the addition of bFGF results in activation of ERK1/2 within 5 min, with the highest activity at 30 min, followed by a lower level of activity that persists for 8-12 h. ",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2001 Oct 281(4) L766-75",
                "id": "11557580"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ee2"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "First, Erk phosphorylates HePTP at residues Thr45 and Ser72",
              "citation": {
                "type": "PubMed",
                "name": "J Mol Biol 2005 Nov 18 354(1) 150-63",
                "id": "16226275"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ee1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "The role of SAPK2/p38 as a motogenic pathway in tumor cells was further supported by the finding that HeLa cells stably expressing a kinase-inactive mutant form of SAPK2/p38 had a lower capacity than the parental cells to migrate across a monolayer of HUVEC (Fig. 8, A  andB). ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Sep 7 276(36) 33762-72",
                "id": "11448946"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ee0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 May 2 278(18) 15765-70",
                "id": "12600999"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7edf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "By contrast, serum- and glucocorticoid-inducible kinase 1 (SGK1) was significantly induced in a p53-dependent manner after DNA damage, and this induction was through extracellular signal-regulated kinase 1/2-mediated posttranslational regulation.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2004 Sep 28 101(39) 14057-62",
                "id": "15383658"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ede"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "miR-155 transfected cells showed a significant reduction in angiotensin II-induced extracellular signal-related kinase 1/2 (ERK1/2) activation. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Jul 7 281(27) 18277-84",
                "id": "16675453"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7edd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Elk-1 is phosphorylated by upstream MAPK kinases including the MEK-ERK-1/2 pathway. LPS induced phosphorylation of ERK-1/2 and MEK1/2 occurred within 15 minutes of LPS treatment (data not shown). Phosphorylation of both ERK1/2 and MEK1/2 was inhibited by IL-10 pretreatment (Figure 6C and 6D).",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 2005 Aug 19 97(4) 305-13",
                "id": "16037570"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7edc"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "DFMO leads to inactivation of p42/p44 MAPK and induction of p21Waf/CIP1(CDKN1A)",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Mol Med 7(2) 113-26",
                "id": "12927050"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7edb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2005 Jul 22 333(1) 110-5",
                "id": "15950189"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7eda"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2003 Jul 5(7) 647-54",
                "id": "12792650"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ed9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Rb is directly phosphorylated by active ERK1/2",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Oct 28 280(43) 35992-8",
                "id": "16126730"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ed8"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Active FOXO3a rapidly increased the level of Bcl-2-interacting mediator (bim) in differentiated SH-SY5Y cells, and BDNF decreased the FOXO3a-induced increase of bim through activation of both PI3K/Akt and Erk signaling pathways.",
              "citation": {
                "type": "PubMed",
                "name": "Brain Res Mol Brain Res 2004 Jul 5 126(1) 45-56",
                "id": "15207915"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ed7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "These results suggested that Ang II enhances foam cell formation by upregulating ACAT1 expression predominantly through the actions of AT(1) receptor via the G protein/c-Src/PKC/MAPK pathway in human monocyte-macrophages.",
              "citation": {
                "type": "PubMed",
                "name": "Hypertens Res 2008 Sep 31(9) 1801-10",
                "id": "18971559"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ed6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Monocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Platelet-derived growth factor (PDGF) is an important regulator of vascular smooth muscle (VSM) cell growth and migration and has been identified as a key mediator of neointima formation resulting from vascular injury. PDGF exerts its effects, in part, through activation of ERK1/2. ",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2005 Jun 288(6) C1193-201",
                "id": "15677375"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ed5"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": "vascular smooth muscle"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Immunoblotting with antibodies that detect only the phosphorylated and active forms of these kinases indicated that oxLDL activated both ERK1/2 and PKB in BMDM whereas n-LDL or ac-LDL had no effect (Fig. 8A). ",
              "citation": {
                "type": "PubMed",
                "name": "J Lipid Res 2001 Sep 42(9) 1483-91",
                "id": "11518769"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ed4"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Thus, insulin stimulation of MAP kinase activation occurred more rapidly and was prolonged in WT-Shc cells, while the activation was delayed and transient in 317Y/F-Shc cells compared with that in HIRc cells. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1997 Apr 4 272(14) 9581-6",
                "id": "9083103"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ed3"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "in embryonic kidney cells expressing full-length DCC, NTN1 causes increased transient phosphorylation and activity of ERK1 and ERK2 but not of JNK1, JNK2 or MAPK14 this phosphorylation was mediated by MAP2K1 (aka MEK1) and/or MAP2K2 (aka MEK2)",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2002 May 23 417(6887) 443-7",
                "id": "11986622"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ed2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "embryonic kidney cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "LPA mediated Akt activation was inhibited by pertussis toxin (PTX), whereas Erk1/2 activation was completely inhibited by a blocker of phospholipase Cbeta, U-73122.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2005 Jul 289(1) C2-11",
                "id": "15728708"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ed1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "inhibition of CaMKII activity by specific inhibitors inhibited Erk-1/2 phosphorylation. Whereas CaMK inhibition affected neither integrin-stimulated Akt phosphorylation nor p21Ras or Mek-1 activity, it was necessary for Raf-1 activity...Active CaMKII phosphorylated Raf-1 in vitro. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Nov 14 278(46) 45101-8",
                "id": "12954639"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ed0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "activation of p38 kinase by overexpression of TAK1 and TAB1, without affecting PPARgamma expression, led the up-regulation of transcriptional activity of PPARgamma.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 2003 Feb 14(2) 545-55",
                "id": "12589053"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ecf"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": "mesenchyme"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "To determine if the ERK-MAPK pathway was also activated by TLR2 in megakaryocytes, lysates of Meg-01 cells were treated with 1 ?g/mL Pam3CSK4 for up to 1 hour and were immunoblotted for phosphorylated ERK1/2. As shown in Figure 1A, there was an increase in the phosphorylation of ERK beginning at 5 minutes that peaks at 30 minutes (105.8% 3.9).",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2011 Mar 31",
                "id": "21454454"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ece"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "PK1 induced a time-dependent increase in expression of IL-8 and COX-2, which was significantly reduced by inhibitors of Gq, cSrc, epidermal growth factor receptor (EGFR), and MAPK kinase. Treatment of third-trimester placenta with 40 nm PK1 induced a rapid phosphorylation of cSrc, EGFR, and ERK1/2. Phosphorylation of ERK1/2 in response to PK1 was dependent on sequential phosphorylation of cSrc and EGFR.",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 2008 Jul 149(7) 3470-7",
                "id": "18372330"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ecd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "we remark the role of PKC, probably isoform epsilon, in the negative control of ERK-1/2",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 1999 Sep 1 163(5) 2452-62",
                "id": "10452980"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ecc"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "PRL is shown to stimulate the differential tyrosyl phosphorylation of three isoforms (ERK-1, 2, and 4) of mitogen-activated protein kinases (MAP kinase) in a rat pre-T lymphoma cell line (Nb2)",
              "citation": {
                "type": "PubMed",
                "name": "Proc Soc Exp Biol Med 1997 Jun 215(2) 198-202",
                "id": "9160049"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ecb"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "phosphorylation of extracellular signal-regulated kinase (ERK), but not of c-Jun NH2-terminal kinase or p38, was induced by cross-linking of Fas",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2000 Mar 15 60(6) 1766-72",
                "id": "10749152"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7eca"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cell Growth Differ 2001 Jul 12(7) 379-86",
                "id": "11457735"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ec9"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "As shown in Figure 5A, the Erk1/Erk2 MAP kinase inhibitor PD9805912 drastically reduced both IL-3- and VEGF-induced SMC migration.",
              "citation": {
                "type": "PubMed",
                "name": "Circulation 2001 Jan 30 103(4) 549-54",
                "id": "11157721"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ec8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": "vascular tissue"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 1999 Oct 1 343 Pt 1 21-7",
                "id": "10493907"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ec7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Tyrosine 759 of gp130 is also essential for the activation of the MAPK cascade. Mutation of tyrosine 759 to phenylalanine was shown to abolish IL-6-mediated activation of Erk1/Erk2 (55). ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Jan 3 278(1) 661-71",
                "id": "12403768"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ec6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "calcium-independent pathways are accounted for in part by MAPK activation (Rap1/B-Raf/MAPK-ERK kinase/ERK1/2) AtT-20 corticotrophs express B-Raf, as do other cells in which cAMP stimulates MAPK. CRH/cAMP stimulated ERK2 (Mapk1) activity and increased transcriptional activity of a Gal4-Elk1 protein, which was blocked by overexpression of dominant negative mutants and kinase inhibitors and stimulated by expression of B-Raf.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Endocrinol 2002 Jul 16(7) 1638-51",
                "id": "12089357"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ec5"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Significant and specific knockdown of endogenous M-BAR mRNA levels was observed (Fig. 3b), and the cells treated with M-BAR siRNAs also showed potent suppression of DC-induced EGFR tyrosine phosphorylation and ERK1/2 activation (Fig. 3c). These results suggest that DC-induced activation of EGFR in AGS cells involves the activity of M-BAR/TGR5.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2007 Mar 2 354(1) 154-9",
                "id": "17214962"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ec4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Oct 24(19) 8671-80",
                "id": "15367685"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ec3"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Sorbitol resulted in activation of the extracellular signal-regulated kinase (ERK), p54 c-Jun N-terminal kinase (JNK), and protein kinase B",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Oct 3 278(40) 38484-94",
                "id": "12881532"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ec2"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "myocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "HDGF also activated specific ERK1/2 signaling",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2004 Jun 286(6) L1194-201",
                "id": "14751852"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ec1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Pharmacologic and genetic inhibition of alpha-CaMKII by using trifluoperazine, KN93, and alpha-CaMKII small interfering RNA decreases the phosphorylation of ERK and of cAMP-response element-binding protein, leading to a significant decrease in the transactivation of serum response element and cAMP-response element. Inhibition of alpha-CaMKII decreases the expression of c-fos, AP-1 transactivation, and AP-1 DNA binding activity.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Feb 25 280(8) 7049-59",
                "id": "15590632"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ec0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "osteoblast",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "On the contrary, D-tubocurarine reduced the levels of phospho- ERK (Fig. 9, panel A, Lanes 4 and 5).",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2004 Jan 1 64(1) 135-45",
                "id": "14729617"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ebf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasm",
                "cell": "",
                "tissue": "mesothelium"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "As shown in Figs. 3A and B, acrolein (10 uM) was able to induce phosphorylation of ERK, but not JNK and p38 MAPK, in a timedependent manner up to 120 min.",
              "citation": {
                "type": "PubMed",
                "name": "Toxicol Appl Pharmacol 2010 May 15 245(1) 76-82",
                "id": "20153347"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ebe"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "In cycling cells, the effects of Nox1 were dose dependent: levels of Nox1 that induced 3- to 10-fold increases in ROS promoted phosphorylation of ERK1/2 and expression of cyclin D1,",
              "citation": {
                "type": "PubMed",
                "name": "Antioxid Redox Signal 8(9-10) 1447-59",
                "id": "16987002"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ebd"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "p38 MAPK has been reported to activate PPAR-a through increased phosphorylation of PPAR-a and increased co-activation specifically by PGC-1 (refs 22, 23), thereby stimulating fatty-acid oxidation.",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2003 Jun 12 423(6941) 762-9",
                "id": "12802337"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ebc"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "overexpression of either dominant negative Rac2 or the N-terminal regulatory domain of PAK1 inhibits Ras-mediated activation of ERK2",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1996 Jul 16(7) 3707-13",
                "id": "8668187"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ebb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "It was not affected by an inhibitor of protein tyrosine kinase and was reduced by mitogen-activated protein kinase inhibitors.",
              "citation": {
                "type": "PubMed",
                "name": "Naunyn Schmiedebergs Arch Pharmacol 2001 Dec 364(6) 487-95",
                "id": "11770002"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7eba"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2004 May 7 14(3) 319-30",
                "id": "15125835"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7eb9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "the dual specificity phosphatase MKP-3 is selective for inactivation of ERK",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1996 Nov 1 271(44) 27205-8",
                "id": "8910287"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7eb8"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "resulting in an enhanced phosphorylation state of the hER alpha Ser118.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2002 Jul 1 21(13) 3443-53",
                "id": "12093745"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7eb7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "CO activated p38 MAPK, pERK1/2 and Akt at 30 min as determined by phosphorylation in a dose (Figure 4A) and time (Figure 4B) dependent manner.",
              "citation": {
                "type": "PubMed",
                "name": "PLoS One 2009 4(12) e8139",
                "id": "19956541"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7eb6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "AEBP1, a transcriptional repressor that is down-regulated during adipogenesis, complexes and protects MAPK from its specific phosphatase in mammalian cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Mar 30 276(13) 10199-206",
                "id": "11152475"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7eb5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Furthermore, we found that melanoma cell integrin alphav was required for MAPK kinase (MEK) 1 and extracellular signal-regulated kinase (ERK)1/2 activity in 3D-collagen",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2004 Nov 22 167(4) 745-56",
                "id": "15557124"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7eb4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "ARMS is rapidly tyrosine phosphorylated after binding of neurotrophins to Trk receptors and provides a docking site for the CrkL-C3G complex, resulting in Rap1-dependent sustained ERK activation. (CRKL= #1399; KIDINS220 = #57498; RAPGEF = #2889)",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2004 Jun 16 23(12) 2358-68",
                "id": "15167895"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7eb3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "In mice treated for 1 h with IL-6, phosphorylation of ERK1/2 and JNK in the aortas was increased 4.0- and 3.0-fold, respectively (levels in aortas of IL-6 treated, insulin-stimulated mice versus levels in aortas of non-IL-6-treated, insulin-stimulated mice; P < 0.01) (Fig. 9a and b)....IL-6 effects were reversed by treatment with PD98059 and JNK inhibitor I, respectively (Fig. 9a, b, c, and d).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2007 Mar 27(6) 2372-83",
                "id": "17242212"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7eb2"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "We investigated the possibility that the induction of CD13/APN is mediated by phosphorylation of Ets-2 via RAS/MAPK. A phosphorylation-defective Ets-2 mutant, T72A, failed to transactivate CD13/APN, suggesting that Ets-2 phosphorylation is obligatory for CD13/APN induction.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Dec 5 278(49) 49358-68",
                "id": "14507917"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7eb1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Furthermore, oncogenic HER2/Neu, which induces phosphorylation and thereby activation of ER81, was less able to activate acetylation-deficient ER81 mutants, indicating that both acetyltransferase and protein kinase-specific regulatory mechanisms control ER81 activity. Importantly, HER2/Neu overexpression stimulates the ability of p300 to acetylate ER81, likely by inducing phosphorylation of p300 through the Ras-->Raf-->mitogen-activated protein kinase pathway.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2003 Sep 23(17) 6243-54",
                "id": "12917345"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7eb0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2004 Jun 1 172(11) 7053-9",
                "id": "15153527"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7eaf"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Introduction of a kinase-defective mutant of BREK into PC12 cells enhanced both ERK phosphorylation and neurite outgrowth in response to NGF, suggesting that BREK is a negative regulator of NGF-induced neuronal differentiation.",
              "citation": {
                "type": "PubMed",
                "name": "Genes Cells 2004 Mar 9(3) 219-32",
                "id": "15005709"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7eae"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "MAP kinase phosphatase (MKP)-3 is a cytoplasmic dual specificity protein phosphatase that specifically binds to and inactivates the ERK1/2 MAP kinases in mammalian cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Oct 1 279(40) 41882-91",
                "id": "15269220"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ead"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1997 Apr 15 16(8) 1909-20",
                "id": "9155017"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7eac"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Oct 27 275(43) 33302-7",
                "id": "10915800"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7eab"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "However, upon the expression of Epac2, F/H and EGF were able to synergistically and robustly activate ERKs in a PKA-independent manner (Fig. 6A and B). Importantly, Rap1a contributed to the robust ERK activation by F/H and EGF in the presence of Epac2, as knockdown of Rap1a with shRNA (Fig. 6C) significantly reduced this effect (Fig. 6D).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2008 Dec 28(23) 7109-25",
                "id": "18824540"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7eaa"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 1999 Oct 1 85(7) 565-74",
                "id": "10506481"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ea9"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "This interaction between HIF-1alpha and p42/p44 MAPK suggests a cooperation between hypoxic and growth factor signals that ultimately leads to the increase in HIF-1-mediated gene expression.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Nov 12 274(46) 32631-7",
                "id": "10551817"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ea8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "p44MAPK/extracellular signal-regulated kinase 1 (ERK1) and p42 MAPK/ERK2 are activated by IL-3, colocalize with mitochondrial Bcl2, and can directly phosphorylate Bcl2 on Ser-70 in a stauro-resistant manner both in vitro and in vivo",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2000 Feb 15 97(4) 1578-83",
                "id": "10677502"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ea7"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "As shown in Fig. 1A, POVPC treatment at 10 ug/ml induced ERK1/2 phosphorylation at 30 min, 2 h, and 6 h, but not at 24 h, suggesting that POVPC elicits a transient activation of the MEK-ERK1/2 pathway. ",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2008 Nov 295(5) C1175-82",
                "id": "18768922"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ea6"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Eur J Biochem 2002 Feb 269(4) 1060-6",
                "id": "11856337"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ea5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Pretreatment with the ICAM-1peptide increased TGF-alpha-induced phospho-ERK1/2; the peptide alone had no significant effect (Fig. 3C). Addition of exogenous fibrinogen or the fibrinogen peptide prevented the ICAM-1peptide-dependent increase in phospho-ERK1/2 (Fig. 3C), while the control fibrinogen(scrambled) peptide had no effect on this increase (Fig. 3C). ",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2009 Jul 297(1) L174-83",
                "id": "19429776"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ea4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Culture with CCL2 enhanced phosphorylation of extracellular signal-related kinase 1 (ERK1) and ERK2, but not phosphorylation of p38 or Src.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2001 Nov 1 167(9) 5381-5",
                "id": "11673556"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ea3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "In addition to inducing G protein- and non-G protein-related signaling pathways, ANG II, via AT(1) receptors, carries out its functions via MAP kinases (ERK 1/2, JNK, p38MAPK), receptor tyrosine kinases [PDGF, EGFR, insulin receptor], and nonreceptor tyrosine kinases [Src, JAK/STAT, focal adhesion kinase (FAK)].",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2007 Jan 292(1) C82-97",
                "id": "16870827"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ea2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "In addition, introduction of B-Raf enhances and sustains integrin-mediated activation of ERK in wild-type primary fibroblasts",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Nov 24 275(47) 36532-40",
                "id": "10976102"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ea1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Neurochem 2001 Oct 79(1) 35-44",
                "id": "11595755"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ea0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Nov 2 276(44) 41014-22",
                "id": "11535599"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e9f"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "calcimycin, a calcium mobilizer, activates the RAF/MEK/ERK pathway through RAS,",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 2005 Sep 16(9) 4437-53",
                "id": "16000378"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e9e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Because PDGFRb activation, through transphosphorylation of tyrosine residues in its cytoplasmic domain, triggers a cascade of phosphorylation events which eventually lead to the activation of extracellular regulated-protein kinases (Erks), phosphorylated- Erk1/2 was used as an indicator of PDGFRb activation [7].",
              "citation": {
                "type": "PubMed",
                "name": "PLoS One 2009 4(9) e6922",
                "id": "19742316"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e9d"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "In hyperplastic lung tissues and in tumors induced at early times after BRafVE expression, a high percentage of cells stain positive for Ki67 (Fig. 4E,F), phospho-histone H3, and BrdU incorporation. However, in tumors observed at later times, the percentage of Ki67-positive cells is dramatically decreased even though the BRafVEMEKERK signaling pathway remains active in these cells (Figs. 3A,B, 4G).",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2007 Feb 15 21(4) 379-84",
                "id": "17299132"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e9c"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Similar to cell proliferation, the chemotactic effect of FGF2 requires the activation of the MAPK signaling pathway [30] and is abolished by PKC down-regulation [31].",
              "citation": {
                "type": "PubMed",
                "name": "Cytokine Growth Factor Rev 2005 Apr 16(2) 159-78",
                "id": "15863032"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e9b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "D2R stimulation activated ERK",
              "citation": {
                "type": "PubMed",
                "name": "J Neurochem 2003 May 85(3) 729-39",
                "id": "12694399"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e9a"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "H2320 was transfected (together with pRlSV40) into MCT cells, together with empty expression vector (vector), expression vectors for WT c-Ets2 a mutant c-Ets2 that cannot be phosphorylated by ERK1/2",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Oct 15 274(42) 30273-9",
                "id": "10514521"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e99"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Such action of HGF was dependent on the activation of extracellular signal-regulated kinase-1 and -2",
              "citation": {
                "type": "PubMed",
                "name": "J Am Soc Nephrol 2004 Jun 15(6) 1402-12",
                "id": "15153551"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e98"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Consistent with the earlier results, p42/44 MAPK and its upstream kinase MEK1/2 were activated in a time-dependent manner by the induction of Pak1 (Fig. 3C).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Nov 17 275(46) 36238-44",
                "id": "10945974"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e97"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "the Grb2/Sos complex connects Pyk2 to the activation of ERK, whereas adaptor proteins p130Cas and Crk link Pyk2 with the JNK pathway.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 May 21 274(21) 14893-901",
                "id": "10329689"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e96"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "E2 sensitivity is regulated by acetylation of lysines 302 and 303, by CREB-binding protein (CBP).",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2002 Feb 2(2) 101-12",
                "id": "12635173"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e95"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Constitutive activation of Ras promoted cellular senescence and drastically induced expression of proinflammatory cytokines in the primary cultures of human vascular cells, in part through extracellular signal-regulated kinase (ERK) activation.",
              "citation": {
                "type": "PubMed",
                "name": "Circulation 2003 Nov 4 108(18) 2264-9",
                "id": "14557365"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e94"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Atherosclerotic lesion",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": "vascular tissue"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "V12S35 transformed NIH-3T3 cells showed enhanced Erk1/2 activity which led to increase in tumorigenicity and metastasis.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 1998 Jul 21 95(15) 8773-8",
                "id": "9671754"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e93"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "LOX metabolites 5-HETE and 12-HETE stimulate cancer growth through activation of p44/42 mitogen-activated protein kinase and PI3/Akt kinase pathways",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cancer Ther 2002 Sep 1(11) 929-35",
                "id": "12481414"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e92"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Mechanically stretching cardiomyocytes by 20% for 8 min activated ERKs, and this activation was significantly inhibited by an AT1 receptor blocker, candesartan, as reported previously7 (Fig. 1a, lanes 2 and 4)",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2004 Jun 6(6) 499-506",
                "id": "15146194"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e91"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "cardiomyocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2003 Feb 23(3) 1095-111",
                "id": "12529413"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e90"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "the growth factor-stimulated signaling network controlled by MAPK1,2/PKC can operate with 1 or 2 stable states at low concentrations of MAPK phosphatase, DUSP1, the system exhibits bistable behavior, such that brief stimulus results in sustained MAPK activation",
              "citation": {
                "type": "PubMed",
                "name": "Science 2002 Aug 9 297(5583) 1018-23",
                "id": "12169734"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e8f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "PTPD1 activates src tyrosine kinase and increases the magnitude and duration of epidermal growth factor (EGF) signaling. EGF receptor phosphorylation and downstream activation of ERK 1/2 and Elk1-dependent gene transcription are enhanced by PTPD1.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Jun 24(11) 4613-26",
                "id": "15143158"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e8e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Genetic and biochemical experiments have demonstrated that kaposin A activates the ERK1/2 pathway by recruiting the guanine nucleotide exchange factor cytohesin-1 to membranes, leading to enhanced GTP binding of the GTPase, ARF1",
              "citation": {
                "type": "PubMed",
                "name": "Microbiol Mol Biol Rev 2003 Jun 67(2) 175-212, table of contents",
                "id": "12794189"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e8d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "The recombinant N-terminal domain of ADD1/SREBP-1c was phosphorylated predominantly on serine and slightly on threonine residues by MAP kinases ERK1 and ERK2 in vitro",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 1998 Aug 19 249(2) 375-9",
                "id": "9712704"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e8c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "U0126 (the inhibitor for MAP/ERK kinase) suppressed chymase-induced migration of EoL-1 cells and mouse eosinophils.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2005 Jul 15 332(4) 969-75",
                "id": "15919053"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e8b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Fibroblasts electroinjected with a mouse monoclonal anti-IRAK antibody to block the recruitment of IRAK into FACs failed to activate ERK after IL-1 treatment, indicating that FAC-associated IRAK is required for the activation of ERK.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Aug 4 275(31) 23509-15",
                "id": "10823834"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e8a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "In both cell types, ERK phosphorylation was suppressed by MKK inhibitors U-0126 or PD-98059 (3, 5, 17), indicating that the mechanism of phosphorylation requires active MKK1/2 (Fig. 1).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2002 Oct 22(20) 7226-41",
                "id": "12242299"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e89"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "The ER coactivator AIB1, like ER itself, is phosphorylated and activated by different signaling kinases, including the p42/44 MAPK, which can be activated by HER2 (64)",
              "citation": {
                "type": "PubMed",
                "name": "Clin Cancer Res 2003 Jan 9(1 Pt 2) 447S-54S",
                "id": "12538499"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e88"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Stimulation by IL-18 strongly enhanced tyrosine phosphorylation of STAT3 and of the mitogen-activated protein kinases (MAPK) p44erk-1and p42erk-2.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2000 Aug 1 165(3) 1307-13",
                "id": "10903731"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e87"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "natural killer cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "It is known that LPS stimulation leads to increased activation of three subgroups of MAPKs, i.e., ERK, JNK, and p38, in murine macrophages and human monocytes (38, 39).",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2002 Aug 1 169(3) 1401-9",
                "id": "12133965"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e86"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "In contrast with the parental 32D cells, which showed no Erk activation following treatment with either GA or EGF, Erk of D1 cells was stimulated by EGF but not by GA (Fig 2D) and only cells in which ErbB-2 was expressed (D2 cells) demonstrated an induction of Erk following treatment with GA.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO Rep 2004 Dec 5(12) 1165-70",
                "id": "15568014"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e85"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Myeloid Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "endogenous GMF is rapidly phosphorylated upon stimulation of astrocytes by phorbol 12-myristate 13-acetate We further observed that protein kinase A (PKA)-phosphorylated GMF is a potent inhibitor (IC50 = 3 nM) of the ERK1/ERK2 (p44/p42) subfamily of mitogen-activated protein (MAP) kinase.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1996 Sep 20 271(38) 22953-6",
                "id": "8798479"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e84"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "astrocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "In all three groups of rats, insulin significantly increased ERK2, RSK2, Akt, and p70S6k activities",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 1999 Jan 140(1) 106-11",
                "id": "9886813"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e83"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "We report here that VHR, a Vaccinia virus VH1-related dual-specific protein phosphatase that inactivates the mitogen-activated kinases Erk2 and Jnk, is phosphorylated at Y138 by ZAP-70.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Immunol 2003 Jan 4(1) 44-8",
                "id": "12447358"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e82"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "To determine if other receptor-associated cofactors were targets of cAMP-dependent signaling pathways, we examined the phosphorylation of steroid receptor coactivator 1 (SRC-1). We detected a 1.8-fold increase in SRC-1 phosphorylation in transfected COS-1 cells incubated with 8-bromo-cAMP. Phosphorylation was increased on two mitogen-activated protein kinase (MAPK) sites, threonine 1179 and serine 1185.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2000 Dec 20(23) 8720-30",
                "id": "11073973"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e81"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "dok-4 and dok-5 enhance c-Ret-dependent activation of mitogen-activated protein kinase.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2001 Jul 23 154(2) 345-54",
                "id": "11470823"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e80"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Activated ERK2 phosphorylated PPARa, as demonstrated by SDS-PAGE autoradiography (Figure 4b).",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Invest 2000 Jun 105(12) 1723-30",
                "id": "10862787"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e7f"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "In summary, PKCalpha, which was activated in senescent cells by ROS strongly activated Erk1/2, and the SA-pErk1/2 in turn phosphorylated Sp1 on Ser(59). Sp1-enhanced transcription of p21(Sdi1) resulted in regulation of cellular senescence in primary human diploid fibroblast cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2009 Jun 5 284(23) 15475-86",
                "id": "19318349"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e7e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Analysis of Ras/Raf downstream signaling with specific pharmacological inhibitors reveals that the decrease in tTG expression is mediated by the p38 MAPK, c-Jun NH2-terminal kinase, and phosphatidylinositol 3-kinase pathways.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Sep 12 278(37) 35609-19",
                "id": "12832399"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e7d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Cell attachment to fibronectin through ITGAV.ITGB3 activated the phosphorylation of ERK-2 within 60 minutes. ERK-2 activation was detected even in the presence of dn Cdc42 or dn Rac1 after attachment to fibronectin, indicating that these integrin-induced signaling components are still activated by attachment when Cdc42 and Rac1 are blocked.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2002 Jul 22(13) 4587-97",
                "id": "12052868"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e7c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "although all of these effects are far less substantial than those of the accepted activators AMP kinase kinase, phosphoinositide-dependent kinase 1, and CaMKK, respectively (24-26). Finally, Ras-independent activation of the mitogen-activated protein kinases ERK2, p38, and JNK1 was observed in cells transfected with constitutively active CaMKIV and further enhanced by cotransfection with CaMKK (27).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Feb 2 276(5) 2975-8",
                "id": "11096122"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e7b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 1996 Jun 133(6) 1383-90",
                "id": "8682872"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e7a"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1996 Oct 16(10) 5674-82",
                "id": "8816480"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e79"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2005 Apr 22 121(2) 179-93",
                "id": "15851026"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e78"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2003 Aug 1 102(3) 1019-27",
                "id": "12689928"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e77"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "ErbB2 over-expression was functional since we observed an approximately 6-fold increase in P-Ser 473 of Akt, and a 2.4 fold increase in P-Erk 1/2 levels in CAErbB2 cells compared to vector control (Fig. 1B)",
              "citation": {
                "type": "PubMed",
                "name": "BMC Cell Biol 2009 10 64",
                "id": "19754954"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e76"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "VWF-induced Erk2 phosphorylation and thromboxane A2 (TXA2) release were completely blocked by PP2, an Src family kinase inhibitor, suggesting that Erk is downstream of Src family kinases.",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2005 Nov 15 106(10) 3410-4",
                "id": "16020504"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e75"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Blood Platelets",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Nov 26 274(48) 34029-35",
                "id": "10567369"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e74"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "This loading of macrophages with free cholesterol activates NF-?B and the MAPKs p38, extracellular-signal-regulated kinase 1 (ERK1) and ERK2, and JNK, thereby inducing the expression of genes encoding inflammatory cytokines (including TNF-? and IL-6)66",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2008 Jul 24 454(7203) 455-62",
                "id": "18650916"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e73"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 May 25 276(21) 18075-81",
                "id": "11278548"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e72"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "In addition, ERK1 and ERK2 activation by phosphorylation occurred following CD53 antigen ligation.",
              "citation": {
                "type": "PubMed",
                "name": "Kidney Int 2003 Feb 63(2) 534-42",
                "id": "12631118"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e71"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "mesangial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Indeed, mucin1 is also overexpressed in breast cancers and tyrosine phosphorylation of the CT domain of MUC1 mucin leads to activation of amitogen-activated protein kinase pathway through the Ras-MEK-ERK2 pathway (38, 39).",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2001 Dec 18 98(26) 15203-8",
                "id": "11752463"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e70"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "cells exposed to 10 J/m2 of UV showed phosphorylation of not only ERK1 and ERK2 but also JNK1/2 and p38 (Fig. 3).",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2001 Jul 15 61(14) 5396-401",
                "id": "11454682"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e6f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "gAd induced the phosphorylation of MEK1/2 and ERK1/2 in RAW264 cells. In addition, the gAd-induced phosphorylation of MEK1/2 and ERK1/2 was dramatically reduced by PD98059 and U0126, respectively. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Endocrinol 2008 Sep 24 292(1-2) 20-5",
                "id": "18555587"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e6e"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "LPS has also been shown to induce TNF-a biosynthesis through an additional Ras/Raf1/MEK1/ERK-2 pathway [137]. LPS-induced derepression of TNF-a translation is found to be mediated through the activation of the MEK-4 (mitogen-activated protein kinase kinase 4)/MAPK10 pathway in RAW-264.7 macrophages [138]. LPS-induced signaling pathways leading to TNF-a biosynthesis are depicted in Figure 7.",
              "citation": {
                "type": "PubMed",
                "name": "Exp Lung Res 2009 Aug 35(6) 439-85",
                "id": "19842832"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e6d"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "H2O2 used as a positive control to induce oxidative stress also resulted in a reduction of ERK activation in PLD1 siRNA-transfected cells when compared to control siRNA-transfected cells (Figures 4E).",
              "citation": {
                "type": "PubMed",
                "name": "PLoS One 2010 5(3) e9600",
                "id": "20231899"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e6c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Bcl-2 positively regulates Sox9-dependent chondrocyte gene expression by suppressing the MEK-ERK1/2 signaling pathway.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Aug 26 280(34) 30517-25",
                "id": "15975921"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e6b"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 1998 Feb 23 82(3) 337-45",
                "id": "9486662"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e6a"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Cytosolic b-arrestins are phosphorylated: S412 in b-arrestin1 by the extracellular regulated kinase (ERK) mitogen-activated protein (MAP) kinase (Lin et al., 1999), T383 in rat (Lin et al., 2002) or T382 in bovine b-arrestin2 by casein kinase II (Kim et al., 2002).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2006 Dec 8 24(5) 643-52",
                "id": "17157248"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e69"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "H2320 was transfected (together with pRlSV40) into MCT cells, together with empty expression vector (vector), expression vectors for WT c-Ets2 a mutant c-Ets2 that cannot be phosphorylated by ERK1/2",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Oct 15 274(42) 30273-9",
                "id": "10514521"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e68"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "chondrocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "since in PKR-null MEFs there is a marked defect in Erk1 and Erk2 activation by PDGF (Figure1D), it appears that PKR is involved in serine phosphorylation of Stat3 through the activation of Erks.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2001 May 15 20(10) 2487-96",
                "id": "11350938"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e67"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Ectopic expression of the wild type APS, but not C-terminal truncated APS, in NIH3T3 fibroblasts suppressed PDGF-induced MAP kinase (Erk2) activation, c-fos and c-myc induction as well as cell proliferation.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1999 Jan 21 18(3) 759-67",
                "id": "9989826"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e66"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Pubmed:gene: Leukocyte-specific protein 1 targets the ERK/MAP kinase scaffold protein KSR and MEK1 and ERK2 to the actin cytoskeleton. The F-actin binding protein leukocyte-specific protein 1 (LSP1) binds to PKCbetaI and expression of B-LSP1, an LSP1 truncate containing the PKCbetaI binding residues, inhibits anti-IgM-induced translocation of PKCbetaI to the plasma membrane and anti-IgM-induced activation of ERK2.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 2004 Apr 15 117(Pt 10) 2151-7",
                "id": "15090600"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e65"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Here we demonstrate that activated EphB1 recruits the adaptor proteins Grb2 and p52Shc and promotes p52Shc and c-Src tyrosine phosphorylation as well as MAPK/extracellular signal-regulated kinase (ERK) activation. ",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2003 Aug 18 162(4) 661-71",
                "id": "12925710"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e64"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Results reveal that nicotine induces phosphorylation and activation of ERK1/2 in a dose-dependent manner (Fig. 2A).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cancer Res 2009 Dec 7(12) 1954-61",
                "id": "19903766"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e63"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Transfection of the native Src inhibitor, C-terminal Src kinase (Csk), also suppressed crystal-induced c-Src, ERK1/2, and IkappaBalpha phosphorylation and IL-8 expression.",
              "citation": {
                "type": "PubMed",
                "name": "J Leukoc Biol 2001 Dec 70(6) 961-8",
                "id": "11739559"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e62"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "MAPK. Stimulation of ERK by endothelial-cell integrins is mediated by either FAK, or the Src-family kinases Fyn and Yes.",
              "citation": {
                "type": "PubMed",
                "name": "Biochim Biophys Acta 2004 Mar 4 1654(1) 51-67",
                "id": "14984767"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e61"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "# Ariadne: Indeed, ERK and RSK (ribosomal S6 kinase), which is activated by ERK , phosphorylate MITF and promote its degradation, thereby leading to an inhibition of tyrosinase expression and melanogenesis ( 25 , 26 ). [ProtModification]",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Sep 13 277(37) 33690-7",
                "id": "12093801"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e60"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2002 Mar 1 62(5) 1549-54",
                "id": "11888934"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e5f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "As shown in Fig. 1A, the phosphorylation level of type 1 and type 2 JNKs was significantly increased within 60 min after H2O2 treatment, peaking (?5.5-fold, compared with the no treatment sample) at 2 h. The p38 and ERK proteins were also phosphorylated and activated in response to oxidative stress but to a substantially lesser than was JNK (Fig. 1B).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 Sep 28 282(39) 28395-407",
                "id": "17681939"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e5e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2002 May 1 168(9) 4711-20",
                "id": "11971021"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e5d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Inhibiting TSP1 activity reduced the elevated activation of MEK/ERK and expression of key fibrogenic proteins. TSP1 also blocked platelet-derived growth factor (PDGF)-induced contractile activity and MEK/ERK activation.",
              "citation": {
                "type": "PubMed",
                "name": "Fibrogenesis Tissue Repair 2011 4(1) 9",
                "id": "21453480"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e5c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "IGF1 binding activates the IGF1 receptor (IGFR), a receptor tyrosine kinase. The IGFR subsequently recruits the insulin receptor substrate (IRS1), which results in the activation of two signaling pathways: the RasRaf MEK ERK pathway  and the PI3K Akt pathway",
              "citation": {
                "type": "PubMed",
                "name": "Trends Mol Med 2003 Aug 9(8) 344-50",
                "id": "12928036"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e5b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Neurosci 2000 Sep 15 20(18) 6962-7",
                "id": "10995840"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e5a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 1995 Jun 6 92(12) 5361-5",
                "id": "7777512"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e59"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "8631994;9535909;12637502",
              "citation": {
                "type": "PubMed",
                "name": "BMC Bioinformatics 2004 Jun 22 5 79",
                "id": "15212693"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e58"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "These data demonstrate that it is the hemin-induced surge in cellular ROS levels, in particular the superoxide generated most likely from NADPH oxidase activity, and consequent oxidative stress which mediates Egr-1 upregulation via ERK-1/2 activation.",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 2008 Jan 4 102(1) 42-50",
                "id": "17967787"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e57"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 May 3 277(18) 15376-84",
                "id": "11859076"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e56"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Wild type as well as substrate-trapping DA forms of PTPepsilonM suppressed phosphorylation of IR downstream enzymes such as Akt, extracellular regulated kinase (ERK) and glycogen synthase kinase 3 (GSK3).",
              "citation": {
                "type": "PubMed",
                "name": "Zoolog Sci 2005 Feb 22(2) 169-75",
                "id": "15738637"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e55"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "from full text - As shown in Fig. 1A, ERK1/2 in wild-type MEFs is phosphorylated after IGF-1 stimulation with a peak at 510 min, after which pERK declined substantially. In b-arrestin1 KO MEFs, on the other hand, ERK1/2 remained essentially inactivated upon IGF-1 stimulation (Fig. 1A).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 Apr 13 282(15) 11329-38",
                "id": "17303558"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e54"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "The formed transductosome mediates the activation of MAP kinase, PI 3-kinase, Jun kinase, cGMP-dependent kinase and focal adhesion kinase",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1999 Feb 15 18(4) 882-92",
                "id": "10022831"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e53"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cell Growth Differ 2000 Jun 11(6) 305-14",
                "id": "10910097"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e52"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "activation of ERK depended on EGFR, Src tyrosine kinase and calcium calmodulin in PC12 cells (31), while requiring ras/Raf-1/MEK activation in human neutrophils (58).",
              "citation": {
                "type": "PubMed",
                "name": "Front Biosci 2009 14 4809-14",
                "id": "19273391"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e51"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Inhibition of I kappa B-alpha phosphorylation, PI3-kinase or ERK1/2 activation blocked IL-8 release",
              "citation": {
                "type": "PubMed",
                "name": "Eur J Immunol 2004 Jun 34(6) 1733-43",
                "id": "15162444"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e50"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Human recombinant CyPA can mimic the effects of secreted CyPA to stimulate ERK1/2 and cell growth. The peptidyl-prolyl isomerase activity is required for ERK1/2 activation by CyPA.",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 2000 Oct 27 87(9) 789-96",
                "id": "11055983"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e4f"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "These data agree with previous observations in this cell type, demonstrating that CD40 ligation activated MAPK, its substrate MAPKAPK-2, and the c-Jun N-terminal kinase. 130,131",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 2001 Dec 7 89(12) 1092-103",
                "id": "11739273"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e4e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Monocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "3 independent signaling pathways, STAT3, MEK1-ERK1/2, and AKT activation, that are coinduced by Lif stimulation were completely suppressed by SOCS3 overexpression",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Invest 2001 Nov 108(10) 1459-67",
                "id": "11714737"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e4d"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "In the PD98059-treatment group only a mild vasospasm was observed and the mean reduction of the basilar artery diameter was 18.9%.",
              "citation": {
                "type": "PubMed",
                "name": "Surg Neurol 2000 Sep 54(3) 221-7; discussion 227-8",
                "id": "11118568"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e4c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Renal Physiol 2000 Nov 279(5) F954-9",
                "id": "11053056"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e4b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Nevertheless, we confirmed that VEGFR-1 mediated signaling by utilizing the VEGFR-1-specific ligand VEGF-B. Activated Erk-1/2 signaling was again observed in both L3.6pl and Panc-1 cells, with maximal stimulation at 3 minutes that decreased to baseline levels by 30 minutes (Fig. 3). No activation of Akt or JNK/SAPK signaling was detected (data not shown).",
              "citation": {
                "type": "PubMed",
                "name": "Cancer 2005 Jul 15 104(2) 427-38",
                "id": "15952180"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e4a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Sep 3 274(36) 25273-80",
                "id": "10464250"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e49"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Inhibition of ERK with the MEK inhibitor UO126, the ERK protein phosphatase MKP-3, inhibited ERK activation, but only inhibited alpha-adrenergic-induced NCX1 upregulation by 30%.",
              "citation": {
                "type": "PubMed",
                "name": "Ann N Y Acad Sci 2002 Nov 976 237-47",
                "id": "12502566"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e48"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "PAFR promoter 2 contained AP-2 and Sp-1 binding sites we demonstrated that PAF activates p44ERK1/p42ERK2 in CHO cells stably expressing PAF receptor",
              "citation": {
                "type": "PubMed",
                "name": "Prog Lipid Res 2000 Jan 39(1) 41-82",
                "id": "10729607"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e47"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Enzastaurin specifically inhibits TPA-triggered phosphorylation of signaling molecules downstream of PKC...enzastaurin inhibited TPA-induced phosphorylation of downstream PKCu/ PKD, MARCKS, GSK3b, JNK1/2, ERK1/2, and c-Myc, but did not inhibit phosphorylation of PDK-1, a signaling molecule upstream of PKC, which triggers activation loop phosphorylation of cPKCs and nPKCs",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2007 Feb 15 109(4) 1669-77",
                "id": "17023575"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e46"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "when G-CSF-induced signaling was examined (Figure 1C-D), Erk1/2 phosphorylation was found reproducibly reduced in Gfi1 -/- bone marrow mononuclear cells  (MNCs)",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2010 May 13 115(19) 3970-9",
                "id": "20203268"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e45"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Monocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Kinase-defective point and deletion variants of RIP2 also significantly blocked the activation of ERK2 by TNFalpha but not epidermal growth factor.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Nov 19 274(47) 33684-90",
                "id": "10559258"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e44"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "from full text - IEC-18 cells were stimulated with Ang II or EGF. These stimuli promoted a marked increase in ERK phosphorylation but with different kinetics (Fig. 5A).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Jan 14 280(2) 1582-93",
                "id": "15525649"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e43"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "In previous studies we have demonstrated that 5-HT7 receptors couple to activation of ERK in cultured hippocampal neurons (Errico et al. 2001).",
              "citation": {
                "type": "PubMed",
                "name": "J Neurochem 2003 Dec 87(5) 1076-85",
                "id": "14622088"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e42"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "neuron",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "ERK/Ets-1 pathway",
              "citation": {
                "type": "PubMed",
                "name": "PLoS Pathog 2007 Mar 3(3) e44",
                "id": "17397260"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e41"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "the activation of Erk and phospholipase C (PLC)-g observed following stimulation of HeLa cells with a low dose of EGF was accelerated and potentiated following co-treatment with a low dose of GA (Fig 2E).",
              "citation": {
                "type": "PubMed",
                "name": "EMBO Rep 2004 Dec 5(12) 1165-70",
                "id": "15568014"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e40"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Figure 1 | The ErbB signalling network.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Mol Cell Biol 2001 Feb 2(2) 127-37",
                "id": "11252954"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e3f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "NIH3T3/MUC4 cells also showed an increased phosphorylation of ERKs (p42/44 MAPK) as compared to the control NIH3T3/ pSecTag cells.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2008 Nov 15 68(22) 9231-8",
                "id": "19010895"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e3e"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Re-expression of HSulf-1 in ovarian cancer cell lines resulted in diminished HSPG sulfation, diminished phosphorylation of receptor tyrosine kinases that require sulfated HSPGs as co-receptors for their cognate ligands, and diminished downstream signaling through the extracellular signal-regulated kinase pathway after treatment with fibroblast growth factor-2 or heparin-binding epidermal growth factor.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Jun 20 278(25) 23107-17",
                "id": "12686563"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e3d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "As single agents, FAS blocker C75 and Taxol induced a significant stimulation of the proliferation and cell survival mitogen-activated protein kinase extracellular signal-regulated kinase (ERK1/ERK2 MAPK) activity, whereas, in combination, they interfered with ERK1/ERK2 activation",
              "citation": {
                "type": "PubMed",
                "name": "Int J Cancer 2005 May 20 115(1) 19-35",
                "id": "15657900"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e3c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "# Ariadne: In contrast,  ERK2 phosphorylates RGS-Galpha-interacting protein, which enhances its capacity  to act as a GAP on Galpha i3 ( 24 ). [ProtModification]",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Dec 21 276(51) 48532-8",
                "id": "11602604"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e3b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Dec 20 277(51) 50081-6",
                "id": "12401798"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e3a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Human recombinant CyPA can mimic the effects of secreted CyPA to stimulate ERK1/2 and cell growth. The peptidyl-prolyl isomerase activity is required for ERK1/2 activation by CyPA.",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 2000 Oct 27 87(9) 789-96",
                "id": "11055983"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e39"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": "vascular smooth muscle"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Phosphorylation at Thr 125 is sufficient to block caspase-9 processing and subsequent caspase-3 activation",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2003 Jul 5(7) 647-54",
                "id": "12792650"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e38"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "AGTR2 inhibition with PD diminished p38 and p42/44 phosphorylation in fibroblast isolated from bleomycin-, but not saline-treated mouse lungs (Figures 6A?6D).",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2007 Dec 37(6) 640-50",
                "id": "17630322"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e37"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "the phosphorylation of extracellular signal-regulated kinase, c-Jun NH(2)-terminal protein kinase, and p38 was significantly higher in the cell lines expressing reduced laminin receptor, regardless of the exposure to exogenous laminin.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2004 May 15 64(10) 3572-9",
                "id": "15150114"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e36"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "MMP-9 expression by HBE1 cells was found to depend on ERK1/2 and PI3K/Akt and was dramatically attenuated after cell treatment with the MEK1/2 inhibitor U0126 (10 M) or the PI3K inhibitor LY294002",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2008 Jun 27 283(26) 17919-28",
                "id": "18424783"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e35"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": "Epithelium"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "We found that tuberin expression increases p42/44 MAPK phosphorylation and B-Raf kinase activity. Short interfering RNA down-regulation of tuberin decreased the p42/44 MAPK phosphorylation and B-Raf activity. Expression of Rheb, the target of the GTPase-activating domain of tuberin, inhibited wild-type B-Raf kinase but not activated forms of B-Raf.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jul 16 279(29) 29930-7",
                "id": "15150271"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e34"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "expression of ATIP1 in eukaryotic cells leads to inhibition of insulin, basic fibroblast growth factor, and epidermal growth factor-induced ERK2 activation and DNA synthesis, and attenuates insulin receptor autophosphorylation",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jul 9 279(28) 28989-97",
                "id": "15123706"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e33"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "In this paper, we present a comprehensive pathway map of EGFR signaling and other related pathways. The map reveals that the overall architecture of the pathway is a bow-tie (or hourglass) structure with several feedback loops.  See figure 2: The bow-tie architecture of the EGFR signaling pathway.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Syst Biol 2005 1 2005.0010",
                "id": "16729045"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e32"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Biochemistry 2004 Sep 28 43(38) 12133-40",
                "id": "15379552"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e31"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "We now show that the phosphorylation of these two residues is critical for determining the stability of Myc. Phosphorylation of Ser 62 is required for Ras-induced stabilization of Myc, likely mediated through the action of ERK.",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2000 Oct 1 14(19) 2501-14",
                "id": "11018017"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e30"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "PMA and granulocyte/macrophage colony-stimulating factor induce Egr-1 expression through ERK and p38 activation, respectively.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 May 23 278(21) 18859-67",
                "id": "12618431"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e2f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Stem Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jan 30 279(5) 3862-8",
                "id": "14585838"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e2e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Pretreatment with PP2, a specific inhibitor of Src family tyrosine kinase, completely blocked the NHERF2-dependent increase of the phosphorylation of ERK and Akt, suggesting that NHERF2 up-regulates Erk phosphorylation through a Src family kinase-dependent pathway.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2004 Jul 16(7) 791-800",
                "id": "15115658"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e2d"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 2003 Mar 7 92(4) 419-27",
                "id": "12600897"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e2c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "The P-1 domain mediates a constitutive interaction of SLP-76 with the SH3 domain of PLC-gamma1 and is required for TCR-mediated activation of Erk, PLC-gamma1, and NFAT (nuclear factor of activated T cells).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2001 Jul 21(13) 4208-18",
                "id": "11390650"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e2b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "% The ligation-associated induction of Homer1a was dependent on activation of NMDA receptors and the extracellular signal-regulated kinase 1 and 2 (ERK1/2) pathway. The non-competitive NMDA-receptor antagonist, MK-801, and a specific inhibitor of the ERK1/2 pathway, U0126, significantly attenuated the injury-elicited increases in Homer1a mRNA when compared to saline-treated animals.",
              "citation": {
                "type": "PubMed",
                "name": "Neurosci Lett 2006 May 8 398(3) 296-9",
                "id": "16448751"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e2a"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "neuron",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "FFx MTD caused brisk PMN Ca flux, activated PMN p44/42 MAPK, and caused PMN release of interleukin-8 and matrix metalloproteinase-9. Responses to MTD were inhibited by formyl peptide receptor-1 blockade using cyclosporine H or anti-formyl peptide receptor ",
              "citation": {
                "type": "PubMed",
                "name": "J Orthop Trauma 2010 Sep 24(9) 534-8",
                "id": "20736789"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e29"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Jan 29 274(5) 2893-8",
                "id": "9915826"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e28"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Further, the expression of the catalytically inactive mutants of Ha-Ras, RhoA, c-Raf, and Erk2 or addition of the Mek1-specific inhibitor PD 098059 abrogated the stimulation of the urokinase promoter by HGF/SF.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Jun 4 274(23) 16377-86",
                "id": "10347197"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e27"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "S118 can be phosphorylated by the ERK1/2 mitogen activated protein kinases (MAPK) and by the cyclin-dependent protein kinase Cdk7",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2002 Jul 25 21(32) 4921-31",
                "id": "12118371"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e26"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Activation of IL-4Ralpha by IL-13 or IL-4 induced signal transducer and activation of transcription-6 (STAT6), p42/ p44 ERK, p38, and to a lesser extent, SAPK/JNK mitogen-activated protein kinase phosphorylation.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Crit Care Med 2002 Apr 15 165(8) 1161-71",
                "id": "11956062"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e25"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2001 Dec 14 107(6) 715-26",
                "id": "11747808"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e24"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "In human bronchial airway epithelial (BEAS-2B) cells, Ni-induced VEGFA transcription by stimulating an extracellular regulated kinase (ERK) signaling cascade that involved Src kinase-activated Sp1 transactivation, as well as increased hypoxia-inducible factor-1a (HIF-1a) stabilization and DNA binding",
              "citation": {
                "type": "PubMed",
                "name": "Toxicol Sci 2009 Jul 110(1) 212-23",
                "id": "19403854"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e23"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "To elucidate the Gab1-dependent signals required for epithelial morphogenesis, we undertook a structure-function approach and demonstrate that association of Gab1 with the tyrosine phosphatase SHP-2 is required for sustained Erk activation and for epithelial morphogenesis downstream from the Met receptor.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2000 Nov 20(22) 8513-25",
                "id": "11046147"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e22"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "These results reveal selective signaling differences between NK cells and T lymphocytes; in NK cells, the MKK/ERK pathway and not p38 MAPK plays a critical positive regulatory role during activation by IL-2.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2000 Jun 15 164(12) 6244-51",
                "id": "10843677"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e21"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "natural killer cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": ": In vitro, gefitinib inhibited cell proliferation with differing IC(50), and suppressed activation of EGFR and downstream signaling molecules protein kinase B (AKT), extracellular signal-regulated kinase 1/2, signal transducer and activator of transcription 3 (STAT3), and nuclear factor kappaB. ",
              "citation": {
                "type": "PubMed",
                "name": "Clin Cancer Res 2009 Apr 1 15(7) 2361-72",
                "id": "19318490"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e20"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Data in isolated fibroblasts (26,56), neutrophils (57,58), endothelial and vascular smooth muscle cells (5961), neural cells (31,62), cardiomyocytes (63) and whole lung tissue (64) showed that, in addition to other known oxidants, peroxynitrite is also a powerful activator of ERK.",
              "citation": {
                "type": "PubMed",
                "name": "Front Biosci 2009 14 4809-14",
                "id": "19273391"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e1f"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Previously, we have shown that phosphorylation of beta-arrestin1 by ERKs at Ser-412",
              "citation": {
                "type": "PubMed",
                "name": "Biochemistry 2002 Aug 27 41(34) 10692-9",
                "id": "12186555"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e1e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Jun 8 276(23) 19800-6",
                "id": "11279172"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e1d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Both the growth-stimulating activity of low-dose NO for endothelial cells and suppression of TSP1 expression were ERK-dependent. Conversely, exogenous TSP1 suppressed NO-mediated pERK",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2005 Sep 13 102(37) 13147-52",
                "id": "16141331"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e1c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "PD98059, a specific inhibitor of ERK kinase (MEK1), reduced H2O2-induced AR expression. EGF alone elicited activation of ERK and induction of AR expression",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2001 Jul 15 31(2) 205-16",
                "id": "11440832"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e1b"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": "Muscle, Smooth"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Moreover, calpain, which is increased in Parkinson's disease neurons [66], appears to be a direct cytoplasmic target of ERK1/2 [67].",
              "citation": {
                "type": "PubMed",
                "name": "Eur J Biochem 2004 Jun 271(11) 2060-6",
                "id": "15153095"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e1a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Inhibition of Duox1 activation with DPI or after siRNA-mediated specific Duox1 silencing significantly inhibited localized ERK activation in wounded HBE1 monolayers (Fig. 4, C and D), ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 Feb 2 282(5) 3213-20",
                "id": "17135261"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e19"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "TGF-b was also shown to induce Egr-1 expression in normal dermal fibroblasts [32]. The response was rapid and transient, occurred via an ERK1/2- dependent and Smad-independent mechanism, and involved transcriptional stimulation.",
              "citation": {
                "type": "PubMed",
                "name": "Curr Opin Rheumatol 2007 Nov 19(6) 568-73",
                "id": "17917537"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e18"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "It has been shown that chemokines, for example, SDF-1?, can induce the activation of two downstream effectors of Ras, i.e., ERK and PI3-K [34, 46].",
              "citation": {
                "type": "PubMed",
                "name": "J Mol Med 2003 Jan 81(1) 4-19",
                "id": "12545245"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e17"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "b-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Cholesterol has been recently suggested to regulate the early steps of keratinocyte differentiation through lipid rafts. In many cell types, depletion of cholesterol activates signaling proteins like epidermal growth factor receptor (EGFR), human epidermal growth factor receptor 2 (HER2), or extracellular signal-regulated kinase (ERK) known to affect cell differentiation",
              "citation": {
                "type": "PubMed",
                "name": "J Invest Dermatol 2004 Sep 123(3) 564-73",
                "id": "15304097"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e16"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Oct 26 276(43) 39892-7",
                "id": "11518717"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e15"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Recombinant TTP was phosphorylated by three members of the mitogen-activated protein (MAP) kinase family, p42, p38, and JNK, with half-maximal phosphorylation occurring at approximately 0.5, 0.25, and 0.25 microM protein, respectively....we expressed human and mouse TTP as glutathione S-transferase and maltose-binding protein (MBP) fusion proteins in Escherichia coli, and purified them by affinity resins and Mono Q chromatography. ",
              "citation": {
                "type": "PubMed",
                "name": "Arch Biochem Biophys 2003 Apr 1 412(1) 106-20",
                "id": "12646273"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e14"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Exp Mol Med 2002 Dec 31 34(6) 451-61",
                "id": "12526087"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e13"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "As with GAL4-Sap, phosphorylation of Myc?Sap-1a was induced by both BXB and ERK-1 and p38 MAPK in vivo. Specifically, increased labeling of phosphopeptides 2'?4', which indicates phosphorylation at Ser381 and Ser387, as well as phosphopeptide d', which indicates phosphorylation at residues 420 and 425, was observed",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1997 Apr 1 16(7) 1620-7",
                "id": "9130707"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e12"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Engagement of Gi- and Gq-protein-coupled ETB receptors by ET-1 led to phosphorylation of ERK1/2, p38 MAPK, and JNK1/2 and then activated transcription factor NF-?B. ",
              "citation": {
                "type": "PubMed",
                "name": "Cell Commun Signal 2013 11(1) 8",
                "id": "23343326"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e11"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2005 Jul 22 19(2) 159-70",
                "id": "16039586"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e10"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "S100A1-mediated anti-apoptotic effects involve specific activation of the extracellular signal-regulated kinase 1/2 (ERK1/2) pro-survival pathway, including activation of phospholipase C, protein kinase C, mitogen-activated protein kinase kinase 1, and ERK1/2.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Nov 28 278(48) 48404-12",
                "id": "12960148"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e0f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "cardiomyocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Sp1, SRE-1 binding protein, and CBP are part of the transcriptional complex resulting in induction of LDL receptor expression in response to activation of the Raf/MEK/p42/44MAPK cascade. MEK=MAP2K1,2 p42=MAPK1 44MAP=MAPK3",
              "citation": {
                "type": "PubMed",
                "name": "J Lipid Res 2003 Mar 44(3) 584-93",
                "id": "12562867"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e0e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Because the non-receptor tyrosine phosphatase Src homology 2 domain-containing protein tyrosine phosphatase-2 (SHP-2) is enriched in focal adhesions and IL-1-induced ERK activation requires increased Ca(2+), we determined whether SHP-2 modulates IL-1-induced Ca(2+) signaling.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Mar 4 280(9) 8397-406",
                "id": "15563458"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e0d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Phosphorylation of SRC-1 by MAPK was required for optimal ligand-independent activation of the AR by IL-6.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Oct 11 277(41) 38087-94",
                "id": "12163482"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e0c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "This hypoxia-induced increase in Bad phosphorylation was abolished in presence of 10 ?M PD98059, an inhibitor of the MEK/ERK 2 pathway (Fig. 5B). ",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2010 Jun 298(6) C1501-9",
                "id": "20200209"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e0b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Additionally, over-expression of CREG dampened the stretched cardiomyocyte hypertrophy through ERK1/2.",
              "citation": {
                "type": "PubMed",
                "name": "J Hypertens 2004 Aug 22(8) 1579-87",
                "id": "15257182"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e0a"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "cardiomyocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "their expression is up-regulated by the activation of leukemia inhibitory factor receptor (LIF-R) and prostacyclin receptor (IP-R) via the extracellular signal-regulated kinase (ERK) pathway and cAMP production, respectively.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Endocrinol 2001 Nov 15(11) 2037-49",
                "id": "11682632"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e09"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "preadipocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "AEBP1, a transcriptional repressor that is down-regulated during adipogenesis, complexes and protects MAPK from its specific phosphatase in mammalian cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Mar 30 276(13) 10199-206",
                "id": "11152475"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e08"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Adipocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "ERK 1/2 signaling pathway negatively controls claudin-2 expression",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Feb 4 280(5) 3780-8",
                "id": "15569684"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e07"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "we further showed that Stat3 DNA binding activity and its tyrosine phosphorylation are also inhibited under the same conditions.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1998 Dec 17 17(24) 3157-67",
                "id": "9872331"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e06"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "HSV-1 infection of HCECs resulted in a two-phase activation of nuclear factor-kappaB (NF-kappaB), JNK and p38, with the first peak at 1-4 hr and a second peak at 8 hr. HSV-1 infection resulted in I?B-? phosphorylation and degradation in a time-dependent manner in both HUCL cells and primary HCECs.",
              "citation": {
                "type": "PubMed",
                "name": "Immunology 2006 Feb 117(2) 167-76",
                "id": "16423052"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e05"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2001 Sep 1 61(17) 6360-6",
                "id": "11522626"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e04"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Suramin, a growth factor receptor antagonist, completely abolished ERK activation, significantly blocked MKP-1 expression, but not JNK/SAPK and p38 MAPK activation, in response to mechanical stress.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Sep 3 274(36) 25273-80",
                "id": "10464250"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e03"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "In human HaCaT keratinocytes for instance, ERK1/2 phosphorylation increases in dependence of EGF-R recruitment to transadhering E-cadherin, and E-cadherin-mediated activation of MAPK was also reported in intestinal epithelial cells (Pece and Gutkind, 2000; Laprise et al., 2004).    ",
              "citation": {
                "type": "PubMed",
                "name": "J Invest Dermatol 2008 Mar 128(3) 501-16",
                "id": "18268536"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e02"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": "Epithelium"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "In response to mitogenic stimulation with platelet-derived growth factor (PDGF), SMC rapidly express NOR1 through an ERK-MAPK-dependent signaling pathway. 5'-deletion analysis, site-directed mutagenesis, and transactivation experiments demonstrate that PDGF-induced NOR1 expression is mediated through a cAMP-response element-binding protein (CREB)-dependent transactivation of the NOR1 promoter.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Nov 3 281(44) 33467-76",
                "id": "16945922"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e01"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "As shown in Fig. 3A and B, exposure to eckol caused an increase in the phosphorylation of Erk, and Akt in a time-dependent manner.",
              "citation": {
                "type": "PubMed",
                "name": "Int J Biochem Cell Biol 2010 Feb 42(2) 297-305",
                "id": "19931411"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7e00"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2003 Jul 15 171(2) 802-11",
                "id": "12847248"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7dff"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "the phosphorylation of BAD at Ser-112 was blocked by PD98059 (MAPKK inhibitor) phosphorylation of  BAD Ser-136 via the PI-3K-Akt cascade paclitaxel induces the phosphorylation of BAD Ser-112 via the ERK cascade, and the phosphorylation of both BAD Ser-136 Ser-136 and Raf-1 Ser-259 via the PI-3K-Akt",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Sep 6 277(36) 33490-500",
                "id": "12087097"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7dfe"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "TGF-beta1 treatment activated the MAPK pathway, as shown by an increased phosphorylation of extracellular-regulated kinases (ERK)1/2 after 30 min of exposure.",
              "citation": {
                "type": "PubMed",
                "name": "Pharmacol Res 2008 Apr 57(4) 274-82",
                "id": "18346908"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7dfd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Activation of p44/42 appeared to be antiapoptotic, since MAPK stimulation with epidermal growth factor or a dominant-positive p42 construct inhibited apoptosis.",
              "citation": {
                "type": "PubMed",
                "name": "J Pharmacol Exp Ther 2003 Dec 307(3) 861-9",
                "id": "14557375"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7dfc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Arthritis Rheum 2004 Jun 50(6) 1850-60",
                "id": "15188362"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7dfb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "This stimulation and the phosphorylation of GAIP by Erk2 were abrogated when serine at position 151 in the RGS domain was substituted by an alanine residue using site-directed mutagenesis. Furthermore, the lysosomal-autophagic pathway was not stimulated in S151A-GAIP mutant-expressing cells when compared with wild-type GAIP-expressing cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Dec 15 275(50) 39090-5",
                "id": "10993892"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7dfa"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Genes Cells 2004 Jan 9(1) 59-70",
                "id": "14723708"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7df9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "inhibition of ERK1/2 signaling resulted in marked attenuation in IR-induced ATR activity with little, if any, effect on IR-induced ATM activation. Furthermore, inhibition of ERK1/2 signaling resulted in >/=85% attenuation in IR-induced G2/M arrest and concomitant diminution of IR-induced activation of ataxia telangiectasia mutated- and rad3-related (ATR), Chk1 and Wee1 kinases as well as phosphorylation of Cdc25A-Thr506, Cdc25C-Ser216 and Cdc2-Tyr15.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2007 Jul 12 26(32) 4689-98",
                "id": "17297454"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7df8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "In prostate DU145 cells, both FGF1 and FGF2 activated ERK1/2 potently and p38 moderately.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2001 Aug 30 20(38) 5359-65",
                "id": "11536048"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7df7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "We show that the sustained ERK-MAP kinase signalling resulting from transformation by oncogenic Ras down-regulates ROCK1 and Rho-kinase, two Rho effectors required for actin stress fibre formation. The repression of Rho- dependent stress fibre formation by ERK-MAP kinase signalling",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2001 Feb 15 20(4) 755-66",
                "id": "11179220"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7df6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "MKP-1 was a target in vivo and in vitro for p42(MAPK) or p44(MAPK), which phosphorylates MKP-1 on two carboxyl-terminal serine residues, Serine 359 and Serine 364.",
              "citation": {
                "type": "PubMed",
                "name": "Science 1999 Dec 24 286(5449) 2514-7",
                "id": "10617468"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7df5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "The results support the conclusion that PRL1 enhances the invasiveness of lung cancer cells by increasing MMP2/9 expression through the Src and ERK1/2 pathways.",
              "citation": {
                "type": "PubMed",
                "name": "Biochemistry 2009 Mar 3 48(8) 1838-46",
                "id": "19199380"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7df4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Carcinoma, Non-Small-Cell Lung",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "up-regulation of BGN mRNA was preceded by a delayed increase in the phosphorylation of p38 and its upstream activator MKK6 in TGF-beta 1-treated PANC-1 cells,",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Mar 28 278(13) 11041-9",
                "id": "12538652"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7df3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": " Human ASM cells exposed to the primary proasthmatic T helper type 2 (Th2) cytokine, IL-13, exhibited upregulated expression of 11beta-HSD1, an effect that was attributed to activation of the transcription factor, AP-1, coupled to MAPK signaling via the ERK1/2 and JNK pathways.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2009 May 296(5) L790-803",
                "id": "19251840"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7df2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Muscle, Smooth"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "We show that expression of cyt-PTP significantly reduces kinase activity of ERK1 and ERK2. Presence of PTP also reduces phosphorylation of ERK proteins at both Thr and Tyr residues of their activating TEY motif in NIH3T3 cells and in mammary tumor cells.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cancer Res 2003 May 1(7) 541-50",
                "id": "12754301"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7df1"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Ang II and H2O2 induced marked activation of extracellular signal-responsive kinase1/2 (ERK1/2), which was blocked by NAC. Ang II and H2O2 also activated p38MAPK, and they were blocked by pre-treatment with NAC. However, the level of activated p38MAPK was quite low in comparison with ERK1/2. Ang II- or H2O2 -induced Gax down-regulation was significantly inhibited by PD98059, an ERK1/2 inhibitor but not SB203580, a p38MAPK inhibitor",
              "citation": {
                "type": "PubMed",
                "name": "Regul Pept 2005 Apr 15 127(1-3) 159-67",
                "id": "15680482"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7df0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Muscle, Smooth"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "NNKmediated ERK activation was prevented by U0126 but not by SN50 (fig. 8d).",
              "citation": {
                "type": "PubMed",
                "name": "Eur Respir J 2008 Oct 32(4) 911-23",
                "id": "18508827"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7def"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "FHL2 inhibited the ability of activated ERK2 to reside within the nucleus, thus blocking ERK-dependent transcriptional responsiveness of ELK-1, GATA4, and the atrial natriuretic factor promoter.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Feb 24(3) 1081-95",
                "id": "14729955"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7dee"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "The human beta-defensins (-1, -2, -3, -4) and cathelicidin LL-37 induce IL-18 secretion through p38 and ERK MAPK activation in primary human keratinocytes.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2005 Aug 1 175(3) 1776-84",
                "id": "16034119"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ded"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Reconstitution of PKCbetaI expression in these cells by retroviral transfection increased Ras/ERK activation by 3050%, indicating full restoration of Ras/ERK activation (Fig. 2 D and E). ",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2003 Aug 5 100(16) 9470-5",
                "id": "12881490"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7dec"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "mast cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Leptin-induced MUC5B expression was blocked by the ERK1/2 and p38 pathway inhibitors, but not by the JAK2/STAT3 pathway inhibitor.",
              "citation": {
                "type": "PubMed",
                "name": "Exp Lung Res 2010 Jun 36(5) 262-9",
                "id": "20497020"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7deb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Lung airway"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "We show that the type I neurotensin receptor-3 (also called sortilin) is the only known neurotensin receptor expressed in a murine microglial cell line and that its activation leads to phosphorylation of both extracellular signaling-regulated (Erk1/2) and Akt kinases.",
              "citation": {
                "type": "PubMed",
                "name": "J Neurosci Res 2004 Oct 1 78(1) 92-9",
                "id": "15372498"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7dea"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "As shown in Fig. 4A, 100 nM Ang II phosphorylated ERK at its tyrosine residue in PSCs, indicating that Ang II activates ERK. ",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2004 Mar 19 315(4) 905-11",
                "id": "14985098"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7de9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "In addition to NF-?B, among the known pathways that can be activated by RAGE are phosphoinositide 3-kinases (PI3K)/Akt (also termed as protein kinase B), and mitogen-activated protein kinase members (MAPKs) (52,53). The latter group includes Jun-N-terminal kinase (JNK), p38, and extracellular signal-regulated kinases (ERK) (54,55) (Figure 2).",
              "citation": {
                "type": "PubMed",
                "name": "Front Biosci 2009 14 1403-13",
                "id": "19273137"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7de8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "vascular tissue"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Autocrine Wnt signalling through the GPCR frizzled 1 contributes to breast cancer cell proliferation in part through EGFR transactivation92. To add another layer of complexity, progesterone receptor signalling through WnT1 induced EGFR transactivation and SRCdependent sustained activation of ErkMAPK signalling in breast cancer cells93",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2008 Dec 8(12) 929-41",
                "id": "19005493"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7de7"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "Neoplasm",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Oct 15 274(42) 30154-62",
                "id": "10514505"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7de6"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Pharmacol 2003 Mar 63(3) 690-8",
                "id": "12606779"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7de5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "We found that BMPs/Smad1 signaling inhibits the growth of androgen-sensitive prostate cancer cells.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2007 Jan 24 26(2) 346-57",
                "id": "17183365"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7de4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Prostatic Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "We found that the catalytic activity of MKP-2 was enhanced dramatically by ERK and JNK but was affected only minimally by p38. By contrast, p38 and ERK bound MKP-2 with comparably strong affinities, whereas JNK and MKP-2 interacted very weakly",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Aug 3 276(31) 29440-9",
                "id": "11387337"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7de3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "A 162-base pair segment of the human MCL1 5'-flank was found to direct luciferase reporter activity, allowing approximately 10-fold induction with TPA that was suppressible upon inhibition of the extracellular signal-regulated kinase (ERK) pathway. Serum response factor (SRF), Elk-1, and Sp1 bound to cognate sites within this segment, SRF and Elk-1 acting coordinately to affect both basal activity and TPA inducibility, whereas Sp1 affected basal activity only.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Jan 15 274(3) 1801-13",
                "id": "9880563"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7de2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Genes Cells 2003 Jun 8(6) 515-23",
                "id": "12786942"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7de1"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "The elevation of secreted PSA level by the forced expression of ErbB-2 was inhibited by an MEK inhibitor, PD98059. In C-81 cells, the expression of a dominant negative mutant of ErbB-2 reduced the secreted level of PSA. ErbB-2 signal pathway via MAP kinases (ERK1/2) is involved in regulating the secretion of PSA by androgen-independent human prostate cancer LNCaP C-81 cells in an androgen-depleted environment.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2003 Feb 6 22(5) 781-96",
                "id": "12569372"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7de0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "ERK1/2 are the Raf effectors for suppression of integrin activation, and PEA-15 reverses suppression by binding ERK1/2.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Dec 26 278(52) 52587-97",
                "id": "14506247"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ddf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1998 Jan 23 273(4) 2052-8",
                "id": "9442043"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7dde"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "For the PAR2 receptor expressed in NIH3T3 cells, b-arrestin-mediated ERK activation leads to reorganization of the actin cytoskeleton, polarized pseudopod extension, and chemotaxis with enrichment of a PAR2/b-arrestin scaffolding complex in the pseudopodia (Ge et al., 2003).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2006 Dec 8 24(5) 643-52",
                "id": "17157248"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ddd"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "OUr results indicted that AURKA was a direct downstream target of MAPK1",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2006 Aug 10 25(35) 4831-9",
                "id": "16532023"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ddc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Pretreatment of LNCaP cells with SB202190, PD98059, or tyrphostin AG879 [p38 mitogen-activated protein kinase (MAPK), MAP/extracellular signal-regulated protein kinase kinase 1/2, and ErbB2 MAPK inhibitors, respectively) but not wortmannin (PI3-kinase inhibitor) blocked IL-6-mediated induction of the PSA promoter, which demonstrates that IL-6 activity is dependent on a MAPK pathway.",
              "citation": {
                "type": "PubMed",
                "name": "Clin Cancer Res 2001 Jun 7(6) 1773-81",
                "id": "11410519"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ddb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "In this study, we have shown that E(2) induces a slow but persistent activation of Erk in MCF-7 breast carcinoma cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Jun 21 277(25) 22558-65",
                "id": "11960991"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7dda"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Figure 3 Activation of ERKs by IL-1b and TNFa in ventricular myocytes. ",
              "citation": {
                "type": "PubMed",
                "name": "J Mol Cell Cardiol 1999 Dec 31(12) 2087-99",
                "id": "10640438"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7dd9"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "myocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "(c) the phosphorylation of the extracellular signal-regulated protein kinases 1 and 2 (ERK1/2);",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Physiol 2004 Sep 200(3) 428-39",
                "id": "15254971"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7dd8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Ras acting via Erk MAP kinases causes phosphorylation of Smad2 and Smad3 at specific sites in the region linking the DNA-binding domain and the transcriptional activation domain.",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 1999 Apr 1 13(7) 804-16",
                "id": "10197981"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7dd7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "carcinoma of breast",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "The MAP kinase phosphorylation and cell proliferation were suppressed by diphenylene iodonium chloride, an NADPH oxidase inhibitor, and by calphostin C, a protein kinase C (PKC)-specific inhibitor.",
              "citation": {
                "type": "PubMed",
                "name": "Liver Int 2005 Oct 25(5) 1018-26",
                "id": "16162162"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7dd6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "hepatic stellate cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Time course experiments clearly indicated NGF-induced transient phosphorylation in ECs of all three major signaling molecules Erk1/2, Akt and PLCg. The NGF-induced phosphorylation of these signaling molecules was blocked by K252a, a TrkA inhibitor, confirming that these signaling pathways are initiated by NGF-stimulated TrkA receptors in ECs. ",
              "citation": {
                "type": "PubMed",
                "name": "Vascul Pharmacol 53(3-4) 107-14",
                "id": "20434587"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7dd5"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 1995 Nov 108 ( Pt 11) 3599-609",
                "id": "8586671"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7dd4"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "The second subfamily comprises DUSP6, DUSP7 and DUSP9. They consist of 3 exons, are cytoplasmic in their subcellular localization and preferentially recognize ERK1 and ERK2 in vitro.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Drug Discov 2007 May 6(5) 391-403",
                "id": "17473844"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7dd3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Mitogen-activated protein kinases such as ERK phosphorylate and activate MNK1, which in turn is able to phosphorylate eIF4E",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2001 Dec 1(3) 222-31",
                "id": "11902577"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7dd2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Immunoblot analysis of lysates of mesangial cells with a phospho-Erk1/2-specific antibody that specifically recognizes the activated form of Erk1/2 type MAPK showed a time-dependent increase in activation of MAPK in response to EGF (Fig. 5A).",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Renal Physiol 2005 Jul 289(1) F72-82",
                "id": "15701816"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7dd1"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "mesangial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "disrupted the growth factor-stimulated activation of Erk and the dephosphorylation of Pyk2",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2001 Dec 21(23) 8068-81",
                "id": "11689697"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7dd0"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Also, inhibitors of Src and of Erk1/2 kinases markedly reduced NE-stimulated R2 expression.",
              "citation": {
                "type": "PubMed",
                "name": "Exp Cell Res 2002 Apr 1 274(2) 207-15",
                "id": "11900481"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7dcf"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "brown adipocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "The FAK-ERK1/2 pathway, a genistein-sensitive tyrosine kinase, and a distinct classical/novel PKC appear selectively required for increased production of collagen XII in cells under tensile stress,",
              "citation": {
                "type": "PubMed",
                "name": "Biochim Biophys Acta 2003 Feb 17 1593(2-3) 239-48",
                "id": "12581868"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7dce"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "ANG II activates Src leading to an increase in ERK1/ERK2 phosphorylation and an increase in NOS protein in PAECs",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2007 Jun 292(6) C2185-96",
                "id": "17329403"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7dcd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Expression of wild-type (wt) Cbp remarkably suppressed EGF-induced activation of Src, ERK1/2, and Akt-1 enzymes, and NIH3T3 cell transformation, as well as colony formation of a breast cancer cell line (MDA-MB-468) in soft agar.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2006 Sep 7 25(40) 5495-506",
                "id": "16636672"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7dcc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jun 18 279(25) 26143-8",
                "id": "15073167"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7dcb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Plasminogen, fibrinogen, and P2-C suppressed apoptosis via activation of Akt and ERK1/2 kinases, while angiostatin and P1 failed to activate these prosurvival pathways and did not prevent neutrophil apoptosis. ",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2008 Sep 1 181(5) 3609-19",
                "id": "18714035"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7dca"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Taken together, RhoA, ROCK, p38MAPK, ERK1/2, and p47(PHOX) may be subsequently activated, leading to activation of NADPH oxidase to produce superoxide. ",
              "citation": {
                "type": "PubMed",
                "name": "Exp Mol Med 2005 Dec 31 37(6) 575-87",
                "id": "16391519"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7dc9"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "SOCS6 reduced SCF-induced activation of ERK1/2 and p38",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jan 5",
                "id": "14707129"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7dc8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "upregulation of fatty acid metabolism during in vitro transformation of human mammary epithelial cells and in breast cancer cells was driven by increased MAP kinase and PI 3-kinase signaling, which increased SREBP-1 levels",
              "citation": {
                "type": "PubMed",
                "name": "Exp Cell Res 2003 Jan 15 282(2) 132-7",
                "id": "12531699"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7dc7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Cot expression has been shown to induce ERK and JNK activation",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Nov 21 278(47) 47089-97",
                "id": "12975377"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7dc6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "KGF treatment increased phosphorylation of ERK1/2",
              "citation": {
                "type": "PubMed",
                "name": "Exp Hematol 2002 Apr 30(4) 297-305",
                "id": "11937263"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7dc5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Subsequent kinetic analyses and transfection studies demonstrated that VHR specifically dephosphorylates and inactivates ERK1 and ERK2 in vitro and in vivo.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 May 7 274(19) 13271-80",
                "id": "10224087"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7dc4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Overexpression of gene 33 protein in mouse fibroblasts inhibited (i) cell proliferation driven by ErbB-2 but not by serum and sustained activation of ERK 1 and 2 by ErbB-2 but not by serum.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2000 Oct 20(20) 7735-50",
                "id": "11003669"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7dc3"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "The haematopoietic protein tyrosine phosphatase (HePTP) is a negative regulator of the MAP kinases Erk1, Erk2 and p38.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 1999 Sep 1(5) 305-11",
                "id": "10559944"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7dc2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Nature 1998 May 7 393(6680) 83-5",
                "id": "9590694"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7dc1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Jan 13 281(2) 915-26",
                "id": "16286470"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7dc0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2004 Oct 15 64(20) 7439-46",
                "id": "15492268"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7dbf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2001 Nov 30 289(2) 376-81",
                "id": "11716483"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7dbe"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Exposure of SCLC or PNECs to NNK or nicotine increased expression of the a7nAChR and caused influx of Ca2+, activation of PKC, Raf-1, ERK1/2, and c-myc, resulting in the stimulation of cell proliferation.",
              "citation": {
                "type": "PubMed",
                "name": "Mutat Res 659(3) 221-31",
                "id": "18495523"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7dbd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasm",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "AG 1478 (EGF receptor tyrosine kinase inhibitor), PD 98059 (ERK1/2 inhibitor), and SB 203580 (p38 inhibitor) significantly inhibited EGF-induced p11 expression.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Oct 11 277(41) 38431-40",
                "id": "12163506"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7dbc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2003 Mar 1 101(5) 1818-26",
                "id": "12406907"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7dbb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "The present study confirmed that Ang II elicits a rapid and robust phosphorylation of ERK1/2 with a peak at 10 min in HSCs in a time-dependent manner, as demonstrated byWestern blot (Fig. 8A,B).",
              "citation": {
                "type": "PubMed",
                "name": "Regul Pept 2007 Jan 10 138(1) 15-25",
                "id": "16971004"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7dba"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "hepatic stellate cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "beta 2 receptors can also couple to Gi proteins, resulting in stimulation of of the ERK and p38 MAPK pathways.  Activation of this pathway by the beta 2 receptor requires that the receptor be phosphorylated by PKA",
              "citation": {
                "type": "PubMed",
                "name": "J Allergy Clin Immunol 2006 Jan 117(1) 18-24; quiz 25",
                "id": "16387578"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7db9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "IGF1 stimulates the phosphorylation of ERK1/2.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Jul 13 276(28) 26699-707",
                "id": "11323435"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7db8"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Nov 23 276(47) 44315-22",
                "id": "11551923"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7db7"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Overexpression of Naf1 alpha suppressed ERK2 entering into the nucleus and inhibited the ERK2-dependent Elk1-driven luciferase transcription, suggesting Naf1 alpha to be an attenuator of activated ERK2 signaling.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2002 Sep 13 297(1) 17-23",
                "id": "12220502"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7db6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "In turn, this impaired ERK1/2 activation in K8-null hepatocytes is associated with a drastic reduction in c-Flip protein, an event that also holds in a K8-null mouse mammary cell line.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Aug 24(16) 7072-81",
                "id": "15282307"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7db5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Moreover, CXCR4-evoked activation of extracellular signal-regulated kinase 1/2 (ERK1/2) was attenuated by CyPA RNAi, by overexpression of a PPIase-deficient mutant of CyPA (CyPA-R55A), and by pretreatment of the immunosuppressive drugs, cyclosporine A and sanglifehrin A.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2008 Jan 4 283(1) 623-37",
                "id": "17991743"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7db4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "These results indicate that ERK-1/ ERK-2 signaling and transcriptional activation through AP-1 and NF-kappaB are essential for the induction of IL-8 expression in mononuclear phagocytes in response to CPPD and MSU crystals.",
              "citation": {
                "type": "PubMed",
                "name": "Arthritis Rheum 2000 May 43(5) 1145-55",
                "id": "10817569"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7db3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Smoke exposure of GM-Ms also resulted in the rapid activation of the MAP kinases ERK and p38 (Figure 4).",
              "citation": {
                "type": "PubMed",
                "name": "Exp Lung Res 2008 Nov 34(9) 599-629",
                "id": "19005923"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7db2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "This report describes the identification of a consensus ERK phosphorylation site in the linker region of Smad4 at Thr276.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2003 Oct 285(4) C823-30",
                "id": "12801888"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7db1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2001 Sep 21(17) 5958-69",
                "id": "11486034"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7db0"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Recombinant HVH2 phosphatase exhibited a high substrate specificity toward activated ERK and dephosphorylated both threonine and tyrosine residues of activated ERK1 and ERK2",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1995 Mar 31 270(13) 7197-203",
                "id": "7535768"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7daf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Inhibition of MEK1 significantly inhibited extracellularly regulated kinase (ERK)1/2 activation and insulin-regulated Gene33 transcription and protein levels in H4IIE cells.",
              "citation": {
                "type": "PubMed",
                "name": "Biochim Biophys Acta 2004 Sep 17 1679(3) 248-55",
                "id": "15358516"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7dae"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "We show that both HSP60s activate the stress-activated protein kinases p38 and JNK1/2, the mitogen-activated protein kinases ERK1/2, and the I-kappaB kinase (IKK).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Aug 17 276(33) 31332-9",
                "id": "11402040"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7dad"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Preincubation with GF109203X, a PKC inhibitor, significantly reduced the level of early (3 min) IL-8-induced p47phox phosphorylation (Fig. 4A), but had no effect on the level of later (15 min) IL-8-induced p67phox phosphorylation (Fig. 4B). Furthermore, ERK1/2 and Akt/PKB phosphorylation transiently peaked after exposure to IL-8 for 3min (Fig. 4C).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Nov 4 280(44) 37021-32",
                "id": "16115878"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7dac"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Accordingly, NOX4 activation was associated with intracellular ERK1/2 signaling and phosphorylation of nuclear or ER proteins, such as retinoblastoma protein and eukaryotic translation initiation factor 4E binding protein-1, thereby mediating smooth muscle cell proliferation and hypertrophy (186,193).",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2008 Mar 15 44(6) 938-55",
                "id": "18164271"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7dab"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "The inhibition of ERK1/2 increases the activity of STAT3, which, in turn, enhances the hypertrophic effect of CT-1.",
              "citation": {
                "type": "PubMed",
                "name": "Chin Med J (Engl) 2004 Aug 117(8) 1135-42",
                "id": "15361284"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7daa"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "cardiomyocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Apr 12 277(15) 12710-7",
                "id": "11821415"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7da9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "In VSMCs, ERK1/2 phosphorylation induced by Ang II was abrogated in cells pretreated with AG 1024, a highly selective inhibitor of IGF-1R-PTK (46) ",
              "citation": {
                "type": "PubMed",
                "name": "Cell Biochem Biophys 2007 47(1) 1-10",
                "id": "17406055"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7da8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Nov 5 274(45) 32333-41",
                "id": "10542274"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7da7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Endocrinol 2000 Oct 14(10) 1557-69",
                "id": "11043572"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7da6"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "These data suggest that Spred-1 negatively regulates hematopoiesis by suppressing not only SCF-induced but also IL-3-induced ERK activation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Dec 10 279(50) 52543-51",
                "id": "15465815"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7da5"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "SSB-1 also enhanced HGF-induced Erk phosphorylation",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Apr 22 280(16) 16393-401",
                "id": "15713673"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7da4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "EGF and thrombin triggered a rapid activation of the EGF receptor, followed by the phosphorylation and activation of the extracellular signal-regulated protein kinase (ERK)",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biochem 2002 85(2) 381-91",
                "id": "11948693"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7da3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "UVBcaused phosphorylation of ERK1/2 (Fig. 1A) and Akt (Fig. 1D) was strongly enhanced by silibinin pre-treatment at 100 M dose without any change in their total protein levels.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 May 27 280(21) 20375-83",
                "id": "15792956"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7da2"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "epidermal growth factor induces immediate, ERK1/ERK2-dependent activation of endogenous ribosomal transcription inactivation of ERK1/ERK2 causes an equally immediate reversion to the basal transcription level",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2001 Nov 8(5) 1063-73",
                "id": "11741541"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7da1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Erk phosphorylates serine residues in the linker regions of Smad1 (Kretzschmar et al., 1997), Smad2 and Smad3 (Kretzschmar et al., 1999), and substitution of these serines by negatively charged residues inhibits nuclear translocation of Smads and thus signalling.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 2001 Dec 114(Pt 24) 4359-69",
                "id": "11792802"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7da0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Further analysis reveals that expression of beta-arrestin2 strengthened CXCR4-mediated activation of both p38 MAPK and ERK, and the suppression of beta-arrestin2 expression blocked the activation of two kinases",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Dec 20 277(51) 49212-9",
                "id": "12370187"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d9f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "S100A4 is a direct target of ERBB2 signaling in medulloblastoma cells via a pathway involving phosphatidylinositol 3-kinase, AKT1, and extracellular signal-regulated kinase 1/2",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2003 Jan 1 63(1) 140-8",
                "id": "12517790"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d9e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "we reported in H9C2 cardiomyocytes that peroxynitritemediated activation of ERK, although dependent on Raf-1 and MEK, was not due to upstream activation of p21ras (63).",
              "citation": {
                "type": "PubMed",
                "name": "Front Biosci 2009 14 4809-14",
                "id": "19273391"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d9d"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "cardiomyocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "exercise leads to the activation of at least three MAPK signalling pathways, i.e. ERK1/2, p38 MAPK and JNK, in skeletal muscle (Zierath, 2002).",
              "citation": {
                "type": "PubMed",
                "name": "Proc Nutr Soc 2004 May 63(2) 227-32",
                "id": "15294035"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d9c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Muscle, Skeletal"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Depletion of cholesterol from the cells using beta-cyclodextrin blocked insulin stimulation of glucose uptake, insulin inhibition of perilipin phosphorylation in response to isoproterenol, and insulin stimulation of protein kinase B and Map-kinases extracellular signal-related kinase (ERK)1/2 phosphorylation",
              "citation": {
                "type": "PubMed",
                "name": "Eur J Biochem 2004 Jun 271(12) 2471-9",
                "id": "15182363"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d9b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Ectopic expression of the wild type APS, but not C-terminal truncated APS, in NIH3T3 fibroblasts suppressed PDGF-induced MAP kinase (Erk2) activation, c-fos and c-myc induction as well as cell proliferation.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1999 Jan 21 18(3) 759-67",
                "id": "9989826"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d9a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "nduction of IL-1beta caused by CSE was dependent on ERK1/2 and NF-{kappa}B in the human alveolar type II-like epithelial cell line A549 and HBEC. Surprisingly, phosphorylated I{kappa}B levels were decreased in a dose-dependent manner in spite of sustained activation of NF-{kappa}B (113).",
              "citation": {
                "type": "PubMed",
                "name": "Physiol Rev 2007 Jul 87(3) 1047-82",
                "id": "17615396"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d99"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "bronchial epithelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1999 Oct 19(10) 7203-15",
                "id": "10490655"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d98"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Mnk1, activated by phosphorylation with Erk2, phosphorylates the eukaryotic initiation factor (eIF) 4E and the eIF4G components of eIF4F.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Sep 10 279(37) 38649-57",
                "id": "15234964"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d97"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2001 Oct 4 20(45) 6531-7",
                "id": "11641777"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d96"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "TNIP1 attenuates the EGF/ERK2 nuclear signal ",
              "citation": {
                "type": "PubMed",
                "name": "Expert Rev Clin Immunol 2009 Jul 5(4) 433-43",
                "id": "20477039"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d95"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Sep 10 279(37) 38921-35",
                "id": "15247285"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d94"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "activation of extracellular signal-regulated kinase 1/2 (ERK1/2) and matrix metalloproteinase-9 (MMP-9) by thrombin was inhibited by the EGFR inhibitor AG1478 and in Nox1 KO SMCs",
              "citation": {
                "type": "PubMed",
                "name": "Cardiovasc Res 2012 Mar 1 93(3) 406-13",
                "id": "22102727"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d93"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Stimulation of G1E-ER2 cells by SCF resulted in significant but only transient activation of ERK-1 and ERK2. Activation peaked 10 minutes after SCF stimulation and dropped to baseline thereafter. When alpha5beta1 integrin was activated by fibronectin peptide, SCF strongly induced ERK-1 and ERK-2 activation as early as 10 minutes after stimulation that persisted and reached maximum levels at 120 minutes.",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2001 Apr 1 97(7) 1975-81",
                "id": "11264161"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d92"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "\\\"SB-202190\\\"-dependent increase in LDL receptor expression was accompanied by induction of p42/44(MAPK)",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Jul 9 274(28) 19593-600",
                "id": "10391894"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d91"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Further results showed that VEGFA induced the activation of JNK/SAPK, p38 kinase and extracellular signal-regulated kinases 1 and 2 (ERK1/2), while JNK/SAPK inhibitor SP600125 and specific siRNA both blocked all those angiogenic effects induced by VEGFA. ",
              "citation": {
                "type": "PubMed",
                "name": "Cell Biochem Biophys 2012 May 17",
                "id": "22592917"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d90"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Thus, FGF2-induced cell survival is a progressive adaptive phenomenon involving ERK2 activation by excreted FGF1",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1999 Dec 9 18(52) 7584-93",
                "id": "10602518"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d8f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2003 Mar 1 170(5) 2427-34",
                "id": "12594266"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d8e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Mol Endocrinol 1999 Apr 13(4) 555-65",
                "id": "10194762"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d8d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Together, the results show that K/E-FR3 is transforming and that the Ras-ERK and the PI3K-Akt signaling pathways, which are positively regulated by SHP2, are important for K/E-FR3-induced transformation.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2003 Oct 9 22(44) 6909-18",
                "id": "14534538"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d8c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "The NADPH oxidase subunits p67 and p47 undergo phosphorylation by ERK1/2 and stimulate the production of reactive oxygen species.95 ##phosphorylation of p67 and p47 is scripted as increased activity of NADPH oxidase##",
              "citation": {
                "type": "PubMed",
                "name": "N Engl J Med 2009 May 7 360(19) 1989-2003",
                "id": "19420368"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d8b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "ERK directly phosphorylates SGK at Ser78 and indirectly activates SGK at Thr256 and Ser422 through unknown intermediate molecules. ",
              "citation": {
                "type": "PubMed",
                "name": "Eur J Neurosci 2006 Mar 23(5) 1311-20",
                "id": "16553792"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d8a"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Recently, serine phosphorylation of Stat3 on Ser-727 by ERK has been identified in response to epidermal growth factor (EGF).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Oct 22 274(43) 31055-61",
                "id": "10521505"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d89"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 1995 Mar 6(3) 273-82",
                "id": "7612963"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d88"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "GRP induced rapid activation of p44/42 MAPK in lung cancer cells through EGFR.",
              "citation": {
                "type": "PubMed",
                "name": "Neoplasia 2005 Apr 7(4) 426-31",
                "id": "15967120"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d87"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Carcinoma, Non-Small-Cell Lung",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "The 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced activation of ERK1/2 through the phosphorylation of threonine and tyrosine at 202 and 204, respectively",
              "citation": {
                "type": "PubMed",
                "name": "Mol Carcinog 2006 Jan 45(1) 26-37",
                "id": "16267831"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d86"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "overexpression of wild-type PTEN in the MCF-7 breast cancer line results in phosphatase activity-dependent decreases in the phosphorylation of ETS-2 PTEN blocks insulin-stimulated ETS-2 phosphorylation Our observations, therefore, suggest that PTEN blocks insulin-stimulated ETS-2 phosphorylation through inhibition of the ERK members of the MAP kinase family",
              "citation": {
                "type": "PubMed",
                "name": "Hum Mol Genet 2002 Jul 15 11(15) 1687-96",
                "id": "12095911"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d85"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Additionally, Mig and SDF-1alpha activated MAPKs p44/42 and p38 on melanoma cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Nov 30 276(48) 45098-105",
                "id": "11571298"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d84"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Invest 1998 Jan 1 101(1) 153-9",
                "id": "9421477"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d83"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "The nuclear export of Bach1 was dependent on Crm1/Exportin-1 as well as the extracellular signal-regulated kinase-1/2 (ERK1/2) activity.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Dec 5 278(49) 49246-53",
                "id": "14504288"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d82"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Jun 4 274(23) 16377-86",
                "id": "10347197"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d81"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "ERK2, upon activation, it translocates to the nucleus of the stimulated cell, where it phosphorylates nuclear targets",
              "citation": {
                "type": "PubMed",
                "name": "Cell 1998 May 15 93(4) 605-15",
                "id": "9604935"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d80"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "CD43 ligation resulted in enhanced formation of Vav.SLP-76 complexes and in the activation and nuclear translocation of ERK2.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1998 Jun 5 273(23) 14218-24",
                "id": "9603925"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d7f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "\\\"Erythropoietin-induced serine 727 phosphorylation of STAT3 in erythroid cells is mediated by a MEK-, ERK-, and MSK1-dependent pathway.\\\"",
              "citation": {
                "type": "PubMed",
                "name": "Exp Hematol 2003 May 31(5) 398-405",
                "id": "12763138"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d7e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "erythrocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Here, we demonstrate that stimulation of Rat-2 or embryonic stem cells with activators of ERK1/2 or of cAMP-dependent protein kinase induced phosphorylation of endogenously expressed LKB1 at Ser(431).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Jun 1 276(22) 19469-82",
                "id": "11297520"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d7d"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "embryonic stem cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Histamine induced a time-dependent, H1 receptor-mediated activation of p38 MAP kinase (p38), p44/42 MAP kinase (ERK), and c-jun terminal NH2 kinase (JNK).",
              "citation": {
                "type": "PubMed",
                "name": "Circulation 2005 Jul 19 112(3) 341-9",
                "id": "16009787"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d7c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "An important finding is that intact BRCA1 also prevents EGF and IGF-I signaling through ERK to cell proliferation. EGF and IGF-1 are strongly implicated in the biology of human breast cancer, where they signal through this member of the MAP kinase family to cell growth (27, 52).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Jul 24(13) 5900-13",
                "id": "15199145"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d7b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Aug 22 278(34) 32448-56",
                "id": "12794087"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d7a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Oct 29 279(44) 45685-92",
                "id": "15337761"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d79"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "The expression of cyclin D1 in mid-G1 phase is associated with sustained ERK activity, and we show here that Rho is required for the sustained ERK signal.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2001 Nov 3(11) 950-7",
                "id": "11715015"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d78"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "we show that Ang II-induced serine phosphorylation of STAT3 in VSMCs is mediated by mitogen-activated protein kinase and that dephosphorylation is mediated by protein phosphatase 2A (PP2A).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Jul 9 274(28) 19846-51",
                "id": "10391929"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d77"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": "vascular smooth muscle"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": " As can be seen in Figure 5B, VEGF-induced ERK phosphorylation in MM.1S and patient MM cells (Figure 5A) was inhibited by 60-minute pretreatment with anti-VEGF antibody (Figure 5A), confirming specific VEGF signaling.",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2001 Jul 15 98(2) 428-35",
                "id": "11435313"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d76"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Multiple Myeloma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Binding of (pro)renin to the receptor mediates (pro)renin cellular effects by activating MAP kinases ERK1/2.",
              "citation": {
                "type": "PubMed",
                "name": "Bull Acad Natl Med 2004 188(4) 621-8; discussion 628-9",
                "id": "15587681"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d75"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Eur J Immunol 2004 Feb 34(2) 587-97",
                "id": "14768064"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d74"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2001 Aug 15 61(16) 6050-4",
                "id": "11507052"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d73"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "We show that Cdc2 inhibits EGF-mediated ERK activation through direct interaction and phosphorylation of several ERK pathway proteins, including the guanine nucleotide exchange factor, Sos-1, and Raf-1 kinase.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Jul 1 280(26) 24524-31",
                "id": "15888452"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d72"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Upstream proteins known to phosphorylate BAD include Akt, extracellular signal-regulated kinase/mitogen-activated protein kinase (Erk/ MAPK), Pim-1 and Pim-2.",
              "citation": {
                "type": "PubMed",
                "name": "Br J Haematol 2006 Sep 134(5) 500-9",
                "id": "16869825"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d71"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "siRNA-mediated RPTP-kappa knockdown resulted in a 2-fold increase of basal phosphorylation of p44 and p42 Erk, in primary human keratinocytes (Fig. 9C). Similarly, RPTP-kappa knockdown resulted in a further 2-fold increase of EGF-induced phosphorylation of Erk (Fig. 9C).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Dec 30 280(52) 42694-700",
                "id": "16263724"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d70"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Neurosci 2003 Dec 24(4) 851-7",
                "id": "14697653"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d6f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2000 Apr 1 95(7) 2391-6",
                "id": "10733512"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d6e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "TPA stimulates increased generation of ROS and initiates the stress-activated protein kinase (SAPK) pathway via protein kinase C (PKC) bII activation (Datta et al., 2000), representing typical characteristics of STASIS...Activation of stress kinases (JNK, MAPK, p38) (Day 2008;  Gao et al., 2008; Kirkham and Rahman, 2006;  Kliment et al., 2008; Koli et al., 2008) ",
              "citation": {
                "type": "PubMed",
                "name": "Biol Chem 2008 Mar 389(3) 211-20",
                "id": "18208352"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d6d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Sep 20 277(38) 35282-8",
                "id": "12084708"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d6c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Mar 24(6) 2499-512",
                "id": "14993287"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d6b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Aug 16 277(33) 29730-6",
                "id": "12055189"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d6a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "The anti-apoptotic effect of calbindin-D28k involves inhibition of glucocorticoid induced caspase 3 activation as well as ERK activation.",
              "citation": {
                "type": "PubMed",
                "name": "J Bone Miner Res 2004 Mar 19(3) 479-90",
                "id": "15040837"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d69"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": " In human macrophages fibrinogen stimulated interleukin (IL)6 expression and ERK (extracellular signal-related kinase) phosphorylation.",
              "citation": {
                "type": "PubMed",
                "name": "Thromb Haemost 2008 Aug 100(2) 301-7",
                "id": "18690351"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d68"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Invest Dermatol 2003 Nov 121(5) 997-1004",
                "id": "14708598"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d67"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "In HepG2 cells, ectopic expression of miR-34a potently inhibited tumor cell migration and invasion in a c-Met-dependent manner. miR-34a directly targeted c-Met and reduced both mRNA and protein levels of c-Met; thus, decreased c-Met-induced phosphorylation of extracellular signal-regulated kinases 1 and 2 (ERK1/2). ",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Lett 2009 Mar 8 275(1) 44-53",
                "id": "19006648"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d66"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "inhibition of extracellular signal regulated kinase (ERK) phosphorylation and p38 mitogen-activated protein kinase (MAPK) activation in response to fMLP by CYL-26z up to 30microM was obtained",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Pharmacol 2006 Sep 14 72(6) 749-60",
                "id": "16887102"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d65"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Eur J Biochem 1995 Jul 15 231(2) 491-7",
                "id": "7635160"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d64"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Finally, we demonstrated that CXCL5 mediates pancreatic cancer-derived angiogenesis through activation of several signaling pathways, including protein kinase B (Akt), extracellular signal-regulated kinase (ERK), and signal transducer and activator of transcription (STAT) in human endothelial cells",
              "citation": {
                "type": "PubMed",
                "name": "Am J Pathol 2011 Mar 178(3) 1340-9",
                "id": "21356384"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d63"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1997 Feb 21 272(8) 5128-32",
                "id": "9030579"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d62"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Insulin induced phosphorylation of IRS-1 followed by complex formation with Grb2 and SOS, activation of RAS/Raf/MEK1/ERK and finally cyclin D expression. MEK inhibitor PD980059 inhibited insulin induced downstream signaling.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Oct 22 279(43) 44344-54",
                "id": "15294900"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d61"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "In many cells PKA inhibits the extracellular receptor kinase (ERK1/2) cascade of the mitogen-activated protein kinase (MAPK) pathway leading to inhibition of cell proliferation.",
              "citation": {
                "type": "PubMed",
                "name": "Hum Mol Genet 2003 Jul 1 12(13) 1475-84",
                "id": "12812976"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d60"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "we found that IL-33R signaling induced a time-dependent activation of Erk1/2, protein kinase B (PKB), JNK1/2, NF-kB, and p38, and degradation of IkB (supplemental Figure 1B).",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2010 May 13 115(19) 3899-906",
                "id": "20200353"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d5f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "mast cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2003 Dec 23(24) 9389-404",
                "id": "14645548"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d5e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "These stimulatory effects of IL-6 were paralleled by time-dependent increases in the phosphorylation of JNK and ERK1/2, respectively (Fig. 1b and d).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2007 Mar 27(6) 2372-83",
                "id": "17242212"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d5d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "umbilical vein endothelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Thus, thrombin suppresses eNOS and upregulates ECE-1 expression via Rho/ROCK and ERK pathway, respectively.",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 2001 Sep 28 89(7) 583-90",
                "id": "11577023"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d5c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Exposure of rats to the smoke from 5 to 15 cigarettes produced a marked increase in phosphorylation of p38, JNK and ERK2 (maximal inductions of ~2.4-fold, ~2.5-fold and ~1.6-fold, respectively).",
              "citation": {
                "type": "PubMed",
                "name": "Chem Biol Interact 2005 Jun 30 155(1-2) 31-42",
                "id": "15970277"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d5b"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "The ERK pathway is the best characterized of the MAPK pathways. Binding of ANG II to AT1Rs activates ERK1/2 within 5 minutes, and in VSMCs ERK 1/2 activity is blocked by inhibition of PLC, suggesting its dependency on calcium (42).",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2007 Jan 292(1) C82-97",
                "id": "16870827"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d5a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "vascular smooth muscle"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Natl Cancer Inst 2002 Nov 20 94(22) 1704-11",
                "id": "12441326"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d59"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Epo induced tyrosine phosphorylation of ERK1 and ERK2 was markedly reduced in cells expressing mutant Epor.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1994 Nov 25 269(47) 29962-9",
                "id": "7961995"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d58"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "The inhibitor U0126 completely blocked TNF-? release, indicating that TNF-? release in response to CSM exposure is dependent on the activation of erk1/2 (Fig. 3). In contrast, PI3-K inhibitor LY294002 and EGFR-specific inhibitor AG1478 had no effect on CSM-induced TNF-? release by macrophages (",
              "citation": {
                "type": "PubMed",
                "name": "Biochim Biophys Acta 2006 Jun 1762(6) 592-7",
                "id": "16777389"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d57"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": " We show here that neither BAFF nor APRIL was able to induce STAT3 phosphorylation but did activate ERK1/2 and PI3K/Akt pathways.",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2004 Apr 15 103(8) 3148-57",
                "id": "15070697"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d56"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Multiple Myeloma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "ERK activation in macrophages by TLR4 and -7 is mediated via a MAP3K, called TPL2/COT, which under unstimulated conditions is associated with NF kappa B1 p105, a member of the I kappa B family of proteins. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Immunol 2007 Jul 44(15) 3715-23",
                "id": "17507094"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d55"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "These observations indicate that phosphorylation of Ser 362 and Ser 374 prime c-Fos for additional growth factor-regulated phosphorylation... ERK phosphorylates Thr 325 and Thr 331 in primed c-Fos.   [Figure 2c shows the experimental results, done with ERK 1/2.]",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2002 Aug 4(8) 556-64",
                "id": "12134156"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d54"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "To address this, 293T cells were transfected with constructs for beta2AR, HA-tagged hSpry2, and FLAG-tagged ERK2....The data shown in Fig. 5 demonstrate that ERK2 phosphorylation was elevated 5 min after isoprenaline addition and that this level was sustained for the next 25 min at least. hSpry2 substantially inhibited ERK2 phosphorylation to the degree that any level of phosphorylation in the data shown was only evident at 5 min.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Feb 1 277(5) 3195-201",
                "id": "11698404"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d53"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "The amounts of IL-1Ra stimulated by WPE or beta-LG + alpha-LA significantly reduced the IL-1 activity in EL4 cells. Inhibitors of p38 and extracellular signal-regulated kinases (ERK)1/2 mitogen-activated protein kinase, and nuclear factor-kappaB cascades reduced neutrophil production of IL-1Ra.",
              "citation": {
                "type": "PubMed",
                "name": "J Nutr 2010 Feb 140(2) 382-91",
                "id": "20032479"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d52"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "The anti-apoptotic effect of calbindin-D28k involves inhibition of glucocorticoid induced caspase 3 activation as well as ERK activation.",
              "citation": {
                "type": "PubMed",
                "name": "J Bone Miner Res 2004 Mar 19(3) 479-90",
                "id": "15040837"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d51"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "osteoblast",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "The ability of TNF-alpha to activate ERKs was also confirmed by the ability of the MEK inhibitor, PD098059 [43], to attenuate both in vitro kinase activity and ERK phosphorylation in a concentration-dependent manner",
              "citation": {
                "type": "PubMed",
                "name": "J Leukoc Biol 1998 Oct 64(4) 537-45",
                "id": "9766635"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d50"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "This survival-promoting activity is totally due to IL-10 stimulating the insulin receptor substrate-2/PI 3-kinase/Akt pathway, which increases the anti-apoptotic activity of ERK1/2.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2001 Oct 15 167(8) 4436-42",
                "id": "11591769"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d4f"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Cytosolic b-arrestins are phosphorylated: S412 in b-arrestin1 by the extracellular regulated kinase (ERK) mitogen-activated protein (MAP) kinase (Lin et al., 1999), T383 in rat (Lin et al., 2002) or T382 in bovine b-arrestin2 by casein kinase II (Kim et al., 2002).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2006 Dec 8 24(5) 643-52",
                "id": "17157248"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d4e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "siRNA-mediated depletion of B-Raf reduced cell proliferation by up to 65% through the inhibition of ERK1/2 activation, irrespective of the mutational status of B-Raf.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Apr 7 281(14) 9238-50",
                "id": "16452469"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d4d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "VEGF-induced PGI2 production is mediated via ERK1/2-dependent activation of cytosolic phospholipase A2",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2001 Jun 280(6) C1375-86",
                "id": "11350732"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d4c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "In cells stably transfected with empty vector, AVP rapidly stimulated ERK, JNK, and p38 activity (Fig. 7A), similar to what we have previously reported (11). ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Oct 10 278(41) 39830-8",
                "id": "12882977"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d4b"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Overexpression of PLCdelta4 selectively activates protein kinase C-phi and upregulates the expression of epidermal growth factor receptors EGFR/erbB1 and HER2/erbB2, leading to constitutive activation of extracellular signal-regulated kinases 1 and 2 (ERK1/2) pathway in MCF-7 cells. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cancer 2004 May 13 3 15",
                "id": "15140260"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d4a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1995 Dec 1 14(23) 5920-30",
                "id": "8846784"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d49"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "We isolated by two-dimensional gel electrophoresis a PD098059-sensitive phosphoprotein of 38 kDa that we identified, by mass spectrometry, as tropomyosin-1. In fact, H(2)O(2) induced a time-dependent phosphorylation of tropomyosin that was sensitive to inhibition by PD098059 and UO126",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 2003 Apr 14(4) 1418-32",
                "id": "12686598"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d48"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Consistent with the in vivo phosphorylation and inactivation by ras, ERF is efficiently phosphorylated in vitro by Erk2 and cdc2/cyclin B kinases, at sites similar to those detected in vivo.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1995 Oct 2 14(19) 4781-93",
                "id": "7588608"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d47"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Apr 5 277(14) 12144-50",
                "id": "11823472"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d46"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Phosphorylation of both ERKs remained high for 2 h in the T47D/puro cells, whereas it decreased to the basal level in the T47D/5R cells after 2 h.....More striking differences between the two cell lines were observed when cells were stimulated with NDF (Fig. 4B).....Therefore, we conclude that both EGF- and NDF-induced MAPK activation is impaired by the absence of cell surface ErbB-2.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1995 Mar 15(3) 1182-91",
                "id": "7532277"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d45"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "This migration shift of FRS2 is completely abrogated by U0126, a specific MAPK kinase 1 (MEK1) inhibitor, suggesting that ERK1/2 acts as serine/threonine kinase upstream of FRS2.",
              "citation": {
                "type": "PubMed",
                "name": "Biol Chem 2003 Aug 384(8) 1215-26",
                "id": "12974390"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d44"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "ZAK-silencing A549 cells inhibited the expressions of phosphorylated ERK and JNK without affecting the expression of phosphorylated p38 compared with vector control or parental cells (Fig. 3b).",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Sci 2010 Feb 18",
                "id": "20331627"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d43"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Moreover, molecular mechanism studies indicated that NOK could concomitantly activate both MAP kinase and phosphatidylinositol 3'-kinases (PI3K) pathways in stable BaF3 cells.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2004 May 15 64(10) 3491-9",
                "id": "15150103"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d42"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Western blot analysis using phospho-ERK antibodies indicated that serum and PMA rapidly activated ERKs by 0.5-1 min in IMLF+/+  (Fig. 2A).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2009 Apr 3 284(14) 9596-611",
                "id": "19176526"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d41"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "In human colon carcinoma cells, exogenous addition of PAF inhibited proliferation while concomitantly activating Erk, Mek, and Jun N-terminal kinases",
              "citation": {
                "type": "PubMed",
                "name": "FASEB J 2004 Mar 18(3) 568-70",
                "id": "14715700"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d40"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "addition of AG1478 also suppressed ATP-mediated phosphorylation of ERK1/2 and I-?B? (Fig. 4A), indicating the involvement of EGFR activation in these signaling events. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2009 Jun 26 284(26) 17858-67",
                "id": "19386603"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d3f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "The most notable impact on IGF-I signaling was a significant blunting of IGF-I induced increase in S6K1 phosphorylation by PD-98059 coinfusion  approximately 5-fold,",
              "citation": {
                "type": "PubMed",
                "name": "J Appl Physiol 2004 Jan 96(1) 203-10",
                "id": "12959952"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d3e"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Taken together, our data suggest that hyperoxia, by virtue of activating NADPH oxidase, generates reactive oxygen species (ROS), which mediates cell death of lung epithelium via ERK1/2 MAPK activation, and functions upstream of caspase activation in lung epithelial cells.  ",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2003 Mar 28(3) 305-15",
                "id": "12594056"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d3d"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "To confirm further activation of the AT1 receptor by mechanical stretch without the involvement of AII, we stretched cardiomyocytes prepared from ATG-deficient (ATG?/?) mice, in which AII is not detected14.Mechanical stress activated ERKs in the cardiomyocytes prepared from both neonatal (Fig. 2f, top) and adult ATG?/? mice (Fig. 2f, bottom). ",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2004 Jun 6(6) 499-506",
                "id": "15146194"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d3c"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "cardiomyocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Furthermore, we find that JAM-1-depleted HUVECs failed to activate extracellular signal-related kinase (ERK) in response to bFGF treatment.",
              "citation": {
                "type": "PubMed",
                "name": "Arterioscler Thromb Vasc Biol 2003 Dec 23(12) 2165-71",
                "id": "12958043"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d3b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Mitogen-activated protein (MAP) kinase lies at the convergence of various extracellular ligand-mediated signaling pathways. It is activated by the dual-specificity kinase, MAP kinase kinase or MEK. MAP kinase inactivation is mediated by dephosphorylation via specific MAP kinase phosphatases (MKPs).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1995 Jun 16 270(24) 14587-96",
                "id": "7782322"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d3a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "The E2-ER alpha complex rapidly activated multiple signal transduction pathways (i.e., ERK/MAPK, PI3K/AKT) committed to both cell cycle progression and apoptotic cascade prevention.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Physiol 2005 Apr 203(1) 193-201",
                "id": "15389627"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d39"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Nov 15 277(46) 43623-30",
                "id": "12218049"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d38"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Rapid ERK1/2 activation that preceded FAK and paxillin activation was detected",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2005 Nov 289(5) C1343-50",
                "id": "15944210"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d37"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "vascular smooth muscle"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "the CL100 phosphatase has been shown to inactivate p42mapk in vitro",
              "citation": {
                "type": "PubMed",
                "name": "Curr Biol 1995 Mar 1 5(3) 283-95",
                "id": "7780739"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d36"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "We determined the steady-state kinetic parameters of [Tyr(P)185]ERK2 with respect to the phosphorylation of MBP (Fig.1, Table II). The overall rate of substrate processing (k  cat) was ?1000-fold higher than that of [unP]ERK2 and 50-fold lower than that of the fully active [PP]ERK2. The K  m value for ATP, which is 12-fold higher in [unP]ERK2 compared with [PP]ERK2, was completely restored by phosphorylation at Tyr185 alone.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Nov 2 276(44) 40817-23",
                "id": "11524422"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d35"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "The present study indicated that TGF-beta-responsive ERK1/2 and JNK cascades negatively regulate Smad3-induced transcriptional activity as well as ALP activity and mineralization in osteoblasts",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Sep 27 277(39) 36024-31",
                "id": "12130649"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d34"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "A mutant ErbB3 protein was generated in which Tyr-1325 in a consensus Shc phosphotyrosine-binding domain recognition site was mutated to Phe (ErbB3-Y/F). This mutation abolished the association of Shc with ErbB3 and blocked the activation of mitogen-activated protein kinase by heregulin.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1998 Aug 14 273(33) 20996-1002",
                "id": "9694850"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d33"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Expression of activated ALK7 in PC12 cells resulted in activation of Smad2 and Smad3, but not Smad1, as well as the mitogen-activated protein kinases extracellular signal-regulated kinase and c-Jun N-terminal kinase",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Feb 16 276(7) 5140-6",
                "id": "11084022"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d32"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Here, we show that Erk downregulates Forkhead box O 3a (FOXO3a) by directly interacting with and phosphorylating FOXO3a at Ser 294, Ser 344 and Ser 425, which consequently promotes cell proliferation and tumorigenesis",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2008 Feb 10(2) 138-48",
                "id": "18204439"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d31"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Hydrogen peroxide treatment of AGS-B cells increased the phosphorylation and kinase activity of ERK-1 and ERK-2, but did not affect Jun kinase tyrosine phosphorylation or kinase activity.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1998 Sep 4 273(36) 23046-54",
                "id": "9722530"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d30"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "91332050;1651323;17081983",
              "citation": {
                "type": "PubMed",
                "name": "BMC Bioinformatics 2004 Jun 22 5 79",
                "id": "15212693"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d2f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2003 May 15 22(19) 2869-81",
                "id": "12771938"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d2e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Estrogen rapidly activates the mitogen-activated protein kinases, Erk-1 and Erk-2, via an as yet unknown mechanism. requires the expression of the G protein-coupled receptor homolog, GPR30. We show that 17beta-estradiol activates Erk-1/-2 not only in MCF-7 cells, which express both estrogen receptor alpha (ER alpha) and ER beta, but",
              "citation": {
                "type": "PubMed",
                "name": "Mol Endocrinol 2000 Oct 14(10) 1649-60",
                "id": "11043579"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d2d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "We have shown that polyamine depletion protects cells against apoptosis and that DFMO increases ERK and integrin ?3-mediated Src activation within 30 min [24].",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2007 Aug 15",
                "id": "17825525"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d2c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "intestinal epithelium"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 May 9 278(19) 16713-9",
                "id": "12609980"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d2b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "GSTP1 overexpression in SAOS-2 osteosarcoma cells caused the cells to be more resistant to doxorubicin and cisplatin. GSTP1 suppression in HOS cells caused more apoptosis and extensive DNA damage in response to doxorubicin and cisplatin. GSTP1 contributes to doxorubicin and cisplatin resistance in osteosarcoma, which may be mediated in part by the activation of extracellular signal-regulated kinase 1/2.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cancer Ther 2007 May 6(5) 1610-9",
                "id": "17513610"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d2a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "osteosarcoma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Fibronectin increased Rho protein expression that was detected at 60 min and stimulated the phosphorylation of Erk1/2 which was detected at both 15 and 60 min in H1838 cells (Fig. 4).",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Lett 2005 Feb 28 219(1) 71-81",
                "id": "15694666"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d29"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Carcinoma, Non-Small-Cell Lung",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "IGF-1 increased active ERK1/2 within 5 min, a response that was ablated by pretreatment with LY294002.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Oct 8 279(41) 42709-18",
                "id": "15304489"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d28"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Fig. 7. (A and B) Simultaneous signalling via VEGFR-2 and VEGFR-3 upon VEGF-C stimulation leads to sustained p42/p44 MAPK activation in HMVECs.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2001 Sep 3 20(17) 4762-73",
                "id": "11532940"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d27"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "PMA (100 nM) and EGF (25 ng/ml) induced the activation of ERK1/ ERK2 in glioblastoma cell lines ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Mar 4 280(9) 7729-38",
                "id": "15618223"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d26"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Nature 1997 Oct 9 389(6651) 618-22",
                "id": "9335504"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d25"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "in embryonic kidney cells expressing full-length DCC, NTN1 causes increased transient phosphorylation and activity of ERK1 and ERK2 but not of JNK1, JNK2 or MAPK14 this phosphorylation was mediated by MAP2K1 (aka MEK1) and/or MAP2K2 (aka MEK2)",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2002 May 23 417(6887) 443-7",
                "id": "11986622"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d24"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Src kinase was phosphorylated and mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/ERK) activated in a time-related fashion after SDF-1 stimulation.",
              "citation": {
                "type": "PubMed",
                "name": "J Hematother Stem Cell Res 2002 Dec 11(6) 923-8",
                "id": "12590707"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d23"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "leukemia",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "prolong treatment (16?18 h) with PMA (Fig. 5A), or with dequalinium (Fig. 2C and D), blocked both PKB and ERK1-2 phosphorylation (Fig. 5B?E). In addition, the SMS inhibitor D609 blocked phosphorylation of PKB and ERK1-2 (Fig. 6),",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 2010 Feb 5 584(3) 517-24",
                "id": "19948174"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d22"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Data in isolated fibroblasts (26,56), neutrophils (57,58), endothelial and vascular smooth muscle cells (5961), neural cells (31,62), cardiomyocytes (63) and whole lung tissue (64) showed that, in addition to other known oxidants, peroxynitrite is also a powerful activator of ERK.",
              "citation": {
                "type": "PubMed",
                "name": "Front Biosci 2009 14 4809-14",
                "id": "19273391"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d21"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Neural Stem Cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "We found that inhibiting ERK1/2 reduced DISC formation relative to JNK, p38 inhibition, suggesing that ERK1/2 pathway may participate in apoptosis (Fig. 3).",
              "citation": {
                "type": "PubMed",
                "name": "J Toxicol Sci 2010 35(1) 33-9",
                "id": "20118622"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d20"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "NGF activates Erk1/Erk2 and JNK but not p38MAPK in J774 cells",
              "citation": {
                "type": "PubMed",
                "name": "Blood 1996 Dec 15 88(12) 4630-7",
                "id": "8977255"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d1f"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "acrolein exclusively increased the phosphorylation of ERK among these MAPK, suggesting a role for the ERK pathway in acrolein-induced 5-LO expression with subsequent production of LTB(4).",
              "citation": {
                "type": "PubMed",
                "name": "Toxicol Appl Pharmacol 2010 May 15 245(1) 76-82",
                "id": "20153347"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d1e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2003 Apr 1 63(7) 1684-95",
                "id": "12670923"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d1d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Biochemistry 2005 Jun 21 44(24) 8890-7",
                "id": "15952796"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d1c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2001 Apr 21(8) 2659-70",
                "id": "11283246"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d1b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "EGF activated the epidermal growth factor receptor to the same extent in SPP-1-expressing cells, yet ERK1/2 activation was impaired.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Aug 13 279(33) 34290-7",
                "id": "15180992"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d1a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "PGF2alpha also induced eIF4E and 4E-BP1 phosphorylation, global protein synthesis and basic fibroblast growth factor-2 (bFGF-2) expression in VSMC",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Apr 30 274(18) 12925-32",
                "id": "10212283"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d19"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "from full text - we found that in turn, ectopic expression of WT and Foxo1 mutants in primary cultures of rat hepatocytes increased the phosphorylation of ERK1/2, JNK1/2, and p38",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 2007 Feb 15",
                "id": "17303659"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d18"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "hepatocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Apr 27 276(17) 14466-73",
                "id": "11278290"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d17"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Wy-L4,643 increases phosphorylation of ERK and p38",
              "citation": {
                "type": "PubMed",
                "name": "Thromb Haemost 2003 Oct 90(4) 611-9",
                "id": "14515181"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d16"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "OsM activates Stat1, Stat3, and MAPK.",
              "citation": {
                "type": "PubMed",
                "name": "Arterioscler Thromb Vasc Biol 1999 Jun 19(6) 1421-9",
                "id": "10364072"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d15"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "We found that activation of the MAPK pathway was responsible for motility, invasion and production of angiogenic factors.",
              "citation": {
                "type": "PubMed",
                "name": "Clin Exp Metastasis 2002 19(4) 301-11",
                "id": "12090470"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d14"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Nov 21 278(47) 47326-39",
                "id": "12963734"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d13"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "ectopic expression of blr1 causes an increase in ERK2 MAPK activation and promotes retinoic acid-induced G(1)/G(0) growth arrest and cell differentiation.",
              "citation": {
                "type": "PubMed",
                "name": "Exp Cell Res 2000 Feb 1 254(2) 287-98",
                "id": "10640427"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d12"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2004 Jul 16 320(1) 108-15",
                "id": "15207709"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d11"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Sep 27 277(39) 36181-7",
                "id": "12110689"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d10"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "expression of a catalytically inactive mutant of SHP-2 in COS cells was shown to block ERK phosphorylation in response to leptin studies in COS cells coexpressing ERK1 and obRa or obRb suggested that the magnitude of ERK phosphorylation in response to leptin was significantly greater in cells transfected with obRb Consequences of ERK activation by leptin are many and include induction of specific gene expression, activating c-fos",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2002 Aug 14(8) 655-63",
                "id": "12020765"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d0f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "...we found that serine 220 was phosphorylated by p42 MAP kinase in vitro....Expression of mutant TTP in fibroblasts confirmed that serine 220 was one of the major, mitogen-stimulated phosphorylation sites on the protein in intact cells",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1995 Jun 2 270(22) 13341-7",
                "id": "7768935"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d0e"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Western blotting showed that both types of flows induced ERK1/2 activation that was inhibited by disruption of heparan sulfate proteoglycans (HSPGs). ",
              "citation": {
                "type": "PubMed",
                "name": "PLoS One 2010 5(8)",
                "id": "20808940"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d0d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "We also observed a transient activation of p42 MAP kinase following activation of Mer by Gas6. Thus, Gas6 exerts its biological effects through multiple receptor tyrosine kinases.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1997 May 1 14(17) 2033-9",
                "id": "9160883"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d0c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Treatment with 1% CSE for 15 min activated ERK1/2 (Fig. 8A, panel 1).",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2008 Oct 295(4) L624-36",
                "id": "18689604"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d0b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Here, we report that in BCR/ABL+ cell lines and in patient-derived CML blast crisis mononuclear and CD34+ cells, p210(BCR/ABL) increases expression and activity of the transcriptional-inducer and translational-regulator heterogeneous nuclear ribonucleoprotein K (hnRNP K or HNRPK) in a dose- and kinase-dependent manner through the activation of the MAPK(ERK1/2) pathway.",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2006 Mar 15 107(6) 2507-16",
                "id": "16293596"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d0a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "We find that although pretreatment of BMMs with IL-4 does not alter M-CSF signaling, it reversibly blocks RANKL-dependent activation of the NF-kappa B, JNK, p38, and ERK signals.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Feb 22 277(8) 6622-30",
                "id": "11719504"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d09"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Interestingly, treatment with specific p38 mitogen-activated protein kinase inhibitors blocks both myotube formation and caveolin-3 expression",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Oct 15 274(42) 30315-21",
                "id": "10514527"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d08"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "We have shown previously that ERF is phosphorylated in vitro and in vivo by Erks at multiple sites. This phosphorylation determines its cytoplasmic localization and inactivation.....ERF nuclear export is dependent on extensive phosphorylation and is a CRM1-dependent process. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Feb 24(3) 1206-18",
                "id": "14729966"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d07"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "The up-regulation of CBP transcriptional activity in response to NGF was, however, prevented by the specific inhibitor of mitogen-activated protein kinase (p42/44(MAPK)) activation, PD98059, which had no effect on the up-regulation induced by cyclic AMP, indicating that activation of the mitogen-activated protein kinase signal pathway is specifically involved in the NGF-induced activation of CBP.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1998 Dec 4 273(49) 32400-7",
                "id": "9829969"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d06"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "We show that phospholipase C gamma, phosphatidylinositol 3-kinase/p70 S6 kinase, Shc, Grb2, Raf-1, and mitogen-activated protein kinase are downstream components of the Nyk/Mer signal transduction pathways. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1995 Dec 15(12) 6582-92",
                "id": "8524223"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d05"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "ITSN-1 knockdown acts as a proapoptotic signal that causes mitochondrial outer membrane permeabilization, dissipation of the mitochondrial membrane potential, and generation of reactive oxygen species.These effects were secondary to decreased activation of Erk1/2 and its direct activator MEK. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 Jun 8 282(23) 17166-78",
                "id": "17405881"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d04"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "The hypertrophic effect of CT-1 was essentially mediated by STAT3, independent of PI3-K, and negatively regulated by ERK1/2 via inhibiting the phosphorylation of STAT3.",
              "citation": {
                "type": "PubMed",
                "name": "Acta Pharmacol Sin 2004 Sep 25(9) 1157-64",
                "id": "15339391"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d03"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "cardiomyocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2005 Feb 25(3) 907-20",
                "id": "15657420"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d02"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Oct 29 274(44) 31223-8",
                "id": "10531317"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d01"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2002 Sep 15 169(6) 2851-60",
                "id": "12218097"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7d00"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "The activation of Erk1/2 by Mos, but not by MosKD, was shown by immunoblotting using antibodies specific to residues phosphorylated by Mek1/2 (34, 48) (Fig. 3B).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2007 Jun 27(11) 3936-50",
                "id": "17371847"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7cff"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Induction of TGF-alpha caused increased pERK1/2 as measured by Western blot of whole-lung homogenate (Figures 1A) ",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2012 Mar 46(3) 380-8",
                "id": "22021337"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7cfe"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "CD40 lacks intrinsic catalytic activity, but the cytoplasmic domain of CD40 has two binding sites for TRAF...TRAFs 1, 2, 3, 5, and 6 have been found in association with CD40, and these adaptors couple CD40 to the phosphoinositide 3-kinase (PI3K), phospholipase C (PLC-), mitogen-activated protein kinase (MAPK-ERK, p38, and JNK), and nuclear factor B (NF-B) signaling pathways",
              "citation": {
                "type": "PubMed",
                "name": "Sci STKE 2004 Jun 15 2004(237) pe25",
                "id": "15199223"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7cfd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "TRAF6 activates the extracellular signalregulated kinases (ERK) 1 and 2 as well as p38 mitogen-activated protein kinase (MAPK),11,118125",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 2001 Dec 7 89(12) 1092-103",
                "id": "11739273"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7cfc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "the effect of phosphorylation by ERK of PDE4 long isoforms is to cause their inhibition",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Soc Trans 2003 Dec 31(Pt 6) 1186-90",
                "id": "14641023"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7cfb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Feb 11 275(6) 4475-83",
                "id": "10660621"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7cfa"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "These results suggest that CpG ODN activates the TLR9-MyD88-ERK1/2 pathway causing expression of Egr-1 and its target genes such as TF and Nab2, thus inducing foam cell formation.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2009 Dec 11 390(2) 196-200",
                "id": "19737531"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7cf9"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "AVP induces extracellular signal-related kinase, ERK1 [p44mapk] and ERK2 [p42mapk] activation, a response prevented by treatment with mitogen-activated protein kinase kinase",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2002 Mar 282(3) C434-50",
                "id": "11832328"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7cf8"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Inhibition of Cam (using a dominant negative) was sufficient to block GnRH-induced ERK",
              "citation": {
                "type": "PubMed",
                "name": "Mol Endocrinol 2005 Sep 19(9) 2412-23",
                "id": "15890671"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7cf7"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "ER81 is activated by many signals through phosphorylation directly mediated by mitogen-activated protein kinases (MAPKs), but also by an unknown protein kinase",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2003 Feb 6 22(5) 746-55",
                "id": "12569367"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7cf6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2002 Jul 1 62(13) 3729-35",
                "id": "12097282"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7cf5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "In summary, these data demonstrate that adiponectin initially increases TNF alpha production by macrophages via ERK1/2 Egr-1 and NFkB-dependent mechanisms; these increases in TNF-alpha in turn lead to increased expression of interleukin-10 and an eventual dampening of LPS-mediated cytokine production in macrophages. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 Jul 27 282(30) 21695-703",
                "id": "17537727"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7cf4"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Oct 6 275(40) 31444-50",
                "id": "10896947"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7cf3"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Gene 33 inhibits EGFR autophosphorylation and specifically blunts epidermal growth factor (EGF)-induced activation and/or phosphorylation of Ras, ERK, JNK, Akt/PKB, and retinoblastoma protein.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Jan 28 280(4) 2924-33",
                "id": "15556944"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7cf2"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jun 11 279(24) 25211-8",
                "id": "15069082"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7cf1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1998 Jun 15 17(12) 3372-84",
                "id": "9628874"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7cf0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "transient knockdown of cortactin in serum-supplemented FaDu cells led to decreased activation of Erk and Akt (49).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2010 Nov 30(21) 5057-70",
                "id": "20805359"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7cef"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Head and Neck Neoplasms",
                "cell": "squamous cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Stimulation of EGFR and mitogen-activated protein kinase signaling by GM3 depletion involves the phosphorylation of EGFR at tyrosine residues 845, 1068, and 1148 but not 1086 or 1173. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Dec 5 278(49) 48770-8",
                "id": "14512423"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7cee"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Both early passage and immortalized MEF cells from GSTpi(-/-) animals expressed significantly elevated activity of extracellular signal-regulated kinases ERK1/ERK2, kinases linked to cell proliferation pathways",
              "citation": {
                "type": "PubMed",
                "name": "J Pharmacol Exp Ther 2001 Jul 298(1) 339-45",
                "id": "11408560"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ced"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Ligation of this receptor by EGF activates Erk1 and Erk2, members of the mitogen-activated protein (MAP) kinase family, through a Ras-dependent signal transduction pathway. ",
              "citation": {
                "type": "PubMed",
                "name": "Nature 1998 Oct 15 395(6703) 713-6",
                "id": "9790194"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7cec"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "To assess the effects of Shp2 tyrosyl phosphorylation, we monitored ERK activation by phospho-specific antibody immunoblotting in cells expressing WT Shp2 or the phosphorylation site mutants (Fig. 2). ERK activity induced by FGF (Fig. 2B) or PDGF (Fig. 2C) was decreased in Y542F and Y580F mutant cells compared with WT cells, although it remained higher than that in control (vector alone) cells. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Oct 24 278(43) 41677-84",
                "id": "12923167"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ceb"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "In vitro treatment with activin A increased VEGF secretion, as well as p38 and p42/44 MAPK activity in corneal epithelial cells, whereas concurrent administration of specific inhibitors of p38 or p42/44 MAPK abolished the stimulatory effect of activin A on VEGF production. We conclude that activin A stimulates inflammatory corneal angiogenesis by increasing VEGF levels through a p38 and p42/44 MAPK-dependent mechanism.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Pathol 2004 Apr 164(4) 1293-302",
                "id": "15039217"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7cea"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cell Growth Differ 1999 Oct 10(10) 677-83",
                "id": "10547071"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ce9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "immuno-precipitation of MAPK and its upstream activator, mitogen-activated protein kinase kinase, indicated decreased phosphorylation of MAPK and its kinase in response to insulin in cells exposed to TNF-alpha",
              "citation": {
                "type": "PubMed",
                "name": "Eur J Biochem 1996 May 15 238(1) 214-20",
                "id": "8665940"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ce8"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "We found that KGF induced rapid activation of Akt, p70 S6K, JNK, and extracellular signal-regulated (ERK) ",
              "citation": {
                "type": "PubMed",
                "name": "J Lipid Res 2005 Dec 46(12) 2624-35",
                "id": "16162944"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ce7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Cells were treated with LY294002 prior to CS exposure, and CS-induced ERK1/2 kinase activation was assayed by immunoblot analysis (Fig. 4A). PI3K inhibitor completely blocked CS-stimulated ERK1/2 activation.  # from full text",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Apr 14 281(15) 10174-81",
                "id": "16490785"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ce6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "respiratory epithelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Exposure of cells to alpha2M* (50 pM) induced phosphatidylinositol 3-kinase-dependent activation of Akt by phosphorylation at Thr-308 and Ser-473 with a concomitant 60-80% increase in Akt-associated kinase activity. ERK1/2 and p38 MAPK were also activated",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 May 12 281(19) 13694-707",
                "id": "16543232"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ce5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Prostatic Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "from full text - Furthermore, the decreased expression of either b-arrestin 1 or b-arrestin 2 (via siRNA) resulted in a decrease in ERK1/2 activity",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Apr 21 281(16) 10856-64",
                "id": "16492667"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ce4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "activation of ERK depended on EGFR, Src tyrosine kinase and calcium calmodulin in PC12 cells (31), while requiring ras/Raf-1/MEK activation in human neutrophils (58).",
              "citation": {
                "type": "PubMed",
                "name": "Front Biosci 2009 14 4809-14",
                "id": "19273391"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ce3"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "siRNA-mediated depletion of B-Raf reduced cell proliferation by up to 65% through the inhibition of ERK1/2 activation, irrespective of the mutational status of B-Raf.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Apr 7 281(14) 9238-50",
                "id": "16452469"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ce2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Fig.1",
              "citation": {
                "type": "PubMed",
                "name": "Science 2004 Nov 26 306(5701) 1506-7",
                "id": "15567848"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ce1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "In addition to chemotaxis, Fprs also mediate neutrophil activation by Listeria lysate as shown by increased phosphorylation of extracellular regulatory kinase (Erk) 1/2 in WT mouse neutrophils, which was reduced by Fpr1 or Fpr2 antagonist.",
              "citation": {
                "type": "PubMed",
                "name": "Sci Rep 2012 2 786",
                "id": "23139859"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ce0"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Figure 1. Pathways to MUC5AC expression in COPD",
              "citation": {
                "type": "PubMed",
                "name": "Physiol Rev 2007 Jul 87(3) 1047-82",
                "id": "17615396"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7cdf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "CaMKIV, and p38 MAPK were also the kinases involved in CREB Ser(133) phosphorylation induced by CD3/CD28.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2001 Jan 1 166(1) 284-92",
                "id": "11123304"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7cde"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "These effects were completely prevented by calphostin C, a protein kinase C inhibitor.",
              "citation": {
                "type": "PubMed",
                "name": "Hepatology 2001 May 33(5) 1130-40",
                "id": "11343241"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7cdd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "MAPK3 and MAPK1 was activated and phosphorylated in response to both OSM and EGF. Kinetics of phosphorylation were different with EGF and OSM.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2001 Mar 1 166(5) 3491-8",
                "id": "11207308"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7cdc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 May 23 278(21) 18859-67",
                "id": "12618431"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7cdb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2005 Apr 15 387(Pt 2) 507-17",
                "id": "15568999"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7cda"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "These results suggest that high glucose suppresses apoptosis via upregulation of bcl-xL and bfl-1/A1 levels through PI 3-K and ERK1/2 pathways in CASMC.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2002 Aug 283(2) C422-8",
                "id": "12107051"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7cd9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "rac2-/- neutrophils displayed significant defects in... and p38 and, unexpectedly, p42/p44 MAP kinase activation",
              "citation": {
                "type": "PubMed",
                "name": "Immunity 1999 Feb 10(2) 183-96",
                "id": "10072071"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7cd8"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Endocrinol 1999 Jan 13(1) 24-37",
                "id": "9892010"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7cd7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Raf-1 phosphorylates and activates MEK-1, a kinase that activates the extracellular signal regulated kinases (ERK)",
              "citation": {
                "type": "PubMed",
                "name": "Nature 1999 Sep 9 401(6749) 173-7",
                "id": "10490027"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7cd6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 May 31 277(22) 19382-8",
                "id": "11896055"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7cd5"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "The treatment of NCI-N87 cells with EGF resulted in increases in phosphorylation of Erk1/2, Akt, and P38. Blockade of the Erk, phosphatidylinositol-3 kinase/Akt, or P38 pathways in this cell line",
              "citation": {
                "type": "PubMed",
                "name": "Br J Cancer 2003 Mar 10 88(5) 796-802",
                "id": "12618892"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7cd4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "The sarcoendoplasmic reticulum Ca2+ ATPase (SERCA) inhibitor thapsigargin (Tg), as well as the Ca2+ ionophores ionomycin (Io) and A23187 (A2), each increased Akt and ERK1/2- phosphorylation, and this activity was similarly inhibited by AG1478 (Figure 2C).",
              "citation": {
                "type": "PubMed",
                "name": "Carcinogenesis 2006 Nov 27(11) 2331-40",
                "id": "16774943"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7cd3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "he independent signaling competence of Tnfr1 and Tnfr2 was further confirmed in the studies of various kinases of the Erk/Mapk signal transduction cascade; Erk1, Erk2, Raf-1, Raf-B, Mek-1, Mekk, and p90rsk all were found to be activated independently by Tnfr1 as well as Tnfr2. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1996 Nov 8 271(45) 28097-104",
                "id": "8910423"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7cd2"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "It is known that LPS stimulation leads to increased activation of three subgroups of MAPKs, i.e., ERK, JNK, and p38, in murine macrophages and human monocytes (38, 39).",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2002 Aug 1 169(3) 1401-9",
                "id": "12133965"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7cd1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Monocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Leptin induced phosphorylation and activation of p38 mitogen-activated protein (p38 MAP) kinase and of signal transducers and activators of transcription 3 in a concentration- and time-dependent manner.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2005 Apr 1 329(1) 18-24",
                "id": "15721267"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7cd0"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "On the other hand the cell survival effects of Ras were accompanied by a strong upregulation of ERK activity (represented by phosphorylated ERK1/2 Thr202/Tyr204) and by upregulation of the activity of p70S6K (represented by the phosphorylation status of the major p70S6K target S6) (Figures 3b and c)",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2008 Mar 27 27(14) 2072-83",
                "id": "17922028"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ccf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Pretreatment with inhibitors for MEK1/2, Raf1 and MSK1, and overexpression of a Raf1 dominant-negative mutant significantly diminished IL-17F-induced CCL20 production.",
              "citation": {
                "type": "PubMed",
                "name": "J Allergy (Cairo) 2011 2011 587204",
                "id": "22013453"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7cce"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Ang II-stimulated StAR transcription in H295R cells is dependent upon both influx of external Ca2+ and tyrosine kinase signaling and is enhanced by protein kinase C and mitogen-activated protein kinase (ERK1/2) activation. In particular, Janus tyrosine kinase-2 (Jak2) activation was increased with Ang-II treatment of H295R cells",
              "citation": {
                "type": "PubMed",
                "name": "Endocr Res 2004 Nov 30(4) 685-93",
                "id": "15666812"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ccd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Here we have identified a novel MAP kinase kinase kinase (MAPKKK), termed MLTK (for MLK-like mitogen-activated protein triple kinase), whose expression is increased by activation of the ERK/MAPK pathway.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Feb 9 276(6) 4276-86",
                "id": "11042189"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ccc"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "In the presence of an inhibitor of farnesly transferase (Ftase-1), which prevent the maturation of Ras, both Estradiol and TGF alpha induced ERK activation was significantly inhibited.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 May 3 277(18) 15514-22",
                "id": "11854297"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ccb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "PD-98059, an inhibitor of phosphorylation of ERK1/2, caused a marked inhibition of HSP60-induced COX-2 and NOS-2 expression.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2002 Oct 283(4) C1267-77",
                "id": "12225989"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7cca"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "a study from our group has recently shown that ERK can also directly phosphorylate TSC2 on Ser664, leading to the inhibition of the complex (Ma et al., 2005a).",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2008 Sep 18 27(41) 5527-41",
                "id": "18794886"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7cc9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasm",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "An increase in c-Jun phosphorylation by ERK was also found to accompany the increased AP-1 activity as detected by Western blot.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2002 May 17 293(4) 1248-53",
                "id": "12054510"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7cc8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "FGF-2 (>/=10(-12) m) up-regulated the phosphorylation of cellular proteins, including p42/p44 mitogen-activated protein (MAP) kinase, and increased the kinase activity of immunoprecipitated FGFR1 in mouse osteoclasts.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Oct 6 275(40) 31444-50",
                "id": "10896947"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7cc7"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "osteoclast",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Feb 16 276(7) 4747-55",
                "id": "11085989"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7cc6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "The p38 MAPK [MAPK1] is activated by insulin, muscle contraction...",
              "citation": {
                "type": "PubMed",
                "name": "Sci STKE 2003 Feb 11 2003(169) PE5",
                "id": "12582199"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7cc5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "jubilant",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2000 Jun 15 164(12) 6244-51",
                "id": "10843677"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7cc4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "The inhibition of CTGF-induced p42/44 MAPK or phosphatidylinositol 3-kinase (PI3K)/protein kinase B pathway activities abrogated the induction of fibronectin expression.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Nov 15 277(46) 44187-94",
                "id": "12218048"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7cc3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "mesangial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "ET and A II attenuated the expression of HRG-1 in the aorta, thus activating mitogen activated protein kinase (MAPK).",
              "citation": {
                "type": "PubMed",
                "name": "Zhonghua Yi Xue Za Zhi 2001 Feb 10 81(3) 162-7",
                "id": "11798869"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7cc2"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "the presence of an anti-CD14 Ab completely abolished the phosphorylation of ERK proteins after stimulation with LPS",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2006 Sep 15 177(6) 4086-93",
                "id": "16951373"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7cc1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "We found increased Erk-1/2 and p38 MAP kinase activities to be important components of ROS-mediated signaling. The pro-oxidant state also contributed to constitutive elevation of AP-1, NFkappaB and cAMP response element transactivation in the malignant phenotype. ",
              "citation": {
                "type": "PubMed",
                "name": "Carcinogenesis 1999 Nov 20(11) 2063-73",
                "id": "10545407"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7cc0"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "IL-33 rapidly activated ERK1/2, JNK, p38, and NF-kB signaling cascades, as evidenced by phosphorylation of MAP kinases and phosphorylation and degradation of the NF-kB inhibitor IkB-a.",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2009 Feb 12 113(7) 1526-34",
                "id": "18955562"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7cbf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "basophil",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Furthermore, endogenous Ras and ERK activation was partly reduced by PG-I in vitro.",
              "citation": {
                "type": "PubMed",
                "name": "Gastroenterology 2001 Sep 121(3) 657-67",
                "id": "11522750"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7cbe"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Data in isolated fibroblasts (26,56), neutrophils (57,58), endothelial and vascular smooth muscle cells (5961), neural cells (31,62), cardiomyocytes (63) and whole lung tissue (64) showed that, in addition to other known oxidants, peroxynitrite is also a powerful activator of ERK.",
              "citation": {
                "type": "PubMed",
                "name": "Front Biosci 2009 14 4809-14",
                "id": "19273391"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7cbd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "STAT3 inhibited myogenic differentiation induced by low serum or MyoD as efficiently as the Ras/mitogen-activated protein kinase cascade",
              "citation": {
                "type": "PubMed",
                "name": "Trends Immunol 2003 Dec 24(12) 659-66",
                "id": "14644140"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7cbc"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "As previously reported, expression of Dok-R in EGF-stimulated cells resulted in a dramatic decrease in the induction of Erk-2 activation as well as a delay in the activation kinetics (Fig. 1), while Dok-R {Delta}PRR completely lost this Erk-2 attenuating capacity, which demonstrates that the key residues for mediating this attenuation are found within the PRR.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2005 May 25(9) 3831-41",
                "id": "15831486"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7cbb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Moreover, mitogen-activated protein kinase (MEK) /extracellular-signal-regulated kinase (ERK) pathway inhibitors; U0126 (1.4-diamino-2, 3-dicyano-1, 4-bis [2-amino-phenylthio] butadiene) and PD98059 (2'-Amino-3'-methoxyflavone) inhibited inducible Glvr-2 mRNA expression,",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Physiol 2004 Jan 198(1) 40-7",
                "id": "14584042"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7cba"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Nov 12 279(46) 47912-28",
                "id": "15310753"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7cb9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "TGF-alpha exerts a neuroprotective action against NMDA toxicity, in which Erk1/2 activation plays a key role, and suggest that the underlying mechanisms involve recovery of translation inhibition, mediated at least in part by eIF4E phosphorylation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Aug 8 278(32) 29552-9",
                "id": "12771152"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7cb8"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2001 Aug 1 61(15) 5911-8",
                "id": "11479233"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7cb7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "n a mammalian cell line, ERK1/2 interacts with Cdc25C in interphase and phosphorylates Cdc25C at T48 in mitosis. Inhibition of ERK activation partially inhibits T48 phosphorylation, Cdc25C activation, and mitotic induction.",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2007 Mar 23 128(6) 1119-32",
                "id": "17382881"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7cb6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Menshikov, M., Torosyan, N., Elizarova, E., Plakida, K., Vorotnikov, A., Parfyonova, Y., et al. 2006b. Urokinase induces matrix metalloproteinase-9/gelatinase B expression in THP-1 monocytes via ERK1/2 and cytosolic phospholipase A2 activation and eicosanoid production. J. Vasc. Res. 43: 482490. doi:10. 1159/000095248. PMID:16926552.",
              "citation": {
                "type": "PubMed",
                "name": "J Lipid Res 2009 Apr 50 Suppl S189-94",
                "id": "19064999"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7cb5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "SpD, a substance P analogue, stimulates Erk1 and Erk2 activation in H345 SCLC cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Jul 27 276(30) 28083-91",
                "id": "11323408"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7cb4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Lung Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Hum Mol Genet 2001 Mar 15 10(6) 605-16",
                "id": "11230180"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7cb3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2005 Jan 26 24(2) 294-304",
                "id": "15616583"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7cb2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Pak4-induced arrest appears to be mediated by a pathway that requires the ERK mitogen-activated protein kinase, as well as the cell cycle inhibitors p16(INK4) and p19(ARF).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2005 Nov 25(21) 9532-42",
                "id": "16227603"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7cb1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Cells expressing dominant-negative ERK2 showed a significant reduction in mitosis that was most evident in metaphase, compared to cells expressing WT ERK2 (Fig. 8B)",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2002 Oct 22(20) 7226-41",
                "id": "12242299"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7cb0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "S100-A9 binds the transcription factors NF-kB and P53, and activates the P38 and ERK MAPK kinases and the receptor for advanced glycated end products (RAGE) (50).",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2008 May 38(5) 541-50",
                "id": "18079489"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7caf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1999 Jun 19(6) 4121-33",
                "id": "10330152"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7cae"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Activation of ERK1/2 and NF-kB was seen after exposure to DSPs.",
              "citation": {
                "type": "PubMed",
                "name": "ScientificWorldJournal 2010 10 2139-56",
                "id": "21057728"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7cad"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Membrane array analysis suggested that both extracellular signal-regulated kinase (ERK) 1/2 and c-Jun- NH2-terminal kinase (JNK) signal but not p38 MAPK signaling was activated in response to nicotine",
              "citation": {
                "type": "PubMed",
                "name": "Mutat Res 659(3) 221-31",
                "id": "18495523"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7cac"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "bronchial epithelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "PD-98059, an inhibitor of phosphorylation of ERK1/2, caused a marked inhibition of HSP60-induced COX-2 and NOS-2 expression.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2002 Oct 283(4) C1267-77",
                "id": "12225989"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7cab"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Hypoxia and PDGF-BB induced synthesis of soluble collagen type I via Erk1/2 and p38 MAP kinase",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 Jan 12 282(2) 908-15",
                "id": "17099219"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7caa"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Sep 10 274(37) 26485-92",
                "id": "10473609"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ca9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Western blot with phosphospecific antibodies for each of the respective MAPK (JNK, ERK, and p38)...Phosphorylation of all three MAPK increased during this time, with ERK MAPK showing the most profound increase (Fig. 4).",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2005 Aug 1 39(3) 355-64",
                "id": "15993334"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ca8"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "re hyperosmotic stress This element includes the same Sp1 DNA binding site found for FSH regulation of the SGK promoter, and the hyperosmotic stress stimulation of SGK transcription requires the stimulus-regulated binding of the Sp1 transcription factor to this site (filled box labeled Sp1 in figure 2). Sorbitol activates the SGK hyperosmotic stress regulated element as a downstream target of the MKK3 MKK6-p38 MAPK stress signaling cascade",
              "citation": {
                "type": "PubMed",
                "name": "Cell Physiol Biochem 2003 13(1) 1-12",
                "id": "12649597"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ca7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "reduction in CD45 expression caused the duration of peak PMA-induced MEK and extracellular signal-regulated kinase (ERK) 1/2 activity to increase from 5 min to 30 min while leading to a 4-fold increase in PMA-dependent PKCdelta activation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Mar 30 276(13) 10212-7",
                "id": "11124968"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ca6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "the phosphorylation of and protein levels of p42/44 mitogen-activated protein kinase (p42/44MAP kinase) were increased about 3.9- and 3.2-fold in ALD livers",
              "citation": {
                "type": "PubMed",
                "name": "Hepatology 2002 Feb 35(2) 425-32",
                "id": "11826419"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ca5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Although it interacts with the ErbB2 C terminus through the PDZ domain, Erbin has no effect on ErbB2 tyrosine phosphorylation or binding to the adaptor proteins Shc and Grb2. In contrast, expression of Erbin greatly impairs activation of Erk, but not Akt, by ligands that activate receptor tyrosine kinases.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Jan 10 278(2) 1108-14",
                "id": "12379659"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ca4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "diethylmaleate, an intracellular ROS inducer of H2O2 was found to increase ERK1/2 phosphorylation in a Src-independent manner in rat-2 fibroblasts (36).",
              "citation": {
                "type": "PubMed",
                "name": "Cell Biochem Biophys 2007 47(1) 1-10",
                "id": "17406055"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ca3"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Here we show that the angiotensin II type 1A receptor-mediated activation of extracellular signal-regulated kinases 1 and 2 (ERK1/2) in HEK-293 cells is increased when the cellular level of beta-arrestin1 is down-regulated by RNA interference but is decreased or eliminated when the cellular level of beta-arrestin2 is diminished",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Feb 27 279(9) 7807-11",
                "id": "14711824"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ca2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "insulin significantly increased MAP kinase [isoforms p42(MAPK) and p44(MAPK) (ERK1 and ERK2)] phosphorylation and activity, and the activity of its upstream activator MEK1. Insulin also increased the activity of the MAP kinase downstream substrate, the p90 ribosomal S6 kinase 2 (RSK2) almost twofold",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Endocrinol Metab 2000 Jun 278(6) E992-9",
                "id": "10827000"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ca1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "In this study, we showed that cigarette smoke directly induced MMP-1 mRNA and protein expression and increased the collagenolytic activity of human airway cells. Treatment with various chemical kinase inhibitors revealed that this response was dependent on the extracellular regulated kinase-1/2 (ERK) mitogen activated protein kinase pathway.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Apr 23 279(17) 17690-6",
                "id": "14764579"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ca0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 May 21 279(21) 22404-11",
                "id": "14988395"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c9f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Adenovirus-mediated expression of mSef but not GFP resulted in a reduction in the levels of activated ERK1/2, whereas overall levels of ERK1/2 were unaffected (Fig. 2  A). ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Apr 18 278(16) 14087-91",
                "id": "12604616"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c9e"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "It is known that there are two isoforms of ERK, ERK1 and ERK2, and they phosphorylate and activate various transcription factors, such as Elk-1 and Elk-2. These transcription factors regulate expression of diverse genes that relates to the proliferation and growth of the cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Jan 20 281(3) 1332-7",
                "id": "16287813"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c9d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "TRAIL-induced Erk activation was observed in both control and cytokine-pretreated cells (Fig. 6AGo), but the kinetics of Erk activation was delayed in IL-1/TNF{alpha}-treated cells (Fig. 6AGo). ",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Endocrinol Metab 2004 Jan 89(1) 250-7",
                "id": "14715858"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c9c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "thymic epithelium",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "These demonstrate that Ang II is capable of inducing CRP generation in macrophages via AT(1)-ROS-ERK1/2/p38MAPK-NF-kB signal pathway, which contributes to better understanding of the proinflammatory and proatherosclerotic actions of Ang II.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Physiol Biochem 2011 27(1) 63-70",
                "id": "21325823"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c9b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Our cellular and molecular dissection showed that the PDGF-BB/PDGFRbeta kinase axis promoted MM tumor growth and vessel sprouting by activating ERK1/2, AKT, and the transcription of MMEC-released proangiogenic factors, such as vascular endothelial growth factor (VEGF) and interleukin-8 (IL-8)",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2008 Aug 15 112(4) 1346-56",
                "id": "18524994"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c9a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Multiple Myeloma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "The mechanism by which CCL19 activates ERK1/2 was determined to be beta-arrestin-dependent, because it is reduced both by depletion of beta-arrestin-2 with small interfering RNA and by elimination of the phosphorylation sites in the tail of the receptor",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 May 28 279(22) 23214-22",
                "id": "15054093"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c99"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Rapid activation of mitogen-activated protein kinases (Erk1/2, p38, and JNK MAPK) were observed in CSE-treated NL cells.  ",
              "citation": {
                "type": "PubMed",
                "name": "Proc Am Thorac Soc 2006 Aug 3(6) 466",
                "id": "16921106"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c98"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biochem 2000 Sep 7 79(3) 355-69",
                "id": "10972974"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c97"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Insulin-stimulated Na(+),K(+)-ATPase activation, phosphorylation, and translocation of alpha-subunits to the plasma membrane were abolished by 20 microm PD98059, which is an inhibitor of MEK1/2, an upstream kinase of ERK1/2. Furthermore, inhibitors of phosphatidylinositol 3-kinase (100 nm wortmannin) and protein kinase C (10 microm GF109203X) had similar effects.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jun 11 279(24) 25211-8",
                "id": "15069082"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c96"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Muscle, Skeletal"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Exposure of cultured IMCD cells to an additional 75 mmol/L NaCl in culture media (final osmolality 475 mosm/kg) resulted in an approximately 4-fold increase in Sgk1 protein levels after 7 hours. The Sgk1 induction was almost completely inhibited by the p38 MAPK inhibitor SB203580, indicating that NaCl activates Sgk1 through the p38 MAPK pathway.",
              "citation": {
                "type": "PubMed",
                "name": "Hypertension 2004 Apr 43(4) 866-71",
                "id": "15007040"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c95"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "# Ariadne: Sod2 regulates MMP-1 transcription by activating ERK1/2. [Expression]",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Apr 27 276(17) 14264-70",
                "id": "11297530"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c94"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "ERK activated upon peroxynitrite exposure triggered the upregulation of beta2-integrin CD11b/CD18 in human PMNs, increased their adhesion to the endothelium (58), and enhanced their production of oxygen free radicals (57).",
              "citation": {
                "type": "PubMed",
                "name": "Front Biosci 2009 14 4809-14",
                "id": "19273391"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c93"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "granulocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Previous study carried out on PC12 cells expressing each alpha(2)-adrenergic receptor subtype individually (PC12/alpha(2A), /alpha(2B) or /alpha(2C)) have shown that epinephrine causes activation of PI3K and phosphorylation of Erk 1/2",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2006 May 18(5) 729-39",
                "id": "16098714"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c92"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "FROM FULL TEXT: VES induces early and sustained activation of ERK1/2 starting at 1 h, peaking at 2 h, and returning to barely detectable levels by 6 h after treatment (Fig. 1A, top panel). Levels of ERK1/2 proteins were not increased by VES treatment (Fig. 1A, bottom panel).",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2001 Sep 1 61(17) 6569-76",
                "id": "11522656"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c91"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "hyperactivation of the extracellular signal-regulated kinase (ERK) via the hematopoietic-specific Rho GTPase, Rac2, directly contributes to the hyperproliferation of Nf1-deficient mast cells in vitro and in vivo",
              "citation": {
                "type": "PubMed",
                "name": "J Exp Med 2001 Jul 2 194(1) 57-69",
                "id": "11435472"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c90"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "mast cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2004 Jul 8 23(31) 5301-15",
                "id": "15241487"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c8f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Glucose stimulates nuclear USF2 protein accumulation through protein kinase C, p38 MAPK, and extracellular signal-regulated kinase pathways. Increased PKG activity down-regulates USF2 protein levels and its DNA binding activity under high glucose conditions, resulting in inhibition of glucose-induced TSP1 transcription and TGF-beta",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Aug 13 279(33) 34311-22",
                "id": "15184388"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c8e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "the ability of epidermal growth factor to inhibit PDE4D3 through ERK2 action inherent inhibitory effect that ERK2 phosphorylation exerts on the PDE4D catalytic unit",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Jun 2 275(22) 16609-17",
                "id": "10828059"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c8d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Endostatin blocked VEGF-induced tyrosine phosphorylation of KDR/Flk-1 and activation of ERK, p38 MAPK, and p125(FAK) in human umbilical vein endothelial cells",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Aug 2 277(31) 27872-9",
                "id": "12029087"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c8c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Data in isolated fibroblasts (26,56), neutrophils (57,58), endothelial and vascular smooth muscle cells (5961), neural cells (31,62), cardiomyocytes (63) and whole lung tissue (64) showed that, in addition to other known oxidants, peroxynitrite is also a powerful activator of ERK.",
              "citation": {
                "type": "PubMed",
                "name": "Front Biosci 2009 14 4809-14",
                "id": "19273391"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c8b"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": "vascular smooth muscle"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 2004 Jun 145(6) 2845-57",
                "id": "15001544"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c8a"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Jan 24(1) 25-35",
                "id": "14673140"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c89"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Using phosphoinositide 3-kinase (PI3-kinase) inhibitor LY294002 and Src inhibitor PP2, we show that interleukin (IL)-18-induced ERK1/2 activation is Src kinase-dependent.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Sep 20 277(38) 34679-91",
                "id": "12105209"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c88"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "In turn, IEX-1 potentiates ERK activation",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2002 Oct 1 21(19) 5151-63",
                "id": "12356731"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c87"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "HGF can induce serine/threonine phosphorylation of paxillin most probably mediated directly by ERK",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Mar 22 277(12) 10452-8",
                "id": "11784715"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c86"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Mar 1 277(9) 7076-85",
                "id": "11751884"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c85"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Apr 16 279(16) 16883-93",
                "id": "14963034"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c84"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "U-0126, an inhibitor of MAPK activation, completely inhibited both the activation of MAPK and goblet cell secretion stimulated by carbachol. (Fig. 2)",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2003 Apr 284(4) C988-98",
                "id": "12620895"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c83"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Goblet Cell",
                "tissue": "Epithelium"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "p38 MAPK was required for the IL-33-mediated responses of endothelial cells, whereas ERK was required for IL-33-mediated IL-8 production by epithelial cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2010 Nov 15 185(10) 5743-50",
                "id": "20926795"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c82"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "We also show that both Cbl and Gab1 enhance Met-induced activation of another MAP kinase cascade, the ERK pathway, in a Crk-independent manner. Taken together, our studies demonstrate a previously unidentified functional role for Cbl in Met signaling and suggest that Met utilizes at least two docking proteins, Gab1 and Cbl, to activate downstream signaling pathways. ",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2000 Aug 17 19(35) 4058-65",
                "id": "10962563"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c81"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "15302935;15184391",
              "citation": {
                "type": "PubMed",
                "name": "BMC Bioinformatics 2004 Jun 22 5 79",
                "id": "15212693"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c80"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Endocrinol 2003 Mar 17(3) 487-97",
                "id": "12554784"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c7f"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "We also show that activation of extracellular signal-regulated kinase (Erk) by BDNF is required to overcome inhibition by MAG, and that activated Erk transiently inhibits phosphodiesterase 4 (PDE4), the enzyme that hydrolyzes cAMP. Inhibition of PDE4 then allows cAMP to increase and so initiates the pathway to overcome inhibition.",
              "citation": {
                "type": "PubMed",
                "name": "J Neurosci 2003 Dec 17 23(37) 11770-7",
                "id": "14684879"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c7e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Endocrinol 2004 Dec 183(3) 561-7",
                "id": "15590982"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c7d"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Both PD98059 and SB203580, inhibitors of ERK1/ERK2 and p38 strongly suppressed IL-1beta induced COX-2 expression in a dose dependent manner, indicating that they mediate IL-1beta induced COX-2 expression.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Pharmacol 2002 Nov 62(5) 1112-8",
                "id": "12391274"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c7c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "the augmentation of kinase activity of RAGE-bound ERK upon the stimulation of cells with amphoterin was demonstrated by determining the phosphorylation level of myelin basic protein, an ERK substrate.....In vitro binding studies using a series of C-terminal deletion mutants of human RAGE revealed the importance of the membrane-proximal cytoplasmic region of RAGE for the direct ERK-RAGE interaction",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 2003 Aug 28 550(1-3) 107-13",
                "id": "12935895"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c7b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "hyperoxia stimulated ERK-1 and ERK-2 phosphorylation {SE: Canonical ERK phosphorylation leading directly to activation}",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Oct 1 279(40) 42302-12",
                "id": "15292179"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c7a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": "Epithelium"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "These events have been detected in primary scleroderma fibroblasts, which generate reactive oxygen species-Ras-ERK1/2",
              "citation": {
                "type": "PubMed",
                "name": "N Engl J Med 2009 May 7 360(19) 1989-2003",
                "id": "19420368"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c79"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Phosphorylation of ERKs 1 and 2 by asbestos were inhibited by the addition of catalase (21), suggesting that this is an oxidant-dependent process. [Fig. 5.   H2O2-induced ERK activation is inhibited by catalase (Cat). Fig. 6.   Cat reduces Croc-induced ERK2 activity. ERK2 was immunoprecipitated with anti-ERK2 to assess kinase activity as described in MATERIALS AND METHODS. ]",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2006 Jun 34(6) 666-9",
                "id": "16484683"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c78"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "pleural mesothelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Figure 4.  T1/ST2 activates MAP kinases p42/44 and p38",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Dec 20 277(51) 49205-11",
                "id": "12368275"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c77"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "We further show that p42/p44 MAPK is critical for the hypoxia-induced transactivation of endothelial PAS-domain protein 1 (EPAS1),",
              "citation": {
                "type": "PubMed",
                "name": "Comp Biochem Physiol B Biochem Mol Biol 2001 Feb 128(2) 187-204",
                "id": "11207433"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c76"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "NGF activates Erk1/Erk2 and JNK but not p38MAPK in J774 cells... NGF also induced phosphorylation of JNK",
              "citation": {
                "type": "PubMed",
                "name": "J Leukoc Biol 2001 Jun 69(6) 1019-26",
                "id": "11404390"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c75"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2003 Jul 1 63(13) 3539-45",
                "id": "12839939"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c74"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Stem cell factor (SCF) induced activation of Erk1 and 2.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2002 Oct 1 21(19) 5097-108",
                "id": "12356726"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c73"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Lung Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "The protein-tyrosine phosphatase Shp2 is required for normal activation of the ERK mitogen-activated protein kinase in multiple receptor tyrosine kinase signaling pathways.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Oct 24 278(43) 41677-84",
                "id": "12923167"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c72"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "a specific extracellular signal-regulated protein kinase (ERK) pathway inhibitor, PD98059",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 2003 May 1 116(Pt 9) 1699-706",
                "id": "12665551"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c71"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "melanocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "To examine directly the role of MKP-1 in the regulation of these protein kinases in vivo, we established a U937 cell line that conditionally expresses MKP-1 from the human metallothionein IIa promoter. Conditional expression of MKP-1 inhibited PMA-induced ERK2, SAPK, and p38 MAPK activity.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1997 Jul 4 272(27) 16917-23",
                "id": "9202001"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c70"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Finally, we found that overexpression of a mutant form of C/EBPbeta, lacking the consensus ERK phosphorylation site at Thr-235 (T235A), blocked the ability of F/R and PMA to induce SOCS-3 expression in COS1 cells in a dominant-negative fashion. Together, these results implicate ERK-dependent C/EBPbeta phosphorylation and activation as essential requirements for effective SOCS-3 induction in response to cyclic AMP and PKC activation in COS1 cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2009 Jun 26 284(26) 17391-403",
                "id": "19423709"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c6f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "from full text - isoprenaline challenge also increases ERK1/2 phosphorylation (Fig. 4c). This effect increases dramatically after the addition of rolipram through a process attenuated in cells treated with either pertussis toxin or H89 (Fig. 4 c and d),",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2003 Feb 4 100(3) 940-5",
                "id": "12552097"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c6e"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "cardiomyocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "from full text - Exposure of serum-starved cells to the calcium ionophore, A23187, was sufficient to induce detectable tyrosine phosphorylation of FAK but failed to increase either Shc phosphotyrosine content or Erk 1/2 phosphorylation. Stimulation of cells with phorbol ester modestly increased both FAK and Shc phosphotyrosine content and caused weak Erk 1/2 activation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1997 Dec 12 272(50) 31648-56",
                "id": "9395506"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c6d"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Pretreatment with Triptorelin or [d-Lys(6)]GnRH-II blocked EGF-induced autophosphoryla-tion of EGF receptor and activation of mitogen-activated protein kinase (extracellular-signal-regulated kinase 1/2 (ERK1/2)) in these cells.",
              "citation": {
                "type": "PubMed",
                "name": "Eur J Endocrinol 2005 Oct 153(4) 613-25",
                "id": "16189183"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c6c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Figure 4 shows the inhibitory effect of gefitinib on EGFinduced autophosphorylation of EGFR, and phophorylation of Akt and ERK1/2 in three of the NSCLC cell lines. EGF stimulated EGFR autophosphorylation and activation of Akt and ERK1/2 in PC9 (A), A549 (B), and QG56 (C) cells, and activation was blocked to different extents by gefitinib.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cancer Ther 2004 Apr 3(4) 465-72",
                "id": "15078990"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c6b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "MEKK3-dependent activation of an NF-kappaB reporter gene as well as ERK, JNK, and p38 MAP kinases correlated with a requirement for serine at position 526. Constitutively active mutants of MEKK3, consisting of S526D and S526E, were capable of activating a NF-kappaB luciferase reporter gene as well as ERK and MEK, suggesting that a negative charge at Ser526 was necessary for MEKK3 activity and implicating Ser526 as a phosphorylation site.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Mar 10 281(10) 6236-45",
                "id": "16407301"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c6a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Components of these pathways (Shc, p44/42 MAPK kinase, Akt/protein kinase B and p70s6k) are phosphorylated in response to progranulin7,10 and have been previously implicated in the ability of progranulin to stimulate cell division.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Med 2003 Feb 9(2) 225-9",
                "id": "12524533"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c69"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Together, the results demonstrate that OxPAPC induces TF expression in HUVECs through activation of PKC/ERK/EGR-1 and Ca(++)/calcineurin/NFAT pathways rather than by NF-kappa B-mediated transcription",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2002 Jan 1 99(1) 199-206",
                "id": "11756172"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c68"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "umbilical vein endothelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "U0126 indeed inhibited the insulin-induced phosphorylation of ERK1/2",
              "citation": {
                "type": "PubMed",
                "name": "Diabetes 2003 May 52(5) 1073-80",
                "id": "12716735"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c67"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Endocrinol 2003 Nov 17(11) 2268-82",
                "id": "12907754"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c66"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Stimulation of TLRs leads to activation of NF-?B, MAPKs, JuN N-terminal kinases (JNKs), p38 and ERKs, and interferon regulatory factor (IRF3, IRF5 and IRF7) signalling pathways5.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2009 Jan 9(1) 57-63",
                "id": "19052556"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c65"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Finally, Ark-mediated repression was significantly attenuated by a dominant negative MEF2C, whereas repression induced by constitutively active Rac was unaffected, indicating that MEF2 proteins are not targets of the Ark -- Rac -- MEK -- ERK cascade.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Oct 11 277(41) 38133-40",
                "id": "12138087"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c64"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "p90Rsk (Rsk1) is a well known downstream substrate for ERKs. Upon serum stimulation, phosphorylation of p90Rsk at Ser-369 (corresponding to Ser-380 of human p90Rsk) was detected in all ES lines examined",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2003 Oct 28 100(22) 12759-64",
                "id": "14566055"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c63"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2003 May 15 34(10) 1333-42",
                "id": "12726921"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c62"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "After stimulation with the mitogen phorbol 12-myristate 13- acetate (PMA) or serum, conditionally expressed RASSF1A specifically enhanced the activating phosphorylation of ERK, but not of p38 kinase or c-Jun NH2 kinase (Fig. 5A).",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2009 Mar 1 69(5) 1748-57",
                "id": "19223555"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c61"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "In macrophages, CD74 demonstrates high-affinity binding to MIF. MIF binds to the extracellular domain of CD74; this complex is required for MIF-mediated MAPK activation and cell proliferation [16] .",
              "citation": {
                "type": "PubMed",
                "name": "Oncology 2008 75(3-4) 127-33",
                "id": "18791328"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c60"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "from full text - we used the dominant negative approach by transfecting the HEK 293 cell line with D556A-PDE4D5. Challenge of these cells with isoprenaline causes a marked potentiation of ERK1/2 phosphorylation (Fig. 3 d and e)",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2003 Feb 4 100(3) 940-5",
                "id": "12552097"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c5f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Heterologous expression of PSD-95 enhanced NRG activation of ErbB4 and MAP kinase.",
              "citation": {
                "type": "PubMed",
                "name": "Neuron 2000 May 26(2) 443-55",
                "id": "10839362"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c5e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "These findings indicate that G-CSF induces human neutrophil migration via activation of MEK/ERK and PI3K.",
              "citation": {
                "type": "PubMed",
                "name": "Immunology 2006 Nov 119(3) 393-403",
                "id": "16903868"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c5d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "NAC treatment markedly suppressed ERK phosphorylation. It inhibited ERK activation",
              "citation": {
                "type": "PubMed",
                "name": "Int Immunopharmacol 2005 Oct 5(11) 1641-51",
                "id": "16039554"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c5c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "umbilical vein endothelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "stimulation of Erk by alpha6beta4 was suppressed by dominant-negative Shc, Ras and RhoA",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1997 May 1 16(9) 2365-75",
                "id": "9171350"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c5b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "XFLRT3 signalling results in phosphorylation of ERK and is blocked by MAPK phosphatase 1, but not by expression of a dominant-negative phosphatidyl inositol 3-OH kinase (PI(3)K) mutant.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2004 Jan 6(1) 38-44",
                "id": "14688794"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c5a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Neutrophils stimulated with FMLP exhibited phosphorylation of the cAMP response element binding protein (CREB), and this reaction was inhibited by SB 203580 and PD 98059.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 1999 Oct 15 163(8) 4527-36",
                "id": "10510396"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c59"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "The Raf-1 inhibitor, GW5074, dose-dependently blocked strain-induced Erk activation and Raf-1 phosphorylation. ",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2005 Mar 17(3) 311-20",
                "id": "15567062"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c58"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "mesangial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "ERK1/2 activation via adenosine A3 receptors may be an important mechanism for the regulation of the receptor itself, regulating its desensitisation and internalisation in a GRK2-dependent manner [138].",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2003 Sep 15(9) 813-27",
                "id": "12834807"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c57"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "RKIP has been shown to disrupt the Raf-1-MEK1/2 [mitogen-activated protein kinase-ERK (extracellular signal-regulated kinase) kinase-1/2]-ERK1/2 and NF-kappaB signaling pathways, via physical interaction with Raf-1-MEK1/2 and NF-kappaB-inducing kinase or transforming growth factor beta-activated kinase-1, respectively, thereby abrogating the survival and antiapoptotic properties of these signaling pathways.",
              "citation": {
                "type": "PubMed",
                "name": "Adv Cancer Res 2004 91 169-200",
                "id": "15327891"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c56"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Densitometry analysis of five experiments revealed that 1 mM S1P inhibited 43.5+12.5% of TLR2-mediated ERK2 activation. ",
              "citation": {
                "type": "PubMed",
                "name": "Cardiovasc Res 2008 Aug 1 79(3) 537-44",
                "id": "18411230"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c55"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "the extracellular signal-regulated kinases (ERK1/2) were shown to beinhibited in both phosphorylation status and enzymatic activity afteroverexpression of PTPepsilon.",
              "citation": {
                "type": "PubMed",
                "name": "Scand J Immunol 2002 Aug 56(2) 195-203",
                "id": "12121439"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c54"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Jul 8 280(27) 25611-20",
                "id": "15890648"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c53"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "NGF promotes VEGF production in cultured hGCs. Blockade of trkA receptor tyrosine kinase activity blocks this effect. NGF induces MAPK-ERK2 phosphorylation, and blockade of this signaling pathway prevents the NGF-induced increase in VEGF production.",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Endocrinol Metab 2009 Aug 94(8) 3065-71",
                "id": "19454577"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c52"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "ovarian granulosa cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Exposure to H2O2 enhances c-Myc recruitment to gamma-GCS regulatory regions through ERK-dependent phosphorylation. Phosphorylation at Ser-62 is required for c-Myc recruitment to gamma-GCS promoters and determines the cellular response to oxidative stress induced by different stimuli.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2006 Feb 17 21(4) 509-19",
                "id": "16483932"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c51"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "In vitro kinase assays using the combined STAT1 proteins as substrates from immunoprecipitation and glutathione S-transferase pull down show that active ERK1, JNK1, p38 kinase, MEK1 and MSK1 stimulated phosphorylation of STAT1 (Ser727) indirectly through an unidentified factor or a downstream kinase.",
              "citation": {
                "type": "PubMed",
                "name": "Carcinogenesis 2004 Jul 25(7) 1165-75",
                "id": "14963018"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c50"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Fig. 9: In vivo delivery of cadmium leads to activation of Erk1/2 and secretion of the IL-8 homolog MIP-2. ",
              "citation": {
                "type": "PubMed",
                "name": "Toxicol Sci 2012 Feb 125(2) 418-29",
                "id": "22094458"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c4f"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "The major protein binding to this site was identified as the nuclear hormone receptor HNF4. An increase in HNF4 mRNA and protein levels was observed in HepG2 cells after treatment with PD98059, indicating that the MAP kinase pathway regulates the expression of the HNF4 gene.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Nov 12 274(46) 33050-6",
                "id": "10551874"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c4e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Nat Immunol 2002 Apr 3(4) 392-8",
                "id": "11896392"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c4d"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Nicotine can also activate the MAP kinase pathway and increase levels of Raf-1, ERK1/2 and MEK1 in a a7-nAChR-dependent manner [16,19,39].",
              "citation": {
                "type": "PubMed",
                "name": "Trends Pharmacol Sci 2008 Mar 29(3) 151-8",
                "id": "18262664"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c4c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasm",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "VEGF-induced Erk activation was not dependent on phosphoinositide (PI) 3-kinase activation but required sequential phosphorylation of type 2 VEGF receptor, PLCgamma and c-Src, as demonstrated by inhibitors SU1498, U73122, and PP1, respectively.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Aug 5 280(31) 28402-11",
                "id": "15919658"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c4b"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "whereas the inhibition of MAPK was able to block the invasive phenomena in both cell types.",
              "citation": {
                "type": "PubMed",
                "name": "Thromb Haemost 2005 May 93(5) 964-75",
                "id": "15886816"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c4a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Jan 24(2) 675-86",
                "id": "14701740"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c49"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "In human HaCaT keratinocytes for instance, ERK1/2 phosphorylation increases in dependence of EGF-R recruitment to transadhering E-cadherin, and E-cadherin-mediated activation of MAPK was also reported in intestinal epithelial cells (Pece and Gutkind, 2000; Laprise et al., 2004).    ",
              "citation": {
                "type": "PubMed",
                "name": "J Invest Dermatol 2008 Mar 128(3) 501-16",
                "id": "18268536"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c48"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol 1999 Aug 277(2 Pt 1) C253-61",
                "id": "10444401"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c47"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "It was observed that the stimulatory effect of nicotine was associated with activation of protein kinase C and mitogen-activated protein kinases, increased levels of intracellular cAMP, and phosphorylation and DNA binding of the transcription factor CREB. Increased transcription of the gene was dependent on cAMP-response elements (CREs) present on the 50 end of its gene promoter.",
              "citation": {
                "type": "PubMed",
                "name": "Mutat Res 659(3) 221-31",
                "id": "18495523"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c46"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "For instance, activation of epidermal growth factor receptor (EGFR) by EGF leads to phosphorylation of the Ser118 residue in the ERalpha AF-1 domain by p44/42 mitogen-activated protein kinase (MAPK), which in turn recruits the coactivator p68/p72 and activates target gene transcription in a ligand-independent manner [80,81].",
              "citation": {
                "type": "PubMed",
                "name": "Breast Cancer Res 2004 6(1) 39-52",
                "id": "14680484"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c45"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Ag stimulation of Lyn unique domain transfectants was accompanied by enhanced phosphorylation of MEK and ERK-2, which are required for leukotriene C4 (LTC4) release, and production of LTC4 was increased 3- to 5-fold, compared with cells transfected with vector alone. ",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2005 Oct 1 175(7) 4543-54",
                "id": "16177098"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c44"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "mast cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Indeed, ERK directly phosphorylates TTF-1 at three serine residues, and concomitant mutation of these serines to alanines completely abolishes ERK-mediated phosphorylation both in vitro and in vivo.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2000 Apr 20(8) 2783-93",
                "id": "10733581"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c43"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "We report that EphB1 receptors are localized in caveolae, and directly interact with caveolin-1 upon ligand stimulation. This interaction, as well as EphB1-mediated activation of extracellular-signal-regulated kinase (ERK), was abrogated by overexpression of a caveolin-1 mutant lacking a functional scaffolding domain.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 2006 Jun 1 119(Pt 11) 2299-309",
                "id": "16723736"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c42"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Here, we show that exposure to 100 ng/ml EGF for 15 min, 1 U/ml GO for 30 min, or smoke from one cigarette for 45 min activates downstream ERK1/2 and Akt signaling (Fig. 7A) ",
              "citation": {
                "type": "PubMed",
                "name": "FASEB J 2008 Mar 22(3) 910-7",
                "id": "17971399"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c41"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "In tumor cells, activation of extracellular-regulated kinase (ERK) 1/2 results in phosphorylation of several ERK1/2 effectors, including the proapoptotic protein Bad. Phosphorylation of Ser112 by ERK1/2 inactivates Bad and protects the tumor cell from apoptosis.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2003 Feb 1 63(3) 616-20",
                "id": "12566304"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c40"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "bombesin specifically induced mitogen-activated protein (MAP) kinase activation as shown by increased extracellular regulated kinase (ERK) phosphorylation and epidermal growth factor (EGF) receptor transactivation in prostate cancer cells, which express functional gastrin-releasing peptide receptor",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2003 Oct 15(10) 945-53",
                "id": "12873708"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c3f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "induction of MKP-1 correlated with the inhibition of extracellular signal- regulated kinase (ERK1/2) and c-Jun N-terminal kinase (JNK) activity",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Feb 11 280(6) 4117-24",
                "id": "15590693"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c3e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "from full text - introduction of the specific antisense morpholino oligonucleotide against ADAM10 inhibited the bombesin-mediated transactivation of Erk1/2",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2002 Jul 22 158(2) 221-6",
                "id": "12119356"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c3d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Consistent with EGFR activation, AKT and ERK phosphorylation was also observed during the course of ATP-?-S stimulation. Furthermore, ATP-?-S also elicited a similar response in primary HCE cells and BEAS 2B cells, although its effect on signaling in BEAS 2B cells was more transient than that in THCE cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 2007 Mar 1 120(Pt 5) 815-25",
                "id": "17284517"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c3c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "bronchial epithelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1998 Aug 3 17(15) 4426-41",
                "id": "9687510"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c3b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Importantly, CA-MEK1 rescued TNF-stimulated IL-6 expression in A549 FAK shRNA cells without effects on basal IL-6 production (Fig. 8D). Together, these results support the conclusion that TNF-stimulated FAK activity promotes signals leading to ERK/MAPK activation necessary for efficient IL-6 production in fibroblasts and carcinoma cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 Jun 15 282(24) 17450-9",
                "id": "17438336"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c3a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Carcinoma, Non-Small-Cell Lung",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Oct 24 278(43) 42409-18",
                "id": "12917419"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c39"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Using specific inhibitors of MAPK pathways, we demonstrate that, in our experimental system, p38 signals survival, while ERK activity is required for apoptosis.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2000 May 11 19(20) 2377-85",
                "id": "10828879"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c38"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1998 Jun 12 273(24) 15294-300",
                "id": "9614146"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c37"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Platelets contain several potential H-Ras effectors, including PI 3-kinase and Raf-1, and thrombin induces activation of MAP (ERK2) kinase in platelets, possibly through the classical H-Ras pathway.96",
              "citation": {
                "type": "PubMed",
                "name": "Blood 1998 Apr 15 91(8) 2645-57",
                "id": "9531572"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c36"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Overexpression of Gab2 enhanced the gp130 or Src-related kinases-mediated ERK2 activation as that of Gab1 did.",
              "citation": {
                "type": "PubMed",
                "name": "Blood 1999 Mar 15 93(6) 1809-16",
                "id": "10068651"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c35"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "MEK1/2 inhibitors, such as PD98059 and U0126, reduced RA-induced ERK1/2 activity, but could not block the genistein effects.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biochem 2005 Dec 1 96(5) 1061-70",
                "id": "16149052"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c34"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Furthermore, our data indicate that the HRG-induced ErbB2.ErbB4 complexes stimulate ErbB2 tyrosine kinase, which induces both ERK phosphorylation and kinase activity.  The activated ERK then increases the phosphorylation of HAS1, HAS2, and HAS3.  Consequently, all three HAS isozymes are activated resulting in hyaluronan (HA) production. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 Jul 6 282(27) 19426-41",
                "id": "17493932"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c33"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "RAGE-mediated NF-kappaB activation was suppressed by the selective p38 MAPK inhibitor SB203580 and by coexpression of a kinase-dead p38 dominant-negative mutant.",
              "citation": {
                "type": "PubMed",
                "name": "Diabetes 2001 Jun 50(6) 1495-504",
                "id": "11375353"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c32"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Monocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Restoration of phosphorylation at S338, either by expression of highly active PAK or by expression of an S338 phospho-mimetic Raf-1 mutation, led to a partial rescue of ERK activation in suspended cells. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2005 Jun 25(11) 4466-75",
                "id": "15899852"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c31"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "The Akt kinase substrate was GSK3, and the ERKs substrate was Elk1. Our results indicated that phosphorylation of GSK3-a and -b decreased in UVB-treated DNMFyn- JB6 cells (Fig. 9A)....Phosphorylation of Elk1 dramatically decreased in UVB-treated DNM-Fyn-JB6 cells com-pared with WT-Fyn-JB6 cells (Fig. 9C)",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Jan 28 280(4) 2446-54",
                "id": "15537652"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c30"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Integrin signaling may be needed for the transcription of cyclin D1, because the cyclin D1 promoter is coordinately regulated by JNK and ERK (37) (Fig. 4).",
              "citation": {
                "type": "PubMed",
                "name": "Science 1999 Aug 13 285(5430) 1028-32",
                "id": "10446041"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c2f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cell Growth Differ 1999 Dec 10(12) 797-804",
                "id": "10616904"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c2e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Consistent with EGFR activation, AKT and ERK phosphorylation was also observed during the course of ATP-?-S stimulation. Furthermore, ATP-?-S also elicited a similar response in primary HCE cells and BEAS 2B cells, although its effect on signaling in BEAS 2B cells was more transient than that in THCE cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 2007 Mar 1 120(Pt 5) 815-25",
                "id": "17284517"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c2d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "We show that expression of cyt-PTP significantly reduces kinase activity of ERK1 and ERK2. Presence of PTP also reduces phosphorylation of ERK proteins at both Thr and Tyr residues of their activating TEY motif in NIH3T3 cells and in mammary tumor cells.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cancer Res 2003 May 1(7) 541-50",
                "id": "12754301"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c2c"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "Neoplasms",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "inhibition of the ERK kinases 1 and 2 (MEK1 and 2) by PD098059 (2'-amino-3'-methoxyflavone)",
              "citation": {
                "type": "PubMed",
                "name": "J Physiol 2003 Jan 15 546(Pt 2) 461-70",
                "id": "12527732"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c2b"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Analysis of embryonic fibroblasts from single KO mice revealed that Mnk1 is responsible for the inducible phosphorylation of eIF4E in response to MAP kinase activation, whereas Mnk2 mainly contributes to eIF4E's basal, constitutive phosphorylation.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Aug 24(15) 6539-49",
                "id": "15254222"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c2a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Sodium salicylate activated p38MAPK through phosphorylation at Thr 180/Tyr 182 and Akt/PKB at Ser 473, whereas it partially activated ERK1/2 through its phosphorylation at Thr 202/Tyr 204.",
              "citation": {
                "type": "PubMed",
                "name": "Int J Oncol 2003 Aug 23(2) 503-8",
                "id": "12851702"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c29"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Overexpression of dominant negative Rac1 (T17N) led to a striking (>80%) inhibition of LPA-induced ERK2 activation.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 2003 Sep 15 116(Pt 18) 3835-46",
                "id": "12902401"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c28"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "The B cell adaptor molecule of 32 kDa (Bam32) is an adaptor that links the B cell antigen receptor (BCR) to ERK and JNK activation and ultimately to mitogenesis. After BCR cross-linking, Bam32 is recruited to the plasma membrane and accumulates within F-actin-rich membrane ruffles.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Sep 17 279(38) 39775-82",
                "id": "15247305"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c27"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "B cell lymphoma",
                "cell": "b-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2003 Oct 12(4) 889-901",
                "id": "14580340"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c26"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Ariadne: However, tenascin-C, another member  of the matricellular family of extracellular matrix proteins that does not  utilize CRT-dependent signaling, also induces ERK phosphorylation (Fig. 7 C )  and stimulates focal adhesion disassembly through a MEK-dependent process.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Jun 7 277(23) 20453-60",
                "id": "11923291"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c25"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "TNF-a induced minimal activation of MAPKerk after brief periods of exposure (515 min); however, phosphoactivation of MAPKerk was observed by 60 min.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2000 Aug 1 165(3) 1618-25",
                "id": "10903772"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c24"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "bronchial epithelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "p62TCF is encoded by three ets-related genes, Elk-1, SAP1(ELK4) and SAP2(ELK3). Each of these factors contain a transcriptional activation domain that is activated by phosphorylation by MAP kinases.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2000 Mar 9 19(11) 1379-85",
                "id": "10723128"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c23"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "We conclude that TNFalpha and IGF-I may additively contribute to fibrosis during intestinal inflammation. TNFR2 is a primary mediator of fibrogenic actions of TNFalpha acting through ERK1/2 to stimulate proliferation and through STAT3 to stimulate TIMP-1 and inhibit collagen degradation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Oct 28 280(43) 36099-109",
                "id": "16141211"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c22"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "completely abolished by pretreatment of the cells with PD 98059, an inhibitor of MEK and GF 109203X, an inhibitor of PKC. These results demonstrated that the PKC/ERK1/2 cascade is the essential signaling pathway by which VLDL activates VLDL receptor mRNA expression.",
              "citation": {
                "type": "PubMed",
                "name": "J Huazhong Univ Sci Technolog Med Sci 2003 23(2) 97-100",
                "id": "12973919"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c21"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Sep 26 278(39) 37681-9",
                "id": "12821672"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c20"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1997 Aug 17(8) 4633-43",
                "id": "9234720"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c1f"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Evidence is provided that attenuation of Erk-1/-2 activity by estrogen occurs via GPR30-dependent stimulation of adenylyl cyclase and cAMP-dependent signaling that results in Raf-1 inactivation.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Endocrinol 2002 Jan 16(1) 70-84",
                "id": "11773440"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c1e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "The adapter protein Grb2 can directly associate with phosphorylated Y703 and Y936 in c-Kit",
              "citation": {
                "type": "PubMed",
                "name": "Cell Mol Life Sci 2004 Oct 61(19-20) 2535-48",
                "id": "15526160"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c1d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "several downstream substrates of ERK1/2 kinase have been identified (Brunet & Pouyssegur, 1997), including p90 ribosomal S6 kinase (p90rsk, also known as MAPK-activated protein kinase (MAPKAP-K) 1; Zhao et al. 1996) and mitogen- and stress-activated kinases (MSK) 1 and 2 (Deak et al. 1998).",
              "citation": {
                "type": "PubMed",
                "name": "Proc Nutr Soc 2004 May 63(2) 227-32",
                "id": "15294035"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c1c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Two activities that could phosphorylate MBP were induced -5- fold by NGF treatment of PC12 cells. These activities corresponded to the MAP kinases ERK2 and ERK1, as demonstrated previously (Boulton et al., 199 lb), and were confirmed by immunoblotting (data not shown).",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1995 Mar 1 14(5) 951-62",
                "id": "7889942"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c1b"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "In multiple cell types, IL-10 co-treatment can significantly reduce CD40-ligand and LPS induced activation of the MEK, p44/42 and p38 MAPK pathways [47, 48].",
              "citation": {
                "type": "PubMed",
                "name": "Curr Vasc Pharmacol 2009 Jul 7(3) 267-76",
                "id": "19601851"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c1a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Monocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "This inhibitory effect was further substantiated by the inhibition of NO on both the shear stress-induced transcriptional activity of Elk-1 (an ERK substrate)",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 1999 Aug 6 85(3) 238-46",
                "id": "10436166"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c19"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "The role of the mitogen-activated protein kinase cascade in the regulation of HGL expression was highlighted by the use of MAP kinase kinase-1/2 inhibitor \\\"PD 98,059\\\", which blunted both the activation of p42/p44(mapk) and the down-regulation of HGL mRNA induced by EGF and/or TGF-alpha.",
              "citation": {
                "type": "PubMed",
                "name": "Gastroenterology 1999 Apr 116(4) 831-41",
                "id": "10092305"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c18"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Chemical inhibition of MEK and RAF eliminated generation of a nuclear signal for phospho-ERK (MEK: UO126, PD98059, both used at 10 ?M; RAF: 1 uM LBT613 and 10 uM AAL881).",
              "citation": {
                "type": "PubMed",
                "name": "Environ Health Perspect 2009 Mar 117(3) 400-9",
                "id": "19337515"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c17"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Kit and other RTKs will activate the MAP kinase signaling pathway and has been reported both to increase the transcriptional activity of Mitf as well as down-regulate Mitf protein levels.",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2000 Jul 15 14(14) 1712-28",
                "id": "10898786"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c16"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Ang II dramatically increased the phosphorylation of ERK1/2, JNK1/2 and p38 (Figure 2 A-C).",
              "citation": {
                "type": "PubMed",
                "name": "Exp Mol Med 2006 Oct 31 38(5) 525-34",
                "id": "17079869"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c15"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Insulin-induced activation of extracellular signal-regulated kinases [ERKs, also known as mitogen-activated protein (MAP) kinases] is mediated by Ras...activation of the insulin receptor results in the interaction of GRB2-Sos with IRS-1 and Shc, thus linking the insulin receptor to Ras signaling pathways.",
              "citation": {
                "type": "PubMed",
                "name": "Science 1993 Jun 25 260(5116) 1953-5",
                "id": "8316835"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c14"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Signaling by the IL-6 receptor is mediated through the signal transducing subunit gp130 and involves the activation of Janus-associated kinases (JAKs), signal transducer and activator of transcription 3 (STAT3), and mitogen-activated protein (MAP) kinase. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1999 Aug 19(8) 5326-38",
                "id": "10409724"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c13"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Erk and p38 phosphorylate MNK1 and MNK2, which stimulates their in vitro kinase activity towards a substrate, EIF-4E",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1997 Apr 15 16(8) 1909-20",
                "id": "9155017"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c12"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Here we show that upon Fas, tumor necrosis factor alpha receptor, or tumor necrosis factor alpha-related apoptosis-inducing ligand receptor stimulation, an inhibition of extracellular signal-regulated kinase 1 and 2 (ERK1/2) activation sensitizes wild-type but not K8-null mouse hepatocytes to apoptosis and that a much weaker ERK1/2 activation occurs in K8-null hepatocytes.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Aug 24(16) 7072-81",
                "id": "15282307"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c11"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "hepatocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Here we show that upon Fas, tumor necrosis factor alpha receptor, or tumor necrosis factor alpha-related apoptosis-inducing ligand receptor stimulation, an inhibition of extracellular signal-regulated kinase 1 and 2 (ERK1/2) activation sensitizes wild-type but not K8-null mouse hepatocytes to apoptosis and that a much weaker ERK1/2 activation occurs in K8-null hepatocytes.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Aug 24(16) 7072-81",
                "id": "15282307"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c10"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "hepatocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "We report that in the CML cell line K562 Ras induces p21Cip1 expression through the Raf-MEK-ERK pathway.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Jan 14 280(2) 1112-22",
                "id": "15528212"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c0f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Using sequence-specific peptides, we found that the second proline-rich domain of DOC-2/DAB2 is the key binding site to Grb2 in the presence of growth factors. Such elevated binding interrupts the binding between SOS and Grb2, which consequently suppresses downstream ERK phosphorylation. Reduced ERK phosphorylation was restored when the binding between DOC-2/DAB2 and Grb2 was interrupted by a specific peptide or by increasing the expression of Grb2.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Jul 27 276(30) 27793-8",
                "id": "11371563"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c0e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Clin Exp Immunol 2002 Mar 127(3) 539-46",
                "id": "11966773"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c0d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "TPO induced strong and sustained activation of ERK1/2. The TPO induced activation of ERK started around 15 minutes of stimulation and reached a maximum around 2 hours of treatment.",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2005 Jun 1 105(11) 4258-63",
                "id": "15705785"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c0c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "hematopoietic",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Treatment with LPS resulted in significant increases in ERK, JNK, and p38 phosphorylation compared with control, and these events were not inhibited by cotreatment with lutein (Fig. 4D).",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2008 Sep 15 45(6) 885-96",
                "id": "18620044"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c0b"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "leukemia",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "inflammatory fluids. Chemerin is secreted as a precursor of low biological activity, which upon proteolytic cleavage of its COOH-terminal domain, is converted into a potent and highly specific agonist of ChemR23, the chemerin receptor. Activation of chemerin receptor results in intracellular calcium release, inhibition of cAMP accumulation, and phosphorylation of p42-p44 MAP kinases, through the Gi class of heterotrimeric G proteins.",
              "citation": {
                "type": "PubMed",
                "name": "J Exp Med 2003 Oct 6 198(7) 977-85",
                "id": "14530373"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c0a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "treatment of A549 cells with SU6656 caused considerable reduction in ERK1/2 activity and significantly reduced MMP2 and MMP9 expression (Figure 6BFigure 6). ",
              "citation": {
                "type": "PubMed",
                "name": "Biochemistry 2009 Mar 3 48(8) 1838-46",
                "id": "19199380"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c09"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Blood 1999 Jan 15 93(2) 537-53",
                "id": "9885215"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c08"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2005 Apr 1 329(1) 266-74",
                "id": "15721302"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c07"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "CD2AP was required for early activation of anti-apoptotic phosphatidylinositol 3-kinase (PI3K)/AKT and extracellular signal-regulated kinase 1/2 by TGF-beta",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem. 2004 Aug 27;279(35):37004-12",
                "id": "15213232"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c06"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 1999 Jun 10(6) 2075-86",
                "id": "10359616"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c05"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "TamR-1 cells also showed a concomitant increase in total ERBB3 but no change in EGFR was noted (Fig. 2A). Most noteworthy, IGF1R appeared down-regulated. Increases in activated AKT, MAPK3/1 and its downstream partner RPS6KA2 were also detected (Fig. 2B and C).",
              "citation": {
                "type": "PubMed",
                "name": "Endocr Relat Cancer 2008 Dec 15(4) 985-1002",
                "id": "18824559"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c04"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "LDL, in pathophysiological concentrations, affect the IGF-I signaling pathway at multiple levels: 1) they induce phosphorylation of IGF-I receptor beta and IRS-1 in a time- and dose-dependent manner; 2) they up-regulate IRS-1-associated PI3 kinase/Akt activation in response to IGF-I at early times; and 3) they show additive effects with IGF-I on extracellular signal-regulated MAPK 1/2 phosphorylation.",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 2001 Nov 142(11) 4852-60",
                "id": "11606453"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c03"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "HGF activates P42/P44MAPK (extracellular signal regulated kinase 2/1) and P38 MAPK two and three-fold respectively compared to basal level in a PKC independent manner. The phosphorylation level peaked within 5-10 minutes of HGF treatment.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2001 Dec 6 20(56) 8125-35",
                "id": "11781826"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c02"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "melanocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Phosphorylated ERK1/2, JNK, p38 and ERK5 were significantly increased by exposure to TS, indicating the activation of these MAPK pathways.",
              "citation": {
                "type": "PubMed",
                "name": "Carcinogenesis 2005 Dec 26(12) 2187-95",
                "id": "16051644"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c01"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "MSK1 is activated in vitro by MAPK2/ERK2 or SAPK2/p38.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1998 Aug 3 17(15) 4426-41",
                "id": "9687510"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7c00"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Recombinant human (rh) CyPA activated ERK1/2, p38MAPK, SAPKs, and Akt in cultured cardiac myocytes. Furthermore, CyPA significantly increased Bcl-2 in cardiac myocytes.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2004 Apr 23 317(1) 162-8",
                "id": "15047162"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7bff"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "cardiomyocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Furthermore, expression of VACM-1 but not S730AVACM-1 protein retarded cytokinesis and prevented MAPK phosphorylation.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2003 Dec 285(6) C1386-96",
                "id": "12917106"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7bfe"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "To test for direct involvement of Lyn PTK activity inAMPA-receptor-mediated MAPK activation, we generated recombinant adenoviruses carrying wild-type Lyn (AdexLyn) or the kinase-negative form of Lyn (AdexLynKN). MAPK activation in response to AMPA-receptor stimulation was enhanced by infection with Adex- Lyn. Moreover, MAPK activation was almost completely inhibited when cerebellar primary culture cells were infected with Adex- LynKN (Fig. 3b).",
              "citation": {
                "type": "PubMed",
                "name": "Nature 1999 Jan 7 397(6714) 72-6",
                "id": "9892356"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7bfd"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "from full text - Introduction of GRK 2 or 3 strikingly reduced primarily the late activation of ERK after AngII stimulation in a pattern similar to that observed with GRK 5 or 6 siRNA transfection (compare Figs. 3C and 4B). On the contrary, GRK 5 or 6 overexpression enhanced AngII-induced ERK activation especially at the later time points (Fig. 4 A and C), similar to the pattern observed in GRK 2 or 3 siRNA-transfected cells (Fig. 3B)",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2005 Feb 1 102(5) 1442-7",
                "id": "15671181"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7bfc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "over-expression of gamma-synuclein leads to constitutive activation of ERK1/2 and down-regulation of JNK1",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Sep 20 277(38) 35050-60",
                "id": "12121974"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7bfb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Pretreatment of THP-1 cells with pharmacological inhibitors of PI3K (LY294002), MAPK (PD98059), p38 MAPK (SB203580), and JNK (SP600125) inhibited ET-1-mediated MIP-1b mRNA expression by 89 6 5%, 104 6 7%, 102 6 8%, and 118 6 1%, respectively, when compared with that of untreated cells (Fig.1B).",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2010 Oct 15",
                "id": "20952681"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7bfa"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "These results suggest that ERK2 has a regulatory role in activating CREB in vivo in lung neutrophils after hemorrhage or endotoxemia. ",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2001 Jan 1 166(1) 522-30",
                "id": "11123332"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7bf9"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Heusch and Maneckjee (23) have provided evidence that nicotine, at a concentration of 10-6 M or less, activates the MAPK signaling pathway in lung cancer cells, in particular extracellular signal-regulated kinase (ERK2).",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2004 Jan 1 64(1) 135-45",
                "id": "14729617"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7bf8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Lung Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "p90rsk (MAPKAP-K1), one of the main substrates activated by phosphorylated ERK1/2, may be involved in the phosphorylation and inactivation of GSK3 (29-31). Tungstate treatment strongly stimulated the phosphorylation of p90rsk at consensus serine 380, both in CHO-R cells and in primary cultured hepatocytes",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Oct 31 278(44) 42785-94",
                "id": "12925525"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7bf7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Inhibitor experiments suggested that nuclear factor kappaB and p 44/42 mitogen-activated protein kinase are involved in both, basal and adipocytokine-induced TIMP-1 expression.",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 2005 Nov 21 579(28) 6417-22",
                "id": "16288749"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7bf6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Treatment of VSMCs with IL-1beta decreased IkappaBbeta in the RSK1/IkappaBbeta/NF-kappaB complex, an effect that was attenuated by inhibition of ERK activation.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2006 Dec 291(6) C1336-45",
                "id": "16822942"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7bf5"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": "Muscle, Smooth"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "MAPK phosphorylates receptor residues threonine 171 and serine 246, whereas multiple CDK complexes modify serines 224 and 232.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1997 Jul 17(7) 3947-54",
                "id": "9199329"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7bf4"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "PPAR gamma agonists 15-d-PGJ2 and thiazolidinediones such as pioglitazone and troglitazone elicited rapid activation of ERK within 15 min and induced c-fos mRNA expression within 30 min",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Dec 28 276(52) 48950-5",
                "id": "11687581"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7bf3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "IL-1beta also induced activation of ERK and recruitment of phospho-ERK to focal complexes/adhesions. ",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Physiol 2006 Apr 207(1) 132-43",
                "id": "16250012"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7bf2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "glycated albumin stimulates VEGF expression through an ERL-dependent pathway glycated albumin activated mitogen-activate protein kinase, ERK1/2, JNK1/2, but not p38, and that glycated albumin did not activate PI3K and PKB",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Nov 23 276(47) 43836-41",
                "id": "11571295"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7bf1"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Interestingly, although the ERK1/2, p38 and JNK MAPKs were still induced in the Mekk3 knockdown cells, their levels were consistently lower than those in the control cells with similar kinetics at early time-points",
              "citation": {
                "type": "PubMed",
                "name": "Immunology 2007 Feb 120(2) 242-50",
                "id": "17116170"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7bf0"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Interestingly, each of the individual MAPKs evaluated was found to promote Lox-1 expression to varying degrees. As we expected, CpG ODN treatment of macrophages increased three MAPKs phosphorylation, and each inhibitor of three MAPKs significantly attenuated the CpG ODN-induced phosphorylation of the MAPKs (Fig. 7A). ",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2008 Dec 20(12) 2266-75",
                "id": "18817866"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7bef"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "This enzyme, cPLA2, is regulated by Ca2C and by phosphorylation by MAP kinases (57). The stimulation by Ca2C occurs at submicromolar concentrations, and so its activity will be modulated by the intracellular Ca2C changes found in stimulated cells.",
              "citation": {
                "type": "PubMed",
                "name": "Annu Rev Biochem 2000 69 419-45",
                "id": "10966465"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7bee"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Oct 17 278(42) 40851-8",
                "id": "12907681"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7bed"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "FHL2 inhibited the ability of activated ERK2 to reside within the nucleus, thus blocking ERK-dependent transcriptional responsiveness of ELK-1, GATA4, and the atrial natriuretic factor promoter.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Feb 24(3) 1081-95",
                "id": "14729955"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7bec"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "cardiac muscle"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "indicating that this pathway seems to be more specialized in proliferation of foetal brown adipocytes (Valverde et al. 1995). The chemical compound PD98059 is a selective and cell permeable inhibitor of MAPK kinase that acts by inhibiting the activation of MAPK (Alessi et al. 1995). When brown adipocytes were cultured with PD98059 together with insulin or IGF-I, an enhanced FAS mRNA expression was observed (Porras et al. 1998).",
              "citation": {
                "type": "PubMed",
                "name": "Mini Rev Med Chem 2005 Mar 5(3) 269-78",
                "id": "15777261"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7beb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Its (RSK2) activation requires phosphorylation of the linker region at Ser(369), catalyzed by extracellular signal-regulated kinase (ERK)",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Sep 17 274(38) 27168-76",
                "id": "10480933"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7bea"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Treating human Panc-48 adenocarcinoma cells with EGF activated Akt and Erk but not P-38.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer 2003 Aug 15 98(4) 720-9",
                "id": "12910515"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7be9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Expression of active PTPH1 also reduced receptor-induced activation of Erk2 MAP kinase, its upstream activator, Mek, and the Jnk kinases.",
              "citation": {
                "type": "PubMed",
                "name": "Eur J Immunol 2000 May 30(5) 1318-25",
                "id": "10820377"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7be8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "These data indicate that ROS was generated before the ERK activation and ERK was activated before NFATc activation, clarifying the sequence of ROS generation, ERK and NFATc activation.",
              "citation": {
                "type": "PubMed",
                "name": "J Hypertens 2008 Dec 26(12) 2349-60",
                "id": "19008713"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7be7"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "When HEMEC were exposed to acidic pH for various time periods, there was a rapid and significant activation of JNK which was seen as early as 1 min. Activation of p44/42 MAPK was first detected at 15 min and maximized by 30 min, while activation of p38 MAPK was delayed, appearing at 60 min (Fig. 3A).",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2006 Nov 291(5) C931-45",
                "id": "16790501"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7be6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": "vascular tissue"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "8-isoprostane significantly (P=0.03) activated ERK 1/2 and the peak of phosphorylation was reached after 15 min of stimulation (Fig. 4A). Similarly, 8-isoprostane induced significantly (P=0.03) p38 MAPK phosphorylation, but with a peak of phosphorylation after 30 min (Fig. 4B) and the 8-isoprostane induced phosphorylation of both MAP kinases sustained for up to 60 min. ",
              "citation": {
                "type": "PubMed",
                "name": "Cardiovasc Res 2003 Oct 1 59(4) 945-54",
                "id": "14553834"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7be5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "RANKL-induced NFATc1 forms a complex with PU.1 in nuclei of osteoclasts following the nuclear accumulation of NFATc1 phosphorylated by the activated p38 MAP kinase.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Oct 29 279(44) 45969-79",
                "id": "15304486"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7be4"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Brain Res Mol Brain Res 1997 Nov 51(1-2) 220-8",
                "id": "9427524"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7be3"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2003 May 15 170(10) 5281-94",
                "id": "12734378"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7be2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Jun 21 277(25) 22222-30",
                "id": "11956220"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7be1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Depletion of cholesterol from the cells using beta-cyclodextrin blocked insulin stimulation of glucose uptake, insulin inhibition of perilipin phosphorylation in response to isoproterenol, and insulin stimulation of protein kinase B and Map-kinases extracellular signal-related kinase (ERK)1/2 phosphorylation",
              "citation": {
                "type": "PubMed",
                "name": "Eur J Biochem 2004 Jun 271(12) 2471-9",
                "id": "15182363"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7be0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Adipocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Furthermore, activation of phosphorylation of IRE1a and ERK was also repressed, indicating that CIM is required for transduction of the adaptive signals in UPR (Fig. 5D upper panel).",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2010 Dec 1 70(23) 9949-58",
                "id": "21118962"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7bdf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "we found that both ERK1 and ERK2 were expressed in SK-OV-3.ipl cells incubated under various conditions (e.g. untreated (Fig. 2A, panel b, lane 1), treated with HA (lane 2), or pretreated with anti-CD44 antibody, followed by HA treatment (lane 3)). We also observed that ERK2 (and to a lesser extent, ERK1) phosphorylation was significantly up-regulated by HA treatment",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Mar 25 280(12) 11961-72",
                "id": "15655247"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7bde"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Expression of N17Ras attenuated activation of ERK (Figure 4A) and JNK (Figure 4B). In contrast, selective activation of Ras was sufficient for ERK but not JNK activation.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2003 Jun 28(6) 762-9",
                "id": "12600818"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7bdd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "bronchial epithelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Platelets contain several potential H-Ras effectors, including PI 3-kinase and Raf-1, and thrombin induces activation of MAP (ERK2) kinase in platelets, possibly through the classical H-Ras pathway.96",
              "citation": {
                "type": "PubMed",
                "name": "Blood 1998 Apr 15 91(8) 2645-57",
                "id": "9531572"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7bdc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Blood Platelets",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "C2-ceramide was found to inhibit the growth of Bel7402 cells by inducing cell cycle arrest. During the process, the expression of p21 protein increased, while that of cyclinD1, phospho-ERK1/2 and c-myc decreased. Furthermore, the level of CDK7 was downregulated, while the transcriptional activity of PPARgamma was upregulated. ",
              "citation": {
                "type": "PubMed",
                "name": "World J Gastroenterol 2007 Feb 21 13(7) 1129-34",
                "id": "17373752"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7bdb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Cyclic stretch of NRVMs induced rapid (10 min) and sustained (up to 120 min) FAK and ERK1/2 activation (Fig. 1A), as indicated by increases in the amount of FAK andERK1/2 detected by specific antibodies against FAK phosphorylated at Tyr397 and ERK1/2 phosphorylated at Thr202/Tyr204",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Heart Circ Physiol 2005 Oct 289(4) H1488-96",
                "id": "15923313"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7bda"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "myocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 1999 Apr 1 13(7) 804-16",
                "id": "10197981"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7bd9"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "The differentially expressed gene set was integrated with the set of signaling proteins previously shown to be activated by TS: ADAM17 (37), AhR (36, 38), cyclic AMP responsive element binding protein 1 (CREB1; ref. 36), mitogen- activated protein kinase [extracellular signalregulated kinase (ERK)-1/2; ref. 39], protein kinase A catalytic subunit (PRKACA; ref. 36), and SRC.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Prev Res (Phila Pa) 2008 Jul 1(2) 100-11",
                "id": "19138943"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7bd8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "STEP then inactivated ERK2 through dephosphorylation of the tyrosine residue in its activation domain and blocked nuclear translocation of the kinase thus STEP is important in regulating the duration of ERK activation and downstream signaling in neurons",
              "citation": {
                "type": "PubMed",
                "name": "Nat Neurosci 2003 Jan 6(1) 34-42",
                "id": "12483215"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7bd7"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "neuron",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "We found that CCR7 induced a Gi-dependent activation of MAPK members ERK1/2, JNK, and p38, with ERK1/2 and p38 controlling JNK. MAPK members regulated chemotaxis, but not the migratory speed, of DCs.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2005 Apr 1 174(7) 4070-80",
                "id": "15778365"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7bd6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "dendritic cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "In contrast to ERK, the activities of p38 and SAPK/JNK are very low in insulin- or EGF-stimulated fibroblasts and, therefore, insufficient to phosphorylate ATF2 Thr71 and/or Thr69 efficiently by themselves (Figures 1D and 4A). However, these low levels of active p38 are essential and appear to be sufficient to phosphorylate Thr69 when ATF2 Thr71 is already mono-phosphorylated by ERK (see the model in Figure 7).",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2002 Jul 15 21(14) 3782-93",
                "id": "12110590"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7bd5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2001 May 3(5) 453-9",
                "id": "11331872"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7bd4"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Biochemistry 2003 Jun 24 42(24) 7571-9",
                "id": "12809513"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7bd3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "At the gene transcriptional level, both IL-6 and Stat3 mRNA levelswere up-regulated in response to MMP12 overexpression (Fig. 4C). Other intracellular oncogenic moleculeswere also analyzed (Supplementary Fig. S2). NFnB, extracellular signal-regulated kinase (ERK), p38, and AKT were all significantly activated in doxycycline-treated bitransgenic mice compared with untreated bitransgenic mice.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2009 Sep 15 69(18) 7252-61",
                "id": "19706765"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7bd2"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Alveolar type II cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2001 Nov 15 20(52) 7658-67",
                "id": "11753643"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7bd1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "This indicates that ERK1/2, reported to be located downstream of PKA, participates in the PKA-mediated CREB phosphorylation elicited by glucose. In ERK1/2-downregulated MIN6 cells by siRNA, glucose-stimulated CREB phosphorylation was highly reduced and CREB protein content was decreased by 60%.% blockade of ERK1/2 activity with PD98059 caused a significant decrease in CREB protein level",
              "citation": {
                "type": "PubMed",
                "name": "Diabetes 2006 Aug 55(8) 2220-30",
                "id": "16873684"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7bd0"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "resulted in an elevation in intracellular Ca(2+) concentration and activation of the mitogen-activated protein kinase cascade, specifically, extracellular signal-regulated kinase 2 (ERK2) mitogen-activated protein kinase.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2001 Feb 15 166(4) 2695-704",
                "id": "11160334"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7bcf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "First, BRAFV600E-mediated induction of IGFBP7 was blocked by addition of a MEK inhibitor (Figure S3A). Second, expression of a constitutively activated ERK mutant (ERK2Q103A or ERK2L73P,S151D) was sufficient to activate IGFBP7 transcription (Figure S3B).",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2008 Feb 8 132(3) 363-74",
                "id": "18267069"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7bce"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "melanocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "HGF induces sustained phosphorylation of Gab1 and sustained activation of extracellular signal-regulated kinase (Erk) in epithelial Madin-Darby canine kidney cells.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2000 Nov 20(22) 8513-25",
                "id": "11046147"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7bcd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "kidney epithelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "In Rac2(-/-) T cells, proliferation was reduced upon stimulation with either plate-bound anti-CD3 or T cell receptor-specific antigen. This defect is accompanied with decreased activation of mitogen activated protein kinase extracellular signal-regulated kinase (ERK)1/2 and p38, and reduced Ca(2)+ mobilization. TCR stimulation-induced actin polymerization is also reduced",
              "citation": {
                "type": "PubMed",
                "name": "J Exp Med 2001 Oct 1 194(7) 915-26",
                "id": "11581314"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7bcc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 May 17 277(20) 18111-7",
                "id": "11877445"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7bcb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Annexin XI was phosphorylated by mitogen-activated protein (MAP) kinase, which was reported to be activated in v-src-transformed fibroblast Annexin",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1993 Jul 25 268(21) 15517-22",
                "id": "8393445"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7bca"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "VEGF also stimulated the mitogen activated protein (MAP) kinases ERK (extracellular signal-regulated kinase) and p38 (stress activated protein kinase-2)",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1997 Oct 15(18) 2169-77",
                "id": "9393975"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7bc9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "alpha2-AR-mediated activation of either endogenous or cotransfected p42/p44 mitogen-activated protein (MAP) kinase",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Apr 16 274(16) 11253-9",
                "id": "10196213"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7bc8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2003 Aug 15 102(4) 1169-77",
                "id": "12714503"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7bc7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Pretreatment of VSMC with IL-19 results in a significant reduction in fetal calf stimulated p44/42 and p38 MAPK activation in cultured human VSMC [38]. It was found that this inhibition was mediated by SOCS5 interaction with these MAP kinases, suggesting that in other cell types, other interleukins could inhibit MAPKs by induction of SOCS proteins.",
              "citation": {
                "type": "PubMed",
                "name": "Curr Vasc Pharmacol 2009 Jul 7(3) 267-76",
                "id": "19601851"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7bc6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": "vascular tissue"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Dec 29 275(52) 41011-7",
                "id": "11018025"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7bc5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Arterioscler Thromb Vasc Biol 2002 Nov 1 22(11) 1811-6",
                "id": "12426209"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7bc4"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "FIGURE 8. Model for neutrophil signaling mechanisms triggered by bacterial DNA. Although the activation of the intermediates indicated in the figure have been probed, a causal relationship between TIR pathway activation and MAPKs, AP-1 and NF-kB, has not been directly determined. ",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2006 Sep 15 177(6) 4037-46",
                "id": "16951367"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7bc3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK1) actsIn kin(p(HGNC:MAPK1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1991 Nov 25 266(33) 22159-63",
                "id": "1939237"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7bc2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(SFAM:\"PRKC Family\")",
        "relation": "hasMember",
        "target": "p(HGNC:PRKCI)",
        "directed": false,
        "label": "p(SFAM:\"PRKC Family\") hasMember p(HGNC:PRKCI)",
        "metadata": {
          "casual": false,
          "createdBy": "Jamboree2014",
          "edgeId": "55775dd92f9e241f18ad8d78",
          "evidences": [
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") hasMember p(HGNC:PRKCI)",
              "summary_text": "This is a non-causal connector edge that does not require literature evidence.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f2c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(SFAM:\"PRKC Family\")",
        "relation": "actsIn",
        "target": "kin(p(SFAM:\"PRKC Family\"))",
        "directed": false,
        "label": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8d79",
          "evidences": [
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "In this study, we reconstitute fibroblasts derived from a TACE knockout mouse (Null cells) with either the rabbit (rb) GHR alone (Null/R) or rbGHR plus murine TACE (Null/R+T). Although GHR in both cells was expressed at similar abundance, dimerized normally and caused JAK2 activation in response to GH independent of TACE expression, PMA was unable to generate GHBP from Null/R cells. In contrast, PMA caused ample GHBP generation from TACE reconstituted (Null/R + T) cells, and this GHBP shedding was substantially inhibited by IC3 pretreatment. Corresponding to the induced shedding of GHBP from Null/R + T cells, PMA treatment caused a significant loss of immunoblottable GHR in Null/R+T, but not in Null/R cells.",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 2000 Dec 141(12) 4342-8",
                "id": "11108241"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8bbf"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "After the initial adhesion of platelets to the extracellular matrix, the repair process requires a rapid response to autocrine and paracrine mediators, including adenosine diphosphate (ADP), thrombin, epinephrine, and thromboxane A2. These mediators amplify and sustain the initial platelet response (Figure 1Figure 1Agonists, Receptors, and Effector Systems in Platelet Activation.), and they recruit circulating platelets from the flowing blood to form a growing hemostatic plug. Most agonists that activate platelets operate through G-protein?coupled receptors.14 The final pathway for all agonists is the activation of the platelet integrin glycoprotein IIb/IIIa (?IIb?3), the main receptor for adhesion and aggregation.15 ",
              "citation": {
                "type": "PubMed",
                "name": "N Engl J Med 2007 Dec 13 357(24) 2482-94",
                "id": "18077812"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8bbe"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Blood Platelets",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "The various inositol 1,4,5-trisphosphate receptor (IP(3)R) isoforms are potential substrates for several protein kinases. We compared the in vitro phosphorylation of purified IP(3)R1 and IP(3)R3 by the catalytic subunit of protein kinase C (PKC). Phosphorylation of IP(3)R1 by PKC was about eight times stronger than that of IP(3)R3 under identical conditions. Protein kinase A strongly stimulated the PKC-induced phosphorylation of IP(3)R1. In contrast, Ca(2+) inhibited its phosphorylation (IC(50)<or=2microM) and this inhibition was further potentiated by calmodulin (CaM), while the Ca(2+)-independent CaM mutant CaM(1234) was ineffective. Ca(2+) and CaM, however, did not inhibit IP(3)R3 phosphorylation by PKC. Taken together, these findings show that Ca(2+) and CaM differentially regulate the PKC-mediated phosphorylation of IP(3)R1 and IP(3)R3 and are indicative for a role for the inhibition of IP(3)R1 phosphorylation by Ca(2+) and CaM in the negative slope of the bell-shaped effect of Ca(2+) on IP(3)R function.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2004 Jul 2 319(3) 888-93",
                "id": "15184066"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8bbd"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Pancreatic lobules were pretreated with or without 1, 5, 10, or 15 micromolar  BIS for 15 min followed by stimulation with or without 100 nM caerulein for 30 min. Nuclear and cytoplasmic extracts were prepared and assayed in EMSAs using the kappa-light-chain enhancer high-affinity kappaB site as probe and Western analysis with anti-IkappaBalpha and anti-IkappaBbeta antibodies. BIS caused a slight induction of NF-kappaB/Rel activity at 1 and 5 micromolar but had no effect on basal NF-kappaB/Rel activity at 10 and 15 micromolar (Fig. 5, lanes 3-6). Caerulein-induced NF-kappaB/Rel activity was efficiently blocked by BIS at 5, 10, and 15 micromolar, with the highest dose being most effective. Degradation of IkappaBalpha by caerulein was already sustained by BIS at 1 micromolar and completely blocked by BIS at 5, 10, or 15 micromolar.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol 1999 Sep 277(3 Pt 1) G678-86",
                "id": "10484394"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8bbc"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "The production of CFI by Hep G2 cells was enhanced in a dose- and time-dependent fashion by 12-O-tetradecanoyl-1,2-phorbol 13-acetate (TPA), a potent PKC activator. 4Alpha-phorbol didecanoate, an inactive phorbol ester, had no effect on CFI synthesis. The TPA-dependent increase in CFI secretion was correlated with an increase in CFI mRNA levels. These results indicate that TPA regulation of CFI gene requires PKC signalling and is mediated by via a TPA response element (TRE) in the CFI promoter region located at -136/-130",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biochem 1999 Nov 201(1-2) 111-23",
                "id": "10630630"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8bbb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Protein kinase C (PKC) regulates activation of the Raf-1 signaling cascade by growth factors, but the mechanism by which this occurs has not been elucidated. Here we report that one mechanism involves dissociation of Raf kinase inhibitory protein (RKIP) from Raf-1. Classic and atypical but not novel PKC isoforms phosphorylate RKIP at serine 153 (Ser-153). RKIP Ser-153 phosphorylation by PKC either in vitro or in response to 12-O-tetradecanoylphorbol-13-acetate or epidermal growth factor causes release of RKIP from Raf-1",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Apr 11 278(15) 13061-8",
                "id": "12551925"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8bba"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "To delineate possible signaling pathways accounting for these gene expression, a subset of specific kinase inhibitors, SB203580, PD98059, rapamycin, LY294002, and Ro-32-0432, which inhibit p38 (HOG), MEK (MAPKK), S6 kinase, PI3 kinase, and protein kinase C (PKC), respectively, were employed. The IEGs were classified into three categories according to their susceptibility to the inhibitors. Expression of the first group (c-fos, jun-B, egr-1, tis11, tis21, thrombospondin-1, erp, thyroid hormone receptor [N-10], cyr61, and zf9) was mainly dependent on PKC and MEK pathways, while that of the second class (gene33 and tis10) exhibited an additional dependence on PI3 kinase pathways.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 1999 Nov 30 265(3) 664-8",
                "id": "10600478"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8bb9"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Intracellular calcium signaling is regulated by PLC?, which generates inositol 1,4,5-trisphosphate and diacylglycerol from PIP2. Inositol 1,4,5-trisphosphate stimulates the release of intracellular calcium stores upon binding to its receptor in the ER. The depletion of ER calcium stores then triggers extracellular calcium influx. Diacylglycerol and intracellular calcium signals cooperate to activate PKCs, which then activate other pathways such as the NF-?B pathway, ultimately leading to mast cell degranulation and cytokine production.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2011 Sep 23 286(38) 32891-7",
                "id": "21799019"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8bb8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "mast cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Simultaneous overexpression of selenophosphate synthetase and phospholipid-hydroperoxide GSH peroxidase (PHGPx) [250] blocks activation of NF-kB by IL-1. Overexpression of SOD [84] or GSH peroxidase [81, 211] abolished NF-kB activation by preventing degradation of IkB after stimulation with TNF-a. The precise mechanism(s) through which oxidants and reductants influence activation of NF-kB is presently unknown; however, there is evidence that antioxidant enzyme (AOE372), a redox-sensitive thioredoxin peroxidase, regulates IkB phosphorylation [246]. Phosphatases The phosphatases are an important component of most signal transduction pathways, because failure to reverse kinase actions can disrupt normal cellular functions. For example, transfection of human fibroblasts with constitutively active ras (hRasV12) inhibits cell growth and ultimately results in a senescentlike phenotype [441]. Similarly, constitutive ERK activation has an inhibitory effect on cell cycle progression [442,443]. Both the serine/threonine phosphatases and the PTPs are known to be redox-sensitive [82,144,153,156,271,281, 444-449]. The mechanism of redox effects on activity is probably best understood for the PTPs. Without exception, the PTPs contain a highly conserved region of 11 amino acid residues in their catalytic domain; specifi- cally, (Ile/Val)-His-Cys-X-Ala-Gly-X-X-Arg-(Ser/Thr)- Gly, where X is a nonconserved amino acid [17]. Either oxidation or mutation of the cysteine renders these molecules inactive [17,281]. H2O2 is a potent inhibitor of PTPs. As in the case of other oxidants, H2O2 probably oxidizes the thiolate anion at the catalytic site [280]. Because formation of a phosphorylcysteine intermediate seems to be critical to PTP activity [450-452], blocking it through oxidation of the cysteine inactivates the molecules. In many cases, treatment of cells with H2O2 stimulates increases in protein phosphorylation by inhibiting phosphatase-catalyzed removal of phosphate groups. Furthermore, mitogens that increase cellular ox- idant production may stimulate phosphorylation indirectly by decreasing phosphatase activity. Additional mechanisms are involved in stimulation of pathways activated by growth factors that increase oxidant production, however, because there are known instances in which the oxidants they produce have no effect on protein phosphorylation. For example, TGF-b1 stimulates phosphorylation of numerous proteins and has been shown to cause a large increase in H2O2 production; however, its effects on protein phosphorylation are not blocked by catalase [453]. Furthermore, H2O2 is effective in promoting phosphorylation of phospholipase D, the PDGF receptor, and PKC-a even after pretreatment of Swiss 3T3 fibroblasts with orthovanadate to inhibit phosphatases [454]. Thus, although diminished phosphatase activity may partially account for increased phosphorylation in some cases, it cannot totally account for oxidation effects on phosphorylation in every case. SPECIFICITY In general, there is good agreement between studies on redox effects on any given gene; albeit, not all oxidizing or reducing treatments exert equivalent effects. This is clearly demonstrated in studies of pag , which encodes a protein associated with cellular proliferation. Pag protein inhibits the tyrosine kinase activity of the Abelson (abl ) protein by binding to its SH3-binding domain [455]. BSO, menadione, sodium arsenate, and diethyl maleate all stimulate pag expression, but H2O2 does not [269]. Conversely, H2O2 stimulates c-fos expression (Table 1), although 4-hydroynonenal (a product of v-6-polyunsaturated fatty acid peroxidation) not only fails to induce c-fos expression but is actually inhibitory to c-fos induction by EGF and PDGF [185]. Similarly, some oxidants such as diamide decrease hypoxia-induced signals [201], although others such as H2O2 increase them [124]. As might be expected, the effects of any stimu...",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2000 Feb 1 28(3) 463-99",
                "id": "10699758"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8bb7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "The treatment of rat lung epithelial cells with nicotine for various periods differentially mobilizes multiple intracellular pathways [64]. Protein kinase C and PI3-OH-kinase are transiently activated after the treatment. Also, Ras and its downstream effector ERK1/2 are activated after long-term exposure to nicotine. The activation of Ras by nicotine treatment is responsible for the subsequent perturbation of the methotrexate (MTX)-mediated G1 cell cycle restriction, as well as an increase in production of reactive oxygen species [64].",
              "citation": {
                "type": "PubMed",
                "name": "Mutat Res 659(3) 221-31",
                "id": "18495523"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8bb6"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Site-directed mutagenesis, electron microscopy, and X-ray crystallography were used to probe the structural basis of annexin IV-induced membrane aggregation and the inhibition of this property by protein kinase C phosphorylation. Site-directed mutants that either mimic (Thr6Asp, T6D) or prevent (Thr6Ala, T6A) phosphorylation of threonine 6 were produced for these studies and compared with wild-type annexin IV.  In vitro assays showed that unmodified wild-type annexin IV and the T6A mutant, but not PKC-phosphorylated wild-type or the T6D mutant, promote vesicle aggregation. ",
              "citation": {
                "type": "PubMed",
                "name": "Biochemistry 2001 Apr 3 40(13) 4192-9",
                "id": "11300800"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8bb5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "The tyrosine kinase inhibitor, genestein, blocks 1,25(OH)2D3/CSF-1 induced phosphorylation of the putative CSF-1 receptor but has no effect on talin phosphorylation which occurs exclusively on serine. In contrast to genestein, staurosporin, an inhibitor of PKC, inhibits phosphorylation of talin. Moreover, exposure of 1,25(OH)2D3 pretreated cells to phorbol 12-myristate 13-acetate (PMA) in place of CSF-1 also prompts talin phosphorylation.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biochem 1993 Oct 53(2) 145-55",
                "id": "8227187"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8bb4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "This work provides evidence that transcription of the human connexin-43 gene is induced through protein kinase C activation in uterine smooth muscle cells, and that the induction involves up-regulation and activation of c-Jun and c-Fos.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1996 Sep 27 271(39) 23667-74",
                "id": "8798588"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8bb3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Astrocytes in the central nervous system are involved in a variety of functions including storage of glycogen, maintenance of the extracellular ionic equilibrium, and support for the migration and the differentiation of neurons. Astrocytes express membrane receptors allowing them to respond to extracellular signals. Activation of receptors induces a cascade of events, such as stimulation of protein kinases and subsequent phosphorylation of target proteins. To understand the regulatory processes underlying neuroglial interactions, attempts were made to identify major phosphorylated proteins in striatal astrocytes, grown in primary culture and labeled with [32P]phosphate. Two-dimensional gel electrophoresis revealed a major doublet, Pa and Pb, of highly labeled spots, with a low molecular weight (M(r) = 15,000) and acidic pI (pI = 5.2 and 5.3, respectively). Using an enriched, heat-stable, cytosolic fraction, Pa and Pb were eluted from semi-preparative two-dimensional gels and subjected to a limited proteolysis and partial microsequencing. The same sequences were obtained within Pa and Pb and had no homology with other known protein. Antibodies raised against corresponding synthetic peptides confirm that the doublet represents two isoelectric variants of the same protein, which also exists under a nonphosphorylated form, N. We propose to name this protein PEA-15, for Phosphoprotein Enriched in Astrocytes-15 kDa, according to its large enrichment in these cells. Treatment of intact astrocytes with 12-O-tetradecanoylphorbol-13-acetate (TPA), which stimulates protein kinase C (PKC), increased the phosphorylation of the more acidic spot (Pb) while decreasing Pa intensity. Stimulations of astrocytes known to increase PKC activity, i.e. noradrenaline, or its inhibition by decreasing extracellular calcium concentrations, staurosporine, or desensitization following long term treatment with TPA, induced a phosphorylation or a dephosphorylation of PEA-15, respectively. Using purified PKC, PEA-15 appeared to be a good substrate in vitro. Two-dimensional peptide mapping revealed that the phosphorylation site in intact cells was identical with the site phosphorylated by PKC in vitro. Mapping the phosphopeptides by HPLC following endolysine C treatment lead to the identification of a sequence, phosphorylated in intact astrocytes and in vitro by PKC, containing a consensus site for PKC: LTRIPSAKK. Antibodies raised against a synthetic peptide derived from this sequence recognized N and Pa in control conditions and Pb after its dephosphorylation. Thus, PEA-15 is an endogenous substrate for PKC, the kinase mediating the transition from Pa to Pb.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1993 Mar 15 268(8) 5911-20",
                "id": "8449955"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8bb2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "In this study, we reconstitute fibroblasts derived from a TACE knockout mouse (Null cells) with either the rabbit (rb) GHR alone (Null/R) or rbGHR plus murine TACE (Null/R+T). Although GHR in both cells was expressed at similar abundance, dimerized normally and caused JAK2 activation in response to GH independent of TACE expression, PMA was unable to generate GHBP from Null/R cells. In contrast, PMA caused ample GHBP generation from TACE reconstituted (Null/R + T) cells, and this GHBP shedding was substantially inhibited by IC3 pretreatment. Corresponding to the induced shedding of GHBP from Null/R + T cells, PMA treatment caused a significant loss of immunoblottable GHR in Null/R+T, but not in Null/R cells.",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 2000 Dec 141(12) 4342-8",
                "id": "11108241"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8bb1"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "In the present study, cells from a poorly differentiated squamous cell carcinoma NPC cell line, CNE2, were stimulated by TPA and proteomics technology was carried out to find protein discrepancies between control and TPA-treated cells. Results revealed that TPA treatment in CNE2 cells could upregulate the expression of \\\"triosephosphate isomerase\\\" and \\\"14-3-3 protein sigma\\\" and downregulate the expression of \\\"reticulocalbin 1 precursor\\\", \\\"nucleophosmin\\\", \\\"mitochondrial matrix protein p1 precursor\\\", and \\\"stathmin\\\".",
              "citation": {
                "type": "PubMed",
                "name": "Acta Biochim Biophys Sin (Shanghai) 2005 Feb 37(2) 97-106",
                "id": "15685366"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8bb0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "squamous cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Transfection of GH4C1 cells with an expression plasmid containing nPKC epsilon cDNA leads to the transient overexpression of cellular nPKC epsilon and confers enhanced phorbol ester binding activity. Transient expression of an inactive point mutant (nPKC epsilon K--R) of nPKC epsilon, where Lys436 at the putative ATP-binding site is replaced with Arg, also confers elevated binding activity. However, only overproduction of the wild type in transfected cells increases the basal levels and stimulates the secretion of prolactin (PRL) by 12-O-tetradecanoylphorbol-13-acetate or thyrotropin-releasing hormone (TRH).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1994 Feb 11 269(6) 4653-60",
                "id": "8308036"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8baf"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "E2-stimulated ERK required ER in breast cancer and endothelial cells and was substantially prevented by expression of a dominant negative EGFR or by tyrphostin AG1478, a specific inhibitor for EGFR tyrosine kinase activity. Transactivation/phosphorylation of EGFR by E2 was dependent on the rapid liberation of heparin-binding EGF (HB-EGF) from cultured MCF-7 cells and was blocked by antibodies to this ligand for EGFR. Expression of dominant negative mini-genes for Galpha(q) and Galpha(i) blocked E2-induced, EGFR-dependent ERK activation, and Gbetagamma also contributed. G protein activation led to activation of matrix metalloproteinases (MMP)-2 and -9. This resulted from Src-induced MMP activation, implicated using PP2 (Src family kinase inhibitor) or the expression of a dominant negative Src protein.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Jan 24 278(4) 2701-12",
                "id": "12421825"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8bae"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "On exposure of the cells to TGFbeta1, S100C/A11 was phosphorylated, bound to nucleolin, and transferred to the nucleus, resulting in induction of p21WAF1/CIP1 and p15INK4B through activation of Sp1. Protein kinase C alpha (PKCalpha) was shown to phosphorylate 10Thr of S100C/A11, which is a critical event for the signal transduction. The TGFbeta1-induced growth inhibition was almost completely mitigated when PKCalpha activity was blocked or when S100C/A11 was functionally sequestered.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2004 Mar 29 164(7) 979-84",
                "id": "15051732"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8bad"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Although the mechanisms of these activities have not been well defined, {alpha}-TOC inhibits protein kinase C, a ubiquitously expressed signaling molecule that is involved in the early steps of many proinflammatory signaling pathways (47, 64). (See Boscoboinik, D., et al. 1991. Inhibition of cell proliferation by alpha-tocopherol. Role of protein kinase C. J. Biol. Chem. 266:61886194)",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2003 Oct 29(4) 427-31",
                "id": "14500253"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8bac"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "D3 mRNA was markedly induced by treatment for 6 h with epidermal growth factor, acid or basic fibroblast growth factors (10 ng/ml), or a 3-h treatment with a phorbol ester [12-O-tetradecanoylphorbol-13-acetate (TPA), 1 microM] or 10% fetal bovine serum. However, preincubation of cells overnight with 50 nM DEX completely blocked the D3-inducing effects of basic fibroblast growth factor",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 2002 Jul 143(7) 2652-8",
                "id": "12072398"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8bab"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Conventional (c)PKC beta 1, novel (n)PKC delta and nPKC epsilon efficiently phosphorylated the MARCKS protein in vitro. ... Site analysis revealed that only serine residues S152, S156 and S163 were phosphorylated, with S163 phosphorylated highest, followed by S156 and S152; in contrast, S160 and S167 were not phosphorylated. No further PKC phosphorylation sites could be detected in MARCKS. The phosphorylation pattern was independent of the type of PKC isotype used.",
              "citation": {
                "type": "PubMed",
                "name": "Eur J Biochem 1995 Oct 15 233(2) 448-57",
                "id": "7588787"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8baa"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "The expression of various low Mr GTP-binding proteins at various states of differentiation of a human megakaryoblastic leukemia cell line, MEG-01, was analyzed using thermocycle amplification of mRNA and immunoblotting. MEG-01 cells were found to express mRNAs of rap1A, rap1B, rap2B, ralA, rhoA, rac1, rac2, CDC42Hs, rab1, rab3B, rab6, ram and ran, but not rab4, and the proteins of Rap1, Rap2, RhoA, Rac1, Rac2, Rab3B, Rab4, Rab6 and Rab8 were expressed. Differentiation of MEG-01 cells induced by 100 nM 12-O-tetradecanoylphorbol-13-acetate revealed the considerable increases in mRNA expression of rap1B, rab3B, rab4, ram and ran whereas the levels of rap2B, rhoA and rac1 decreased. During the differentiation process, significant changes in protein levels of Rap1, RhoA, Rac1, Rac2, Rab3B, Rab4 and Rab6 were observed among three subcellular (cytosol, Triton X-100-soluble membrane and -insoluble cytoskeleton) fractions. The present investigation may be useful for the study of the megakaryocyte differentiation.",
              "citation": {
                "type": "PubMed",
                "name": "Thromb Haemost 1997 Feb 77(2) 368-75",
                "id": "9157598"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8ba9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "leukocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Flavopiridol regulates a subset of cell cycle regulatory proteins, leading to cell cycle arrest at the G1/S phase and the G2/M phase transitions #-------------------------------------------------- Table 2. CDK Inhibition by Small Molecule CDKIs. With the exception of alsterpaullone, compound 15b, fascaplysin, indolylmethylene-indolinone 8a, and SU9516, all of the inhibitors listed were identified through co-crystallization with CDK2. The IC50 values (or the Ki values as indicated by *) are provided in micromolar concentrations. Inhibitor CDK1-cyclin B CDK2-cyclin A,Ea CDK4-cyclin Da CDK5-p25 References Alsterpaullone 0.035 0.015 (A), 0.2 (E) >10 0.04 78 Aminopurvalanol (NG97) 0.033 0.033 (A), 0.028 (E) unknown 0.02 62 Anilinoquinazoline 2 1 unknown unknown unknown 79 CINK4 >100 >50 (A), >50(E) 1.5 (D1) 25 12 Compound 15b 1.8 0.44 (A) 0.0023 unknown 5, 6 Compound 26a 0.12 0.078 0.042 unknown 5, 6 Compound 66 0.675 0.0129 (A), 0.410 (E) 0.032 unknown 70 Deschloroflavopiridol unknown unknown unknown unknown 67 Fascaplysin >100 >50 (A), >50 (E) 0.35 (D1) 20 69 Flavopiridol 0.4 0.1 (A) 0.4 unknown 67 H717 0.23 0.050 (E) unknown unknown 64 Hymenialdisine 0.022 0.07 (A), 0.04 (E) 0.6 0.028 66 Indirubin-3'-monoxime 0.180 0.44 (A), 0.25 (E) 3.33 0.1 74 Indirubin-5-sufonate 0.055 0.04 (A), 0.15 (E) 0.3 0.065 74 Indolylmethylene-indolinone 8a 5.8 unknown unknown 25 73 Indolylmethylene-indolinone 8e 2.2 unknown unknown 1.8 73 N6-Isopentenyladine 45 50 (A) >100 80 59 NU2058 5* 12* unknown unknown 65 NU6027 2.5* 1.3* unknown unknown 65 OL567 0.23 unknown unknown unknown 63 Olomucine 7 7 >1000 3 59 Oxindole 16 (compound 3) 0.78 0.060 unknown unknown 72 Oxindole 91 0.11 0.010 (A) 0.13 unknown 18 PD0183812 >40 0.21 (A), 0.17 (E) 0.008 unknown 71 PKF049365 1.3 1.6 unknown unknown 76 PNU112455A unknown 2* (E) unknown 2* 77 Purvalanol B 0.006 0.006 (A), 0.009 (B) >10 0.006 61 Quinazoline 51 unknown 0.65 (E) >2.1 unknown 80 Roscovitine 0.45 0.7 >100 0.16 60 Staurosporine 0.006 0.007 <10 unknown 68 SU9516 0.040 0.022 (A) 0.2 unknown 75 a The specific cyclin (A, E, D1) is indicated in parentheses. Staurosporine is a potent inhibitor of protein kinase C (PKC) that was initially isolated from the culture broth of Streptomyces. Cell cycle arrest was observed upon staurosporine treatment in both normal and transformed cells. Staurosporine induced G1 cell cycle arrest at low nanomolar concentrations, and cellular apoptosis was observed at higher concentrations. The 7-hydroxy analogue of staurosporine, UCN-01, was subsequently identified as a more potent and selective inhibitor of PKC. In several cell lines, UCN-01 inhibited cellular growth and induced apoptosis, correlating with the activation of CDK1 and CDK2. The observation that GF10923X, an even more selective PKC antagonist than UCN-01, inhibited PKC activity but did not inhibit growth, suggested that the CDK activation by UCN-01 may have contributed to its cellular apoptotic effects. Interestingly, UCN-01 inhibits CDC2 and CDK2 in vitro, and it activates these same enzymes in intact cells (reviewed in [64]).",
              "citation": {
                "type": "PubMed",
                "name": "Curr Cancer Drug Targets 2004 Aug 4(5) 403-24",
                "id": "15320717"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8ba8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "We studied the effects of protein kinase C (PKC) and tyrosine kinase on the expression of CTGF and observed that at the mRNA level CTGF expression is inhibited by the activation of PKC, but stimulated by the inhibition of PKC and tyrosine kinase. We further determined that the novel and the classical PKC isoforms are needed for the inhibition, but the atypical isoforms are not involved. Our data suggest that phosphorylation on serine/threonine and tyrosine by PKC and by tyrosine kinase are all inhibitory to the expression of CTGF.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2000 Aug 28 275(2) 312-21",
                "id": "10964664"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8ba7"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Second, our recent study suggests that binding of phospho-GSK-3b to ANT {Official Gene Symbol: Slc25a4} suppresses interaction of ANT with CypD {Official Gene Symbol: Ppid}, a trigger of mPTP opening.51 In isolated rat hearts, reperfusion after sustained ischemia induced translocation of cytosolic GSK-3b to the mitochondria, where it formed a complex with ANT and VDAC. Phosphorlylation of GSK-3b by ischemic preconditioning and erythropoietin (EPO) receptor activation was dependent on protein kinase C (PKC) and phosphatidiylinositol 3-phosphate kinase (PI3K), and phospho-GSK-3b was bound to ANT but not to VDAC at reperfusion (Figure 2A). {Phosphorylation of GSK3b is at what's described in the literature as Serine 9}",
              "citation": {
                "type": "PubMed",
                "name": "Circ J 2009 Jul 73(7) 1184-92",
                "id": "19506320"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8ba6"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "In the present study, cells from a poorly differentiated squamous cell carcinoma NPC cell line, CNE2, were stimulated by TPA and proteomics technology was carried out to find protein discrepancies between control and TPA-treated cells. Results revealed that TPA treatment in CNE2 cells could upregulate the expression of \\\"triosephosphate isomerase\\\" and \\\"14-3-3 protein sigma\\\" and downregulate the expression of \\\"reticulocalbin 1 precursor\\\", \\\"nucleophosmin\\\", \\\"mitochondrial matrix protein p1 precursor\\\", and \\\"stathmin\\\".",
              "citation": {
                "type": "PubMed",
                "name": "Acta Biochim Biophys Sin (Shanghai) 2005 Feb 37(2) 97-106",
                "id": "15685366"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8ba5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "The PTEN gene (phosphatase and tensin homologous on chromosome 10) is frequently mutated or deleted in a number of malignancies including human hepatocellular carcinoma (HCC). We reported previously that the hepatitis B virus X (HBx) protein, known to be a causative agent in the formation of HCC, activates insulin-like growth factor II (IGF-II) expression through Sp1 phosphorylation by protein kinase C (PKC) or mitogen-activated protein kinase (MAPK) signaling. In this report we demonstrate that the PTEN effect on HBx induced IGF-II activation in a hepatoma cell line. Expression of PTEN and IGF-II was inversely related in different hepatoma cell lines. PTEN expression induced decreased Sp1 DNA binding by dephosphorylating Sp1 and interfered with transcriptional transactivation of IGF-II by HBx in hepatoma cells. The protein phosphatase activity was involved in PTEN downregulation of IGF-II transcription through downregulation of MAPK, MAPK kinase phosphorylation and PKC translocation. Our data suggest that PTEN blocks Sp1 phosphorylation in response to HBx, by inactivating PKC, MAPK and MAPK kinase which eventually downregulate IGF-II expression, during the formation of HCC.",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 2003 Jun 19 545(2-3) 203-8",
                "id": "12804776"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8ba4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "This region contains four copies of NF-kappaB binding sites. These elements are in close proximity to one another and can form a complex with nuclear proteins derived from stretched cells as demonstrated by gel mobility shift assay. ... Conversely, preincubation of the cells with protein kinase C inhibitors suppressed mechanical stretch-induced PAF receptor gene expression at the mRNA levels and abrogated upstream events of NF-kappaB activation in the cytoplasm. These data strongly suggest that stretch-induced PAF receptor gene expression is mediated by NF-kappaB binding to the PAF receptor gene promoter and that protein kinase C activation is among the molecular features of NF-kappaB activation and translocation into the nucleus in mechanically stretched cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Mol Cell Cardiol 1999 Jul 31(7) 1345-55",
                "id": "10403752"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8ba3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Mast cells are the major effector cell type in IgE-mediated immediate hypersensitivity. Traditionally, it is thought that mast cells bound to Ag-specific Fc?RI, so-called sensitized mast cells, encounter multivalent Ag, and then IgE-bound receptors are aggregated or cross-linked, leading to cell activation (1). Activated mast cells secrete preformed and newly synthesized proinflammatory mediators involved in inflammatory processes of allergy, such as histamine, proteases, lipids, cytokines, and chemokines. The mouse Fc?RI consists of an IgE-binding ? subunit, a signal-amplifying {beta} subunit, and disulfide-bonded two molecules of signal-generating ? subunit (2). Fc?RI aggregation leads to the activation of {beta} subunit-bound Lyn, a prominent Src family protein-tyrosine kinase (PTK)3 in mast cells (3). Lyn phosphorylates the tyrosine residues in the ITAMs of the {beta} and ? subunits (4). Phosphorylated ITAMs of {beta} and ? subunits, respectively, recruit Lyn and Syk, a member of another PTK family with two tandemly arranged Src homology 2 domains, leading to the activation of these PTKs. Active Lyn and Syk phosphorylate numerous cellular target proteins, leading to the activation of multiple signaling pathways, including PI3K and phospholipase C (PLC)-?. An alternative pathway involving Fyn (another Src family PTK) was shown to activate PI3K (5). PLC hydrolyzes phosphatidylinositol 4,5-bisphosphate into two second messengers, i.e., diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3). IP3 triggers Ca2+ release from intracellular stores and then Ca2+ influx. Increased DAG and Ca2+ lead to the activation of protein kinase C (PKC) (reviewed in Ref. 6). Both PKC and Ca2+ are required for optimal degranulation (7). ",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2005 Apr 15 174(8) 4495-504",
                "id": "15814670"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8ba2"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "mast cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Simultaneous overexpression of selenophosphate synthetase and phospholipid-hydroperoxide GSH peroxidase (PHGPx) [250] blocks activation of NF-kB by IL-1. Overexpression of SOD [84] or GSH peroxidase [81, 211] abolished NF-kB activation by preventing degradation of IkB after stimulation with TNF-a. The precise mechanism(s) through which oxidants and reductants influence activation of NF-kB is presently unknown; however, there is evidence that antioxidant enzyme (AOE372), a redox-sensitive thioredoxin peroxidase, regulates IkB phosphorylation [246]. Phosphatases The phosphatases are an important component of most signal transduction pathways, because failure to reverse kinase actions can disrupt normal cellular functions. For example, transfection of human fibroblasts with constitutively active ras (hRasV12) inhibits cell growth and ultimately results in a senescentlike phenotype [441]. Similarly, constitutive ERK activation has an inhibitory effect on cell cycle progression [442,443]. Both the serine/threonine phosphatases and the PTPs are known to be redox-sensitive [82,144,153,156,271,281, 444-449]. The mechanism of redox effects on activity is probably best understood for the PTPs. Without exception, the PTPs contain a highly conserved region of 11 amino acid residues in their catalytic domain; specifi- cally, (Ile/Val)-His-Cys-X-Ala-Gly-X-X-Arg-(Ser/Thr)- Gly, where X is a nonconserved amino acid [17]. Either oxidation or mutation of the cysteine renders these molecules inactive [17,281]. H2O2 is a potent inhibitor of PTPs. As in the case of other oxidants, H2O2 probably oxidizes the thiolate anion at the catalytic site [280]. Because formation of a phosphorylcysteine intermediate seems to be critical to PTP activity [450-452], blocking it through oxidation of the cysteine inactivates the molecules. In many cases, treatment of cells with H2O2 stimulates increases in protein phosphorylation by inhibiting phosphatase-catalyzed removal of phosphate groups. Furthermore, mitogens that increase cellular ox- idant production may stimulate phosphorylation indirectly by decreasing phosphatase activity. Additional mechanisms are involved in stimulation of pathways activated by growth factors that increase oxidant production, however, because there are known instances in which the oxidants they produce have no effect on protein phosphorylation. For example, TGF-b1 stimulates phosphorylation of numerous proteins and has been shown to cause a large increase in H2O2 production; however, its effects on protein phosphorylation are not blocked by catalase [453]. Furthermore, H2O2 is effective in promoting phosphorylation of phospholipase D, the PDGF receptor, and PKC-a even after pretreatment of Swiss 3T3 fibroblasts with orthovanadate to inhibit phosphatases [454]. Thus, although diminished phosphatase activity may partially account for increased phosphorylation in some cases, it cannot totally account for oxidation effects on phosphorylation in every case. SPECIFICITY In general, there is good agreement between studies on redox effects on any given gene; albeit, not all oxidizing or reducing treatments exert equivalent effects. This is clearly demonstrated in studies of pag , which encodes a protein associated with cellular proliferation. Pag protein inhibits the tyrosine kinase activity of the Abelson (abl ) protein by binding to its SH3-binding domain [455]. BSO, menadione, sodium arsenate, and diethyl maleate all stimulate pag expression, but H2O2 does not [269]. Conversely, H2O2 stimulates c-fos expression (Table 1), although 4-hydroynonenal (a product of v-6-polyunsaturated fatty acid peroxidation) not only fails to induce c-fos expression but is actually inhibitory to c-fos induction by EGF and PDGF [185]. Similarly, some oxidants such as diamide decrease hypoxia-induced signals [201], although others such as H2O2 increase them [124]. As might be expected, the effects of any stimu...",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2000 Feb 1 28(3) 463-99",
                "id": "10699758"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8ba1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "In addition, we found that MCP-1 has a novel function in airway epithelium, increasing the two major airway mucins MUC5AC and MUC5B, an effect mediated, at least in part, by a cascade of events initiated by interaction of its receptor CCR2B with G(q) subunits in caveolae, followed by PLC??, PKC, and (44/42)MAPK activation. We also have shown that MCP-1 is able to induce its own expression using the same receptor but through a different pathway that involves RhoA GTPase.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2011 Feb 300(2) L204-15",
                "id": "21097527"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8ba0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Simultaneous overexpression of selenophosphate synthetase and phospholipid-hydroperoxide GSH peroxidase (PHGPx) [250] blocks activation of NF-kB by IL-1. Overexpression of SOD [84] or GSH peroxidase [81, 211] abolished NF-kB activation by preventing degradation of IkB after stimulation with TNF-a. The precise mechanism(s) through which oxidants and reductants influence activation of NF-kB is presently unknown; however, there is evidence that antioxidant enzyme (AOE372), a redox-sensitive thioredoxin peroxidase, regulates IkB phosphorylation [246]. Phosphatases The phosphatases are an important component of most signal transduction pathways, because failure to reverse kinase actions can disrupt normal cellular functions. For example, transfection of human fibroblasts with constitutively active ras (hRasV12) inhibits cell growth and ultimately results in a senescentlike phenotype [441]. Similarly, constitutive ERK activation has an inhibitory effect on cell cycle progression [442,443]. Both the serine/threonine phosphatases and the PTPs are known to be redox-sensitive [82,144,153,156,271,281, 444-449]. The mechanism of redox effects on activity is probably best understood for the PTPs. Without exception, the PTPs contain a highly conserved region of 11 amino acid residues in their catalytic domain; specifi- cally, (Ile/Val)-His-Cys-X-Ala-Gly-X-X-Arg-(Ser/Thr)- Gly, where X is a nonconserved amino acid [17]. Either oxidation or mutation of the cysteine renders these molecules inactive [17,281]. H2O2 is a potent inhibitor of PTPs. As in the case of other oxidants, H2O2 probably oxidizes the thiolate anion at the catalytic site [280]. Because formation of a phosphorylcysteine intermediate seems to be critical to PTP activity [450-452], blocking it through oxidation of the cysteine inactivates the molecules. In many cases, treatment of cells with H2O2 stimulates increases in protein phosphorylation by inhibiting phosphatase-catalyzed removal of phosphate groups. Furthermore, mitogens that increase cellular ox- idant production may stimulate phosphorylation indirectly by decreasing phosphatase activity. Additional mechanisms are involved in stimulation of pathways activated by growth factors that increase oxidant production, however, because there are known instances in which the oxidants they produce have no effect on protein phosphorylation. For example, TGF-b1 stimulates phosphorylation of numerous proteins and has been shown to cause a large increase in H2O2 production; however, its effects on protein phosphorylation are not blocked by catalase [453]. Furthermore, H2O2 is effective in promoting phosphorylation of phospholipase D, the PDGF receptor, and PKC-a even after pretreatment of Swiss 3T3 fibroblasts with orthovanadate to inhibit phosphatases [454]. Thus, although diminished phosphatase activity may partially account for increased phosphorylation in some cases, it cannot totally account for oxidation effects on phosphorylation in every case. SPECIFICITY In general, there is good agreement between studies on redox effects on any given gene; albeit, not all oxidizing or reducing treatments exert equivalent effects. This is clearly demonstrated in studies of pag , which encodes a protein associated with cellular proliferation. Pag protein inhibits the tyrosine kinase activity of the Abelson (abl ) protein by binding to its SH3-binding domain [455]. BSO, menadione, sodium arsenate, and diethyl maleate all stimulate pag expression, but H2O2 does not [269]. Conversely, H2O2 stimulates c-fos expression (Table 1), although 4-hydroynonenal (a product of v-6-polyunsaturated fatty acid peroxidation) not only fails to induce c-fos expression but is actually inhibitory to c-fos induction by EGF and PDGF [185]. Similarly, some oxidants such as diamide decrease hypoxia-induced signals [201], although others such as H2O2 increase them [124]. As might be expected, the effects of any stimu...",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2000 Feb 1 28(3) 463-99",
                "id": "10699758"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b9f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "b-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "A cultured myocardial cell model was used to examine the role of protein kinase C-dependent pathways in the transcriptional activation of two cardiac muscle genes [myosin light chain 2 (MLC-2) and atrial natriuretic factor (ANF)] during alpha-adrenergic receptor-mediated hypertrophy. Phorbol ester (phorbol 12-myristate 13-acetate) and the alpha-adrenergic agonist phenylephrine both activate protein kinase C (PKC) and induce 4- to 5-fold increases in the expression of MLC-2 and ANF promoter/luciferase reporter genes with little effect on Rous sarcoma virus/luciferase or minimal prolactin promoter/luciferase genes.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 1992 Feb 15 89(4) 1305-9",
                "id": "1531537"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b9e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Insulin-stimulated Na(+),K(+)-ATPase activation, phosphorylation, and translocation of alpha-subunits to the plasma membrane were abolished by 20 microm PD98059, which is an inhibitor of MEK1/2, an upstream kinase of ERK1/2. Furthermore, inhibitors of phosphatidylinositol 3-kinase (100 nm wortmannin) and protein kinase C (10 microm GF109203X) had similar effects.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jun 11 279(24) 25211-8",
                "id": "15069082"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b9d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Muscle, Skeletal"
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "PDE3A (phosphodiesterase 3A) was identified as a phosphoprotein that co-immunoprecipitates with endogenous 14-3-3 proteins from HeLa cell extracts, and binds directly to 14-3-3 proteins in a phosphorylation-dependent manner (Ser428). Among cellular stimuli tested, PMA promoted maximal binding of PDE3A to 14-3-3 proteins. While p42/p44 MAPK (mitogen-activated protein kinase), SAPK2 (stress-activated protein kinase 2)/p38 and PKC (protein kinase C) were all activated by PMA in HeLa cells, the PMA-induced binding of PDE3A to 14-3-3 proteins was inhibited by the non-specific PKC inhibitors Ro 318220 and H-7, but not by PD 184352, which inhibits MAPK activation, nor by SB 203580 and BIRB0796, which inhibit SAPK2 activation.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2005 Nov 15 392(Pt 1) 163-72",
                "id": "16153182"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b9c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "We have discovered that the lipid-soluble thiamine derivative benfotiamine can inhibit these three pathways (the hexosamine pathway, the advanced glycation end product (AGE) formation pathway and the diacylglycerol (DAG)-protein kinase C (PKC) pathway) as well as hyperglycemia-associated NF-kappaB activation, by activating the pentose phosphate pathway enzyme transketolase, which converts glyceraldehyde-3-phosphate and fructose-6-phosphate into pentose-5-phosphate",
              "citation": {
                "type": "PubMed",
                "name": "Nat Med 2003 Mar 9(3) 294-9",
                "id": "12592403"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b9b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Using isolated human platelets, we report that PKCdelta, but not PKCalpha or PKCbeta, is required for collagen-induced phospholipase C-dependent signaling, activation of alpha(IIb)beta(3), and platelet aggregation. Analysis of PKCdelta phosphorylation and translocation to the membrane following activation by both collagen and thrombin indicates that it is positively regulated by alpha(IIb)beta(3) outside-in signaling. Moreover, PKCdelta triggers activation of the mitogen-activated protein kinase-kinase (MEK)/extracellular-signal regulated kinase (ERK) and the p38 MAPK signaling. This leads to the subsequent release of thromboxane A(2), ##Phospho-specific antibodies for PKC?, MEK1/2, ERK1/2, and p38 MAPK came from Cell Signaling Technologies (Beverly, MA) and Santa Cruz Biotechnologies (Santa Cruz, CA).##",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Oct 6 281(40) 30024-35",
                "id": "16895913"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b9a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Blood Platelets",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Thus, one function of Rho A may be to regulate cytoskeletal organization and integrin clustering rather than integrin affinity.92 Expression of activated R-Ras increases integrin-mediated adhesion in some cells,93 but its presence in platelets has not been demonstrated. Thrombin stimulation of platelets causes GTP loading of H-Ras in a PKC-dependent manner",
              "citation": {
                "type": "PubMed",
                "name": "Blood 1998 Apr 15 91(8) 2645-57",
                "id": "9531572"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b99"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Blood Platelets",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Pretreatment of HK-2 cells with modulators of PKC- and Ca(2+)/calmodulin-mediated pathways (but not those that modulate PKA-, protein tyrosine kinase-, or nitric oxide-mediated pathways) led to significant alterations in biotin uptake. The results showed biotin uptake to be saturable in PMA-treated and control cells, with the uptake being higher in the former than in the latter",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Renal Physiol 2005 Apr 288(4) F823-31",
                "id": "15561972"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b98"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Renal Epithelial Cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "tsc-22 mRNA is expressed in almost all organs of mice and humans and its expression is induced in a variety of cell lines by many different factors including TGF-beta, phorbol ester, serum, and progestin",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biochem 2005 Mar 271(1-2) 23-8",
                "id": "15881652"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b97"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "while phorbol ester induced rapid phosphorylation of both the phospho-sensitive epitope and the functionally defined major protein kinase C site present near the carboxy-terminus (serine 724) of alpha-adducin",
              "citation": {
                "type": "PubMed",
                "name": "Mol Immunol 2004 Jun 41(4) 435-47",
                "id": "15163540"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b96"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Stimulation of platelets with the PAR-1 agonist SFLLRN resulted in rapid and transient phosphorylation of PDE3A on Ser(312), Ser(428), Ser(438), Ser(465), and Ser(492). Furthermore, phosphorylation and activation of PDE3A required the activation of PKC, but not of PI3K/PKB, mTOR/p70S6K, or ERK/RSK. Activation of PKC by phorbol esters also resulted in phosphorylation of the same PDE3A sites in a PKC-dependent manner.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2009 May 1 284(18) 12339-48",
                "id": "19261611"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b95"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Blood Platelets",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Phorbol ester-dependent activation of peroxiredoxin I gene expression via a protein kinase C, Ras, p38 mitogen-activated protein kinase signaling pathway. The data indicate that a protein kinase C, Ras, MEKK1, p38 MAPK signaling pathway plays a major role for the transcriptional up-regulation of Prx I gene expression.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Nov 14 278(46) 45419-34",
                "id": "12960165"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b94"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Furthermore, eIF6 interacts in the cytoplasm with RACK1, a receptor for activated protein kinase C (PKC). RACK1 is a major component of translating ribosomes, which harbour significant amounts of PKC. Loading 60S subunits with eIF6 caused a dose-dependent translational block and impairment of 80S formation, which were reversed by expression of RACK1 and stimulation of PKC in vivo and in vitro. PKC stimulation led to eIF6 phosphorylation, and mutation of a serine residue in the carboxy terminus of eIF6 impaired RACK1/PKC-mediated translational rescue.",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2003 Dec 4 426(6966) 579-84",
                "id": "14654845"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b93"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "The major excreted protein of transformed mouse fibroblasts, a secreted, mannose 6-phosphate-containing glycoprotein, is induced in nontransformed cells by a variety of transforming agents, by phorbol esters, and by platelet-derived growth factor.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1985 Mar 5(3) 466-73",
                "id": "3990681"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b92"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Using a series of specific small molecule inhibitors, both protein kinase C (PKC) and phosphoinositide-3 kinase (PI-3K) appeared to be required for SDF-1alpha-mediated phosphorylation of focal adhesion proteins and the migration of both CTS and primary marrow CD34(+) cells, whereas the mitogen-activated protein kinases ERK-1 and -2 were not.",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2000 Apr 15 95(8) 2505-13",
                "id": "10753828"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b91"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Different agents activated the 5-LO kinase activities, including stimuli for cellular leukotriene biosynthesis (A23187, thapsigargin, N-formyl-leucyl-phenylalanine), compounds that up-regulate the capacity for leukotriene biosynthesis (phorbol 12-myristate 13-acetate, tumor necrosis factor alpha, granulocyte/macrophage colony-stimulating factor), and well known p38 stimuli as sodium arsenite and sorbitol. For all stimuli, 5-LO kinase activation was counteracted by SB203580 (3 microM or less), an inhibitor of p38 kinase",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2000 May 9 97(10) 5261-6",
                "id": "10779545"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b90"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "leukocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Go6976 inhibits the classical PKC isoforms and PKCmu, whereas Go6983 suppresses kinase activity of PKC isoenzymes from all 3 major subgroups but does not effectively inhibit PKCmu...Pretreatment of H929 cells with Go6976 or Go6983 for 1 hour inhibited migration through the HS-27 cell line in a dose-dependent manner...Taken together, these observations with results from the translocation studies suggest that Wnt-mediated migration is PKCdependent and that PKCmu is one member of this family facilitating the migratory process.",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2005 Sep 1 106(5) 1786-93",
                "id": "15886323"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b8f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Multiple Myeloma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Local Ca2+ entry is detected by Syk, which then activates two distinct signaling pathways. Syk recruits protein kinase C and the MEK/ERK cascade, resulting in activation of cPLA2 and 5-lipoxygenase. This generates the intracellular messenger arachidonic acid (AA) and the proinflammatory paracrine signal leukotriene C4 (LTC4) (18). At the same time, Syk phosphorylates the transcription factor STAT5, which then migrates to the nucleus, where it increases c-fos expression. The Ca2+ microdomain can therefore be processed by Syk through two parallel pathways into the activation of temporally distinct cellular responses. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2009 Sep 11 284(37) 24767-72",
                "id": "19584058"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b8e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "mast cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "In this study the expression of C-type lectins during the early activation of PMA-stimulated peripheral blood lymphocytes was examined. To investigate the influence of de novo protein synthesis on activation-dependent expression of C-type lectins, cells were cultured in presence of cycloheximide (CHX) and mRNA levels were analyzed by semi-quantitative reverse transcription-polymerase chain reaction. Upregulated levels of CD69, AICL, and LLT1, but less pronounced changes of CD161/NKR-P1A and CD94 mRNA were found at early time points of cellular activation.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biochem Suppl 2001 Suppl 36 201-8",
                "id": "11455585"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b8d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "lymphocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Overactivation of DAG-responsive PKC isoforms in muscle, including PKCalpha, -delta, -epsilon, -theta, and -beta, is linked to muscle insulin resistance (19, 53?58). In contrast to the conventional and novel PKC isoforms, atypical PKC isoforms do not respond to DAG, but rather they mediate insulin signaling (59). Since membrane localization is a measure of lipid-mediated activation of PKC (53, 54), we quantified membrane and cytosol fractions of PKC and calculated the percentage of membrane-bound PKC in each muscle specimen. The overall PKC activity (all isoforms combined) in the membrane fraction was increased in HFD-fed WT mice but remained low in transgenic Dgat1 mice on the same HFD,",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Invest 2007 Jun 117(6) 1679-89",
                "id": "17510710"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b8c"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": "Muscle, Skeletal"
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "We also needed to determine whether the PKC-dependence of cholic acid-induced egr applied to MAPK as well. Therefore stellate cells were pretreated with the PKC inhibitor GF-109203X (2 mM) and then stimulated with cholic acid for 10 min (Figure 5). This pretreatment abolished the ability of cholic acid to stimulate MAPK. This inhibitor abolishes responsiveness to phorbol esters in numerous cell systems and displays a high degree of specificity for PKC inhibition [23,24].",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 1996 Jun 15 316 ( Pt 3) 765-9",
                "id": "8670150"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b8b"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "hepatic stellate cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Activation of protein kinase C by 1-oleoyl-2-acetyl-sn-glycerol (OAG) (10 microM) decreased this current approximately 33% at a holding potential of -114 mV and 56% at -94 mV..... The effects of OAG on cardiac Na+ current were blocked in cells that had been previously microinjected with a peptide inhibitor of protein kinase C but not with a peptide inhibitor of cAMP-dependent protein kinase, indicating that protein kinase C is responsible for the effect of OAG.....Thus, the substantial reduction in Na+ current at normal diastolic depolarizations with 10 microM OAG is due to failure of channel opening in response to depolarization.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 1994 Apr 12 91(8) 3289-93",
                "id": "8159741"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b8a"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "The TSH-induced increase in cathepsin B mRNA concentrations (approximately fivefold over that in untreated cells) was partially mimicked by forskolin (approximately threefold) and ionomycin, while phorbol ester decreased cathepsin B mRNA concentrations. Similar changes were observed for thyroglobulin and actin mRNA concentrations.... These results demonstrate (1) that cathepsin B expression in the thyroid is regulated in parallel with that of thyroglobulin and actin, and (2) that cyclic AMP- and Ca2+-dependent processes stimulate gene expression, while phorbol ester treatment inhibits gene expression in FRTL5 cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Mol Endocrinol 1989 May 2(3) 207-12",
                "id": "2751829"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b89"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "In mesangial cells, TPA induces the synthesis of a nuclear protein, PDGF-A gene binding protein-1, which binds to the sequence -102 to -82 relative to the transcription start site (45). Elements located at nucleotides -223 to -135 and -71 to -55 have been shown to be important for serum-induced and TPA-induced expression of PDGF-A, respectively (242, 461).",
              "citation": {
                "type": "PubMed",
                "name": "Physiol Rev 1999 Oct 79(4) 1283-316",
                "id": "10508235"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b88"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "In addition, recent reports have shown that NAD(P)H oxidases exist in pancreatic beta-cells and adipocytes, and this oxidase-generated ROS production may play an important role in both the progressive beta-cell dysfunction and the dysregulated adipocytokine production and subsequent obesity-induced metabolic syndrome.",
              "citation": {
                "type": "PubMed",
                "name": "Curr Drug Targets 2005 Jun 6(4) 495-501",
                "id": "16026268"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b87"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Adipocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "PTH promoted the expression of Smad3 mRNA within 10 min and the protein level in a dose-dependent manner in MC3T3-E1 and rat osteoblastic UMR-106 cells. Protein kinase A (PKA) activator as well as protein kinase C (PKC) activators increased Smad3 protein level, and both PKA and PKC inhibitors antagonized PTH-induced Smad3, indicating that PTH promotes the production of Smad3 through both PKA and PKC pathways.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Dec 26 278(52) 52240-52",
                "id": "14517210"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b86"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "osteoblast",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "L-PGDS expression was induced by 12-O-tetradecanoylphorbol-13-acetate in TE671 cells, and this induction was inhibited by a protein kinase C inhibitor. Stimulation of TE671 cells with 12-O-tetradecanoylphorbol-13-acetate or transfection with protein kinase Calpha expression vector induced phosphorylation of Hes-1, inhibition of DNA binding of Hes-1 to the N-box, and activation of the AP-2beta function to up-regulate L-PGDS gene expression.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 May 6 280(18) 18452-61",
                "id": "15743775"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b85"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Increased expression of PKC in malignant and aggressive breast cancers was recently demonstrated, and PKC activity has been shown to be higher in breast cancers than in normal breast tissue [68, 69]. In addition, high levels of PKC? and -? were correlated with enhanced uPA secretion in highly invasive MDA-MB- 231 breast cancer cells [70]. Furthermore, the introduction of PKC? gene to nonmetastatic MCF-7 breast cancer cells resulted in more aggressive neoplastic phenotype, and the stimulation of PKC activity with phorbol ester, phorbol-12- myristate-13-acetate (PMA), resulted in increases in both invasiveness and uPA expression",
              "citation": {
                "type": "PubMed",
                "name": "Curr Cancer Drug Targets 2004 Jun 4(4) 327-36",
                "id": "15180498"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b84"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Oligonucleotides were designed for unique parts of three mouse ubiquitin gene complementary DNA clones. The overexpressed transcripts at 2.4, 2.8, 6.4, and 7.8 kilobases (kb) were detected by an oligonucleotide specific for a mouse UbC polyubiquitin clone.... All three classes of transcripts were induced in mouse skin by the hyperproliferative agent ethylphenyl propionate and by the tumor promoting agent 12-O-tetradecanoylphorbol-13- acetate.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Growth Differ 1992 May 3(5) 269-78",
                "id": "1321656"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b83"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "Neoplasms",
                "cell": "squamous cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "wild-type p21 translocates to the cytoplasm after PKC activation",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2005 Aug 25(16) 7364-74",
                "id": "16055744"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8121"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Rac-GTP enhances phosphorylation of LIMK1 and cofilin, which leads to accumulation of F-actin, while Rac-GDP and PMA reduce these effects. LIMK1 is therefore a key component of a signal transduction network that connects extracellular stimuli to changes in cytoskeletal structure.",
              "citation": {
                "type": "PubMed",
                "name": "Int J Biochem Cell Biol 31(3-4) 389-94",
                "id": "10224665"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8120"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Our data suggest that RACK1 may function as a scaffold for the association and modification of AR by PKC enabling translocation of AR to the nucleus but rendering AR unable to activate transcription of its target genes.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Nov 14 278(46) 46087-93",
                "id": "12958311"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad811f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Annexin 7 is preferentially phosphorylated in intact chromaffin cells, and the levels of annexin 7 phosphorylation increase quantitatively in proportion to the extent of catecholamine secretion phosphorylation of annexin 7 by protein kinase C significantly potentiates the ability of the protein to fuse phospholipid vesicles and lowers the half-maximal concentration of calcium needed for this fusion process",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Apr 20 276(16) 12813-21",
                "id": "11278415"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad811e"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "This was associated with decreased activation of protein kinase C and decreased protein glycation and oxidative stress",
              "citation": {
                "type": "PubMed",
                "name": "Diabetes 2003 Aug 52(8) 2110-20",
                "id": "12882930"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad811d"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "By fusing the promoters of the genes for these enzymes to readily assayed reporter genes and transiently transfecting cultured cells with these constructions, we have identified the regions of each promoter that confer basal expression, induction by cAMP, and repression by activators of protein kinase C.",
              "citation": {
                "type": "PubMed",
                "name": "Clin Chem 1993 Feb 39(2) 333-40",
                "id": "8432024"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad811c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Recent studies by our group have shown that activation of peripheral blood T lymphocytes with the mitogens PMA and ionomycin results in a 10- and 15-fold induction of IMPDH type II mRNA expression and total cellular enzymatic activity, respectively",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1995 Mar 24 270(12) 6808-14",
                "id": "7896827"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad811b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "guanosine triphosphate, GTP, and its non-hydrolyzable analogues optimally enhance the phosphorylation of annexin 7 by protein kinase C",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Jul 12 277(28) 25217-25",
                "id": "11994295"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad811a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Upon the activation of protein kinase C S100A8/A9 heterodimers are released from human monocytes by a novel secretion pathway that is energy-consuming and depends on an intact microtubule network",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Nov 12 274(46) 32672-9",
                "id": "10551823"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8119"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "9804763;15035643",
              "citation": {
                "type": "PubMed",
                "name": "BMC Bioinformatics 2004 Jun 22 5 79",
                "id": "15212693"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8118"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "It is also noted that increased intrinsic angiotensin II production may amplify such a PKC-dependent activation of NAD(P)H oxidase in diabetic vascular tissues.",
              "citation": {
                "type": "PubMed",
                "name": "Curr Drug Targets 2005 Jun 6(4) 495-501",
                "id": "16026268"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8117"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": "vascular tissue"
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Selective inhibitors of PKC such as GF109203X and Calphostin C both caused approximately 80% inhibition of chemotaxis.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Jul 11 278(28) 25317-22",
                "id": "12724308"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8116"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Monocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Northern blot analysis of TFPI mRNA also showed a decrease of the 1.4-kb transcript after 4 hours of incubation with UFH, followed by recovery and an increase over the control level after 24 hours. Incubation of ECs with phorbol ester (PMA) significantly enhanced the secretion of TFPI and increased its activity on the cell surface, probably by preventing invagination of caveolae.",
              "citation": {
                "type": "PubMed",
                "name": "Arterioscler Thromb Vasc Biol 1999 Sep 19(9) 2251-62",
                "id": "10479670"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8115"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium"
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "In MCF-7 human breast cancer cells, the action of the PKC activator 4beta-phorbol-12-myristate-13-acetate (PMA) evokes ceramide formation, which in turn prevents PKCalpha/betaII translocation to the pericentrion. Upon PMA treatment, HEK-293 cells displayed dual phosphorylation of PKCalpha/betaII at carboxyl-terminal sites (Thr-638/641 and Ser-657/660), whereas in MCF-7 cells PKCalpha/betaII were phosphorylated at Ser-657/660 but not Thr-638/641. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 Jul 13 282(28) 20647-56",
                "id": "17504762"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8114"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "NNK has been found to promote Ca2+ influx, to release serotonin and to activate both protein kinase C (PKC) and the MAP kinase pathway to stimulate the proliferation of SCLC cells [42,45].",
              "citation": {
                "type": "PubMed",
                "name": "Trends Pharmacol Sci 2008 Mar 29(3) 151-8",
                "id": "18262664"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8113"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Carcinoma, Small Cell",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "The resulting products, inositol-1,4,5-trisphosphate (InsP3) and diacylglycerol45,46, induce mobilization of cytosolic calcium and activation of protein kinase C (PKC), respectively.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Immunol 2006 Mar 6(3) 218-30",
                "id": "16470226"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8112"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "mast cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "TR expression in HUVECs was down-regulated by transiently exposing cells to the phorbol ester PMA for periods as short as 1 min",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 1999 Aug 15 342 ( Pt 1) 111-7",
                "id": "10432307"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8111"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Moreover, levels of both hNRP mRNA and protein increased rapidly in cultured T-lymphocytes induced to proliferate by incubation with phorbol ester and ionomycin.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 1994 Jan 15 297 ( Pt 2) 389-97",
                "id": "8297347"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8110"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Furthermore, we found that PDGFalphaR stimulated a protein kinase C-dependent activation of integrin alpha(v)beta3",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2002 Apr 15 21(8) 1957-66",
                "id": "11953315"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad810f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2003 Nov 12(5) 1225-37",
                "id": "14636580"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad810e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "transmembrane adaptor molecule LAT becomes tyrosine-phosphorylated LAT can bind and therefore recruite PI3K and PLCg1, both key enzymes in the activation of PKC",
              "citation": {
                "type": "PubMed",
                "name": "Mol Immunol 2002 Jun 38(15) 1087-99",
                "id": "12044776"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad810d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "We previously reported that S100B, a 20-kDa Ca(2+)-binding homodimer, inhibited the postinfarct myocardial hypertrophic response mediated by alpha(1)-adrenergic stimulation through the protein kinase C (PKC) signaling pathway.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Heart Circ Physiol 2003 Jan 284(1) H193-203",
                "id": "12388300"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad810c"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Upon either direct activation of PKC or in response to integrin engagement, p190 RhoGAP is rapidly translocated to regions of membrane ruffling, where it colocalizes with polymerized actin. ",
              "citation": {
                "type": "PubMed",
                "name": "Development 2000 Nov 127(22) 4891-903",
                "id": "11044403"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad810b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "PKC (protein kinase C) enzymes which phosphorylate IkappaBalpha, leading to its degradation",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2004 Dec 15 384(Pt 3) 543-9",
                "id": "15330761"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad810a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "In cytosol from Jurkat cells, A-II is phosphorylated only by Ca2+/phospholipid-stimulated kinases such as Ca(2+)-dependent protein kinases C (cPKCs). ",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 1995 Aug 15 310 ( Pt 1) 243-8",
                "id": "7646452"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8109"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Gelsolin suppresses tumorigenicity through inhibitingPKC activation",
              "citation": {
                "type": "PubMed",
                "name": "Br J Cancer 2003 Feb 24 88(4) 606-12",
                "id": "12592377"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8108"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "PMA induced ECE-1a promoter activity about 2.5-fold in EA.hy926 cells. Similarly, coexpression of Ets-1 protein resulted in a dose-dependent increase in ECE-1a promoter activity (more than 8-fold).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Pharmacol 2001 Dec 60(6) 1332-42",
                "id": "11723240"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8107"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "AII-induced WPB exocytosis and the resultant P-selectin surface expression....knock-down of either PKD2 or PKCalpha expression inhibited AII-mediated P-selectin surface expression and monocyte adhesion.",
              "citation": {
                "type": "PubMed",
                "name": "J Pharmacol Sci 2007 Oct 105(2) 168-76",
                "id": "17951978"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8106"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Figure 1 | The ErbB signalling network.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Mol Cell Biol 2001 Feb 2(2) 127-37",
                "id": "11252954"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8105"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Phorbol-12-myristate-13-acetate increased PPARalpha mRNA levels",
              "citation": {
                "type": "PubMed",
                "name": "Toxicol Lett 2001 Dec 15 125(1-3) 133-41",
                "id": "11701232"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8104"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "hepatocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Pharmacol 2001 Oct 15 62(8) 997-1012",
                "id": "11597569"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8103"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "It was observed that the stimulatory effect of nicotine was associated with activation of protein kinase C and mitogen-activated protein kinases, increased levels of intracellular cAMP, and phosphorylation and DNA binding of the transcription factor CREB. Increased transcription of the gene was dependent on cAMP-response elements (CREs) present on the 50 end of its gene promoter.",
              "citation": {
                "type": "PubMed",
                "name": "Mutat Res 659(3) 221-31",
                "id": "18495523"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8102"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "IFN-gamma induces the serine/threonine phosphorylation of PU.1 in cultured monocytes ... This phosphorylation, as well as the IFN-gamma-induced PU.1 binding and gp91(phox) protein synthesis, is slightly affected by the casein kinase II inhibitor, daidzein, but is abrogated by the protein kinase C (PKC) -alpha and -beta inhibitor, Go6976",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2004 Apr 15 172(8) 4941-7",
                "id": "15067074"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8101"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Monocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "PMA induced the accumulation of mRNA and an increased expression of hsp90 and, to a lesser extent, hsp/hsc70 These results suggest that O2-. is not involved in the PMA-mediated induction of hsp70 and hsp90 and that, in contrast to HS, PMA increases the expression of HSP as a result of PKC-induced mRNA stabilization rather than of transcriptional activation of HS genes.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1995 Jun 9 270(23) 14094-9",
                "id": "7775471"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8100"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "The results showed that both PMA and TNFalpha inhibited insulin-induced Akt phosphorylation and promoted IRS1 phosphorylation on Ser-307.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Jan 3 278(1) 180-6",
                "id": "12409308"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80ff"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Phorbol myristate acetate (PMA) induces a protein kinase C (PKC)-dependent increase in bovine pulmonary EC permeability without significantly increasing MLC phosphorylation,",
              "citation": {
                "type": "PubMed",
                "name": "J Appl Physiol 2001 Oct 91(4) 1487-500",
                "id": "11568129"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80fe"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Histamine-induced release of NE activates PKC, which increases ecto-5'-nucleotidase activity and augments release of adenosine.",
              "citation": {
                "type": "PubMed",
                "name": "Nippon Yakurigaku Zasshi 2002 May 119(5) 273-9",
                "id": "12061138"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80fd"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "PKC activation with phorbol myristic acetate also stimulated an increase in phosphorylation of TnI and MLC2.",
              "citation": {
                "type": "PubMed",
                "name": "Anesthesiology 2003 Jun 98(6) 1363-71",
                "id": "12766644"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80fc"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Jul 20 276(29) 26753-61",
                "id": "11342557"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80fb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Addition of xanthine oxidase inhibitors protects against phorbol ester-mediated injury of endothelial cells.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Med 1991 Sep 30 91(3C) 89S-94S",
                "id": "1928218"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80fa"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Inhibition of AR attenuated TNF-alpha and hyperglycemia-induced activation of protein kinase C (PKC), phosphorylation of the inhibitory subunit of nuclear factor-kappaB (NF-kappaB), and stimulation of NF-kappaB",
              "citation": {
                "type": "PubMed",
                "name": "FASEB J 2003 Feb 17(2) 315-7",
                "id": "12490536"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80f9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Epithelium"
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "We showed that CD86 stimulation increased the nuclear localization of NF-kappaB1 (p50) and phosphorylated RelA (p65) and increased Oct-2 expression and binding to the 3'-IgH enhancer, in a protein kinase C-dependent manner",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 May 28 279(22) 23394-404",
                "id": "15024018"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80f8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "b-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "activation of protein kinase C (PKC) by 12-O-tetradecanoylphorbol-13-acetate (TPA) induces DOC-2/DAB2 phosphorylation, including a serine residue at position 24",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Nov 5 274(45) 31981-6",
                "id": "10542228"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80f7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Ceramides are the core structures of naturally occurring sphingolipids. They lead to inhibition of the classical PKC subtypes as well as inhibition of NFkB activity [52], and to activation of the atypical PKC subtype z [53].",
              "citation": {
                "type": "PubMed",
                "name": "Cell Mol Life Sci 2006 Jun 63(11) 1236-48",
                "id": "16568236"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80f6"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Jun 30 275(26) 19567-76",
                "id": "10867018"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80f5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Instead, the collagen receptor glycoprotein VI seems to mediate FAK phosphorylation by a protein kinase C-dependent pathway. In many different cell lines, alpha1beta1 stimulation induces collagen type I synthesis [86]. Expression of GPVI is only found in platelets and their precursor cells.",
              "citation": {
                "type": "PubMed",
                "name": "Eur J Dermatol 11(6) 506-14",
                "id": "11701397"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80f4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Blood Platelets",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "we show that the expression of 4E-BP1 protein and transcript decreases in hematopoietic cell lines cultivated in the presence of phorbol 12-myristate 13-acetate (PMA)",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 May 23 278(21) 18859-67",
                "id": "12618431"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80f3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Stem Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "High glucose, angiotensin II, phorbol 12-myristate 13-acetate and transforming growth factor-beta 1 (TGF-beta1) stimulated OPN mRNA expression in IRPTCs",
              "citation": {
                "type": "PubMed",
                "name": "Kidney Int 2006 Mar 69(6) 1005-15",
                "id": "16528250"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80f2"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Tube Cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "We have also shown that TPA significantly increased expression of PLD1a and PLD1b mRNAs",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2004 May 7 317(3) 689-96",
                "id": "15081395"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80f1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "These results suggested that Ang II enhances foam cell formation by upregulating ACAT1 expression predominantly through the actions of AT(1) receptor via the G protein/c-Src/PKC/MAPK pathway in human monocyte-macrophages.",
              "citation": {
                "type": "PubMed",
                "name": "Hypertens Res 2008 Sep 31(9) 1801-10",
                "id": "18971559"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80f0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Monocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Arch Biochem Biophys 1993 Sep 305(2) 570-80",
                "id": "8080473"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80ef"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "The up-regulation of Thy-1 by PBu, but not TNF, was inhibited by the protein kinase C inhibitor RO31-8220, suggesting the presence of protein kinase C-dependent and -independent pathways for Thy-1 expression.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 1996 Jul 15 157(2) 874-83",
                "id": "8752941"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80ee"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Both GM-CSF and TPA also elicited rapid, transient expression of TIS8 and TIS11 mRNA in postmitotic human neutrophils. However, neither agent could induce accumulation of TIS1 mRNA in human neutrophils.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1989 Aug 9(8) 3580-3",
                "id": "2677677"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80ed"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "The FAK-ERK1/2 pathway, a genistein-sensitive tyrosine kinase, and a distinct classical/novel PKC appear selectively required for increased production of collagen XII in cells under tensile stress,",
              "citation": {
                "type": "PubMed",
                "name": "Biochim Biophys Acta 2003 Feb 17 1593(2-3) 239-48",
                "id": "12581868"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80ec"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Fig. 10 shows that Ro 31-8220 and calphostin C, at doses known to selectively inhibit PKC (56), inhibited GBS- and LPSinduced TNF-a release to a similar extent",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2002 Aug 1 169(3) 1401-9",
                "id": "12133965"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80eb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Monocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2002 Apr 1 99(7) 2418-26",
                "id": "11895774"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80ea"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "The results support the following pathway, whereby TNF-alpha enhances expression of ICAM-1 in NHBE cells: TNF-alpha --> TNF-RI --> PC-PLC --> DAG --> PKC --> (NF-kappaB?) --> ICAM-1 mRNA --> ICAM-1 surface expression.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2000 Jun 22(6) 685-92",
                "id": "10837365"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80e9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "bronchial epithelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "In this paper, we report that stimulation of protein kinase C (PKC) in several cell types induces phosphorylation of AR",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 2003 Jan 16 534(1-3) 175-9",
                "id": "12527382"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80e8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Fig.1",
              "citation": {
                "type": "PubMed",
                "name": "Science 2004 Nov 26 306(5701) 1506-7",
                "id": "15567848"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80e7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Jan 18 277(3) 1728-38",
                "id": "11700305"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80e6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Neurosci 1999 Jun 15 19(12) 4748-54",
                "id": "10366608"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80e5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Glypican-1 and syndecan-1 mRNA expression was up-regulated under PKC activation",
              "citation": {
                "type": "PubMed",
                "name": "Biochimie 2002 Jul 84(7) 681-6",
                "id": "12453641"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80e4"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "sertoli cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Cells and organs producing PAF in response to exogenous stimulations Neutrophils Human IL-6 Human GM-CSF and zymosan Eosinophils Human IgG, IL-5, PMA Monocytes Human LPS [361] Human HIV infection Peritoneal macrophages Mouse HGF, TNF-a Lung mast cells Human Anti-IgE [363] Bone marrow mast cells Mouse Monoclonal IgE and antigen",
              "citation": {
                "type": "PubMed",
                "name": "Prog Lipid Res 2000 Jan 39(1) 41-82",
                "id": "10729607"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80e3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "we identified a key amino acid residue (Ser24) in its N terminus. The phosphorylation of this residue by protein kinase C (PKC)1 activator 12-O-tetradecanoylphorbol-13-acetate (TPA) can modulate its inhibitory activity on TPA-induced gene transcription (11). These data indicate that the DOC-2/DAB2 protein, particularly its N terminus, is a potent negative regulator for the PKC-elicited signal pathway.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Apr 12 277(15) 12622-31",
                "id": "11812785"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80e2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "The primary site of phosphorylation by protein kinase C was also near the amino terminus at Ser-27. The major site of phosphorylation by adenosine cyclic 3',5'-phosphate dependent protein kinase was on the carboxy-terminal half of the molecule at Thr-216. ",
              "citation": {
                "type": "PubMed",
                "name": "Biochemistry 1988 May 17 27(10) 3682-90",
                "id": "2457390"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80e1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "mechanism by which PKA increases functional activities of SAF-1.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Jun 20 278(25) 22586-95",
                "id": "12697757"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80e0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Inhibition of protein kinase C with chelerythrine chloride (5 microM) depressed the osmotically-induced release of aspartate, glutamate, taurine and glycine",
              "citation": {
                "type": "PubMed",
                "name": "J Pharm Pharmacol 1998 Nov 50(11) 1280-6",
                "id": "9877315"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80df"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1989 Mar 25 264(9) 5164-71",
                "id": "2925687"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80de"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "We propose that CK8 is an in vivo substrate for protein kinase C and that the specific phosphorylation of CK8 plays a role in protein kinase C signal transduction.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 1992 Nov 4(6) 715-22",
                "id": "1283312"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80dd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "These findings demonstrate that protein kinase C activation down-regulated NPR-C expression through transcriptional and post-translational pathways and that immediate functional receptor loss was mediated via a post-translational mechanism, such as enhanced receptor internalization.",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 1997 Dec 1 418(3) 333-6",
                "id": "9428739"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80dc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Mol Pharmacol 2001 May 59(5) 960-4",
                "id": "11306676"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80db"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1986 Jun 25 261(18) 8334-41",
                "id": "2941417"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80da"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "CS extracts activated PKC activ-ity in human bronchial epithelial cells in vitro.  Moreover, PKC was transiently activated in the lung of rats exposed to sidestream CS, which may contribute to the promotion of CS-related lung cancer",
              "citation": {
                "type": "PubMed",
                "name": "Eur J Cancer 2005 Sep 41(13) 1864-74",
                "id": "15953715"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80d9"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "On subcellular fractionation followed by immunoblotting analysis, membrane-bound p50 was shown to be released from the membrane following activation of PKC in T cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Biochem (Tokyo) 1995 Jan 117(1) 222-9",
                "id": "7775393"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80d8"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "We have reported that unsaturated fatty acids (oleic acid and arachidonic acid) can activate protein kinase C independently of Ca2+ and phospholipid",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1986 Nov 25 261(33) 15424-9",
                "id": "3096987"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80d7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "The t-PA gene is transcriptionally induced by the phorbol ester PMA in HeLa cells, but suppressed by PMA in HT-1080 cells.",
              "citation": {
                "type": "PubMed",
                "name": "Eur J Biochem 2001 Feb 268(4) 987-96",
                "id": "11179965"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80d6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Lysophosphatidylcholine (Lyso-PC) elicited PKC and tyrosine kinases activation and subsequent NF-kB activation and overexpression of ICAM-1, VCAM-1 and MCP-1.[37  40]",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Res 2004 Jun 38(6) 541-51",
                "id": "15346645"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80d5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Taken from CST pathway map, \\\"G-protein Coupled Receptor Signaling to MAPK/ERK\\\"  www.cellsignal.com.",
              "citation": {
                "type": "PubMed",
                "name": "Trends Pharmacol Sci 2001 Jul 22(7) 368-76",
                "id": "11431032"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80d4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "These include increased polyol pathway flux, increased advanced glycosylation end product formation, activation of protein kinase C, and increased hexosamine pathway flux.",
              "citation": {
                "type": "PubMed",
                "name": "Diabetes Care 2003 May 26(5) 1589-96",
                "id": "12716823"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80d3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "The differentiation was mediated though activation of the protein kinase A (PKA) and phosphatidylinositol-3 kinase (PI-3K) pathways",
              "citation": {
                "type": "PubMed",
                "name": "J Neurosci Res 2006 Jun 1 83(8) 1415-24",
                "id": "16547973"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80d2"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "These data suggest that Syk phosphorylates cortactin in K562 cells upon TPA treatment.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1996 Mar 22 271(12) 6631-5",
                "id": "8636079"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80d1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Carbachol and the C kinase activator 120-tetradecanoylphorbol-13-acetate also stimulated histamine release",
              "citation": {
                "type": "PubMed",
                "name": "Gastroenterology 1993 Aug 105(2) 449-61",
                "id": "7687574"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80d0"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "enterocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Treatment of WKY rat brain cultures with a phorbol ester, phorbol 12-myristate 13-acetate (PMA), causes a time- and dose-dependent increase in the levels of an approximately 2.3-kb AT1 receptor mRNA transcript.",
              "citation": {
                "type": "PubMed",
                "name": "J Neurochem 1994 Jun 62(6) 2079-84",
                "id": "8189216"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80cf"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "protein kinase C phosphorylation of cTnI plays a dominant role in depressing contractility and exerts an antithetic role on the ability of protein kinase A to increase relaxation",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Jan 7 280(1) 703-14",
                "id": "15507454"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80ce"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Biochemistry 1999 Aug 10 38(32) 10344-51",
                "id": "10441128"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80cd"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Thus, AR and IGF1 cooperate to prevent apoptosis by activating a specific PKC-p90(rsk)-dependent pathway, which leads to Bad and Bax inactivation",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 May 20 280(20) 19757-67",
                "id": "15767261"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80cc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Physiol 2000 Nov 185(2) 155-73",
                "id": "11025438"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80cb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Ariadne: In vitro , OTR  expression is increased by activation of protein kinase A (PKA) or protein kinase C (PKC) (Bale and Dorsa, 1998 ).",
              "citation": {
                "type": "PubMed",
                "name": "J Neurosci 2001 Apr 1 21(7) 2546-52",
                "id": "11264328"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80ca"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "heparin completely abolished the increase in DNA synthesis and ODC mRNA expression elicited by a number of PKC activators.",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 1998 Feb 13 423(1) 98-104",
                "id": "9506849"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80c9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium"
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "using metabolic inhibitors demonstrated that the agonist caused neutrophil death via the activation of protein kinase C in the presence of intracellular ATP.",
              "citation": {
                "type": "PubMed",
                "name": "J Leukoc Biol 2000 Aug 68(2) 187-93",
                "id": "10947062"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80c8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "These effects appear to be protein kinase A-dependent.  Furthermore inhibition of protein kinase C restored the beta(3)-receptor-mediated reductions in insulin-induced IRS-1 tyrosine phosphorylation and IRS-1-associated PI3-kinase activity",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Dec 3 274(49) 34795-802",
                "id": "10574950"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80c7"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": "brown adipose"
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "PKC is known to induce cellular reactive oxygen species (ROS) and PKC-dependent activation of the reduced form of nicotinamide adenine dinucleotide phosphate (NADPH oxidase has recently been shown to be responsible, in part, for increased oxidative stress in diabetes.",
              "citation": {
                "type": "PubMed",
                "name": "Kidney Int 2004 Apr 65(4) 1170-9",
                "id": "15086456"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80c6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Ariadne: While phorbol 12-myristate 13-acetate (PMA) upregulated the PAI-1 mRNA expression, a calcium ionophore, ionomycin, had little effect.",
              "citation": {
                "type": "PubMed",
                "name": "Biochim Biophys Acta 1999 Apr 1 1449(3) 217-26",
                "id": "10209301"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80c5"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "NF-kB may be activated by cytokines, such as tumor necrosis factor-A (TNFa) and protein kinase C (PKC), which has been demonstrated in many inflammatory cells.4",
              "citation": {
                "type": "PubMed",
                "name": "Lab Invest 2006 Sep 86(9) 867-72",
                "id": "16865089"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80c4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Like phorbol esters, okadaic acid treatment also activates AP-1 enhancer activity and induces the phosphorylation of c-Jun protein.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Physiol 1992 May 151(2) 415-26",
                "id": "1315324"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80c3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Jan 7 280(1) 207-14",
                "id": "15509562"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80c2"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "c-fos gene expression was increased by PMA but not involved in MAO B gene transcription",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Jun 21 277(25) 22222-30",
                "id": "11956220"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80c1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Furthermore, activity of protein kinase C is necessary for HIV induction of C3, since inhibition of protein kinase C by prolonged exposure to the phorbol ester tetradecanoyl phorbol acetate partly abolished the HIV effect.",
              "citation": {
                "type": "PubMed",
                "name": "J Virol 2002 Apr 76(7) 3179-88",
                "id": "11884542"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80c0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Rat and human vascular smooth muscle cell proliferation is specifically sensitive to alpha-tocopherol, but not beta-tocopherol. The former, but not the latter, is capable of limiting proliferation and inhibiting protein kinase C activity in a dose-dependent manner",
              "citation": {
                "type": "PubMed",
                "name": "Biofactors 1998 7(1-2) 3-14",
                "id": "9523023"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80bf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Muscle, Smooth"
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "We have recently shown that phorbol 13-myristate 12-acetate (PMA)-stimulated SPRR1B transcription in Clara-like H441 cells is mainly mediated by activator protein-1 (AP-1) and c-Jun N-terminal kinase-1 (JNK1).",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2002 Jul 27(1) 64-70",
                "id": "12091247"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80be"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "data indirectly indicate that inhibition occurred by direct interaction between annexin V and PKC.",
              "citation": {
                "type": "PubMed",
                "name": "Biochemistry 1992 Feb 18 31(6) 1886-91",
                "id": "1310621"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80bd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "TALL-1 expression is dramatically down-regulated by phorbol myristate acetate/ionomycin.",
              "citation": {
                "type": "PubMed",
                "name": "J Leukoc Biol 1999 May 65(5) 680-3",
                "id": "10331498"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80bc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Together, the results demonstrate that OxPAPC induces TF expression in HUVECs through activation of PKC/ERK/EGR-1 and Ca(++)/calcineurin/NFAT pathways rather than by NF-kappa B-mediated transcription",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2002 Jan 1 99(1) 199-206",
                "id": "11756172"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80bb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "umbilical vein endothelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Pharmacologic inhibition of protein kinase C (PKC) and protein kinase A (PKA), which are involved in hexosamine-mediated matrix production, blocked the CREB phosphorylation and fibronectin synthesis seen in HG and GlcN conditions.",
              "citation": {
                "type": "PubMed",
                "name": "Diabetes 2001 Oct 50(10) 2355-62",
                "id": "11574420"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80ba"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "When GM-CSF-deprived 32D clone 3 cells were exposed to GM-CSF or to TPA, four TIS mRNAs (TIS7, TIS8, TIS10, and TIS11) were rapidly and transiently induced.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1989 Aug 9(8) 3580-3",
                "id": "2677677"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80b9"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 1995 Mar 28 208(3) 999-1007",
                "id": "7702631"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80b8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Raf kinase inhibitor protein (RKIP) is a physiological inhibitor of GRK-2. After stimulation of GPCR, RKIP dissociates from its known target, Raf-1 (refs 6-8), to associate with GRK-2 and block its activity. This switch is triggered by protein kinase C (PKC)-dependent phosphorylation of the RKIP on serine 153.",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2003 Dec 4 426(6966) 574-9",
                "id": "14654844"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80b7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "inhibition of PKC delta by rottlerin increased the binding activity of endogenous Fli1 and decreased that of Ets1.",
              "citation": {
                "type": "PubMed",
                "name": "Nucleic Acids Res 2005 33(4) 1337-51",
                "id": "15741186"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80b6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Fas ligation resulted in partial blockade of cellular PKC activity",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 May 28 274(22) 15320-8",
                "id": "10336417"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80b5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "enzastaurin-induced sustained PKC binding to the plasma-cell membrane, thereby blocking release of activated PKC into the cytoplasm",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2007 Feb 15 109(4) 1669-77",
                "id": "17023575"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80b4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "In human platelets activated with thrombin or phorbol esters, and in COS-1 cells expressing pleckstrin, a combination of phosphopeptide analysis and site-directed mutagenesis shows that three residues in the intervening sequence between the two pleckstrin PH domains become phosphorylated: Ser113, Thr114, and Ser117",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1995 Oct 6 270(40) 23317-21",
                "id": "7559487"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80b3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Blood Platelets",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Aggregation of high affinity FcR for IgE (Fc epsilon RI) on mast cells activates intracellular signal transduction pathways, including the activation of protein tyrosine kinases, phosphatidylinositol 3-kinase (PI3-kinase), and protein kinase C.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 1999 Feb 15 162(4) 2087-94",
                "id": "9973482"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80b2"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "mast cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Glucose stimulates nuclear USF2 protein accumulation through protein kinase C, p38 MAPK, and extracellular signal-regulated kinase pathways. Increased PKG activity down-regulates USF2 protein levels and its DNA binding activity under high glucose conditions, resulting in inhibition of glucose-induced TSP1 transcription and TGF-beta",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Aug 13 279(33) 34311-22",
                "id": "15184388"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80b1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "These results are consistent with the hypothesis that CGRP produces hyperalgesia by a direct action on CGRP1 receptors in the spinal cord dorsal horn and suggest that the effects of CGRP are mediated by both PKA and PKC second-messenger pathways.",
              "citation": {
                "type": "PubMed",
                "name": "J Neurophysiol 2004 Nov 92(5) 2859-66",
                "id": "15486424"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80b0"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "(2) Inhibition of MP by the protein kinase C-potentiated inhibitor protein of 17 kDa (CPI-17). Phosphorylation of CPI-17 at Thr38 enhances its inhibitory potency about 1000 fold and the kinase responsible is primarily PKC",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biochem 2004 Apr 259(1-2) 197-209",
                "id": "15124925"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80af"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1995 Dec 15 270(50) 30075-83",
                "id": "8530412"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80ae"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "We found that the expression of gp130 was dramatically induced at both the mRNA and protein levels by the two megakaryocytic inducers sodium butyrate (NaBut) and PMA.",
              "citation": {
                "type": "PubMed",
                "name": "Leuk Res 1999 Dec 23(12) 1113-9",
                "id": "10613356"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80ad"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Both PKC and Pak3 have been implicated to phosphorylate and activate Raf",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2000 Apr 15 14(8) 895-900",
                "id": "10783161"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80ac"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "which is a critical activating cofactor for the classic isoforms of protein kinase-C, -beta, -delta, and -alpha",
              "citation": {
                "type": "PubMed",
                "name": "Diabetes 2005 Jun 54(6) 1615-25",
                "id": "15919781"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80ab"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Here we demonstrate that functional uncoupling between CD38 and Cx43 in CD38-transfected 3T3 murine fibroblasts is paralleled by decreased [Ca(2+)](i) levels as a result of reduced intracellular conversion of NAD(+) to cADPR",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Dec 21 276(51) 48300-8",
                "id": "11602597"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80aa"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "completely abolished by pretreatment of the cells with PD 98059, an inhibitor of MEK and GF 109203X, an inhibitor of PKC. These results demonstrated that the PKC/ERK1/2 cascade is the essential signaling pathway by which VLDL activates VLDL receptor mRNA expression.",
              "citation": {
                "type": "PubMed",
                "name": "J Huazhong Univ Sci Technolog Med Sci 2003 23(2) 97-100",
                "id": "12973919"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80a9"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Human endothelial cells and VSMCs express telomerase activity, which is drastically activated by mitogenic stimuli via a protein kinase Cdependent pathway,67 but the activity declined with in vitro aging because of a decrease in expression of TERT, leading to telomere shortening and cellular senescence.68,69",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 2007 Jan 5 100(1) 15-26",
                "id": "17204661"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80a8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "In contrast, the activation of PKC promotes BSP gene expression.",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 2000 Dec 141(12) 4671-80",
                "id": "11108282"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80a7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "PKC translocates to the plasma membrane upon activation with agonists such as phorbol ester or DAG.",
              "citation": {
                "type": "PubMed",
                "name": "J Nutr 1995 Jun 125(6 Suppl) 1673S-1676S",
                "id": "7782924"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80a6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "PKC inhibition by staurosporine (10 and 100 nM) had no effect on either basal or IFNgamma-induced expression of WRS in either cell line. Consequently, PKC is not an indispensable element in WRS induction by IFNgamma. Rather, PKC may activate WRS gene expression only by a distinct pathway.",
              "citation": {
                "type": "PubMed",
                "name": "Biochemistry (Mosc) 2003 Apr 68(4) 482-6",
                "id": "12765533"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80a5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Treatment with palmitate rapidly induced the association of myeloid differentiation factor 88 (MyD88) with the TLR2 receptor, activated the stress-linked kinases p38, JNK, and protein kinase C, induced degradation of IkappaBalpha, and increased NF-kappaB DNA binding...TLR2 mediates the initial events of fatty acid-induced insulin resistance in muscle",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Sep 15 281(37) 26865-75",
                "id": "16798732"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80a4"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Activation of PKC by the phorbol ester TPA induced ZO-1 and occludin transcription, whereas PKC inhibition lead to decreased expression levels.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Physiol 2005 Jul 204(1) 83-6",
                "id": "15622522"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80a3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "whereas mutation of the CRE/TRE element abolished the PMA response. These results demonstrate that activation of the protein kinase C pathway by PMA results in an early up-regulation of H3.3B gene expression via the CRE/TRE element.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 1998 Feb 1 329 ( Pt 3) 609-13",
                "id": "9445389"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80a2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "The biological activity of u-PA, t-PA, as well as that of limiting concentration of FCS (1%), was mediated by PTK and PKC.",
              "citation": {
                "type": "PubMed",
                "name": "Growth Factors 2000 17(4) 249-68",
                "id": "10801075"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80a1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Activation of classical protein kinase C reduces the expression of human cationic amino acid transporter 3 (hCAT-3) in the plasma membrane ... Microscopic analyses revealed a PMA-induced reduction in the cell-surface expression of fusion proteins between hCAT-3 and enhanced green fluorescent protein expressed in X. laevis oocytes and glioblastoma cells. ",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2006 Apr 1 395(1) 117-23",
                "id": "16332251"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad80a0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "glioblastoma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "The levels of APOBEC3G mRNA and protein were unaffected by treatment of proliferating H9 cells with interferons or tumor necrosis factor-a, but were enhanced up to 20-fold by phorbol myristate acetate.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Aug 5",
                "id": "15297452"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad809f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "These results indicate that continuous stretch-induced IL-6 secretion in HUVECs depends on outside-in signaling via integrins followed by a PI3-K-PLC-gamma-PKC-IKK-NF-kappaB signaling cascade.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2005 May 288(5) C1012-22",
                "id": "15613495"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad809e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "umbilical vein endothelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Chelerythrine, a PKC inhibitor, delayed increased CFTR activity induced with phorbol 12-myristate 13-acetate or with the cAMP-generating agents (-)-epinephrine or forskolin plus 8-(4-chlorophenylthio)adenosine 3',5'- cyclic monophosphate.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol 1998 Nov 275(5 Pt 1) C1357-64",
                "id": "9814985"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad809d"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "inhibition of PKC resulted in differential augmentation of both beta2- and beta3-adrenoceptor-mediated relaxation",
              "citation": {
                "type": "PubMed",
                "name": "Eur J Pharmacol 2004 Jul 8 495(1) 75-81",
                "id": "15219823"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad809c"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": "Muscle, Smooth"
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "In addition, O2 ?? has been shown to directly activate protein kinase C, by interacting with its cysteine-rich zinc finger motif and facilitating zinc release (66), and can inactivate the protein phosphatase calcineurin, presumably by direct oxidation of the binuclear Fe2+-Zn2+ center within the active site (67).",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2008 Mar 15 44(6) 938-55",
                "id": "18164271"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad809b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "alpha-adrenergic-mediated force reduction is mediated through troponin I protein kinase C phosphorylation",
              "citation": {
                "type": "PubMed",
                "name": "J Appl Physiol 2005 Apr 98(4) 1163-70",
                "id": "15579573"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad809a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Furthermore, mutation of S741 and S746, the two serine sites involved in negative regulation by PKC, led to increased mitogenic response and increased activation of PI3-kinase, as well as enhanced Akt activation, Bad phosphorylation and survival",
              "citation": {
                "type": "PubMed",
                "name": "Cell Mol Life Sci 2004 Oct 61(19-20) 2535-48",
                "id": "15526160"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8099"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Protein kinase C inhibitors, H7 and bisindolylmaleimide, were able to block the induction.",
              "citation": {
                "type": "PubMed",
                "name": "Biochim Biophys Acta 1998 Oct 21 1405(1-3) 29-34",
                "id": "9784597"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8098"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "EpCAM expression, which is regulated negatively by TNFalpha and TPA through the activation of NF-kappaB",
              "citation": {
                "type": "PubMed",
                "name": "Cancer 2001 Aug 1 92(3) 620-8",
                "id": "11505407"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8097"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "PKCalpha can directly phosphorylate wild-type but not phosphorylation-negative and loss of function S70A Bcl2 in vitro",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1998 Sep 25 273(39) 25436-42",
                "id": "9738012"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8096"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2002 Jun 4(6) 399-407",
                "id": "12032545"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8095"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Furthermore, ANG II has also been shown to increase phosphorylation of CPI-17 (a MLCP inhibitor) via PKC (171). ",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2007 Jan 292(1) C82-97",
                "id": "16870827"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8094"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "vascular tissue"
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "addition of ATP to rat liver cytosol increased supernatant protein factor activity by more than 2-fold and could be prevented by the addition of inhibitors of protein kinases A and C.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Feb 21 278(8) 5646-51",
                "id": "12454003"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8093"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Furthermore, when HL-60 myeloid leukemic cells were differentiated with phorbol ester (TPA), PBK/TOPK protein expression was strongly down-regulated by 24 h. Under these same conditions, phosphorylated c-Myc was rapidly down-regulated (by 4 h), while the levels of cyclin D1 and phosphorylated p38 were constant.",
              "citation": {
                "type": "PubMed",
                "name": "Blood Cells Mol Dis 32(1) 240-5",
                "id": "14757441"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8092"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "DAG produced in response to various stimulations is known to activate PKC [32].",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 1999 Sep 1 342 ( Pt 2) 449-55",
                "id": "10455033"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8091"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "In this study, the down-regulation of the uPAR expression seemed to inhibit signaling pathways depending on the uPA proteolytic activity and also on the binding to the uPAR. The uPA catalytic activity seemed to activate protein kinase C through the matrix destruction and the disruption of integrin ligation, whereas the uPAR occupation activated the MAP-kinase pathway.",
              "citation": {
                "type": "PubMed",
                "name": "Biochemistry (Mosc) 2002 Jan 67(1) 119-34",
                "id": "11841347"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8090"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Human ECs and VSMCs express telomerase activity, which is drastically activated by mitogenic stimuli via a protein kinase C-dependent pathway [64] but the activity declined with in vitro aging due to a decrease in expression of TERT, leading to telomere shortening and cellular senescence [41,65].",
              "citation": {
                "type": "PubMed",
                "name": "J Mol Cell Cardiol 2004 Feb 36(2) 175-83",
                "id": "14871544"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad808f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": "vascular tissue"
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Four consequences of hyperglycemia of particular pathological relevance (1) are the formation, auto-oxidation, and interaction with cell receptors of advanced glycation end products (AGEs); activation of various isoforms of protein kinase C; induction of the polyol pathway; and increased hexosamine pathway flux.",
              "citation": {
                "type": "PubMed",
                "name": "Diabetes 2004 Feb 53 Suppl 1 S110-8",
                "id": "14749275"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad808e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "We found that cells stably transfected with chimeras between the regulatory domain of PKCdelta and the catalytic domains of PKCalpha or epsilon inhibited the expression of GS",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1998 Nov 13 273(46) 30713-8",
                "id": "9804846"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad808d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Human ECs and VSMCs express telomerase activity, which is drastically activated by mitogenic stimuli via a protein kinase C-dependent pathway [64] but the activity declined with in vitro aging due to a decrease in expression of TERT, leading to telomere shortening and cellular senescence [41,65].",
              "citation": {
                "type": "PubMed",
                "name": "J Mol Cell Cardiol 2004 Feb 36(2) 175-83",
                "id": "14871544"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad808c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "The data in Fig. 4, E to G, further support the idea that PKC phosphorylates Dvl2 to increase its interactions with betaarr2.",
              "citation": {
                "type": "PubMed",
                "name": "Science 2003 Sep 5 301(5638) 1391-4",
                "id": "12958364"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad808b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "In the TPC-1 cell line, stimulation by TSH and serum up-regulated Id-1 mRNA expression 1.5- and 4.0-fold, respectively. Activation of the mitogen intracellular protein kinase A and protein kinase C signaling pathways also up-regulated Id-1 mRNA expression",
              "citation": {
                "type": "PubMed",
                "name": "Surgery 2003 Aug 134(2) 235-41",
                "id": "12947323"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad808a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": "thyroid"
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "It has been reported that in vitro both Thr145 and Ser146 phosphorylation by Akt and PKC, respectively, leads to dissociation of PCNA from p21 (46",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cancer Res 2007 Sep 5(9) 909-22",
                "id": "17855660"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8089"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Curr Biol 1999 Oct 21 9(20) 1173-6",
                "id": "10531036"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8088"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "antisense ablation of AR prevented both TNF-alpha-induced PKC and NF-kappaB activation",
              "citation": {
                "type": "PubMed",
                "name": "FASEB J 2004 Aug 18(11) 1209-18",
                "id": "15284221"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8087"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 May 4 276(18) 14980-6",
                "id": "11278470"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8086"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "JDP2 potentiated and synergized with 12-O-tetradecanoylphorbol-13-acetate to induce muscle cell differentiation of RD cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Oct 18 277(42) 40043-54",
                "id": "12171923"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8085"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "In addition, treatment of a potent PKC inhibitor, H-7 in glucose-deprived HepG2 cells suppressed hypoglycemia-elevated VEGF expression as well as the increased AP-1 DNA-binding activity.",
              "citation": {
                "type": "PubMed",
                "name": "Int J Mol Med 2001 Jan 7(1) 91-6",
                "id": "11115615"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8084"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "The proapoptotic effect of BMP-2 is PKC-dependent, because BMP-2 increases PKC activity, and the selective PKC inhibitor calphostin C blocks the BMP-2-induced increased Bax/Bcl-2, caspase activity, and apoptosis.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Aug 3 276(31) 29028-36",
                "id": "11395480"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8083"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "PGDH promoter was strongly induced by phorbol ester",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 2000 Feb 141(2) 581-97",
                "id": "10650939"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8082"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "The annexin II-p11 interaction is mediated through the unique N-terminal domain of annexin II and is inhibited by protein kinase C phosphorylation of a serine residue in annexin II...A comparison of the phosphorylation patterns obtained identified Ser-II as the protein kinase C site responsible for regulating the annexin II-p11 interaction. ",
              "citation": {
                "type": "PubMed",
                "name": "Biochim Biophys Acta 1996 Oct 11 1313(3) 283-9",
                "id": "8898866"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8081"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "These in vitro and in vivo results probably suggest that reactive oxygen species generated from a protein kinase C-dependent NAD(P)H oxidase pathway plays a role in the high glucose-induced up-regulation of SR-A, leading to the increased endocytic degradation of modified LDL for foam cell formation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Feb 4 280(5) 3355-64",
                "id": "15556945"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8080"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Monocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Biochemistry 2001 Dec 11 40(49) 15031-7",
                "id": "11732925"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad807f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 1998 Jun 29 82(12) 1272-8",
                "id": "9648723"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad807e"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "ACPD-induced HO-1 expression was inhibited by the mGluR antagonist MCPG and the protein kinase C (PKC) inhibitor calphostin C.",
              "citation": {
                "type": "PubMed",
                "name": "Neuropharmacology 1999 Jun 38(6) 825-34",
                "id": "10465686"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad807d"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "We therefore investigated the effect of PKC on the NO-induced down-regulation of neutral ceramidase. Treatment of mesangial cells with spermine-NO in the presence of TPA dose-dependently reversed the inhibitory action of NO on neutral ceramidase activity",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Nov 29 277(48) 46184-90",
                "id": "12359735"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad807c"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "As shown in Figure 1-Figure 6 and Table 4, pan-PKC inhibitor RO-31-8220 (2 uM) completely blocked HNE- or acrolein-induced expression of GCLC, NQO1, NQO2, and GST-M1 and partially reduced the induction of HO-1 mRNA.",
              "citation": {
                "type": "PubMed",
                "name": "Toxicol Ind Health 25(4-5) 269-78",
                "id": "19651797"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad807b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "bronchial epithelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "The 20,000-dalton myosin light chain (LC20) is phosphorylated by both myosin light chain kinase (MLC kinase) and Ca2+, phospholipid-dependent protein kinase (protein kinase C [PKC]).",
              "citation": {
                "type": "PubMed",
                "name": "Blood 1991 Dec 15 78(12) 3224-31",
                "id": "1835891"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad807a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "this activity was enhanced by protein kinase C activator, phorbol 12-myristate 13-acetate (PMA), in an ETS consensus-dependent manner, while PMA could also enhance the expression level of ETS2 Endogenous expression of GM-CSF mRNA was increased by ETS2 transfection and the increased expression was further enhanced by PMA",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2003 Mar 28 303(1) 190-5",
                "id": "12646185"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8079"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Overexpression of PKC alpha was found to suppress mitochondrial PP2A activity by a mechanism that, at least in part, involves suppressed expression of the regulatory subunit comprising the Bcl2 phosphatase (ie the PP2A/B56 alpha subunit).",
              "citation": {
                "type": "PubMed",
                "name": "Leukemia 2004 Mar 18(3) 505-12",
                "id": "14737078"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8078"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "From CST pathway map for GPCR Signaling to ERK. ",
              "citation": {
                "type": "PubMed",
                "name": "Trends Endocrinol Metab 2006 Sep 17(7) 276-83",
                "id": "16890451"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8077"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Using classical biochemical approaches, it was established that S197 and S203 within the RA domain of RASSF1A are phosphorylated by PKC in vitro and in vivo. ",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 2008 Jun 25 582(15) 2270-6",
                "id": "18514071"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8076"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "We also show that the anti-inflammatory cytokine interleukin-10 (IL-10), which inhibits PKC activity, blocks secretion of vimentin. In contrast, the pro-inflammatory cytokine tumour necrosis factor alpha (TNF-alpha) can trigger secretion of vimentin. Finally, we found that extracellular vimentin is involved in bacterial killing and the generation of oxidative metabolites, two important functions of activated macrophages.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2003 Jan 5(1) 59-63",
                "id": "12483219"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8075"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Arterioscler Thromb Vasc Biol 2000 Apr 20(4) 940-8",
                "id": "10764657"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8074"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Although the growth factors epidermal growth factor (EGF) and neuregulin (NRG) 1 similarly stimulated Erk1/2 in MDA-MB-361 cells, EGF acting through an EGF receptor/ErbB2 heterodimer preferentially stimulated protein kinase C, and NRG1beta acting through an ErbB2/ErbB3 heterodimer preferentially stimulated Akt. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Jun 22 276(25) 22685-98",
                "id": "11297548"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8073"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "PKC isoforms have been reported to contribute to the phosphorylation and degradation of b-catenin. Consequently, a marked accumulation of b-catenin has been seen after treatment with bisindoylmaleimide inhibitors of PKC (eg, BIM I).",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2009 Feb 12 113(7) 1513-21",
                "id": "19018094"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8072"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "endothelin enhanced both adult rat myocyte contractile performance and cardiac troponin-I phosphorylation. Protein kinase C participated in both responses",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Sep 5 278(36) 33694-700",
                "id": "12815045"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8071"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "myocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Treatment of the human tumorigenic, TL, and BeWo cells with a differentiating agent and a potent protein kinase C activator-the tumor-promoting agent-or the JEG-3 cells with cholera toxin-a potent cyclic adenosine 3':5'monophosphate (cAMP) inducer-or its analogue 8-bromo-cAMP, potentiates TGFbeta production",
              "citation": {
                "type": "PubMed",
                "name": "In Vitro Cell Dev Biol Anim 2001 Apr 37(4) 245-50",
                "id": "11409691"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8070"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "8-Isoprostane led to increased ROCK-II protein expression through activation of PKC (Fig. 6)",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2006 Sep 15 41(6) 942-9",
                "id": "16934677"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad806f"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Moreover, the RGPR-p117 mRNA expression in H4-II-E cells was stimulated in the presence of dibutyryl cAMP, PMA, insulin, 17beta-estradiol, or serum in culture medium",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biochem 2002 87(2) 188-93",
                "id": "12244571"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad806e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "At 170 pg/ml, the tumor promoter 12-O-tetradecanoylphorbol-13-acetate (TPA) caused a 50% inhibition of heparin-binding growth factor type one (HBGF-1)",
              "citation": {
                "type": "PubMed",
                "name": "FASEB J 1988 Sep 2(12) 2797-800",
                "id": "2457532"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad806d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "CONCLUSIONS: The results suggest that, in fresh MCA, the ETA receptor is the most prominent subtype, while after organ culture ETB receptors also contribute to the contraction. This upregulation is due to de novo transcription of receptors. Protein kinase C is involved in the upregulation as Ro-31-8220 attenuates the contraction and the mRNA increase.",
              "citation": {
                "type": "PubMed",
                "name": "Stroke 2003 Jun 34(6) 1479-83",
                "id": "12750545"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad806c"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "The t-PA gene is transcriptionally induced by the phorbol ester PMA in HeLa cells, but suppressed by PMA in HT-1080 cells.",
              "citation": {
                "type": "PubMed",
                "name": "Eur J Biochem 2001 Feb 268(4) 987-96",
                "id": "11179965"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad806b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "TGF-beta1 also decreased the levels of membrane-associated PKC activity coincident with its inhibitory effect on PKC alpha's membrane association.",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 1997 Nov 138(11) 4657-64",
                "id": "9348191"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad806a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "These findings suggest that protein kinase C phosphorylates PI-PLC, resulting in a decrease in PI-PLC activity",
              "citation": {
                "type": "PubMed",
                "name": "Biochim Biophys Acta 1994 Nov 10 1224(2) 302-10",
                "id": "7981246"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8069"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Adipocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "94179362",
              "citation": {
                "type": "PubMed",
                "name": "BMC Bioinformatics 2004 Jun 22 5 79",
                "id": "15212693"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8068"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "The TPA-induced monocytic differentiation of U937, which also resulted in growth arrest, abruptly downregulated the expression of 3-PGDH. Removal of TPA restored cell growth through the retrodifferentiation process and subsequent expression of 3-PGDH",
              "citation": {
                "type": "PubMed",
                "name": "Gene 2000 Mar 7 245(1) 193-201",
                "id": "10713460"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8067"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Pretreatment of Swiss 3T3 cells with either of these inhibitors decreased LPA-induced GSK-3 phosphorylation in a dosage-dependent manner (Fig.4A)",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2002 Apr 22(7) 2099-110",
                "id": "11884598"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8066"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "These data indicate that PKCdelta is activated by TGF-beta1 in human mesangial cells. TGF-beta1-stimulated PKCdelta activity positively regulates Smad transcriptional activity and is required for COL1A2 gene transcription",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Renal Physiol 2003 Sep 285(3) F413-22",
                "id": "12759229"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8065"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Ro318220 (10 uM) and GF109203X (10 uM),  which inhibit PKC, attenuated the increase in total c-Jun protein induced by 10 ng/ml IL-1b [Fig. 7(a)].",
              "citation": {
                "type": "PubMed",
                "name": "J Mol Cell Cardiol 1999 Dec 31(12) 2087-99",
                "id": "10640438"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8064"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "myocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Deletion of phospholipase C-gamma2 or pharmacological interference with conventional PKCs resulted in marked reduction in both Thr-133 phosphorylation and Ras activation. ",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2004 Nov 23 101(47) 16612-7",
                "id": "15545601"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8063"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "b-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "The PKC inhibitors GF109203X and H7 attenuated the BK-induced increase in [Ca(2+)](i) and inhibited the BK-induced PGI(2) synthesis. Phorbol 12-myristate 13-acetate increased cPLA(2) activity and PGI(2) synthesis but failed to alter [Ca(2+)](i).",
              "citation": {
                "type": "PubMed",
                "name": "Microvasc Res 1999 Sep 58(2) 144-55",
                "id": "10458930"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8062"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium"
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Activation of the A2AAR also induces formation of the inositol phosphates to raise intracellular calcium and activate protein kinase C in COS-7 cells via pertussis toxin insensitive Galpha15 and Galpha16 proteins",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Drug Discov 2006 Mar 5(3) 247-64",
                "id": "16518376"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8061"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Leptin activation of HIF-1alpha was mainly linked to canonic (MAPK, PI-3K) and non-canonic (PKC, JNK and p38 MAP) signalling pathways",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2010 Sep 22(9) 1350-62",
                "id": "20466060"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8060"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "We observed that certain cytokine and growth factors [such as TNF alpha, basic fibroblast growth factor, transforming growth factor beta, and protein kinase C-activating agents plus calcium ionophore], when added to differentiated adipocytes, cause rapid down-regulation of PPARgamma mRNA expression",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 1997 Jul 138(7) 2776-83",
                "id": "9202217"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad805f"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Adipocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Interestingly, treatment of platelets with these PKC inhibitors (Ro31-8220 and Bisindolylmaleimide I (BIM-1), and G6976, an inhibitor of conventional PKC isoforms) significantly reduced peroxynitrite-mediated phosphorylation of both sites, indicating that phosphorylation occurred through PKC-dependent mechanism.",
              "citation": {
                "type": "PubMed",
                "name": "Platelets 2010 21(6) 421-8",
                "id": "20624010"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad805e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Blood Platelets",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "In addition, TGFbeta(1)- and BMP-2-induced increases in alpha1(I) collagen mRNA levels were both dependent on protein kinase C and protein tyrosine kinase activities.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 1999 Oct 1 343 Pt 1 21-7",
                "id": "10493907"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad805d"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": " IP(3) stimulates intracellular Ca(2+) release from the sarcoplasmic reticulum and DAG causes protein kinase C (PKC) activation.",
              "citation": {
                "type": "PubMed",
                "name": "J Am Soc Hypertens 3(2) 84-95",
                "id": "20161229"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad805c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "vascular smooth muscle"
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "RO31-7549 (protein kinase C (PKC) inhibitor) inhibited activation of PDE4 by PMA.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 1999 Apr 15 162(8) 4864-75",
                "id": "10202031"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad805b"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Myeloid Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Stimulation of PKC by phorbol 12-myristate 13-acetate (PMA) leads to the activation of ERK1/2, p38 MAPK, and JNK in LNCaP cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Sep 5 278(36) 33753-62",
                "id": "12824193"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad805a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "These data suggest that C-type natriuretic peptide attenuates neurotransmitter efflux by a mechanism involving suppression of neuronal protein kinase C activity via an interaction with the NPR-C.",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 2003 Jan 144(1) 94-100",
                "id": "12488334"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8059"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Thr206 is a functionally critical cTnT PKC phosphorylation residue. Its exclusive phosphorylation by PKC-alpha or replacement by Glu (mimicking phosphorylation) significantly decreased maximum tension, actomyosin Mg-ATPase activity, myofilament Ca2+ sensitivity, and cooperativity",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Sep 12 278(37) 35135-44",
                "id": "12832403"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8058"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "cardiomyocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Ser-726 and Ser-713 in the C-terminal MARCKS-related domains of alpha- and beta-adducin, respectively, were identified as the major phosphorylation sites common for PKA and PKC. PKA, in addition, phosphorylated alpha-adducin at Ser-408, -436, and -481 in the neck domain. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1996 Oct 11 271(41) 25157-66",
                "id": "8810272"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8057"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "In bone marrow (BM) neutrophils isolated from rac2(-/-) mice generated by gene targeting, we previously reported that PMA-induced superoxide production was reduced by about 4-fold",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2001 Jan 15 166(2) 1223-32",
                "id": "11145705"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8056"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Induced DRA expression involves activation of restricted protein kinase C (PKC) isoforms, resulting in activated activator protein-1-dependent transcription",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 1998 Nov 1 161(9) 4819-24",
                "id": "9794414"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8055"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Stimulation of neutrophil-like HL-60 cells with phorbol 12-myristate 13-acetate led to the secretion of S100A8/A9 protein complex, which carried the released arachidonic acid.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Nov 12 274(46) 32672-9",
                "id": "10551823"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8054"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "These results suggest that cigarette smoke particulate constituents activate protein kinase C, leading to increased surface expression of adhesive ligand CD11b on peripheral blood monocytes and counter receptor(s) ICAM-1 and ELAM-1 in endothelial cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Physiol 1994 Jul 160(1) 154-62",
                "id": "7517402"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8053"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "peripheral blood monocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "It is also induced in the T-lymphoblastoid cell line HUT 78 after phorbol ester (phorbol myristate acetate) treatment.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1994 Feb 14(2) 1431-7",
                "id": "8289818"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8052"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "H(1)-receptor antagonists/inverse agonists (mepyramine, triprolidine) and PKC inhibitor completely blocked the effect of histamine.",
              "citation": {
                "type": "PubMed",
                "name": "Inflamm Res 2004 Jun 53(6) 245-52",
                "id": "15167971"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8051"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "TPA-induced expression of cyclooxygenase-2",
              "citation": {
                "type": "PubMed",
                "name": "Oncol Res 2002 13(1) 37-45",
                "id": "12201673"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8050"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "While treatment of EGF, TGFalpha and PMA induced expression of COUP-TFII, COUP-TFI did not respond to these agents",
              "citation": {
                "type": "PubMed",
                "name": "J Endocrinol 2003 Jan 176(1) 83-94",
                "id": "12525252"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad804f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "TPA-induced genes, such as Sprr1A, Saa3, JunB, Il4ralpha, Gp38, RalGDS and Slpi",
              "citation": {
                "type": "PubMed",
                "name": "Int J Cancer 2003 May 10 104(6) 699-708",
                "id": "12640676"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad804e"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Ank gene expression is also upregulated after treating quiescent fibroblasts with several other mitogenic agents (e.g., calf serum or platelet-derived growth factor-BB) or the tumor promoter phorbol 12-myristate 13-acetate.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biochem 2001 84(1) 27-38",
                "id": "11746513"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad804d"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": " Figure 7A shows that PKC blockade with BIM, but not MEK-1 blockade with PD89059, abrogates migration in MM.1S cells.",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2001 Jul 15 98(2) 428-35",
                "id": "11435313"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad804c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Am J Pathol 1998 Jul 153(1) 39-45",
                "id": "9665463"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad804b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "The signal transduction pathway activated by ET-1 includes the Rap1/B-Raf and the Ras/Raf-1 complexes, protein kinase C (PKC) together with extracellular signal-regulated kinases (ERK), and the ribosomal S6 kinase (RSK) isoforms RSK2 and RSK3, two kinases that lie immediately downstream of ERK and are able to phosphorylate CREB.",
              "citation": {
                "type": "PubMed",
                "name": "J Neurosci 2001 Nov 15 21(22) 8842-53",
                "id": "11698596"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad804a"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "astrocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Ariadne: S100A1 additionally inhibits phosphorylation of the actin-capping molecule  MARCKS",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2003 Feb 23(3) 1034-43",
                "id": "12529407"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8049"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "These antibodies revealed a protein with the expected 43 kDa molecular mass, up-regulated by phorbol ester, retinoids and 1,25-(OH)2 vitamin D3 in U937 cells.",
              "citation": {
                "type": "PubMed",
                "name": "Biochim Biophys Acta 1999 Jul 8 1450(3) 364-73",
                "id": "10395947"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8048"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biochem 2003 Apr 15 88(6) 1101-11",
                "id": "12647293"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8047"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Pharmacologic inhibition of protein kinase C (PKC) and protein kinase A (PKA), which are involved in hexosamine-mediated matrix production, blocked the CREB phosphorylation and fibronectin synthesis seen in HG and GlcN conditions.",
              "citation": {
                "type": "PubMed",
                "name": "Diabetes 2001 Oct 50(10) 2355-62",
                "id": "11574420"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8046"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "mesangial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "we demonstrate that binding of both lipoprotein and non-lipoprotein ligands to MSR-A induced protein tyrosine phosphorylation and increased protein kinase C (PKC) activity leading to up-regulated urokinase-type plasminogen activator (uPA) expression",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1998 Jan 9 273(2) 1240-6",
                "id": "9422792"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8045"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "The binding of TCF11/MafG to the iNOS promoter could be enhanced by phorbol 12-myristate 13-acetate and suppressed by the protein kinase C inhibitor staurosporine. Moreover, the induction of TCF11/MafG binding by TGF-beta and Smad6-short could be blocked by staurosporine, and the effect of TGF-beta was blocked by the selective protein kinase C inhibitor calphostin C. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 Dec 21 282(51) 36837-44",
                "id": "17928287"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8044"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Muscle, Smooth"
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "The presence of this modification enhances the activity of 14-3-3 as an inhibitor of protein kinase C nearly 2-fold. In this report we show by a combination of electrospray mass spectrometry and protein microsequencing that alpha and delta are in vivo post-translationally modified forms of beta and zeta, respectively, and the site of phosphorylation, serine 185, is in a consensus sequence motif for proline-directed kinases.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1995 Mar 17 270(11) 5706-9",
                "id": "7890696"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8043"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "We report here that PPARgamma agonists, thiazolidinedione class drugs (TZDs), or 15-deoxy-Delta12,14-prostaglandin J2 (15d-PGJ2) were capable of activating diacylglycerol (DAG) kinase (DGK), resulting in attenuation of DAG levels and inhibition of protein kinase C (PKC) activation.",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 2004 Jun 11 94(11) 1515-22",
                "id": "15117825"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8042"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Recombinant GBPI-1-fusion protein inhibits PP1 activity with IC50=3 nM after phosphorylation by PKC.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2004 Jan 1 377(Pt 1) 171-81",
                "id": "12974676"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8041"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "FGF-1 induction of Fnk mRNA expression is first detected at 30 min after mitogen addition, reflects transcriptional activation, and does not require de novo protein synthesis. FGF-2, platelet-derived growth factor-BB, calf serum, or phorbol myristate acetate treatment of quiescent cells also induces fnk gene expression",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1995 Apr 28 270(17) 10351-7",
                "id": "7730342"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8040"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "This stimulation was mimicked by exposure of cells to biologically active phorbol esters, suggesting that thrombin action may be mediated through activation of kinase C (Ca2+/phospholipid-dependent enzyme).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1986 Jul 25 261(21) 9579-82",
                "id": "2426251"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad803f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium, Vascular"
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Protein kinase C (PKC)-induced phosphorylation of cardiac troponin I (cTnI)",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Jun 24 280(25) 24135-42",
                "id": "15840586"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad803e"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Furthermore, in MSR gene promoter-driven luciferase reporter assays with TNF, PKC activator increases, but antioxidant N-acetylcysteine, PK inhibitors, and dominant negative constructs decrease luciferase activity in MSR gene promoter-transfected cells",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Dec 29 275(52) 41035-48",
                "id": "10969071"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad803d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Ang II-stimulated StAR transcription in H295R cells is dependent upon both influx of external Ca2+ and tyrosine kinase signaling and is enhanced by protein kinase C and mitogen-activated protein kinase (ERK1/2) activation. In particular, Janus tyrosine kinase-2 (Jak2) activation was increased with Ang-II treatment of H295R cells",
              "citation": {
                "type": "PubMed",
                "name": "Endocr Res 2004 Nov 30(4) 685-93",
                "id": "15666812"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad803c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Instead, the collagen receptor glycoprotein VI seems to mediate FAK phosphorylation by a protein kinase C-dependent pathway. In many different cell lines, alpha1beta1 stimulation induces collagen type I synthesis [86]. Expression of GPVI is only found in platelets and their precursor cells.",
              "citation": {
                "type": "PubMed",
                "name": "Eur J Dermatol 11(6) 506-14",
                "id": "11701397"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad803b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Inhibition of AR attenuated TNF-alpha and hyperglycemia-induced activation of protein kinase C (PKC), phosphorylation of the inhibitory subunit of nuclear factor-kappaB (NF-kappaB), and stimulation of NF-kappaB",
              "citation": {
                "type": "PubMed",
                "name": "FASEB J 2003 Feb 17(2) 315-7",
                "id": "12490536"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad803a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "% 12-O-Tetradecanoylphorbol-13-acetate-induced sequence 7 (TIS7) acts as a transcriptional co-repressor",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Dec 2 280(48) 39795-801",
                "id": "16204248"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8039"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "FFAs, probably through protein kinase C, can activate IKK and JNK (85).",
              "citation": {
                "type": "PubMed",
                "name": "Diabetes 2005 Apr 54(4) 917-27",
                "id": "15793228"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8038"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "In contrast, HO-2 has low activity at low substrate concentrations, and even its maximum activity is limited to less than 10% that of HO-1 (Table 1) (Maines and Panahian, 2001). However, the enzymatic activity of HO-2 can be increased in a protein kinase C-dependent manner (Dore et al., 1999). ",
              "citation": {
                "type": "PubMed",
                "name": "Pharmacol Rev 2003 Sep 55(3) 551-71",
                "id": "12869663"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8037"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Moreover, we observed that Ca2+ levels remarkably increased under low glucose condition. Consistently, an intracellular Ca2+ chelator, BAPTA/AM significantly decreased hypoglycemia-induced VEGF expression and AP-1 DNA-binding activity.",
              "citation": {
                "type": "PubMed",
                "name": "Int J Mol Med 2001 Jan 7(1) 91-6",
                "id": "11115615"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8036"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "hepatocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "TCR/CD28 stimulation leading to IL2 expression requires activation of PKC PKCtheta was identified to be essential for IL2 expression in T-cells",
              "citation": {
                "type": "PubMed",
                "name": "Mol Immunol 2002 Jun 38(15) 1087-99",
                "id": "12044776"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8035"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 1996 Jun 1 56(11) 2641-8",
                "id": "8653710"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8034"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Interestingly, its gene expression was enhanced by various differentiation-inducing agents, such as phorbol ester, dihydroxy vitamin D3, retinoic acid, and dimethyl sulfoxide.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1995 May 4 10(9) 1731-8",
                "id": "7753550"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8033"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "We observed that TPA (30nM) decreased G-CSF mRNA levels in MNCs, while ionomycin increased G-CSF in a dose-dependent manner.",
              "citation": {
                "type": "PubMed",
                "name": "Blood Cells Mol Dis 1995 21(3) 192-200",
                "id": "8673471"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8032"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "peripheral blood mononuclear cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Arterioscler Thromb Vasc Biol 1997 Jan 17(1) 141-8",
                "id": "9012649"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8031"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Our study extend recent findings which implicate PDK1 in the activation of protein kinases B and C and p70(S6K)",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Sep 17 274(38) 27168-76",
                "id": "10480933"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8030"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "we identified two intracellular signaling molecules protein kinase C (PKC) and extracellular signal-related kinase (ERK). They mediated both the phorbol myristate acetate (PMA) downregulation of DMBT1 expression",
              "citation": {
                "type": "PubMed",
                "name": "Carcinogenesis 2005 Jun 26(6) 1129-37",
                "id": "15760920"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad802f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "The CREB analogue CREM can also be  phosphorylated by PKC and p70 S6 kinase .",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2001 Jan 1 166(1) 284-92",
                "id": "11123304"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad802e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "PP17b synthesis in HeLa cells, which was significantly inhibited by protein kinase C (PKC) inhibitor This data shows that PP17b is a neutral lipid droplet-associated protein, and its expression is regulated by PKC- and PKA-dependent pathways.",
              "citation": {
                "type": "PubMed",
                "name": "Eur J Biochem 2003 Mar 270(6) 1176-88",
                "id": "12631276"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad802d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "HGF-induced expression of Egr-1, PDGFA, and VEGF was suppressed by pharmacologic and siRNA inhibitors of mitogen-activated protein kinase kinase 1/2 (MEK1/2) and protein kinase C (PKC) pathways. ",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2005 Aug 15 65(16) 7071-80",
                "id": "16103054"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad802c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Head and Neck Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "The PKC activator PMA and the nitric oxide (NO) donor 3-morpholinosydnonimine decreased TAUT activity",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Regul Integr Comp Physiol 2004 Oct 287(4) R886-93",
                "id": "15166008"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad802b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "High glucose-enhanced SR-A expression was prevented by protein kinase C High glucose-enhanced SR-A expression was prevented by protein kinase C and NAD(P)H oxidase inhibitors as well as antioxidants.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Feb 4 280(5) 3355-64",
                "id": "15556945"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad802a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "The effect of PDGF on g(j) involved a decrease in both gamma(j) and Po and required serine 368 in the C-terminus. These data implicate protein kinase C as the mediator of the PDGF effect and strongly suggest that acute regulation of gap junction function by PDGF-activated signaling cascades is conferred by low levels of expression of a sensitive connexin in cells that otherwise express insensitive connexins.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Commun Adhes 10(4-6) 287-91",
                "id": "14681030"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8029"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "The Na+/H+ exchanger regulatory factor (NHERF) binds to CFTR and increases its open probability (Po). Protein kinase C disrupts the stimulatory effect of NHERF on CFTR channel Po.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2003 Aug 5 100(16) 9620-5",
                "id": "12881487"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8028"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Epithelium"
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Surprisingly, however, we demonstrate that after CD3/CD28 engagement, deficiency of PKCtheta primarily abrogates NFAT transactivation",
              "citation": {
                "type": "PubMed",
                "name": "J Exp Med 2003 Jun 2 197(11) 1525-35",
                "id": "12782715"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8027"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "treatment of cells with activators of PKC or overexpression of PKC-betaII in transfected cells increased expression of an SAF-regulated promoter.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Dec 15 275(50) 39727-33",
                "id": "10995778"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8026"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "The activation of the p38-MAPK was dependent on protein kinase-C.",
              "citation": {
                "type": "PubMed",
                "name": "Diabetologia 2003 Apr 46(4) 531-7",
                "id": "12679868"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8025"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Appl Physiol 2000 Nov 89(5) 1985-90",
                "id": "11053353"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8024"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "FROM FULL TEXT: Multiple PKC inhibitors suppressed Epo-induced signaling. Most likely, the PKC isoform responsible for control of EpoR signalling is PKCalpha. Go6976, an inhibitor fo rthis PKC class, was particularly effective in attenuating EpoR signalling.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2004 Jul 3(7) 876-9",
                "id": "15254422"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8023"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "12-O-tetradecanoylphorbol-13-acetate (TPA) could induce cell apoptosis via induction of TR3 and E2F1 expression in LNCaP prostate cancer cells",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Oct 31 278(44) 42840-5",
                "id": "12947120"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8022"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "PKA activation by beta-adrenoreceptor (isoproterenol) stimulation results in stoichiometric phosphorylation of troponin I (TnI) and C-protein. PKC activation by either 12-O-tetradecanoylphorbol-13-acetate (TPA) or by alpha-adrenoreceptor (phenylephrine plus propranolol) stimulation results in phosphorylation of the same two proteins to similar extents",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1993 Feb 5 268(4) 2705-11",
                "id": "8381412"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8021"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "myocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Instead, inhibition of PKC resulted in a 2-fold increase in Oxo-M-stimulated ACK-1 phosphorylation, whereas acute activation of PKC with phorbol ester decreased ACK-1 phosphorylation. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Feb 23 276(8) 5622-8",
                "id": "11087735"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8020"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Treatment of PMN with phosphatidylinositol-specific phospholipase C to remove FcgammaRIIIb also decreased phagocytosis of SAP-opsonized zymosan, but not CRP-opsonized zymosan.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2001 Jun 1 166(11) 6735-41",
                "id": "11359830"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad801f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "enhanced calcyclin expression which is seen in quiescent cells following mitogenic stimuli may result from activation of the PKC system.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Growth Differ 1992 Nov 3(11) 847-53",
                "id": "1467312"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad801e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "After PMA stimulation, Northern blot analysis showed that steady state levels of CD6 mRNA increased in response to PMA treatment.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 1994 Jul 1 153(1) 1-9",
                "id": "8207228"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad801d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Overexpression of PLCdelta4 selectively activates protein kinase C-phi and upregulates the expression of epidermal growth factor receptors EGFR/erbB1 and HER2/erbB2, leading to constitutive activation of extracellular signal-regulated kinases 1 and 2 (ERK1/2) pathway in MCF-7 cells. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cancer 2004 May 13 3 15",
                "id": "15140260"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad801c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "PKC and PKA phosphorylate at Ser726 in the MARCKS domain (42).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Aug 18 275(33) 25805-13",
                "id": "10823823"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad801b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Cell Growth Differ 1998 May 9(5) 405-13",
                "id": "9607561"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad801a"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "These effects were completely prevented by calphostin C, a protein kinase C inhibitor.",
              "citation": {
                "type": "PubMed",
                "name": "Hepatology 2001 May 33(5) 1130-40",
                "id": "11343241"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8019"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "activation of both protein kinase-A-and protein kinase-C-mediated signaling pathways also results in a decrease in BMP-3 mRNA levels in GL cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Endocrinol Metab 1996 Nov 81(11) 3877-82",
                "id": "8923832"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8018"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Ro 31-8425, a potent and highly specific PKC inhibitor abrogated the suppressive effect of TPA on p18(INK4c) gene expression.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2004 Jul 8 23(31) 5409-14",
                "id": "15107819"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8017"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "The MAP kinase phosphorylation and cell proliferation were suppressed by diphenylene iodonium chloride, an NADPH oxidase inhibitor, and by calphostin C, a protein kinase C (PKC)-specific inhibitor.",
              "citation": {
                "type": "PubMed",
                "name": "Liver Int 2005 Oct 25(5) 1018-26",
                "id": "16162162"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8016"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "hepatic stellate cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "PKC has been shown to play an important role in the activation of both phagocytic and nonphagocytic NADPH oxidase",
              "citation": {
                "type": "PubMed",
                "name": "J Am Soc Nephrol 2003 Aug 14(8 Suppl 3) S241-5",
                "id": "12874439"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8015"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "The FGFR-1 mediates activation of protein kinase C (PKC) through direct binding and activation of phospholipase C-gamma (PLC-gamma)",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1999 Jun 3 18(22) 3354-64",
                "id": "10362356"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8014"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "t-PA expression is modulated by PMA on the level of transcription. the PMA-mediated induction",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1990 Aug 25 265(24) 14618-26",
                "id": "2167321"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8013"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Moreover, PKC activation was found to be required for the activation of the MAP kinase pathway in response to CD43 ligation.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2004 Dec 3 325(1) 133-43",
                "id": "15522211"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8012"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Treatment of PMN with phosphatidylinositol-specific phospholipase C to remove FcgammaRIIIb also decreased phagocytosis of SAP-opsonized zymosan, but not CRP-opsonized zymosan.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2001 Jun 1 166(11) 6735-41",
                "id": "11359830"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8011"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Peptide loading also resulted in a significant inhibition of phorbol ester-induced adducin Ser662 phosphorylation, an intracellular monitor of PKC kinase activity, ERK1/2 activation, and Ser789 phosphorylation of the actin binding protein caldesmon",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Heart Circ Physiol 2004 Jan 286(1) H91-8",
                "id": "12969891"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8010"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "vascular smooth muscle"
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Platelet-derived growth factor-induced phosphorylation could be inhibited by phosphokinase C (PKC) inhibitory compounds, and 14-3-3gamma could be phosphorylated in the absence of PDGF by compounds that activate PKC.",
              "citation": {
                "type": "PubMed",
                "name": "DNA Cell Biol 1999 Jul 18(7) 555-64",
                "id": "10433554"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad800f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": "vascular tissue"
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Activation of PKC resulted in marked induction of NeuroD mRNA and NeuroD protein. NeuroD mRNA induction was inhibited by calphostin C, an inhibitor of PKC",
              "citation": {
                "type": "PubMed",
                "name": "Neurosci Lett 1999 Sep 3 272(1) 45-8",
                "id": "10507539"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad800e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "The specific PKC-inhibitor enzastaurin effectively blocks growth, survival, and migration of MM cells both in vitro and in vivo.",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2009 Feb 12 113(7) 1513-21",
                "id": "19018094"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad800d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Multiple Myeloma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Similarly, CSC treatment of HUVEC resulted in a twofold increase in membrane-associated PKC activity at 30 min, with a concomitant decrease of 35-4096 in cytosolic PKC activity. Figure 7 shows the increase in the ratio of membrane-associated to cytosolic activity at 30 min after treatment of HWEC with CSC.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol 1996 May 270(5 Pt 2) H1624-33",
                "id": "8928867"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad800c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Insulin-induced VEGF expression requires p38 MAPK and PI 3-kinase, whereas hyperglycemia-induced VEGF expression is HIF-1alpha-independent and requires PKC and p42/p44 MAPK.",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Invest 2002 Mar 109(6) 805-15",
                "id": "11901189"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad800b"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Mar 5 274(10) 6190-4",
                "id": "10037704"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad800a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Further, TCR ligation results in the formation of a ZAP-70-CrkL-WIP-WASP complex, which is recruited to lipid rafts and the immunological synapse. TCR engagement also causes PKCtheta-dependent phosphorylation of WIP, causing the disengagement of WASP from the WIP-WASP complex, thereby releasing it from WIP inhibition. These results suggest that the ZAP-70-CrkL-WIP pathway and PKCtheta link TCR to WASP activation.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2002 Dec 10(6) 1269-81",
                "id": "12504004"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8009"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "(ii) EDF-1 is phosphorylated in vitro and in vivo by protein kinase C;...In addition, 12-O-tetradecanoylphorbol-13-acetate treatment of human umbilical vein endothelial cell stimulates the nuclear translocation of EDF-1. and (iii) EDF-1-CaM interaction is modulated by the concentrations of Ca(2+) and by the phosphorylation of EDF-1 by protein kinase C both in vitro and in vivo.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Aug 4 275(31) 24047-51",
                "id": "10816571"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8008"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Depletion of protein kinase C (PKC) by phorbol 12-myristate 13 acetate or inhibition of PKC by calphostin C blocked MKP-1 induction",
              "citation": {
                "type": "PubMed",
                "name": "Arterioscler Thromb Vasc Biol 1999 Aug 19(8) 1862-71",
                "id": "10446064"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8007"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "PKCdelta, a member of the novel protein kinase C (PKC) subclass, was rapidly phosphorylated and activated upon exposure to IL-13. Treatment of cells with rottlerin, a PKCdelta inhibitor, blocked IL-13-induced 15-LO mRNA and protein expression",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Apr 16 279(16) 15954-60",
                "id": "14757756"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8006"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Monocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Experiments using signal transduction inhibitors and a metal transcription factor (MTF)-1 null cell line demonstrate that copper-inducible MT-I transcription is regulated by protein kinase C and mitogen-activated protein kinase signaling pathways and requires MTF-1.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2004 Feb 286(2) C293-301",
                "id": "14576086"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8005"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Receptor-like PTP PTP-U2 is expressed during phorbol ester-induced differentiation of monoblastoid leukemia U937 cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1998 Aug 14 273(33) 21187-93",
                "id": "9694875"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8004"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "PMA induced ECE-1a promoter activity about 2.5-fold in EA.hy926 cells. Similarly, coexpression of Ets-1 protein resulted in a dose-dependent increase in ECE-1a promoter activity (more than 8-fold).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Pharmacol 2001 Dec 60(6) 1332-42",
                "id": "11723240"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8003"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "umbilical vein endothelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Phorbol-12-myristate-13-acetate, a PKC activator, robustly increased RGS2. This signal was attenuated by the PKC inhibitor GF 109203X (50 +/- 4%) and by phorbol-12, 13-dibutyrate-mediated down-regulation of PKC",
              "citation": {
                "type": "PubMed",
                "name": "Mol Pharmacol 2000 Mar 57(3) 460-7",
                "id": "10692485"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8002"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Oct 31 278(44) 42829-39",
                "id": "12941954"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8001"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "TPA induced trans-membrane protein (TTMP)",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2005 Apr 8 329(2) 755-64",
                "id": "15737651"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8000"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "carcinoma Of pancreas",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "PKC phosphorylates Ser-332",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Apr 30 279(18) 18623-32",
                "id": "14985363"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7fff"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": "Muscles"
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "We have also established that EGF receptor activation, which is known to function upstream of HD disassembly, results in the phosphorylation of only one or more of these three residues and the partial disassembly of HDs in keratinocytes. Additionally, we show that S1360 and S1364 of beta4 are the only residues phosphorylated by PKC and PKA in cells, respectively. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 2007 Jul 5",
                "id": "17615294"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ffe"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Epithelium"
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "The PKC inhibitors GF109203X and H7 attenuated the BK-induced increase in [Ca(2+)](i) and inhibited the BK-induced PGI(2) synthesis. Phorbol 12-myristate 13-acetate increased cPLA(2) activity and PGI(2) synthesis but failed to alter [Ca(2+)](i).",
              "citation": {
                "type": "PubMed",
                "name": "Microvasc Res 1999 Sep 58(2) 144-55",
                "id": "10458930"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ffd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Insulin release from pancreatic islets of ob/ob mice in response to stimulation of PKC was decreased by leptin",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2002 Aug 14(8) 655-63",
                "id": "12020765"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ffc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Neurosci 1997 Feb 15 17(4) 1291-301",
                "id": "9006973"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ffb"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Interestingly, dephosphorylation was dramatically induced by PKC activation,",
              "citation": {
                "type": "PubMed",
                "name": "Exp Cell Res 2006 Oct 15 312(17) 3336-48",
                "id": "16935280"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ffa"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "TPA induced both TXS and PES mRNAs in HEL cells in a dose-dependent manner at 36 h",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 1992 Jul 20 306(2-3) 161-4",
                "id": "1633871"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ff9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Both hypoxia and oxidative stress have been demonstrated to induce the secretion of MIF from cardiomyocytes through an atypical protein kinase Cdependent export mechanism and to result in extracellular signal-regulated kinase activation.65,66",
              "citation": {
                "type": "PubMed",
                "name": "Circulation 2008 Mar 25 117(12) 1594-602",
                "id": "18362243"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ff8"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "cardiomyocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Agonist-AT1R interaction also leads to PLD activation, resulting in hydrolysis of phosphatidylcholine (PC) to choline and phosphatidic acid (PA). PA is rapidly converted to DAG, leading to sustained PKC activation, and sustained muscle contraction. ",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2007 Jan 292(1) C82-97",
                "id": "16870827"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ff7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "vascular smooth muscle"
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Ebp1 (S360A), which cannot be phosphorylated by PKC, barely binds Akt or inhibits DNA fragmentation, whereas Ebp1 S360D, which mimics phosphorylation, strongly binds Akt and suppresses apoptosis.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2006 May 17 25(10) 2083-95",
                "id": "16642037"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ff6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "indicating that PKCdelta played the functional role in mediating the gene activation of 12(S)-lipoxygenase induced by PMA.",
              "citation": {
                "type": "PubMed",
                "name": "J Biomed Sci 9(2) 156-65",
                "id": "11914583"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ff5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Similar responses were observed when neutrophils were stimulated with chemotactic N-formyl-methionyl-leucyl-phenylalanine, phorbol ester, or the calcium ionophore ionomycin.",
              "citation": {
                "type": "PubMed",
                "name": "J Leukoc Biol 1998 Jun 63(6) 699-706",
                "id": "9620662"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ff4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "IL-1beta and TNF-alpha activated the PKC signaling pathway in RPMVEC, and up-regulated the gene and protein expression of SSeCKS.",
              "citation": {
                "type": "PubMed",
                "name": "Inflamm Res 2010 Nov 59(11) 949-58",
                "id": "20454828"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ff3"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Fig. 3. CREB phosphorylation is induced by OxPAPC via PKA, PKC, p38MAPK, and ERK1/2.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Dec 19 278(51) 51006-14",
                "id": "14523007"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ff2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Phosphorylation of eEF1Bbeta was insensitive to pertussis toxin or wortmannin, however, stimulation of cellular protein kinase C (PKC) directly phosphorylated eEF1Bbeta",
              "citation": {
                "type": "PubMed",
                "name": "Life Sci 2003 Oct 24 73(23) 2991-3004",
                "id": "14519448"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ff1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Ariadne: Phorbol myristate acetate and 1-oleoyl-2-acetyl-sn-glycerol, activators of protein kinase C, were able to induce pp68 in mouse peritoneal macrophages.",
              "citation": {
                "type": "PubMed",
                "name": "Infect Immun 1994 Dec 62(12) 5242-6",
                "id": "7960100"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7ff0"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Anti-CD40 monoclonal antibody can significantly suppress CD40L-induced DAG-PKC and IP(3)-[Ca(2+)]i signal pathway activation in HUVEC. ",
              "citation": {
                "type": "PubMed",
                "name": "Clin Chim Acta 2003 Nov 337(1-2) 133-40",
                "id": "14568189"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7fef"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "umbilical vein endothelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Oligonucleotides were designed for unique parts of three mouse ubiquitin gene complementary DNA clones. The overexpressed transcripts at 2.4, 2.8, 6.4, and 7.8 kilobases (kb) were detected by an oligonucleotide specific for a mouse UbC polyubiquitin clone.... All three classes of transcripts were induced in mouse skin by the hyperproliferative agent ethylphenyl propionate and by the tumor promoting agent 12-O-tetradecanoylphorbol-13- acetate.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Growth Differ 1992 May 3(5) 269-78",
                "id": "1321656"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7fee"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 1991 Oct 1 88(19) 8425-9",
                "id": "1924301"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7fed"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Nicotine-induced calcium influx was mediated by protein kinase C (PKC) and p38 MAPK in HBEC and activated ERK1/2 in airway fibroblasts",
              "citation": {
                "type": "PubMed",
                "name": "Physiol Rev 2007 Jul 87(3) 1047-82",
                "id": "17615396"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7fec"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "bronchial epithelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Selective inhibitors of PKC such as GF109203X and Calphostin C both caused approximately 80% inhibition of chemotaxis.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Jul 11 278(28) 25317-22",
                "id": "12724308"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7feb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "We report here that the human glutathione S-transferase P1 (GSTP1) protein, involved in phase II metabolism of many carcinogens and anticancer agents and in the regulation of c-Jun NH(2)-terminal kinase-mediated cell signaling, undergoes phosphorylation by the Ser/Thr protein kinases, cAMP-dependent protein kinase (PKA) and protein kinase C (PKC), resulting in a significant enhancement of its metabolic activity. ",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2004 Dec 15 64(24) 9131-8",
                "id": "15604283"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7fea"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "At the posttranslational level, alpha-tocopherol inhibits protein kinase C, 5-lipoxygenase and phospholipase A2 and activates protein phosphatase 2A and diacylglycerol kinase",
              "citation": {
                "type": "PubMed",
                "name": "Brain Res 2000 May 2 864(1) 114-23",
                "id": "10793193"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7fe9"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Since P2 receptor stimulation induces Ca2+ mobilization, it is not surprising that extracellular ATP is capable of stimulating DUOX-mediated H2O2 production by airway epithelial cells. This appears to be mediated primarily by P2Y receptor stimulation (84,87), which mediates intracellular Ca2+ mobilization and activates PKC (Fig. 4) (158,159). ",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2008 Mar 15 44(6) 938-55",
                "id": "18164271"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7fe8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "PAK3 and PKC  were reported to result in activation of MEKK1 in vivo",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 May 11 276(19) 16406-10",
                "id": "11278263"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7fe7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Phorbol 12-myristate 13-acetate (PMA) is known as PKC activator, significantly enhanced the c-mpl promoter activity and PKC inhibitor, 2-methylpiperazine dihydrochloride (H-7) suppressed the up-regulation of PMA-induced promoter activity and this effect decreased in a time-dependent manner.",
              "citation": {
                "type": "PubMed",
                "name": "Okajimas Folia Anat Jpn 2010 Nov 87(3) 151-4",
                "id": "21174945"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7fe6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "megakaryocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "PRK1 phosphorylates MARCKS at the PKC sites: serine 152, serine 156 and serine 163.",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 1996 Jan 15 378(3) 281-5",
                "id": "8557118"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7fe5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "These results demonstrate that high glucose considerably and specifically decreases intracellular taurine content, taurine transport activity, and TAUT mRNA, possibly through PKC-mediated transcriptional and posttranslational pathways",
              "citation": {
                "type": "PubMed",
                "name": "Metabolism 2003 Jul 52(7) 827-33",
                "id": "12870156"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7fe4"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "myocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "a PKC inhibitor, and PD98059, a mitogen-activated protein/ERK kinase inhibitor, suppressed the histamine-induced ERK activation and the production of granulocyte macrophage colony-stimulating factor and IL-8.",
              "citation": {
                "type": "PubMed",
                "name": "Int Arch Allergy Immunol 2006 139(4) 279-93",
                "id": "16491014"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7fe3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Protein kinase C stimulated the activation of p21-activated kinase (PAK), as well. However, it also stimulated the selective and transient down-regulation of PAK1",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2003 Mar 15(3) 307-18",
                "id": "12531429"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7fe2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Dec 26 278(52) 52240-52",
                "id": "14517210"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7fe1"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "We conclude that phosphorylation of the C-terminal domain of p53 by PKC increases its ubiquitination and degradation in unstressed cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Aug 24 276(34) 31819-24",
                "id": "11431470"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7fe0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Moreover, we found that the changes in expression of flavo-protein, JKTBP and bcl-xL induced by TPA were blocked by treatment with protein kinase C (PKC) or mitogen-activated protein (MAP) kinase inhibitors that prevent TPA-induced differentiation of TSU-Pr1 cells.",
              "citation": {
                "type": "PubMed",
                "name": "Int J Mol Med 2002 Dec 10(6) 735-9",
                "id": "12430000"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7fdf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "FASEB J 2002 Dec 16(14) 1982-4",
                "id": "12397090"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7fde"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "In these cells, FGF-BP was up-regulated by treatment with epidermal growth factor (EGF), dependent on protein kinase C and p38 mitogen-activated protein kinase signaling.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2003 Apr 1 63(7) 1696-705",
                "id": "12670924"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7fdd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Thus, exposure of a human histiocytic lymphoma cell line to phorbol 12-myristate 13-acetate or interleukins up-regulates CLIC1",
              "citation": {
                "type": "PubMed",
                "name": "Am J Pathol 2002 Aug 161(2) 471-80",
                "id": "12163372"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7fdc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "PKC phosphorylation of Nrf2 at serine 40 results in the escape or release of Nrf2 from INrf2",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2004 May 15 36(10) 1199-207",
                "id": "15110384"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7fdb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Altogether, our results indicate that LHRH specifically  induces the phosphorylation of stathmin through a PKC-dependent pathway.",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 1998 May 139(5) 2235-9",
                "id": "9564828"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7fda"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 1997 Dec 1 11(23) 3168-81",
                "id": "9389649"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7fd9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Phosphorylation of p47(phox) by protein kinase C partially replaces the effects of AA",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 May 5 275(18) 13793-801",
                "id": "10788501"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7fd8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Recombinant tagged PHI-1 was phosphorylated by protein kinase C at two sites, one a Ser and one a Thr; phosphorylation enhanced inhibitory potency 50-fold.",
              "citation": {
                "type": "PubMed",
                "name": "Biochemistry 1999 Dec 21 38(51) 16952-7",
                "id": "10606530"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7fd7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "The combined effect of TPA and oestradiol further increased TGF-beta 1 mRNA above the levels seen with TPA alone.",
              "citation": {
                "type": "PubMed",
                "name": "Br J Cancer 1991 Oct 64(4) 671-6",
                "id": "1911215"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7fd6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "antisense ablation of AR prevented both TNF-alpha-induced PKC and NF-kappaB activation",
              "citation": {
                "type": "PubMed",
                "name": "FASEB J 2004 Aug 18(11) 1209-18",
                "id": "15284221"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7fd5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium"
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Here, we show that SHP expression increases during monocytic differentiaton with exposure HL-60 leukemia cells to a 12-O-tetradecanoylphorbol-13-acetate (TPA) response element, whose treatment induced the SHP promoter activity dependent on c-Jun expression,",
              "citation": {
                "type": "PubMed",
                "name": "J Leukoc Biol 2004 Nov 76(5) 1082-8",
                "id": "15292277"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7fd4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "A prominent PKC substrate in platelets is pleckstrin, a protein with two PH domains,78 but no functional link between pleckstrin and IIb3 has been established. Parenthetically, MARCKS proteins are prominent PKC substrates in some cells, and they have been implicated in integrin-dependent spreading of macrophages.79 ",
              "citation": {
                "type": "PubMed",
                "name": "Blood 1998 Apr 15 91(8) 2645-57",
                "id": "9531572"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7fd3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "The phosphorylation sites for PKC, identified in the present study with respect to the domain organization of the proteins, as Thr614 in APLP1 and Thr723 in APLP2, correspond to Ser655 in APP.",
              "citation": {
                "type": "PubMed",
                "name": "Biochemistry 1997 Apr 15 36(15) 4643-9",
                "id": "9109675"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7fd2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "The myristoylated alanine-rich C kinase substrate (MARCKS) is a major protein kinase C (PKC) substrate in brain that binds the inner surface of the plasma membrane, calmodulin, and cross-links filamentous actin, all in a PKC phosphorylation-reversible manner.",
              "citation": {
                "type": "PubMed",
                "name": "J Neurochem 2003 Apr 85(2) 462-8",
                "id": "12675922"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7fd1"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "CAIR-1/BAG-3 is phosphorylated in vivo in the absence of stimulation. Basal phosphorylation is inhibited by treatment with d-erythrosphingosine (d-ES), a broad inhibitor of the protein kinase C family. ",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2000 Sep 7 19(38) 4385-95",
                "id": "10980614"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7fd0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Translocation of S100A11 onto vimentin IF-bound S100B was also observed upon activation of protein kinase C (PKC).",
              "citation": {
                "type": "PubMed",
                "name": "Microsc Res Tech 2003 Apr 15 60(6) 639-51",
                "id": "12645011"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7fcf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Inasmuch as stimulation or inhibition of GFAT increased or decreased high glucose-stimulated activity of protein kinase C (PKC), respectively, the observed effects appear to be transduced by PKC",
              "citation": {
                "type": "PubMed",
                "name": "Kidney Int Suppl 2000 Sep 77 S13-8",
                "id": "10997685"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7fce"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "The observations that (a) staurosporine completely abolished the effects of aFGF on ANP gene expression and release and (b) ANP secretory and gene expression inducing effects of phorbol ester were not augmented by aFGF, suggest an important role of protein kinase C in mediating aFGF-induced ANP gene expression and secretion",
              "citation": {
                "type": "PubMed",
                "name": "Eur J Pharmacol 1994 Apr 15 267(2) 195-206",
                "id": "7519562"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7fcd"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Moreover, this LDL-increased AP-1 binding is suppressed by several protein kinase (PK) inhibitors: the PKC inhibitor calphostin C, the cAMP-dependent PK inhibitor H89, and the tyrosine PK inhibitors genistein and lavendustin A.",
              "citation": {
                "type": "PubMed",
                "name": "Arterioscler Thromb Vasc Biol 1998 Mar 18(3) 473-80",
                "id": "9514417"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7fcc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "umbilical vein endothelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "rat liver cholesterol ester hydrolase is activated by cyclic AMP dependent protein kinase and protein kinase C. Deactivation is accomplished by dephosphorylation catalyzed by a phosphoprotein phosphatase, dependent on Mg2+.",
              "citation": {
                "type": "PubMed",
                "name": "Lipids 1989 Aug 24(8) 733-6",
                "id": "2555647"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7fcb"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "hnRNP A1 is directly phosphorylated in vitro by PKA, casein kinase II (CKII) and PKC",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2000 Apr 17 149(2) 307-16",
                "id": "10769024"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7fca"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "In the cultured activated HSC, AT-II induced VEGF in a dose- and time-dependent manner. ARB and LY333531, a protein kinase C (PKC) inhibitor, attenuated this augmentation. ",
              "citation": {
                "type": "PubMed",
                "name": "Hepatol Res 2006 Oct 36(2) 124-9",
                "id": "16919500"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7fc9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "hepatic stellate cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Thus, novel PKCtheta and PKCepsilon rescue T lymphocytes from Fas-mediated apoptosis via a p90Rsk-dependent phosphorylation and inactivation of BAD",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Nov 24 275(47) 37246-50",
                "id": "10976111"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7fc8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Inhibition of protein kinases by means of staurosporine suppressed the stress-induced expression of Cyr61 and CTGF.",
              "citation": {
                "type": "PubMed",
                "name": "Biochim Biophys Acta 2004 Apr 1 1691(1) 33-40",
                "id": "15053922"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7fc7"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "title := \\\"Glucose-induced fibronectin expression in endothelial cells is mediated by protein kinase C.\\\"",
              "citation": {
                "type": "PubMed",
                "name": "Exp Clin Endocrinol Diabetes 1997 105(1) 32-8",
                "id": "9088892"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7fc6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium"
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Furthermore, direct activation of protein kinase C with 1,2-myristate 1,3-acetate did not induce the expression of vinculin or beta 1-integrin mRNA, but did activate c-fos expression.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1991 Jun 25 266(18) 12008-14",
                "id": "1711046"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7fc5"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "In this paper, we show that ROS may activate aldose reductase, induce diacylglycerol, activate PKC, induce advanced glycation end product formation, and activate the pleiotropic transcription factor nuclear factor-kappa B (NF-kappaB)",
              "citation": {
                "type": "PubMed",
                "name": "Kidney Int Suppl 2000 Sep 77 S26-30",
                "id": "10997687"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7fc4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Figure 1. Pathways to MUC5AC expression in COPD",
              "citation": {
                "type": "PubMed",
                "name": "Physiol Rev 2007 Jul 87(3) 1047-82",
                "id": "17615396"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7fc3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Inhibition of the Fzd5 receptor results in a decrease in PKC activation. The Wnt5a transfectants were treated with a functional antibody to the receptor. This resulted in a decrease in PKC activation in the antibody-treated cells, but not the IgG-treated cells.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Cell 2002 Apr 1(3) 279-88",
                "id": "12086864"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7fc2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "melanoma",
                "cell": "melanocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "PDPK1 selectively phosphorylates the 70-kD ribosomal protein S6 kinase (p70-RPS6K) at thr229, which is required for its activation. Thr229 of p70-RPS6K is homologous to thr308 of the PKB protein.",
              "citation": {
                "type": "PubMed",
                "name": "Science 1998 Jan 30 279(5351) 707-10",
                "id": "9445476"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7fc1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "ET-1-induced transcription of the immediate early gene c-fos requires the concomitant activation of both the PKC/ERK- and p38MAPK-dependent pathways, because inhibitors of either pathway block the ET-1-induced increase of c-fos mRNA.",
              "citation": {
                "type": "PubMed",
                "name": "J Neurosci 2001 Nov 15 21(22) 8842-53",
                "id": "11698596"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7fc0"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "PTP epsilon-cytoplasmic mRNA is the product of a delayed early response gene in NIH 3T3 fibroblasts, and its transcription isregulated through a pathway that requires protein kinase C.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 1995 Dec 19 92(26) 12235-9",
                "id": "8618876"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7fbf"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "The alpha2 adrenoceptor agonist, UK14,304-induced sustained contraction and Ca2+ oscillations may be due to PKC activation and opening",
              "citation": {
                "type": "PubMed",
                "name": "J Smooth Muscle Res 2000 Dec 36(6) 205-18",
                "id": "11398898"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7fbe"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 1998 Jun 29 247(3) 569-75",
                "id": "9647734"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7fbd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "West et al. showed that activation of nAChR resulted in downstream activation of the Akt pathway (1), protein kinase C pathway, and the mitogen-activated protein kinase (MAPK) pathways, leading to inhibition of apoptosis and promotion of growth and proliferation in human bronchial epithelial cells (HBEC; refs. 1, 25).",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2007 May 15 67(10) 4638-47",
                "id": "17510389"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7fbc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "bronchial epithelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "In this study we describe the phosphorylation of annexins from cultured rat mesangial cells by protein kinase C (PKC) both in vitro and in vivo...Phosphoamino acid analysis of annexins, either by two-dimensional chromatography or by using a specific antiphosphotyrosine antibody, revealed only phosphoserine in these experiments in vivo. ",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 1993 May 15 292 ( Pt 1) 63-8",
                "id": "8503863"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7fbb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "The full-length Ly-GDI cDNA encodes a 27-kDa protein which binds to RhoA and inhibits GDP dissociation from RhoA. Stimulation of T lymphocytes with phorbol ester leads to phosphorylation of Ly-GDI, suggesting an involvement of Ly-GDI in lymphocyte activation pathways.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 1993 Aug 15 90(16) 7568-72",
                "id": "8356058"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7fba"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Here we characterize a new MAP kinase phosphatase, MKP-2, that is induced in human peripheral blood T cells with phorbol 12-myristate 13-acetate",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1996 Mar 15 271(11) 6497-501",
                "id": "8626452"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7fb9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "As shown in Figure 2A, protein kinase A (PKA) inhibitor, H89, and protein kinase C (PKC) inhibitor, GF109302X, significantly inhibited I-BOP-induced Nurr1 expression",
              "citation": {
                "type": "PubMed",
                "name": "Carcinogenesis 2009 Sep 30(9) 1606-13",
                "id": "19570744"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7fb8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Lung Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Treatment of cells with an inhibitor of protein kinase C, GF109203X, and azaserine, an inhibitor of the hexosamine pathway, suppressed high glucose-induced Rho activation.",
              "citation": {
                "type": "PubMed",
                "name": "Arterioscler Thromb Vasc Biol 2004 Feb 24(2) 276-81",
                "id": "14670931"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7fb7"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": "Muscle, Smooth"
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "PMA-induced galectin-3 overexpression was blocked by: protein kinase C inhibitors staurosporine, calphostin C, and apigenin; tyrosine-specific protein kinase inhibitors genistein and tyrphostin A25; PD 98059, a selective inhibitor of mitogen-activated protein kinase (MAPK) kinase 1 (MEK1 or MKK1); and SB 203580, a specific inhibitor of p38 MAPK",
              "citation": {
                "type": "PubMed",
                "name": "Biochim Biophys Acta 2003 Jun 17 1641(1) 13-23",
                "id": "12788225"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7fb6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "# Ariadne: In confirmation of the linkage of P2Y1 receptor activation in the muscle cells to PKC ( Fig. 1 A ), the application of PKC inhibitors staurosporine (Sp) and chelerythrine chloride (ChCl) significantly reduced the P2Y1 receptor-mediated AChE gene activation. [Regulation] The pathway to activation of the AChE gene was shown to involve protein kinase C and intracellular Ca 2+ release.",
              "citation": {
                "type": "PubMed",
                "name": "J Neurosci 2003 Jun 1 23(11) 4445-56",
                "id": "12805285"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7fb5"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Dec 15 275(50) 39090-5",
                "id": "10993892"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7fb4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Stimulation of alpha(1A)-receptors by applying 20 microM phenylephrine caused hERG current reduction due to a 9.6-mV shift of the activation curve towards more positive potentials.",
              "citation": {
                "type": "PubMed",
                "name": "J Mol Med 2004 Dec 82(12) 826-37",
                "id": "15365637"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7fb3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "We show that, in contrast to hypoxia, the induction of HIF-1alpha by Ang II in VSMC is dependent on active transcription and ongoing translation. We demonstrate that stimulation of VSMC by Ang II strongly increases HIF-1alpha gene expression. The activation of diacylglycerol-sensitive protein kinase C (PKC) plays a major role in the increase of HIF-1alpha gene transcription.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Dec 13 277(50) 48403-9",
                "id": "12379645"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7fb2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "vascular smooth muscle"
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "CaM inhibits phosphorylation of EWS, TLS/FUS, and PSF by PKC.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1997 Oct 24 272(43) 27369-77",
                "id": "9341188"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7fb1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "phorbol myristoyl-13 acetate (PMA) induced the expression of transcripts of collagenase, stromelysin-1, gelatinase-B, TIMP-1, and TIMP-3",
              "citation": {
                "type": "PubMed",
                "name": "Exp Gerontol 31(1-2) 207-23",
                "id": "8706790"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7fb0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "1,25-dihydroxyvitamin D3 [1,25-(OH)2D3; 10 nM] and phorbol myristate acetate (10 ng/ml), doses that cause monocytic differentiation of the HL-60 cell, induced small increases in CA-II mRNA",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 1994 Mar 134(3) 1493-8",
                "id": "8119191"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7faf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Monocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Treatment of human KB epidermoid carcinoma cells with phorbol 12-myristate 13-acetate (PMA) lead to a rapid induction of GCF RNA after 1 h and a decline to lower than control levels after 6 h.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1992 Jan 25 267(3) 1689-94",
                "id": "1370479"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7fae"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Similar results were obtained with protein kinase C, a serine/threonine kinase",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1997 Nov 28 272(48) 30429-38",
                "id": "9374534"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7fad"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Exposure of SCLC or PNECs to NNK or nicotine increased expression of the a7nAChR and caused influx of Ca2+, activation of PKC, Raf-1, ERK1/2, and c-myc, resulting in the stimulation of cell proliferation.",
              "citation": {
                "type": "PubMed",
                "name": "Mutat Res 659(3) 221-31",
                "id": "18495523"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7fac"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasm",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Insulin release from pancreatic islets of ob/ob mice in response to stimulation of PKC was decreased by leptin",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2002 Aug 14(8) 655-63",
                "id": "12020765"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7fab"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "pancreatic beta cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Angiotensin-induced CPI-17 phosphorylation in cultured smooth muscle cells is inhibited by a PKC inhibitor, but not by Y-27632, whereas the opposite is the case for MYPT1 phosphorylation",
              "citation": {
                "type": "PubMed",
                "name": "Physiol Rev 2003 Oct 83(4) 1325-58",
                "id": "14506307"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7faa"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Several PKC inhibitors (staurosporine, Ro31-8220, myristoylated PKC peptide inhibitor and Go6983) block VEGF-induced but not histamine-induced VWF secretion.",
              "citation": {
                "type": "PubMed",
                "name": "J Thromb Haemost 2008 Nov 6(11) 1962-9",
                "id": "18752579"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7fa9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "These data demonstrate that MPL can be upregulated in differentiating megakaryocytic cells via stimulation of protein kinase C, the intracellular target of PMA",
              "citation": {
                "type": "PubMed",
                "name": "Leuk Lymphoma 1996 Dec 24(1-2) 149-57",
                "id": "9049971"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7fa8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Neurochem 1998 Sep 71(3) 1307-14",
                "id": "9721757"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7fa7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "PEA-15 is a phosphoprotein containing a serine 104 residue phosphorylated by PKC and a serine 116 residue phosphorylated by Cam Kinase II or AKT.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2005 May 26",
                "id": "15916534"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7fa6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "These results suggest that phosphorylation enhances pleckstrin's activity",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1995 Oct 6 270(40) 23317-21",
                "id": "7559487"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7fa5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "JDP2 potentiated and synergized with 12-O-tetradecanoylphorbol-13-acetate to induce muscle cell differentiation of RD cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Oct 18 277(42) 40043-54",
                "id": "12171923"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7fa4"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "rhabdomyosarcoma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "alpha(2)-adrenoceptor agonists induce interleukin-12 production in mouse macrophages via a PKC/p38 MAPK signaling pathway",
              "citation": {
                "type": "PubMed",
                "name": "Eur J Pharmacol 2003 Apr 25 467(1-3) 223-31",
                "id": "12706479"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7fa3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Phosphorylation of PTPH1 by protein kinase C resulted in a decrease in Km but had no effect on Vmax.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1995 Aug 25 270(34) 20067-72",
                "id": "7544351"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7fa2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Thus, this result indicates that downstream of the TCR, PLC-DAG activates PKC resulting in an increase in beta-catenin levels. ",
              "citation": {
                "type": "PubMed",
                "name": "PLoS One 2010 5(9)",
                "id": "20862283"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7fa1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "% both c-jun terminal kinase (JNK) and protein kinase C (PKC)/mitogen-activated protein (MAP) kinase",
              "citation": {
                "type": "PubMed",
                "name": "J Neurosci 2001 Jul 15 21(14) 4987-95",
                "id": "11438574"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7fa0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Both PMA and cAMP decreased CYP7B1 activity by 60% and 34%, respectively, in a time-dependent fashion.",
              "citation": {
                "type": "PubMed",
                "name": "Hepatology 2002 Jun 35(6) 1400-8",
                "id": "12029625"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f9f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Meanwhile, activation of protein kinase C by 12-O-tetradecanoylphorbol acetate (TPA) markedly decreased the level of IRK1 mRNA,",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1997 Aug 22 272(34) 21227-32",
                "id": "9261131"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f9e"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Pretreatments of cells with staurosporine (non-specific inhibitor of PKC) and rottlerin (a specific inhibitor of PKC-delta) in separate experiments inhibited tBHQ-mediated stabilization of Nrf2 (Fig. 1B).",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 2009 Dec 15 122(Pt 24) 4452-64",
                "id": "19920073"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f9d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Nucleic Acids Res 2003 Apr 15 31(8) 2196-208",
                "id": "12682370"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f9c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Pretreatment of cells with phorbol ester for 24 h, reducing functional protein kinase C activity, abolished the ability of phorbol esters to increase beta-actin transcription.",
              "citation": {
                "type": "PubMed",
                "name": "Exp Cell Res 1992 Jun 200(2) 532-5",
                "id": "1572414"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f9b"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "p36, a major in vivo substrate of protein-tyrosine kinases, is shown to be phosphorylated at serine 25, a site very close to the major site of tyrosine phosphorylation by pp60v-src, tyrosine 23 (J. R. Glenney, Jr., and B. F. Tack, Proc. Natl. Acad. Sci. USA 82:7884-7888, 1985). We present evidence suggesting that protein kinase C mediates phosphorylation of serine 25",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1986 Jul 6(7) 2738-44",
                "id": "2946940"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f9a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Tryptic peptide analysis of PKC phosphorylated MARCKS or peptide, we found 32P was in peptides of (K)S152FK, (R)FS156FK and LS160GFS163FK. Further digestion of LSGFSFK with alpha-chymotrypsin revealed that 32P incorporation occurred only at Ser163 but not at Ser160.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 1993 Jan 15 190(1) 236-41",
                "id": "8422248"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f99"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2001 Aug 21(15) 5169-78",
                "id": "11438671"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f98"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Transcription of the second transcript is induced by phorbol esters, but not PAF, and this response requires a functional AP-1 site (53). The second transcript also is regulated by retinoic acid and thyroid hormone",
              "citation": {
                "type": "PubMed",
                "name": "Annu Rev Biochem 2000 69 419-45",
                "id": "10966465"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f97"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "In Sdc2 the central portion of the cytoplasmic domain is known to be phosphorylated on serines 197 and 198 by PKC doesn't affect dimer formation",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cells 2004 Apr 30 17(2) 181-7",
                "id": "15179029"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f96"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "The TIS11 gene is an immediate early gene that is induced rapidly and transiently by phorbol 12-myristate 13-acetate",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biochem 2000 Oct 213(1-2) 119-26",
                "id": "11129950"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f95"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "# Ariadne: On the other hand,  previous studies have shown that acetaldehyde induces the levels of c-Jun  through a PKC-dependent mechanism and enhances murine alpha2(I) collagen  promoter mediated by PKC activation ( 46 , 47 ). [Expression]",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 May 12 275(19) 14684-90",
                "id": "10799556"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f94"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "The S100A4-binding region contains two putative phosphorylation sites by protein kinase C and protein kinase CK2. S100A4-liprin beta1 interaction resulted in the inhibition of liprin beta1 phosphorylation by both kinases in vitro.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Feb 15 277(7) 5229-35",
                "id": "11836260"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f93"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Rat smooth muscle cells when exposed to 1.6 nmol/L of EGF, an increase in DNA synthesis was observed. Calphostin C (a protein kinase C inhibitor) treatment reduced the increase in thymidine uptake induced by EGF to 55+/-5%, of the control value.",
              "citation": {
                "type": "PubMed",
                "name": "Arterioscler Thromb Vasc Biol 1998 Dec 18(12) 1861-9",
                "id": "9848877"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f92"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "We conclude that HNE induces MUC5AC mucin expression via a cascade involving PKC-ROS-TACE in human airway epithelial cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2005 Sep 15 175(6) 4009-16",
                "id": "16148149"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f91"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Insulin inhibited the stimulatory effect of a high level of glucose (25 mM) and phorbol 12-myristate 13-acetate, an activator of protein kinase C) on the secretion of ANG and the expression of the ANG messenger RNA in IRPTC.",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 1999 Nov 140(11) 5285-92",
                "id": "10537159"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f90"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Significantly, phosphorylation of hPOMp100/PSF by protein kinase C inhibits its binding to RNA but stimulates its binding to DNA and D-loop formation and may represent a regulatory mechanism to direct this multifunctional protein to DNA metabolic pathways.",
              "citation": {
                "type": "PubMed",
                "name": "Nucleic Acids Res 2000 Aug 15 28(16) 3022-30",
                "id": "10931916"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f8f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Human endothelial cells and VSMCs express telomerase activity, which is drastically activated by mitogenic stimuli via a protein kinase Cdependent pathway,67 but the activity declined with in vitro aging because of a decrease in expression of TERT, leading to telomere shortening and cellular senescence.68,69",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 2007 Jan 5 100(1) 15-26",
                "id": "17204661"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f8e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": "vascular tissue"
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "syndecan-4 cytoplasmic domain can associate with and potentiate the activity of protein kinase C, which is required for focal adhesion formation.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 1999 Oct 112 ( Pt 20) 3421-31",
                "id": "10504291"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f8d"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Thyrotropin releasing hormone (TRH) causes phosphatidylinositol bisphosphate hydrolysis to form inositol trisphosphate and diacylglycerol. Since diacylglycerol activates protein kinase C (Ca2+/phospholipid-dependent enzyme), this enzyme may be involved in mediating the physiological response to TRH. Activation of protein kinase C leads to phosphorylation of receptors for epidermal growth factor (EGF) and decreased EGF affinity.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1988 Sep 25 263(27) 13588-93",
                "id": "2458349"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f8c"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Acute treatment with the PKC agonist TPA stimulated phosphorylation of both isoforms of GSK-3 in Swiss 3T3 (Fig. 6A) and other cell lines, including HEK293 (data not shown), providing further support for the involvement of PKC in the regulation of GSK-3.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2002 Apr 22(7) 2099-110",
                "id": "11884598"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f8b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "PDK1 has now been shown to play a central role in activating many of the AGC subfamily members (reviewed in [150,151]). Apart from phosphorylating PKB on Thr308, PDK1 phosphorylates the equivalent residues on PKC isoforms [48,152,153], p70-S6K [32,154], the three isoforms of SGK [27,28,155] and PKA [156] (Figure 6).",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2000 Mar 15 346 Pt 3 561-76",
                "id": "10698680"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f8a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Therefore, PDGF beta receptor, ERK1/2, PLC and PKC are involved in the signal transduction of PDGF-induced growth response of rat cardiac myocytes.",
              "citation": {
                "type": "PubMed",
                "name": "Regul Pept 2005 Apr 15 127(1-3) 11-8",
                "id": "15680465"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f89"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "cardiomyocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "SERCA2 downregulation can be simulated in cultured neonatal rat ventricular myocytes (NRVM) by treatment with the protein kinase C (PKC) activator phorbol 12-myristate 13-acetate (PMA)",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2003 Jul 285(1) C39-47",
                "id": "12606313"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f88"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "myocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "GGT expression was up-regulated on peripheral blood T cells following activation in vitro by either superantigen, phorbol ester, or IL-15",
              "citation": {
                "type": "PubMed",
                "name": "Int Immunol 1999 Nov 11(11) 1791-800",
                "id": "10545483"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f87"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Hypothalamic cells transfected with rat TRH promoter (-776/+85) linked to the luciferase reporter showed increased transcription by protein kinase (PK) A and PKC activators, or by dexamethasone (dex), but co-incubation with dex and 8Br-cAMP decreased their stimulatory effect (as observed for proTRH mRNA levels).",
              "citation": {
                "type": "PubMed",
                "name": "J Mol Endocrinol 2005 Feb 34(1) 177-97",
                "id": "15691887"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f86"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "CD95/EGF-R association was inhibited by NAC, JNK, or protein kinase C inhibition",
              "citation": {
                "type": "PubMed",
                "name": "Gastroenterology 2003 Sep 125(3) 839-53",
                "id": "12949729"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f85"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Oct 5 276(40) 37472-81",
                "id": "11438522"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f84"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Stimulation of protein kinase C (PKC) in vivo decreased the binding of p97 to AldA-NRE and stimulated transcription, while inhibition of PKC stimulated p97 binding and downregulated transcription.",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 1999 Jul 2 454(1-2) 61-6",
                "id": "10413096"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f83"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "We conclude that synthesis and expression of ANPR-C but not ANPR-A is suppressed by serum, platelet-derived growth factor, and phorbol myristate acetate.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1993 Aug 25 268(24) 18205-12",
                "id": "8349696"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f82"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "mesangial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Phorbol 12-myristate 13-acetate treatment progressively caused a decrease of CD97 antigen expression in all cell lines to about 30% of their initial levels after 48 h.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 1997 May 1 57(9) 1798-806",
                "id": "9135025"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f81"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1993 Jul 5 268(19) 14294-300",
                "id": "8390988"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f80"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "phorbol myristate acetate-induced von Willebrand factor expression",
              "citation": {
                "type": "PubMed",
                "name": "Antioxid Redox Signal 2002 Feb 4(1) 5-15",
                "id": "11970838"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f7f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium"
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "The PTHrP expression and secretion into culture medium were enhanced by supplemental TGF-beta and PMA. PMA also seemed to affect PTHrP upregulation via TGF-beta activation. ",
              "citation": {
                "type": "PubMed",
                "name": "Leuk Lymphoma 2001 Apr 41(3-4) 397-409",
                "id": "11378553"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f7e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Multiple Myeloma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "S100A1-mediated anti-apoptotic effects involve specific activation of the extracellular signal-regulated kinase 1/2 (ERK1/2) pro-survival pathway, including activation of phospholipase C, protein kinase C, mitogen-activated protein kinase kinase 1, and ERK1/2.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Nov 28 278(48) 48404-12",
                "id": "12960148"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f7d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "cardiomyocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "RGS2 mRNA levels were increased in differentiated cells by heat shock, carbachol, and activation of protein kinase C.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2001 Apr 27 283(1) 102-6",
                "id": "11322774"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f7c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "On subcellular fractionation followed by immunoblotting analysis, membrane-bound p50 was shown to be released from the membrane following activation of PKC in T cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Biochem (Tokyo) 1995 Jan 117(1) 222-9",
                "id": "7775393"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f7b"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "pS2 mRNA, but not cathepsin-D mRNA, was also induced up to 8-fold by protein kinase-C activation with 12-O-tetradecanoylphorbol-13-acetate",
              "citation": {
                "type": "PubMed",
                "name": "Mol Endocrinol 1989 Mar 3(3) 552-8",
                "id": "2664475"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f7a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "To determine if PKC activation is required for serum-stimulated AA release, the general PKC inhibitor GF109203X was tested. PMA activation of cPLA2? in IMLF+/+ was inhibited by 95% by GF109203X (Fig. 3D).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2009 Apr 3 284(14) 9596-611",
                "id": "19176526"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f79"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Primer extension, using RNA from cells transiently transfected with MEP-CAT fusion plasmids, demonstrates that phorbol ester treatment increases the amount of transcript",
              "citation": {
                "type": "PubMed",
                "name": "Cell Growth Differ 1991 Jan 2(1) 23-31",
                "id": "1848774"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f78"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Cells and organs producing PAF in response to exogenous stimulations Neutrophils Human IL-6 Human GM-CSF and zymosan Eosinophils Human IgG, IL-5, PMA Monocytes Human LPS [361] Human HIV infection Peritoneal macrophages Mouse HGF, TNF-a Lung mast cells Human Anti-IgE [363] Bone marrow mast cells Mouse Monoclonal IgE and antigen",
              "citation": {
                "type": "PubMed",
                "name": "Prog Lipid Res 2000 Jan 39(1) 41-82",
                "id": "10729607"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f77"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "eosinophil",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "In the (beta)arr2-KO but not WT mice, morphine tolerance can be completely reversed with a low dose of the classical protein kinase C (PKC) inhibitor chelerythrine",
              "citation": {
                "type": "PubMed",
                "name": "J Neurosci 2002 Dec 1 22(23) 10494-500",
                "id": "12451149"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f76"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Feb 16 276(7) 4709-16",
                "id": "11085981"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f75"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "These results indicate that downregulation of CapZ, or other changes associated with CapZ downregulation, increases cardiac myofilament Ca2+ sensitivity, inhibits PKC-mediated control of myofilament activation, and decreases myofilament-associated PKC-beta.",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 2002 Jun 28 90(12) 1299-306",
                "id": "12089068"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f74"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "We previously have described polyribosomal formation and protein synthesis in response to group I metabotropic glutamate receptor (mGluR) agonist administration to a synaptoneurosome preparation and have shown this to require receptor-coupled phospholipase C activation of protein kinase C (PKC) (23-25). We report here specific mechanisms that appear to link PKC activation to polyribosomal formation and protein synthesis. ",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 1998 Dec 8 95(25) 15078-83",
                "id": "9844018"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f73"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "The differentiation was mediated though activation of the protein kinase A (PKA) and phosphatidylinositol-3 kinase (PI-3K) pathways",
              "citation": {
                "type": "PubMed",
                "name": "J Neurosci Res 2006 Jun 1 83(8) 1415-24",
                "id": "16547973"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f72"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "neuron",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Transcription activation is independent of de novo protein synthesis and requires the activities of phospholipase C, protein kinase C, and nitric-oxide synthase.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Sep 5 278(36) 33943-50",
                "id": "12821676"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f71"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "1-(5-Isoquinolinesulfonyl)-2-methylpiperazine (H-7), which has been identified as a potent inhibitor of protein kinase C in vitro.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1984 Dec 10 259(23) 14321-3",
                "id": "6238960"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f70"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "PLCG1-mediated production of diacylglycerol leads to activation of PKC, and this pathway plays an important role in mediating VEGF-induced activation of ERKs ERK activation mediates cytosolic PLA2-mediated PGI2 synthesis",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2001 Jun 280(6) C1375-86",
                "id": "11350732"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f6f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "title := \\\"Glucose-induced fibronectin expression in endothelial cells is mediated by protein kinase C.\\\"",
              "citation": {
                "type": "PubMed",
                "name": "Exp Clin Endocrinol Diabetes 1997 105(1) 32-8",
                "id": "9088892"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f6e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Previously (Qian, Y., Galli, A., Ramamoorthy, S., Risso, S., DeFelice, L. J., and Blakely, R. D. (1997) J. Neurosci. 17, 45-47), we demonstrated that protein kinase (PKC)-linked pathways in transfected HEK-293 cells lead to the internalization of cell-surface human (h) SERT protein and a reduction in 5HT uptake capacity.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1998 Jan 23 273(4) 2458-66",
                "id": "9442097"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f6d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "As demonstrated in Fig. 2a, the PKC inhibitors staurosporine (20 nM) and bisindolylmaleimide I (5 mM) almost completely abrogated the response to PMA (9.0 6 9 and 1.8 6 0.4% PMA response, respectively; n 5 3; p , 0.01).",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2000 Aug 1 165(3) 1618-25",
                "id": "10903772"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f6c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "bronchial epithelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Pleckstrin is the major substrate of protein kinase C (PKC)",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2002 Apr 26 293(1) 640-6",
                "id": "12054651"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f6b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "This increase in GRP78 protein and mRNA induced by hypoxia can be abolished by a 1-h pretreatment of cells before hypoxia with the protein kinase C (PKC) inhibitors staurosporine and H7 at concentrations at which the drugs themselves do not cause cytotoxicity.",
              "citation": {
                "type": "PubMed",
                "name": "Radiat Res 1994 Apr 138(1 Suppl) S60-3",
                "id": "8146329"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f6a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Oct 19 276(42) 38480-6",
                "id": "11502742"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f69"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "TALL-1 expression is dramatically down-regulated by phorbol myristate acetate/ionomycin.",
              "citation": {
                "type": "PubMed",
                "name": "J Leukoc Biol 1999 May 65(5) 680-3",
                "id": "10331498"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f68"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Monocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "PMA treatment rapidly activated PLD (3) in Jurkat, as detected either in intact or broken cells",
              "citation": {
                "type": "PubMed",
                "name": "Immunol Lett 1996 Nov 53(2-3) 69-76",
                "id": "9024981"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f67"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "To investigate further the mechanism by which integrin signaling and PKC activation mediate cell spreading, we studied the effects of these processes on MARCKS, a substrate of PKC and a protein known to regulate actin dynamics.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 2002 May 15 115(Pt 10) 2151-63",
                "id": "11973356"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f66"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Fig. 8A shows that PKC activity in IEC6 cells increased steadily until 8 h after Wnt11 treatment and remained above base-line level at 24 h following treatment.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jun 18 279(25) 26707-15",
                "id": "15084607"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f65"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "direct activation of protein kinase C (PKC) by the phorbol ester PMA in the BCR-ABL(+) CML cell line K562 and primary CML blasts induced nonterminal differentiation into cells with typical DC morphology (cytoplasmic dendrites), characteristic surface markers (MHC class I, MHC class II, CD86, CD40)",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2003 Aug 15 171(4) 1780-91",
                "id": "12902478"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f64"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "carcinoma of blood",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "PKC phosphorylates Smad2 in vivo and in vitro at Ser47 and Ser110, and Smad3 at the analogous Ser37 and Ser70 (Yakymovych et al., 2001). Phosphorylation of Smad3 by PKC blocks DNA-binding and consequently transcriptional regulation.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 2001 Dec 114(Pt 24) 4359-69",
                "id": "11792802"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f63"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "As further support, the B1 isoform could also be induced by phorbol ester, and subsequently inhibited by staurosporine, implicating a role for protein kinase C-mediated phosphorylation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1996 Mar 1 271(9) 4589-92",
                "id": "8617716"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f62"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "BMSC-UbP mRNA decreased in BMSC stimulated with PMA and increased in HL60 cells stimulated with LPS",
              "citation": {
                "type": "PubMed",
                "name": "Immunol Lett 2003 Apr 3 86(2) 169-75",
                "id": "12644319"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f61"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Neurochem 2000 Feb 74(2) 540-6",
                "id": "10646504"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f60"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Nov 8 277(45) 42769-74",
                "id": "12198130"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f5f"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "GnRH receptor activation induced MKP-2 expression in both clonal (alphaT3-1) and primary gonadotropes. Activation of PKC isozymes was sufficient and required for MKP-2 induction. Inhibition of the extracellular signal-regulated kinase (ERK) or c-Jun N-terminal kinase (JNK) but not the p38 MAPK cascade was sufficient to block GnRH-induced MKP-2 expression",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Endocrinol 2001 Feb 14 172(1-2) 79-89",
                "id": "11165042"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f5e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "High glucose level and free fatty acids stimulate de novo diacylglycerol (DAG)-PKC pathway and subsequently stimulate reactive oxygen species (ROS) production through a PKC-dependent activation of NAD(P)H oxidase.",
              "citation": {
                "type": "PubMed",
                "name": "Curr Drug Targets 2005 Jun 6(4) 495-501",
                "id": "16026268"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f5d"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2000 Jun 26 149(7) 1503-12",
                "id": "10871288"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f5c"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "These results suggest that smoke invokes the activation of PKC in BEAS-2B to increase the ability of these epithelial cells to adhere THP-1 cells. In addition, airway epithelial/THP-1 binding induced by smoke or C5a appear to operate through the local, cellular effects of TNF-{alpha}.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2003 Oct 29(4) 472-82",
                "id": "12714373"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f5b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "bronchial epithelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "activation of protein kinase C (PKC) is required for DNAM-1 functioning",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 1998 Aug 15 161(4) 1671-6",
                "id": "9712030"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f5a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "natural killer cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "These results suggest that cigarette smoke particulate constituents activate protein kinase C, leading to increased surface expression of adhesive ligand CD11b on peripheral blood monocytes and counter receptor(s) ICAM-1 and ELAM-1 in endothelial cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Physiol 1994 Jul 160(1) 154-62",
                "id": "7517402"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f59"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "umbilical vein endothelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Estrogen and phorbol esters regulate amphiregulin expression by two separate mechanisms in human breast cancer cell lines",
              "citation": {
                "type": "PubMed",
                "name": "J Mol Endocrinol 2004 Apr 32(2) 397-414",
                "id": "15072547"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f58"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "PKC activation by DAG can lead to serine phosphorylation of the insulin receptor, a mechanism similar to the effect of TNF-a (155), although the resulting insulin resistance can be blocked differentially by PKC inhibitors, which do not block TNF-a - induced insulin resistance, or by PTPase inhibitors, which do not block PKC-induced insulin resistance (156).",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Invest 1999 Apr 103(7) 931-43",
                "id": "10194465"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f57"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Treatment of HL-60 cells with phorbol 12-myristate 13-acetate (PMA), a protein kinase C (PKC) activator, or dibutyryl-cyclic AMP (dbcAMP), a protein kinase A (PKA) activator, resulted in a 90% decrease in the level of TfR mRNA",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 1995 May 29 365(2-3) 137-40",
                "id": "7781766"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f56"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "PMA at 100 nmol/L strongly potentiated adhesion and tyrosine phosphorylation of p125(FAK) and p72(syk)",
              "citation": {
                "type": "PubMed",
                "name": "Arterioscler Thromb Vasc Biol 1999 Dec 19(12) 3044-54",
                "id": "10591686"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f55"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Furthermore, inhibition of protein kinase C, but not that of actin polymerization, inhibited the PINCH-ILK-CH-ILKBP complex formation, suggesting that the PINCH-ILK-CH-ILKBP complex likely serves as a downstream effector of protein kinase C in the cellular control of focal adhesion assembly.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 2002 Dec 15 115(Pt 24) 4777-86",
                "id": "12432066"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f54"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "In addition, treatment of cells with the PKC activator phorbol ester stimulated the ubiquitination of p53 and reduced its ability to accumulate after stress. H7 did not induce the phosphorylation of human p53 on Ser-15 (Ser-18 in mouse protein), a modification that occurs in response to DNA damage and leads to the release of MDM2 and to transactivation by p53",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Aug 24 276(34) 31819-24",
                "id": "11431470"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f53"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "This in turn activates multiple protein kinase cascades including mitogen-activated protein kinases and protein kinase C isozymes in a cell-specific manner.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Interv 2003 May 3(3) 157-68",
                "id": "14993422"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f52"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Platelet activation also led to  adducin proteolysis; inhibition by calpeptin suggests that the protease was  calpain. The kinase inhibitor staurosporine inhibited PKC phosphorylation of adducin and also inhibited proteolysis of adducin.",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2002 Apr 1 99(7) 2418-26",
                "id": "11895774"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f51"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Blood Platelets",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "PACAP induced expression of GLAST  via activation of PKA-dependent signaling pathways only, but it affected the  expression of GLT-1 via both PKA and PKC-dependent signaling pathways.",
              "citation": {
                "type": "PubMed",
                "name": "J Neurosci 2000 May 15 20(10) 3596-605",
                "id": "10804201"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f50"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Under identical conditions, treatment with AR inhibitors also prevented the activation of protein kinase C (PKC) by TNF-alpha, bFGF, Ang-II, and PDGF-AB",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Aug 30 277(35) 32063-70",
                "id": "12063254"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f4f"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": "Muscle, Smooth"
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Arch Biochem Biophys 1997 Aug 1 344(1) 67-74",
                "id": "9244383"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f4e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "As shown in Fig. 6A, membrane PKC activity increased 3-fold after treatment with TNF-a for 10 min",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2000 Sep 1 165(5) 2719-28",
                "id": "10946303"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f4d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Phosphorylation of the leukocyte-specific L-plastin plays important roles in regulating L-plastin function and leukocyte activation.",
              "citation": {
                "type": "PubMed",
                "name": "DNA Cell Biol 1998 Dec 17(12) 1041-6",
                "id": "9881671"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f4c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "stimulation of human neutrophils with the Gi-coupled receptor agonists N-formyl-methionyl-leucyl-phenylalanine (fMLP) and leukotriene B4 (LTB4) leads to a rapid and transient increase in the GTP-bound state of Rac2, whereas phorbol myristate acetate (PMA) causes a slow but more sustained activation of Rac2",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Jun 18 274(25) 18055-9",
                "id": "10364257"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f4b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "protein kinase C (PKC) inhibitors staurosporine and GF-109203X (10(-6) M) significantly inhibited histamine-stimulated c-fos mRNA while not altering c-jun expression",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2000 Jun 278(6) C1246-55",
                "id": "10837353"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f4a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Arch Fr Pediatr 32(7) 647-54",
                "id": "176960"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f49"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "The ectodomain of SHPS-1 has now been shown to be shed from cells in a reaction likely mediated by a metalloproteinase. This process was promoted by activation of protein kinase C or of Ras, and the released ectodomain exhibited minimal CD47-binding activity.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jul 2 279(27) 27878-87",
                "id": "15123722"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f48"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Under identical conditions, treatment with AR inhibitors also prevented the activation of protein kinase C (PKC) by TNF-alpha, bFGF, Ang-II, and PDGF-AB",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Aug 30 277(35) 32063-70",
                "id": "12063254"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f47"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "ecto-ATPase activity in human neutrophils after stimulation with phorbol myristate acetate or N-formylmethionyl-leucyl-phenylalanine",
              "citation": {
                "type": "PubMed",
                "name": "Histochem Cell Biol 1997 May 107(5) 353-63",
                "id": "9208326"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f46"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "H2O2 causes lipid peroxidation and activates cPLA2 to increase PGE2 production, which, in turn, stimulates the synthesis of free-radical scavengers through the PKC-MAPK pathway.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Gastrointest Liver Physiol 2002 Jul 283(1) G87-94",
                "id": "12065295"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f45"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Muscles"
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Both HB-EGF and phorbol esters activated the classic MAPK pathway, albeit via PKC-independent and PKC-dependent mechanisms, respectively.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Apr 26 277(17) 14370-8",
                "id": "11782486"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f44"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1994 Nov 25 269(47) 29367-70",
                "id": "7525583"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f43"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "High glucose-induced ROS generation in mesangial cells is effectively blocked by calphostin C, a protein kinase C (PKC) inhibitor, or by depletion of intracellular PKC by preincubating cells with PMA for 24 h",
              "citation": {
                "type": "PubMed",
                "name": "J Am Soc Nephrol 2003 Aug 14(8 Suppl 3) S241-5",
                "id": "12874439"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f42"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "mesangial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "We found that bFGF and a protein kinase C (PKC) activator, phorbol 12-myristate 13-acetate, significantly induced luciferase activity driven by the LDL receptor promoter, whereas 25-hydroxycholesterol reduced the luciferase activity in bFGF-stimulated cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1994 Mar 25 269(12) 9213-20",
                "id": "7510705"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f41"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "PC12-E2 cells were treated with the specific PKC inhibitor Calphostin C (400 nM). This treatment led to an inhibition of NCAM-dependent neurite outgrowth. These results confirm that NCAM signaling involves the FGF receptor and PLCgamma and indicate a thus far unrecognized role for PKC in NCAM stimulated outgrowth.",
              "citation": {
                "type": "PubMed",
                "name": "J Neurosci 2000 Mar 15 20(6) 2238-46",
                "id": "10704499"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f40"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "the acute effect of glucose on insulin receptor kinase was paralleled by a decrease in both the membrane and insulin receptor co-precipitated protein kinase C activities and a decrease in receptor Ser/Thr phosphorylation",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Oct 1 274(40) 28637-44",
                "id": "10497232"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f3f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "The levels of Nurr1, NGFI-B and NOR-1 mRNA were elevated markedly in NTera2 teratocarcinoma-derived neurons (NTera2-N), a model of differentiated human neurons, following a 1.5 or 3 h-exposure to 1 mM dibutyryl cyclic AMP or 100 nm phorbol 12-myristate 13-acetate",
              "citation": {
                "type": "PubMed",
                "name": "Neuropathology 2002 Dec 22(4) 219-32",
                "id": "12564761"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f3e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Incubation of B-chronic lymphocytic leukemia (B-CLL) cells with phorbol esters resulted in the phosphorylation of two major PKC substrates, MARCKS (myristoylated, alanine-rich C kinase substrate) and MRP (MARCKS-related protein),and of a third protein, with an apparent m.w. of 60,000 ... p60 was purified from CESS cells and peptide microsequencing of this protein revealed that it was lymphocyte-specific protein 1 (LSP1)",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 1996 Mar 1 156(5) 1709-13",
                "id": "8596017"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f3d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "b-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "The t-PA gene is transcriptionally induced by the phorbol ester PMA in HeLa cells, but suppressed by PMA in HT-1080 cells.",
              "citation": {
                "type": "PubMed",
                "name": "Eur J Biochem 2001 Feb 268(4) 987-96",
                "id": "11179965"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f3c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Taken together, these results indicate that the phosphorylation of Nrf2 at Ser40 by PKC is required for Nrf2 to evade INrf2-mediated degradation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Nov 7 278(45) 44675-82",
                "id": "12947090"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f3b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2001 Mar 7(3) 551-8",
                "id": "11463380"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f3a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "protein kinase C (PKC) activation negatively influences ALA-S mRNA levels",
              "citation": {
                "type": "PubMed",
                "name": "Arch Biochem Biophys 1997 May 15 341(2) 259-66",
                "id": "9169013"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f39"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2000 May 23 97(11) 6185-90",
                "id": "10823959"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f38"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "in vitro redox activity of APE/Ref-1 is stimulated by PKC phosphorylation. Furthermore, when human cells were exposed to the PKC activator phorbol 12-myristate 13-acetate, an increase in redox activity was observed that corresponded to an increase in the phosphorylation status of APE/Ref-1",
              "citation": {
                "type": "PubMed",
                "name": "Nucleic Acids Res 2001 Jul 15 29(14) 3116-22",
                "id": "11452037"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f37"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "PED cloning shows that it encodes a 15 kDa phosphoprotein identical to the protein kinase C (PKC) substrate PEA-15.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1998 Jul 15 17(14) 3858-66",
                "id": "9670003"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f36"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "We also showed that thrombin induced dephosphorylation of beta-catenin and phosphorylation of p120.  Thrombin-induced interendothelial gap formation and increased endothelial permeability were blocked by protein kinase C inhibition using chelerythrine [PKC-dependent, though obviously not directly].",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2003 Aug 285(2) L434-42",
                "id": "12740216"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f35"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium, Vascular"
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "98019251",
              "citation": {
                "type": "PubMed",
                "name": "BMC Bioinformatics 2004 Jun 22 5 79",
                "id": "15212693"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f34"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "The induction of A1 by TNF in this system is mediated via a protein kinase C pathway",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1996 Nov 1 271(44) 27201-4",
                "id": "8910286"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f33"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium"
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Ro-31-8220, an inhibitor of PKC which returned glucose transport to control values, caused a further decrease in plasma membrane GLUT4 levels.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 1997 Jun 15 324 ( Pt 3) 981-5",
                "id": "9210425"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f32"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Bradykinin-induced VEGF secretion was dependent on the B2 bradykinin receptor, activation of protein kinase C",
              "citation": {
                "type": "PubMed",
                "name": "FASEB J 2001 Nov 15(13) 2480-8",
                "id": "11689473"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f31"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Ligand-independent trans-activation of the platelet-derived growth factor receptor {beta} by reactive oxygen species requires protein kinase C-delta and c-Src.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Nov 22 277(47) 44695-700",
                "id": "12226102"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f30"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Enforced MTA1 expression in HT1080 cells reduced basal and 12-myristate 13-acetate-induced 92-kDa type IV collagenase (MMP-9) protein/mRNA levels.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Jan 24 278(4) 2309-16",
                "id": "12431981"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f2f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Upregulation of p21(WAF1/CIP1) cyclin-dependent kinase inhibitor protein was observed in a manner dependent on PKC or MAP kinase.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2001 Mar 8 20(10) 1220-8",
                "id": "11313866"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f2e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKC Family\") actsIn kin(p(SFAM:\"PRKC Family\"))",
              "summary_text": "Following ischemia, the phosphorylation of NR1 by protein kinase C and tyrosine phosphorylation of NR2A and NR2B was increased in both lipid rafts and PSDs, with a greater increase in tyrosine phosphorylation occurring in the raft fraction. ",
              "citation": {
                "type": "PubMed",
                "name": "J Neurochem 2005 Apr 93(1) 186-94",
                "id": "15773918"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad7f2d"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:FYN))",
        "relation": "directlyIncreases",
        "target": "p(HGNC:NFE2L2,pmod(P,Y,576))",
        "directed": false,
        "label": "kin(p(HGNC:FYN)) directlyIncreases p(HGNC:NFE2L2,pmod(P,Y,576))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8d7a",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:FYN)) directlyIncreases p(HGNC:NFE2L2,pmod(P,Y,576))",
              "summary_text": "Phosphorylated Fyn accumulates in the nucleus and phosphorylates Nrf2 at tyrosine 568. This leads to nuclear export, ubiquitination, and degradation of Nrf2",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 Jun 1 282(22) 16502-10",
                "id": "17403689"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8122"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:AKT1)",
        "relation": "actsIn",
        "target": "kin(p(HGNC:AKT1))",
        "directed": false,
        "label": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8d7b",
          "evidences": [
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "IGFs induced the expression of VEGF ligands and up-regulated in vitro vascular vessel formation. IGF-IR/dn reduced VEGF expression, reduced the activation of both protein kinase B (Akt) and mitogen-activated protein kinase (MAPK), and reduced vascular formation, indicating that IGF-IR/dn inhibited tumor growth in mice by inhibiting both angiogenesis and lymphangiogenesis. However, IGF-IR/dn did not affect either blood sugar or body weight in these mice. The combination of IGF-IR/dn and bevacizumab was highly effective against these xenograft tumors, and only this combination resulted in the complete regression of 43% of tumors, reduced the expression of VEGF, and induced apoptosis.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer 2011 Jul 15 117(14) 3135-47",
                "id": "21264842"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8bdd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Carcinoma of gastrointestinal tract",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Genes Up-regulated by myr-Akt [Constitutively active Akt1 - SE] To enable comparison between experiments expression data were globally scaled to an average intensity of 1500 using the Affymetrix Microarray SuiteTMsoftware. A minimum value of 150 was assigned to all average differences (AvDiffs) with an intensity measurement below 150. Two parameters, the AvDiff and the absolute call (present or absent), extracted from the Affymetrix data files, were used in the data analysis, which was performed using GenespringTM (Silicon Genetics, CA). Results were sorted using a combination of high and low stringency filtering criteria. High stringency filtering required that a gene should have an absolute call of present in six of six samples with a mean -fold change of ?1.6. Low stringency filtering required that the gene be called present in two of the three replicates in the more highly expressing group with a mean AvDiff of ?750 and mean -fold change of ?2. Mean -fold changes between groups were calculated from the mean AvDiffs. Data passing these criteria were combined and subjected to statistical analysis.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Jun 21 277(25) 22528-33",
                "id": "11956204"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8bdc"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "The forkhead box class O (FOXO) transcription factors family members, FOXO1a and FOXO3a, are phosphorylated in an AKT-dependent manner in SCF-stimulated BMMCs [76]. FOXO3a phosphorylation leads to its proteosomal degradation following ubiquitination thereby blocking its transcriptional control of the pro-apopototic factor, Bim. SCF also induces the AKT- and MAPK-dependent phosphorylation of Bim in mouse bone marrow-derived mast cells and it has been proposed that this also leads to its proteosomal degradation [76]. Thus these observations would account for the ablity of PI3K-AKT driven pathways to promote mast cell survival.",
              "citation": {
                "type": "PubMed",
                "name": "Trends Immunol 2008 Oct 29(10) 493-501",
                "id": "18775670"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8bdb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "mast cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Treatment of human umbilical vein endothelial cells (HUVECs) with betacellulin (BTC, 10 ng/ml) increased phosphorylation of two MAPKs, ERK1 (p44MAPK) and ERK2 (p42MAPK) and AKT as early as 1 minute and produced a maximal effect at 5 minutes, which declined and returned to control levels at 60 minutes. BTC treatment also phosphorylated all three Erb receptors ErbB2, ErbB3, and ErbB4 but not ErbB1. BTC induced phosphorylation of MAPK and AKT was not suppressed by a selectilvely inhibitory concentration of ErbB1 receptor inhibitor, AG1478), suggesting that BTC induced MAPK and AKT activation was mediated through ErbB4 homodimer, ErbB2/ErbB3, or ErbB2/ErbB4.",
              "citation": {
                "type": "PubMed",
                "name": "FASEB J 2003 Feb 17(2) 318-20",
                "id": "12475887"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8bda"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "We further demonstrate that these events are Src family tyrosine kinase-dependent and specifically identify the role of hematopoietic cell kinase (Hck) as a new Gab family adapter protein kinase. Conversely, inhibition of Src family tyrosine kinases by the pyrazolopyrimidine PP2, as in kinase-inactive Hck mutants, significantly reduces IL-6-triggered activation of extracellular signal-regulated kinase and AKT-1, leading to significant reduction of multiple myeloma cell proliferation and survival. Taken together, these results delineate a key role for Hck-mediated phosphorylation of Gab1 and Gab2 docking proteins in IL-6-induced proliferation and survival of multiple myeloma cells and identify tyrosine kinases and downstream adapter proteins as potential new therapeutic targets in multiple myeloma.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 May 14 279(20) 21658-65",
                "id": "15010462"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8bd9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Multiple Myeloma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Significantly, active PKB fully restored Survivin expression in OX40 KO T cells (Figure 2A). Survivin can also be phosphorylated on Thr34, and this has been correlated with the total levels of Survivin in malignant cells ([Grossman et al., 2001] and [O'Connor et al., 2000]). Immunoprecipitation revealed lower levels of phosphorylated Survivin in OX40 KO T cells, and levels were increased to those in wt T cells after transduction of active PKB (Figure 2B). ",
              "citation": {
                "type": "PubMed",
                "name": "Immunity 2005 May 22(5) 621-31",
                "id": "15894279"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8bd8"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "TGF-beta1 induced biphasic increases in extracellular signal-regulated kinase (ERK), p38 MAPK, c-Jun-NH2-terminal kinase (JNK), and Akt phosphorylation. (3) The inhibitor for PI3K/Akt (i.e., LY294002), but not those for MAPKs (i.e., SB203580, PD98059, and SP600125), attenuated the TGF-beta1-induced SMalpha-actin and SM-MHC expressions in 10T1/2 cells;in addition, transfection of 10T1/2 cells with the Akt-specific small interfering RNA (siRNA) significantly reduced their SMalpha-actin and SM-MHC expressions.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2006 Aug 18(8) 1270-8",
                "id": "16310342"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8bd7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "IGF-1 rapidly induced the phosphorylation of Akt and FKHRL1 in PC12 cells. The phosphorylation of Akt and FKHRL1 induced by 10 nm IGF-1 was inhibited by the phosphatidylinositide 3-kinase (PI3K) inhibitors wortmannin (0.25-2 microm) and LY294002 (12.5-100 microm), but not by the MEK inhibitor PD98059 (50 microm) or the p70 S6 kinase pathway inhibitor rapamycin (50 nm), suggesting that the phosphorylation of FKHRL1 induced by IGF-1 is mediated by the PI3K pathway. As observed for IGF-1, an in vitro kinase assay with purified active Akt kinase demonstrated that the kinase is capable of directly phosphorylating FKHRL1 at Thr(32) and Ser(253)",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Dec 15 275(50) 39152-8",
                "id": "10995739"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8bd6"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "neuron",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "n addition, in vitro stimulation of PMN with recombinant HMGB1 caused TLR4-dependent activation of NAD(P)H oxidase as well as increased ROS production through both MyD88-IRAK4-p38 MAPK and MyD88-IRAK4-Akt signaling pathways. Thus, PMN NAD(P)H oxidase activation, induced by HS/R and as mediated by HMGB1/TLR4 signaling, is an important mechanism responsible for PMN-mediated inflammation and organ injury after hemorrhage...PMN isolated from the mice ",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2007 May 15 178(10) 6573-80",
                "id": "17475888"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8bd5"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Since insulin activates eNOS through Akt, we then investigated whether FFAs have any effects on basal and insulin-stimulated Akt activation, which was monitored by phosphorylation at Ser473 and Ser308 sites. We observed that while linoleic acid had no effects on Akt phosphorylation at Ser473, palmitic acid inhibited Akt phosphorylation at both Ser473 and Ser308 sites in a dose-dependent fashion (Fig. 2A). Palmitic acid also inhibited insulin-stimulated Akt phosphorylation at Ser473 (Fig. 2B), suggesting that palmitic acid may block upstream signaling. ",
              "citation": {
                "type": "PubMed",
                "name": "Diabetes 2006 Aug 55(8) 2301-10",
                "id": "16873694"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8bd4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Experiments with exogenous [(3)H]S1P showed a multi-exponential influx kinetic of intracellular uptake of [(3)H]S1P up to a steady state level over 2h. This process could be inhibited or enhanced by various synthetic modulators targeting both, S1P(1) receptor-dependent (Akt, ERK1/2) as well as independent DMS-sensitive pathways. The S1P(1) receptor signalling was shown to drive the sphingosine kinase - the rate limiting enzyme for the formation of S1P - to a higher or lower activity. Furthermore, S1P as an intracellular messenger induced the phosphorylation and nuclear translocation of the p65 subunit of NF-kappaB and in turn the expression of E-selectin and monocyte adhesion.",
              "citation": {
                "type": "PubMed",
                "name": "Eur J Cell Biol 2010 Oct 89(10) 733-41",
                "id": "20656374"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8bd3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": "vascular tissue"
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "After Fc?RI-stimulation, Akt (T308) phosphorylation in PTEN-deficient cells was further increased. Akt is well known to function as a PI3K-dependent prosurvival protein through its regulation of Bcl family members, the Forkhead family of transcription factors, and p53 family members (15). Analysis of events that can initiate apoptosis (mitochondrial membrane potential and DNA compaction) under conditions of growth factor starvation revealed a significant reduction (16 h) in these events in PTEN-deficient cells",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2006 May 1 176(9) 5167-71",
                "id": "16621980"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8bd2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "mast cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "identified four sites (Ser-124, Thr-308, Thr-450, and Ser-473) on Akt1 that are phosphorylated in vivo. Thr-308 and Ser-473 are inducibly phosphorylated after treatment of cells with extracellular stimuli, whereas Ser-124 and Thr-450 appear to be basally phosphorylated The third mechanism by which 3'-phosphorylated phosphoinositides regulate Akt activity is by controlling the accessibility of Akt as a substrate for PDKs. In in vitro reconstitution assays, the binding of PI3,4,5P to the Akt PH domain is required for PDK-1 to phosphorylate Akt In addition, PDK-1 complexed with either a fragment of PRK2, PRK2, or a PRK2-related peptide may be regulated by increased phospholipid concentrations",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 1999 Nov 15 13(22) 2905-27",
                "id": "10579998"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8bd1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Upon stimulation with insulin, AKT is recruited to cellular membranes by binding of its amino terminal pleckstrin (PH) domain to membrane bound phosphatidylinositol 3,4,5, trisphosphate (PIP3) [3]. The membrane bound form of AKT then becomes phosphorylated on two regulatory residues, a threonine within the activation loop (Thr308 in AKT1,Thr309 in AKT2, Thr305 in AKT3) and a serine in the C-terminus of the enzyme (Ser473 in AKT1,Ser474 in AKT2, Ser472 in AKT3), and both phosphorylations are considered to be required for AKT to reach maximum kinase activity [1]. The kinase responsible for phosphorylation of Thr308/309/305 has been identified as phosphoinositide-dependent kinase 1 (PDK1) [3].",
              "citation": {
                "type": "PubMed",
                "name": "Biochim Biophys Acta 2005 Oct 10 1725(3) 340-7",
                "id": "15890450"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8bd0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "PIP3 that is generated by PI3K enzymes recruits several signaling proteins to the cell membrane via interaction with pleckstrin homology domains in these proteins, thereby propagating intracellular signaling. These signaling effectors include PDK1, which activates Akt to promote cell proliferation and survival (54), and Btk (37, 60), which activates PLC?. PIP3 also has regulatory effects on PLD and SphK. PI3K is positively regulated by RasGRP1 (61), in addition to being activated by Fyn. Mast cells from RasGRP1 knock-out mice show defects in multiple pathways downstream of PIP3, including reduced phosphorylation of Akt. This results in reduced degranulation and cytokine production upon Fc?RI activation of RasGRP1 knock-out",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2011 Sep 23 286(38) 32891-7",
                "id": "21799019"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8bcf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "mast cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Overexpression of wild-type SHIP2 (WT-SHIP2) inhibited insulin-induced phosphorylation of Akt at both Thr(308) and Ser(473) in Rat1 fibroblasts expressing insulin receptors. The degree of inhibition was less in the cells expressing either a mutant SHIP2 with R47Q change (R/Q-SHIP2) in the SH2 domain, or a mutant SHIP2 with Y987F change (Y/F-SHIP2) in the C-terminal tyrosine phosphorylation site. However, on addition of a myristoylation signal, WT-SHIP2, R/Q-SHIP2, and Y/F-SHIP2 all efficiently inhibited insulin-induced Akt phosphorylation at both residues, whereas a 5'-phosphatase-defective mutant SHIP2 (deltaIP-SHIP2) with the myristoylation signal did not.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Endocrinol 2002 Oct 16(10) 2371-81",
                "id": "12351701"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8bce"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Whereas the function of CKIs as tumour suppressors is well characterized in the nucleus, they also seem to function in the cytoplasm,where they regulate cytoskeletal functions. This occurs through the modulation of the Rho signalling pathway. This cytoplasmic function could be oncogenic, as inhibition of the Rho pathway can result in increased migratory capacity. Phosphorylation of p21 on Thr145 by protein kinase B (PKB)/Akt48 or Pim1 inhibits the nuclear localization of p21. In the cytoplasm, p21 can protect the cell from apoptosis, as well as bind and inhibit the Rho kinases ROCK1 and -2 to modulate actin cytoskeleton organization46,47.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2004 Dec 4(12) 948-55",
                "id": "15573116"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8bcd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Western blotting with the anti-phospho-Akt1 antibody, which recognizes only phosphorylated Ser-473 residue, was performed in human esophageal cancer cell lines (TE-2, TE-5, TE-8, TE-9, TE-10, and TE-12 cells) (top panel). PDGF-treated NIH3T3 cells served as a positive control. The phospho-Akt antibody demonstrated two bands at 60 kDa. The phosphorylation of Akt was enhanced by EGF stimulation in all the esophageal cancer cell lines examined, although TE-5 cells showed high basal phosphorylation of Akt.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Oct 6 275(40) 30934-42",
                "id": "10908564"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8bcc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Furthermore, serum starvation-induced apoptosis caused a twofold increase in caspase 3 activity in C1-TEN-overexpressing cells vs. mock cells. In addition, C1-TEN-overexpressing cells showed a markedly reduced phosphorylation of Akt/PKB kinase and its substrate GSK3, as well as reduced Akt enzymatic activity.  Equal amounts of total cell lysates were subjected to 10% SDSPAGE. The membrane was then probed with polyclonal antibody against GSK3 specifically phosphorylated at Ser21/9 (pGSK3?/?, CST), after which the membrane was stripped (stripping buffer, Pierce) and reprobed with polyclonal anti-total Akt antibody (CST). and Western blotting for detection of either Akt kinase specifically phosphorylated at Ser473 (pAkt) or both 42 and 44 kDa isoforms of phosphorylated ERK (pERK) using specific antibodies (Santa Cruz Biotechnology, Santa Cruz, CA).",
              "citation": {
                "type": "PubMed",
                "name": "FASEB J 2005 Jun 19(8) 971-3",
                "id": "15817639"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8bcb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "FAK appears to play a major role in conveying survival signals from the ECM (50, 51). Because FAK binds PI 3-kinase, the protective effect against anoikis may be the result of PI 3-kinase-mediated activation of protein kinase B/Akt (52). Akt promotes survival, at least in part, by phosphorylating and thereby inactivating two proapoptotic proteins, Bad and caspase-9 (53) (Fig. 4). Inhibition of p53 prevents FAKdeficient cells from undergoing anoikis when deprived of growth factors, suggesting that p53 mediates the death signal under FAK deficiency (51).",
              "citation": {
                "type": "PubMed",
                "name": "Science 1999 Aug 13 285(5430) 1028-32",
                "id": "10446041"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8bca"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "ERK phosphorylation that was constitutive in mutant ras MM cells was completely abolished by the MEK inhibitor PD98059 (Figure 2C, left panels), as was the ERK phosphorylation reinduced in wild-type cells by readdition of IL-6 (Figure 2C, right panel).......In addition, re-exposure to IL-6 could reinduce AKT phosphorylation in wild-type cells in a wortmannin-sensitive fashion. Moreover, the constitutively maintained AKT phosphorylation in the mutation-containing cells was also sensitive to wortmannin. These data indicate the PI3-K/AKT cascade is a ras effector in these mutant rascontaining MM cells.",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2003 Apr 15 101(8) 3126-35",
                "id": "12515720"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8bc9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "FOXO1 is a major substrate of AKT. Indeed, our data showed that pFOXO1 expression was closely and positively correlated with the expression of the active form of AKT (pAKT, P < 0.001). Since we found previously that AKT activation induced angiogenesis in gastric cancer xenografts [17], our results suggest that AKT/FOXO1 pathway is involved in angiogenesis in gastric cancer. Furthermore, we found that pFOXO1 expression was positively correlated with the nuclear expression of NF-?B (P = 0.040), which is also known to induce tumor angiogenesis [34]. However, no association was found between pFOXO1 expression and the expressions of pSTAT3 and nuclear ?-catenin in the present study, although they have been reported to be involved in angiogenesis in several cancer types [35,36]. ",
              "citation": {
                "type": "PubMed",
                "name": "BMC Cancer 2011 11 264",
                "id": "21696576"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8bc8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Carcinoma of gastrointestinal tract",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "COX-2 inhibitors can also activate prosurvival pathways. The PI3K/Akt pathway is a survival pathway, frequently activated in cancer cells [49]. PI3K produces PIP3 (phosphatidylinositol 3,4,5 triphosphate) that activates PDK1 (pyruvate deshydrogenase kinase). This protein phosphorylates and activates PKB (protein kinase B), which, in turn, is responsible for the phosphorylation of several targets playing a modulator function in apoptosis. An anti-cancer effect of celecoxib due to the inhibition of Akt signaling [111] was observed in a gastric cancer model. ",
              "citation": {
                "type": "PubMed",
                "name": "Int J Cell Biol 2010 2010 215158",
                "id": "20339581"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8bc7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasm",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Figure 2. A schematic diagram shows the cellular signalling pathway by which ENaC is regulated by the hormones aldosterone and insulin. The effect of aldosterone and insulin is mediated via a phosphatidylinositol 3-kinase (PI3K) and phosphoinositide-dependent protein kinase (PDK) pathway, which activates serum and glucocorticoid-dependent protein kinase (Sgk1) and protein kinase B (Akt1). Both Sgk1 and Akt1 phosphorylate Nedd4-2. The phosphorylated form of Nedd4-2 interacts with 14-3-3, preventing it from binding to and inducing ubiquitination of ENaC. ",
              "citation": {
                "type": "PubMed",
                "name": "Clin Exp Pharmacol Physiol 2008 Feb 35(2) 235-41",
                "id": "18197893"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8bc6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "To investigate molecular mechanisms involved in the development of cardiac hypertrophy and heart failure, we developed a tetracycline-regulated transgenic system to conditionally switch a constitutively active form of the Akt1 protein kinase on or off in the adult heart. Short-term activation (2 wk) of Akt1 resulted in completely reversible hypertrophy with maintained contractility. In contrast, chronic Akt1 activation (6 wk) induced extensive cardiac hypertrophy, severe contractile dysfunction, and massive interstitial fibrosis. The focus of this study was to create a transcript expression profile of the heart as it undergoes reversible Akt1-mediated hypertrophy and during the transition from compensated hypertrophy to heart failure. Heart tissue was analyzed before transgene induction, 2 wk after transgene induction, 2 wk of transgene induction followed by 2 days of repression, 6 wk after transgene induction, and 6 wk of transgene induction followed by 2 wk of repression. Acute overexpression of Akt1 (2 wk) leads to changes in the expression of 826 transcripts relative to noninduced hearts, whereas chronic induction (6 wk) led to changes in the expression of 1,611, of which 65% represented transcripts that were regulated during the pathological phase of heart growth. Another set of genes identified was uniquely regulated during heart regression but not growth, indicating that nonoverlapping transcription programs participate in the processes of cardiac hypertrophy and atrophy. These data define the gene regulatory programs downstream of Akt that control heart size and contribute to the transition from compensatory hypertrophy to heart failure.",
              "citation": {
                "type": "PubMed",
                "name": "Physiol Genomics 2006 Oct 11 27(2) 156-70",
                "id": "16882883"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8bc5"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Platelet-derived growth factor (PDGF) has multiple functions including inhibition of apoptosis and promotion of cell proliferation. In this study, we show that Na(+)/H(+) exchanger regulatory factor 2 (NHERF2) binds to the carboxyl-terminal PDZ domain-binding motif of the PDGF receptor through a PDZ domain-mediated interaction, and evaluate the consequence on PDGF-induced proliferation. Stable transfection with NHERF2 increased the PDGF-induced phosphorylation of ERK and Akt in Rat1 embryonic fibroblasts.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2004 Jul 16(7) 791-800",
                "id": "15115658"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8bc4"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": "embryonic tissue"
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "The UCN homologues SCP and SRP bind specifically to the CRFR2 receptor, whereas UCN binds to both CRFR1 and CRFR2. We have previously demonstrated that all three peptides are cardioprotective, and both the Akt and MAPK p42/44 pathways are essential for this effect. Here we tested the hypertrophic effects of these peptides. We examined the effects of the peptides on cell area, protein synthesis, and induction of the natriuretic peptides ANP and BNP. All three peptides were able to increase all the markers of hypertrophy examined, with SCP being the most potent of the three, followed by UCN and SRP last. In addition, we provide a mechanism of action for the three peptides and show that Akt phosphorylation is important for their hypertrophic action, whereas MAPK p42/44 is not involved in this effect. SCP=Ucn2 SRP=Uts2 CRFR2=CRHR2",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2005 Mar 11 328(2) 442-8",
                "id": "15694367"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8bc3"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "To investigate the normal intracellular distribution of 14-3-3 proteins and their ligands, U2OS cells were immunostained with a polyclonal antibody that recognizes all 14-3-3 isotypes (pan-14-3-3) or with a monoclonal antibody generated against the 14-3-3sigma isotype (Fig. 1 A). Upon growth factor stimulation, Akt is activated, directly phosphorylating FKHRL1 at T32 and S253, and to a lesser extent at S315, and resulting in FKHRL1 relocalization from the nucleus to the cytoplasm ....  Similar AKT-dependent changes in subcellular localization have also been observed for the additional FKHRL1 human homologs AFX and FKHR.... Phosphorylation at T32 and S253 causes FKHRL1 to bind to 14-3-3, suggesting that the interaction between FKHRL1 and 14-3-3 may play an important role in regulating the subcellular localization of the complex.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2002 Mar 4 156(5) 817-28",
                "id": "11864996"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8bc2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "glycogen synthase kinase GSK3 which itself is a target of protein kinase B (PKB) and the serum and glucocorticoid inducible kinase SGK1. Phosphorylation of GSK3 by PKB or SGK1 inhibits GSK3 activity an the present study explored whether mineralocorticoid excess had any effect on the phosphorylation status of the a and beta isoforms of GSK3. Western blotting using an antibody specific for the PKB/SGK1 consensus phosphorylation site in GSK3a/beta (serine 21 and 9 respectively) revealed an increase in GSK3a/beta phosphorylation in human embryonic kidney 293 (HEK293) cells overexpressing wild type SGK1, constitutively active SGK1, but not catalytically inactive SGK1. The effect of SGK1 was mimicked by PKB and SGK3.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Physiol Biochem 2006 17(3-4) 137-44",
                "id": "16543730"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8bc1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Western blotting with the anti-phospho-Akt1 antibody, which recognizes only phosphorylated Ser-473 residue, was performed in human esophageal cancer cell lines (TE-2, TE-5, TE-8, TE-9, TE-10, and TE-12 cells) (top panel). PDGF-treated NIH3T3 cells served as a positive control. The phospho-Akt antibody demonstrated two bands at 60 kDa. The phosphorylation of Akt was enhanced by EGF stimulation in all the esophageal cancer cell lines examined, although TE-5 cells showed high basal phosphorylation of Akt.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Oct 6 275(40) 30934-42",
                "id": "10908564"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8bc0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Carcinoma of esophagus",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Under these circumstances, ceramide activated PKCzeta, leading to phosphorylation of the PKB-PH domain on Thr(34). This phosphorylation inhibited phosphatidylinositol 3,4,5-trisphosphate (PIP(3)) binding to PKB, thereby preventing activation of the kinase by insulin.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2003 Nov 23(21) 7794-808",
                "id": "14560023"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8261"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Nov 24 275(47) 36750-7",
                "id": "10973962"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8260"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "In this report, we demonstrate that androgen activates phosphatidylinositol 3-kinase (PI3K) and Akt, including AKT1 and AKT2, in AR-positive cells",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Oct 31 278(44) 42992-3000",
                "id": "12933816"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad825f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Akt1 phosphorylates Tsc2, thereby activating mTOR at least in part by disrupting the Tsc1 Tsc2 complex",
              "citation": {
                "type": "PubMed",
                "name": "Trends Mol Med 2003 Aug 9(8) 344-50",
                "id": "12928036"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad825e"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "DFMO increased ERK1/2 and AKT activation within 2 min, and activities remained elevated for 10 min. Addition of putrescine or spermine along with DFMO prevented maximal ERK1/2 and AKT activation observed at 5 min. Preincubation of cells with AG1478 for 30 min (D+AG) completely inhibited ERK1/2 and AKT activation induced in response to DFMO.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2007 Aug 15",
                "id": "17825525"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad825d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "intestinal epithelium"
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Sep 27 277(39) 36045-51",
                "id": "12138086"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad825c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "mTORC2 promoted phosphorylation of protein kinase B (PKB, or Akt) and PKC, Akt activity, and nuclear NF-kappaB transcription factors in response to T cell activation. Complementation with active Akt restored only T-bet transcription factor expression and Th1 cell differentiation,",
              "citation": {
                "type": "PubMed",
                "name": "Immunity 2010 Jun 25 32(6) 743-53",
                "id": "20620941"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad825b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Th1 cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Jun 21 277(25) 22528-33",
                "id": "11956204"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad825a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Phosphorylation at Ser473 in the hydrophobic motif, along with Thr308 in its activation loop, is considered necessary for Akt function.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2010 Sep 10 400(1) 16-20",
                "id": "20691662"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8259"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2001 Sep 21(17) 5797-805",
                "id": "11486019"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8258"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "The dn-AKT used in this study was also able to inhibit the phosphorylation of GSK-3beta by endogenous AKT after stimulation with TNF-alpha",
              "citation": {
                "type": "PubMed",
                "name": "FASEB J 2002 Nov 16(13) 1732-7",
                "id": "12409315"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8257"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "cardiomyocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2002 Aug 20 99(17) 11357-62",
                "id": "12169659"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8256"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Indeed, insulin stimulated a prominent increase in PKB/Akt activity, as determined by in vitro kinase assays (Fig. 3B).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2002 Apr 22(7) 2099-110",
                "id": "11884598"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8255"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Jun 21 277(25) 22902-8",
                "id": "11943768"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8254"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "It has been reported that in vitro both Thr145 and Ser146 phosphorylation by Akt and PKC, respectively, leads to dissociation of PCNA from p21 (46",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cancer Res 2007 Sep 5(9) 909-22",
                "id": "17855660"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8253"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "inhibition of PI3K by LY294002 or wortmannin suppressed NK lysis of tumor cells in a dose-dependent pattern (Fig. 1d,e). All doses effectively suppressed Ser473 phosphorylation of Akt (Fig. 1d,e). Inhibition of PI3K also blocked the movement of perforin and granzyme B towards target cells (Fig. 1a,b).",
              "citation": {
                "type": "PubMed",
                "name": "Nat Immunol 2000 Nov 1(5) 419-25",
                "id": "11062502"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8252"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "natural killer cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 2002 Mar 143(3) 820-8",
                "id": "11861503"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8251"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "upregulation of Jagged1 by mTOR was due, at least in part, to higher levels of Jagged1 mRNA in the Tsc2-null and mutant AKT-expressing cell lines (Figure 3B) and appeared to be directly responsible for Notch activation and Hes1 expression, as these were blocked by decreased Jagged1 expression using siRNA (Figure 3C).",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Invest 2010 Jan 120(1) 103-14",
                "id": "20038814"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8250"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "HMG-CoA reductase inhibition results in the activation of protein kinase Akt and the posttranslational phosphorylation of the eNOS protein.82,83",
              "citation": {
                "type": "PubMed",
                "name": "Arterioscler Thromb Vasc Biol 2004 Mar 24(3) 405-12",
                "id": "14656742"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad824f"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "On the other hand, G-CSF-induced Akt phosphorylation was markedly inhibited by wortmannin",
              "citation": {
                "type": "PubMed",
                "name": "Immunology 2006 Nov 119(3) 393-403",
                "id": "16903868"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad824e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "However, after co-transfection of ZIP kinase into the reactions, the half-life of p21WAF1 protein is increased (Figure 6(A), lanes 2-4 versus (B), lanes 2?4). A similar increase in p21WAF1 half-life was shown after co-transfection of Akt kinase, which also targets Thr145 of p21WAF1, while phosphorylation at Ser146 by atypical PKCs decreased the half life of p21WAF1.",
              "citation": {
                "type": "PubMed",
                "name": "J Mol Biol 2004 Mar 12 337(1) 115-28",
                "id": "15001356"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad824d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Carcinoma, Non-Small-Cell Lung",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Depletion of cholesterol from the cells using beta-cyclodextrin blocked insulin stimulation of glucose uptake, insulin inhibition of perilipin phosphorylation in response to isoproterenol, and insulin stimulation of protein kinase B and Map-kinases extracellular signal-related kinase (ERK)1/2 phosphorylation",
              "citation": {
                "type": "PubMed",
                "name": "Eur J Biochem 2004 Jun 271(12) 2471-9",
                "id": "15182363"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad824c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Adipocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Mar 8 277(10) 8068-75",
                "id": "11779849"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad824b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Pretreatment with PP2, a specific inhibitor of Src family tyrosine kinase, completely blocked the NHERF2-dependent increase of the phosphorylation of ERK and Akt, suggesting that NHERF2 up-regulates Erk phosphorylation through a Src family kinase-dependent pathway.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2004 Jul 16(7) 791-800",
                "id": "15115658"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad824a"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Dec 19 278(51) 51386-94",
                "id": "14551200"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8249"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "ROS production with ischemia was significantly reduced in lungs with knockout of Akt1 while the response of Akt2 null lungs to ischemia was similar to wild type (Fig. 4A and B). Thus, Akt1 is required for activation of endothelial ROS production with ischemia.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Heart Circ Physiol 2011 Oct 14",
                "id": "22003059"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8248"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "(3) Akt/PKB Ser129 is phosphorylated by CK2 in vitro and in vivo; (4) such a phosphorylation of activated Akt/PKB correlates with a further increase in catalytic activity.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Death Differ 2005 Jun 12(6) 668-77",
                "id": "15818404"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8247"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2001 Jan 1 61(1) 383-91",
                "id": "11196191"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8246"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "transient knockdown of cortactin in serum-supplemented FaDu cells led to decreased activation of Erk and Akt (49).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2010 Nov 30(21) 5057-70",
                "id": "20805359"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8245"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Head and Neck Neoplasms",
                "cell": "squamous cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2002 Oct 1 21(19) 5097-108",
                "id": "12356726"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8244"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Lung Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Table 1. Genes upregulated during the early initiation of adipose conversion in wild-type MEFs are fewer or not expressed at all in the absence of PKBa*",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 2006 Mar 1 119(Pt 5) 889-97",
                "id": "16478789"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8243"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Fully activated AKT inhibits TSC2 by phosphorylation [20], thereby negating its inhibitory effect on mTORC1.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Immunol 2009 May 9(5) 324-37",
                "id": "19390566"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8242"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Finally we show that HoxA5 increases Akt1 mRNA, protein expression and further enhances Akt activity via a coordinate down regulation of PTEN....Figure 7...HoxA5 induces Akt mRNA and protein expression and increases Akt activity in endothelial cells. ",
              "citation": {
                "type": "PubMed",
                "name": "Cell Adh Migr 2007 Oct 1(4) 185-95",
                "id": "19262140"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8241"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Expression of myrAkt is associated with increased phosphorylation of Sp1 and its increased binding to a probe corresponding to the -88/-66 promoter region. In conclusion, our results indicate that Sp1 is required for transactivation of the VEGF by Akt. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 2004 Nov 15(11) 4841-53",
                "id": "15342781"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8240"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "astrocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Aug 22 278(34) 31964-71",
                "id": "12775712"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad823f"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2001 May 1 355(Pt 3) 757-63",
                "id": "11311139"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad823e"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Small interfering RNA (siRNA)-mediated knockdown of AMPKalpha1or Akt1 impaired the stimulatory effects of both VEGF and S1P on eNOS activation. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 Jul 13 282(28) 20351-64",
                "id": "17519230"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad823d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium"
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Subsequent studies showed that PDGF activated extracellular signal-regulated kinase, Jun N-terminal protein kinase, and phosphatidylinositol 3 (PI3)-kinase pathways in SMCs.  Inhibition of these pathways blocked SMC proliferation in response to PDGF, but only inhibition of PI3-kinase or its effector, Akt, blocked PDGF-induced CREB loss.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2006 Jul 26(13) 4934-48",
                "id": "16782881"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad823c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Muscle, Smooth"
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Activation of the protein kinase B (Akt1) pathway is a necessary requirement for nicotinamide protection,",
              "citation": {
                "type": "PubMed",
                "name": "J Cereb Blood Flow Metab 2004 Jul 24(7) 728-43",
                "id": "15241181"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad823b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Nat Genet 2004 Feb 36(2) 131-7",
                "id": "14745448"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad823a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2001 Dec 4 98(25) 14416-21",
                "id": "11734644"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8239"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "KGF-induced activation of the multifunctional pro-survival Akt signaling",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2003 May 13 100(10) 6098-103",
                "id": "12732722"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8238"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Transgenic mice overexpressing a constitutively active mutant form of Akt1 displayed decreased phosphorylation of cardiac alpha-AMPK. Isolated neonatal cardiac myocytes infected with an adenovirus expressing constitutively active mutant forms of either Akt1 or Akt2 also suppressed AMPK phosphorylation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Oct 10 278(41) 39422-7",
                "id": "12890675"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8237"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "cardiomyocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Akt becomes activated upon phosphorylation of Ser473 and Thr308. In the absence of insulin, dexamethasone reduced Ser473 phosphorylation by 33% (P <\t 0.05 vs. no treatment, n =  3).",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2007 May 292(5) C1874-9",
                "id": "17229808"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8236"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Renal Epithelial Cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Consistent with increased resistance to apoptosis, we found increased phosphorylation of the antiapoptotic protein Akt (protein kinase B) in PPT1-overexpressing cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Neurochem 2000 Apr 74(4) 1478-88",
                "id": "10737604"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8235"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "The members of the TCL1 proto-oncogene family (TCL1, MTCP1, and TCL1b) bind to Akt1, increasing its phosphorylation status and kinase activity in contrast to Akt1 and Akt2, which bind to all members of the TCL1 family,",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Feb 1 277(5) 3743-51",
                "id": "11707444"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8234"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2002 Jun 15 62(12) 3538-43",
                "id": "12068001"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8233"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Akt, a serine/threonine kinase that is a major target of phosphatidylinositol 3-kiniase (PI3K), phosphorylates eNOS at Ser1177, and this phosphorylation enhances eNOS activity and increases NO production in vascular endothelial cells.",
              "citation": {
                "type": "PubMed",
                "name": "Hypertension 2006 Nov 48(5) 958-64",
                "id": "17000928"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8232"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": "vascular tissue"
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2001 Aug 1 61(15) 5911-8",
                "id": "11479233"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8231"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Epo regulation of ZO-1 in the human fetal immature H4 IEC cell line was examined and demonstrated Epo stimulated ZO-1 expression in a dose-dependent manner through the PI3K/Akt pathway.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2011 Jan 24",
                "id": "21262973"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8230"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "As AKT is the principal kinase that phosphorylates the inhibitory site of GSK3-beta, this result points to an important role of melusin in regulating this pathway.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Med 2003 Jan 9(1) 68-75",
                "id": "12496958"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad822f"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "the sensitivity of insulin-stimulated activation of PKC zeta/lambda, Akt1, Akt2 and Akt3 to wortmannin correlated closely with inhibition of GLUT4 translocation",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Dec 7 276(49) 46079-87",
                "id": "11598141"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad822e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Phosphorylation of Thr-308 correlates with the activation of PKB, whereas phosphorylation of GSK3b on Ser-9, GSK3a on Ser-21 and FKHR-L1 on Thr-32 is indicative of inhibition of these PKB substrates",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2002 Jul 15 365(Pt 2) 537-45",
                "id": "11942857"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad822d"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "Carcinoma of liver",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Immunoblotting with antibodies that detect only the phosphorylated and active forms of these kinases indicated that oxLDL activated both ERK1/2 and PKB in BMDM whereas n-LDL or ac-LDL had no effect (Fig. 8A). ",
              "citation": {
                "type": "PubMed",
                "name": "J Lipid Res 2001 Sep 42(9) 1483-91",
                "id": "11518769"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad822c"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Fluid shear stress stimulates phosphorylation of Akt in human endothelial cells: involvement in suppression of apoptosis.",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 2000 Aug 4 87(3) 179-83",
                "id": "10926866"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad822b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Components of these pathways (Shc, p44/42 MAPK kinase, Akt/protein kinase B and p70s6k) are phosphorylated in response to progranulin7,10 and have been previously implicated in the ability of progranulin to stimulate cell division.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Med 2003 Feb 9(2) 225-9",
                "id": "12524533"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad822a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "As shown in Fig. 2A, activated Akt induces the phosphorylation of FLAGp38, suggesting that p38 is a downstream target of Akt signaling. The activity of p38 in response to M-Akt was also measured by p38 kinase assay, and, as shown in Fig. 2A, M-Akt stimulated the activity of p38 to phosphorylate the transcription factor ATF-2, a known p38 substrate.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Jun 1 276(22) 18934-40",
                "id": "11259436"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8229"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Stimulation of wild-type neural stem cells with ciliary neurotrophic factor (CNTF) results in phosphatidylinositol-3-OH kinase/Akt1 kinase-dependent phosphorylation of N-CoR, and causes a temporally correlated redistribution of N-CoR to the cytoplasm",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2002 Oct 31 419(6910) 934-9",
                "id": "12410313"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8228"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Fig. 3a shows that exposure of neutrophils to E. coli DNA resulted in Akt activation.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2006 Sep 15 177(6) 4037-46",
                "id": "16951367"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8227"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Akt becomes activated upon platelet stimulation with diverse agonists, such as collagen [6], ristocetin/vWF [7], thrombin [3,58], ADP [59], IGF-1 [60] and Gas6 [61]. In each case, stimulation of Akt phosphorylation is dependent upon PI3K. ",
              "citation": {
                "type": "PubMed",
                "name": "Expert Rev Hematol 2010 Feb 3(1) 81-91",
                "id": "20352060"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8226"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Blood Platelets",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "CXCR4 was localized to lipid rafts in PC cells and initiated Akt phosphorylation.",
              "citation": {
                "type": "PubMed",
                "name": "Prostate 2006 Jan 1 66(1) 32-48",
                "id": "16114056"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8225"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "p27Kip1, another major target of oncogenic ErbB2, is affected at two levels. Blocking ErbB2 activity leads to downregulation of PI-3K/ PKB signaling. As a consequence, p27Kip, which is cytoplasmic when phosphorylated by PKB on a specific threonine residue, relocalizes to the nucleus [75-77].",
              "citation": {
                "type": "PubMed",
                "name": "Exp Cell Res 2003 Mar 10 284(1) 99-110",
                "id": "12648469"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8224"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Furthermore, we show that inhibition of mTOR by rapamycin induces the activation of Akt as shown by increased Akt phosphorylation at Ser(473) and the inhibition of 6-TG-induced apoptosis and cell death.  Activated Akt is a well-known inhibitor of autophagy. ",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2008 Apr 1 68(7) 2384-90",
                "id": "18381446"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8223"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "NIC functions through Akt1 activation, Bad phosphorylation, and the downstream modulation of mitochrondrial membrane potential, cytochrome c release, caspase 1, 3, and 8 - like activities, and PARP integrity to prevent genomic DNA degradation and PS externalization during anoxia.",
              "citation": {
                "type": "PubMed",
                "name": "Curr Neurovasc Res 2005 Oct 2(4) 271-85",
                "id": "16181120"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8222"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "3 independent signaling pathways, STAT3, MEK1-ERK1/2, and AKT activation, that are coinduced by Lif stimulation were completely suppressed by SOCS3 overexpression",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Invest 2001 Nov 108(10) 1459-67",
                "id": "11714737"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8221"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Wild type and constitutively active Akt were both shown to phosphorylate p27KIP1 at threonine157, leading to cytoplasmic localisation of p27KIP1. ",
              "citation": {
                "type": "PubMed",
                "name": "Breast Cancer Res 2003 5(3) 162-3",
                "id": "12793899"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8220"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Figure 2 Tcl1 enhances Akt1 kinase activity. ",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2000 Mar 28 97(7) 3028-33",
                "id": "10716693"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad821f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "With stimulation of the respiratory burst, cytosolic oxidase components, p47(phox), p67(phox), and Rac, translocate to the phagolysomal and plasma membranes where they form a complex with cytochrome b(558) and express enzyme activity.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Nov 22 277(47) 45181-7",
                "id": "12121978"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad821e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "we found that IL-33R signaling induced a time-dependent activation of Erk1/2, protein kinase B (PKB), JNK1/2, NF-kB, and p38, and degradation of IkB (supplemental Figure 1B).",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2010 May 13 115(19) 3899-906",
                "id": "20200353"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad821d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "mast cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "It was shown that PI3K activity was constitutively active in a panel of SCLC cell lines and that the PI3K inhibitor LY294002 blocked SCLC cell growth by inhibiting the Akt/PKB activity (26).",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2004 Dec 1 64(23) 8723-30",
                "id": "15574783"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad821c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Carcinoma, Small Cell",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "once Akt1 is activated, it initiates a cascade of phosphorylation events targeting mammalian target of rapamycin, mTOR, which in turn phosphorylates the p70S6 kinase and GSK3B",
              "citation": {
                "type": "PubMed",
                "name": "Sci STKE 2004 Aug 3 2004(244) re11",
                "id": "15292521"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad821b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "MTOR complex 1 (mTORC1) phosphorylates S6K1, while mTOR complex 2 (mTORC2) phosphorylates Akt.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2008 Apr 14",
                "id": "18411301"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad821a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "The amount of Nur77 was detected by using anti-GFP antibody, and the amount of phospho-Ser- 350-Nur77 was detected by using an anti-Phospho-Ser-350 antibody (Fig. 3A). In the presence of overexpressed Akt, the amount of phosphorylated Nur77 increased .10-fold. In the similar experiment, overexpression of inactive K179 M Akt mutant (7) did not show any effect on phosphorylation of Nur77 (not shown). This result suggests that Akt phosphorylates Nur77 in vivo.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2001 Mar 27 98(7) 3690-4",
                "id": "11274386"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8219"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 1999 Nov 12 461(1-2) 120-4",
                "id": "10561508"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8218"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "three isoforms, AKT1 (PKBalpha), AKT2 (PKBbeta) and AKT3 (PKBgamma) they all contain a central kinase domain with an activation-loop phosphorylation site, Thr308, and a conserved, regulatory C-terminal phosphorylation site, Ser473",
              "citation": {
                "type": "PubMed",
                "name": "Mol Immunol 2002 Jun 38(15) 1087-99",
                "id": "12044776"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8217"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Inhibition of this phosphorylation by PI3K inhibitors or by dominant-negative Akt (T308A/S473A) expression abrogated the effects of bleomycin on fibroblast proliferation and collagen production, suggesting the role of PI3K/Akt in the fibrogenic process.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2010 Apr 42(4) 432-41",
                "id": "19520917"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8216"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Treatment of neurons with Ref-1 antisense oligonucleotide reduced the ability of Grx2 to activate Akt and AP-1 but had no effect on the phosphorylation of JNK1/2, suggesting that Akt/NF-kappaB and AP-1 are regulated by Ref-1.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Jun 15 276(24) 21618-26",
                "id": "11290748"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8215"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "PIP3 has been described as a downstream component of a wide range of receptors, including the c-Met receptor [5], the epidermal growth factor receptor family [6], fibroblast growth factor receptor [7], insulin growth factor receptor [8] and platelet-derived growth factor receptor",
              "citation": {
                "type": "PubMed",
                "name": "Breast Cancer Res 2005 7(4) R394-401",
                "id": "15987444"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8214"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Aug 31 276(35) 32799-805",
                "id": "11438550"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8213"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "In vivo 32P labeling and mutagenesis demonstrated that m/p-PKBalpha activity was due to phosphorylation on Thr308 and Ser473, that are normally induced on PKB following stimulation of the cells with insulin or insulin-like growth factor-1 (IGF-1).... Following activation the kinase detached from the membrane and translocated to the nucleus.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1997 Dec 12 272(50) 31515-24",
                "id": "9395488"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8212"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Sep 20 277(38) 34679-91",
                "id": "12105209"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8211"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": " IL-10 activates the class I phosphatidylinositol 3-kinase (PI3K) pathway, which results in the phosphorylation of p70S6K through the activation of Akt and a mammalian target of the rapamycin complex 1 (mTORC 1).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Immunol 2011 Jan 48(4) 720-7",
                "id": "21095008"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8210"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "constitutive Akt signaling is believed to promote proliferation and increased cell survival and thereby contribute to cancer progression",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2002 May 14(5) 381-95",
                "id": "11882383"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad820f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2002 Jul 15 62(14) 4132-41",
                "id": "12124352"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad820e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Ceramide reverted the interleukin 13-dependent inhibition of macroautophagy by interfering with the activation of protein kinase B.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Apr 30 279(18) 18384-91",
                "id": "14970205"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad820d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "hypertonicity stimulates Rac and Cdc42.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2002 Sep 283(3) C850-65",
                "id": "12176742"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad820c"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Following transfection of A549, U87, MDA-MB-468, and DU145 cell lines with miR-7, we observed reductions in basal and EGF-induced phosphorylation of Akt (Fig. 3, C and D, and supplemental Fig. 2A) in all four cell lines. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2008 Dec 10",
                "id": "19073608"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad820b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "we show that in cultured myotubes undergoing atrophy, the activity of the PI3K/AKT pathway decreases, leading to activation of Foxo transcription factors and atrogin-1 induction.",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2004 Apr 30 117(3) 399-412",
                "id": "15109499"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad820a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Dissociated Akt1 binds to SEK1 and ASK1 and inhibits their enzyme activity by phosphorylating SEK1 on the Ser-80 residue and ASK1 on the Ser-83 residue.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Jul 22 280(29) 26845-55",
                "id": "15911620"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8209"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Jun 27 278(26) 23630-8",
                "id": "12714585"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8208"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Exposure of human umbilical vein endothelial cells (HUVECs) to TNF-alpha elicited the rapid phosphorylation of Akt/PKB.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2000 Sep 24 276(2) 791-6",
                "id": "11027549"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8207"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "umbilical vein endothelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "expression of GSK3a, which has previously been shown to be deactivated by Akt (16) and in rat skeletal muscle is inhibited by both IGF1 and insulin and increased by stretch and contraction",
              "citation": {
                "type": "PubMed",
                "name": "FASEB J 2004 Jun 18(9) 1025-7",
                "id": "15084522"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8206"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "As shown in Fig. 3A, upon NGF treatment, TrkA phosphorylation was increased within 10 minutes. Concomitantly, the levels of phospho Akt (pAkt) and phospho ERK (pERK) were increased within 10 minutes and remained high even after 2 h of treatment with NGF. Furthermore, pharmacological inhibition of TrkA (K252a), PI3K (LY294002) and MEK 1/2 (PD98059) (Fig. 3B) totally abolished NGF stimulated invasion (Fig. 3C).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cancer 2010 9 157",
                "id": "20569463"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8205"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2003 Jun 1 17(11) 1352-65",
                "id": "12782654"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8204"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Sodium salicylate activated p38MAPK through phosphorylation at Thr 180/Tyr 182 and Akt/PKB at Ser 473, whereas it partially activated ERK1/2 through its phosphorylation at Thr 202/Tyr 204.",
              "citation": {
                "type": "PubMed",
                "name": "Int J Oncol 2003 Aug 23(2) 503-8",
                "id": "12851702"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8203"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Pretreatment of the cells with staurosporine, UCN-01, and LY294002, but not the PKC inhibitor calphostin C, suppressed Akt kinase activity (Figure 1c). The Akt inactivation was also consistent with phospho-Akt (Thr308) level decrease (Figure 1c, inset).",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2002 Mar 7 21(11) 1727-38",
                "id": "11896604"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8202"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Mechanistically, the loss of Akt1 reduces the basal phosphorylation of several Akt substrates, the migration of fibroblasts and ECs, and NO release. ",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Invest 2005 Aug 115(8) 2119-27",
                "id": "16075056"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8201"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium"
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "The FOXO1 is inactivated by Akt through direct phosphorylation, resulting in translocation to the cytoplasm and degradation by proteosomes (23,24). Akt-induced inactivation of Foxo1 results in transcriptional inhibition of the p27Kip1 promoter.",
              "citation": {
                "type": "PubMed",
                "name": "Diabetes 2006 Feb 55(2) 318-25",
                "id": "16443763"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8200"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "exogenous CXCL12 induced Akt1 phosphorylation is indispensable for proMMP-9 secretion, migration, and invasion of PC cells",
              "citation": {
                "type": "PubMed",
                "name": "Prostate 2006 Jan 1 66(1) 32-48",
                "id": "16114056"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81ff"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Bone and Bones"
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Pathological elevations in Akt activity are a common occurrence in tumors, due to loss of tumor suppressor PTEN, hyperactivity of PI3K-activating growth factors receptors and oncoproteins, and other mechanisms (Testa and Bellacosa, 2001).",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Cell 2003 Jan 3(1) 17-22",
                "id": "12559172"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81fe"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "tumor"
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "We used phosphospecific antibodies to Erk1/2 and Akt (protein kinase B) to determine whether these pathways are activated in response to CXCL12 in brain tumor cells. CXCL12 stimulates activation of Erk1/2 and Akt in both medulloblastoma and glioblastoma cells (Fig. 6, which is published as supporting information on the PNAS web site). In both Daoy and U87 cells, these rapid responses to CXCL12 are attenuated by AMD 3100.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2003 Nov 11 100(23) 13513-8",
                "id": "14595012"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81fd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Induction of eNOS mRNA was maximal in EC exposed to LSS and atorvastatin and this was dependent upon activation of Akt (Fig. 6E).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2009 Jul 10 284(28) 18882-92",
                "id": "19457866"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81fc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "umbilical vein endothelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Analysis of human or mouse DC treated with the B7-DC cross-linking Ab revealed PI3K-dependent phosphorylation of AKT accompanied by mobilization of NF-kappaB. ",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2007 Feb 1 178(3) 1426-32",
                "id": "17237390"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81fb"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "dendritic cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "The sarcoendoplasmic reticulum Ca2+ ATPase (SERCA) inhibitor thapsigargin (Tg), as well as the Ca2+ ionophores ionomycin (Io) and A23187 (A2), each increased Akt and ERK1/2- phosphorylation, and this activity was similarly inhibited by AG1478 (Figure 2C).",
              "citation": {
                "type": "PubMed",
                "name": "Carcinogenesis 2006 Nov 27(11) 2331-40",
                "id": "16774943"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81fa"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Preincubation with GF109203X, a PKC inhibitor, significantly reduced the level of early (3 min) IL-8-induced p47phox phosphorylation (Fig. 4A), but had no effect on the level of later (15 min) IL-8-induced p67phox phosphorylation (Fig. 4B). Furthermore, ERK1/2 and Akt/PKB phosphorylation transiently peaked after exposure to IL-8 for 3min (Fig. 4C).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Nov 4 280(44) 37021-32",
                "id": "16115878"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81f9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Consistent with EGFR activation, AKT and ERK phosphorylation was also observed during the course of ATP-?-S stimulation. Furthermore, ATP-?-S also elicited a similar response in primary HCE cells and BEAS 2B cells, although its effect on signaling in BEAS 2B cells was more transient than that in THCE cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 2007 Mar 1 120(Pt 5) 815-25",
                "id": "17284517"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81f8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "However, lutein effectively suppressed LPS-induced Akt and NIK phosphorylation (Fig. 4E).",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2008 Sep 15 45(6) 885-96",
                "id": "18620044"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81f7"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "leukemia",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Measurement of caspase-3 activity also showed that overexpression of myr-Akt inhibited the activation of caspase-3 (Figure 5d).",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2002 Mar 7 21(11) 1727-38",
                "id": "11896604"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81f6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "fibrosarcoma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "We now show that the regulation of E2F1 by TopBP1 involves the phosphoinositide 3-kinase (PI3K)-Akt signaling pathway, and is independent of pocket proteins. Akt phosphorylates TopBP1 in vitro and in vivo.... The Akt-dependent oligomerization is crucial for TopBP1 to interact with and repress E2F1.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2006 Oct 18 25(20) 4795-807",
                "id": "17006541"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81f5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "IGF1 binding activates the IGF1 receptor (IGFR), a receptor tyrosine kinase. The IGFR subsequently recruits the insulin receptor substrate (IRS1), which results in the activation of two signaling pathways: the RasRaf MEK ERK pathway  and the PI3K Akt pathway",
              "citation": {
                "type": "PubMed",
                "name": "Trends Mol Med 2003 Aug 9(8) 344-50",
                "id": "12928036"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81f4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Jun 14 277(24) 21639-42",
                "id": "11956222"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81f3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "p73-mediated induction of Bax expression following DNA damage requires YAP function and is attenuated by Akt phosphorylation of YAP.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2003 Jan 11(1) 11-23",
                "id": "12535517"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81f2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "As shown in Figure 2A, NECA-stimulated Akt, pan PKC, ERK, p38, JNK MAPKs, and NF-kB phosphorylation. Moreover, Cx43 phosphorylation was blocked by targeted inhibitors of PI3K (LY 294002), Akt (Akt inhibitor), PKC (bisindolylmaleimide I, staurosporine), p38 MAPK (SB 203580), ERK (PD 98059), c-Jun N-terminal kinase (JNK) (SP 600125), and NF-kB (Bay 11-7082, SN50) pathways, respectively (Fig. 2B?E).",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Physiol 2010 Jul 224(1) 187-94",
                "id": "20232318"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81f1"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "embryonic stem cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Figure 4. S939 and T1462 Are the Major PI3K-Dependent Phosphorylation Sites on Tuberin",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2002 Jul 10(1) 151-62",
                "id": "12150915"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81f0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Thrombin induces the activation of platelet serine/threonine kinase Akt. Akt activation is dependent on its phosphorylation at threonine 308 and serine 473. ",
              "citation": {
                "type": "PubMed",
                "name": "J Thromb Haemost 2007 Sep 19",
                "id": "17883592"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81ef"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Blood Platelets",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Jun 11 274(24) 17184-92",
                "id": "10358076"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81ee"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Akt signaling results in increased P-selectin levels, ROS production, and ?IIb?3 activation.",
              "citation": {
                "type": "PubMed",
                "name": "Infect Immun 2002 Dec 70(12) 6524-33",
                "id": "12438321"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81ed"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Blood Platelets",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "However, in response to activated Akt, the IKKb-/- cells were deficient in NF-kB-dependent transcriptional activation, and, furthermore, reintroduction of IKKb by transfection restored this activity.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Jun 1 276(22) 18934-40",
                "id": "11259436"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81ec"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "What is the implication of these findings for human disease? Since various growth factors that contribute to atherosclerosis have been shown to increase Akt activity,27 atherogenic stimuli may activate Akt in the vasculature and thus promote atherogenesis.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2004 Apr 3(4) 449-51",
                "id": "15004530"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81eb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Atherosclerosis",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Fig. 5, the ErbB-3 shRNA efficiently down-regulated ErbB-3 in both the Calu-3 and H3255 cells, leading to a marked reduction in phospho-Akt levels and demonstrating that ErbB-3 couples to the PI3K/Akt pathway in these cells.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2005 Mar 8 102(10) 3788-93",
                "id": "15731348"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81ea"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Ang II enhances TAL NO production via activation of AT(2) and Akt1-dependent phosphorylation of NOS3 at serines 1177 and 633",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2010 May 14 285(20) 14932-40",
                "id": "20299462"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81e9"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Renal Epithelial Cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "p85 beta-/- cells, however, exhibit significantly increased insulin-induced Akt activation, leading to increased anti-apoptosis",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Nov 28 278(48) 48453-66",
                "id": "14504291"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81e8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "brown adipocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "in tubules expressing dominant-negative Akt, endothelin-1 failed to inhibit NKCC2 activity (17 +- 11%; n = 5).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2009 Jan 16 284(3) 1454-60",
                "id": "19033447"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81e7"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Fig. 6A shows that phosphorylation of Nur77 by Akt decreased the transcriptional activity of Nur77 by '50%.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2001 Mar 27 98(7) 3690-4",
                "id": "11274386"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81e6"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Oct 31 278(44) 43363-72",
                "id": "12917431"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81e5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1997 May 30 272(22) 14426-33",
                "id": "9162082"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81e4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Additionally, Syk and Vav1 cooperatively induced activation of Jun N-terminal kinase (JNK), extracellular-signal-regulated kinase 2 (ERK2) and the kinase Akt, and phosphorylation of the oncoprotein Cbl in fibrinogen-adherent cells.",
              "citation": {
                "type": "PubMed",
                "name": "Curr Biol 1998 Dec 3 8(24) 1289-99",
                "id": "9843681"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81e3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "PDK can in turn phosphorylate and activate Akt [also known as protein kinase B (PKB)] as well as the atypical protein kinase C isoforms PKCz and PKCl",
              "citation": {
                "type": "PubMed",
                "name": "Trends Cell Biol 2002 Feb 12(2) 65-71",
                "id": "11849969"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81e2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Reduced Akt phosphorylation/activation may be responsible for the decreased mTOR signaling, as indicated by down-regulation of the phosphorylation of mTOR downstream target proteins, including 4EBP1 (Thr37/46), S6K1 (Thr389), and S6 (Ser235/236).",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2010 Nov 1 49(8) 1255-62",
                "id": "20638473"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81e1"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 1999 Nov 12 461(1-2) 120-4",
                "id": "10561508"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81e0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "SHP-2 knockdown resulted in increased AKT phosphorylation, without effect on ERK1/2 or p38MAPK.",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 2008 Jul 18 103(2) 149-58",
                "id": "18566342"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81df"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": "vascular smooth muscle"
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Nat Med 2002 Oct 8(10) 1145-52",
                "id": "12244301"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81de"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Further analysis revealed that HABP induced phosphorylation of other cellular proteins including the protein kinase Akt/PKB and the p70S6 kinase (p70 S6K).",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2005 Dec 17(12) 1486-94",
                "id": "16153533"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81dd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "In addition, Akt-mediated down-regulation of peroxisome proliferator-activated receptor (PPAR) gamma coactivator-1 (PGC-1) and PPAR-alpha may shift myocytes toward glycolytic metabolism shown to preserve cardiomyocyte function and survival during transient ischemia. [Akt in this context is Akt1 - SE]",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Jun 21 277(25) 22528-33",
                "id": "11956204"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81dc"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "cardiomyocyte",
                "tissue": "cardiac muscle"
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "S100A4 is a direct target of ERBB2 signaling in medulloblastoma cells via a pathway involving phosphatidylinositol 3-kinase, AKT1, and extracellular signal-regulated kinase 1/2",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2003 Jan 1 63(1) 140-8",
                "id": "12517790"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81db"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 1999 Feb 15 162(4) 2087-94",
                "id": "9973482"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81da"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "This was in contrast to PKBalpha, where ceramide treatment led to inhibition of kinase activity concomitant with a reduction in Ser-473 phosphorylation (62). ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Aug 3 276(31) 29550-8",
                "id": "11387345"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81d9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Aug 13 279(33) 34733-40",
                "id": "15181014"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81d8"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "To investigate whether PI(3)K and protein kinase B (PKB) were involved in insulin-induced phosphorylation of AFX, we co-expressed HAAFX with active forms of PI(3)K or PKB. Constitutively active, but not inactive, forms of PI(3)K or PKB induced a strong increase in HAAFX phosphorylation (Fig. 1c).",
              "citation": {
                "type": "PubMed",
                "name": "Nature 1999 Apr 15 398(6728) 630-4",
                "id": "10217147"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81d7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2003 Jan 1 63(1) 236-41",
                "id": "12517803"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81d6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "LO potently downregulated the PI3K and Akt kinases, while partially inhibiting MEK kinase activity.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2003 Apr 23(7) 2251-63",
                "id": "12640111"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81d5"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "IL-18 induced CXCL16 expression via a MyD88 --> IRAK1-IRAK4-TRAF6 (tumor necrosis factor receptor-associated factor 6) --> c-Src--> PI3K --> Akt --> JNK --> AP-1 pathway.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 May 11",
                "id": "15890643"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81d4"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": "vascular smooth muscle"
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "HB-EGF induced AKT phosphorylation but not STAT3 phosphorylation (Figure 5A Figure 5 , lane 3). ",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2004 Mar 1 103(5) 1829-37",
                "id": "14576062"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81d3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Multiple Myeloma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Feb 14 278(7) 5242-9",
                "id": "12456685"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81d2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "In the present work, we studied LPA2-mediated signaling using human colon cancer cell lines, which predominantly express LPA2. LPA2 activated Akt and Erk1/2 in response to LPA.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2005 Jul 289(1) C2-11",
                "id": "15728708"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81d1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "From full text:  In tumor cells AKT phosphorylates transcription factor AFX in PI3-kinase signaling pathway Phosphorylated AFX could not translocate to nucleus for its further activity Mutant AFX was derived to inhibit its phosphorylation",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Apr 19 277(16) 14255-65",
                "id": "11777915"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81d0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Jun 24(12) 5565-76",
                "id": "15169915"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81cf"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "the H(3)R modulates the activity of the Akt/Glycogen synthase kinase 3beta (GSK-3beta) axis both in a constitutive and agonist-dependent fashion. H(3)R stimulation with the H(3)R agonist immepip induces the phosphorylation of both Ser473 and Thr308 on Akt,",
              "citation": {
                "type": "PubMed",
                "name": "J Neurochem 2007 Oct 103(1) 248-58",
                "id": "17623045"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81ce"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Mechanistically, the loss of Akt1 reduces the basal phosphorylation of several Akt substrates, the migration of fibroblasts and ECs, and NO release. ",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Invest 2005 Aug 115(8) 2119-27",
                "id": "16075056"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81cd"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Dec 3 274(49) 34795-802",
                "id": "10574950"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81cc"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "AKT activation resulted in the repression of c-myc, early growth response 1 (EGR1), transforming growth factor beta receptor III (TGF-betar III), and thrombospondin-1 (THBS1)",
              "citation": {
                "type": "PubMed",
                "name": "Physiol Genomics 2001 Dec 21 7(2) 105-14",
                "id": "11773597"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81cb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Time course experiments clearly indicated NGF-induced transient phosphorylation in ECs of all three major signaling molecules Erk1/2, Akt and PLCg. The NGF-induced phosphorylation of these signaling molecules was blocked by K252a, a TrkA inhibitor, confirming that these signaling pathways are initiated by NGF-stimulated TrkA receptors in ECs. ",
              "citation": {
                "type": "PubMed",
                "name": "Vascul Pharmacol 53(3-4) 107-14",
                "id": "20434587"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81ca"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Table 1    Genes with altered expression in PKBalpha-/- FACS sorted DN3 thymocyte subset compared to PKBalpha+/+ cells.",
              "citation": {
                "type": "PubMed",
                "name": "PLoS ONE 2007 2(10) e992",
                "id": "17912369"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81c9"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": "DN3 thymocyte"
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "mTORC2 can be activated by PI3K directly and phosphorylates Akt at S473, which together with phosphorylation at T308 results in the full activation of Akt [12,13].",
              "citation": {
                "type": "PubMed",
                "name": "J Leukoc Biol 2007 Apr 81(4) 1102-10",
                "id": "17200144"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81c8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "CD8+ T-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Jul 16 274(29) 20693-703",
                "id": "10400703"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81c7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Overexpression of PKCalpha increases Ser473 phosphorylation and Akt-1 activity, while inhibition of its activity or expression decreases IGF-1-dependent activation of Akt-1...Furthermore, in vitro, in the presence of phospholipids and calcium, PKCalpha directly phosphorylates Akt-1 at the Ser473 site.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2004 Aug 16(8) 951-7",
                "id": "15157674"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81c6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Furthermore, Akt, another phosphatidylinositol 3-kinase effector and regulator of S6K1, also increased Thr(389) phosphorylation in a S6K1 activity-dependent manner.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Oct 25 277(43) 40281-9",
                "id": "12183455"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81c5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "We found that, in contrast to Akt1 that induces CREB phosphorylation at Ser-133 and CREB target gene expression, Akt2 was unable to induce CREB phosphorylation at Ser-133 in vivo and CREB target gene expression. This difference is specific to CREB as both Akt1 and Akt2 similarly inhibits FoxO1 mediated gene expression. ",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2007 Mar 23 354(4) 1061-6",
                "id": "17276404"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81c4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Our data demonstrated that Akt1 mediated the phosphorylation of Bad at serine 136, which increased the interaction of serine 136-phosphorylated Bad with 14-3-3 proteins and prevented the dimerization of Bad with Bcl-Xl, inhibited the release of cytochrome c to the cytosol and the death effector caspase-3 activation, leading to the survival of neuron.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2007 Sep 19(9) 1844-56",
                "id": "17555943"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81c3"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "neuron",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Our studies indicate that neuropilin-1 maintains constitutively elevated Akt activity in invasive breast carcinoma cells that contributes to cell survival [18]. The fact that these carcinoma cells lack consensus tyrosine kinase VEGF receptors indicates that VEGF autocrine signaling occurs in the context of relevant neuropilin-1 co-receptors that have not yet been identified in these cells.",
              "citation": {
                "type": "PubMed",
                "name": "Semin Cancer Biol 2004 Apr 14(2) 115-22",
                "id": "15018895"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81c2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2004 Jan 16(1) 31-41",
                "id": "14607273"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81c1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Science 1999 Nov 26 286(5445) 1741-4",
                "id": "10576742"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81c0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Here, we demonstrate that Akt phosphorylates the androgen receptor (AR) at Ser-210 and Ser-790.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2001 Jun 19 98(13) 7200-5",
                "id": "11404460"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81bf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2000 Oct 1 60(19) 5390-4",
                "id": "11034077"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81be"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "In turn, Akt phosphorylates the tuberous scleorisis complex, TSC1/TSC2 (hamartin/tuberin) that serves as a GTPase activating protein (GAP) for the small G protein, Ras homolog enriched in brain (Rheb).",
              "citation": {
                "type": "PubMed",
                "name": "Br J Cancer 2006 Jan 30 94(2) 195-9",
                "id": "16404421"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81bd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Akt1 and Akt2 are required for the induced expression of PPARgamma, the master regulator of adipogenesis, establishing a new essential role for Akt in adipocyte differentiation",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2003 Jun 1 17(11) 1352-65",
                "id": "12782654"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81bc"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Finally, ILK reduction by siRNA inhibited strain-induced phosphorylation of myosin light chain and Akt.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2011 Feb 300(2) C356-67",
                "id": "21084641"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81bb"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "ADRP ASO decreased the levels of key gluconeogenic enzymes, G6Pase, and, to a lesser extent, PEPCK (Fig. 6, A and B). ADRP ASO increased the tyrosine phosphorylation of IRS1 and IRS2 (Fig. 6, C and D), p85 subunit of PI3-kinase (Fig. 6E), and Akt phosphorylation (Fig. 6F). On the other hand, ADRP ASO suppressed the protein and mRNA levels of PKC? in the liver (Fig. 6, G and H).",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Gastrointest Liver Physiol 2008 Sep 295(3) G621-8",
                "id": "18669627"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81ba"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Consistent with EGFR activation, AKT and ERK phosphorylation was also observed during the course of ATP-?-S stimulation. Furthermore, ATP-?-S also elicited a similar response in primary HCE cells and BEAS 2B cells, although its effect on signaling in BEAS 2B cells was more transient than that in THCE cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 2007 Mar 1 120(Pt 5) 815-25",
                "id": "17284517"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81b9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "bronchial epithelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2003 Feb 15 170(4) 2093-9",
                "id": "12574380"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81b8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Finally, we found that Cdk5 activity is involved in neuregulin-induced Akt activity and neuregulin-mediated neuronal survival. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Sep 12 278(37) 35702-9",
                "id": "12824184"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81b7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Gastrointest Liver Physiol 2003 May 284(5) G837-52",
                "id": "12684215"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81b6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "It has recently been shown that Akt directly phosphorylates AMPKalpha(1)/alpha(2) on Ser(485/491) in vitro and prevents the AMPK kinase (AMPKK) LKB1 from phosphorylating AMPKalpha at its primary activation site, Thr(172) (S Horman, D Vertommen, R Heath, D Neumann, V Mouton, A Woods, U Schlattner, T Wallimann, D Carling, L Hue, and MH Rider. J Biol Chem 281: 5335-5340, 2006). ",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Heart Circ Physiol 2006 Jun 290(6) H2472-9",
                "id": "16428351"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81b5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Fig.1",
              "citation": {
                "type": "PubMed",
                "name": "Science 2004 Nov 26 306(5701) 1506-7",
                "id": "15567848"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81b4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Neurosci 2000 Sep 15 20(18) 6962-7",
                "id": "10995840"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81b3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "We show that in Jurkat cells, activated forms of Rac1 or Cdc42, but not Rho, stimulate an increase in Akt/PKB activity.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2000 Aug 20(15) 5469-78",
                "id": "10891487"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81b2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Immunoblotting revealed a 40% reduction in cyclin B1 expression in cells transfected with inactive Akt1 compared to WT Akt1 (Fig. 11A).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2002 Oct 22(20) 7226-41",
                "id": "12242299"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81b1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Overexpressed IRS-3 as well as IRS-1 enhanced phosphoinositide (PI) 3-kinase activity in response to insulin and increased phosphorylation of protein kinase B (PKB) at S473 and phosphorylation of one of the members of the forkhead transcription factor FKHRL1 on T32 in both insulin-untreated and -treated states.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2003 Jan 10 300(2) 371-7",
                "id": "12504093"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81b0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "The pathway consisting of PI3K, Akt, and mammalian target of rapamycin (mTOR), which is downstream of EGFR, is activated early in lung carcinogenesis.83  (-- indicated as early event by authors)",
              "citation": {
                "type": "PubMed",
                "name": "N Engl J Med 2008 Sep 25 359(13) 1367-80",
                "id": "18815398"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81af"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Lung Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "positive regulatory events, such as activation of Syk, Btk, JNK, p38, Akt, and NF-kappaB, are substantially reduced in hck(-/-) mast cells. ",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2007 May 18",
                "id": "17513616"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81ae"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "mast cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2000 Jun 12 149(6) 1297-308",
                "id": "10851026"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81ad"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Previous data from our group showed that Pam3CSK4-stimulation of TLR2 activates the PI3K/Akt signaling pathway (8). Here, we measured the phosphorylation kinetics of Akt(Ser473) as a downstream target of PI3K after platelet activation with thrombin or Pam3CSK4 for up to 15 minutes (Figure 2A).",
              "citation": {
                "type": "PubMed",
                "name": "Thromb Haemost 2009 Jul 102(1) 97-110",
                "id": "19572074"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81ac"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Blood Platelets",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Furthermore, we showed that the interaction between PLC-gamma1 and Akt resulted in the phosphorylation of PLC-gamma1 S1248 by Akt.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 2006 May 17(5) 2267-77",
                "id": "16525023"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81ab"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "PRAS40 silencing inactivates insulin-receptor substrate-1 (IRS-1) and Akt, and uncouples the response of mTOR to Akt signals. ",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2007 Mar 9(3) 316-23",
                "id": "17277771"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81aa"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Phosphorylation of Akt (downstream target of PI3K) was decreased in hearts of Grb14 KO mice in comparison with hearts from WT mice (Figure 1E).",
              "citation": {
                "type": "PubMed",
                "name": "Arterioscler Thromb Vasc Biol 2010 Apr 30(4) 724-32",
                "id": "20237330"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81a9"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "The concomitant phosphatidylinositol 3-kinase/Akt activation and glycogen synthase kinase 3-beta phosphorylation induced the inhibition of the proteasomal degradation of beta-catenin.",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 2008 Sep 26 103(7) 694-701",
                "id": "18703780"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81a8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Leukoc Biol 2000 Nov 68(5) 655-61",
                "id": "11073104"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81a7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "uman pDCs were isolated from normal healthy volunteers and subjected to fresh CSE and the levels of IL-8, TNF-alpha, IP-10, IL-6, IL-1, IL-12 and IL-10 and IFN-alpha were studied by both ELISA and real time PCR methods. We observed that CSE augmented the production of IL-8 and suppressed the release of TNF-alpha, IL-6 and IFN-alpha. Moreover, CSE suppressed PI3K/Akt signalling in pDC.",
              "citation": {
                "type": "PubMed",
                "name": "Respir Res 2009 10 47",
                "id": "19515231"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81a6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "dendritic cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2002 Jun 22(12) 4062-72",
                "id": "12024020"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81a5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cancer Res 2003 Apr 1(6) 475-84",
                "id": "12692267"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81a4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Neurosci 1999 May 1 19(9) 3277-86",
                "id": "10212287"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81a3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "MLKB1KO mice had increased insulin-stimulated Akt phosphorylation and a 80% decrease in muscle expression of TRB3, a recently identified Akt inhibitor",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2006 Nov 26(22) 8217-27",
                "id": "16966378"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81a2"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": "Muscle, Skeletal"
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 2002 Jun 19 521(1-3) 180-4",
                "id": "12067713"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81a1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "The (PPARG) agonists appeared to potentiate Akt1 phosphorylation in muscle and liver and both Akt1 and Akt2 in adipose",
              "citation": {
                "type": "PubMed",
                "name": "Diabetes 2002 Aug 51(8) 2412-9",
                "id": "12145152"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad81a0"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Adipocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "cells expressing myrAkt maintained higher levels of transferrin receptor on the cell surface in the absence of IL3 than control cells these results indicate that transferrin receptor surface expression is regulated by IL3 and that myrAkt can support growth factor-independent transferrin receptor expression.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 2002 Jul 13(7) 2276-88",
                "id": "12134068"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad819f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "VEGFVEGR interactions result in the activation of the MAPK and PI3K-Akt signaling pathways in human CD4+ T cells",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2010 Jan 15 184(2) 545-9",
                "id": "20008289"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad819e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "CD4+ T-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "We also show that Akt leads to the accumulation of nuclear SREBP-1 but not SREBP-2, and that activation of SREBP is required for Akt-induced activation of the FAS promoter.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2005 Sep 29 24(43) 6465-81",
                "id": "16007182"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad819d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Western blots revealed that p53 was stabilized in HCT116 PTEN(-/-) cells via an Akt1-dependent and p14(ARF)-independent mechanism",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2007 Jan 27(2) 662-77",
                "id": "17060456"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad819c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "PKB also plays an important role in the stimulaiton of glycogen synthase by insulin via the phosphoryaltion and inactivation of glycogen synthase kinase-3",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Sep 13 277(37) 33895-900",
                "id": "12107176"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad819b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "We show that AHNAK is a phosphorylation substrate of protein kinase B (PKB) in vitro and in vivo.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2001 Sep 3 154(5) 1019-30",
                "id": "11535620"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad819a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Figure 4 shows the inhibitory effect of gefitinib on EGFinduced autophosphorylation of EGFR, and phophorylation of Akt and ERK1/2 in three of the NSCLC cell lines. EGF stimulated EGFR autophosphorylation and activation of Akt and ERK1/2 in PC9 (A), A549 (B), and QG56 (C) cells, and activation was blocked to different extents by gefitinib.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cancer Ther 2004 Apr 3(4) 465-72",
                "id": "15078990"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8199"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "the mutation S256A greatly reduced the rate of phosphorylation of Thr-24 and Ser-319 by PKB in ?itro,",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2001 Mar 15 354(Pt 3) 605-12",
                "id": "11237865"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8198"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "As shown in Fig. 6A, Akt phosphorylation was induced by roflumilast (30 uM) treatment and sustained until 3 h.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2008 May 20(5) 803-14",
                "id": "18276108"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8197"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Aug 2 277(31) 28118-26",
                "id": "12011061"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8196"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Taken together, these results demonstrate that IL-33 stimulates the production of endothelial NO via a ST2/TRAF6- mediated PI3K/Akt/eNOS signaling pathway.",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2009 Oct 1 114(14) 3117-26",
                "id": "19661270"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8195"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "umbilical vein endothelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Akt selectively triggers NFkB p65/RelA heterodimer activation to coordinate monocyte and neutrophil recruitment in response to smoke and infection.",
              "citation": {
                "type": "PubMed",
                "name": "Int J Chron Obstruct Pulmon Dis 2006 1(1) 31-8",
                "id": "18046900"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8194"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Depletion of cholesterol from the cells using beta-cyclodextrin blocked insulin stimulation of glucose uptake, insulin inhibition of perilipin phosphorylation in response to isoproterenol, and insulin stimulation of protein kinase B and Map-kinases extracellular signal-related kinase (ERK)1/2 phosphorylation",
              "citation": {
                "type": "PubMed",
                "name": "Eur J Biochem 2004 Jun 271(12) 2471-9",
                "id": "15182363"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8193"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Insr(-/-) macrophages showed diminished Akt phosphorylation and an augmented ER stress response, leading to induction of scavenger receptor A and increased apoptosis when challenged with cholesterol loading or nutrient deprivation. ",
              "citation": {
                "type": "PubMed",
                "name": "Cell Metab 2006 Apr 3(4) 257-66",
                "id": "16581003"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8192"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Jul 5 277(27) 24169-79",
                "id": "11976320"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8191"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Moreover, we find that activation of the PI3K/Akt pathway by insulin-like growth factor-1 alters Mdm2-mediated GRK2 degradation, leading to enhanced GRK2 stability and increased kinase levels.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2006 Oct 18 25(20) 4752-4762",
                "id": "17006543"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8190"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Akt-dependent phosphorylation of Bad on Ser112 and Ser136 allows it to associate with 14-3-3 proteins and thereby suppresses its pro-apoptotic activity. Apoptotic kinases including JNK directly activate the cell death machinery by phosphorylating Bad at Serine 128 (Donovan et al., 2002Go). The phosphorylation of Bad at this residue disrupts the interaction of Bad with 14-3-3 proteins, thus allowing Bad to induce apoptosis (Konishi et al., 2002Go).",
              "citation": {
                "type": "PubMed",
                "name": "J Neurosci 2003 Dec 10 23(36) 11373-81",
                "id": "14673001"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad818f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "As shown in Figure 3a, fibronectin induced the phosphorylation of the PI3-K downstream signal, Akt, starting at 30 min, while it had no effect on total Akt and protein kinase C (PKC) levels.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2006 Jul 20 25(31) 4341-9",
                "id": "16518410"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad818e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Nature 1999 Jun 10 399(6736) 601-5",
                "id": "10376603"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad818d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": ": In vitro, gefitinib inhibited cell proliferation with differing IC(50), and suppressed activation of EGFR and downstream signaling molecules protein kinase B (AKT), extracellular signal-regulated kinase 1/2, signal transducer and activator of transcription 3 (STAT3), and nuclear factor kappaB. ",
              "citation": {
                "type": "PubMed",
                "name": "Clin Cancer Res 2009 Apr 1 15(7) 2361-72",
                "id": "19318490"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad818c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "These results indicate that NADPH oxidase (CYBB catalytic subunit)-derived ROS play an important role in NF-kB activation by promoting Akt and NIK phosphorylation and PTEN oxidation.",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2008 Sep 15 45(6) 885-96",
                "id": "18620044"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad818b"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 2002 Mar 143(3) 820-8",
                "id": "11861503"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad818a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2002 Aug 1 62(15) 4491-8",
                "id": "12154060"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8189"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "On the other hand, overexpression of MelCAM activated endogenous AKT and inhibited proapoptotic protein BAD in melanoma cells, leading to increased survival under stress conditions.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2003 Oct 9 22(44) 6891-9",
                "id": "14534536"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8188"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "melanoma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Further analysis showed that the TamR-1 cells had elevated levels of BAD phosphorylated on ser112 and ser136 (Fig. 4A),which was inhibited byU0126 and SH6 respectively, confirming the involvement of pRPS6KA2 and AKT respectively",
              "citation": {
                "type": "PubMed",
                "name": "Endocr Relat Cancer 2008 Dec 15(4) 985-1002",
                "id": "18824559"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8187"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Moreover, results showed that Akt kinase activated by EPO directly phosphorylated FKHRL1 protein",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2000 Aug 1 96(3) 941-9",
                "id": "10910908"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8186"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "leukemia",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": " Furthermore, we investigated the quantitative contribution of BAD targeting kinases in phosphorylating serine residues 75, 99, and 118",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2009 Oct 9 284(41) 28004-20",
                "id": "19667065"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8185"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "This survival-promoting activity is totally due to IL-10 stimulating the insulin receptor substrate-2/PI 3-kinase/Akt pathway, which increases the anti-apoptotic activity of ERK1/2.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2001 Oct 15 167(8) 4436-42",
                "id": "11591769"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8184"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "We used phosphospecific antibodies to Erk1/2 and Akt (protein kinase B) to determine whether these pathways are activated in response to CXCL12 in brain tumor cells. CXCL12 stimulates activation of Erk1/2 and Akt in both medulloblastoma and glioblastoma cells (Fig. 6, which is published as supporting information on the PNAS web site). In both Daoy and U87 cells, these rapid responses to CXCL12 are attenuated by AMD 3100.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2003 Nov 11 100(23) 13513-8",
                "id": "14595012"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8183"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Thus overexpression of CD98 and truncation mutants able to interact with ?1 integrins result in increased FAK and AKT phosphorylation.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 2005 Mar 1 118(Pt 5) 889-99",
                "id": "15713750"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8182"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Renal Epithelial Cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "we transiently cotransfected NSCLC cell lines with HA-tagged dominant negative Akt/PKB (K179M Akt/PKB) and GFP and assessed apoptosis in the GFP-positive cells. Fig. 6 shows that in the cell lines with high Akt/PKB activity, transfection of K179M Akt/PKB resulted in a 25-fold increase in basal apoptosis.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer research 2001 May 15;61(10):3986-97",
                "id": "11358816"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8181"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Carcinoma, Non-Small-Cell Lung",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "In this paper, we present a comprehensive pathway map of EGFR signaling and other related pathways. The map reveals that the overall architecture of the pathway is a bow-tie (or hourglass) structure with several feedback loops.  See figure 2: The bow-tie architecture of the EGFR signaling pathway.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Syst Biol 2005 1 2005.0010",
                "id": "16729045"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8180"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Loss of phosphorylated FAK (p-FAK) resulted in a rapid dephosphorylation of the p-FAK-dependent downstream mediator Akt.",
              "citation": {
                "type": "PubMed",
                "name": "Arterioscler Thromb Vasc Biol 2003 Feb 1 23(2) 238-43",
                "id": "12588765"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad817f"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "VEGFR2 forms a complex with VE-cadherin, -catenin, and PI3 kinase that is required for phosphorylation of Akt, which plays an important role in EC survival (15) and migration (27, 28, 80).",
              "citation": {
                "type": "PubMed",
                "name": "Antioxid Redox Signal 2007 Jun 9(6) 731-9",
                "id": "17511588"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad817e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "The phosphatidylinositol 3-kinase (PI 3-kinase)/Akt signaling pathway is an important mediator of growth factor-dependent survival of mammalian cells. A variety of targets of the Akt protein kinase have been implicated in cell survival, including the protein kinase glycogen synthase kinase 3beta (GSK-3beta).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2002 Jan 22(2) 578-86",
                "id": "11756553"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad817d"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "It was shown that the Rac1 peptide and the recombinant protein were phosphorylated by the activated recombinant Akt kinase and the lysate of SK-MEL28 cells, a human melanoma cell line.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Jan 7 275(1) 423-8",
                "id": "10617634"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad817c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "melanoma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 1999 May 25 96(11) 6199-204",
                "id": "10339565"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad817b"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Akt then phosphorylates tuberin on three residues (S939, S1130 and T1462 of full length human tuberin), and this inhibits the tuberin-hamartin complex through an as-yet-undefined mechanism (reviewed in [8]).",
              "citation": {
                "type": "PubMed",
                "name": "Trends Biochem Sci 2003 Nov 28(11) 573-6",
                "id": "14607085"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad817a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "In this study, we find that expression of Akt reduces the protein levels of p53, at least in part by enhancing the degradation of p53.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Jun 14 277(24) 21843-50",
                "id": "11923280"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8179"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Indeed, LY294002 treatment reduced anti-CD3 induced GSK3 phosphorylation downstream of PI3K (Figure 5C, see also Figure 6B, D) as well as AKT phosphorylation (not shown). Moreover, the increase in beta-catenin levels was also drastically reduced in the presence of this inhibitor (Figure 5C, Figure 6 B, D).",
              "citation": {
                "type": "PubMed",
                "name": "PLoS One 2010 5(9)",
                "id": "20862283"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8178"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "In addition to PLCgamma2, both pAkt and alpha-tubulin were found to be associated with Syk in control cells and these associations were slightly increased following IL-4 stimulation and attenuated by piceatannol treatment (Fig. 2, B and C, respectively).",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2009 Oct 15 183(8) 5261-9",
                "id": "19783684"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8177"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "The serine/threonine kinase Akt (also known as protein kinase B) (Akt/PKB) is activated upon T-cell antigen receptor (TCR) engagement or upon expression of an active form of phosphatidylinositide (PI) 3-kinase in T lymphocytes.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2000 Aug 20(15) 5469-78",
                "id": "10891487"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8176"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "PI3K activation, however, results in the recruitment of the serine/threonine kinase PDK1 (3-phosphoinositidedependent protein kinase 1) to the plasma membrane, where PDK1 subsequently phosphorylates and activates another serine/threonine kinase, AKT 86. AKT positively regulates the function of the transcription factor NF-kB by phosphorylating inhibitor of NF-kB (IkB), which is a key regulator of NF-kB 87.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Immunol 2006 Mar 6(3) 218-30",
                "id": "16470226"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8175"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "mast cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Stimulation of VEGFR3 alone protected these cells from serum-deprivation-induced apoptosis and induced cell growth and migration.At least some of these signals were transduced via a protein- kinase-C-dependent activation of the p42/p44 mitogen-activated protein kinase (MAPK) signalling cascade and via AKT phosphorylation40.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2002 Aug 2(8) 573-83",
                "id": "12154350"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8174"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Akt suppresses TSC1/2, leading to the activation of mTOR.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2007 Jan 1 67(1) 1-4",
                "id": "17210675"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8173"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2004 Nov 11 23(53) 8571-80",
                "id": "15467756"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8172"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 May 31 277(22) 19382-8",
                "id": "11896055"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8171"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "As shown in Figure 7A, miR-34b/c caused a significant reduction of phosphorylated Akt in SP6.5 cells, but had no obvious effect on ERK1/2 phosphorylation. Neither total Akt nor ERK1/2 expression changed significantly (Figure 7A).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Vis 2012 18 537-46",
                "id": "22419847"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8170"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "melanoma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Transfection of Akt stimulated the incorporation of 32P in cells overexpressing the p21Cip1 wild type (p21 wt), whereas radioactive labeling of the T145A construct in response to Akt overexpression was markedly lower (Fig. 3C)....Taken together, the present data demonstrate that Akt interacts with and phosphorylates p21Cip1 in vitro and in vivo at Thr 145.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2001 Aug 21(16) 5644-57",
                "id": "11463845"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad816f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "umbilical vein endothelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2002 Apr 18 21(17) 2721-8",
                "id": "11965545"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad816e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2003 Jul 23(13) 4511-21",
                "id": "12808093"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad816d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "CO activated p38 MAPK, pERK1/2 and Akt at 30 min as determined by phosphorylation in a dose (Figure 4A) and time (Figure 4B) dependent manner.",
              "citation": {
                "type": "PubMed",
                "name": "PLoS One 2009 4(12) e8139",
                "id": "19956541"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad816c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1998 Nov 6 273(45) 29600-6",
                "id": "9792669"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad816b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2002 Oct 10(4) 721-33",
                "id": "12419217"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad816a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Aug 30 277(35) 32124-32",
                "id": "12052830"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8169"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "YC-1, in a cGMP-independent manner, inhibited lipopolysaccharide-induced Akt activation, IkappaBalpha degradation and NF-kappaB translocation, all of which are associated with co-stimulatory molecules expression. ",
              "citation": {
                "type": "PubMed",
                "name": "Int Immunopharmacol 2007 Oct 7(10) 1299-310",
                "id": "17673145"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8168"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "dendritic cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Feb 24(4) 1493-504",
                "id": "14749367"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8167"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1999 Jun 10 18(23) 3440-51",
                "id": "10376522"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8166"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Recombinant human (rh) CyPA activated ERK1/2, p38MAPK, SAPKs, and Akt in cultured cardiac myocytes. Furthermore, CyPA significantly increased Bcl-2 in cardiac myocytes.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2004 Apr 23 317(1) 162-8",
                "id": "15047162"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8165"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "cardiomyocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "ectopic expression of either Pim-2 or Akt-1 induced increased cell size and apoptotic resistance.",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2005 Jun 1 105(11) 4477-83",
                "id": "15705789"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8164"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Biochim Biophys Acta 2003 Oct 20 1630(1) 35-40",
                "id": "14580677"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8163"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Invest 2001 May 107(9) 1193-202",
                "id": "11342583"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8162"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "GSK-3 activity is inhibited through phosphorylation of serine 21 in GSK-3 alpha and serine 9 in GSK-3 beta. These serine residues of GSK-3 have been previously identified as targets of protein kinase B (PKB/Akt), a serine/threonine kinase located downstream of phosphatidylinositol 3-kinase.      ",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2000 Oct 24 97(22) 11960-5",
                "id": "11035810"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8161"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "These data demonstrate that Ser 939, Ser 1086/Ser 1088 and Thr 1422 are required for proper in vivo phosphorylation of TSC2 and suggest that they are the Akt-dependent phosphorylation sites.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2002 Sep 4(9) 648-57",
                "id": "12172553"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8160"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Mechanistically, the loss of Akt1 reduces the basal phosphorylation of several Akt substrates, the migration of fibroblasts and ECs, and NO release. ",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Invest 2005 Aug 115(8) 2119-27",
                "id": "16075056"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad815f"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Phosphorylation and activation of each enzyme required the presence of PtdIns (3,4,5)P3",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 1998 Apr 1 331 ( Pt 1) 299-308",
                "id": "9512493"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad815e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "IGF-1 stimulates the phosphorylation of Thr24, Ser256, Ser319, Ser322 and Ser325 in embryonic stem (ES) cells, but not in PDK1-/- ES cells, providing genetic evidence that PDK1 (the upstream activator of PKB) is required for the phosphorylation of FKHR in mammalian cells.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2002 May 1 21(9) 2263-71",
                "id": "11980723"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad815d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "we found that in U2OS cells, cisplatin treatment results in activation of Akt, as judged by phosphorylation at Ser 473 and by phosphorylation of GSK3b at Ser 9, whereas UV-C treatment has the opposite effect (Figures 4A and 4B).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2010 May 28 38(4) 524-38",
                "id": "20513428"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad815c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Aug 20 274(34) 24202-10",
                "id": "10446195"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad815b"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Knock-down of ILK by small, interfering RNA (siRNA) attenuated Akt phosphorylation in response to ligation of beta1 integrin by collagen or activating antibody and enhanced fibroblast apoptosis in response to collagen contraction. Kinase dead ILK attenuated Akt phosphorylation and enhanced fibroblast apoptosis, whereas hyperactive and wild type ILK augmented Akt phosphorylation and protected fibroblasts from apoptosis. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Jul 15 280(28) 26630-9",
                "id": "15905178"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad815a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Phosphorylation status of the three key MAPKs (ERK, JNK, and p38) and AKT in FIZZ2-treated MLFs were analyzed by Western blotting. The results showed rapid (10 min) marked activation of ERK by FIZZ2, with lesser effects on AKT and p38 (Fig. 5B). JNK was not activated by FIZZ2 treatment. ",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2011 Jul 1 187(1) 450-61",
                "id": "21602491"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8159"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "The rate of the BDNF-induced nuclear/cytosolic redistribution was consistent with the time course of BDNF-induced threonine32-phosphorylation of FOXO3a, and was mediated by the PI3K/Akt signaling pathway.",
              "citation": {
                "type": "PubMed",
                "name": "Brain Res Mol Brain Res 2004 Jul 5 126(1) 45-56",
                "id": "15207915"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8158"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Phosphorylation of Ser780 in pRb protein is mediated by the cyclin D1/cdk4 complex (30). A significant increase in endogenous Rb phosphorylation at Ser780 was observed in islets from caAktTg mice, suggesting that cdk4 activity is augmented (Fig. 4B) (P \t 0.05).",
              "citation": {
                "type": "PubMed",
                "name": "Diabetes 2006 Feb 55(2) 318-25",
                "id": "16443763"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8157"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "insulin activated all AKT isoforms in lean muscles, whereas only Akt1 was activated in obese muscles a defect in the ability of insulin to activate Akt2 and Akt3 may explain the impaired insulin-stimulated glucose transport in insulin resistance",
              "citation": {
                "type": "PubMed",
                "name": "Diabetes 2003 Apr 52(4) 935-41",
                "id": "12663464"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8156"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Obesity",
                "cell": "",
                "tissue": "Muscle, Skeletal"
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "In this study we show that in PCCL3 cells 1) TSH inhibits Akt activity via cAMP and PKA; 2) Rap1b is required for cAMP inhibition of Akt; and 3) transduction of the cAMP signal into Akt requires activation as well as phosphorylation of Rap1b by PKA.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Sep 6 277(36) 32799-806",
                "id": "12089143"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8155"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Kit and other RTKs will activate the MAP kinase signaling pathway and has been reported both to increase the transcriptional activity of Mitf as well as down-regulate Mitf protein levels.",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2000 Jul 15 14(14) 1712-28",
                "id": "10898786"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8154"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "In an in vitro Akt kinase assay, phosphorylation of wild-type TTC3, but not S378A-TTC3 (Figure 4B), was detected.",
              "citation": {
                "type": "PubMed",
                "name": "Dev Cell 2009 Dec 17(6) 800-10",
                "id": "20059950"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8153"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1998 Dec 4 273(49) 32377-9",
                "id": "9829964"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8152"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "PKC theta selectively cooperated with Akt1, known to act downstream of CD28 co-receptor signaling, in activating a NF-kappa B reporter in T cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Aug 24 276(34) 31627-34",
                "id": "11410591"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8151"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Insulin resistance in type 2 diabetes is partly due to impaired glucose transport in skeletal muscle. Atypical protein kinase C (aPKC) and protein kinase B (PKB), operating downstream of phosphatidylinositol (PI) 3-kinase and its lipid product, PI-3,4,5-(PO(4))(3) (PIP(3)), apparently mediate insulin effects on glucose transport. insulin receptor substrate (IRS)-1-dependent PI 3-kinase",
              "citation": {
                "type": "PubMed",
                "name": "Diabetes 2003 Aug 52(8) 1926-34",
                "id": "12882907"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8150"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Akt decreased ASK1 kinase activity stimulated by both oxidative stress and overexpression in 293 cells by phosphorylating a consensus Akt site at serine 83 of ASK1.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2001 Feb 21(3) 893-901",
                "id": "11154276"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad814f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Activation of PKB alpha and beta is then achieved at the plasma membrane by phosphorylation of Thr308/309 in the A-loop of the kinase domain and Ser473/474 in the carboxy-terminal regulatory region, respectively.  The upstream kinase that phosphorylates PKB on Thr308, termed PI-dependent protein kinase-1, has been identified and extensively characterised. A candidate for the Ser473/474 kinase, termed the integrin-linked kinase, has been identified recently.",
              "citation": {
                "type": "PubMed",
                "name": "Pharmacol Ther 82(2-3) 409-25",
                "id": "10454216"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad814e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "upregulation of TRB3 through direct transcriptional control by Ppara...TRB3 is an inhibitor of Akt?protein kinase B",
              "citation": {
                "type": "PubMed",
                "name": "Drugs Today (Barc) 2006 Jan 42(1) 39-64",
                "id": "16511610"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad814d"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "AKT1 mediated phosphorylation of GSK3A at serine 21 or GSK3B at serine 9 results in GSK3 inactivation",
              "citation": {
                "type": "PubMed",
                "name": "Biol Reprod 2007 Jul 11",
                "id": "17625112"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad814c"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Exp Cell Res 2004 Aug 1 298(1) 167-77",
                "id": "15242771"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad814b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "We next infected HUVECs with a dominant-negative form of Akt and found that it blocked the Nrf2 activation and HO-1 expression (Figure 7B).",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 2007 Sep 28 101(7) 723-33",
                "id": "17673673"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad814a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "The reduced level of p53 protein in myr-Akt1 salivary glands corresponds with an increase in MDM2 phosphorylation in vivo, suggesting that the Akt/MDM2/p53 pathway is responsible for suppression of apoptosis. Dominant-negative Akt blocked phosphorylation of MDM2 in salivary acinar cells from myr-Akt1 transgenic mice.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2006 Dec 26(23) 8840-56",
                "id": "16982679"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8149"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "As shown in Fig. 6D, a significant decrease (40%) in the induction of p-AKT following STAT3 knockdown was observed.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2009 Mar 15 182(6) 3510-21",
                "id": "19265129"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8148"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Carcinoma, Non-Small-Cell Lung",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "In a study that was recently published in EMBO J,26 we showed that Akt activity increases with cellular senescence and that inhibition of Akt extends the lifespan of primary cultured human endothelial cells.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2004 Apr 3(4) 449-51",
                "id": "15004530"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8147"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2001 Jun 21(11) 3763-74",
                "id": "11340169"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8146"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "While both kinases can phosphorylate Thr-32, SGK displays a marked preference for Ser-315 whereas Akt favors Ser-253.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2001 Feb 21(3) 952-65",
                "id": "11154281"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8145"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1999 Oct 19(10) 7203-15",
                "id": "10490655"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8144"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "insulin activated all AKT isoforms in lean muscles, whereas only Akt1 was activated in obese muscles a defect in the ability of insulin to activate Akt2 and Akt3 may explain the impaired insulin-stimulated glucose transport in insulin resistance",
              "citation": {
                "type": "PubMed",
                "name": "Diabetes 2003 Apr 52(4) 935-41",
                "id": "12663464"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8143"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Muscle, Skeletal"
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "The Akt kinase substrate was GSK3, and the ERKs substrate was Elk1. Our results indicated that phosphorylation of GSK3-a and -b decreased in UVB-treated DNMFyn- JB6 cells (Fig. 9A)....Phosphorylation of Elk1 dramatically decreased in UVB-treated DNM-Fyn-JB6 cells com-pared with WT-Fyn-JB6 cells (Fig. 9C)",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Jan 28 280(4) 2446-54",
                "id": "15537652"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8142"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "The impact of IL-8 binding to AAT or HSA on its ability to stimulate Akt Ser473 phosphorylation, a key step in IL-8? mediated neutrophil chemotaxis (27), was explored. Figure 7D shows that IL-8 (1 ng) stimulated adequate Akt phosphorylation after just 10 minutes and that this effect was unaffected by prebinding of IL-8 to HSA (27.5 uM).",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Invest 2010 Dec 1 120(12) 4236-50",
                "id": "21060150"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8141"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Stimulation of platelets with a PAR1-activating peptide (SFLLRN), PAR4-activating peptide (AYPGKF), and thrombin resulted in Thr308 and Ser473 phosphorylation of Akt, which results in its activation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Feb 6 279(6) 4186-95",
                "id": "14623889"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8140"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Blood Platelets",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Nov 15 277(46) 44317-26",
                "id": "12193597"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad813f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "UVBcaused phosphorylation of ERK1/2 (Fig. 1A) and Akt (Fig. 1D) was strongly enhanced by silibinin pre-treatment at 100 M dose without any change in their total protein levels.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 May 27 280(21) 20375-83",
                "id": "15792956"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad813e"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Active Akt kinase stimulates the phosphorylation of p21Cip1 in vitro (Fig. 2A). To identify the phosphate acceptor amino acid, the putative Akt site Thr 145 of p21Cip1 was replaced by alanine (p21 T145A). Inactivation of Thr 145 markedly reduced the Akt-dependent phosphorylation of p21Cip1 (Fig. 2A).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2001 Aug 21(16) 5644-57",
                "id": "11463845"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad813d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Our data demonstrate that fibronectin mRNA expression and protein production that are induced by high glucose are mediated via activation of Akt/PKB, which is modulated by mitogen-activated protein kinase, phosphatidylinositol 3-kinase, and protein kinase C. Glucose-induced fibronectin mRNA expression and protein production are also mediated by Akt1/PKBalpha-dependent activation of the transcription factors nuclear factor-kappaB and activating protein-1.",
              "citation": {
                "type": "PubMed",
                "name": "Diabetologia 2005 Nov 48(11) 2428-36",
                "id": "16193290"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad813c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "SREBP-2 processing increased in response to various cholesterol depletion approaches (including statin treatment) and this increase was blunted by treatment with a potent and specific inhibitor of PI3K, LY 294002, or when a plasmid encoding a dominant-negative form of Akt (DN-Akt) was expressed.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 2006 Jun 17(6) 2735-45",
                "id": "16571675"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad813b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Pathological elevations in Akt activity are a common occurrence in tumors, due to loss of tumor suppressor PTEN, hyperactivity of PI3K-activating growth factors receptors and oncoproteins, and other mechanisms (Testa and Bellacosa, 2001).",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Cell 2003 Jan 3(1) 17-22",
                "id": "12559172"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad813a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "AKT1 and AKT3 are activated by heat shock and oxidative stress via both phosphatidylinositol 3-kinase-dependent and -independent pathways",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Aug 16 277(33) 29973-82",
                "id": "12048203"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8139"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "the expressions of KDR and CD31 were sharply enhanced in Akt-CA EPCs",
              "citation": {
                "type": "PubMed",
                "name": "J Lipid Res 2008 Jan 49(1) 33-47",
                "id": "17909223"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8138"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "endothelial progenitor cell"
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Sorbitol resulted in activation of the extracellular signal-regulated kinase (ERK), p54 c-Jun N-terminal kinase (JNK), and protein kinase B",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Oct 3 278(40) 38484-94",
                "id": "12881532"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8137"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "myocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "prolong treatment (16?18 h) with PMA (Fig. 5A), or with dequalinium (Fig. 2C and D), blocked both PKB and ERK1-2 phosphorylation (Fig. 5B?E). In addition, the SMS inhibitor D609 blocked phosphorylation of PKB and ERK1-2 (Fig. 6),",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 2010 Feb 5 584(3) 517-24",
                "id": "19948174"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8136"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "On the other hand, Akt only phosphorylates Thr145, whereas PKC~ seems to phosphorylate neither Thr145 nor Ser146 at least under our experimental conditions.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cancer Res 2007 Sep 5(9) 909-22",
                "id": "17855660"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8135"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Carcinoma, Non-Small-Cell Lung",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Indeed, in mostly in vitro assays, SGK has been shown to phosphorylate glycogen synthase kinase-3 (GSK-3), the B-Raf kinase, and the forkhead family member FKHRL1[4, 49, 72], which are also substrates of Akt/PKB.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Physiol Biochem 2003 13(1) 1-12",
                "id": "12649597"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8134"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "We demonstrate that KGF activates distal effectors of the PI3 kinase pathway, PKB/Akt, and p70S6 kinase, as well as p42/44 MAP kinase proteins. ",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2004 Jun 30(6) 901-7",
                "id": "14742297"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8133"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Alveolar type II cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Inhibition of phosphatidylinositol 3-kinase (see {601232}) inhibited Retnlb-activated Akt phosphorylation and also inhibited RPSM proliferation.",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 2003 May 30 92(10) 1065-7",
                "id": "12714564"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8132"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Further, Akt activates eNOS in ECs by phosphorylation of eNOS at serine 1177, resulting in increased activity of the enzyme and enhanced NO  production.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2010 Mar 19 393(4) 643-8",
                "id": "20153722"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8131"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "In contrast, HepG2-CA-Akt/PKB cells showed an upregulation in the basal level of phosphorylated mTOR (Ser 2448) (ca. 40%)",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biochem 2007 Aug 23",
                "id": "17721885"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8130"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2001 Jun 1 15(11) 1406-18",
                "id": "11390360"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad812f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Glutathione-S-transferase (GST) pulldown experiments demonstrated that INI1 and BAF155 were both capable of directly interacting with Akt. Finally, in vitro kinase assays provided additional evidence that BAF155 and potentially INI1 are substrates for Akt phosphorylation.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2006 Mar 27",
                "id": "16568092"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad812e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Here we show that the protein kinase encoded by the Akt proto-oncogene is activated by IL-2.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 1997 Apr 15 94(8) 3627-32",
                "id": "9108028"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad812d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2002 Nov 29 299(2) 291-8",
                "id": "12437985"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad812c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 1999 Feb 1 337 ( Pt 3) 575-83",
                "id": "9895304"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad812b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1998 Sep 18(9) 5457-64",
                "id": "9710629"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad812a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Mar 29 277(13) 11505-12",
                "id": "11809753"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8129"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "mutations in the Par-4 gene have not been reported in cancer cells. Accordingly, endogenous Par-4 must be bound and functionally inactivated by an antiapoptotic protein, which prevents Par-4 from executing its proapoptotic functions. Indeed, our recent studies reveal that binding of Akt1 to Par-4 results in both Par-4 phosphorylation and inactivation of its proapoptotic potential (7).",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2006 Mar 15 66(6) 2889-92",
                "id": "16540633"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8128"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "). Similarly, IL-22 activated STAT1, STAT3, STAT5, ERK1/2, and Akt kinases in primary human hepatocytes isolated from human donors (Supplemental Figures S2 and S3).1",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Gastrointest Liver Physiol 2007 Apr 292(4) G1019-28",
                "id": "17204547"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8127"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "hepatocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2000 Mar 28 97(7) 3207-12",
                "id": "10716737"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8126"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "L6 cells stably overexpressing wild-type PKBalpha (wtPKBalpha) or a constitutively active membrane-targeted PKBalpha (mPKBalpha) showed a 3- and 15-fold increase in PKB activity, respectively. Both wtPKBalpha and mPKBalpha expression led to a significant increase in the basal uptake of glucose and methyl-aminoisobutyric acid (a substrate for the system A amino acid transporter)",
              "citation": {
                "type": "PubMed",
                "name": "Diabetes 1998 Jul 47(7) 1006-13",
                "id": "9648821"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8125"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": "Muscles"
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "AdmSef inhibited FGF-induced, but not PDGF-induced, activation of Akt.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Apr 18 278(16) 14087-91",
                "id": "12604616"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8124"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:AKT1) actsIn kin(p(HGNC:AKT1))",
              "summary_text": "The downstream targets of Src that lead to the up-regulation of IGF-IR expression were previously unknown. We demonstrate here that AKT regulates IGF-IR expression in PANC-1",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2001 Jan 15 61(2) 589-93",
                "id": "11212254"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8123"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(SFAM:\"PRKC Family\"))",
        "relation": "directlyIncreases",
        "target": "p(HGNC:NFE2L2,pmod(P,S,40))",
        "directed": false,
        "label": "kin(p(SFAM:\"PRKC Family\")) directlyIncreases p(HGNC:NFE2L2,pmod(P,S,40))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8d7c",
          "evidences": [
            {
              "bel_statement": "kin(p(SFAM:\"PRKC Family\")) directlyIncreases p(HGNC:NFE2L2,pmod(P,S,40))",
              "summary_text": "Taken together, these results indicate that the phosphorylation of Nrf2 at Ser40 by PKC is required for Nrf2 to evade INrf2-mediated degradation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Nov 7 278(45) 44675-82",
                "id": "12947090"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8262"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:KEAP1),p(HGNC:NFE2L2))",
        "relation": "hasComponent",
        "target": "p(HGNC:KEAP1)",
        "directed": false,
        "label": "complex(p(HGNC:KEAP1),p(HGNC:NFE2L2)) hasComponent p(HGNC:KEAP1)",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8d7d",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:KEAP1),p(HGNC:NFE2L2)) hasComponent p(HGNC:KEAP1)",
              "summary_text": "Moreover, Keap1 was unable to sequester the Nrf2(S40E) mutant, which mimics constitutive phosphorylation, suggesting that phosphorylation of the Ser40 residue affected the stability of the Nrf2-Keap1 complex.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2003 Aug 285(2) C334-42",
                "id": "12700136"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad826f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:KEAP1),p(HGNC:NFE2L2)) hasComponent p(HGNC:KEAP1)",
              "summary_text": "PKC phosphorylation of Nrf2 at serine 40 results in the escape or release of Nrf2 from INrf2",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2004 May 15 36(10) 1199-207",
                "id": "15110384"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad826e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:KEAP1),p(HGNC:NFE2L2)) hasComponent p(HGNC:KEAP1)",
              "summary_text": "stimulation of p38 MAPK isoforms phosphorylated purified Nrf2 protein and caused an increase in the interaction between Nrf2 and Keap1 in vitro and the suppression of Nrf2 translocation into the nucleus.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2006 Sep 1 66(17) 8804-13",
                "id": "16951197"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad826d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:KEAP1),p(HGNC:NFE2L2)) hasComponent p(HGNC:KEAP1)",
              "summary_text": "Collectively, these data support the conclusion that Keap1 dimerization is required for Nrf2 sequestration and transcriptional repression. Furthermore, exposure to inducing agents disrupts the Keap1 dimerization function and results in Nrf2 release.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Sep 27 277(39) 36544-52",
                "id": "12145307"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad826c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:KEAP1),p(HGNC:NFE2L2)) hasComponent p(HGNC:KEAP1)",
              "summary_text": "INrf2 tethering of the transcription factor Nrf2 in the cytosol prevents Nrf2 activation of antioxidant response element (ARE) mediated gene expression.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2002 Oct 3 21(44) 6829-34",
                "id": "12360409"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad826b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:KEAP1),p(HGNC:NFE2L2)) hasComponent p(HGNC:KEAP1)",
              "summary_text": "A downstream product of COX-2, 15-deoxy-Delta(12,14)-prostaglandin J2 (15d-PGJ2), activated the Nrf2 regulatory pathway in HAECs through binding to the cysteines of Keap1. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Jul 22 280(29) 27244-50",
                "id": "15917255"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad826a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:KEAP1),p(HGNC:NFE2L2)) hasComponent p(HGNC:KEAP1)",
              "summary_text": "in vitro; in vivo; Reconstituted Complex",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 1999 Jan 1 13(1) 76-86",
                "id": "9887101"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8269"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:KEAP1),p(HGNC:NFE2L2)) hasComponent p(HGNC:KEAP1)",
              "summary_text": "We propose that exposure of cells to sulforaphane or oxidative stress, by altering the redox state of Cys 151, reduces the ability of Nrf2-bound Keap1 proteins to associate with the Cul3-Rbx1 core complex. As a result, fewer Nrf2 molecules will be targeted for ubiquitination and subsequent degradation, leading to increased accumulation of Nrf2.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Dec 24(24) 10941-53",
                "id": "15572695"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8268"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:KEAP1),p(HGNC:NFE2L2)) hasComponent p(HGNC:KEAP1)",
              "summary_text": "The results show that atheroprotective flow dissociates Nrf2 from Keap1, and this dissociation was blocked when the PI3K/Akt pathway was inhibited (Figure 7D).",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 2007 Sep 28 101(7) 723-33",
                "id": "17673673"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8267"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:KEAP1),p(HGNC:NFE2L2)) hasComponent p(HGNC:KEAP1)",
              "summary_text": "The anti-V5 antibody recognized V5-Keap1 and coimmunoprecipitated Nrf2 (Fig. 4D, lane 1); the inclusion of Flag-DJ-1 eliminated this coimmunoprecipitation (Fig. 4D, lane 2).",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2006 Oct 10 103(41) 15091-6",
                "id": "17015834"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8266"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:KEAP1),p(HGNC:NFE2L2)) hasComponent p(HGNC:KEAP1)",
              "summary_text": "These results demonstrated that tBHQ and PKC-delta are both required for releasing Nrf2 from INrf2 and for Nrf2 stabilization.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 2009 Dec 15 122(Pt 24) 4452-64",
                "id": "19920073"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8265"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:KEAP1),p(HGNC:NFE2L2)) hasComponent p(HGNC:KEAP1)",
              "summary_text": "Accumulation of endogenous p62 or ectopic expression of p62 sequesters Keap1 into aggregates, resulting in the inhibition of Keap1-mediated Nrf2 ubiquitination and its subsequent degradation by the proteasome.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2010 Jul 30(13) 3275-85",
                "id": "20421418"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8264"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:KEAP1),p(HGNC:NFE2L2)) hasComponent p(HGNC:KEAP1)",
              "summary_text": "Also, p62 docks directly onto the Kelch-repeat domain of Kelch-like ECH-associated protein 1 (KEAP1), via a motif designated the KEAP1 interacting region (KIR), thereby blocking binding between KEAP1 and NRF2 that leads to ubiquitylation and degradation of the transcription factor. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2010 Jul 16 285(29) 22576-91",
                "id": "20452972"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8263"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:KEAP1),p(HGNC:NFE2L2))",
        "relation": "hasComponent",
        "target": "p(HGNC:NFE2L2)",
        "directed": false,
        "label": "complex(p(HGNC:KEAP1),p(HGNC:NFE2L2)) hasComponent p(HGNC:NFE2L2)",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8d7e",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:KEAP1),p(HGNC:NFE2L2)) hasComponent p(HGNC:NFE2L2)",
              "summary_text": "Moreover, Keap1 was unable to sequester the Nrf2(S40E) mutant, which mimics constitutive phosphorylation, suggesting that phosphorylation of the Ser40 residue affected the stability of the Nrf2-Keap1 complex.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2003 Aug 285(2) C334-42",
                "id": "12700136"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad827c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:KEAP1),p(HGNC:NFE2L2)) hasComponent p(HGNC:NFE2L2)",
              "summary_text": "Accumulation of endogenous p62 or ectopic expression of p62 sequesters Keap1 into aggregates, resulting in the inhibition of Keap1-mediated Nrf2 ubiquitination and its subsequent degradation by the proteasome.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2010 Jul 30(13) 3275-85",
                "id": "20421418"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad827b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:KEAP1),p(HGNC:NFE2L2)) hasComponent p(HGNC:NFE2L2)",
              "summary_text": "A downstream product of COX-2, 15-deoxy-Delta(12,14)-prostaglandin J2 (15d-PGJ2), activated the Nrf2 regulatory pathway in HAECs through binding to the cysteines of Keap1. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Jul 22 280(29) 27244-50",
                "id": "15917255"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad827a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:KEAP1),p(HGNC:NFE2L2)) hasComponent p(HGNC:NFE2L2)",
              "summary_text": "Also, p62 docks directly onto the Kelch-repeat domain of Kelch-like ECH-associated protein 1 (KEAP1), via a motif designated the KEAP1 interacting region (KIR), thereby blocking binding between KEAP1 and NRF2 that leads to ubiquitylation and degradation of the transcription factor. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2010 Jul 16 285(29) 22576-91",
                "id": "20452972"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8279"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:KEAP1),p(HGNC:NFE2L2)) hasComponent p(HGNC:NFE2L2)",
              "summary_text": "The anti-V5 antibody recognized V5-Keap1 and coimmunoprecipitated Nrf2 (Fig. 4D, lane 1); the inclusion of Flag-DJ-1 eliminated this coimmunoprecipitation (Fig. 4D, lane 2).",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2006 Oct 10 103(41) 15091-6",
                "id": "17015834"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8278"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:KEAP1),p(HGNC:NFE2L2)) hasComponent p(HGNC:NFE2L2)",
              "summary_text": "in vitro; in vivo; Reconstituted Complex",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 1999 Jan 1 13(1) 76-86",
                "id": "9887101"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8277"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:KEAP1),p(HGNC:NFE2L2)) hasComponent p(HGNC:NFE2L2)",
              "summary_text": "INrf2 tethering of the transcription factor Nrf2 in the cytosol prevents Nrf2 activation of antioxidant response element (ARE) mediated gene expression.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2002 Oct 3 21(44) 6829-34",
                "id": "12360409"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8276"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:KEAP1),p(HGNC:NFE2L2)) hasComponent p(HGNC:NFE2L2)",
              "summary_text": "We propose that exposure of cells to sulforaphane or oxidative stress, by altering the redox state of Cys 151, reduces the ability of Nrf2-bound Keap1 proteins to associate with the Cul3-Rbx1 core complex. As a result, fewer Nrf2 molecules will be targeted for ubiquitination and subsequent degradation, leading to increased accumulation of Nrf2.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Dec 24(24) 10941-53",
                "id": "15572695"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8275"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:KEAP1),p(HGNC:NFE2L2)) hasComponent p(HGNC:NFE2L2)",
              "summary_text": "The results show that atheroprotective flow dissociates Nrf2 from Keap1, and this dissociation was blocked when the PI3K/Akt pathway was inhibited (Figure 7D).",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 2007 Sep 28 101(7) 723-33",
                "id": "17673673"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8274"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:KEAP1),p(HGNC:NFE2L2)) hasComponent p(HGNC:NFE2L2)",
              "summary_text": "stimulation of p38 MAPK isoforms phosphorylated purified Nrf2 protein and caused an increase in the interaction between Nrf2 and Keap1 in vitro and the suppression of Nrf2 translocation into the nucleus.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2006 Sep 1 66(17) 8804-13",
                "id": "16951197"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8273"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:KEAP1),p(HGNC:NFE2L2)) hasComponent p(HGNC:NFE2L2)",
              "summary_text": "These results demonstrated that tBHQ and PKC-delta are both required for releasing Nrf2 from INrf2 and for Nrf2 stabilization.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 2009 Dec 15 122(Pt 24) 4452-64",
                "id": "19920073"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8272"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:KEAP1),p(HGNC:NFE2L2)) hasComponent p(HGNC:NFE2L2)",
              "summary_text": "Collectively, these data support the conclusion that Keap1 dimerization is required for Nrf2 sequestration and transcriptional repression. Furthermore, exposure to inducing agents disrupts the Keap1 dimerization function and results in Nrf2 release.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Sep 27 277(39) 36544-52",
                "id": "12145307"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8271"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:KEAP1),p(HGNC:NFE2L2)) hasComponent p(HGNC:NFE2L2)",
              "summary_text": "PKC phosphorylation of Nrf2 at serine 40 results in the escape or release of Nrf2 from INrf2",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2004 May 15 36(10) 1199-207",
                "id": "15110384"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8270"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:KEAP1),p(HGNC:NFE2L2))",
        "relation": "decreases",
        "target": "tloc(p(HGNC:NFE2L2),GOCC:cytoplasm,GOCC:nucleus)",
        "directed": false,
        "label": "complex(p(HGNC:KEAP1),p(HGNC:NFE2L2)) decreases tloc(p(HGNC:NFE2L2),GOCC:cytoplasm,GOCC:nucleus)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8d7f",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:KEAP1),p(HGNC:NFE2L2)) decreases tloc(p(HGNC:NFE2L2),GOCC:cytoplasm,GOCC:nucleus)",
              "summary_text": "A downstream product of COX-2, 15-deoxy-Delta(12,14)-prostaglandin J2 (15d-PGJ2), activated the Nrf2 regulatory pathway in HAECs through binding to the cysteines of Keap1. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Jul 22 280(29) 27244-50",
                "id": "15917255"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad827d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:MAPK3))",
        "relation": "increases",
        "target": "tscript(p(HGNC:NFE2L2))",
        "directed": false,
        "label": "kin(p(HGNC:MAPK3)) increases tscript(p(HGNC:NFE2L2))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8d80",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:MAPK3)) increases tscript(p(HGNC:NFE2L2))",
              "summary_text": "Overexpression of the ERK-1 mutant, but not the ERK-2 mutant, significantly inhibited hyperoxia-induced ARE transcription, suggesting that ERK-1 at least in part mediates Nrf2 translocation and its downstream target expression (Fig. 7B).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Oct 1 279(40) 42302-12",
                "id": "15292179"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad827e"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:GSK3B,pmod(P,Y,216))",
        "relation": "directlyIncreases",
        "target": "kin(p(HGNC:GSK3B))",
        "directed": false,
        "label": "p(HGNC:GSK3B,pmod(P,Y,216)) directlyIncreases kin(p(HGNC:GSK3B))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8d81",
          "evidences": [
            {
              "bel_statement": "p(HGNC:GSK3B,pmod(P,Y,216)) directlyIncreases kin(p(HGNC:GSK3B))",
              "summary_text": "We further demonstrate that hydrogen peroxide phosphorylates tyrosine 216 of GSK-3beta. This leads to activation of GSK-3beta.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 Jun 1 282(22) 16502-10",
                "id": "17403689"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8282"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B,pmod(P,Y,216)) directlyIncreases kin(p(HGNC:GSK3B))",
              "summary_text": "GSK3 requires tyrosine phosphorylation on Y279 (a isoform) or Y216 (b isoform), a residue in the activation loop of the catalytic domain, for kinase activity",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2001 Sep 1 98(5) 1374-81",
                "id": "11520785"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8281"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B,pmod(P,Y,216)) directlyIncreases kin(p(HGNC:GSK3B))",
              "summary_text": "Glycogen synthase kinase 3 (GSK3), a key component of the insulin and wnt signaling pathways, is unusual, as it is constitutively active and is inhibited in response to upstream signals. Kinase activity is thought to be increased by intramolecular phosphorylation of a tyrosine in the activation loop (Y216 in GSK3beta), whose timing and mechanism is undefined. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2006 Nov 17 24(4) 627-33",
                "id": "17188038"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8280"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B,pmod(P,Y,216)) directlyIncreases kin(p(HGNC:GSK3B))",
              "summary_text": "In mammals GSK3 is present in two isoforms, alpha and beta regulated by phosphorylation: phosphorylation of Ser9 in GSK3beta or Ser21 in GSK3alpha leads to inactivation while phosphorylation of Tyr216 in GSK3beta or Tyr279 in GSK3alpha leads to activation.",
              "citation": {
                "type": "PubMed",
                "name": "Neurosci Lett 2004 Aug 5 366(1) 67-70",
                "id": "15265592"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad827f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:GSK3B)",
        "relation": "hasModification",
        "target": "p(HGNC:GSK3B,pmod(P,Y,216))",
        "directed": false,
        "label": "p(HGNC:GSK3B) hasModification p(HGNC:GSK3B,pmod(P,Y,216))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8d82",
          "evidences": [
            {
              "bel_statement": "p(HGNC:GSK3B) hasModification p(HGNC:GSK3B,pmod(P,Y,216))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8283"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:MAPK11)",
        "relation": "actsIn",
        "target": "kin(p(HGNC:MAPK11))",
        "directed": false,
        "label": "p(HGNC:MAPK11) actsIn kin(p(HGNC:MAPK11))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8d83",
          "evidences": [
            {
              "bel_statement": "p(HGNC:MAPK11) actsIn kin(p(HGNC:MAPK11))",
              "summary_text": "From full text...Phosphorylation of the T286 cyclin D1 residue allows it to be recognized by the nuclear exporter CRM1, which transports it to the cytoplasm where it is rapidly degraded. Glycogen synthase kinase-3 (GSK-3) phosphorylates T286 of cyclin D1, and activation of GSK-3 has been shown to result in cyclin D1 nuclear export and degradation [Diehl et al., [1998]]. Other kinases also phosphorylate cyclin D1 at the T286 position, including p38SAPK2 and ERK2, as reviewed [Alao, [2007]]. Varying forms of cellular stress can trigger cyclin D1 degradation, including ionizing radiation and a variety of genotoxic, osmotic, viral, and oxidative stimuli, as reviewed",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biochem 2007 Sep 14",
                "id": "17868090"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8be3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK11) actsIn kin(p(HGNC:MAPK11))",
              "summary_text": "EGF stimulates the phosphorylation (activation) of the signaling intermediate p38 (MAPK11/14), and blocking phosphorylation pharmacologically with either SB203580 or SB202190 strongly inhibited spontaneous and EGF-stimulated secretion of CGB.  --From Materials and Methods: Primary antibodies to cyclin D1/CCND1and p21/CDKN1A (catalog numbers 2926 and 2946; mouse monoclonal) and phosphorylated (p)-MAPK11/14 (catalog number 9211; rabbit polyclonal) were obtained from Cell Signaling Technology (Beverley, MA) and used at a dilution of 1:500.  -- From Cell Signaling Technologies: Phospho-p38 MAP Kinase (Thr180/Tyr182) Antibody detects endogenous levels of p38 MAP kinase only when activated by phosphorylation at threonine 180 and tyrosine 182.",
              "citation": {
                "type": "PubMed",
                "name": "Biol Reprod 2005 Dec 73(6) 1282-8",
                "id": "16120828"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8be2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "trophoblast",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK11) actsIn kin(p(HGNC:MAPK11))",
              "summary_text": "p38 and FAK were inhibited by SB203580 (20 microM) or by specific FAK antisense nucleotides or FAK siRNA, respectively, and adhesion quantitated. Interestingly, the SB compound also significantly inhibited FAK phosphorylation at Y397 (23 +/- 3% in adherent, 30 +/- 4% in non-adherent cells at 30 minutes and 35 +/- 4% in adherent, 46 +/- 14% in non-adherent cells after 6 hours, p<0.05 for each) and greatly enhanced phosphorylation of ERK1/2, a putative anti-apoptotic component of the MAPK cascade.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Physiol Biochem 2003 13(3) 135-46",
                "id": "12876384"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8be1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK11) actsIn kin(p(HGNC:MAPK11))",
              "summary_text": "However, SB203580 pretreatment only inhibited p38 MAPK activation and had no effect on Akt activation (Fig. 2C, lane 5). These data indicated that the activation of p38 MAPK by CO is PI3K/Akt-dependent. We next tested whether CO modulated STAT1 and STAT3 via PI3K/Akt and p38 MAPK pathways. We pretreated PAEC with SB203580 and observed that CO can no longer modulate STAT1 or STAT3 activation (Fig. 2D, lane 5). Consistent with our data that PI3K/Akt activation is upstream of p38 MAPK activation by CO during A-R (Fig. 2C), when we blocked the PI3K/Akt pathway with LY294002, CO lost its ability to decrease STAT1 and increase STAT3 activation during A-R (Fig. 2D, lane 4). These data demonstrated that the opposing effect of CO on STAT1 and STAT3 activation is dependent upon PI3K/Akt and p38 MAPK pathways. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Mar 11 280(10) 8714-21",
                "id": "15590660"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8be0"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK11) actsIn kin(p(HGNC:MAPK11))",
              "summary_text": "in fetal rat brown adipocyte primary cultures the PPARgamma agonist rosiglitazone (Rosi), as well as retinoic acids 9-cis-retinoic acid and all-trans-retinoic acid also have  extragenic  effects and induce p44/p42 and p38 mitogen-activated protein kinase (p38MAPK) activation. The latter is involved in UCP-1 gene expression, because inhibition of p38MAPK activity with PD169316 impairs the ability of Rosi and retinoids for UCP-1 induction.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Jan 3 278(1) 263-9",
                "id": "12414803"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8bdf"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "brown adipocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK11) actsIn kin(p(HGNC:MAPK11))",
              "summary_text": "Extracellular signal-regulated kinase (ERK) is critical for the expression of immediate-early genes in the striatum in response to cocaine and Delta9-tetrahydrocannabinol and for the rewarding properties of these drugs. Here we show that in mice a single injection of cocaine (10 mg/kg) activates mitogen- and stress-activated protein kinase 1 (MSK1) in dorsal striatum and nucleus accumbens. Cocaine-induced phosphorylation of MSK1 threonine 581 and cAMP response element-binding protein (CREB) serine 133 (Ser133) were blocked by SL327, a drug that prevents ERK activation. C",
              "citation": {
                "type": "PubMed",
                "name": "J Neurosci 2005 Dec 7 25(49) 11444-54",
                "id": "16339038"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8bde"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK11) actsIn kin(p(HGNC:MAPK11))",
              "summary_text": "Using chemical and genetic inhibitors, we show that Fyn activity is required for SAPK2/p38 but not for FAK activation in response to VEGF. In contrast, c-Src permits activation of FAK, but not that of SAPK2/p38. In addition, Fyn is required for stress fiber formation and endothelial cell migration. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Nov 10 281(45) 34009-20",
                "id": "16966330"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8299"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK11) actsIn kin(p(HGNC:MAPK11))",
              "summary_text": "Treatment with SP600125, an inhibitor of JNK1, 2 and 3 Group 1 includes two transcripts, whose expression levels are increased at least twofold when compared with baseline by either of the SB203580 and SP600125 treatments.",
              "citation": {
                "type": "PubMed",
                "name": "Development 2005 Apr 132(8) 1773-83",
                "id": "15772134"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8298"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": "embryo"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK11) actsIn kin(p(HGNC:MAPK11))",
              "summary_text": "stimulation of p38 MAPK isoforms phosphorylated purified Nrf2 protein and caused an increase in the interaction between Nrf2 and Keap1 in vitro and the suppression of Nrf2 translocation into the nucleus.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2006 Sep 1 66(17) 8804-13",
                "id": "16951197"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8297"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK11) actsIn kin(p(HGNC:MAPK11))",
              "summary_text": "prominent p38 MAPK target, the Ser/Thr kinase MAPKAP2, is also activated by PM, as evidenced by phosphorylation of the actin-binding protein, HSP27. These events are again consistent with PM-mediated activation of p38 MAPK (10)",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2010 Apr 42(4) 442-9",
                "id": "19520919"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8296"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK11) actsIn kin(p(HGNC:MAPK11))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2003 Dec 23(23) 8890-901",
                "id": "14612426"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8295"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK11) actsIn kin(p(HGNC:MAPK11))",
              "summary_text": "insulin-dependent p38 alpha and p38 beta MAPK activities were also markedly reduced by wortmannin",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Dec 7 276(49) 46079-87",
                "id": "11598141"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8294"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK11) actsIn kin(p(HGNC:MAPK11))",
              "summary_text": "treatment with SB203580, a specific inhibitor of p38 alpha and beta MAPKs",
              "citation": {
                "type": "PubMed",
                "name": "Development 2005 Apr 132(8) 1773-83",
                "id": "15772134"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8293"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK11) actsIn kin(p(HGNC:MAPK11))",
              "summary_text": "Silencing of p38alpha by isoform-specific small interfering RNAs increased claudin-4 and -8 mRNAs, whereas silencing of p38beta only increased claudin-4 mRNA.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2009 Sep 297(3) C775-87",
                "id": "19605737"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8292"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK11) actsIn kin(p(HGNC:MAPK11))",
              "summary_text": "The pyridinylimidazoles SB202190 and SB203580 are the most widely used inhibitors of p38alpha MAPK and beta.",
              "citation": {
                "type": "PubMed",
                "name": "Acta Physiol Scand 2003 Aug 178(4) 287-96",
                "id": "12864733"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8291"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK11) actsIn kin(p(HGNC:MAPK11))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2006 Mar 1 394(Pt 2) 379-87",
                "id": "16351573"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8290"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK11) actsIn kin(p(HGNC:MAPK11))",
              "summary_text": "GRP94/gp96 reported to activate macrophage NF-kB signaling and nitric oxide production, as well as the MAP kinase p38, JNK and ERK signaling cascades.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Aug 22 278(34) 31853-60",
                "id": "12805368"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad828f"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK11) actsIn kin(p(HGNC:MAPK11))",
              "summary_text": "An inhibition of p38 with PD169316 impairs the upregulation of involucrin mRNAs by a treatment with MbetaCD, but not by a p38delta-activating TPA treatment, which might suggest that cholesterol depletion alters involucrin gene expression through activation of p38alpha/beta.",
              "citation": {
                "type": "PubMed",
                "name": "J Invest Dermatol 2004 Sep 123(3) 564-73",
                "id": "15304097"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad828e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK11) actsIn kin(p(HGNC:MAPK11))",
              "summary_text": "p38-beta is activated by proinflammatory cytokines and environmental stress",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1996 Jul 26 271(30) 17920-6",
                "id": "8663524"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad828d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK11) actsIn kin(p(HGNC:MAPK11))",
              "summary_text": "These  results suggest that p38eta increases the AP-1 by stimulation of c-Jun  phosphorylation, whereas p38gamma and p38delta inhibit this by mechanisms  involving suppression of the c- jun transcription.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Feb 14 278(7) 4831-9",
                "id": "12475989"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad828c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK11) actsIn kin(p(HGNC:MAPK11))",
              "summary_text": "We recently reported that activation of SAPK2/p38, by leading to the phosphorylation of the actin-polymerizing factor HSP27, is importantly involved in transducing the motogenic signal elicited by VEGF in endothelial cells (20, 22). ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Sep 7 276(36) 33762-72",
                "id": "11448946"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad828b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK11) actsIn kin(p(HGNC:MAPK11))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2004 Jan 286(1) C145-52",
                "id": "14522818"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad828a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK11) actsIn kin(p(HGNC:MAPK11))",
              "summary_text": "This p38 MAP kinase, like p38 alpha, is inhibited by the pyridinyl imidazole drug SB203580.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1998 Jan 16 273(3) 1741-8",
                "id": "9430721"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8289"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK11) actsIn kin(p(HGNC:MAPK11))",
              "summary_text": "MSK1 is activated in vitro by MAPK2/ERK2 or SAPK2/p38.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1998 Aug 3 17(15) 4426-41",
                "id": "9687510"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8288"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK11) actsIn kin(p(HGNC:MAPK11))",
              "summary_text": "we showed that increased extracellular tonicity promotes increased type A natriuretic peptide receptor (NPR-A) expression through a p38 MAPKbeta pathway",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Sep 6 277(36) 32498-504",
                "id": "12082097"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8287"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK11) actsIn kin(p(HGNC:MAPK11))",
              "summary_text": "nhibition of p38 MAPK signaling with the specific SB203580 inhibitor totally prevented the H2O2-mediated activation of the two Sp1 binding sites of the caveolin-1 promoter (?244/?222 and ?124/?101; Fig. 3B)",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2006 Nov 15 66(22) 10805-14",
                "id": "17108117"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8286"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK11) actsIn kin(p(HGNC:MAPK11))",
              "summary_text": "Consistent with this finding, SB203580 and overexpression of a dominant-negative mutant of p38alpha or p38beta also inhibited NTHi-induced MUC5AC transcription as assessed using a human MUC5AC promoter-luciferase reporter construct ( Fig. 1 C ), thus confirming the requirement for p38 MAPK in MUC5AC induction.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Jul 25 278(30) 27811-9",
                "id": "12734193"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8285"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK11) actsIn kin(p(HGNC:MAPK11))",
              "summary_text": "Following the initial description of p38 (p38a), three additional isoforms of this MAP kinase group have been cloned and characterized: p38b (18), p38g (also termed ERK6 or SAPK3) (22, 24, 30), and p38d (also termed SAPK4) (4, 17, 41). Two MAP kinase kinases (MKK), MKK3 and MKK6, are the upstream activators of the p38 group MAP kinases (6, 12, 14, 37).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1999 Jan 19(1) 21-30",
                "id": "9858528"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8284"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(MGI:Bach1),p(MGI:Maff))",
        "relation": "decreases",
        "target": "p(HGNC:HMOX1)",
        "directed": false,
        "label": "complex(p(MGI:Bach1),p(MGI:Maff)) decreases p(HGNC:HMOX1)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8d84",
          "evidences": [
            {
              "bel_statement": "complex(p(MGI:Bach1),p(MGI:Maff)) decreases p(HGNC:HMOX1)",
              "summary_text": "Overexpression of Bach1, together with MafK, represses basal and UVA-mediated HO-1 protein expression, whereas silencing of the Bach1 gene by Bach1-specific siRNAs causes robust enhancement of constitutive HO-1 levels.",
              "citation": {
                "type": "Other",
                "name": "",
                "id": "22107958"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad829e"
              },
              "experiment_context": {
                "species_common_name": "human",
                "disease": "",
                "cell": "fibroblasts",
                "tissue": "skin"
              }
            },
            {
              "bel_statement": "complex(p(MGI:Bach1),p(MGI:Maff)) decreases p(HGNC:HMOX1)",
              "summary_text": "Enhanced expression of either MafK or Bach1 was enough to suppress the electrophile-inducible expression of HO-1 ....Knockdown of MafK and Bach1 by siRNA abolished TGF--dependent suppression of HO-1.",
              "citation": {
                "type": "Other",
                "name": "",
                "id": "23737527"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad829d"
              },
              "experiment_context": {
                "species_common_name": "mouse",
                "disease": "",
                "cell": "nmumg",
                "tissue": "mammary gland"
              }
            },
            {
              "bel_statement": "complex(p(MGI:Bach1),p(MGI:Maff)) decreases p(HGNC:HMOX1)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad829c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(MGI:Bach1),p(MGI:Maff)) decreases p(HGNC:HMOX1)",
              "summary_text": "heme-binding factor, Bach1, is a critical physiological repressor of ho-1. Bach1 bound to the multiple Maf recognition elements (MAREs) of ho-1 enhancers with MafK in vitro and repressed their activity in vivo,",
              "citation": {
                "type": "Other",
                "name": "",
                "id": "12356737"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad829b"
              },
              "experiment_context": {
                "species_common_name": "mouse",
                "disease": "",
                "cell": "nih 3t3",
                "tissue": "various"
              }
            },
            {
              "bel_statement": "complex(p(MGI:Bach1),p(MGI:Maff)) decreases p(HGNC:HMOX1)",
              "summary_text": "Enhanced expression of either MafK or Bach1 was enough to suppress the electrophile-inducible expression of HO-1 ....Knockdown of MafK and Bach1 by siRNA abolished TGF--dependent suppression of HO-1.",
              "citation": {
                "type": "Other",
                "name": "",
                "id": "23737527"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad829a"
              },
              "experiment_context": {
                "species_common_name": "human",
                "disease": "",
                "cell": "hek 293",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(MGI:Bach1),p(MGI:Maff))",
        "relation": "hasComponent",
        "target": "p(HGNC:BACH1)",
        "directed": false,
        "label": "complex(p(MGI:Bach1),p(MGI:Maff)) hasComponent p(HGNC:BACH1)",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8d85",
          "evidences": [
            {
              "bel_statement": "complex(p(MGI:Bach1),p(MGI:Maff)) hasComponent p(HGNC:BACH1)",
              "summary_text": "Small Maf proteins serve as dual-function transcription factors through an exchange of their heterodimerization partners. For example, as heterodimers with hematopoietic cell-specific p45 NF-E2 or NF-E2-related factors (Nrf), they activate the beta-globin or antioxidative stress enzyme heme oxygenase 1 (HO-1) genes, respectively. In contrast, together with Bach1, they repress these same genes",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2004 Feb 10 101(6) 1461-6",
                "id": "14747657"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8be4"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(MGI:Bach1),p(MGI:Maff))",
        "relation": "hasComponent",
        "target": "p(HGNC:MAFF)",
        "directed": false,
        "label": "complex(p(MGI:Bach1),p(MGI:Maff)) hasComponent p(HGNC:MAFF)",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8d86",
          "evidences": [
            {
              "bel_statement": "complex(p(MGI:Bach1),p(MGI:Maff)) hasComponent p(HGNC:MAFF)",
              "summary_text": "Small Maf proteins serve as dual-function transcription factors through an exchange of their heterodimerization partners. For example, as heterodimers with hematopoietic cell-specific p45 NF-E2 or NF-E2-related factors (Nrf), they activate the beta-globin or antioxidative stress enzyme heme oxygenase 1 (HO-1) genes, respectively. In contrast, together with Bach1, they repress these same genes",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2004 Feb 10 101(6) 1461-6",
                "id": "14747657"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8be5"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:KEAP1),p(HGNC:IKBKB))",
        "relation": "hasComponent",
        "target": "p(HGNC:IKBKB)",
        "directed": false,
        "label": "complex(p(HGNC:KEAP1),p(HGNC:IKBKB)) hasComponent p(HGNC:IKBKB)",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8d87",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:KEAP1),p(HGNC:IKBKB)) hasComponent p(HGNC:IKBKB)",
              "summary_text": "In this study, we show that KEAP1 is a new IKK binding partner, which is responsible for the down-regulation of TNFalpha-stimulated NF-kappaB activation. The E(T/S)GE motif, which is found only in the IKKbeta subunit of the IKK complex, is essential for interaction with the C-terminal Kelch domain of KEAP1. ",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2010 Nov 22(11) 1645-54",
                "id": "20600852"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad829f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:KEAP1),p(HGNC:IKBKB))",
        "relation": "hasComponent",
        "target": "p(HGNC:KEAP1)",
        "directed": false,
        "label": "complex(p(HGNC:KEAP1),p(HGNC:IKBKB)) hasComponent p(HGNC:KEAP1)",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8d88",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:KEAP1),p(HGNC:IKBKB)) hasComponent p(HGNC:KEAP1)",
              "summary_text": "In this study, we show that KEAP1 is a new IKK binding partner, which is responsible for the down-regulation of TNFalpha-stimulated NF-kappaB activation. The E(T/S)GE motif, which is found only in the IKKbeta subunit of the IKK complex, is essential for interaction with the C-terminal Kelch domain of KEAP1. ",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2010 Nov 22(11) 1645-54",
                "id": "20600852"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82a0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:FYN)",
        "relation": "hasModification",
        "target": "p(HGNC:FYN,pmod(P,T))",
        "directed": false,
        "label": "p(HGNC:FYN) hasModification p(HGNC:FYN,pmod(P,T))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8d89",
          "evidences": [
            {
              "bel_statement": "p(HGNC:FYN) hasModification p(HGNC:FYN,pmod(P,T))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82a1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:FYN,pmod(P,T))",
        "relation": "increases",
        "target": "kin(p(HGNC:FYN))",
        "directed": false,
        "label": "p(HGNC:FYN,pmod(P,T)) increases kin(p(HGNC:FYN))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8d8a",
          "evidences": [
            {
              "bel_statement": "p(HGNC:FYN,pmod(P,T)) increases kin(p(HGNC:FYN))",
              "summary_text": "The activated GSK-3beta phosphorylates Fyn at threonine residue(s). Phosphorylated Fyn accumulates in the nucleus and phosphorylates Nrf2 at tyrosine 568. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 Jun 1 282(22) 16502-10",
                "id": "17403689"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82a2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:KEAP1)",
        "relation": "directlyDecreases",
        "target": "tscript(p(HGNC:NFE2L2))",
        "directed": false,
        "label": "p(HGNC:KEAP1) directlyDecreases tscript(p(HGNC:NFE2L2))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8d8b",
          "evidences": [
            {
              "bel_statement": "p(HGNC:KEAP1) directlyDecreases tscript(p(HGNC:NFE2L2))",
              "summary_text": "Antioxidant response element (ARE) and nuclear transcription factor Nrf2 are known to regulate expression and coordinated induction of NQO1 and other detoxifying enzyme genes in response to antioxidants and xenobiotics.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2001 Jun 28 20(29) 3906-17",
                "id": "11439354"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82a5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:KEAP1) directlyDecreases tscript(p(HGNC:NFE2L2))",
              "summary_text": "INrf2 tethering of the transcription factor Nrf2 in the cytosol prevents Nrf2 activation of antioxidant response element (ARE) mediated gene expression.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2002 Oct 3 21(44) 6829-34",
                "id": "12360409"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82a4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:KEAP1) directlyDecreases tscript(p(HGNC:NFE2L2))",
              "summary_text": "# Pubmed:gene: Redox-sensitive interaction between KIAA0132 and Nrf2 mediates indomethacin-induced expression of gamma-glutamylcysteine synthetase. # Ariadne: These results also support the hypothesis that indomethacin-induced transcriptional activation of GCLC involves the redox-dependent release of KIAA0132 from Nrf2 followed by the nuclear translocation of Nrf2. [MolTransport]",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2002 Apr 1 32(7) 650-62",
                "id": "11909699"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82a3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:KEAP1)",
        "relation": "decreases",
        "target": "tloc(p(HGNC:NFE2L2),GOCC:cytoplasm,GOCC:nucleus)",
        "directed": false,
        "label": "p(HGNC:KEAP1) decreases tloc(p(HGNC:NFE2L2),GOCC:cytoplasm,GOCC:nucleus)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8d8c",
          "evidences": [
            {
              "bel_statement": "p(HGNC:KEAP1) decreases tloc(p(HGNC:NFE2L2),GOCC:cytoplasm,GOCC:nucleus)",
              "summary_text": "Coexpression of Keap1 resulted in localization of the wild-type Nrf2-GFP fusion protein in the cytoplasm of the majority of transfected cells, and nuclear distribution was seen in a very small number of cells (Fig. 4, B and C).",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2003 Aug 285(2) C334-42",
                "id": "12700136"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82a6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:KEAP1)",
        "relation": "decreases",
        "target": "p(HGNC:IKBKB)",
        "directed": false,
        "label": "p(HGNC:KEAP1) decreases p(HGNC:IKBKB)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8d8d",
          "evidences": [
            {
              "bel_statement": "p(HGNC:KEAP1) decreases p(HGNC:IKBKB)",
              "summary_text": "Depletion of KEAP1 led to the accumulation and stabilization of IKKbeta and to upregulation of NF-kappaB-derived tumor angiogenic factors.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2009 Oct 9 36(1) 131-40",
                "id": "19818716"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82a8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:KEAP1) decreases p(HGNC:IKBKB)",
              "summary_text": "Ectopic expression of KEAP1 decreased the expression of IKKbeta, which was restored by an autophagy inhibitor. ",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2010 Nov 22(11) 1645-54",
                "id": "20600852"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82a7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(SCOMP:\"p85/p110 PI3Kinase Complex\")",
        "relation": "increases",
        "target": "kin(p(HGNC:AKT1))",
        "directed": false,
        "label": "complex(SCOMP:\"p85/p110 PI3Kinase Complex\") increases kin(p(HGNC:AKT1))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8d8e",
          "evidences": [
            {
              "bel_statement": "complex(SCOMP:\"p85/p110 PI3Kinase Complex\") increases kin(p(HGNC:AKT1))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82a9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(SCOMP:\"p85/p110 PI3Kinase Complex\")",
        "relation": "actsIn",
        "target": "kin(p(SFAM:\"PIK3C Class IA Family\"))",
        "directed": false,
        "label": "complex(SCOMP:\"p85/p110 PI3Kinase Complex\") actsIn kin(p(SFAM:\"PIK3C Class IA Family\"))",
        "metadata": {
          "casual": false,
          "createdBy": "Jamboree2014",
          "edgeId": "55775dd92f9e241f18ad8d8f",
          "evidences": [
            {
              "bel_statement": "complex(SCOMP:\"p85/p110 PI3Kinase Complex\") actsIn kin(p(SFAM:\"PIK3C Class IA Family\"))",
              "summary_text": "",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "16172382"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82ab"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(SCOMP:\"p85/p110 PI3Kinase Complex\") actsIn kin(p(SFAM:\"PIK3C Class IA Family\"))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82aa"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:MAPK12))",
        "relation": "directlyIncreases",
        "target": "p(HGNC:NFE2L2,pmod(P,S))",
        "directed": false,
        "label": "kin(p(HGNC:MAPK12)) directlyIncreases p(HGNC:NFE2L2,pmod(P,S))",
        "metadata": {
          "casual": true,
          "createdBy": "Jamboree2014",
          "edgeId": "55775dd92f9e241f18ad8d90",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:MAPK12)) directlyIncreases p(HGNC:NFE2L2,pmod(P,S))",
              "summary_text": "As shown in Fig. 6A , stimulation of all p38 MAPK isoforms by anisomycin strongly phosphorylated Nrf2 protein (lanes 2-5), whereas no phosphorylation was detected in the control immunoprecipitates (lane 1)...HeLa cells were stimulated with anisomycin (10 _g/mL) for 30 minutes and FLAG-p38 MAPK isoforms were immunoprecipitated using agarose-conjugated anti-FLAG M2 monoclonal antibody. Purified GST-Nrf2 protein was immunoprecipitated with FLAG-p38 MAPK isoforms and was incubated with 32P-labeled ATP in the presence of the precipitated p38 MAPK isoforms. Phosphorylation of Nrf2 protein by activated p38 MAPK isoforms was visualized by autoradiography.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "16951197"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8be6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "HeLa",
                "tissue": ""
              }
            },
            {
              "bel_statement": "kin(p(HGNC:MAPK12)) directlyIncreases p(HGNC:NFE2L2,pmod(P,S))",
              "summary_text": "As shown in Fig. 6A  , stimulation of all p38 MAPK isoforms by anisomycin strongly phosphorylated Nrf2 protein (lanes 2-5), whereas no phosphorylation was detected in the control immunoprecipitates (lane 1). ",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2006 Sep 1 66(17) 8804-13",
                "id": "16951197"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82ad"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "kin(p(HGNC:MAPK12)) directlyIncreases p(HGNC:NFE2L2,pmod(P,S))",
              "summary_text": "As shown in Fig. 6A , stimulation of all p38 MAPK isoforms by anisomycin strongly phosphorylated Nrf2 protein (lanes 2-5), whereas no phosphorylation was detected in the control immunoprecipitates (lane 1)...HeLa cells were stimulated with anisomycin (10",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "16951197"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82ac"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:EIF2AK3))",
        "relation": "directlyDecreases",
        "target": "complex(p(HGNC:NFE2L2),p(HGNC:KEAP1),p(HGNC:RBX1),p(HGNC:CUL3))",
        "directed": false,
        "label": "kin(p(HGNC:EIF2AK3)) directlyDecreases complex(p(HGNC:NFE2L2),p(HGNC:KEAP1),p(HGNC:RBX1),p(HGNC:CUL3))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8d91",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:EIF2AK3)) directlyDecreases complex(p(HGNC:NFE2L2),p(HGNC:KEAP1),p(HGNC:RBX1),p(HGNC:CUL3))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82ae"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:EIF2AK3))",
        "relation": "directlyIncreases",
        "target": "p(HGNC:NFE2L2,pmod(P))",
        "directed": false,
        "label": "kin(p(HGNC:EIF2AK3)) directlyIncreases p(HGNC:NFE2L2,pmod(P))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8d92",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:EIF2AK3)) directlyIncreases p(HGNC:NFE2L2,pmod(P))",
              "summary_text": "PERK also directly phosphorylates Nrf2, thereby releasing it from its cytoplasmic inhibitor, Kelch-like ECHassociated protein 1 (Keap1) and allowing translocation to the nucleus (32, 33).",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2008 May 38(5) 541-50",
                "id": "18079489"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82af"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:PTGS2)",
        "relation": "actsIn",
        "target": "cat(p(HGNC:PTGS2))",
        "directed": false,
        "label": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8d93",
          "evidences": [
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Our results show that tobacco smoke led to increased generation of reactive oxygen species with an increase in NF-kB activation.Gel shift analysis also revealed the elevated level of the oxidative stress sensitive proinflammatory nuclear transcription factor-kappa B and activator protein-1 in different regions of the brain of cigarette smoke exposed mice. Tobacco smoke led to activation of COX-2 in all the regions of the brain. Activation of mitogen activated protein kinase and c-Jun N-terminal kinase were also observed in various regions of brain of ETS exposed mice.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Pharmacol 2006 May 28 71(11) 1602-9",
                "id": "16569398"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8bf2"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "where CO takes over the roles of NO under conditions of oxidative stress (Maines, 1997). Therefore, HO activity is important in controlling the activity of heme proteins, such as cytochromes P450, COX, guanylyl cyclase, and NOS, not only at the level of the intracellular heme pool available for the apo-heme proteins (Kappas and Drummond, 1986) but possibly also at the level of HO's downstream effector molecule CO by interactions with the heme group (Haider et al., 2002). ",
              "citation": {
                "type": "PubMed",
                "name": "Pharmacol Rev 2003 Sep 55(3) 551-71",
                "id": "12869663"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8bf1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "In the present study, we demonstrated that COX-2 inhibits genotoxic stress-induced apoptosis by using an adenoviral COX-2 overexpression system. In addition, we found that COX-2 regulates the transcription function of p53 as evidenced by suppression of p53 target gene induction by COX-2 cotransfection. Furthermore, COX-2 interacted with p53 in vitro and in vivo, which was inhibited by the treatment with NS-398.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2005 Mar 25 328(4) 1107-12",
                "id": "15707991"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8bf0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Prostaglandins, particularly prostaglandin E2 (PGE2), play an important role during inflammation. This is exemplified by the clinical use of cyclooxygenase 2 inhibitors, which interfere with PGE2 synthesis, as effective antiinflammatory drugs. In human purified naive T cells, PGE2 acts via prostaglandin receptor EP2- and EP4-mediated signaling and cyclic AMP pathways to up-regulate IL-23 and IL-1 receptor expression. ",
              "citation": {
                "type": "PubMed",
                "name": "J Exp Med 2009 Mar 16 206(3) 535-48",
                "id": "19273625"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8bef"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "naive T-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Cultured myometrial cells expressed low levels of Cox-2 mRNA under baseline conditions, but interleukin-1beta (IL-1beta) caused a 17-fold induction of expression of the Cox-2 transcript after incubation for 6 h. IL-1beta also induced expression of biologically active Cox-2 protein, as detected by immunofluorescence, Western blot analysis, and measuring the conversion of arachidonic acid to prostanoids in the presence and absence of a Cox-2-selective inhibitor, NS-398.",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Endocrinol Metab 2000 Sep 85(9) 3468-75",
                "id": "10999850"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8bee"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "myometrium"
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Mechanisms of cancer promotion by COX-2 are not fully understood, but signaling through prostaglandin (PG)E2 receptors is a contributing factor. The major PGE2 receptors on epithelial cells, EP2 and EP4, increase cAMP production, which promotes growth and inhibits apoptosis in some cell types.  To explore the hypothesis that PGE2-stimulated cAMP  is a key intracellular mediator of COX-2-dependent antiapoptosis and define the underlying mechanisms, we used the T84 human colon epithelial cell line, which exhibits inducible apoptosis and is responsive to PGE2  stimulation (31, 34, 35). The major PGE2 receptors on colon epithelial cells are EP2 and EP4  (25), a finding we confirmed by RT-PCR of T84 cells (data not shown). Both EP2 and EP4 receptors activate adenylyl cyclase and increase cAMP as a second messenger, suggesting that cAMP mediates antiapoptotic functions in epithelial cells. Consistent with this idea, we found that a membrane-permeant  cAMP analog, 8-CPT-cAMP, and CTX, which catalyzes the ADP-ribosylation of Gs regulatory protein, leading to the activation of adenylyl  cyclase, also inhibited Fas- and staurosporine-promoted apoptosis  (Fig. 1 A). These findings were confirmed by evidence that CTX and 8-CPT-cAMP also inhibited the formation of apoptosis-associated DNA laddering in T84 cells (Fig. 1B and data not shown). We obtained similar results with the normal rat intestinal epithelial  cell line, RIE-1 (Fig. 1C). Thus, the antiapoptotic response to increases in cAMP in intestinal epithelial cells is independent of their state of transformation and conserved across at least two species.\\\"From full text\\\"",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2003 Jul 22 100(15) 8921-6",
                "id": "12837940"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8bed"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Several anticancer therapies target, albeit indirectly, the PI3K/ Akt1 axis and cause inhibition of Akt1 phosphorylation and induction of apoptosis. Examples include herceptin, which inhibits ErbB2 in breast cancer cells; cyclooxygenase-2 (COX-2) inhibitors, which inhibit COX-2 and PDK1 in colon and prostate cancer; gefitnib (Iressa), which targets mutant epidermal growth factor receptor in lung cancer cells; and imatinib mesylate (Gleevec, STI- 571), which targets bcr-abl in leukemia. Conversely, inhibition of anoikis, which contributes to metastasis by trkB or TWIST, involves Akt activation. Given that Akt1 binds to Par-4 in diverse cell types, the action of these therapeutic agents may involve regulation of Par-4 function via Akt1.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2006 Mar 15 66(6) 2889-92",
                "id": "16540633"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8bec"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "One of the several genes that were highly up-regulated by over expressed Cox-2 was MDR1. MDR1 or P-glycoprotein (P-gp), the product of the MDR1 gene, is implicated as the primary cause of multidrug resistance (MDR) in tumors where it acts as an efflux pump for chemotherapeutic agents. It is also expressed in normal tissues of the liver and kidney where it functions to actively transport lipophilic xenobiotics. Reverse transcriptase-PCR analysis confirmed the results of the microarray, showing increased mRNA levels for MDR1 in Cox-2 overexpressing cells.e again confirm that Cox-2 overexpressing RMC have increased MDR1 expression. We also observed that the addition of NS398 blocked the up-regulation of the MDR1 protein, consistent with the R123 efflux assay showing reduced MDR1 activity. These additional results show that the Cox-2-mediated MDR1 response is dependent on Cox-2 activity. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Oct 11 277(41) 38915-20",
                "id": "12138126"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8beb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "JAK/STATs C225 Phase I treatment (47) AG490 Preclinical treatment (48-51) #----------------------------------------------------------------- Table II. Chemopreventive Agents for Targeting Signal Transduction Pathways Target Drug Phase of Testing Reference Cox-2 Celecoxib Preclinical treatment (164,174-177) and prevention Nimesulide, Valdecoxib, Preclinical treatment (178) Parecoxib, Etoricoxib, Lumaricoxib Sulindac Phase II treatment (179-181) Exisulind Phase I treatment",
              "citation": {
                "type": "PubMed",
                "name": "J Mammary Gland Biol Neoplasia 2003 Jan 8(1) 45-73",
                "id": "14587863"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8bea"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "A COX-2-selective inhibitor, NS-398 (10 M), was used to determine whether COX-2 was responsible for the observed increases in PGE2 synthesis by CSE-treated fibroblasts (62). Two different strains of human lung fibroblasts were pretreated with NS-398 for 1 h before treatment with 1% CSE for 24 h, and supernatants were analyzed for PGE2. As shown in Fig. 2, the fibroblast strains incubated with 1% CSE had a three- to fourfold induction in PGE2 synthesis over basal levels after 24 h, depending on the strain. However, cells treated with both CSE and NS-398 had significantly decreased PGE2 levels relative to fibroblasts treated with CSE alone, supporting the idea that the elevated PGE2 levels are a result of COX-2 activity. ",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2004 Nov 287(5) L981-91",
                "id": "15234907"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8be9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "was able to prevent the development of N-methylnitrosurea-induced prostate and mammary carcinomas in rats by 50% (REF. 38). Celecoxib, an inhibitor of the inducible prostaglandin G/H synthase COX2, was able to reduce the number of colorectal polyps in patients with familial adenomatous polyposis (FAP). Patients with FAP are at high risk of developing colorectal neoplasias39.COX2 inhibitors are anti-inflammatory agents with anti-angiogenic activities that downregulate the expression of the pro-angiogenic factors FGF and VEGF40.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2003 Jun 3(6) 401-10",
                "id": "12778130"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8be8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Cultured myometrial cells expressed low levels of Cox-2 mRNA under baseline conditions, but interleukin-1beta (IL-1beta) caused a 17-fold induction of expression of the Cox-2 transcript after incubation for 6 h. IL-1beta also induced expression of biologically active Cox-2 protein, as detected by immunofluorescence, Western blot analysis, and measuring the conversion of arachidonic acid to prostanoids in the presence and absence of a Cox-2-selective inhibitor, NS-398.",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Endocrinol Metab 2000 Sep 85(9) 3468-75",
                "id": "10999850"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8be7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Inhibition of COX-2 by acetyl salicylic acid (1 mM), NS-398 (5 microM), or celecoxib (3 microM) abolished the increase in cAMP and markedly reduced alpha(2C)-AR induction in response to serum stimulation.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Heart Circ Physiol 2005 Jan 288(1) H69-76",
                "id": "15345481"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8301"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Using NS398 or small interferent RNA specifically targeting COX-2 attenuated the appearance of the SA-beta-Gal activity and growth arrest in both stress situations.",
              "citation": {
                "type": "PubMed",
                "name": "Exp Cell Res 2007 Aug 15 313(14) 3046-56",
                "id": "17560572"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8300"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Carcinogenesis 2000 Jul 21(7) 1403-9",
                "id": "10874020"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82ff"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "The PI3K pathway is negatively regulated by PTEN (phosphatase and TENsin homolog), which converts PIP3 in PIP2, preventing PKB activation and Bad phosphorylation/sequestration. Thus PTEN is considered as a tumor suppressor gene. It has been shown that NS-398 was able to increase the level of PTEN in human gastric carcinoma cell line MKN45 [114]. ",
              "citation": {
                "type": "PubMed",
                "name": "Int J Cell Biol 2010 2010 215158",
                "id": "20339581"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82fe"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasm",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "LPS caused dose- and time-dependent release of arachidonate and only cyclooxygenase products",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol 1988 Jun 254(6 Pt 1) C809-15",
                "id": "3132045"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82fd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Cigarette smoke up-regulates experimentally the production of cytokines, such as interleukin (IL)-1b, and the Th-1 cytokines, which increase cyclooxygenase (COX)-2 enzymatic activity and can promote an inflammatory response through lymphocytes, resulting in an overproduction of cytokines, such as IL-6, IL-8, and IL- 10.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Am Thorac Soc 2008 Dec 1 5(8) 842-7",
                "id": "19017739"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82fc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Lung Neoplasms",
                "cell": "immune cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": " Inhibition of cyclooxygenase-2 activity by specific chemical inhibitor or siRNA attenuates the H(2)O(2)-induced increase of senescence associated beta-galactosidase positive cells and attenuates growth arrest. In this work, p38(MAPK) activation and increased DNA binding activities of ATF-2 and p53 are shown to mediate cyclooxygenase-2 overexpression in premature senescence.",
              "citation": {
                "type": "PubMed",
                "name": "Biogerontology 2009 Jun 10(3) 291-8",
                "id": "19082758"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82fb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Ariadne: PGE 2 inhibits S14 gene transcription in primary hepatocytes  To examine the effects of PGE 2 on parenchymal cell gene transcription, primary hepatocytes were transiently transfected with either an S14 CAT reporter gene (S170) or RSVCAT (R100).",
              "citation": {
                "type": "PubMed",
                "name": "J Lipid Res 1999 Jun 40(6) 1045-52",
                "id": "10357836"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82fa"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "hepatocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Dexamethasone and niflumic acid, a cyclooxygenase-2 inhibitor, both inhibited haptoglobin release. There was release of haptoglobin by both isolated adipocytes and the adipose tissue matrix remaining after collagenase digestion of human adipose tissue",
              "citation": {
                "type": "PubMed",
                "name": "J Lipid Res 2004 Mar 45(3) 536-42",
                "id": "14657203"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82f9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Adipose Tissue"
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "FACL4 and COX-2 synergistically inhibit apoptosis by reducing the intracellular level of free arachidonic acid. Here, we report that expression of FACL4 is significantly increased in colon adenocarcinoma",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2001 Dec 1 61(23) 8429-34",
                "id": "11731423"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82f8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Arthritis Rheum 2001 Sep 44(9) 2078-83",
                "id": "11592370"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82f7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "COX-2-mediated down-regulation of PPARgamma2 and C/EBPalpha",
              "citation": {
                "type": "PubMed",
                "name": "J Biosci Bioeng 2010 Mar 109(3) 297-303",
                "id": "20159581"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82f6"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Adipocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "# sentences for pubmedID=12970159: # GeneRif: COX-2 exerts a negative feedback on the expression of cathepsin D to reduce the generation of the antiangiogenic factor angiostatin, hence promoting a proangiogenic environment. # Pubmed:gene: Cyclooxygenase-2 overexpression inhibits cathepsin D-mediated cleavage of plasminogen to the potent antiangiogenic factor angiostatin.",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 2003 Dec 144(12) 5322-8",
                "id": "12970159"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82f5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Pleckstrin phosphorylation and serotonin secretion in human platelets stimulated with vWF are blocked by the cyclooxygenase inhibitor acetylsalicylic acid",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Jul 13 276(28) 26022-9",
                "id": "11344169"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82f4"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Blood Platelets",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "TGF? can also suppress gastrointestinal inflammatory activity by stimulating the expression of the prostaglandin-degrading enzyme 15-PGDH, which antagonizes the proinflammatory action of COX2 (Yan et al., 2004).",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2008 Jul 25 134(2) 215-30",
                "id": "18662538"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82f3"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "nonsteroidal antiinflammatory drugs up-regulate the synthesis of LTB(4), supporting the shunt hypothesis from COX to 5-LOX.",
              "citation": {
                "type": "PubMed",
                "name": "Arthritis Rheum 2004 Dec 50(12) 3925-33",
                "id": "15593193"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82f2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "chondrocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Cyclooxygenase-2 (COX-2) is a crucial enzyme in the conversion of arachidonicacid to prostaglandin E2 (PGE(2)) and is significantly upregulated in many typesof adenocarcinomas.",
              "citation": {
                "type": "PubMed",
                "name": "Ann N Y Acad Sci 2003 Dec 1010 504-9",
                "id": "15033780"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82f1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "These results confirm the importance of COX-2 activity in prolonged PGI2 release in response to thrombin",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Apr 28 281(17) 11792-804",
                "id": "16467309"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82f0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "umbilical vein endothelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "The defect in PDGF-induced PGE2 release occurs prior to action of prostaglandin H synthase/cyclooxygenase as release of arachadonic acid (in response to PDGF) does not occur in the superoxide dismutase-overexpressing clones.",
              "citation": {
                "type": "PubMed",
                "name": "Arch Biochem Biophys 1995 Sep 10 322(1) 31-8",
                "id": "7574691"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82ef"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "ANXA1 inhibits the expression and/or activity of other inflammatory enzymes like inducible nitric oxide synthase (iNOS) in macrophages and inducible cyclooxygenase (COX2) in activated microglia.",
              "citation": {
                "type": "PubMed",
                "name": "Inflamm Res 2004 Apr 53(4) 125-32",
                "id": "15060718"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82ee"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Resveratrol was found to act as a competitive inhibitor of purified 5-lipoxygenase and 15-lipoxygenase and prostaglandin H synthase",
              "citation": {
                "type": "PubMed",
                "name": "Eur J Biochem 1999 Oct 1 265(1) 27-34",
                "id": "10491155"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82ed"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "COX-2 synthesizes prostaglandin E2 (PGE2) which stimulates bcl-2 and inhibits apoptosis, and induces interleukin-6 (IL-6) which enhances haptoglobin synthesis. PGE2 is associated with tumor metastases, IL-6 with cancer cell invasion, and haptoglobin with implantation and angiogenesis",
              "citation": {
                "type": "PubMed",
                "name": "Ann Clin Lab Sci 2000 Jan 30(1) 3-21",
                "id": "10678579"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82ec"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "# Ariadne: Indeed, we found that HDL and APOE suppress aortic smooth muscle cell cycle progression by stimulating Cox-2 expression, leading to prostacyclin synthesis and an IP-dependent inhibition of the cyclin A gene. [Regulation]",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Invest 2004 Feb 113(4) 609-18",
                "id": "14966570"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82eb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "vascular smooth muscle"
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "The elevated PGE2 production by metastatic cancer cells was due to COX-2 activity since dual COX-1/2 inhibitor indomethacin and selective COX-2 inhibitor NS-398 equally suppressed both basal and inducible (by IFN-gamma/LPS or Ca2+-ionophores) PGE2 accumulation.",
              "citation": {
                "type": "PubMed",
                "name": "Exp Cell Res 2003 Oct 1 289(2) 265-74",
                "id": "14499627"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82ea"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Interestingly,  expression of the proapoptotic proteins Bax and Bcl-x L was reduced in Cox-2- expressing tumors. Cox-2-induced tumor tissue expressed reduced levels of the proapoptotic proteins Bax and Bcl-x(L) and an increase in the anti-apoptotic protein Bcl-2, suggesting that decreased apoptosis of mammary epithelial cells contributes to tumorigenesis. \\\"From full text\\\"",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 May 25 276(21) 18563-9",
                "id": "11278747"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82e9"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Macrophage activation promotes the secretion of pro-inflammatory cytokines, such as tumor necrosis factor-alpha (TNF-alpha) and interleukin-1beta (IL-1beta), and of secondary mediators (through activation of Cox2), leukotrienes and prostaglandins (PGs) such as PGE2. ",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2002 Sep 16 21(18) 4831-40",
                "id": "12234923"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82e8"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "A prostate apoptosis response 4 (Par-4) gene was up-regulated after NSAID treatment. Par-4 was first isolated from prostate carcinoma cells undergoing apoptosis, and expression of Par-4 sensitized cancer cells to apoptotic stimuli. ",
              "citation": {
                "type": "PubMed",
                "name": "Gastroenterology 2000 Jun 118(6) 1012-7",
                "id": "10833474"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82e7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "These results indicate that PGE(2) synthetic capacity in AECs is predominantly COX-2-dependent under both basal and stimulated conditions",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2002 Dec 27(6) 752-8",
                "id": "12444036"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82e6"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Alveolar type II cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "The enzymatic activity of 15-PGDH as a COX-2 antagonist, plus the observed loss of 15-PGDH expression in colon cancer, suggested that 15-PGDH might have tumor suppressor activity.  From full text",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2004 Dec 14 101(50) 17468-73",
                "id": "15574495"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82e5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "COX-2 inhibitors...in the vasculature prevents the accumulation of COX-2- derived 15d-PGJ2, which is associated with the atheroprotective nature of laminar flow.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2005 Sep 27 102(39) 14010-5",
                "id": "16172382"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82e4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium, Vascular"
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Both transforming growth factor-alpha and amphiregulin were released in response to over-expression of cyclooxygenase-2",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2007 Sep 19(9) 1956-63",
                "id": "17572069"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82e3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Incubation with NS-398, a COX-2 inhibitor, blocked the effect of AA, but not of ethanol, on COL1A2 expression suggesting that CYP2E1 activates COX-2 expression, and the oxidation of AA by COX-2 is responsible for the increase in COL1A2.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Jun 30 275(26) 20136-45",
                "id": "10770928"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82e2"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "hepatic stellate cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Prostanoids are lipid mediators generated from AA by the enzymatic action of the cyclooxygenases (COX) 1 and 2 to form the intermediate PGH 2 , with subsequent metabolism to specifi c prostanoid species (e.g., PGD 2 , PGE 2 , PGF 2  , PGI 2 , and thromboxane) by prostaglandin synthases",
              "citation": {
                "type": "PubMed",
                "name": "J Exp Med 2008 Nov 24 205(12) 2791-801",
                "id": "18955568"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82e1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "We report that overexpression of human (h) cyclooxygenase-2 h(COX-2) in the brain of a transgenic mouse line leads to selective induction of endogenous complement component C1qB expression in neurons. No detectable induction of the C3 and C4 complement components in the brain was found. Chronic treatment of mice with the selective COX-2 inhibitor nimesulide reduced the hCOX-2-mediated induction of hippocampal C1qB mRNA expression.",
              "citation": {
                "type": "PubMed",
                "name": "Acta Neuropathol (Berl) 2002 Feb 103(2) 157-62",
                "id": "11810182"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82e0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol 1998 Apr 274(4 Pt 2) F673-9",
                "id": "9575890"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82df"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "we did IL-6-specific ELISA on supernatants of COX-2-S and COX-2-AS cells and showed that IL-6 is significantly increased in COX-2-S",
              "citation": {
                "type": "PubMed",
                "name": "Clin Cancer Res 2005 Nov 1 11(21) 7674-82",
                "id": "16278387"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82de"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "There was a significant increase in IL-5 and IL-13 mRNA in the OVA-COX-1 inhibitor group, OVA-COX-2 inhibitor group, and OVA-indomethacin group compared with the untreated OVA group, with the OVA- COX-2 inhibitor group and OVA-indomethacin groups showing greater expression of these cytokines than the OVA- COX-1 inhibitor group.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Crit Care Med 2002 Apr 15 165(8) 1154-60",
                "id": "11956061"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82dd"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "PGH2 are metabolized to PGE2, PGI2, PGD2, PGF2alpha, and thromboxane A2 (TXA2) by respective actions of PGE2 synthase (PGES), PGI2 synthase (PGIS), PGD2 synthase (PGDS), PGF2 synthase (PGFS), and thromboxane synthase. ",
              "citation": {
                "type": "PubMed",
                "name": "Immune Netw 2011 Dec 11(6) 364-7",
                "id": "22346776"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82dc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Other pathways underlying nAChR-induced cell proliferation include activation of NF-kB, Src, the 5-lipooxygenase pathway [36], Akt, HIF-1a [37,38] and COX-2 [19,26,33].",
              "citation": {
                "type": "PubMed",
                "name": "Trends Pharmacol Sci 2008 Mar 29(3) 151-8",
                "id": "18262664"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82db"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasm",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "These data suggest that H2O2 stimulates CFTR Cl(-) channel-mediated Cl(-) secretion through cyclooxygenase- and mPGES-1-dependent release of PGE2 and subsequent activation of PKA.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Renal Physiol 2007 Nov 293(5) F1571-6",
                "id": "17699556"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82da"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "renal medulla"
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "tumor growth (sarcoma-180, Lewis lung carcinoma) was markedly suppressed in EP3(-/-), in which tumor-associated angiogenesis was also reduced.",
              "citation": {
                "type": "PubMed",
                "name": "J Exp Med 2003 Jan 20 197(2) 221-32",
                "id": "12538661"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82d9"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "The expression of cyclooxygenase (COX)-2 is induced by growth factors, tumor promoters and cytokines, and is correlated with carcinogenesis, tumor progression and inhibition of apoptosis.",
              "citation": {
                "type": "PubMed",
                "name": "Int J Oncol 2005 Feb 26(2) 353-60",
                "id": "15645119"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82d8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Dec 20 277(51) 50081-6",
                "id": "12401798"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82d7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Ku70 and Ku80 expression is mediated by constitutively activated NF-kappaB and constitutively expressed COX-2 in gastric cancer cells",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Nov 29 277(48) 46093-100",
                "id": "12324457"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82d6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "LPS upregulated COX-2 expression 2.8-fold and alpha(v) integrin expression twofold. The COX-2 inhibitor celecoxib increased alpha(v) integrin mRNA expression twofold. Both exogenous PGE(2) and the specific EP(3) receptor agonist, MB28767, reduced constitutive alpha(v) integrin mRNA expression to half normal values",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Pathol 2004 May 57(5) 553-5",
                "id": "15113870"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82d5"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "COX-2 protein and activity clearly decreased in cells transfected with -catenin after treatment compared to cells transfected with non-specific siRNA (Fig. 4A, B).",
              "citation": {
                "type": "PubMed",
                "name": "FASEB J 2007 Jun 21(8) 1831-43",
                "id": "17317723"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82d4"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "To test whether the PGE2 produced was through COX-2, a COX-2-selective inhibitor NS398 was used (51). At 300 nM, there was complete inhibition of TNF-induced PGE2 production, suggesting a key role for COX-2 in the PGE2 response to TNF in this system (Fig. 1B).",
              "citation": {
                "type": "PubMed",
                "name": "FASEB J 2003 Aug 17(11) 1411-21",
                "id": "12890694"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82d3"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "A substantial body of literature indicates that endothelial COX-2 activity is upregulated by a number of cytokines and mitogenic stimuli, including Interleukin-1 alpha and beta (IL-l alpha and beta), tumour necrosis factor alpha (TNFa), transforming growth factor beta (TGFbeta), phorbol ester, lipolysaccharide (LPS) and interferon gamma (IFNy) I2 13.",
              "citation": {
                "type": "PubMed",
                "name": "Dig Liver Dis 2001 Dec 33 Suppl 2 S12-20",
                "id": "11827357"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82d2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Treatment with a COX-2 inhibitor, celecoxib... beta 3Gal-T5 and ST3Gal III and IV expression was inhibited by celecoxib and was enhanced by prostaglandin E(2) treatment.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2002 Mar 1 62(5) 1567-72",
                "id": "11888937"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82d1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Cyclooxygenase (COX)-2 and the subsequent production of prostaglandin E2 (PGE2) were also induced by H-Ras",
              "citation": {
                "type": "PubMed",
                "name": "Int J Cancer 2006 Oct 15 119(8) 1767-75",
                "id": "16721810"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82d0"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Ku70 and Ku80 expression is mediated by constitutively activated NF-kappaB and constitutively expressed COX-2 in gastric cancer cells",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Nov 29 277(48) 46093-100",
                "id": "12324457"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82cf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Cyclooxygenase-2 (COX-2) is up-regulated in human colon carcinomas, and its inhibition is associated with a reduction in tumorigenesis and a promotion of apoptosis.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2005 Dec 15 65(24) 11447-58",
                "id": "16357153"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82ce"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Carrageenin-induced acute lung inflammation was also exacerbated in Nrf2?/? mice compared with Nrf2+/+ mice (Mochizuki et al., 2005). A selective COX-2 inhibitor (NS-398) suppressed the antiinflammatory 15-deoxy-delta (12,14)-prostaglandin J2 (15d-PGJ2) accumulation and ARE responsiveness, and caused greater lung injury in Nrf2?/? mice than in Nrf2+/+ mice (Mochizuki et al., 2005).",
              "citation": {
                "type": "PubMed",
                "name": "Toxicol Appl Pharmacol 2009 Jul 29",
                "id": "19646463"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82cd"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "COX-2-specific inhibitor, NS-398,",
              "citation": {
                "type": "PubMed",
                "name": "J Rheumatol 2002 Mar 29(3) 546-53",
                "id": "11908571"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82cc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Overexpressing of COX-2 showed reduced DR-4 and DR-5 mRNA and protein expression. COX-2-overexpressing cells were treated with 20micro M sulindac sulfide  for 24h, which increased both DR-4 and DR-5 mRNA levels in HCT-15 cells.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2002 Sep 1 62(17) 4903-8",
                "id": "12208739"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82cb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Conversely, calcium ionophore greatly enhanced SR-A up-regulation This enhancement was dependent upon concurrent up-regulation of SMC cyclooxygenase-2 expression and activity and was blocked by the cyclooxygenase-2 inhibitors NS-398 and Resveratrol",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Jun 9 275(23) 17661-70",
                "id": "10837497"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82ca"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Circulation 2001 Aug 21 104(8) 921-7",
                "id": "11514380"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82c9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Recent experiments have demonstrated that COX-2 promotes tumor angiogenesis.",
              "citation": {
                "type": "PubMed",
                "name": "Biochim Biophys Acta 2004 Mar 4 1654(1) 51-67",
                "id": "14984767"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82c8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "To confirm that COX-2 was the source of peroxides in the K-rasV12 transfected cells, we treated the cells with COX-2- specific inhibitor, SC58125.",
              "citation": {
                "type": "PubMed",
                "name": "Carcinogenesis 2004 Nov 25(11) 2231-7",
                "id": "15284181"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82c7"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Cyclooxygenase-2 (COX-2) antagonists, by blocking prostaglandin production, might inhibit this pathway 149.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2002 Feb 2(2) 101-12",
                "id": "12635173"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82c6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Inhibition of COX-2 by acetyl salicylic acid (1 mM), NS-398 (5 microM), or celecoxib (3 microM) abolished the increase in cAMP and markedly reduced alpha(2C)-AR induction in response to serum stimulation.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Heart Circ Physiol 2005 Jan 288(1) H69-76",
                "id": "15345481"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82c5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "vascular smooth muscle"
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Theseeffects were reversed by NS398, a COX-2-specific inhibitor, suggesting thatlipopolysaccharide-mediated inhibition of CUGBP2 is a PG-dependent mechanism.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2004 Sep 21 101(38) 13873-8",
                "id": "15358864"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82c4"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "nonsteroidal antiinflammatory drugs up-regulate the synthesis of LTB(4), supporting the shunt hypothesis from COX to 5-LOX.",
              "citation": {
                "type": "PubMed",
                "name": "Arthritis Rheum 2004 Dec 50(12) 3925-33",
                "id": "15593193"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82c3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Otolaryngol 2003 Aug 32(4) 226-9",
                "id": "14587561"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82c2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "# Ariadne: Indeed, we found that HDL and APOE suppress aortic smooth muscle cell cycle progression by stimulating Cox-2 expression, leading to prostacyclin synthesis and an IP-dependent inhibition of the cyclin A gene. [Regulation]",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Invest 2004 Feb 113(4) 609-18",
                "id": "14966570"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82c1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "the JNK2/c-jun/COX-2 pathway functions upstream of PI3-K and Nrf2 (26) in the signaling cascade",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2005 Sep 27 102(39) 14010-5",
                "id": "16172382"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82c0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "chondrocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Administration of the cyclooxygenase 2 inhibitor NS-398 to mice with carrageenan-induced pleurisy caused persistence of neutrophil recruitment and, in macrophages, attenuated the 15d-PGJ(2) accumulation and PrxI expression.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Jan 24(1) 36-45",
                "id": "14673141"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82bf"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Tumor COX-2 overexpression seems to affect numerous cellular pathways;...37 genes were increased (Fig. 1C; Table 1) and eight genes were decreased (data not shown) in both A549-S and H157-S cell lines.",
              "citation": {
                "type": "PubMed",
                "name": "Clin Cancer Res 2005 Nov 1 11(21) 7674-82",
                "id": "16278387"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82be"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Lung Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "To test whether the PGE2 produced was through COX-2, a COX-2-selective inhibitor NS398 was used (51). At 300 nM, there was complete inhibition of TNF-induced PGE2 production, suggesting a key role for COX-2 in the PGE2 response to TNF in this system (Fig. 1B).",
              "citation": {
                "type": "PubMed",
                "name": "FASEB J 2003 Aug 17(11) 1411-21",
                "id": "12890694"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82bd"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Inhibition of the enzyme inducible cyclooxygenase (COX-2) and the transcription factor nuclear factor-kappaB (NF-kappaB) significantly diminished the free radicals' signal intensity, implicating these factors in the formation of free radicals",
              "citation": {
                "type": "PubMed",
                "name": "Diabetes 2003 Aug 52(8) 1994-9",
                "id": "12882915"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82bc"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "in both benign and malignant mouse intestinal tumors, stromal expression of COX2 results in elevated PGE2 levels that stimulate, in turn, cell surface receptor EP2, followed by induction of VEGF and angiogenesis",
              "citation": {
                "type": "PubMed",
                "name": "Endocr Rev 2004 Aug 25(4) 581-611",
                "id": "15294883"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82bb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "The production of prostaglandins begins with the liberation of arachidonic acid from membrane phospholipids by phospholipase A2 in response to inflammatory stimuli. Arachidonic acid is converted to PGH2 by the cyclooxygenase enzymes COX-1 and COX-2 (known formally as prostaglandin endoperoxide H synthases). ",
              "citation": {
                "type": "PubMed",
                "name": "Trends Immunol 2002 Mar 23(3) 144-50",
                "id": "11864843"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82ba"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Sulindac sulfide,  but not sulindac sulfone, inhibits cyclooxygenase (COX) enzyme activities,",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Nov 28 278(48) 47762-75",
                "id": "14506281"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82b9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "COX-2 inhibition prevented ETS-1 expression in response to ANG II, suggesting that COX-2 is required for ETS-1 induction.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Renal Physiol 2008 May 294(5) F1094-100",
                "id": "18337545"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82b8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "mesangial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Inhibition of COX-2 caused apoptosis of the anergy-resistant lupus T cells by augmenting Fas signaling and markedly decreasing the survival molecule c-FLIP (cellular homolog of viral FLICE inhibitory protein).",
              "citation": {
                "type": "PubMed",
                "name": "Nat Med 2004 Apr 10(4) 411-5",
                "id": "14991050"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82b7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Nonsteroidal antiinflammatory drugs, which inhibit COX-2, prevent colon cancer and cause apoptosis.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2000 Oct 10 97(21) 11280-5",
                "id": "11005842"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82b6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "E4BP4 is a negative regulator of the cyclooxygenase-2 (COX-2) pathway that drives the expression of both Runx2 and Osterix...Runx2 and Osterix as major osteoblast transcriptional activators",
              "citation": {
                "type": "PubMed",
                "name": "Clin Cancer Res 2008 Oct 1 14(19) 6081-91",
                "id": "18829486"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82b5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "osteoblast",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Overexpression of the COX2 gene in COS-1 cells significantly inhibited StAR promoter activity.",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 2003 Aug 144(8) 3368-75",
                "id": "12865315"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82b4"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Herein, we demonstrate that 15-PGDH is active in vivo as a highly potent suppressor of colon neoplasia development and acts in the colon as a required physiologic antagonist of the prostaglandin-synthesizing activity of the cyclooxygenase 2 (COX-2) oncogene.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2006 Aug 8 103(32) 12098-102",
                "id": "16880406"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82b3"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "These results indicate that the COX-2 pathway contributes to Nrf2 activation in the acute phase (i.e. 6 h) following exposure to L-flow. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Jul 22 280(29) 27244-50",
                "id": "15917255"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82b2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "PGD2, is synthesized from arachidonic acid via the catalytic activities of COX in epithelial cells and mast cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Allergy (Cairo) 2012 2012 372384",
                "id": "22500183"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82b1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Chronic Obstructive Pulmonary Disease",
                "cell": "",
                "tissue": "Lung airway"
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "in fact, eicosanoids produced by macrophages expressing COX-2 are known to have proinflammatory effects increasing vascular permeability, promoting chemotaxis and favouring cell proliferation and cholesterol ester retention.",
              "citation": {
                "type": "PubMed",
                "name": "Dig Liver Dis 2001 Dec 33 Suppl 2 S12-20",
                "id": "11827357"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad82b0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:SQSTM1),p(HGNC:KEAP1))",
        "relation": "directlyDecreases",
        "target": "complex(p(HGNC:KEAP1),p(HGNC:NFE2L2))",
        "directed": false,
        "label": "complex(p(HGNC:SQSTM1),p(HGNC:KEAP1)) directlyDecreases complex(p(HGNC:KEAP1),p(HGNC:NFE2L2))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8d94",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:SQSTM1),p(HGNC:KEAP1)) directlyDecreases complex(p(HGNC:KEAP1),p(HGNC:NFE2L2))",
              "summary_text": "RNA interference (RNAi) depletion of SQSTM1 resulted in an increase in the protein level of Keap1 and a concomitant decrease in the protein level of Nrf2 in the absence of changes in Keap1 or Nrf2 mRNA levels. The increased protein level of Keap1 in cells depleted of SQSTM1 by RNAi was linked to a decrease in its rate of degradation; the half-life of Keap1 was almost doubled by RNAi depletion of SQSTM1. The decreased level of Nrf2 in cells depleted of SQSTM1 by RNAi was associated with decreases in the mRNA levels, protein levels, and function of several Nrf2-regulated cell defense genes.",
              "citation": {
                "type": "Other",
                "name": "",
                "id": "20378532"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8bf3"
              },
              "experiment_context": {
                "species_common_name": "human",
                "disease": "",
                "cell": "hek293",
                "tissue": "kidney"
              }
            },
            {
              "bel_statement": "complex(p(HGNC:SQSTM1),p(HGNC:KEAP1)) directlyDecreases complex(p(HGNC:KEAP1),p(HGNC:NFE2L2))",
              "summary_text": "Also, p62 docks directly onto the Kelch-repeat domain of Kelch-like ECH-associated protein 1 (KEAP1), via a motif designated the KEAP1 interacting region (KIR), thereby blocking binding between KEAP1 and NRF2 that leads to ubiquitylation and degradation of the transcription factor. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2010 Jul 16 285(29) 22576-91",
                "id": "20452972"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8303"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:SQSTM1),p(HGNC:KEAP1)) directlyDecreases complex(p(HGNC:KEAP1),p(HGNC:NFE2L2))",
              "summary_text": "an interaction between p62/SQSTM1 and Keap1. This interaction allows nuclear accumulation of the nuclear factor erythroid 2-like 2 (NFE2L2, also known as nuclear factor related factor 2 or NRF2),",
              "citation": {
                "type": "Other",
                "name": "",
                "id": "23795962"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8302"
              },
              "experiment_context": {
                "species_common_name": "human",
                "disease": "",
                "cell": "wi38",
                "tissue": "fibroblasts"
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:SQSTM1),p(HGNC:KEAP1))",
        "relation": "hasComponent",
        "target": "p(HGNC:KEAP1)",
        "directed": false,
        "label": "complex(p(HGNC:SQSTM1),p(HGNC:KEAP1)) hasComponent p(HGNC:KEAP1)",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8d95",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:SQSTM1),p(HGNC:KEAP1)) hasComponent p(HGNC:KEAP1)",
              "summary_text": "These findings demonstrate a physical and functional interaction between Keap1 and SQSTM1",
              "citation": {
                "type": "Other",
                "name": "",
                "id": "20378532"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8307"
              },
              "experiment_context": {
                "species_common_name": "human",
                "disease": "",
                "cell": "hek cell line",
                "tissue": "kidney"
              }
            },
            {
              "bel_statement": "complex(p(HGNC:SQSTM1),p(HGNC:KEAP1)) hasComponent p(HGNC:KEAP1)",
              "summary_text": "These effects appear to be mediated in part by an interaction between p62/SQSTM1 and Keap1.",
              "citation": {
                "type": "Other",
                "name": "",
                "id": "23795962"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8306"
              },
              "experiment_context": {
                "species_common_name": "human",
                "disease": "",
                "cell": "w138",
                "tissue": "fibroblasts"
              }
            },
            {
              "bel_statement": "complex(p(HGNC:SQSTM1),p(HGNC:KEAP1)) hasComponent p(HGNC:KEAP1)",
              "summary_text": "In this current study, we identified the direct interaction between p62 and Keap1 and the residues required for the interaction have been mapped to 349-DPSTGE-354 in p62 and three arginines in the Kelch domain of Keap1.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2010 Jul 30(13) 3275-85",
                "id": "20421418"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8305"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:SQSTM1),p(HGNC:KEAP1)) hasComponent p(HGNC:KEAP1)",
              "summary_text": "Also, p62 docks directly onto the Kelch-repeat domain of Kelch-like ECH-associated protein 1 (KEAP1), via a motif designated the KEAP1 interacting region (KIR), thereby blocking binding between KEAP1 and NRF2 that leads to ubiquitylation and degradation of the transcription factor. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2010 Jul 16 285(29) 22576-91",
                "id": "20452972"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8304"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:SQSTM1),p(HGNC:KEAP1))",
        "relation": "hasComponent",
        "target": "p(HGNC:SQSTM1)",
        "directed": false,
        "label": "complex(p(HGNC:SQSTM1),p(HGNC:KEAP1)) hasComponent p(HGNC:SQSTM1)",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8d96",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:SQSTM1),p(HGNC:KEAP1)) hasComponent p(HGNC:SQSTM1)",
              "summary_text": "In this current study, we identified the direct interaction between p62 and Keap1 and the residues required for the interaction have been mapped to 349-DPSTGE-354 in p62 and three arginines in the Kelch domain of Keap1.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2010 Jul 30(13) 3275-85",
                "id": "20421418"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8309"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:SQSTM1),p(HGNC:KEAP1)) hasComponent p(HGNC:SQSTM1)",
              "summary_text": "Also, p62 docks directly onto the Kelch-repeat domain of Kelch-like ECH-associated protein 1 (KEAP1), via a motif designated the KEAP1 interacting region (KIR), thereby blocking binding between KEAP1 and NRF2 that leads to ubiquitylation and degradation of the transcription factor. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2010 Jul 16 285(29) 22576-91",
                "id": "20452972"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8308"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:GADD45GIP1)",
        "relation": "directlyIncreases",
        "target": "deg(p(HGNC:NFE2L2))",
        "directed": false,
        "label": "p(HGNC:GADD45GIP1) directlyIncreases deg(p(HGNC:NFE2L2))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8d97",
          "evidences": [
            {
              "bel_statement": "p(HGNC:GADD45GIP1) directlyIncreases deg(p(HGNC:NFE2L2))",
              "summary_text": "CRIF1, unlike KEAP1 (which only interacts with N-terminal region of NRF2), physically interacts with both N- and C-terminal regions of NRF2 and promotes NRF2 ubiquitination and subsequent proteasome-mediated NRF2 protein degradation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2010 Jul 9 285(28) 21258-68",
                "id": "20427290"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad830a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "deg(p(HGNC:NFE2L2))",
        "relation": "directlyDecreases",
        "target": "p(HGNC:NFE2L2)",
        "directed": false,
        "label": "deg(p(HGNC:NFE2L2)) directlyDecreases p(HGNC:NFE2L2)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8d98",
          "evidences": [
            {
              "bel_statement": "deg(p(HGNC:NFE2L2)) directlyDecreases p(HGNC:NFE2L2)",
              "summary_text": "CRIF1, unlike KEAP1 (which only interacts with N-terminal region of NRF2), physically interacts with both N- and C-terminal regions of NRF2 and promotes NRF2 ubiquitination and subsequent proteasome-mediated NRF2 protein degradation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2010 Jul 9 285(28) 21258-68",
                "id": "20427290"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8315"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:NFE2L2)) directlyDecreases p(HGNC:NFE2L2)",
              "summary_text": "Nrf2 disappeared in cells with siDJ-1 (Fig. 4B), indicating that DJ-1 stabilizes Nrf-2 protein.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2006 Oct 10 103(41) 15091-6",
                "id": "17015834"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8314"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:NFE2L2)) directlyDecreases p(HGNC:NFE2L2)",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Jan 24 278(4) 2396-402",
                "id": "12441344"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8313"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:NFE2L2)) directlyDecreases p(HGNC:NFE2L2)",
              "summary_text": "Downregulation of Nrf2 by si-NOX1 could be prevented by the addition of the proteasome inhibitor MG132, suggesting that NOX1-derived ROS interfere with the redox dependent proteasomal degradation of Nrf2 (Fig. 3C).",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2010 Jun 15 48(12) 1626-35",
                "id": "20347035"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8312"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:NFE2L2)) directlyDecreases p(HGNC:NFE2L2)",
              "summary_text": "Whereas the Nrf2 level was very low in the cells cotransfected with WT Keap1, treatment of cells with the proteasome inhibitor MG132 stabilized the Nrf2 protein (Fig. 3A, lanes 1 and 2). The Nrf2 level in cells cotransfected with the R272C mutant was very high and was not induced effectively by MG132 (Fig. 3A, lanes 3 and 4). These results indicate that the R272C mutant impaired Nrf2 degradation.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2008 Mar 1 68(5) 1303-9",
                "id": "18316592"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8311"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Lung Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:NFE2L2)) directlyDecreases p(HGNC:NFE2L2)",
              "summary_text": "These results demonstrated that tBHQ and PKC-delta are both required for releasing Nrf2 from INrf2 and for Nrf2 stabilization.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 2009 Dec 15 122(Pt 24) 4452-64",
                "id": "19920073"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8310"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:NFE2L2)) directlyDecreases p(HGNC:NFE2L2)",
              "summary_text": "Keap1 targets its substrate, the Nrf2 transcription factor, for ubiquitination and subsequent degradation by the 26 S proteasome. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Aug 26 280(34) 30091-9",
                "id": "15983046"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad830f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:NFE2L2)) directlyDecreases p(HGNC:NFE2L2)",
              "summary_text": "These results suggest that, under oxidative stress conditions, DJ-1 stabilizes NRF2 protein by interfering with proteasomal degradation and enhances cellular NRF2-dependent antioxidants.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Crit Care Med 2008 Sep 15 178(6) 592-604",
                "id": "18556627"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad830e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:NFE2L2)) directlyDecreases p(HGNC:NFE2L2)",
              "summary_text": "# Ariadne: Under normal conditions, Nrf2 is targeted  for proteasomal degradation by INrf2. [MolTransport]",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Nov 7 278(45) 44675-82",
                "id": "12947090"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad830d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:NFE2L2)) directlyDecreases p(HGNC:NFE2L2)",
              "summary_text": "We propose that exposure of cells to sulforaphane or oxidative stress, by altering the redox state of Cys 151, reduces the ability of Nrf2-bound Keap1 proteins to associate with the Cul3-Rbx1 core complex. As a result, fewer Nrf2 molecules will be targeted for ubiquitination and subsequent degradation, leading to increased accumulation of Nrf2.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Dec 24(24) 10941-53",
                "id": "15572695"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad830c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:NFE2L2)) directlyDecreases p(HGNC:NFE2L2)",
              "summary_text": "Investigators have also proposed Nrf2 stabilization by Keap1; Keap1 may bind to culin-3 (Cul3)-ring box 1 (Rbx1) to form core E3 ubiquitin ligase complex, which renders Nrf2 ubiquitination for targeting of proteasomal degradation (McMahon et al., 2003; Furukawa and Xiong, 2005).",
              "citation": {
                "type": "PubMed",
                "name": "Toxicol Appl Pharmacol 2009 Jul 29",
                "id": "19646463"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad830b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:EIF2AK3)",
        "relation": "actsIn",
        "target": "kin(p(HGNC:EIF2AK3))",
        "directed": false,
        "label": "p(HGNC:EIF2AK3) actsIn kin(p(HGNC:EIF2AK3))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8d99",
          "evidences": [
            {
              "bel_statement": "p(HGNC:EIF2AK3) actsIn kin(p(HGNC:EIF2AK3))",
              "summary_text": "Compared with MEFWT cells, the hypoxia-induced phosphorylation of eIF2alpha was delayed and reduced in MEFPERK-/- cells (Figure 1A), which agreed with previous reports [26,28]. Moreover, our data also showed that the phosphorylation of eIF2alpha was similarly delayed and reduced in MEFGCN2-/- cells (Figure 1A). These results demonstrate that both PERK and GCN2 are involved in the hypoxia-induced phosphorylation of eIF2alpha",
              "citation": {
                "type": "PubMed",
                "name": "Neoplasia 2010 Jan 12(1) 61-8",
                "id": "20072654"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8bfd"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EIF2AK3) actsIn kin(p(HGNC:EIF2AK3))",
              "summary_text": "{From full text}  For example, phosphorylation of eIF2{alpha} by GCN2 (EIF2AK4) is enhanced by amino acid limitation, UV irradiation, and proteasome inhibition (13?16). Phosphorylation of eIF2{alpha} inhibits general protein synthesis by reducing the levels of eIF2-GTP that are required for binding of initiator tRNA to the translation apparatus. Concomitant with lowered protein synthesis, eIF2{alpha} phosphorylation leads to preferential translation of ATF4, a basic zipper (bZIP) transcription activator important for directing transcription of stress-related genes (17?20). Reduced protein synthesis conserves energy and provides the cell time for ATF4 and other stress-responsive transcription factors to reconfigure gene expression slated to alleviate damage elicited by the underlying stress. Other members of the eIF2 kinase family include PEK/Perk (EIF2AK3), whose activity is enhanced by endoplasmic reticulum (ER) stress (21, 22); HRI (EIF2AK1), which is regulated by heme deficiency and oxidative stress (23); and PKR (EIF2AK2), which functions in an antiviral pathway (24).{P@S52 is the common phosphorylation site between all 4 kinases and confirmed in Uniprot}",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 Feb 9 282(6) 3755-65",
                "id": "17170114"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8bfc"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EIF2AK3) actsIn kin(p(HGNC:EIF2AK3))",
              "summary_text": "Inhalation exposure of the mice to environmentally-relevant fine particulate matter (aerodynamic diameter < 2.5 mum, PM(2.5)) induces endoplasmic reticulum (ER) stress and activation of unfolded protein response (UPR) in the lung and liver tissues as well as in the mouse macrophage cell line RAW264.7. Ambient PM(2.5) exposure activates double-strand RNA-activated protein kinase-like ER kinase (PERK), leading to phosphorylation of translation initiation factor eIF2alpha and induction of C/EBP homologous transcription factor CHOP/GADD153. ",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2010 Jun 16",
                "id": "20554909"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8bfb"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EIF2AK3) actsIn kin(p(HGNC:EIF2AK3))",
              "summary_text": "Activated PERK then phosphorylates the translation-initiation factor eIF2a, reducing the overall frequency of messenger RNA translation initiation. However, selected mRNAs, such as ATF4 mRNA, are preferentially translated in the presence of phosphorylated eIF2a. ATF4 activates the transcription of UPR target genes encoding factors involved in amino-acid biosynthesis, the antioxidative-stress response and apoptosis. ",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2008 Jul 24 454(7203) 455-62",
                "id": "18650916"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8bfa"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EIF2AK3) actsIn kin(p(HGNC:EIF2AK3))",
              "summary_text": "Inhalation exposure of the mice to environmentally-relevant fine particulate matter (aerodynamic diameter < 2.5 mum, PM(2.5)) induces endoplasmic reticulum (ER) stress and activation of unfolded protein response (UPR) in the lung and liver tissues as well as in the mouse macrophage cell line RAW264.7. Ambient PM(2.5) exposure activates double-strand RNA-activated protein kinase-like ER kinase (PERK), leading to phosphorylation of translation initiation factor eIF2alpha and induction of C/EBP homologous transcription factor CHOP/GADD153. ",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2010 Jun 16",
                "id": "20554909"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8bf9"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EIF2AK3) actsIn kin(p(HGNC:EIF2AK3))",
              "summary_text": "We find that the stress of unfolded proteins in the endoplasmic reticulum (ER) activates P58(IPK) gene transcription through an ER stress-response element in its promoter region. P58(IPK) interacts with and inhibits the PKR-like ER-localized eIF2alpha kinase PERK, which is normally activated during the ER-stress response to protect cells from ER stress by attenuating protein synthesis and reducing ER client protein load.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2002 Dec 10 99(25) 15920-5",
                "id": "12446838"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8bf8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EIF2AK3) actsIn kin(p(HGNC:EIF2AK3))",
              "summary_text": "Upon removal of Grp78, PERK oligomerizes in ER membranes, inducing its autophosphorylation and activating the kinase domain. PERK phosphorylates and inactivates eIF2alpha, thereby globally shutting off mRNA translation and reducing the protein load on the ER.  However, certain mRNAs gain a selective advantage for translation under these conditions, including the mRNA encoding transcription factor ATF4. The ATF4 protein is a member of the bZIP family of transcription factors, which regulates the promoters of several genes implicated in the UPR.",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Invest 2005 Oct 115(10) 2656-64",
                "id": "16200199"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8bf7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EIF2AK3) actsIn kin(p(HGNC:EIF2AK3))",
              "summary_text": "FIG. 7. The signaling arms of the mammalian UPR diverge to regulate some targets and converge to regulate others. The mammalian UPR activates three signal transducers, ATF6, Ire1, and PERK. 1) Activation of ATF6 leads to increased expression of genes regulated by ERSEs in their promoters including ER chaperones like BiP and GRP94, as well as the transcription factor XBP-1. Activation of Ire1 leads to alternative XBP-1 splicing, which in turn up-regulates XBP-1 specific targets like ERdj4, as well as targets with ERSEs in their promoter. A PERK-dependent target other than ATF4 can influence the activation of the ERSE site by an unknown mechanism, which is indicated by a question mark in the schematics. 2) PERK activation leads to eIF-2{alpha} phosphorylation, which allows the expression of the ATF4 transcription factor that in turn induces GADD34 transcription. There is no evidence at this time for members of the ATF6 and Ire1/XBP-1 pathways to impact on the PERK pathway. 3) Finally, the ATF6, Ire1/XBP-1 and PERK pathways converge to optimally induce targets that include CHOP and Herp. Those targets that are downstream of the PERK branch of the UPR are shared with various other cellular stress conditions like heme deficiency, amino acid deprivation, and dsRNA expression. These stresses all activate an eIF-2{alpha} kinase and as a result induce downstream targets like ATF4 and GADD34, as well as those that are dually regulated by both the shared and the ER stress-specific branches of the UPR, which are represented by CHOP and Herp.  ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Apr 2 279(14) 13792-9",
                "id": "14742429"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8bf6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EIF2AK3) actsIn kin(p(HGNC:EIF2AK3))",
              "summary_text": "eIF2alpha phosphorylation at serine 51 promotes expression of stress-induced genes, such as the transcription factors ATF4 and CHOP (Scheuner et al., 2001). Expression of these genes, as well as GADD34, under conditions of ER stress or amino acid deprivation, requires activity of the upstream eIF2alpha kinases PERK and GCN2 (Harding et al., 2000a; Novoa et al., 2001). ",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2003 Mar 3 22(5) 1180-7",
                "id": "12606582"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8bf5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EIF2AK3) actsIn kin(p(HGNC:EIF2AK3))",
              "summary_text": "PERK phosphorylates the eukaryotic translation initiation factor-2a (eIF2a), which results in both the initial decrease in general translation initiation and the selective translation of the transcription factor ATF4. In turn, ATF4 induces growth arrest and DNA damage-inducible protein (GADD153/ CHOP), resulting in cell cycle arrest and thereby preventing further damage to the cell.",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2009 Feb 12 113(7) 1513-21",
                "id": "19018094"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8bf4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EIF2AK3) actsIn kin(p(HGNC:EIF2AK3))",
              "summary_text": "We find that expression of activating transcription factor 3 (ATF3), a member of the ATF/CREB subfamily of basic-region leucine zipper (bZIP) proteins, is induced in response to endoplasmic reticulum (ER) stress or amino acid starvation by a mechanism requiring eIF2 kinases PEK (Perk or EIF2AK3) and GCN2 (EIF2AK4), respectively",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Feb 24(3) 1365-77",
                "id": "14729979"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8331"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EIF2AK3) actsIn kin(p(HGNC:EIF2AK3))",
              "summary_text": "## from full text ## PERK becomes phosphorylated and activated under hypoxia and may be involved in hypoxia-induced eIF2{alpha} phosphorylation.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2002 Nov 22(21) 7405-16",
                "id": "12370288"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8330"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EIF2AK3) actsIn kin(p(HGNC:EIF2AK3))",
              "summary_text": "This response centers on the phosphorylation state of eukaryotic initiation factor (eIF)-2 alpha, which is induced by kinases like protein kinase R-like ER kinase (PERK) and GCN2 to suppress translation and is later reversed so translation resumes.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Sep 12 278(37) 34864-73",
                "id": "12840028"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad832f"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EIF2AK3) actsIn kin(p(HGNC:EIF2AK3))",
              "summary_text": "We have identified the Nrf2 transcription factor as a novel PERK substrate.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2003 Oct 23(20) 7198-209",
                "id": "14517290"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad832e"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EIF2AK3) actsIn kin(p(HGNC:EIF2AK3))",
              "summary_text": "In contrast, dominant-negative inhibition of PERK or eIF2a significantly suppressed the activation of the CHOP gene promoter (Fig. 6C and D). Furthermore, treatment with CSE, DMNQ or SIN-1 rapidly phosphorylated PERK and eIF2a (Fig. 6E-G, Supplemental Fig. 3A-C). These results support induction of CHOP by CSE, O2- and ONOO- via the PERK-eIF2a pathway.",
              "citation": {
                "type": "PubMed",
                "name": "Toxicology 2011 Jun 15",
                "id": "21703327"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad832d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EIF2AK3) actsIn kin(p(HGNC:EIF2AK3))",
              "summary_text": "phosphorylated (p)-PERK was significantly elevated in cells treated with PM2.5 and PM10 compared to that in control cells (p < 0.001)",
              "citation": {
                "type": "PubMed",
                "name": "Toxicol Sci 2009 Nov 112(1) 111-22",
                "id": "19675143"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad832c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EIF2AK3) actsIn kin(p(HGNC:EIF2AK3))",
              "summary_text": "Yeast GCN2 and mammalian PKR and PERK have been shown to be required for autophagy induced by starvation, viral infection, and ER stress, respectively (He and Klionsky, 2009).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2010 Oct 22 40(2) 280-93",
                "id": "20965422"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad832b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EIF2AK3) actsIn kin(p(HGNC:EIF2AK3))",
              "summary_text": "the eIF2alpha phosphorylation increased <0.5-fold in MEF PERK-/- (Fig. 7B, lane 2 versus 1, and Table 1), whereas there was no increase in MEF GCN2-/- cells (Fig. 7C, lane 2 versus 1, and Table 1) after UVB irradiation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2009 Sep 4 284(36) 24281-8",
                "id": "19586904"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad832a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EIF2AK3) actsIn kin(p(HGNC:EIF2AK3))",
              "summary_text": "The second arm of the UPR involves activation of PEK/PERK, which phosphorylates eukaryotic initiation factor 2alpha (eIF2alpha) (Fig. 1).",
              "citation": {
                "type": "PubMed",
                "name": "Endocr Rev 2003 Feb 24(1) 91-101",
                "id": "12588811"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8329"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EIF2AK3) actsIn kin(p(HGNC:EIF2AK3))",
              "summary_text": "The enhanced transcription of folding and degradation machinery messages is initiated by IRE1 through its endonuclease activity and ATF6, which is itself a transcription factor. In addition, the kinase PERK attenuates general protein synthesis through its phosphorylation of eIF2a.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2006 Sep 15 23(6) 773-5",
                "id": "16973428"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8328"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EIF2AK3) actsIn kin(p(HGNC:EIF2AK3))",
              "summary_text": "The results indicate that both PERK and GCN2 contribute to the phosphorylation of eIF2alpha in human keratinocytes upon UVB irradiation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2009 Sep 4 284(36) 24281-8",
                "id": "19586904"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8327"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EIF2AK3) actsIn kin(p(HGNC:EIF2AK3))",
              "summary_text": "phosphorylation of JNK was induced 2 fold in normal cells but not in Perk-/- MEF cells (Figure 4).",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2006 Jan 1 393(Pt 1) 201-9",
                "id": "16124869"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8326"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EIF2AK3) actsIn kin(p(HGNC:EIF2AK3))",
              "summary_text": "The extensive beta-cell death in PERK-/- islets appears to be caused by the accumulation of unfolded proteins in the ER, as suggested by abnormal ER morphology in PERK-/- cells (10).",
              "citation": {
                "type": "PubMed",
                "name": "Endocr Rev 2003 Feb 24(1) 91-101",
                "id": "12588811"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8325"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "pancreatic beta cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EIF2AK3) actsIn kin(p(HGNC:EIF2AK3))",
              "summary_text": "These effects were paralleled by an increase in sbPBS-dependent eIF2a {Eif2s1} phosphorylation. Activated PERK {Eif2ak3} provokes a rapid shutdown of general protein synthesis through eIF2? phosphorylation.",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2008 Mar 15 44(6) 1097-107",
                "id": "18206657"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8324"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EIF2AK3) actsIn kin(p(HGNC:EIF2AK3))",
              "summary_text": "The endoplasmic reticulum (ER)-resident protein kinase PERK attenuates protein synthesis in response to ER stress through the phosphorylation of translation initiation factor eIF2alpha at serine 51. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2008 Jan 4 283(1) 469-75",
                "id": "17998206"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8323"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EIF2AK3) actsIn kin(p(HGNC:EIF2AK3))",
              "summary_text": "In human umbilical vein endothelial cells, exogenous CO activated Nrf2 through the phosphorylation of protein kinase R-like endoplasmic reticulum kinase (PERK), resulting in HO-1 expression.",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 2007 Oct 26 101(9) 919-27",
                "id": "17823375"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8322"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EIF2AK3) actsIn kin(p(HGNC:EIF2AK3))",
              "summary_text": "The ER-membrane-bound protein kinase double-stranded RNA-activated protein kinase-like ER kinase (PERK)-mediated signalling pathway appeared to be responsible for induction of the remaining genes",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2002 Sep 1 366(Pt 2) 585-94",
                "id": "12014989"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8321"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EIF2AK3) actsIn kin(p(HGNC:EIF2AK3))",
              "summary_text": "As expected, PERK activated by oxLDLs, in turn, induced the phosphorylation of its substrate eukaryotic initiation factor (eIF)2alpha (Figure 2E), which is known to inhibit the general pathway of protein biosynthesis. ",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 2009 Feb 13 104(3) 328-36",
                "id": "19106412"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8320"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EIF2AK3) actsIn kin(p(HGNC:EIF2AK3))",
              "summary_text": "Upon ER stress, unfolded proteins relieve the repression by triggering the release of BiP from the NLDs of IRE1 and PERK",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 May 24 277(21) 18346-56",
                "id": "11897784"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad831f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EIF2AK3) actsIn kin(p(HGNC:EIF2AK3))",
              "summary_text": "expression of XBP-1s in Tsc2-/- cells using an adenoviral expression system resulted in decreased PERK phosphorylation validating this approach to reduce ER stress and UPR signaling (Figure 5G).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2008 Mar 14 29(5) 541-51",
                "id": "18342602"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad831e"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EIF2AK3) actsIn kin(p(HGNC:EIF2AK3))",
              "summary_text": "Treatment of tumor cells with FAS inhibitors induces robust PERK-dependent phosphorylation of the translation initiation factor eIF2alpha and concomitant inhibition of protein synthesis. ",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2007 Feb 1 67(3) 1262-9",
                "id": "17283163"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad831d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "tumor"
              }
            },
            {
              "bel_statement": "p(HGNC:EIF2AK3) actsIn kin(p(HGNC:EIF2AK3))",
              "summary_text": "Mammalian cells respond to endoplasmic reticulum (ER) stress by attenuation of protein translation The disruption of PERK function or the blocking of eIF2alpha Ser51 phosphorylation fails to attenuate translation after ER stress and also results in substantial impairment of Grp78/BiP induction by ER stress.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Sep 26 278(39) 37375-85",
                "id": "12871976"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad831c"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EIF2AK3) actsIn kin(p(HGNC:EIF2AK3))",
              "summary_text": "Temporal Changes in gene expression (RT-PCR) following Perk ablation in 832/13 cells (derived from INS-1 cells)",
              "citation": {
                "type": "PubMed",
                "name": "BMC Cell Biol 2009 10 61",
                "id": "19732428"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad831b"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "pancreatic beta cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EIF2AK3) actsIn kin(p(HGNC:EIF2AK3))",
              "summary_text": "% The unfolded protein response (UPR) events triggered by the accumulation of unfolded protein in endoplasmic reticulum (ER) activate the three UPR signaling pathways mediated by IRE1, ATF6 and PERK.",
              "citation": {
                "type": "PubMed",
                "name": "J Toxicol Sci 2006 May 31(2) 149-56",
                "id": "16772704"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad831a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EIF2AK3) actsIn kin(p(HGNC:EIF2AK3))",
              "summary_text": "Parallel analysis of ATF4 mRNA in the polysomes of PERK+/+ and PERK/ MEFs revealed that in the absence of PERK there was a significant decrease in the amount of ATF4 mRNA recruited to polysomes and translated under both normoxic and hypoxic conditions (Fig. 5B and C). ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Sep 24(17) 7469-82",
                "id": "15314157"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8319"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EIF2AK3) actsIn kin(p(HGNC:EIF2AK3))",
              "summary_text": "As shown in Fig. 4B, thapsigargin treatment results in an apparently more robust activation of PERK in MEFs depleted of both isoforms of Nck (dKO) compared with WT, whereas PERK appears only weakly activated in MEFs dKO rescued by expression of high levels of Nck-1 (Nck-1R).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Mar 5 279(10) 9662-71",
                "id": "14676213"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8318"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EIF2AK3) actsIn kin(p(HGNC:EIF2AK3))",
              "summary_text": "Treatment with CSE for 24 hours increased GRP78 protein in concentration-dependent fashion (P , 0.005) (Figure 6). The maximum increase was observed at CSE concentrations of 15 to 30% CSE. CSE extract (30%) also rapidly increased phosphorylation of eIF2a, a target of PERK, without affecting total eIF2a (Figure 7A). CSE (30%) also increased nuclear expression of the PERKregulated transcription factors, ATF4 and Nrf2 (Figure 7B).",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2008 May 38(5) 541-50",
                "id": "18079489"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8317"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EIF2AK3) actsIn kin(p(HGNC:EIF2AK3))",
              "summary_text": "Figure 2E shows  increased phosphorylation of the ER-resident kinase PKR-like ER  kinase (PERK) in cells subjected to CSE followed by gradual  up-regulation of the early autophagic protein ATG12 (Figure 2H). towards necrosis. ",
              "citation": {
                "type": "PubMed",
                "name": "Cardiovasc Res 2011 Jul 3",
                "id": "21676957"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8316"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "umbilical vein endothelial cell",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:PRKCI)",
        "relation": "actsIn",
        "target": "kin(p(HGNC:PRKCI))",
        "directed": false,
        "label": "p(HGNC:PRKCI) actsIn kin(p(HGNC:PRKCI))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8d9a",
          "evidences": [
            {
              "bel_statement": "p(HGNC:PRKCI) actsIn kin(p(HGNC:PRKCI))",
              "summary_text": "Akt has been suggested to be important in transmission of the insulin signal, by phosphorylation of the enzyme GSK-3 (see below), the forkhead transcription factors and cAMP response element-binding protein38,39 Other AGC kinases that are downstream of PI(3)K include serum- and glucocorticoid- regulated kinase and the atypical PKCs, PKC-z and -l42. Akt and/or the atypical PKCs seem to be required for insulinstimulated glucose transport.",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2001 Dec 13 414(6865) 799-806",
                "id": "11742412"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c02"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PRKCI) actsIn kin(p(HGNC:PRKCI))",
              "summary_text": "Sprague-Dawley rats were randomly assigned to either normal (n=16) or high fat (n=16) dietary groups. Following a 12 week dietary period, animals were subjected to hind limb perfusions in the presence (n=8 per group) or absence (n=8 per group) of insulin. In normal skeletal muscle, total PI3-kinase, Akt2 and aPKC zeta/lambda activities were increased by insulin. PM-associated aPKC zeta and lambda, and aPKC zeta/lambda activity, but not Akt2 or Akt2 activity, were increased by insulin in normal muscle.",
              "citation": {
                "type": "PubMed",
                "name": "J Physiol 2005 Jun 1 565(Pt 2) 627-36",
                "id": "15802290"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c01"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": "Muscle, Skeletal"
              }
            },
            {
              "bel_statement": "p(HGNC:PRKCI) actsIn kin(p(HGNC:PRKCI))",
              "summary_text": "PKCtheta cooperates physically and functionally with AKT1 in NFkappaB signaling in TCR/CD28 stimulated T-cells plasma membrane targeting of PKCtheta and AKT1 exerted synergistic transactivation of the IKKbeta/IkappaB/NFkappaB signaling cascade independent of T-cell activation PKCalpha and PKCiota were implicated in the NFkappaB signaling cascade PKCalpha has been functionally implicated in TCR/CD28 induced IL2 gene expression PKCalpha increased and co-stimulation-independent proliferation and IL2 production has been reported",
              "citation": {
                "type": "PubMed",
                "name": "Mol Immunol 2002 Jun 38(15) 1087-99",
                "id": "12044776"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c00"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PRKCI) actsIn kin(p(HGNC:PRKCI))",
              "summary_text": "Jung et al. [36] recently investigated TNF-a-induced HIF-1a accumulation and demonstrated that an NFkB-mediated event that is normally associated with inflammation and cell survival caused protein accumulation in normoxic cells. Although the report fails to identify the mechanism of HIF-1a accumulation, it is suggested that this might interfere with the pVHL-mediated HIF-1a degradation process. Further studies support the concept of a pVHL-dependent cytotoxicity to TNF-a in RCC cells [37,38]. In particular, it has been reported that RCC cells can be sensitized to TNF-a-induced cytotoxicity by re-introducing wild-type VHL [38]. The authors highlight the fact that TNFreceptor engagement by TNF-a triggers the activation of atypical protein kinase C (aPKC), which, through IKKb phosphorylation, liberates NFkB, thereby initiating the transcription of genes that are involved in apoptosis.",
              "citation": {
                "type": "PubMed",
                "name": "Trends Mol Med 2004 Sep 10(9) 466-72",
                "id": "15350900"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8bff"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PRKCI) actsIn kin(p(HGNC:PRKCI))",
              "summary_text": "# Ariadne: Results (Fig. 9 A) show that the  presence of etaPKC triggers the activation of ERK5 to phosphorylate MEF2C in a  manner that is dependent on MEK5. [Regulation] Consistent with the role of the aPKCs in the MEK5-ERK5 pathway, we show that zetaPKC and lambda/iotaPKC activate the Jun promoter through the MEF2C element, a well-established target of ERK5. From all these results, we conclude that MEK5 is a critical target of the aPKCs during mitogenic signaling.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2001 Feb 21(4) 1218-27",
                "id": "11158308"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8bfe"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PRKCI) actsIn kin(p(HGNC:PRKCI))",
              "summary_text": "We report that in glioma cells, CAK (cdk7) is constitutively associated with PKC-iota. In vitro phosphorylation, co-immunoprecipitation, and analysis of phosphorylated proteins by autoradiography indicate that CAK (cdk7) is a substrate for PKC-iota and PKC-betaII hyperphosphorylation. ",
              "citation": {
                "type": "PubMed",
                "name": "Cell Prolif 2002 Feb 35(1) 23-36",
                "id": "11856176"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8346"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "Carcinoma of brain",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PRKCI) actsIn kin(p(HGNC:PRKCI))",
              "summary_text": "In comparison, overexpression of atypical PKC-iota was by itself sufficient to activate NF-kappaB and shift the kinetics of NGF-induced kappaB activity.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Death Differ 1999 Aug 6(8) 753-64",
                "id": "10467349"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8345"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PRKCI) actsIn kin(p(HGNC:PRKCI))",
              "summary_text": "Atypical protein kinase C iota/lambda (PKCiota/lambda) is essential for protein transport in the early secretory pathway. The small GTPase Rab2 selectively recruits the kinase to vesicular tubular clusters (VTCs) where PKCiota/lambda phosphorylates glyceraldehyde-3-phosphate dehydrogenase (GAPDH). VTCs are composed of small vesicles and tubules and serve as transport intermediates that shuttle cargo from the endoplasmic reticulum to the Golgi complex.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Dec 26 278(52) 52524-30",
                "id": "14570876"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8344"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PRKCI) actsIn kin(p(HGNC:PRKCI))",
              "summary_text": "Coexpression of aPKC{iota} with Nrf2-GFP and Keap1 induced the nuclear  accumulation of the fusion protein; however, the kinase inactive mutant aPKC{iota}(K274W) did not affect the cytoplasmic localization of Nrf2-GFP (Fig. 5A).",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2003 Aug 285(2) C334-42",
                "id": "12700136"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8343"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PRKCI) actsIn kin(p(HGNC:PRKCI))",
              "summary_text": "In this study, we found that PKCiota/lambda phosphorylates GAPDH. Moreover, GAPDH interacts directly with the PKCiota/lambda regulatory domain.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Feb 1 277(5) 3334-41",
                "id": "11724794"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8342"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PRKCI) actsIn kin(p(HGNC:PRKCI))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2003 Oct 15 375(Pt 2) 385-93",
                "id": "12841849"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8341"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PRKCI) actsIn kin(p(HGNC:PRKCI))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2003 Feb 23(3) 852-63",
                "id": "12529391"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8340"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PRKCI) actsIn kin(p(HGNC:PRKCI))",
              "summary_text": "We discovered that NNK potently induces multisite Bad phosphorylation at Ser-112, Ser-136, and Ser-155 via activation of PKCiota in association with increased survival of human lung cancer cells. Purified, active PKCiota can directly phosphorylate both endogenous and recombinant Bad at these three sites and disrupt Bad/Bcl-XL binding in vitro. Overexpression of PKCiota results in an enhancement of Bad phosphorylation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Apr 22 280(16) 16045-52",
                "id": "15705582"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad833f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Lung Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PRKCI) actsIn kin(p(HGNC:PRKCI))",
              "summary_text": "high levels of Bcr-Abl activate a signaling cascade involving the sequential activation of Ras, phosphatidylinositol-3 kinase, atypical protein kinase C, Raf-1, and mitogen-activated protein kinase kinase, leading to the ultimate expression of OPN.",
              "citation": {
                "type": "PubMed",
                "name": "J Leukoc Biol 2005 Jul 78(1) 289-300",
                "id": "15857938"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad833e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PRKCI) actsIn kin(p(HGNC:PRKCI))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Nov 19 274(47) 33691-5",
                "id": "10559259"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad833d"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PRKCI) actsIn kin(p(HGNC:PRKCI))",
              "summary_text": "Presently, in 3T3/L1 adipocytes, rosiglitazone induced sizable increases in basal glucose transport that were: dependent on PI3K, 3-phosphoinositide-dependent protein kinase-1 (PDK-1), and PKC-lambda; accompanied by increases in tyrosine phosphorylation of Cbl and Cbl-dependent increases in PI3K and PKC-lambda activity",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 2002 May 143(5) 1705-16",
                "id": "11956152"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad833c"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PRKCI) actsIn kin(p(HGNC:PRKCI))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2001 Dec 21(24) 8414-27",
                "id": "11713277"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad833b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PRKCI) actsIn kin(p(HGNC:PRKCI))",
              "summary_text": "Molecular dissection of signaling down-stream of PKCiota demonstrates that Rac1 is a critical molecular target for PKCiota-dependent transformation, whereas PKCiota is not necessary for NFkappaB activation in vitro or in vivo.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Sep 2 280(35) 31109-15",
                "id": "15994303"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad833a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PRKCI) actsIn kin(p(HGNC:PRKCI))",
              "summary_text": "The two members of the atypical protein kinase C (aPKC) subfamily of isozymes (zetaPKC and lambda/iotaPKC) are involved in the control of nuclear factor kappaB (NF-kappaB) through IKKbeta activation.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1999 Jun 1 18(11) 3044-53",
                "id": "10356400"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8339"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PRKCI) actsIn kin(p(HGNC:PRKCI))",
              "summary_text": "Nicotine also induces activation of c-Src, which is a known PKCiota upstream kinase.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Feb 17 281(7) 4457-66",
                "id": "16361262"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8338"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PRKCI) actsIn kin(p(HGNC:PRKCI))",
              "summary_text": "from full text - When we transfected the constitutively active PKCCAT constructs, the CAT mutants of PKCs a, b1, b2, g, e, n, z, and i   caused significant activation of the cyclin D1 promoter (3-to 12-fold).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Sep 5 278(36) 34709-16",
                "id": "12794082"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8337"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PRKCI) actsIn kin(p(HGNC:PRKCI))",
              "summary_text": "Nicotine also induced activation of c-Src, which is a known PKCi upstream kinase. Treatment of cells with a- BGT can block nicotine-induced calpain phosphorylation with suppression of calpain activity, wound healing, cell migration, and invasion",
              "citation": {
                "type": "PubMed",
                "name": "Mutat Res 659(3) 221-31",
                "id": "18495523"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8336"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasm",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PRKCI) actsIn kin(p(HGNC:PRKCI))",
              "summary_text": "PDK can in turn phosphorylate and activate Akt [also known as protein kinase B (PKB)] as well as the atypical protein kinase C isoforms PKCz and PKCl",
              "citation": {
                "type": "PubMed",
                "name": "Trends Cell Biol 2002 Feb 12(2) 65-71",
                "id": "11849969"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8335"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PRKCI) actsIn kin(p(HGNC:PRKCI))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Diabetes 2001 Aug 50(8) 1901-10",
                "id": "11473054"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8334"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PRKCI) actsIn kin(p(HGNC:PRKCI))",
              "summary_text": "We show here that mice that lack PKClambda specifically in the liver (L-lambdaKO mice), produced with the use of the Cre-loxP system, exhibit increased insulin sensitivity as well as a decreased triglyceride content and reduced expression of the sterol regulatory element-binding protein-1c (SREBP-1c) gene in the liver",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Invest 2003 Sep 112(6) 935-44",
                "id": "12975478"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8333"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PRKCI) actsIn kin(p(HGNC:PRKCI))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Diabetes 2003 Aug 52(8) 1935-42",
                "id": "12882908"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8332"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:MAPK13)",
        "relation": "actsIn",
        "target": "kin(p(HGNC:MAPK13))",
        "directed": false,
        "label": "p(HGNC:MAPK13) actsIn kin(p(HGNC:MAPK13))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8d9b",
          "evidences": [
            {
              "bel_statement": "p(HGNC:MAPK13) actsIn kin(p(HGNC:MAPK13))",
              "summary_text": "Figure 7 Scheme for CLCA1/MAPK13 signaling to mucus production. The CLCA1/MAPK13 signaling pathway is initiated when environmental stimuli (e.g., allergen or virus) stimulate IL-13 production and subsequent activation of IL-13 receptor on the surface of mucous precursor cells. IL-13 receptor activation leads to STAT6 activation and consequent induction of CLCA1 gene expression. The CLCA1 protein is secreted as N-terminal and C-terminal CLCA1 (N-CLCA1 and C-CLCA1) peptide fragments that might activate a putative CLCA1 receptor and in turn MAPK13 to drive a consequent increase in mucin (especially MUC5AC) gene expression and mucus production in airway mucous cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Invest 2012 Dec 3 122(12) 4555-68",
                "id": "23187130"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c03"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Chronic Obstructive Pulmonary Disease",
                "cell": "bronchial epithelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK13) actsIn kin(p(HGNC:MAPK13))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2002 Oct 15 367(Pt 2) 525-32",
                "id": "12171600"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad834e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK13) actsIn kin(p(HGNC:MAPK13))",
              "summary_text": "The substrate specificity of SAPK4 in vitro was similar to that of SAPK3. Both enzymes phosphorylated the transcription factors ATF2, Elk-1 and SAP-1 at similar rates",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1997 Jun 16(12) 3563-71",
                "id": "9218798"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad834d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK13) actsIn kin(p(HGNC:MAPK13))",
              "summary_text": "These  results suggest that p38eta increases the AP-1 by stimulation of c-Jun  phosphorylation, whereas p38gamma and p38delta inhibit this by mechanisms  involving suppression of the c- jun transcription.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Feb 14 278(7) 4831-9",
                "id": "12475989"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad834c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK13) actsIn kin(p(HGNC:MAPK13))",
              "summary_text": "Following the initial description of p38 (p38a), three additional isoforms of this MAP kinase group have been cloned and characterized: p38b (18), p38g (also termed ERK6 or SAPK3) (22, 24, 30), and p38d (also termed SAPK4) (4, 17, 41). Two MAP kinase kinases (MKK), MKK3 and MKK6, are the upstream activators of the p38 group MAP kinases (6, 12, 14, 37).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1999 Jan 19(1) 21-30",
                "id": "9858528"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad834b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK13) actsIn kin(p(HGNC:MAPK13))",
              "summary_text": "stimulation of p38 MAPK isoforms phosphorylated purified Nrf2 protein and caused an increase in the interaction between Nrf2 and Keap1 in vitro and the suppression of Nrf2 translocation into the nucleus.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2006 Sep 1 66(17) 8804-13",
                "id": "16951197"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad834a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK13) actsIn kin(p(HGNC:MAPK13))",
              "summary_text": "94064639;16083285;16094384;8245003;9731215;8325880;17081983",
              "citation": {
                "type": "PubMed",
                "name": "BMC Bioinformatics 2004 Jun 22 5 79",
                "id": "15212693"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8349"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK13) actsIn kin(p(HGNC:MAPK13))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2001 Aug 15 20(16) 4360-9",
                "id": "11500363"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8348"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK13) actsIn kin(p(HGNC:MAPK13))",
              "summary_text": "SAPK4 requires phosphorylation at either or both of these residues for activation",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1997 Sep 19 272(38) 23668-74",
                "id": "9295308"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8347"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:BACH1)",
        "relation": "actsIn",
        "target": "tscript(p(HGNC:BACH1))",
        "directed": false,
        "label": "p(HGNC:BACH1) actsIn tscript(p(HGNC:BACH1))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8d9c",
          "evidences": [
            {
              "bel_statement": "p(HGNC:BACH1) actsIn tscript(p(HGNC:BACH1))",
              "summary_text": "It has long been hypothesized that a heme protein is involved in oxygen sensing, which is important in various molecular and cellular processes. However, in mammalians no such protein has been found yet. In yeast, heme signals are mainly mediated by the heme activator protein Hap1, which in response to heme, activates the transcription of genes necessary for respiration and control of oxidative damage (Pfeifer et al., 1987; Lee et al., 2001). Heme repression is achieved through the action of the ROX1 repressor, the expression of which is transcriptionally activated by heme (Zhang and Hach, 1999).  Recently, a mammalian transcription repressor, Bach1, was identified, which is inactivated upon heme binding (Ogawa et al., 2001).",
              "citation": {
                "type": "PubMed",
                "name": "Pharmacol Rev 2003 Sep 55(3) 551-71",
                "id": "12869663"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c04"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:BACH1) actsIn tscript(p(HGNC:BACH1))",
              "summary_text": "Bandshift and supershift assays revealed that Bach1 binds to the ARE as a heterodimer with small Maf proteins ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Apr 29 280(17) 16891-900",
                "id": "15734732"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad835f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:BACH1) actsIn tscript(p(HGNC:BACH1))",
              "summary_text": "A ChIP assay with UT-7/TPO cells demonstrated that BACH1 bound to the promoter and enhancer regions in vivo. ....As expected, cotransfection with BACH1 or B1K expression plasmids repressed the reporter gene activity driven by the TXAS promoter in a dose-dependent manner (Figure 9)",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2005 Apr 15 105(8) 3100-8",
                "id": "15613547"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad835e"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:BACH1) actsIn tscript(p(HGNC:BACH1))",
              "summary_text": "p53 apoptosis effector related to PMP22 (Perp), another target gene of p53 (see below), was also inhibited by Bach1. ",
              "citation": {
                "type": "PubMed",
                "name": "Nat Struct Mol Biol 2008 Dec 15(12) 1246-54",
                "id": "19011633"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad835d"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": "embryonic tissue"
              }
            },
            {
              "bel_statement": "p(HGNC:BACH1) actsIn tscript(p(HGNC:BACH1))",
              "summary_text": "Heterodimers of the small Maf proteins and NF-E2 related factor 2 (Nrf2), which belongs to the basic leucin zipper (bZip) family of transcriptional factors, activate HO-1 through binding to MAREs (1619). In contrast, heterodimers of small Maf and Bach1 or Bach2 repress MAREdependent transcription (20).",
              "citation": {
                "type": "PubMed",
                "name": "Hypertens Res 2008 Apr 31(4) 783-92",
                "id": "18633191"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad835c"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:BACH1) actsIn tscript(p(HGNC:BACH1))",
              "summary_text": "Therefore, Bach1 functions as a hypoxia-inducible repressor for the HO-1 gene, thereby contributing to fine-tuning of oxygen homeostasis in human cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Mar 14 278(11) 9125-33",
                "id": "12511571"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad835b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:BACH1) actsIn tscript(p(HGNC:BACH1))",
              "summary_text": "Furthermore, at baseline and in hyperoxia, chromatin immunoprecipitation (ChIP) revealed increased Bach1 binding to the HO-1 distal enhancers (DEs) in the neonates compared with adults. These data suggest that elevated levels of Bach1 may help to limit HO-1 induction in the newborn at baseline and in response to oxidative stress.",
              "citation": {
                "type": "PubMed",
                "name": "Pediatr Res 2009 Feb 65(2) 145-9",
                "id": "18948842"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad835a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:BACH1) actsIn tscript(p(HGNC:BACH1))",
              "summary_text": "## full text ## These results indicate that, although cadmium inactivates the repressor activity of Bach1, the CLS-directed nuclear export is not the sole mechanism for the cadmium effect. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Dec 5 278(49) 49246-53",
                "id": "14504288"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8359"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:BACH1) actsIn tscript(p(HGNC:BACH1))",
              "summary_text": "unexpectedly, however, the levels of IL-6 in bronchoalveolar lavage (BAL) fluid from Bach1(-/-) mice were significantly higher than those of WT mice. ..... In addition, a chromatin immunoprecipitation analysis revealed the binding of Bach1 to the IL-6 promoter and its detachment after oxidative stress. ",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2009 Apr 15 46(8) 1119-26",
                "id": "19439223"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8358"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:BACH1) actsIn tscript(p(HGNC:BACH1))",
              "summary_text": "Bach1 Repression of Ferritin and Thioredoxin Reductase1 ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 Nov 23 282(47) 34365-71",
                "id": "17901053"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8357"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:BACH1) actsIn tscript(p(HGNC:BACH1))",
              "summary_text": "Using chromatin immunoprecipitation assays in NIH 3T3 cells, we show that heme, an inducer of ho-1, promotes displacement of Bach1 from the MafK-occupied ho-1 enhancers, which is followed by Nrf2 binding to these elements. ",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2004 Feb 10 101(6) 1461-6",
                "id": "14747657"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8356"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:BACH1) actsIn tscript(p(HGNC:BACH1))",
              "summary_text": "These results suggest that Bach1 impedes p53-mediated transactivation by binding to a subset of target genes along with p53 and by recruiting Hdac1.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Struct Mol Biol 2008 Dec 15(12) 1246-54",
                "id": "19011633"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8355"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:BACH1) actsIn tscript(p(HGNC:BACH1))",
              "summary_text": "We observed that Bach1 binding to E1 and E2 enhancers was enriched in control cells, while the binding decreased with arsenite treatment for 8 h (Figs. 4C and E). ",
              "citation": {
                "type": "PubMed",
                "name": "Toxicol Appl Pharmacol 2010 May 1 244(3) 291-9",
                "id": "20083128"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8354"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": "vascular tissue"
              }
            },
            {
              "bel_statement": "p(HGNC:BACH1) actsIn tscript(p(HGNC:BACH1))",
              "summary_text": "Bach1 functions as a transcriptional repressor of heme oxygenase-1 (HO-1) and the beta-globin genes.",
              "citation": {
                "type": "PubMed",
                "name": "J Biochem (Tokyo) 2005 Mar 137(3) 287-96",
                "id": "15809329"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8353"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:BACH1) actsIn tscript(p(HGNC:BACH1))",
              "summary_text": "Bach1 is a transcriptional repressor of heme oxygenase-1 and beta-globin genes, both of which are known to be transcriptionally induced by heme.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2004 Jul 7 23(13) 2544-53",
                "id": "15175654"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8352"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:BACH1) actsIn tscript(p(HGNC:BACH1))",
              "summary_text": "Conversely, following treatment with 25 um arsenite, NFE2L2 is highly bound at both elements, and BACH1 binding is lost. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2008 Aug 15 283(33) 22363-70",
                "id": "18550526"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8351"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:BACH1) actsIn tscript(p(HGNC:BACH1))",
              "summary_text": "The DNA-binding activity of Bach1 as a MafK hetero-oligomer was markedly inhibited by heme in gel mobility shift assays. The repressor activity of Bach1 was lost upon addition of hemin in transfected cells. These results suggest that increased levels of heme inactivate the repressor Bach1, resulting in induction of a host of genes with MARES:",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2001 Jun 1 20(11) 2835-43",
                "id": "11387216"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8350"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:BACH1) actsIn tscript(p(HGNC:BACH1))",
              "summary_text": "The repression of HO-1 reporter activity by Bach1 was attenuated by co-transfecting IHABP in a dose-dependent manner. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biochem (Tokyo) 2005 Mar 137(3) 287-96",
                "id": "15809329"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad834f"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "path(SDIS:\"laminar shear stress\")",
        "relation": "increases",
        "target": "p(HGNC:PTGS2)",
        "directed": false,
        "label": "path(SDIS:\"laminar shear stress\") increases p(HGNC:PTGS2)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8d9d",
          "evidences": [
            {
              "bel_statement": "path(SDIS:\"laminar shear stress\") increases p(HGNC:PTGS2)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8360"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "path(SDIS:\"laminar shear stress\")",
        "relation": "increases",
        "target": "tloc(p(HGNC:NFE2L2),GOCC:cytoplasm,GOCC:nucleus)",
        "directed": false,
        "label": "path(SDIS:\"laminar shear stress\") increases tloc(p(HGNC:NFE2L2),GOCC:cytoplasm,GOCC:nucleus)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8d9e",
          "evidences": [
            {
              "bel_statement": "path(SDIS:\"laminar shear stress\") increases tloc(p(HGNC:NFE2L2),GOCC:cytoplasm,GOCC:nucleus)",
              "summary_text": "Figure 1 Shear stress increases Nrf2 protein expression and induces Nrf2 translocation into nuclei. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biomed Sci 2009 16 12",
                "id": "19272177"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8362"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "path(SDIS:\"laminar shear stress\") increases tloc(p(HGNC:NFE2L2),GOCC:cytoplasm,GOCC:nucleus)",
              "summary_text": "Transfection of Nrf2-siRNA diminished, albeit not completely, the L-flow-induced nuclear accumulation of Nrf2 (Fig. 2A) and the gene expressions of both NQO1 and HO-1  (Fig. 2B). These results demonstrate that Nrf2 activity is indispensable for the inducible expression of ARE-regulated genes in response to L-flow in HAECs. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Jul 22 280(29) 27244-50",
                "id": "15917255"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8361"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:NFE2L2)",
        "relation": "actsIn",
        "target": "tscript(p(HGNC:NFE2L2))",
        "directed": false,
        "label": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8d9f",
          "evidences": [
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "In the present study, we have examined the binding specificities of Nrf2/MafK heterodimers to the ARE derived from the rat GST A2 and QR genes using gel mobility shift and DNase I protection assays. Furthermore, we utilized co-transfection assays to explore the role these transcription factors play in basal and inducible expression of the rat GST A2 and QR genes. We found that Nrf2/small Maf heterodimers bind with high affinity to the rat QR ARE but with low affinity to the rat GST A2 ARE. Our data suggest that Nrf2 is involved in regulating basal level expression of the rat GST A2 and QR genes; however, small Maf acts as a transcriptional repressor rather than activator of ARE-mediated transcription. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 May 19 275(20) 15466-73",
                "id": "10747902"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c21"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "Nrf1 and Nrf2 Regulate a Similar Subset of Antioxidant Genes: Expression of Gclm was reduced to the same extent in both Nrf1 and Nrf2 mutant cells. NQO1 was down-regulated to a similar extent in both single mutant cells, whereas mRNA levels of heme-oxygenase-1 (HO-1), ferritin-H (FtH), and metallothionein-1 (MT-1) was lower in nrf2/ cells compared with nrf1/ cells (Fig. 6a). In all cases, however, expression in double knockout cells was abolished compared with single knockout cells, indicating a dependence on both Nrf1 and Nrf2",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Nov 28 278(48) 48021-9",
                "id": "12968018"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c20"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "Overexpression of NF-E2-related factor-2 (Nrf2) augmented the TrxR1 promoter activity. In contrast, overexpression of the dominant negative mutant of Nrf2 suppressed cadmium-induced activation of TrxR1 promoter through the ARE. Chromatin immunoprecipitation (ChIP) assays showed that anti-Nrf2 antibody precipitated ARE from the chromatin of the cadmium-treated cells. These results indicated that cadmium-induced TrxR1 gene expression is mediated by the activation of Nrf2 transcription factor and its binding to ARE in the TrxR1 gene promoter. ",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Physiol 2005 Jun 203(3) 529-37",
                "id": "15521073"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c1f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium, Vascular"
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "In a rat hepatoma cell line, peroxynitrite induced PI3K activation and PKB/Akt phosphorylation, leading to the activation of Nrf2/ARE transcription factor and the upregulated expression of the detoxifying enzyme glutathione-Stransferase (41). A similar conclusion was reached by Li et al, who demonstrated a peroxynitrite-dependent phosphorylation of Akt triggering the activation of Nrf2/ARE, and the subsequent upregulation of the antioxidant and cytoprotective enzyme heme-oxygenase-1 in neural cells, resulting in the limitation of peroxynitrite-mediated apoptosis (42).",
              "citation": {
                "type": "PubMed",
                "name": "Front Biosci 2009 14 4809-14",
                "id": "19273391"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c1e"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "Neoplasm",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "Cotransfection with Nrf2 stimulated the Prdx6 promoter in an ARE-dependent manner, whereas it was negatively regulated by Nrf3. siRNA targeting Nrf2 down-regulated reporter gene expression, whereas siRNA targeting the Nrf2 repressor, Keap1, up-regulated it. Binding of Nrf2 to the ARE sequence in chromatin was confirmed by PCR after chromatin immunoprecipitation. These data demonstrate that the ARE within the Prdx6 promoter is a key regulator of basal transcription of the Prdx6 gene and of its inducibility under conditions of oxidative stress.",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2009 Jan 15 46(2) 146-53",
                "id": "18973804"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c1d"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "Overexpression of Fra-1 downregulated c-Jun and Nrf2 enhanced AP-1- and ARE-mediated reporter gene expression, respectively....In contrast, it markedly stimulated ARE-dependent reporter expression (Fig. 7B). Overexpression of Fra-1 significantly and dose-dependently suppressed basal (Fig. 6B) and c-Jun enhanced (Fig. 6C) TRE-driven reporter expression. Similarly, Fra-1 suppressed basal and Nrf2-enhanced ARE-mediated reporter expression (Fig.  7C). Together, these results indicate that fra-1  induction by DEP may play a role in modulation of c-Jun- and Nrf2-dependent gene expression in alveolar epithelial cells.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2004 Feb 286(2) L427-36",
                "id": "14565943"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c1c"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "CS-dependent hmox1 promoter activation is mainly, but not exclusively, controlled by Nrf2.  Nuclear localization of Nrf2 coincides with increased DNA binding of a putative Nrf2/MafK heterodimer to its cognate cis-regulatory site. Studies on the regulatory elements of the oxidative stress-inducible gene heme oxygenase-1 (hmox1) using various hmox1 promoter/luciferase reporter constructs revealed that the strong CS-dependent expression of this gene is primarily governed by the distal enhancers 1 (\\\"E1\\\") and 2 (\\\"E2\\\"), which both contain three canonical ARE-like stress-responsive elements (StREs). Notably, depletion of Nrf2 levels caused by RNA interference or deletion of E1 or E2 sites significantly compromised CS-induced hmox1 promoter activation, based on the distinct Nrf2 sensitivity exhibited by E1 and E2. ",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2005 Dec 1 39(11) 1438-48",
                "id": "16274879"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c1b"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "The Nrf2/MafG heterodimer bound the Ic-ARE and activated transcription, whereas DEM failed to activate mafG in nrf2-null mutant cells. Chromatin immunoprecipitation further revealed that both Nrf2 and small Maf proteins associate with the Ic-ARE in vivo. These results demonstrate that mafG is itself an ARE-dependent gene that is regulated by an Nrf2/small Maf heterodimer and suggest the presence of an autoregulatory feedback pathway for mafG transcriptional regulation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Feb 11 280(6) 4483-90",
                "id": "15574414"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c1a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "Subsequently, to understand the mechanism of nanoparticles-induced oxidative stress, the involvement of oxidative stress-responding transcription factors, such as, nuclear factor-kappaB (NF-kappaB) and nuclear factor-E2-related factor-2 (Nrf-2), as well as the mitogen-activated protein (MAP) kinase signal transduction pathway were investigated. From the overall results, silica nanoparticles exerted toxicity via oxidative stress, which lead to the induction of HO-1 via the Nrf-2-ERK MAP kinase signaling pathway",
              "citation": {
                "type": "PubMed",
                "name": "Toxicol In Vitro 2009 Oct 23(7) 1326-32",
                "id": "19602432"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c19"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "FGF-1 induced the expression of HO-1 in cultured rat spinal cord astrocytes, which was dependent on FGF receptor activation and prevented by cycloheximide. FGF-1 also induced Nrf2 mRNA and protein levels and prompted its nuclear translocation. HO-1 induction was abolished by transfection of astrocytes with a dominant-negative mutant Nrf2, indicating that FGF-1 regulates HO-1 expression through Nrf2. FGF-1 also modified the expression of other antioxidant genes regulated by Nrf2",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Jul 8 280(27) 25571-9",
                "id": "15870071"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c18"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "Furthermore, LNO(2) triggered nuclear factor-erythroid 2-related factor 2 (Nrf2) nuclear translocation and activation of the antioxidant-responsive element-driven transcriptional activity via impairing Kelch-like ECH-associating protein 1 (Keap1)-mediated negative control of Nrf2 activity in VSMCs. LNO(2) upregulated the expression of Nrf2 protein levels, but not mRNA levels, in VSMCs. A forced activation of Nrf2 led to an upregulation of p27(kip1) and growth inhibition of VSMCs. ",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Heart Circ Physiol 2007 Jul 293(1) H770-6",
                "id": "17468336"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c17"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "In a rat hepatoma cell line, peroxynitrite induced PI3K activation and PKB/Akt phosphorylation, leading to the activation of Nrf2/ARE transcription factor and the upregulated expression of the detoxifying enzyme glutathione-Stransferase (41). A similar conclusion was reached by Li et al, who demonstrated a peroxynitrite-dependent phosphorylation of Akt triggering the activation of Nrf2/ARE, and the subsequent upregulation of the antioxidant and cytoprotective enzyme heme-oxygenase-1 in neural cells, resulting in the limitation of peroxynitrite-mediated apoptosis (42).",
              "citation": {
                "type": "PubMed",
                "name": "Front Biosci 2009 14 4809-14",
                "id": "19273391"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c16"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "Nrf2 knockout decreased expression of Gpx2. An ARE sequence located in the 5' promoter-flanking region of exon 1 of Gpx2 was identified and is highly conserved between mouse, rat, and human. Mutation of this ARE core sequence completely abolished the activity of promoter-reporter gene construct. The binding of Nrf2 to the GPX2 antioxidant response element was confirmed by chromatin immunoprecipation, electrophoretic mobility shift assays and site directed mutagenesis",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2006 Jun 22",
                "id": "16794261"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c15"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "from full text - Another potential candidate of partial Nrf 2 regulation observed in this study is aldh3a1 (subcluster 1.2), a key component of aldehyde detoxification. Exhibiting an (Nrf2-independent) expression profile characteristic for phase 1 genes, which is also supported by a previous promoter analysis (Xie et al., 1996), this gene was found to be constitutively upregulated > 12-fold in lung tissue of unexposed mice exhibiting a Clara cellspecific conditional knock out in the keap1 gene (Jon Maher and Keiko Taguchi, unpublished observation). Thus, we conclude that aldh3a1 is targeted by both the Ah receptor and the Nrf2 pathway, supporting the concept that drug-processing genes may be activated by an AhR-Nrf2 signaling axis (Yeager et al., 2009).",
              "citation": {
                "type": "PubMed",
                "name": "Toxicol Sci 2010 May 115(1) 238-52",
                "id": "20133372"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c14"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "The various AREs bind to a complex of nuclear proteins from cells of different origins (15-23, 25). Analysis of ARE-nuclear protein complexes have identified several nuclear transcription factors including c-Jun, Jun-B, Jun-D, c-Fos, Fra1, Nrf1, Nrf2, YABP, ARE-BP1, MafK, Ah (aromatic hydrocarbon) receptor, and the estrogen receptor (15-32). Among these transcription factors, Nrf1 and Nrf2 have been shown to heterodimerize with c-Jun and up-regulate the ARE-mediated expression and induction of NQO1 in response to antioxidants and xenobiotics (26, 31). ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Dec 22 275(51) 40134-41",
                "id": "11013233"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c13"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "Overexpressed Nrf2 robustly activated ARE-regulated luciferase (Fig. 3B, lanes 1 vs. lane 2). Cells with siCTL produced a basal level of luciferase, whereas tBHQ induced luciferase expression as expected (36) (Fig. 3B, lanes 3 and 4). In the presence of siDJ-1#1 or siDJ-1#2, luciferase activity was reduced (Fig. 3B, lanes 5 and 7), and it was no longer stimulated by tBHQ treatment (lanes 6 and 8).",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2006 Oct 10 103(41) 15091-6",
                "id": "17015834"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c12"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "Nuclear factor erythroid 2-related factor 2 (Nrf2) is a transcription factor that positively regulates the basal and inducible expression of a large battery of cytoprotective genes. These gene products include proteins that catalyze reduction reactions (NAD(P)H:quinone oxidoreductase 1, Nqo1), conjugation reactions (glutathione-S-transferases, Gsts and UDP-glucuronosyltransferases, Ugts), as well as the efflux of potentially toxic xenobiotics and xenobiotic conjugates (multidrug resistance-associated proteins, Mrps)",
              "citation": {
                "type": "PubMed",
                "name": "Toxicol Appl Pharmacol 2010 Apr 1 244(1) 57-65",
                "id": "20122946"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c11"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "The NQO1 promoter contains an antioxidant response element (ARE), the target sequence for Nrf2, and is known to be Nrf2-inducible. We therefore evaluated protein levels of NQO1 in cytoplasmic extracts of p47phox-/- and WT macrophages following zymosan stimulation as an indirect readout of Nrf2 activation. Consistent with Nrf2 nuclear translocation, NQO1 expression was induced by zymosan in WT, but not in p47phox-/-, macrophages (Figure 6C).",
              "citation": {
                "type": "PubMed",
                "name": "PLoS One 2010 5(3) e9631",
                "id": "20300512"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c10"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "Nuclear factor erythroid 2-related factor 2 (Nrf2) is a transcription factor that positively regulates the basal and inducible expression of a large battery of cytoprotective genes. These gene products include proteins that catalyze reduction reactions (NAD(P)H:quinone oxidoreductase 1, Nqo1), conjugation reactions (glutathione-S-transferases, Gsts and UDP-glucuronosyltransferases, Ugts), as well as the efflux of potentially toxic xenobiotics and xenobiotic conjugates (multidrug resistance-associated proteins, Mrps)",
              "citation": {
                "type": "PubMed",
                "name": "Toxicol Appl Pharmacol 2010 Apr 1 244(1) 57-65",
                "id": "20122946"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c0f"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "Nuclear factor erythroid 2-related factor 2 (Nrf2) is a transcription factor that positively regulates the basal and inducible expression of a large battery of cytoprotective genes. These gene products include proteins that catalyze reduction reactions (NAD(P)H:quinone oxidoreductase 1, Nqo1), conjugation reactions (glutathione-S-transferases, Gsts and UDP-glucuronosyltransferases, Ugts), as well as the efflux of potentially toxic xenobiotics and xenobiotic conjugates (multidrug resistance-associated proteins, Mrps)",
              "citation": {
                "type": "PubMed",
                "name": "Toxicol Appl Pharmacol 2010 Apr 1 244(1) 57-65",
                "id": "20122946"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c0e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "Cultures treated with MGd or zinc acetate alone elicited transcriptional responses characterized by induction of metal response element-binding transcription factor-1 (MTF-1)-regulated and hypoxia-inducible transcription factor-1 (HIF-1)-regulated genes. Cultures cotreated with MGd and zinc acetate displayed further increases in the levels of MTF-1- and HIF-1-regulated transcripts as well as additional transcripts regulated by NF-E2-related transcription factor 2",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2005 Dec 15 65(24) 11676-88",
                "id": "16357179"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c0d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "To determine whether the nuclear Nrf2 is capable of binding to DNA, we used an EMSA approach with a 32P-labeled ARE probe (Fig. 2). When incubated with the nuclear extracts from control and hyperoxia-exposed C10 cells, the ARE probe formed two major protein complexes, designated I and II. The formation of these complexes was enhanced in cells exposed to hyperoxic conditions (lane 2, Fig. 2B).In particular, a significant difference was observed at 3 h post-exposure. Similar results were obtained with the nuclear extracts from A549 cells (data not shown).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Oct 1 279(40) 42302-12",
                "id": "15292179"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c0c"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "To determine whether the nuclear Nrf2 is capable of binding to DNA, we used an EMSA approach with a 32P-labeled ARE probe (Fig. 2). When incubated with the nuclear extracts from control and hyperoxia-exposed C10 cells, the ARE probe formed two major protein complexes, designated I and II. The formation of these complexes was enhanced in cells exposed to hyperoxic conditions (lane 2, Fig. 2B).In particular, a significant difference was observed at 3 h post-exposure. Similar results were obtained with the nuclear extracts from A549 cells (data not shown).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Oct 1 279(40) 42302-12",
                "id": "15292179"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c0b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "When MafG was co-expressed with Nrf2 in HeLa cells, MafG exerted a bi-directional transcription regulatory effect. At low concentrations, MafG amplified Nrf2 induced ARE-Luciferase activities in a dose-dependent manner (Fig. 5A). At higher concentrations, the amplification effect of MafG was attenuated and even reversed (Fig. 5A). This observation is consistent with previous reports [48, 49], probably due to the reason that overexpressing MafG may favor the formation of MafG/MafG homodimer.",
              "citation": {
                "type": "PubMed",
                "name": "Biochim Biophys Acta 2008 Oct 1783(10) 1847-56",
                "id": "18585411"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c0a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "Whole-genome microarray revealed that knockdown of KEAP1 resulted in 23 messenger RNAs (mRNAs) being up-regulated > or = 2.0-fold. mRNA for aldo-keto reductase (AKR) 1B10, AKR1C1, AKR1C2 and AKR1C3 were induced to the greatest extent, showing increases of between 12- and 16-fold, whereas mRNA for glutamate-cysteine ligase catalytic and modifier subunits, NAD(P)H:quinone oxidoreductase-1 and haem oxygenase-1 (HMOX1) were induced between 2.0- and 4.8-fold",
              "citation": {
                "type": "PubMed",
                "name": "Carcinogenesis 2009 Sep 30(9) 1571-80",
                "id": "19608619"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c09"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "Expression of phase II detoxifying genes is regulated by NF-E2-related factor 2 (Nrf2)-mediated antioxidant response element (ARE) activation. We showed previously that phosphatidylinositol 3 (PI3)-kinase plays an essential role in ARE-mediated rGSTA2 induction by oxidative stress. In view of the fact that the signaling pathway of PI3-kinase controls microfilaments and translocation of actin-associated proteins, the current study was designed to investigate the PI3-kinase-mediated nuclear translocation of Nrf2 and the interaction of Nrf2 with actin. tert-Butylhydroquinone (t-BHQ) caused Nrf2 to translocate into the nucleus in H4IIE cells, which was prevented by pretreatment of the cells with PI3-kinase inhibitors (wortmannin/LY294002). t-BHQ relocalized Nrf2 in concert with changes in actin microfilament architecture, as visualized by superposition of immunochemically stained Nrf2 and fluorescent phalloidin-stained actin. Furthermore, t-BHQ increased the level of nuclear actin, coimmunoprecipitated with Nrf2, which returned to that of control by pretreatment of the cells with PI3-kinase inhibitors. Cytochalasin B, an actin disruptor, alone stimulated actin-mediated nuclear translocation of Nrf2 and induced rGSTA2. In contrast, phalloidin, an agent that prevents actin filaments from depolymerization, inhibited Nrf2 translocation and rGSTA2 induction by t-BHQ. Subcellular fractionation and immunoblot analyses allowed us to detect both 57- and 100-kDa Nrf2. Immunoblot and immunoprecipitation assays showed that the 100-kDa protein comprised both Nrf2 and actin. The present study demonstrates that the PI3-kinase signaling pathway regulates rearrangement of actin microfilaments in response to oxidative stress and that depolymerization of actin causes a complex of Nrf2 bound with actin to translocate into nucleus.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Pharmacol 2002 Nov 62(5) 1001-10",
                "id": "12391262"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c08"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "Generally, we observed the upregulation of a specific subset of antioxidant and phase IIrelated genes known to be widely controlled by nuclear factor-E2related factor 2 (Nrf2) (for review, see Kobayashi and Yamamoto, 2005Go), thus confirming recent mechanistic investigations showing that Nrf2 activation is a major protective cellular feature in the context of CS exposure in vitro (Knrr-Wittmann et al., 2005Go) and in vivo (Rangasamy et al., 2004Go).",
              "citation": {
                "type": "PubMed",
                "name": "Toxicol Sci 2006 Oct 93(2) 422-31",
                "id": "16870687"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c07"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "At 30 minutes after LPS challenge, gene expression for cytokines such as TNF-alpha, TNFSF9, IL-1alpha, IL-6, IL1F9, IL-10, IL-12b, IL-23p19, CSF1, and CSF2 was significantly higher in lungs of Nrf2-/- compared with Nrf2+/+ mice. Among all cytokines, the expression of IL-6 was highest. Members of C-C family (CCL12 [MCP5], CCL17 [TARC], CCL2 [MCP1], CCL3 [MIP1alpha], CCL4 [MIP1b], and CCL6 and CCL8 [MCP2]) and C-X-C chemokines (MIP2, MIG, KC, ITAC, IP-10, and CXCL13) were greatly upregulated in LPS-challenged Nrf2-/- lungs relative to Nrf2+/+ (Figure 4 and Supplemental Table 1).",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Invest 2006 Apr 116(4) 984-95",
                "id": "16585964"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c06"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "Mutagenesis and transfection experiments identified an antioxidant response element in the forward and reverse strands of the proximal Cul3 and Rbx1 promoters, respectively, that Nrf2 binds and regulates expression and antioxidant induction of the Cul3-Rbx1 genes. In addition, short interfering RNA inhibition and overexpression of Nrf2 led to a respective decrease and increase in Cul3-Rbx1 gene expression. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2010 Jul 9 285(28) 21349-58",
                "id": "20452971"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c05"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "HNE caused a small but rapid increase in nuclear Nrf2 that was seen as early as 1 h postincubation and reached significance 3 h postincubation (Fig. 9).",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2005 Aug 1 39(3) 355-64",
                "id": "15993334"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83e2"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "Using peritoneal macrophages from Nrf2-deficient mice, we show here that Nrf2 also controls the expression of a group of electrophile- and oxidative stress-inducible proteins and activities, which includes heme oxygenase-1, A170, peroxiredoxin MSP23, and cystine membrane transport (system x(c)(-)) activity.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 May 26 275(21) 16023-9",
                "id": "10821856"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83e1"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "Also, several Nrf2 target genes involved in phase 2 drug metabolism and oxidative stress were increased. Examples include Gpx2 (chgf 2), Ho-1 (chgf 1.4), ferritin (chgf 1.1), Mt1 (chgf 6), and Mt2 (chgf 2). Moreover, Gadd45 was upregulated as described by Gebel et al. (chgf 0.8), indicating DNA damage.",
              "citation": {
                "type": "PubMed",
                "name": "Arch Biochem Biophys 2007 Sep 15 465(2) 336-46",
                "id": "17707332"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83e0"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "In contrast, the glutathione level in the Nrf2(-/-) mice was not compensated and remained low. This was because of the decrease in the gene expression of gcs(H) and gcs(L) as well as gss in the livers of the Nrf2(-/-) mice. In addition, the expression of ugt1a6 and gstpi that detoxify APAP by conjugation was also decreased.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2001 Apr 10 98(8) 4611-6",
                "id": "11287661"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83df"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "The basal protein and mRNA levels and nuclear binding activities of c-Jun, c-Fos, p50, and p65 were lower in F1 (Nrf1/Nfe2l1 null) and F2 (Nrf2/Nfe2l2 null) cells and exhibited a blunted response to TBH. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2005 Jul 25(14) 5933-46",
                "id": "15988009"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83de"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "Finally, BRCA1 stimulated antioxidant response element-driven transcriptional activity and enhanced the activity of the antioxidant response transcription factor nuclear factor erythroid-derived 2 like 2 [also called NRF2 (NFE2L2)]. ",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2004 Nov 1 64(21) 7893-909",
                "id": "15520196"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83dd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "In the present study, lungs from the chronic smokers demonstrated up-regulation of the Nrf2-regulated antioxidant enzyme, mitochondrial thioredoxin-dependent peroxide reductase (12).",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2008 May 38(5) 541-50",
                "id": "18079489"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83dc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "This factor is activated by oxidants such as hydrogen peroxide [125], hypochlorous acid [126], or nitric oxide [127] and by environmental toxic metals such as chromium [128].",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2009 Jan 15 46(2) 127-37",
                "id": "18996472"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83db"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "SSAT is transcriptionally regulated through the interaction of two trans-acting transcription factors, NF-E2-related factor 2 (Nrf-2), and polyamine modulated factor-1 (PMF-1)",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2003 Jun 27 306(2) 469-75",
                "id": "12804587"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83da"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "Sulforaphane induces via activation of the Nrf2/Keap1 system phase 2 enzymes that protect against carcinogens and oxidants.",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Res 2006 Aug 40(8) 775-87",
                "id": "17015256"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83d9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "INrf2 tethering of the transcription factor Nrf2 in the cytosol prevents Nrf2 activation of antioxidant response element (ARE) mediated gene expression.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2002 Oct 3 21(44) 6829-34",
                "id": "12360409"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83d8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "Transfection studies with luciferase reporter gene constructs indicate that increased HO-1 gene expression via inhibition of p38 was mediated by the transcription factor Nrf2, which is a central regulator of the cellular oxidative stress response. Accordingly, inhibitors of p38 induced binding of nuclear proteins to a Nrf2 target sequence of the HO-1 promoter, but did not affect HO-1 protein expression and promoter activity in Nrf2(-/-) MEF.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2009 Jun 1 182(11) 7048-57",
                "id": "19454702"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83d7"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Monocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "Overexpression of NOX1 resulted in induction of Nrf2 as demonstrated by Nrf2 Western blot and ARE reporter gene assay (Fig. 3D, right).",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2010 Jun 15 48(12) 1626-35",
                "id": "20347035"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83d6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "In addition, expression of NQO1 or Nrf2 inhibited tumor necrosis factor-alpha-induced activation of VCAM-1 (vascular cell adhesion molecule-1) gene expression in EC",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Jan 10 278(2) 703-11",
                "id": "12370194"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83d5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium"
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "Keap1 or individual Keap1 mutants were cotransfected into NIH3T3 cells with an Nrf2 expression plasmid and a luciferase reporter pRBGP2 (16). Luciferase activity was repressed significantly when WT Keap1 or the H200P mutant was transfected simultaneously (Fig. 2C, lanes 3 and 4).",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2008 Mar 1 68(5) 1303-9",
                "id": "18316592"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83d4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Lung Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "Deletion or site-directed mutagenesis of a potential ARE spanning -784/-764 sequence significantly attenuated hyperoxia-increased Pparg promoter activity in airway epithelial cells overexpressing Nrf2, indicating that the -784/-764 ARE is critical for Nrf2-regulated PPARgamma expression. ",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Crit Care Med 2010 Jul 15 182(2) 170-82",
                "id": "20224069"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83d3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "We demonstrated that submicromolar concentrations of HNE (as little as 0.3 muM) could increase the expression of both GCLC and GCLM. We also found that the induction of GCL expression was abrogated by siRNA for Nrf2.",
              "citation": {
                "type": "PubMed",
                "name": "Redox Rep 2007 12(1) 101-6",
                "id": "17263920"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83d2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "LSS increased Nrf2 activation by 4-fold, whereas atorvastatin alone (0.6 uM) had no effect, nor did it increase activation in EC pre-conditioned with LSS.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2009 Jul 10 284(28) 18882-92",
                "id": "19457866"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83d1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "umbilical vein endothelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "# Ariadne: Both require PKC-mediated phosphorylation of  Nrf2, leading to either release of Nrf2 from INrf2 ( Hypothesis I ) or escape  of Nrf2 from INrf2 ( Hypothesis II ). [ProtModification]",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Nov 7 278(45) 44675-82",
                "id": "12947090"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83d0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "NRF2 (or Nrf2) activation also stimulated growth of lung cancer-derived cell lines expressing KEAP1 at low levels in KEAP1 mutant cell lines and in Keap1-null mouse embryonic fibroblasts under homeostatic conditions (Singh et al., 2006).",
              "citation": {
                "type": "PubMed",
                "name": "Toxicol Appl Pharmacol 2009 Jul 29",
                "id": "19646463"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83cf"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "Neoplasm",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "These data suggest that cinnamaldehyde promotes GCLC and GCLM expression through the activation of the Nrf2 pathway.",
              "citation": {
                "type": "PubMed",
                "name": "Toxicol Sci 2010 Jul 116(1) 151-63",
                "id": "20351055"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83ce"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "Knockdown of Nrf2 significantly decreased NQO1 mRNA and protein levels in cells with or without BaP treatment. NQO1 promoter activity was abrogated by mutation of the Nrf2-binding site in this promoter.",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2011 Jul 1 51(1) 97-106",
                "id": "21569840"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83cd"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium"
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "Here we show that upregulation of NRF2 by OxPLs depends on the activity of protein kinase CK2. Inactivation of CK2 by chemical inhibitors or gene silencing resulted in diminished accumulation of NRF2 and its downstream genes GCLM, HO-1 and NQO1 in response to OxPLs. Furthermore, inhibition of CK2 suppressed NRF2-dependent induction of ATF4 and its downstream gene VEGF. ",
              "citation": {
                "type": "PubMed",
                "name": "J Lipid Res 2010 Oct 8",
                "id": "20934988"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83cc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "Phenethyl isothiocyanate (PEITC) is a promising chemopreventive agent that exerts its effects by induction of phase II enzymes via activation of Nrf2.",
              "citation": {
                "type": "PubMed",
                "name": "Life Sci 2006 Jun 20",
                "id": "16828809"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83cb"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "These results indicated that hARE-mediated expression of the NQO1 gene and its induction by xenobiotics and antioxidants are mediated by Nrf1 and Nrf2. The hARE-mediated basal expression, however, is repressed by overexpression of c-Fos and Fra1",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 1996 Dec 10 93(25) 14960-5",
                "id": "8962164"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83ca"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "Collectively, these data support the conclusion that Keap1 dimerization is required for Nrf2 sequestration and transcriptional repression. Furthermore, exposure to inducing agents disrupts the Keap1 dimerization function and results in Nrf2 release.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Sep 27 277(39) 36544-52",
                "id": "12145307"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83c9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "Ecotopic expression of NF-E2 related factors showed that Nrf2, but not Nrf1, Nrf3, or Bach1, activated TXAS promoter in a dose-dependent manner. Furthermore, chromatin immunoprecipitation assay using the stably transfected A549 cells demonstrated that Nrf2 bound the TXAS NF-E2 site in vivo.",
              "citation": {
                "type": "PubMed",
                "name": "DNA Cell Biol 2003 Aug 22(8) 479-87",
                "id": "14565864"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83c8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "eckol treated cells exhibited significantly elevated Nrf2 binding to the ARE sequence as assessed by the gel shift assay (Fig. 2D)....As illustrated in Fig. 2E, eckol increased the transcriptional activity of Nrf2.",
              "citation": {
                "type": "PubMed",
                "name": "Int J Biochem Cell Biol 2010 Feb 42(2) 297-305",
                "id": "19931411"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83c7"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "lectrophoretic mobility shift assays demonstrate that the ferritin H EpRE/ARE binds Nrf2. Transfection of chimeric ferritin H reporter genes with Nrf2 expression vectors and Nrf2 dominant-negative mutants indicate that Nrf2 functions at the EpRE/ARE to mediate transcriptional activation of ferritin H. Induction of ferritin H and L was not seen in Nrf2 knockout cells,",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Jan 24 278(4) 2361-9",
                "id": "12435735"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83c6"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "We report that KLF2 substantially enhances antioxidant activity of Nrf2 by increasing its nuclear localization and activation. ",
              "citation": {
                "type": "PubMed",
                "name": "Arterioscler Thromb Vasc Biol 2008 May 8",
                "id": "18467642"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83c5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "Smad3E suppressed Nrf2-mediated activation of the GCLC reporter. We demonstrate that TGF-beta increased ATF3 protein levels, as did transient overexpression of Smad3E. Ectopic expression of ATF3 was sufficient to suppress the GCLC reporter activity, as well as endogenous GCLC expression",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2005 Feb 1 38(3) 375-87",
                "id": "15629866"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83c4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "nuclear factor erythroid2-related factor 2 (Nrf2) governs basal and inducible GCLC and GCLM expression by means of the antioxidant response element (ARE)",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2004 Mar 9 101(10) 3381-6",
                "id": "14985508"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83c3"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "ATRA did not block the nuclear accumulation of Nrf2 but reduced the binding of Nrf2 to the ARE enhancer as a consequence of forming a complex with RARalpha.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2007 Dec 4 104(49) 19589-94",
                "id": "18048326"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83c2"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "Herein, we have mapped an antioxidant response element (ARE) in the p62 promoter that is responsible for its induction by oxidative stress via NRF2. Chromatin immunoprecipitation and gel mobility-shift assays verified that NRF2 binds to this cis-element in vivo and in vitro.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2010 Jul 16 285(29) 22576-91",
                "id": "20452972"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83c1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "(EMSA) was used to determine the activation and DNA binding activity of Nrf2 in the lungs in response to acute exposure of the mice to CS (5 hours) ....Supershift analysis with anti-Nrf2 antibody also showed the binding of Nrf2 to the ARE consensus sequence, suggesting the activation of Nrf2 in the lungs of Nrf2+/+ mice in response to CS exposure (Figure 6A).",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Invest 2004 Nov 114(9) 1248-59",
                "id": "15520857"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83c0"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "We show herein that expression of most subunits of 20S and 19S proteasomes, which collectively assemble the 26S proteasome, was enhanced up to threefold in livers of mice following treatment with dithiolethiones, which act as indirect antioxidants. Subunit protein levels and proteasome activity were coordinately increased. No induction was seen in mice where the transcription factor Nrf2 was disrupted. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2003 Dec 23(23) 8786-94",
                "id": "14612418"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83bf"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "In vitro exposure to acrolein, an electrophilic carcinogen in cigarette smoke, stimulated Nrf2 activation and transcriptional induction of phase 2 enzymes (NQO1, GCL) in type II lung cells (Tirumalai et al., 2002).",
              "citation": {
                "type": "PubMed",
                "name": "Toxicol Appl Pharmacol 2009 Jul 29",
                "id": "19646463"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83be"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Alveolar type II cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "We next infected HUVECs with a dominant-negative form of Akt and found that it blocked the Nrf2 activation and HO-1 expression (Figure 7B).",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 2007 Sep 28 101(7) 723-33",
                "id": "17673673"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83bd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "nuclear factor erythroid 2-related factor 2, a tBHQ-activated CNC bZip (cap 'n' collar basic leucine zipper) protein",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2004 Jun 15 380(Pt 3) 695-703",
                "id": "14998373"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83bc"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "OxPLs induced upregulation of ATF4 mRNA and protein in several types of endothelial cells and that these effects were suppressed by short interfering RNA (siRNA) against NRF2.... Chromatin immunoprecipitation revealed OxPL-dependent binding of NRF2 to a putative antioxidant response element site in the ATF4 gene promoter. ",
              "citation": {
                "type": "PubMed",
                "name": "Arterioscler Thromb Vasc Biol 2010 May 30(5) 1007-13",
                "id": "20185790"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83bb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "The accumulation of unfolded proteins elicits a cellular response that triggers both pro-survival and pro-apoptotic signaling events. PERK-dependent activation of NF-E2-related factor-2 (Nrf2) is critical for survival signaling during this response",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 May 7 279(19) 20108-17",
                "id": "14978030"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83ba"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "zinc upregulated the mRNA level of GCL and activated the ARE-Nrf2 pathway",
              "citation": {
                "type": "PubMed",
                "name": "Invest Ophthalmol Vis Sci 2006 Jun 47(6) 2709-15",
                "id": "16723490"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83b9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "retinal epithelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "Antioxidant response element (ARE) and nuclear transcription factor Nrf2 are known to regulate expression and coordinated induction of NQO1 and other detoxifying enzyme genes in response to antioxidants and xenobiotics.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2001 Jun 28 20(29) 3906-17",
                "id": "11439354"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83b8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "Nrf2-deficient murine embryonic fibroblasts showed increased cell death, cytotoxicity, and apoptosis in response to cisplatin treatment compared to wild-type cells. Cisplatin-resistant human ovarian cancer SK-OV cells, which are retaining 25-fold higher levels of GSH than murine fibroblasts, could be sensitized by inhibition of Nrf2.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Lett 2008 Feb 18 260(1-2) 96-108",
                "id": "18036733"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83b7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "The transcriptional start site is located 80 nt upstream of the translation start site. The human GSS promoter efficiently drove luciferase expression in Chang cells. Overexpression of either Nrf1 or Nrf2 induced the GSS promoter activity by 130 and 168% respectively. Two regions homologous to the NFE2 motif are demonstrated to be important for basal expression of human GSS, as mutation of these sites reduced the promoter activity by 66%",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2005 Sep 1 390(Pt 2) 521-8",
                "id": "15890065"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83b6"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "Moreover, despite their elevated levels of ROS, Nrf2(-/-) type II cells were viable and, like their wild-type counterparts, exhibited normal differentiation characteristics.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2007 Jul 37(1) 3-8",
                "id": "17413030"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83b5"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "Supershift analyses revealed that oxLDL stimulates binding of the transcription factors Nrf1, Nrf2, and c-jun to the AREs",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 2003 Mar 7 92(4) 386-93",
                "id": "12600891"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83b4"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "regulation of the proteasome by its inhibitor MG-132. Here, we demonstrate that the stimulation of the proteasome by low levels of MG-132 can be abrogated by small interfering RNAs (siRNAs) targeted against Nrf2.",
              "citation": {
                "type": "PubMed",
                "name": "Ann N Y Acad Sci 2006 May 1067 420-4",
                "id": "16804021"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83b3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "The reporter assay using pTAL-Luc-derived constructs showed that only ARE1 (pTALARE1) demonstrates substantially higher reporter activity in control A549 cells compared with A549-Nrf2shRNA cells (Fig. 5C).",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2009 Feb 1 46(3) 376-86",
                "id": "19027064"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83b2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "We found that cell lines expressing lower levels of KEAP1 (H1437 and II-18) and KEAP1 mutant cells (A549) showed greater resistance to cisplatin than SQ-19 cells with normal KEAP1 (Fig. 4D), indicating that constitutive activation of Nrf2 enhances resistance to chemotherapy reagents.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2008 Mar 1 68(5) 1303-9",
                "id": "18316592"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83b1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "lung adenocarcinoma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "Whereas disruption of nrf2 increased the number of apoptotic cells following UVA irradiation by 1.7-fold, disruption of keap1 decreased the apoptotic cell number by half as compared with wild-type controls.",
              "citation": {
                "type": "PubMed",
                "name": "J Invest Dermatol 2005 Apr 124(4) 825-32",
                "id": "15816842"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83b0"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "Nrf2 activators (oltipraz, ethoxyquin, and butylated hydroxyanisole) down-regulated Oatp1a1 but up-regulated Oatp2b1",
              "citation": {
                "type": "PubMed",
                "name": "Drug Metab Dispos 2005 Sep 33(9) 1276-82",
                "id": "15919853"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83af"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "In the present report, we demonstrate that nuclear transcription factors Nrf2 and Nrf1 associate with Jun (c-Jun, Jun-B and Jun-D) proteins to upregulate ARE-mediated expression and coordinated induction of detoxifying enzymes in response to antioxidants and xenobiotics.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1998 Dec 17 17(24) 3145-56",
                "id": "9872330"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83ae"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "oxidant-inducible Nrf2",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Dec 10 279(50) 52390-8",
                "id": "15375163"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83ad"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "Interestingly, the deletion of the antioxidant gene transcription factor, nuclear erythroid 2 p45- related factor-2 (Nrf2), in DCs leads to oxidative stress in DCs",
              "citation": {
                "type": "PubMed",
                "name": "Mucosal Immunol 2009 May 2(3) 206-19",
                "id": "19262504"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83ac"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "dendritic cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "Bach1 competes with activators, including Nrf2, for the binding to Maf recognition element (MARE). HREs share a nucleotide sequence with the MARE, which is important in development and differentiation (Motohashi et al., 1997; Ogawa et al., 2001). Therefore, stress response genes bearing MARE may be up-regulated via the MARE-binding transcription factors with increased levels of heme (Ogawa et al., 2001). ",
              "citation": {
                "type": "PubMed",
                "name": "Pharmacol Rev 2003 Sep 55(3) 551-71",
                "id": "12869663"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83ab"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "Nrf2 directly activated the GST-P1 gene promoter, up to the 95 deletion position.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2002 Jun 1 364(Pt 2) 563-70",
                "id": "12023900"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83aa"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "Lower c-Jun and p65 expression also occurs in Nrf2 (NFE2L2) null livers.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2005 Jul 25(14) 5933-46",
                "id": "15988009"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83a9"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "oxidative and electrophilic stresses induce the nuclear accumulation of Nrf2 by affecting the Keap1-mediated rapid turnover of Nrf2",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2006 Jan 26(1) 221-9",
                "id": "16354693"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83a8"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "Similar to GCL subunits, Nrf2 also is a positive regulator of GGT expression (Zhang et al., 2006).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Aspects Med 30(1-2) 42-59",
                "id": "18601945"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83a7"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "Reporter analysis, site-directed mutagenesis, and chromatin immunoprecipitation assays demonstrated binding of Nrf2 to two AREs distal to the transcription start site     (in combination with Nrf2 KO lowering GSR mRNA above)",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2009 Feb 15 46(4) 443-53",
                "id": "19028565"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83a6"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "Conversely, following treatment with 25 um arsenite, NFE2L2 is highly bound at both elements, and BACH1 binding is lost. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2008 Aug 15 283(33) 22363-70",
                "id": "18550526"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83a5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "In addition, expression of NQO1 or Nrf2 inhibited tumor necrosis factor-alpha-induced activation of VCAM-1 (vascular cell adhesion molecule-1) gene expression in EC",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Jan 10 278(2) 703-11",
                "id": "12370194"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83a4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "In human umbilical vein endothelial cells, exogenous CO activated Nrf2 through the phosphorylation of protein kinase R-like endoplasmic reticulum kinase (PERK), resulting in HO-1 expression.",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 2007 Oct 26 101(9) 919-27",
                "id": "17823375"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83a3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "Small interfering RNA (SiRNA) against Nrf2 significantly attenuated the expression of Nrf2-regulated genes such as HO-1, SQSTM1, NQO1, glutamate-cysteine ligase modifier subunit (GCLM), and ferritin heavy chain. ",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2007 Jan 15 42(2) 260-9",
                "id": "17189831"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83a2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "Nrf2 regulates expression of genes encoding enzymes with antioxidant (e.g. heme oxygenase-1 (HO-1)) or xenobiotic detoxification (e.g. NAD(P)H:quinone oxidoreductase, glutathione S-transferase) functions via the stress- or antioxidant-response elements (StRE/ARE)",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Jun 15 276(24) 20858-65",
                "id": "11274184"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83a1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "role of Keap1 has been ascertained by investigations of Keap1?/? mice in which constitutive transactivation of Nrf2 and overproduction of its target genes lead to esophagus and forestomach hyperkeratosis (Wakabayashi et al., 2003).",
              "citation": {
                "type": "PubMed",
                "name": "Toxicol Appl Pharmacol 2009 Jul 29",
                "id": "19646463"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83a0"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "Nrf2 activators increased UGT2B3 and 2B12 in both liver and duodenum, and UGT1A6, 1A7, and 2B1 in liver only, and Ugt1a2 and ugt1a3 in duodenum. ",
              "citation": {
                "type": "PubMed",
                "name": "Drug Metab Dispos 2006 Jul 19",
                "id": "16855052"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad839f"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "A conserved antioxidant response element (ARE) in the CFTR minimal promoter, which binds Nrf2, has been identified. Surprisingly, Nrf2 exerts an unexpected repressive role on the CFTR gene promoter activity.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Mol Life Sci 2010 Jul 67(13) 2297-309",
                "id": "20309604"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad839e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "the expression levels of GST-P1, GCLC, and NQO1 mRNAs were significantly lower in the lungs of Nrf2-/- mice than in those of WT mice at both 1 and 3 days after bleomycin administration (Figures 5B-5D). The expression levels of HO-1 and Prx-I mRNAs were also significantly lower in the lungs of Nrf2-/- mice than in those of WT mice 3 days after bleomycin administration (Figures 5E and 5F). ",
              "citation": {
                "type": "PubMed",
                "name": "Respir Res 2010 11 31",
                "id": "20298567"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad839d"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "The binding of TCF11/MafG to the iNOS promoter could be enhanced by phorbol 12-myristate 13-acetate and suppressed by the protein kinase C inhibitor staurosporine. Moreover, the induction of TCF11/MafG binding by TGF-beta and Smad6-short could be blocked by staurosporine, and the effect of TGF-beta was blocked by the selective protein kinase C inhibitor calphostin C. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 Dec 21 282(51) 36837-44",
                "id": "17928287"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad839c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Muscle, Smooth"
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "In contrast, addition of ascorbic acid to KCL22/SR cells resulted in a decrease in Nrf2-DNA binding and decreases in levels of gamma-GCSl mRNA and GSH.",
              "citation": {
                "type": "PubMed",
                "name": "Exp Hematol 2004 Apr 32(4) 375-81",
                "id": "15050748"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad839b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2004 Feb 15 18(4) 357-68",
                "id": "15004004"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad839a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Jun 20 278(25) 22243-9",
                "id": "12646564"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8399"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "In addition, 4-hydroxy-2-nonenal, a lipid peroxidation product of OxLDL, was one of the most effective activators of Nrf2 [137].",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2009 Jan 15 46(2) 127-37",
                "id": "18996472"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8398"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "Nuclear factor-erythroid 2 p45-related factor 2 (Nrf2) is the primary transcription factor protecting cells from oxidative stress",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2009 Feb 15 46(4) 443-53",
                "id": "19028565"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8397"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "Indeed, DEP induced the translocation of Nrf2 to the nucleus and increased protein nuclear binding to the antioxidant responsive element.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2003 Sep 285(3) L671-9",
                "id": "12730081"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8396"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "The findings demonstrated that phosphorylation of Nrf2 at the TA domains by CK2 is an integral component of Nrf2 activation necessary for the nuclear localization and transcription activation function of Nrf2 in neuroblastoma cells.  \t ",
              "citation": {
                "type": "PubMed",
                "name": "J Biochem Mol Toxicol 2008 Feb 22(1) 63-76",
                "id": "18273910"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8395"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "neuroblastoma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "Chromatin immunoprecipitation demonstrated OxPAPC-induced binding of NRF2 protein to a DNA region (-363/-183) containing this site (Figure 4A).",
              "citation": {
                "type": "PubMed",
                "name": "Arterioscler Thromb Vasc Biol 2010 May 30(5) 1007-13",
                "id": "20185790"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8394"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "umbilical vein endothelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "The transcription factor Nrf2 was originally described as a transcription factor controlling expression of the ?-globin gene in erythrocytes.",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2009 Jan 15 46(2) 127-37",
                "id": "18996472"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8393"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "erythrocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "Nrf2 is maintained in the cytoplasm via association with Keap1.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2003 Oct 23(20) 7198-209",
                "id": "14517290"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8392"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "Nrf2 contains two transcription activation domains, Neh4 and Neh5, which act synergistically to attain maximum a activation of reporter gene expression. Neh4 and Neh5 both individually and cooperatively bind to CBP",
              "citation": {
                "type": "PubMed",
                "name": "Genes Cells 2001 Oct 6(10) 857-68",
                "id": "11683914"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8391"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "Interestingly, COPD patients? lungs have decreased expression of Nrf2 target genes, which correlate with increased lung damage and COPD severity (21). ",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2009 Jun 11",
                "id": "19520915"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8390"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "dominant-negative Nrf2 abolished the SIN-1-induced increase in Nrf2-ARE binding and subsequent upregulation of HO-1 expression,",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2006 Oct 1 41(7) 1079-91",
                "id": "16962933"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad838f"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "Nrf2 is a transcription factor that is activated by increased ROS, which induces the transcription of several antioxidant and detoxification enzymes including several classes of GST",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2008 Jul 17 27(31) 4353-62",
                "id": "18372916"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad838e"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "Nrf2(-/-) mice exposed to low-dose DEP showed significantly increased airway hyperresponsiveness and counts of lymphocytes and eosinophils, together with increased concentrations of IL-12 and IL-13, and thymus and activation-regulated chemokine (TARC), in BAL fluid than wild-type mice. In contrast, expression of antioxidant enzyme genes was significantly higher in wild-type mice than in Nrf2(-/-) mice.",
              "citation": {
                "type": "PubMed",
                "name": "Clin Immunol 2008 Sep 128(3) 366-73",
                "id": "18614404"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad838d"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "Increased expression was associated with an increase in the binding of Nrf2 to electrophile response elements (EpRE) in the promoters of these genes. Nrf2 overexpression increased the activity of GCS(h) and GCS(l) promoter/reporter transgenes.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Nov 19 274(47) 33627-36",
                "id": "10559251"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad838c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "The present study was therefore designed to carefully analyze expression of major drug transporters in primary human hepatocytes exposed to dioxin (2,3,7,8-tetrachlorodibenzo-p-dioxin, TCDD) (an AhR activator), rifampicin (RIF) (a PXR activator), phenobarbital (PB) (a CAR activator), and oltipraz (OPZ) (a Nrf2 activator), using mainly reverse transcription-real time polymerase chain reaction assays. ",
              "citation": {
                "type": "PubMed",
                "name": "Drug Metab Dispos 2006 Oct 34(10) 1756-63",
                "id": "16837569"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad838b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "hepatocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "In HBE1 cells, silencing of Nrf2 with siRNA inhibited induction of MRP3 by HNE. ",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2009 Jun 15 46(12) 1650-7",
                "id": "19345732"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad838a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "bronchial epithelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "Gel shift analysis confirmed the increased binding of an Nrf2 containing protein complex to the ets-1 ARE after H2O2 treatment. ",
              "citation": {
                "type": "PubMed",
                "name": "FASEB J 2005 Dec 19(14) 2085-7",
                "id": "16234432"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8389"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "We found that cell lines expressing lower levels of KEAP1 (H1437 and II-18) and KEAP1 mutant cells (A549) showed greater resistance to cisplatin than SQ-19 cells with normal KEAP1 (Fig. 4D), indicating that constitutive activation of Nrf2 enhances resistance to chemotherapy reagents.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2008 Mar 1 68(5) 1303-9",
                "id": "18316592"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8388"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Carcinoma, Non-Small-Cell Lung",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "Hyperoxia-induced mRNA levels of NAD(P)H:quinone oxidoreductase 1 (NQO1), glutathione-S-transferase (GST)-Ya and -Yc subunits, UDP glycosyl transferase (UGT), glutathione peroxidase-2 (GPx2), and heme oxygenase-1 (HO-1) were significantly lower in Nrf2-/- mice compared with Nrf2+/+ mice.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2002 Feb 26(2) 175-82",
                "id": "11804867"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8387"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "The small interference RNA (siRNA) against SMRT abolished SMRT repression of the gene induction by C/EBPbeta or Nrf2. The plasmid transfection and siRNA experiments directly evidenced the functional role of SMRT in GSTA2 repression.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2005 May 25(10) 4150-65",
                "id": "15870285"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8386"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "hyperoxia caused the translocation of Nrf2 from the cytoplasm to the nucleus within 30-60 min of exposure",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Oct 1 279(40) 42302-12",
                "id": "15292179"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8385"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": "Epithelium"
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "In studies of transformed human airway epithelial cells in culture, the authors observed that cigarette smoke induces the UPR and activates the NF-E2related factor 2 (Nrf2) transcription factor.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Med 2008 Oct 14(10) 1024-5",
                "id": "18841140"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8384"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "Table 1 Transcription factors activated by OxLDL",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2009 Jan 15 46(2) 127-37",
                "id": "18996472"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8383"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "Overexpression of SQSTM1 and DPP3 in IMR-32 cells stimulated NF-E2-related factor 2 (NRF2) nuclear translocation and led to increased levels of NAD(P)H:quinone oxidoreductase 1, a protein which is transcriptionally regulated by the ARE.....SQSTM1 and DPP3 were unable to activate the ARE in cells transfected with siRNAs against NRF2",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2007 Mar 20 104(12) 5205-10",
                "id": "17360324"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8382"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "neuroblastoma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "Similarly, Nrf2 activators induced CD36 expression in bone marrow-derived macrophages in a Nrf2-dependent manner.",
              "citation": {
                "type": "PubMed",
                "name": "Arch Biochem Biophys 2008 Sep 1 477(1) 139-45",
                "id": "18585365"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8381"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "Activation of Nrf2-ARE responses by a polyphenol epigallocatechin-3-gallate treatment reduced bleomycin-induced lung injury and inflammation in rats (Sriram et al., 2008).",
              "citation": {
                "type": "PubMed",
                "name": "Toxicol Appl Pharmacol 2009 Jul 29",
                "id": "19646463"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8380"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "Table 1 Transcription factors activated by OxLDL",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2009 Jan 15 46(2) 127-37",
                "id": "18996472"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad837f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "Mutagenesis, transfection, and chromatin immunoprecipitation assays identified an antioxidant-response element in the reverse strand of the proximal INrf2 promoter that binds to Nrf2 and regulates expression and antioxidant induction of the INrf2 gene. In addition, short interfering RNA inhibition or overexpression of Nrf2 led to a respective decrease and increase in INrf2 gene expression.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 Dec 14 282(50) 36412-20",
                "id": "17925401"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad837e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "Compared with wild-type mice, emphysematous lungs of CS-exposed Nrf2-deficient mice exhibited markedly lower proteasomal activity and elevated markers of ER stress",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Crit Care Med 2009 Dec 15 180(12) 1196-207",
                "id": "19797762"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad837d"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "Genes that were induced or suppressed >2-fold by curcumin treatments at 3 hours and 12 hours compared with vehicle in wild-type mice but not in Nfe2l2 knockout mice using Affymetrix mouse genome 430 2.0 array in the liver and small intestine.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cancer Ther 2006 Jan 5(1) 39-51",
                "id": "16432161"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad837c"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "We found that cell lines expressing lower levels of KEAP1 (H1437 and II-18) and KEAP1 mutant cells (A549) showed greater resistance to cisplatin than SQ-19 cells with normal KEAP1 (Fig. 4D), indicating that constitutive activation of Nrf2 enhances resistance to chemotherapy reagents.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2008 Mar 1 68(5) 1303-9",
                "id": "18316592"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad837b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "E47 cells showed increased Nrf2 mRNA and protein expression. Upregulation of GCLC and HO-1 in E47 cells is dependent on Nrf2.",
              "citation": {
                "type": "PubMed",
                "name": "J Gastroenterol Hepatol 2006 Oct 21 Suppl 3 S22-5",
                "id": "16958665"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad837a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "A pharmacological activator of NRF2 signaling, CDDO-IM {1-[2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oyl]imidazole}, induced Ahr, Cyp1a1, and Cyp1b1 transcription in Nrf2+/+ MEFs but not in Nrf2-/- MEFs. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2007 Oct 27(20) 7188-97",
                "id": "17709388"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8379"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "beta-Naphthoflavone, an Nrf2 activator, elevated the level of AR mRNA in HepG2 cells...and increased the promoter activity of the mouse AR (AKR1B3) gene",
              "citation": {
                "type": "PubMed",
                "name": "J Pharmacol Sci 2005 Jan 97(1) 43-51",
                "id": "15655294"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8378"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "Using chromatin immunoprecipitation assays in NIH 3T3 cells, we show that heme, an inducer of ho-1, promotes displacement of Bach1 from the MafK-occupied ho-1 enhancers, which is followed by Nrf2 binding to these elements. ",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2004 Feb 10 101(6) 1461-6",
                "id": "14747657"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8377"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "Luciferase reporter assays indicated that ER stress stimulated HO-1 promoter activity via the antioxidant response element. Moreover, ER stress induced the nuclear import of Nrf2 and the binding of Nrf2 to the HO-1 antioxidant response element.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Jan 14 280(2) 872-7",
                "id": "15546873"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8376"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "vascular smooth muscle"
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "Nrf2 increased phagocytic ability of macrophages by direct transcriptional up-regulation of the scavenger receptor MARCO.",
              "citation": {
                "type": "PubMed",
                "name": "Sci Transl Med 2011 Apr 13 3(78) 78ra32",
                "id": "21490276"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8375"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "In the oesophagus of Keap1-/- mice, the expression of keratin 6 is greatly increased in an NRF2-dependent manner (44).",
              "citation": {
                "type": "PubMed",
                "name": "Carcinogenesis 2009 Sep 30(9) 1571-80",
                "id": "19608619"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8374"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "OKL38 stimulation by OxPAPC was reduced by 86%in cells treated with Nrf2 siRNA (Fig. 6C). Thus, Nrf2 is necessary for OKL38 stimulation by OxPAPC.",
              "citation": {
                "type": "PubMed",
                "name": "J Lipid Res 2007 Mar 48(3) 709-15",
                "id": "17192422"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8373"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "In conclusion, expression of Nrf2-dependent genes is increased during cholestasis.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Stress Chaperones 2006 11(4) 356-63",
                "id": "17278884"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8372"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "Western blot analysis of lung proteins showed that Srx1 proteinwas present constitutively, and its level increased significantly on exposure to CS in Nrf2+/+ mice. By contrast, expression of Srx1 protein was low in Nrf2?/? mice and did not change significantly with CS exposure (Figs. 1B and C).",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2009 Feb 1 46(3) 376-86",
                "id": "19027064"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8371"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "TABLE II Identification of inducible Nrf2-dependent genes in primary cortical astrocytes",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Apr 4 278(14) 12029-38",
                "id": "12556532"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8370"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "astrocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "Regulation of both basal and inducible expression of cytoprotective genes is mediated in part by the antioxidant response element (ARE)3, a cis-acting sequence found in the 5?-flanking region of genes encoding many phase 2 enzymes including mouse glutathione Stransferase (GST) A1, human NAD(P)H quinone oxidoreductase (NQO1) and human ?- glutamylcysteine ligase as well as murine Nrf2 itself (5-8).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Mar 7 278(10) 8135-45",
                "id": "12506115"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad836f"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "From Figure 1",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Invest 2005 Oct 115(10) 2656-64",
                "id": "16200199"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad836e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "Heterodimers of the small Maf proteins and NF-E2 related factor 2 (Nrf2), which belongs to the basic leucin zipper (bZip) family of transcriptional factors, activate HO-1 through binding to MAREs (1619). In contrast, heterodimers of small Maf and Bach1 or Bach2 repress MAREdependent transcription (20).",
              "citation": {
                "type": "PubMed",
                "name": "Hypertens Res 2008 Apr 31(4) 783-92",
                "id": "18633191"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad836d"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "stimulation of p38 MAPK isoforms phosphorylated purified Nrf2 protein and caused an increase in the interaction between Nrf2 and Keap1 in vitro and the suppression of Nrf2 translocation into the nucleus.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2006 Sep 1 66(17) 8804-13",
                "id": "16951197"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad836c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "This hyperoxia-induced expression of Srx was not evident in mice deficient in the transcription factor Nrf2, indicating an essential role for an Nrf2 signaling pathway in this effect",
              "citation": {
                "type": "PubMed",
                "name": "Antioxid Redox Signal 2009 May 11(5) 937-48",
                "id": "19086807"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad836b"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "chromatin immunoprecipitation analysis revealed that Nrf2 binding to the NQO1 ARE was significantly diminished in the case of O-flow compared with that of L-flow",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Jul 22 280(29) 27244-50",
                "id": "15917255"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad836a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "In contrast, the glutathione level in the Nrf2(-/-) mice was not compensated and remained low. This was because of the decrease in the gene expression of gcs(H) and gcs(L) as well as gss in the livers of the Nrf2(-/-) mice. In addition, the expression of ugt1a6 and gstpi that detoxify APAP by conjugation was also decreased.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2001 Apr 10 98(8) 4611-6",
                "id": "11287661"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8369"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "in mouse peritoneal macrophages 15d-PGJ(2) can activate Nrf2 by forming adducts with Keap1, resulting in an Nrf2-dependent induction of heme oxygenase 1 and peroxiredoxin I (PrxI) gene expression.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Jan 24(1) 36-45",
                "id": "14673141"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8368"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "treatment with CSE resulted in no nuclear translocation of Nrf2, resveratrol induced significant nuclear accumulation of Nrf2, and resveratrol plus CSE induced significant nuclear translocation of Nrf2",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2008 Mar 294(3) L478-88",
                "id": "18162601"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8367"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasm",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "The abrogation of shear-induced COX-2 expression by PI3-K activity and/or stimulation of the Nrf2/ARE pathway suggests the existence of PI3-K/Nrf2/ARE negative feedback loops that potentially interfere with c-Jun N-terminal kinase 2 activity upstream of COX-2",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2005 Sep 27 102(39) 14010-5",
                "id": "16172382"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8366"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "chondrocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "HO-1 expression is controlled by a stress-responsive transcription factor, Nrf2, which is a labile protein that is subject to proteasomal degradation. ",
              "citation": {
                "type": "PubMed",
                "name": "Curr Neurovasc Res 2005 Jul 2(3) 189-96",
                "id": "16181113"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8365"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "astrocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "in mouse peritoneal macrophages 15d-PGJ(2) can activate Nrf2 by forming adducts with Keap1, resulting in an Nrf2-dependent induction of heme oxygenase 1 and peroxiredoxin I (PrxI) gene expression.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Jan 24(1) 36-45",
                "id": "14673141"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8364"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2) actsIn tscript(p(HGNC:NFE2L2))",
              "summary_text": "# Pubmed:gene: Redox-sensitive interaction between KIAA0132 and Nrf2 mediates indomethacin-induced expression of gamma-glutamylcysteine synthetase. # Ariadne: These results also support the hypothesis that indomethacin-induced transcriptional activation of GCLC involves the redox-dependent release of KIAA0132 from Nrf2 followed by the nuclear translocation of Nrf2. [MolTransport]",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2002 Apr 1 32(7) 650-62",
                "id": "11909699"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8363"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:BACH1),p(HGNC:MAFK))",
        "relation": "hasComponent",
        "target": "p(HGNC:MAFK)",
        "directed": false,
        "label": "complex(p(HGNC:BACH1),p(HGNC:MAFK)) hasComponent p(HGNC:MAFK)",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8da0",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:BACH1),p(HGNC:MAFK)) hasComponent p(HGNC:MAFK)",
              "summary_text": "The DNA-binding activity of Bach1 as a MafK hetero-oligomer was markedly inhibited by heme in gel mobility shift assays. The repressor activity of Bach1 was lost upon addition of hemin in transfected cells. These results suggest that increased levels of heme inactivate the repressor Bach1, resulting in induction of a host of genes with MARES:",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2001 Jun 1 20(11) 2835-43",
                "id": "11387216"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83e5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:BACH1),p(HGNC:MAFK)) hasComponent p(HGNC:MAFK)",
              "summary_text": "Bandshift and supershift assays revealed that Bach1 binds to the ARE as a heterodimer with small Maf proteins ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Apr 29 280(17) 16891-900",
                "id": "15734732"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83e4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:BACH1),p(HGNC:MAFK)) hasComponent p(HGNC:MAFK)",
              "summary_text": "in vitro; Two-hybrid",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1996 Nov 16(11) 6083-95",
                "id": "8887638"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83e3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:BACH1),p(HGNC:MAFK))",
        "relation": "hasComponent",
        "target": "p(HGNC:BACH1)",
        "directed": false,
        "label": "complex(p(HGNC:BACH1),p(HGNC:MAFK)) hasComponent p(HGNC:BACH1)",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8da1",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:BACH1),p(HGNC:MAFK)) hasComponent p(HGNC:BACH1)",
              "summary_text": "The DNA-binding activity of Bach1 as a MafK hetero-oligomer was markedly inhibited by heme in gel mobility shift assays. The repressor activity of Bach1 was lost upon addition of hemin in transfected cells. These results suggest that increased levels of heme inactivate the repressor Bach1, resulting in induction of a host of genes with MARES:",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2001 Jun 1 20(11) 2835-43",
                "id": "11387216"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83e8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:BACH1),p(HGNC:MAFK)) hasComponent p(HGNC:BACH1)",
              "summary_text": "in vitro; Two-hybrid",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1996 Nov 16(11) 6083-95",
                "id": "8887638"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83e7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:BACH1),p(HGNC:MAFK)) hasComponent p(HGNC:BACH1)",
              "summary_text": "Bandshift and supershift assays revealed that Bach1 binds to the ARE as a heterodimer with small Maf proteins ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Apr 29 280(17) 16891-900",
                "id": "15734732"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83e6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:BACH1),p(HGNC:MAFK))",
        "relation": "decreases",
        "target": "p(HGNC:HMOX1)",
        "directed": false,
        "label": "complex(p(HGNC:BACH1),p(HGNC:MAFK)) decreases p(HGNC:HMOX1)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8da2",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:BACH1),p(HGNC:MAFK)) decreases p(HGNC:HMOX1)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83e9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:CSNK2A1))",
        "relation": "increases",
        "target": "p(HGNC:NFE2L2)",
        "directed": false,
        "label": "kin(p(HGNC:CSNK2A1)) increases p(HGNC:NFE2L2)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8da3",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:CSNK2A1)) increases p(HGNC:NFE2L2)",
              "summary_text": "Here we show that upregulation of NRF2 by OxPLs depends on the activity of protein kinase CK2. Inactivation of CK2 by chemical inhibitors or gene silencing resulted in diminished accumulation of NRF2 and its downstream genes GCLM, HO-1 and NQO1 in response to OxPLs. Furthermore, inhibition of CK2 suppressed NRF2-dependent induction of ATF4 and its downstream gene VEGF. ",
              "citation": {
                "type": "PubMed",
                "name": "J Lipid Res 2010 Oct 8",
                "id": "20934988"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83ea"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:CSNK2A1))",
        "relation": "increases",
        "target": "tscript(p(HGNC:NFE2L2))",
        "directed": false,
        "label": "kin(p(HGNC:CSNK2A1)) increases tscript(p(HGNC:NFE2L2))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8da4",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:CSNK2A1)) increases tscript(p(HGNC:NFE2L2))",
              "summary_text": "Here we show that upregulation of NRF2 by OxPLs depends on the activity of protein kinase CK2. Inactivation of CK2 by chemical inhibitors or gene silencing resulted in diminished accumulation of NRF2 and its downstream genes GCLM, HO-1 and NQO1 in response to OxPLs. Furthermore, inhibition of CK2 suppressed NRF2-dependent induction of ATF4 and its downstream gene VEGF. ",
              "citation": {
                "type": "PubMed",
                "name": "J Lipid Res 2010 Oct 8",
                "id": "20934988"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83eb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:NFE2L2,pmod(P,Y,576))",
        "relation": "directlyIncreases",
        "target": "tloc(p(HGNC:NFE2L2),GOCC:nucleus,GOCC:cytoplasm)",
        "directed": false,
        "label": "p(HGNC:NFE2L2,pmod(P,Y,576)) directlyIncreases tloc(p(HGNC:NFE2L2),GOCC:nucleus,GOCC:cytoplasm)",
        "metadata": {
          "casual": true,
          "createdBy": "Jamboree2014",
          "edgeId": "55775dd92f9e241f18ad8da5",
          "evidences": [
            {
              "bel_statement": "p(HGNC:NFE2L2,pmod(P,Y,576)) directlyIncreases tloc(p(HGNC:NFE2L2),GOCC:nucleus,GOCC:cytoplasm)",
              "summary_text": "Phosphorylated Fyn accumulates in the nucleus and phosphorylates Nrf2 at tyrosine 568. This leads to nuclear export, ubiquitination, and degradation of Nrf2",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "17403689"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83ec"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "HepG2",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:NFE2L2)",
        "relation": "hasModification",
        "target": "p(HGNC:NFE2L2,pmod(P,Y,576))",
        "directed": false,
        "label": "p(HGNC:NFE2L2) hasModification p(HGNC:NFE2L2,pmod(P,Y,576))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8da6",
          "evidences": [
            {
              "bel_statement": "p(HGNC:NFE2L2) hasModification p(HGNC:NFE2L2,pmod(P,Y,576))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83ed"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "tscript(p(HGNC:BACH1))",
        "relation": "directlyDecreases",
        "target": "p(HGNC:HMOX1)",
        "directed": false,
        "label": "tscript(p(HGNC:BACH1)) directlyDecreases p(HGNC:HMOX1)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8da7",
          "evidences": [
            {
              "bel_statement": "tscript(p(HGNC:BACH1)) directlyDecreases p(HGNC:HMOX1)",
              "summary_text": "Overexpression of Bach1, together with MafK, represses basal and UVA-mediated HO-1 protein expression, whereas silencing of the Bach1 gene by Bach1-specific siRNAs causes robust enhancement of constitutive HO-1 levels.",
              "citation": {
                "type": "Other",
                "name": "",
                "id": "22107958"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83f2"
              },
              "experiment_context": {
                "species_common_name": "human",
                "disease": "",
                "cell": "",
                "tissue": "fibroblasts"
              }
            },
            {
              "bel_statement": "tscript(p(HGNC:BACH1)) directlyDecreases p(HGNC:HMOX1)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83f1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "tscript(p(HGNC:BACH1)) directlyDecreases p(HGNC:HMOX1)",
              "summary_text": "Overexpression of Bach1, together with MafK, represses basal and UVA-mediated HO-1 protein expression, whereas silencing of the Bach1 gene by Bach1-specific siRNAs causes robust enhancement of constitutive HO-1 levels.",
              "citation": {
                "type": "Other",
                "name": "",
                "id": "15233805"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83f0"
              },
              "experiment_context": {
                "species_common_name": "human",
                "disease": "",
                "cell": "epithelium",
                "tissue": "retina"
              }
            },
            {
              "bel_statement": "tscript(p(HGNC:BACH1)) directlyDecreases p(HGNC:HMOX1)",
              "summary_text": "BACH1 repression is dominant over NRF2-mediated HMOX1 transcription and inactivation of BACH1 is a prerequisite for HMOX1 induction.",
              "citation": {
                "type": "Other",
                "name": "",
                "id": "17942419"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83ef"
              },
              "experiment_context": {
                "species_common_name": "human",
                "disease": "",
                "cell": "keratinocytes",
                "tissue": "skin"
              }
            },
            {
              "bel_statement": "tscript(p(HGNC:BACH1)) directlyDecreases p(HGNC:HMOX1)",
              "summary_text": "in alveolar macrophages from patients with SE, increased Bach1 and Keap1 expression was associated with decreased HO-1 expression",
              "citation": {
                "type": "Other",
                "name": "",
                "id": "18559366"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83ee"
              },
              "experiment_context": {
                "species_common_name": "human",
                "disease": "emphysema",
                "cell": "",
                "tissue": "alveolar macrophages"
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:BACH1),p(HGNC:MAFG))",
        "relation": "hasComponent",
        "target": "p(HGNC:BACH1)",
        "directed": false,
        "label": "complex(p(HGNC:BACH1),p(HGNC:MAFG)) hasComponent p(HGNC:BACH1)",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8da8",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:BACH1),p(HGNC:MAFG)) hasComponent p(HGNC:BACH1)",
              "summary_text": "MafG interacts with Bach1.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1996 Nov 16(11) 6083-95",
                "id": "8887638"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83f3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:BACH1),p(HGNC:MAFG))",
        "relation": "hasComponent",
        "target": "p(HGNC:MAFG)",
        "directed": false,
        "label": "complex(p(HGNC:BACH1),p(HGNC:MAFG)) hasComponent p(HGNC:MAFG)",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8da9",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:BACH1),p(HGNC:MAFG)) hasComponent p(HGNC:MAFG)",
              "summary_text": "MafG interacts with Bach1.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1996 Nov 16(11) 6083-95",
                "id": "8887638"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83f4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:BACH1),p(HGNC:MAFG))",
        "relation": "decreases",
        "target": "p(HGNC:HMOX1)",
        "directed": false,
        "label": "complex(p(HGNC:BACH1),p(HGNC:MAFG)) decreases p(HGNC:HMOX1)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8daa",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:BACH1),p(HGNC:MAFG)) decreases p(HGNC:HMOX1)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83f5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "bp(GOBP:\"response to oxidative stress\")",
        "relation": "increases",
        "target": "tloc(p(MGI:Keap1),GOCC:cytoplasm,GOCC:nucleus)",
        "directed": false,
        "label": "bp(GOBP:\"response to oxidative stress\") increases tloc(p(MGI:Keap1),GOCC:cytoplasm,GOCC:nucleus)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8dab",
          "evidences": [
            {
              "bel_statement": "bp(GOBP:\"response to oxidative stress\") increases tloc(p(MGI:Keap1),GOCC:cytoplasm,GOCC:nucleus)",
              "summary_text": "However, after oxidative stress induced by a variety of agents, Keap1 redistributed and accumulated in the nucleus (Fig. 1A and D). This redistribution was not unique to NIH 3T3 fibroblasts. In the human hepatoblastoma cell line HepG2 (Fig. 1B), as well as in Cos7 fibroblasts (Fig. 1C), endogenous Keap1 also accumulated in the nucleus after DEM treatment. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2005 Jun 25(11) 4501-13",
                "id": "15899855"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83f6"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "bp(GOBP:\"response to oxidative stress\")",
        "relation": "decreases",
        "target": "complex(p(HGNC:NFE2L2),p(HGNC:KEAP1),p(HGNC:RBX1),p(HGNC:CUL3))",
        "directed": false,
        "label": "bp(GOBP:\"response to oxidative stress\") decreases complex(p(HGNC:NFE2L2),p(HGNC:KEAP1),p(HGNC:RBX1),p(HGNC:CUL3))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8dac",
          "evidences": [
            {
              "bel_statement": "bp(GOBP:\"response to oxidative stress\") decreases complex(p(HGNC:NFE2L2),p(HGNC:KEAP1),p(HGNC:RBX1),p(HGNC:CUL3))",
              "summary_text": "We propose that exposure of cells to sulforaphane or oxidative stress, by altering the redox state of Cys 151, reduces the ability of Nrf2-bound Keap1 proteins to associate with the Cul3-Rbx1 core complex. As a result, fewer Nrf2 molecules will be targeted for ubiquitination and subsequent degradation, leading to increased accumulation of Nrf2.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Dec 24(24) 10941-53",
                "id": "15572695"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83f7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:MAPK12)",
        "relation": "actsIn",
        "target": "kin(p(HGNC:MAPK12))",
        "directed": false,
        "label": "p(HGNC:MAPK12) actsIn kin(p(HGNC:MAPK12))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8dad",
          "evidences": [
            {
              "bel_statement": "p(HGNC:MAPK12) actsIn kin(p(HGNC:MAPK12))",
              "summary_text": "reduced nuclear translocation of glucocorticoid receptor (GR) alpha after binding corticosteroids. This might be due to modification of the GR by means of phosphorylation as a result of activation of several kinases (p38 mitogen-activated protein kinase alpha, p38 mitogen-activated protein kinase gamma, and c-Jun N-terminal kinase 1), which in turn might be due to reduced activity and expression of phosphatases, such as mitogen-activated protein kinase phosphatase 1 and protein phosphatase A2. ",
              "citation": {
                "type": "PubMed",
                "name": "J Allergy Clin Immunol 2013 Jan 26",
                "id": "23360759"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c23"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK12) actsIn kin(p(HGNC:MAPK12))",
              "summary_text": "We therefore tested the effect of MKK3, MKK4, and MKK6 on p38?2 MAP kinase activity in co-transfection assays in vivo. Control experiments were performed using p38? and p38? MAP kinases. MKK3 caused strong activation of p38?, a lower level of activation of p38?, and did not activate p38?2 (Fig.6  A). Similarly, MKK4 activated p38? strongly, weakly activated p38?, and did not activate p38?2 (Fig. 6  B). In contrast, MKK6 caused strong activation of p38?, p38?2, and p38? MAP kinases (Fig. 6  C)",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1998 Jan 16 273(3) 1741-8",
                "id": "9430721"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c22"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK12) actsIn kin(p(HGNC:MAPK12))",
              "summary_text": "The SAPK3/p38gamma-catalysed phosphorylation of SAP97/hDlg triggers its dissociation from GKAP and therefore releases it from the cytoskeleton.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2005 Mar 23 24(6) 1134-45",
                "id": "15729360"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8402"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK12) actsIn kin(p(HGNC:MAPK12))",
              "summary_text": "10212242;17081983",
              "citation": {
                "type": "PubMed",
                "name": "BMC Bioinformatics 2004 Jun 22 5 79",
                "id": "15212693"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8401"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK12) actsIn kin(p(HGNC:MAPK12))",
              "summary_text": "These  results suggest that p38eta increases the AP-1 by stimulation of c-Jun  phosphorylation, whereas p38gamma and p38delta inhibit this by mechanisms  involving suppression of the c- jun transcription.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Feb 14 278(7) 4831-9",
                "id": "12475989"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8400"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK12) actsIn kin(p(HGNC:MAPK12))",
              "summary_text": "stimulation of p38 MAPK isoforms phosphorylated purified Nrf2 protein and caused an increase in the interaction between Nrf2 and Keap1 in vitro and the suppression of Nrf2 translocation into the nucleus.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2006 Sep 1 66(17) 8804-13",
                "id": "16951197"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83ff"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK12) actsIn kin(p(HGNC:MAPK12))",
              "summary_text": "Moreover, in addition to JNK, ERK5, p38alpha, and p38gamma were found to stimulate the c-jun promoter by acting on distinct responsive elements.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1999 Jun 19(6) 4289-301",
                "id": "10330170"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83fe"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK12) actsIn kin(p(HGNC:MAPK12))",
              "summary_text": "Following the initial description of p38 (p38a), three additional isoforms of this MAP kinase group have been cloned and characterized: p38b (18), p38g (also termed ERK6 or SAPK3) (22, 24, 30), and p38d (also termed SAPK4) (4, 17, 41). Two MAP kinase kinases (MKK), MKK3 and MKK6, are the upstream activators of the p38 group MAP kinases (6, 12, 14, 37).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1999 Jan 19(1) 21-30",
                "id": "9858528"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83fd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK12) actsIn kin(p(HGNC:MAPK12))",
              "summary_text": "ERK6 in phosphorylated form phosphorylates myelin basic protein, MBP",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 1996 Apr 30 93(9) 4355-9",
                "id": "8633070"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83fc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK12) actsIn kin(p(HGNC:MAPK12))",
              "summary_text": "The substrate specificity of SAPK4 in vitro was similar to that of SAPK3. Both enzymes phosphorylated the transcription factors ATF2, Elk-1 and SAP-1 at similar rates",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1997 Jun 16(12) 3563-71",
                "id": "9218798"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83fb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK12) actsIn kin(p(HGNC:MAPK12))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Apr 30 274(18) 12626-31",
                "id": "10212242"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83fa"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK12) actsIn kin(p(HGNC:MAPK12))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1997 Jan 15 16(2) 295-305",
                "id": "9029150"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83f9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK12) actsIn kin(p(HGNC:MAPK12))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 1999 Nov 19 461(3) 323-8",
                "id": "10567720"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad83f8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:PARK7)",
        "relation": "decreases",
        "target": "complex(p(HGNC:KEAP1),p(HGNC:NFE2L2))",
        "directed": false,
        "label": "p(HGNC:PARK7) decreases complex(p(HGNC:KEAP1),p(HGNC:NFE2L2))",
        "metadata": {
          "casual": true,
          "createdBy": "Jamboree2014",
          "edgeId": "55775dd92f9e241f18ad8dae",
          "evidences": [
            {
              "bel_statement": "p(HGNC:PARK7) decreases complex(p(HGNC:KEAP1),p(HGNC:NFE2L2))",
              "summary_text": "Huh7 cells were transfected with V5-tagged Keap1 (the tagged epitope is required because of the lack of a sufficient and commercially available Keap1 antibody). The anti-V5 antibody recognized V5-Keap1 and coimmunoprecipitated Nrf2 (Fig. 4 D, lane 1); the inclusion of Flag-DJ-1 eliminated this coimmunoprecipitation (Fig. 4 D, lane 2). Reverse immunoprecipitation shows that antibody to endogenous Nrf2 coprecipitated V5-Keap1 (Fig. 4 D, lane 4), which was also decreased by Flag-DJ-1 (lane 5). These data suggest that DJ-1 stabilizes Nrf2 by preventing its association with Keap1.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "17015834"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c24"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "HuH-7 cell line",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:PARK7)",
        "relation": "decreases",
        "target": "deg(p(HGNC:NFE2L2))",
        "directed": false,
        "label": "p(HGNC:PARK7) decreases deg(p(HGNC:NFE2L2))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8daf",
          "evidences": [
            {
              "bel_statement": "p(HGNC:PARK7) decreases deg(p(HGNC:NFE2L2))",
              "summary_text": "Nrf2 disappeared in cells with siDJ-1 (Fig. 4B), indicating that DJ-1 stabilizes Nrf-2 protein.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2006 Oct 10 103(41) 15091-6",
                "id": "17015834"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8404"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PARK7) decreases deg(p(HGNC:NFE2L2))",
              "summary_text": "These results suggest that, under oxidative stress conditions, DJ-1 stabilizes NRF2 protein by interfering with proteasomal degradation and enhances cellular NRF2-dependent antioxidants.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Crit Care Med 2008 Sep 15 178(6) 592-604",
                "id": "18556627"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8403"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "a(SCHEM:\"Epigallocatechin gallate\")",
        "relation": "increases",
        "target": "tscript(p(HGNC:NFE2L2))",
        "directed": false,
        "label": "a(SCHEM:\"Epigallocatechin gallate\") increases tscript(p(HGNC:NFE2L2))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8db0",
          "evidences": [
            {
              "bel_statement": "a(SCHEM:\"Epigallocatechin gallate\") increases tscript(p(HGNC:NFE2L2))",
              "summary_text": "Activation of Nrf2-ARE responses by a polyphenol epigallocatechin-3-gallate treatment reduced bleomycin-induced lung injury and inflammation in rats (Sriram et al., 2008).",
              "citation": {
                "type": "PubMed",
                "name": "Toxicol Appl Pharmacol 2009 Jul 29",
                "id": "19646463"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8408"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "a(SCHEM:\"Epigallocatechin gallate\") increases tscript(p(HGNC:NFE2L2))",
              "summary_text": "Data from our study are the first to demonstrate in a single experimental system of primary endothelial cells that EGCG regulates HO-1 expression through a mechanism requiring p38 MAPK upstream of Nrf2 that then binds and activates the HO-1 promoter.",
              "citation": {
                "type": "Other",
                "name": "",
                "id": "22137262"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8407"
              },
              "experiment_context": {
                "species_common_name": "human",
                "disease": "",
                "cell": "",
                "tissue": "endothelial cells"
              }
            },
            {
              "bel_statement": "a(SCHEM:\"Epigallocatechin gallate\") increases tscript(p(HGNC:NFE2L2))",
              "summary_text": "Activation of Nrf2 by a polyphenol epigallocatechin-3-gallate treatment reduced bleomycin-induced lung injury and inflammation in rats by inducing phase II enzymes such as GST and NQO1.",
              "citation": {
                "type": "Other",
                "name": "",
                "id": "20298567"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8406"
              },
              "experiment_context": {
                "species_common_name": "mouse",
                "disease": "",
                "cell": "",
                "tissue": "lung"
              }
            },
            {
              "bel_statement": "a(SCHEM:\"Epigallocatechin gallate\") increases tscript(p(HGNC:NFE2L2))",
              "summary_text": "Confocal microscopy, immunoblot and RT-PCR studies confirm that EGCG is a potent inducer of NF-E2-related factor 2 (Nrf2).",
              "citation": {
                "type": "Other",
                "name": "",
                "id": "19138753"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8405"
              },
              "experiment_context": {
                "species_common_name": "rat",
                "disease": "",
                "cell": "",
                "tissue": "lung"
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:CAND1)",
        "relation": "decreases",
        "target": "tscript(p(HGNC:NFE2L2))",
        "directed": false,
        "label": "p(HGNC:CAND1) decreases tscript(p(HGNC:NFE2L2))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8db1",
          "evidences": [
            {
              "bel_statement": "p(HGNC:CAND1) decreases tscript(p(HGNC:NFE2L2))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8409"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "tscript(p(HGNC:NFE2L1))",
        "relation": "increases",
        "target": "p(HGNC:HMOX1)",
        "directed": false,
        "label": "tscript(p(HGNC:NFE2L1)) increases p(HGNC:HMOX1)",
        "metadata": {
          "casual": true,
          "createdBy": "Jamboree2014",
          "edgeId": "55775dd92f9e241f18ad8db2",
          "evidences": [
            {
              "bel_statement": "tscript(p(HGNC:NFE2L1)) increases p(HGNC:HMOX1)",
              "summary_text": "Nrf1 and Nrf2 Regulate a Similar Subset of Antioxidant Genes: Expression of Gclm was reduced to the same extent in both Nrf1 and Nrf2 mutant cells. NQO1 was down-regulated to a similar extent in both single mutant cells, whereas mRNA levels of heme-oxygenase-1 (HO-1), ferritin-H (FtH), and metallothionein-1 (MT-1) was lower in nrf2?/? cells compared with nrf1?/? cells (Fig. 6a). In all cases, however, expression in double knockout cells was abolished compared with single knockout cells, indicating a dependence on both Nrf1 and Nrf2",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "12968018"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c25"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": "fibroblasts"
              }
            }
          ]
        }
      },
      {
        "source": "tscript(p(HGNC:NFE2L1))",
        "relation": "increases",
        "target": "p(HGNC:GCLM)",
        "directed": false,
        "label": "tscript(p(HGNC:NFE2L1)) increases p(HGNC:GCLM)",
        "metadata": {
          "casual": true,
          "createdBy": "Jamboree2014",
          "edgeId": "55775dd92f9e241f18ad8db3",
          "evidences": [
            {
              "bel_statement": "tscript(p(HGNC:NFE2L1)) increases p(HGNC:GCLM)",
              "summary_text": "Nrf1 and Nrf2 Regulate a Similar Subset of Antioxidant Genes: Expression of Gclm was reduced to the same extent in both Nrf1 and Nrf2 mutant cells. NQO1 was down-regulated to a similar extent in both single mutant cells, whereas mRNA levels of heme-oxygenase-1 (HO-1), ferritin-H (FtH), and metallothionein-1 (MT-1) was lower in nrf2?/? cells compared with nrf1?/? cells (Fig. 6a). In all cases, however, expression in double knockout cells was abolished compared with single knockout cells, indicating a dependence on both Nrf1 and Nrf2",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "12968018"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c26"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": "fibroblasts"
              }
            }
          ]
        }
      },
      {
        "source": "tscript(p(HGNC:NFE2L1))",
        "relation": "increases",
        "target": "p(HGNC:NQO1)",
        "directed": false,
        "label": "tscript(p(HGNC:NFE2L1)) increases p(HGNC:NQO1)",
        "metadata": {
          "casual": true,
          "createdBy": "Jamboree2014",
          "edgeId": "55775dd92f9e241f18ad8db4",
          "evidences": [
            {
              "bel_statement": "tscript(p(HGNC:NFE2L1)) increases p(HGNC:NQO1)",
              "summary_text": "In this study, we exploited the availability of cells from Nrf1 knockout mice to study the role of Nrf1 transcription factor in the regulation of antioxidant gene expression and in cellular antioxidant response. Fibroblast cells derived from Nrf1 null embryos showed lower levels of glutathione and enhanced sensitivity to the toxic effects of oxidant compounds.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "10601325"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad840a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": "fibroblasts"
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:MAPK3)",
        "relation": "actsIn",
        "target": "kin(p(HGNC:MAPK3))",
        "directed": false,
        "label": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8db5",
          "evidences": [
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "The chondrocyte cell lines C28/I2, C20/A4, and T/C28a2/a4 expressed functionally active VEGFR-2. VEGF stimulation induced receptor phosphorylation, activation of the mitogen-activated protein kinases ERK 1/2, and long-lasting activation of the transcription factor AP-1 (activator protein-1). VEGF increased secreted MMP-1, MMP-3, and especially MMP-13, which could be effectively reduced by an inhibitor of VEGFR-2 kinase activity. Interestingly, VEGF diminished the expression of TIMP-1 and especially TIMP-2.",
              "citation": {
                "type": "PubMed",
                "name": "J Pathol 2004 Mar 202(3) 367-74",
                "id": "14991903"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c71"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "chondrocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Treatment of human umbilical vein endothelial cells (HUVECs) with betacellulin (BTC, 10 ng/ml) increased phosphorylation of two MAPKs, ERK1 (p44MAPK) and ERK2 (p42MAPK) and AKT as early as 1 minute and produced a maximal effect at 5 minutes, which declined and returned to control levels at 60 minutes. BTC treatment also phosphorylated all three Erb receptors ErbB2, ErbB3, and ErbB4 but not ErbB1. BTC induced phosphorylation of MAPK and AKT was not suppressed by a selectilvely inhibitory concentration of ErbB1 receptor inhibitor, AG1478), suggesting that BTC induced MAPK and AKT activation was mediated through ErbB4 homodimer, ErbB2/ErbB3, or ErbB2/ErbB4.",
              "citation": {
                "type": "PubMed",
                "name": "FASEB J 2003 Feb 17(2) 318-20",
                "id": "12475887"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c70"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "The treatment of rat lung epithelial cells with nicotine for various periods differentially mobilizes multiple intracellular pathways [64]. Protein kinase C and PI3-OH-kinase are transiently activated after the treatment. Also, Ras and its downstream effector ERK1/2 are activated after long-term exposure to nicotine. The activation of Ras by nicotine treatment is responsible for the subsequent perturbation of the methotrexate (MTX)-mediated G1 cell cycle restriction, as well as an increase in production of reactive oxygen species [64].",
              "citation": {
                "type": "PubMed",
                "name": "Mutat Res 659(3) 221-31",
                "id": "18495523"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c6f"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "\\\"Dependence of peroxisome proliferator-activated receptor ligand-induced mitogen-activated protein kinase signaling on epidermal growth factor receptor transactivation.\\\" In the current study, we demonstrate that various PPARalpha (nafenopin) and gamma (ciglitazone and troglitazone) agonists rapidly induced extracellular signal-regulated kinase (Erk) and/or p38 phosphorylation in rat liver epithelial cells (GN4). The selective epidermal growth factor receptor (EGFR) kinase inhibitors, PD153035 and ZD1839 (Iressa), abolished PPARalpha and gamma agonist-dependent Erk activation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Nov 21 278(47) 46261-9",
                "id": "12966092"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c6e"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": " In this study we show that the extracellular signal-regulated kinases 1 and 2 (ERK1/2) interact directly with CIITA, targeting serine residues in the amino terminus of the protein, including serine 288. Inhibition of this phosphorylation by dominant-negative forms of ERK or by treatment of cells with the ERK inhibitor PD98059 resulted in the increase in CIITA-mediated gene expression from a class II promoter, enhanced the nuclear concentration of CIITA, and impaired its ability to bind to the nuclear export factor, CRM1",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2008 Apr 4 283(14) 9031-9",
                "id": "18245089"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c6d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "When serum-deprived MRC-5 lung fibroblasts were incubated in the presence of HABP the phosphorylation of intracellular proteins, many of which act as kinases in signalling pathways was observed (Fig. 1). This included the time-dependent phosphorylation of the MAP kinase ERK1/2 (extracellular signal-related kinase), the MAPK kinase MEK1/2 and c-Raf, a kinase that phosphorylates and thus activates MEK1/2. A transient activation of the p90RSK was detectable as well (Fig. 1A).",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2005 Dec 17(12) 1486-94",
                "id": "16153533"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c6c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Studies with the recently described specific MEK inhibitor, PD184352, at concentrations that inhibited ERK1 and ERK2 but not ERK5 activity demonstrate that the ERK1 and ERK2 modules were involved in regulating fMLP-stimulated chemotaxis and chemokinesis. Our data suggest that the MEK5-ERK5 module is likely to regulate neutrophil responses at very low chemoattractant concentrations whereas at higher concentrations, a shift to the ERK1/ERK2 and p38 modules is apparent.  ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Nov 26 279(48) 49825-34",
                "id": "15381709"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c6b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "As determined by decreased electrophoretic mobility due to phosphorylation, ERK1/2 were activated following stimulation with ET-1, LPA and thrombin, as with control RTK ligands EGF and PDGF (Fig. 4a, b). In HERCD533 transfectants, however, ERK activation by ET-1 and thrombin was blocked and the LPA response was attenuated whereas activation by PDGF or EGF remained unaltered (Fig. 4a). Unpon preincubation with AG1478, GPCR-ligand-triggered ERK activation was blocked at even lower concentrations than those necessary to block the EGF response (Fig. 4b).",
              "citation": {
                "type": "PubMed",
                "name": "Nature 1996 Feb 8 379(6565) 557-60",
                "id": "8596637"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c6a"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Simultaneous overexpression of selenophosphate synthetase and phospholipid-hydroperoxide GSH peroxidase (PHGPx) [250] blocks activation of NF-kB by IL-1. Overexpression of SOD [84] or GSH peroxidase [81, 211] abolished NF-kB activation by preventing degradation of IkB after stimulation with TNF-a. The precise mechanism(s) through which oxidants and reductants influence activation of NF-kB is presently unknown; however, there is evidence that antioxidant enzyme (AOE372), a redox-sensitive thioredoxin peroxidase, regulates IkB phosphorylation [246]. Phosphatases The phosphatases are an important component of most signal transduction pathways, because failure to reverse kinase actions can disrupt normal cellular functions. For example, transfection of human fibroblasts with constitutively active ras (hRasV12) inhibits cell growth and ultimately results in a senescentlike phenotype [441]. Similarly, constitutive ERK activation has an inhibitory effect on cell cycle progression [442,443]. Both the serine/threonine phosphatases and the PTPs are known to be redox-sensitive [82,144,153,156,271,281, 444-449]. The mechanism of redox effects on activity is probably best understood for the PTPs. Without exception, the PTPs contain a highly conserved region of 11 amino acid residues in their catalytic domain; specifi- cally, (Ile/Val)-His-Cys-X-Ala-Gly-X-X-Arg-(Ser/Thr)- Gly, where X is a nonconserved amino acid [17]. Either oxidation or mutation of the cysteine renders these molecules inactive [17,281]. H2O2 is a potent inhibitor of PTPs. As in the case of other oxidants, H2O2 probably oxidizes the thiolate anion at the catalytic site [280]. Because formation of a phosphorylcysteine intermediate seems to be critical to PTP activity [450-452], blocking it through oxidation of the cysteine inactivates the molecules. In many cases, treatment of cells with H2O2 stimulates increases in protein phosphorylation by inhibiting phosphatase-catalyzed removal of phosphate groups. Furthermore, mitogens that increase cellular ox- idant production may stimulate phosphorylation indirectly by decreasing phosphatase activity. Additional mechanisms are involved in stimulation of pathways activated by growth factors that increase oxidant production, however, because there are known instances in which the oxidants they produce have no effect on protein phosphorylation. For example, TGF-b1 stimulates phosphorylation of numerous proteins and has been shown to cause a large increase in H2O2 production; however, its effects on protein phosphorylation are not blocked by catalase [453]. Furthermore, H2O2 is effective in promoting phosphorylation of phospholipase D, the PDGF receptor, and PKC-a even after pretreatment of Swiss 3T3 fibroblasts with orthovanadate to inhibit phosphatases [454]. Thus, although diminished phosphatase activity may partially account for increased phosphorylation in some cases, it cannot totally account for oxidation effects on phosphorylation in every case. SPECIFICITY In general, there is good agreement between studies on redox effects on any given gene; albeit, not all oxidizing or reducing treatments exert equivalent effects. This is clearly demonstrated in studies of pag , which encodes a protein associated with cellular proliferation. Pag protein inhibits the tyrosine kinase activity of the Abelson (abl ) protein by binding to its SH3-binding domain [455]. BSO, menadione, sodium arsenate, and diethyl maleate all stimulate pag expression, but H2O2 does not [269]. Conversely, H2O2 stimulates c-fos expression (Table 1), although 4-hydroynonenal (a product of v-6-polyunsaturated fatty acid peroxidation) not only fails to induce c-fos expression but is actually inhibitory to c-fos induction by EGF and PDGF [185]. Similarly, some oxidants such as diamide decrease hypoxia-induced signals [201], although others such as H2O2 increase them [124]. As might be expected, the effects of any stimu...",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2000 Feb 1 28(3) 463-99",
                "id": "10699758"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c69"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": "mesothelium"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Simultaneous overexpression of selenophosphate synthetase and phospholipid-hydroperoxide GSH peroxidase (PHGPx) [250] blocks activation of NF-kB by IL-1. Overexpression of SOD [84] or GSH peroxidase [81, 211] abolished NF-kB activation by preventing degradation of IkB after stimulation with TNF-a. The precise mechanism(s) through which oxidants and reductants influence activation of NF-kB is presently unknown; however, there is evidence that antioxidant enzyme (AOE372), a redox-sensitive thioredoxin peroxidase, regulates IkB phosphorylation [246]. Phosphatases The phosphatases are an important component of most signal transduction pathways, because failure to reverse kinase actions can disrupt normal cellular functions. For example, transfection of human fibroblasts with constitutively active ras (hRasV12) inhibits cell growth and ultimately results in a senescentlike phenotype [441]. Similarly, constitutive ERK activation has an inhibitory effect on cell cycle progression [442,443]. Both the serine/threonine phosphatases and the PTPs are known to be redox-sensitive [82,144,153,156,271,281, 444-449]. The mechanism of redox effects on activity is probably best understood for the PTPs. Without exception, the PTPs contain a highly conserved region of 11 amino acid residues in their catalytic domain; specifi- cally, (Ile/Val)-His-Cys-X-Ala-Gly-X-X-Arg-(Ser/Thr)- Gly, where X is a nonconserved amino acid [17]. Either oxidation or mutation of the cysteine renders these molecules inactive [17,281]. H2O2 is a potent inhibitor of PTPs. As in the case of other oxidants, H2O2 probably oxidizes the thiolate anion at the catalytic site [280]. Because formation of a phosphorylcysteine intermediate seems to be critical to PTP activity [450-452], blocking it through oxidation of the cysteine inactivates the molecules. In many cases, treatment of cells with H2O2 stimulates increases in protein phosphorylation by inhibiting phosphatase-catalyzed removal of phosphate groups. Furthermore, mitogens that increase cellular ox- idant production may stimulate phosphorylation indirectly by decreasing phosphatase activity. Additional mechanisms are involved in stimulation of pathways activated by growth factors that increase oxidant production, however, because there are known instances in which the oxidants they produce have no effect on protein phosphorylation. For example, TGF-b1 stimulates phosphorylation of numerous proteins and has been shown to cause a large increase in H2O2 production; however, its effects on protein phosphorylation are not blocked by catalase [453]. Furthermore, H2O2 is effective in promoting phosphorylation of phospholipase D, the PDGF receptor, and PKC-a even after pretreatment of Swiss 3T3 fibroblasts with orthovanadate to inhibit phosphatases [454]. Thus, although diminished phosphatase activity may partially account for increased phosphorylation in some cases, it cannot totally account for oxidation effects on phosphorylation in every case. SPECIFICITY In general, there is good agreement between studies on redox effects on any given gene; albeit, not all oxidizing or reducing treatments exert equivalent effects. This is clearly demonstrated in studies of pag , which encodes a protein associated with cellular proliferation. Pag protein inhibits the tyrosine kinase activity of the Abelson (abl ) protein by binding to its SH3-binding domain [455]. BSO, menadione, sodium arsenate, and diethyl maleate all stimulate pag expression, but H2O2 does not [269]. Conversely, H2O2 stimulates c-fos expression (Table 1), although 4-hydroynonenal (a product of v-6-polyunsaturated fatty acid peroxidation) not only fails to induce c-fos expression but is actually inhibitory to c-fos induction by EGF and PDGF [185]. Similarly, some oxidants such as diamide decrease hypoxia-induced signals [201], although others such as H2O2 increase them [124]. As might be expected, the effects of any stimu...",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2000 Feb 1 28(3) 463-99",
                "id": "10699758"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c68"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "from full text - Introduction of GRK 2 or 3 strikingly reduced primarily the late activation of ERK after AngII stimulation in a pattern similar to that observed with GRK 5 or 6 siRNA transfection (compare Figs. 3C and 4B). On the contrary, GRK 5 or 6 overexpression enhanced AngII-induced ERK activation especially at the later time points (Fig. 4 A and C), similar to the pattern observed in GRK 2 or 3 siRNA-transfected cells (Fig. 3B)",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2005 Feb 1 102(5) 1442-7",
                "id": "15671181"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c67"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Our previous study with rat pulmonary epithelial cells showed that the transcription of the Gclc and Gclm  mRNAs is regulated by different upstream kinases [60]  R.M. Liu, Z. Borok and H.J. Forman, 4-Hydroxy-2-nonenal increases gamma-glutamylcysteine synthetase gene expression in alveolar epithelial cells, Am. J. Respir. Cell. Mol. Biol. 24 (2001), pp. 499505. View Record in Scopus | Cited By in Scopus (40)[60]. In cells stimulated with HNE, the ERK  pathway inhibitor PD98059 completely blocked the increase in Gclc  mRNA but had no effect on the increase in Gclm  mRNA",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2005 Mar 1 38(5) 547-56",
                "id": "15683710"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c66"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "The extracellular signal-regulated kinase (ERK) cascade is a central pathway that transmits signals from many extracellular agents to regulate cellular processes such as proliferation, differentiation and cell cycle progression. The signaling via the ERK cascade is mediated by sequential phosphorylation and activation of protein kinases in the different tiers of the cascade. Although the main core phosphorylation chain of the cascade includes Raf kinases, MEK1/2, ERK1/2 (ERKs) and RSKs, other alternatively spliced forms and distinct components exist in the different tiers, and participate in ERK signaling under specific conditions. These components enhance the complexity of the ERK cascade and thereby, enable the wide variety of functions that are regulated by it. Another factor that is important for the dissemination of ERKs' signals is the multiplicity of the cascade's substrates, which include transcription factors, protein kinases and phosphatases, cytoskeletal elements, regulators of apoptosis, and a variety of other signaling-related molecules. About 160 substrates have already been discovered for ERKs, and the list of these substrates, as well as the function and mechanism of activation of representative substrates, are described in the current review. Many of these substrates are localized in the nucleus, and seem to participate in the regulation of transcription upon stimulation. However, other substrates are found in the cytosol as well as in other cellular organelles, and those are responsible for processes such as translation, mitosis and apoptosis. Understanding of these processes may provide a full picture of the distinct, and even opposing cellular processes that are regulated by the ERK cascade.",
              "citation": {
                "type": "PubMed",
                "name": "Growth Factors 2006 Mar 24(1) 21-44",
                "id": "16393692"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c65"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Furthermore, we identified three tyrosines (Tyr-1175, Tyr-1265, and Tyr-1294) within the kinase domain that play critical but overlapping roles in controlling constitutive Erk activation by mRon. Phenylalanine mutations at these three tyrosines results in a receptor that fails to constitutively activate the Erk pathway but retains the ability to induce Erk phosphorylation in response to ligand stimulation. The ability of mRon to activate the MAP kinase pathway is dependent on c-Src activity, and we have shown that c-Src co-immunoprecipitates with mRon. c-Src fails to interact with mRon when the three tyrosines required for MAP kinase activation are mutated, whereas the presence of any one of these tyrosines alone restores Erk phosphorylation and recruitment of c-Src.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Oct 21 280(42) 35098-107",
                "id": "16103119"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c64"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Simultaneous overexpression of selenophosphate synthetase and phospholipid-hydroperoxide GSH peroxidase (PHGPx) [250] blocks activation of NF-kB by IL-1. Overexpression of SOD [84] or GSH peroxidase [81, 211] abolished NF-kB activation by preventing degradation of IkB after stimulation with TNF-a. The precise mechanism(s) through which oxidants and reductants influence activation of NF-kB is presently unknown; however, there is evidence that antioxidant enzyme (AOE372), a redox-sensitive thioredoxin peroxidase, regulates IkB phosphorylation [246]. Phosphatases The phosphatases are an important component of most signal transduction pathways, because failure to reverse kinase actions can disrupt normal cellular functions. For example, transfection of human fibroblasts with constitutively active ras (hRasV12) inhibits cell growth and ultimately results in a senescentlike phenotype [441]. Similarly, constitutive ERK activation has an inhibitory effect on cell cycle progression [442,443]. Both the serine/threonine phosphatases and the PTPs are known to be redox-sensitive [82,144,153,156,271,281, 444-449]. The mechanism of redox effects on activity is probably best understood for the PTPs. Without exception, the PTPs contain a highly conserved region of 11 amino acid residues in their catalytic domain; specifi- cally, (Ile/Val)-His-Cys-X-Ala-Gly-X-X-Arg-(Ser/Thr)- Gly, where X is a nonconserved amino acid [17]. Either oxidation or mutation of the cysteine renders these molecules inactive [17,281]. H2O2 is a potent inhibitor of PTPs. As in the case of other oxidants, H2O2 probably oxidizes the thiolate anion at the catalytic site [280]. Because formation of a phosphorylcysteine intermediate seems to be critical to PTP activity [450-452], blocking it through oxidation of the cysteine inactivates the molecules. In many cases, treatment of cells with H2O2 stimulates increases in protein phosphorylation by inhibiting phosphatase-catalyzed removal of phosphate groups. Furthermore, mitogens that increase cellular ox- idant production may stimulate phosphorylation indirectly by decreasing phosphatase activity. Additional mechanisms are involved in stimulation of pathways activated by growth factors that increase oxidant production, however, because there are known instances in which the oxidants they produce have no effect on protein phosphorylation. For example, TGF-b1 stimulates phosphorylation of numerous proteins and has been shown to cause a large increase in H2O2 production; however, its effects on protein phosphorylation are not blocked by catalase [453]. Furthermore, H2O2 is effective in promoting phosphorylation of phospholipase D, the PDGF receptor, and PKC-a even after pretreatment of Swiss 3T3 fibroblasts with orthovanadate to inhibit phosphatases [454]. Thus, although diminished phosphatase activity may partially account for increased phosphorylation in some cases, it cannot totally account for oxidation effects on phosphorylation in every case. SPECIFICITY In general, there is good agreement between studies on redox effects on any given gene; albeit, not all oxidizing or reducing treatments exert equivalent effects. This is clearly demonstrated in studies of pag , which encodes a protein associated with cellular proliferation. Pag protein inhibits the tyrosine kinase activity of the Abelson (abl ) protein by binding to its SH3-binding domain [455]. BSO, menadione, sodium arsenate, and diethyl maleate all stimulate pag expression, but H2O2 does not [269]. Conversely, H2O2 stimulates c-fos expression (Table 1), although 4-hydroynonenal (a product of v-6-polyunsaturated fatty acid peroxidation) not only fails to induce c-fos expression but is actually inhibitory to c-fos induction by EGF and PDGF [185]. Similarly, some oxidants such as diamide decrease hypoxia-induced signals [201], although others such as H2O2 increase them [124]. As might be expected, the effects of any stimu...",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2000 Feb 1 28(3) 463-99",
                "id": "10699758"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c63"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "astrocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "To see the phosphorylation of MAPK by ETS, the control and ETS-exposed brain tissues were extracted and 100 mg proteins were analyzed by 10% SDS-PAGE and phosphorylated form of MAPK was detected by Western blot using anti-phospho-MAPK antibody. The result shown in Fig. 4B indicates that phosphorylated MAPK was increased in all the regions of the brain exposed to ETS as compared to control brain tissue. The same extracts were probed with anti- ERK antibody and the level of ERK was unchanged in all the lanes indicating equal loading of proteins as well as specificity of the phosphorylation of the MAPK because ERK also undergoes phoshorylation but through different signaling pathway [31]. These results therefore strongly suggest that ETS induces MAPK phosphorylation and that the level of phosphorylation was similar across all the regions of the brain. We next examined the effect of ETS on p38MAP kinase in various regions of the brain. We found that ETS induced the phosphorylation of the p38MAP kinase in all the regions of the brain examined without altering the levels of the p38 MAP kinase protein expression (Fig. 4C).",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Pharmacol 2006 May 28 71(11) 1602-9",
                "id": "16569398"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c62"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "TLR4 and Syk were required for mmLDL activation of guanine nucleotide exchanging factor Vav1, small GTPase Ras, kinases Raf, MEK1 and ERK1/2; in turn, ERK1/2 phosphorylated paxillin at Ser126 and activated small GTPases Cdc42, Rac and Rho (Figure 3 and Online Figure III). These signaling events lead to actin polymerization, a necessary step in membrane ruffling. Our results agree with the reports of Syk-dependent ERK1/2 activation in phagocytosis45, ERK1/2 activation in TLR4-dependent antigen uptake by dendritic cells46, and the role of paxillin and small GTPases in actin reorganization and pinocytic vesicle formation9,26,27,47. ",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 2009 Jun 19 104(12) 1355-63",
                "id": "19461045"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c61"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "To investigate the biological significance of Ras/ERK1/2-induced STAT3 Ser(727) phosphorylation for cell proliferation and transformation, N-Ras-transformed NIH-3T3 cells were employed. These cells displayed elevated levels of activated ERK1/2 and Ser(727)-phosphorylated STAT3, which were inhibited by treatment with U0126. Importantly, overexpression of STAT3, in which the Ser(727) was mutated into Ala (STAT3(S727A)), rescued the transformed phenotype of N-Ras-transformed cells",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 Mar 2 282(9) 6415-24",
                "id": "17209045"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c60"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Two classes of differentiation factors, the neurotrophins and fibroblast growth factors, induce rapid tyrosine phosphorylation of SNT1(FRS2alpha), which in turn enables SNT1 to recruit Shp2 tyrosine phosphatase and Grb2 adaptor protein in complex with the Ras GDP/GTP exchange factor Sos. Mutagenesis of SNT1(IRS)CX identified three classes of effector motifs within SNT critical for both sustained ERK activation and neuronal differentiation: 1) four phosphotyrosine motifs that mediate recruitment of Grb2, 2) two phosphotyrosine motifs that mediate recruitment of Shp2, and 3) a C-terminal motif that functions by helping to recruit Sos.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Apr 20 276(16) 13049-56",
                "id": "11278583"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c5f"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "from full text - In BE cells transfected with b-arrestin1 siRNA no pERK signals were detected (Fig. 1, C and D). These data provide further evidence that b-arrestin1 is necessary for IGF-1-induced ERK activation. We also investigated whether b-arrestin2 played a similar role. However, no significant reduction in IGF-1-stimulated pERK was observed in BE cells transfected with b-arrestin2 siRNA (Fig. 1, C and D). In contrast, down-regulation of b-arrestin2 levels led to an increase in both basal and IGF-1-stimulated ERK activity that was sustained up to 60 min (Fig. 1, C and D).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 Apr 13 282(15) 11329-38",
                "id": "17303558"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c5e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "melanoma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Experiments with exogenous [(3)H]S1P showed a multi-exponential influx kinetic of intracellular uptake of [(3)H]S1P up to a steady state level over 2h. This process could be inhibited or enhanced by various synthetic modulators targeting both, S1P(1) receptor-dependent (Akt, ERK1/2) as well as independent DMS-sensitive pathways. The S1P(1) receptor signalling was shown to drive the sphingosine kinase - the rate limiting enzyme for the formation of S1P - to a higher or lower activity. Furthermore, S1P as an intracellular messenger induced the phosphorylation and nuclear translocation of the p65 subunit of NF-kappaB and in turn the expression of E-selectin and monocyte adhesion.",
              "citation": {
                "type": "PubMed",
                "name": "Eur J Cell Biol 2010 Oct 89(10) 733-41",
                "id": "20656374"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c5d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": "vascular tissue"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "we identified differentially regulated genes that by inspection revealed functionally significant classes of genes regulated by MKK5 and MKK1. These were not identifiable by applying any of the three filters alone, which individually yielded larger sets of genes that were significantly difficult to cluster. The results showed 36 genes that were induced by ERK5 activation, of which 17 were selectively up-regulated by ERK5 and not ERK1/2 (Table 1), and 19 genes were up-regulated by both ERK5 and ERK1/2 (Table 3). ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Jul 28 281(30) 20993-1003",
                "id": "16735500"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c5c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "retinal epithelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Using isolated human platelets, we report that PKCdelta, but not PKCalpha or PKCbeta, is required for collagen-induced phospholipase C-dependent signaling, activation of alpha(IIb)beta(3), and platelet aggregation. Analysis of PKCdelta phosphorylation and translocation to the membrane following activation by both collagen and thrombin indicates that it is positively regulated by alpha(IIb)beta(3) outside-in signaling. Moreover, PKCdelta triggers activation of the mitogen-activated protein kinase-kinase (MEK)/extracellular-signal regulated kinase (ERK) and the p38 MAPK signaling. This leads to the subsequent release of thromboxane A(2), ##Phospho-specific antibodies for PKC?, MEK1/2, ERK1/2, and p38 MAPK came from Cell Signaling Technologies (Beverly, MA) and Santa Cruz Biotechnologies (Santa Cruz, CA).##",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Oct 6 281(40) 30024-35",
                "id": "16895913"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c5b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Blood Platelets",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Platelet-derived growth factor (PDGF) has multiple functions including inhibition of apoptosis and promotion of cell proliferation. In this study, we show that Na(+)/H(+) exchanger regulatory factor 2 (NHERF2) binds to the carboxyl-terminal PDZ domain-binding motif of the PDGF receptor through a PDZ domain-mediated interaction, and evaluate the consequence on PDGF-induced proliferation. Stable transfection with NHERF2 increased the PDGF-induced phosphorylation of ERK and Akt in Rat1 embryonic fibroblasts.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2004 Jul 16(7) 791-800",
                "id": "15115658"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c5a"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": "embryonic tissue"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "in fetal rat brown adipocyte primary cultures the PPARgamma agonist rosiglitazone (Rosi), as well as retinoic acids 9-cis-retinoic acid and all-trans-retinoic acid also have  extragenic  effects and induce p44/p42 and p38 mitogen-activated protein kinase (p38MAPK) activation. The latter is involved in UCP-1 gene expression, because inhibition of p38MAPK activity with PD169316 impairs the ability of Rosi and retinoids for UCP-1 induction.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Jan 3 278(1) 263-9",
                "id": "12414803"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c59"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "brown adipocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "ERK5 is also induced in C10 cells by asbestos fibers through an oxidant-dependent process that is not dependent on EGFR activation (28). ERK1/2 and ERK5 activation by asbestos is Src-dependent, and activation of all three signaling events is essential for the initiation of asbestos-induced epithelial cell proliferation (28). [From primary paper: To confirm the involvement of Src in ERK1/2 and ERK5 activation, a dominant-negative Src construct was used. These experiments showed that Src was essential for ERK1/2 and also ERK5 phosphorylation by asbestos. ]",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2006 Jun 34(6) 666-9",
                "id": "16484683"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c58"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "High-level expression of MEK-DD alone was sufficient to induce clear cellular transformation of chicken embryo fibroblasts, which caused constitutive activation of endogenous MAPK, hyperphosphorylation of Fra-2, and elevation of fra-2 and c-jun gene expression. These results indicate that phosphorylation of Fra-2 by MAPK plays an important role in stimulating endogenous AP-1 activity in a positive autoregulation mechanism, in which phosphorylated Fra-2 induces fra-2 expression through AP-1 binding sites present in its promoter.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Growth Differ 1999 May 10(5) 333-42",
                "id": "10359014"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c57"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "ecause smoke exposure in vivo affects a variety of cell types in the lung, and because cell culture studies cannot mimic the complexity of animal physiology, we performed in vivo studies to examine the signaling pathways activated in murine lung after exposure to cigarette smoke. Western blotting of normal mouse lung homogenates showed increased p-ERK at 10 days of smoke exposure compared with lungs from control (unexposed) mice (Fig. 4A). Immunohistochemistry of lung tissue sections revealed nominal p-ERK staining in airway lining cells and red blood cells in control mice, with no staining in alveolar cells (Figs. 4, B and C). Robust expression of p-ERK is observed in airway lining cells, as well as in macrophages in the alveolar spaces at 10 days of smoke exposure (Figs. 4, D and E).Strong airway and alveolar p-ERK staining was still present at 6 months of exposure (Fig. 4, F and G).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Apr 23 279(17) 17690-6",
                "id": "14764579"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c56"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "In vitro treatment with activin A increased VEGF secretion, as well as p38 and p42/44 MAPK activity in corneal epithelial cells, whereas concurrent administration of specific inhibitors of p38 or p42/44 MAPK abolished the stimulatory effect of activin A on VEGF production. We conclude that activin A stimulates inflammatory corneal angiogenesis by increasing VEGF levels through a p38 and p42/44 MAPK-dependent mechanism.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Pathol 2004 Apr 164(4) 1293-302",
                "id": "15039217"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c55"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Asthma is frequently associated with abnormal airway smooth muscle (ASM) growth that may contribute to airway narrowing and hyperresponsiveness to contractile agents. Although numerous hormones and cytokines have been shown to induce human ASM (HASM) proliferation, the cellular and molecular mechanisms underlying HASM hyperplasia are largely unknown. Here we characterize the roles of the mitogen-activated protein kinase (MAPK) superfamily [p42/p44 MAPK, c-Jun amino-terminal kinase/stress-activated protein kinase (JNK/SAPK), and p38] in mediating hormone- and cytokine-induced HASM proliferation. Significant enhancement of [(3)H]thymidine incorporation in HASM cultures was observed only by treatment with agents (epidermal growth factor, platelet-derived growth factor, thrombin, and phorbol 12-myristate 13-acetate) that promoted a strong and sustained activation of p42/p44 MAPK. Significant activation of the JNK/SAPK and p38 pathways was only observed on stimulation with interleukin (IL)-1beta and tumor necrosis factor-alpha, agents that did not appreciably stimulate HASM proliferation. Two different inhibitors of MAPK/extracellular signal-regulated kinase kinase (MEK), PD-98059 and U-0126, inhibited mitogen-induced [3H]thymidine incorporation in a manner consistent with their ability to inhibit p42/p44 activation. Elk-1 and activator protein-1 reporter activation by mitogens was similarly inhibited by inhibition of MEK, suggesting a linkage between p42/p44 activation, transcription factor activation, and HASM proliferation. These findings establish a fundamental role for p42/p44 activation in regulating HASM proliferation and provide insight into species-specific differences observed among studies in ASM mitogenesis.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol 1999 Sep 277(3 Pt 1) L479-88",
                "id": "10484455"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c54"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "The ability of CXCL12 to stimulate proliferation and survival is mediated by activation of the Erk 1/2 and phosphatidylinositol 3-kinase pathways in many cell types Taken together these data indicate that the ability of AMD 3100 to decrease tumor growth in animal models reflects direct inactivation of CXCR4 in tumor cells and consequent inhibition of Erk 1/2 and phosphatidylinositol 3-kinase pathways, resulting in increased tumor cell apoptosis and decreased proliferation.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2003 Nov 11 100(23) 13513-8",
                "id": "14595012"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c53"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "To elucidate the role of MAPKs in keratinocyte differentiation, activation of ERK, JNK, and p38 in response to stimulation with extracellular calcium was analyzed. We provide evidence that calcium-induced differentiation of keratinocytes is associated with rapid and transient activation of the Raf/MEK/ERK pathway. Stimulation of keratinocytes with extracellular calcium resulted in activation of Raf isozymes and their downstream effector ERK within 10-15 min, but did not increase JNK or p38 activity",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Dec 29 275(52) 41011-7",
                "id": "11018025"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c52"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "control and Sod2-overexpressing cells were treated with the specific inhibitors of ERK1/2 (PD98059) and p38 (SB203580) (Fig. 4B, inset). Northern blotting demonstrated that the ERK1/2 inhibitor blocked basal MMP-1 expression and dramatically decreased MMP-1 mRNA levels in the HT15 cell lines. The p38 inhibitor increased MMP-1 expression in both control and HT15 cell lines......the inductive properties of SB203580 could be blocked by PD98059.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Apr 27 276(17) 14264-70",
                "id": "11297530"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c51"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "fibrosarcoma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Etienne-Manneville and Hall (2003) used primary rat astrocytes in a cell migration assay to demonstrate that PAR6-PKC-zeta interacts directly with and regulates glycogen synthase kinase-3-beta (GSK3-beta; 605004) to promote polarization of the centrosome and to control the direction of cell protrusion. CDC42-dependent phosphorylation of GSK3-beta occurs specifically at the leading edge of migrating cells, and induces the interaction of APC (175100) protein with the plus ends of microtubules. Erk1/2 activates p90RSK",
              "citation": {
                "type": "PubMed",
                "name": "Science 1998 Jan 30 279(5351) 707-10",
                "id": "9445476"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c50"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Pretreatment of VSMC with IL-19 results in a significant reduction in fetal calf stimulated p44/42 and p38 MAPK activation in cultured human VSMC [38]. It was found that this inhibition was mediated by SOCS5 interaction with these MAP kinases, suggesting that in other cell types, other interleukins could inhibit MAPKs by induction of SOCS proteins.",
              "citation": {
                "type": "PubMed",
                "name": "Curr Vasc Pharmacol 2009 Jul 7(3) 267-76",
                "id": "19601851"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c4f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": "vascular tissue"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "It is well recognized that VEGF is regulated by many pathways such as phosphorylated PKCbII, phosphorylated P38, and phosphorylated ERK1/2 [19,21,25]. We found STC-1 could activate PKCbIIand ERK1/2 proteins rather than P38. Blocking PKCbII or ERK1/2 reversed the expression of VEGF induced by STC-1, indicating that STC-1 regulates VEGF expression through PKCbII or ERK1/2 pathways.",
              "citation": {
                "type": "PubMed",
                "name": "J Biomed Sci 2011 18 39",
                "id": "21672207"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c4e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Carcinoma of gastrointestinal tract",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Simultaneous overexpression of selenophosphate synthetase and phospholipid-hydroperoxide GSH peroxidase (PHGPx) [250] blocks activation of NF-kB by IL-1. Overexpression of SOD [84] or GSH peroxidase [81, 211] abolished NF-kB activation by preventing degradation of IkB after stimulation with TNF-a. The precise mechanism(s) through which oxidants and reductants influence activation of NF-kB is presently unknown; however, there is evidence that antioxidant enzyme (AOE372), a redox-sensitive thioredoxin peroxidase, regulates IkB phosphorylation [246]. Phosphatases The phosphatases are an important component of most signal transduction pathways, because failure to reverse kinase actions can disrupt normal cellular functions. For example, transfection of human fibroblasts with constitutively active ras (hRasV12) inhibits cell growth and ultimately results in a senescentlike phenotype [441]. Similarly, constitutive ERK activation has an inhibitory effect on cell cycle progression [442,443]. Both the serine/threonine phosphatases and the PTPs are known to be redox-sensitive [82,144,153,156,271,281, 444-449]. The mechanism of redox effects on activity is probably best understood for the PTPs. Without exception, the PTPs contain a highly conserved region of 11 amino acid residues in their catalytic domain; specifi- cally, (Ile/Val)-His-Cys-X-Ala-Gly-X-X-Arg-(Ser/Thr)- Gly, where X is a nonconserved amino acid [17]. Either oxidation or mutation of the cysteine renders these molecules inactive [17,281]. H2O2 is a potent inhibitor of PTPs. As in the case of other oxidants, H2O2 probably oxidizes the thiolate anion at the catalytic site [280]. Because formation of a phosphorylcysteine intermediate seems to be critical to PTP activity [450-452], blocking it through oxidation of the cysteine inactivates the molecules. In many cases, treatment of cells with H2O2 stimulates increases in protein phosphorylation by inhibiting phosphatase-catalyzed removal of phosphate groups. Furthermore, mitogens that increase cellular ox- idant production may stimulate phosphorylation indirectly by decreasing phosphatase activity. Additional mechanisms are involved in stimulation of pathways activated by growth factors that increase oxidant production, however, because there are known instances in which the oxidants they produce have no effect on protein phosphorylation. For example, TGF-b1 stimulates phosphorylation of numerous proteins and has been shown to cause a large increase in H2O2 production; however, its effects on protein phosphorylation are not blocked by catalase [453]. Furthermore, H2O2 is effective in promoting phosphorylation of phospholipase D, the PDGF receptor, and PKC-a even after pretreatment of Swiss 3T3 fibroblasts with orthovanadate to inhibit phosphatases [454]. Thus, although diminished phosphatase activity may partially account for increased phosphorylation in some cases, it cannot totally account for oxidation effects on phosphorylation in every case. SPECIFICITY In general, there is good agreement between studies on redox effects on any given gene; albeit, not all oxidizing or reducing treatments exert equivalent effects. This is clearly demonstrated in studies of pag , which encodes a protein associated with cellular proliferation. Pag protein inhibits the tyrosine kinase activity of the Abelson (abl ) protein by binding to its SH3-binding domain [455]. BSO, menadione, sodium arsenate, and diethyl maleate all stimulate pag expression, but H2O2 does not [269]. Conversely, H2O2 stimulates c-fos expression (Table 1), although 4-hydroynonenal (a product of v-6-polyunsaturated fatty acid peroxidation) not only fails to induce c-fos expression but is actually inhibitory to c-fos induction by EGF and PDGF [185]. Similarly, some oxidants such as diamide decrease hypoxia-induced signals [201], although others such as H2O2 increase them [124]. As might be expected, the effects of any stimu...",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2000 Feb 1 28(3) 463-99",
                "id": "10699758"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c4d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "In regard to MAP kinase, both p42 and p44 MAP kinase have been shown to phosphorylate HIF-1alpha  in vitro and to stimulate HIF-1alpha transcription activity without affecting the level of the protein (33). Therefore, it is conceivable that the drug PD098059 might decrease glut1 mRNA levels and promoter activity through an effect on HIF-1alpha  function without affecting the level of the protein itself.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem. 2001 Mar 23;276(12):9519-25",
                "id": "11120745"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c4c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "PD98059, an inhibitor of MEK 1 and 2 is able to block ERK1 and ERK2 activation under normal tissue culture conditions (68, 69). PD98059 must be dissolved in dimethyl sulfoxide (DMSO) and crystallizes when added to tissue culture medium at concentrations higher than 100 mM. When studies are done with this compound, an equal amount of DMSO must be added to a control culture dish to exclude a toxic effect from the solvent. PD98059 at 2050 mM can completely inhibit TPO-induced ERK phosphorylation in murine megakaryocytes.",
              "citation": {
                "type": "PubMed",
                "name": "Methods 1999 Mar 17(3) 238-49",
                "id": "10080909"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c4b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "megakaryocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "As shown in Figure 2A, NECA-stimulated Akt, pan PKC, ERK, p38, JNK MAPKs, and NF-kB phosphorylation. Moreover, Cx43 phosphorylation was blocked by targeted inhibitors of PI3K (LY 294002), Akt (Akt inhibitor), PKC (bisindolylmaleimide I, staurosporine), p38 MAPK (SB 203580), ERK (PD 98059), c-Jun N-terminal kinase (JNK) (SP 600125), and NF-kB (Bay 11-7082, SN50) pathways, respectively (Fig. 2B?E).",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Physiol 2010 Jul 224(1) 187-94",
                "id": "20232318"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c4a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "embryonic stem cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Hyperoxia was associated with a significant increase in pJNKs and pERKs in WT mice as seen by Western blot. NOX1, but not NOX2, deficiency decreased ERK and JNK phosphorylation without modification of JNK and ERK protein levels (Figures 7A?7F).NOX1, but not NOX2, deficiency decreased ERK and JNK phosphorylation without modification of JNK and ERK protein levels (Figures 7A?7F). pERK staining was associated with type II pneumocytes and endothelial cell markers during hyperoxia (Figure 8A), whereas pJNK staining was detected mainly in endothelial cells (Figure 8B). ",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Crit Care Med 2009 Nov 15 180(10) 972-81",
                "id": "19661248"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c49"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "To see the phosphorylation of MAPK by ETS, the control and ETS-exposed brain tissues were extracted and 100 mg proteins were analyzed by 10% SDS-PAGE and phosphorylated form of MAPK was detected by Western blot using anti-phospho-MAPK antibody. The result shown in Fig. 4B indicates that phosphorylated MAPK was increased in all the regions of the brain exposed to ETS as compared to control brain tissue. The same extracts were probed with anti- ERK antibody and the level of ERK was unchanged in all the lanes indicating equal loading of proteins as well as specificity of the phosphorylation of the MAPK because ERK also undergoes phoshorylation but through different signaling pathway [31]. These results therefore strongly suggest that ETS induces MAPK phosphorylation and that the level of phosphorylation was similar across all the regions of the brain. We next examined the effect of ETS on p38MAP kinase in various regions of the brain. We found that ETS induced the phosphorylation of the p38MAP kinase in all the regions of the brain examined without altering the levels of the p38 MAP kinase protein expression (Fig. 4C).",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Pharmacol 2006 May 28 71(11) 1602-9",
                "id": "16569398"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c48"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": "striatum"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": " As might be expected from the wide array of hormones, cytokines, and growth factors that can affect adipogenesis, several different signal transduction pathways have been implicated in the process as well. There has been quite a bit of interest in the MAP kinase family of intracellular protein kinases. As just described, many growth factors that exert their influence through tyrosine kinase receptors inhibit fat cell differentiation. It is now clear that much of this inhibition occurs through activation of the \\\"classic\\\" MAP kinases, Erk 1 and 2. These kinases directly phosphorylate PPARg (see subsequent text), and inhibit its adipogenic activity.33",
              "citation": {
                "type": "PubMed",
                "name": "Ann N Y Acad Sci 2002 Dec 979 143-58; discussion 188-96",
                "id": "12543724"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c47"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Adipocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "We show that in the human breast carcinoma T47D cells, upon estrogen treatment, p130Cas rapidly and transiently associates with the estrogen receptor alpha in a multi-molecular complex containing the c-Src kinase and the p85 subunit of PI 3-kinase. Association of p130Cas with the estrogen receptor alpha occurs within 3 minutes of estrogen treatment and is dependent on c-Src kinase activation. Transient overexpression of p130Cas in T47D cells increases estrogen-dependent Src kinase and Erk1/2 MAPKs activities and accelerates their kinetics of stimulation.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 2004 Mar 15 117(Pt 8) 1603-11",
                "id": "15020686"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c46"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "The ERK2 MAP kinase pathway controls cell growth and survival and modulates integrin function. Here, we report that PEA15, a protein variably expressed in multiple cell types, blocks ERK-dependent transcription and proliferation by binding ERKs and preventing their localization in the nucleus. PEA-15 contains a nuclear export sequence required for its capacity to anchor ERK in the cytoplasm. Genetic deletion of PEA-15 results in increased ERK nuclear localization with consequent increased cFos transcription and cell proliferation. Thus, PEA-15 can redirect the biological outcome of MAP kinase signaling by regulating the subcellular localization of ERK MAP kinase.",
              "citation": {
                "type": "PubMed",
                "name": "Dev Cell 2001 Aug 1(2) 239-50",
                "id": "11702783"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c45"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Hyperoxia was associated with a significant increase in pJNKs and pERKs in WT mice as seen by Western blot. NOX1, but not NOX2, deficiency decreased ERK and JNK phosphorylation without modification of JNK and ERK protein levels (Figures 7A?7F).NOX1, but not NOX2, deficiency decreased ERK and JNK phosphorylation without modification of JNK and ERK protein levels (Figures 7A?7F). pERK staining was associated with type II pneumocytes and endothelial cell markers during hyperoxia (Figure 8A), whereas pJNK staining was detected mainly in endothelial cells (Figure 8B). ",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Crit Care Med 2009 Nov 15 180(10) 972-81",
                "id": "19661248"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c44"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Alveolar type II cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Subsequently, to understand the mechanism of nanoparticles-induced oxidative stress, the involvement of oxidative stress-responding transcription factors, such as, nuclear factor-kappaB (NF-kappaB) and nuclear factor-E2-related factor-2 (Nrf-2), as well as the mitogen-activated protein (MAP) kinase signal transduction pathway were investigated. From the overall results, silica nanoparticles exerted toxicity via oxidative stress, which lead to the induction of HO-1 via the Nrf-2-ERK MAP kinase signaling pathway",
              "citation": {
                "type": "PubMed",
                "name": "Toxicol In Vitro 2009 Oct 23(7) 1326-32",
                "id": "19602432"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c43"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Stromal vascular cultures containing newly differentiated human adipocytes were pretreated with a vehicle (dimethyl sulfoxide) for 1 hour, then with 1 microM BRL49653 (PPARgamma agonist) for 24hours and subsequently treated with 30microM trans-10, cis-12 conjugated linoleic acid for an additional 24hours. CLA treatment conferred the ability of ERK1/2 to phosphorylate its nuclear substrate ELK1 in vitro. Pretreatment with BRL49653 blocked the CLA mediated ability of ERK1/2 to phosphorylate ELK-1",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jun 18 279(25) 26735-47",
                "id": "15067015"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c42"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Adipocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "MyD88 also interacts directly with AKT, and a dominant-negative mutant of AKT causes a defect in MyD88-dependent NF-kB transcriptional activity. However, the binding of NF-kB to DNA is not affected by inhibiting AKT, indicating that AKT might be involved in the phosphorylation of the p65 transactivation domain. A dominant-negative mutant of MyD88 was shown to block the kinase activity of AKT generated in response to LPS and IL-1, and a dominant-negative mutant of p85 inhibited the NF-kB activity elicited by LPS and IL-1 but not that elicited by TNF85. These findings indicate that PI3K is a positive mediator of the signalling induced by LPS and IL-1 that leads to NF-kB activation. However, recent studies using mice that lack the p85 regulatory subunit showed an increased production of IL-12 by DCs, possibly because of enhanced activation of the p38 MAPK, indicating that PI3K might have a negative role in TLR signalling in DCs86.  ECSIT. ECSIT has no homology with any known protein and was cloned as a TRAF6-interacting protein by yeast two-hybrid screening87. ECSIT interacts with the conserved TRAF domain of TRAF6. A Drosophila homologue of ECSIT has been identified, and the interaction between TRAF6 and ECSIT is also conserved in Drosophila. ECSIT also interacts with MEKK1 (MAPK/ERK (extracellular signal-regulated kinase) kinase kinase 1), which can phosphorylate and activate the IKK complex. Expression of a dominant-negative mutant of ECSIT blocks signalling through TLR4, indicating that ECSIT might transduce TLR signals by bridging TRAF6 and the IKK complex. Furthermore, the inhibition of ECSIT expression, using siRNA in a macrophage cell line, resulted in impaired LPS-induced, but not TNF-induced, NF-kB activation88. The physiological function of ECSIT was studied by generating ECSIT-deficient mice, which were found to die on about embryonic day 7.5 (Ref. 88). Further characterization showed that ECSIT is an obligatory intermediate in bone morphogenetic protein (BMP) signalling, and therefore ECSIT is an essential component in both the TLR- and BMP-signalling pathways.  SRC family of tyrosine kinases. Bruton's tyrosine kinase (BTK) is a member of the SRC-related TEC-family of protein tyrosine kinases and has an essential role in B-cell development and B-cell receptor (BCR)-mediated signalling. Macrophages from X-linked-immunodeficient mice that lack BTK show reduced responses to LPS, and BTK has also been found to associate with the TIR domain of TLR4,TLR6, TLR8 and TLR9 (Ref. 89). It has also been shown to associate with MyD88, TIRAP and IRAK1, and to be tyrosine phosphorylated in response to LPS, whereas a dominant-negative form of BTK inhibits LPS-induced activation of NF-kB, indicating that BTK is involved in the TLR-mediated signalling pathway. During BCR-mediated signalling, BTK interacts with and is activated by the SRC family of tyrosine kinases, such as FYN, LYN and haematopoietic-cell kinase, HCK; however, SRC-family kinases have only a minor role in LPS signalling90. Therefore, the involvement of BTK in TLR signalling needs to be further investigated.  MAPKKK. Members of the MAPKKK family - such as TAK1, MEKK1, MEKK2, MEKK3, TPL2 (tumour-progression locus 2; also known as cancer Osaka thyroid, COT) and NIK - are implicated in IKK-NF-kB and MAPK activation. Among these members, MEKK3 has been shown to be involved in signalling through TLR4 but not through TLR9 (Ref. 91): in response to stimulation with a TLR4 ligand but not a TLR9 ligand, embryonic fibroblasts from MEKK3-deficient mice were shown to have impaired IL-6 production and defective activation of NF-kB, JNK and the p38 MAPK. Stimulation of TLR4 also induced association of MEKK3 with TRAF6. So, MEKK3 is involved in the TLR4-mediated signalling pathway. Another member of the MKKK family, TPL2 has been shown to be involved in the TLR4-mediated activation of ERK92. In response to TLR4 ligand, TPL2-deficient...",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Immunol 2004 Jul 4(7) 499-511",
                "id": "15229469"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c41"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Cyclindependent kinases (CDKs), mainly CDK1 associated with cyclin B, have been identified as the kinase system that phosphorylates Ser-25 and Ser-38, but the protein kinase involved in phosphorylation of Ser-16 and Ser-63 during mitosis remains to be identified (5, 21). Besides cell cycle-regulated phosphorylation, Op18 is phosphorylated by members of the mitogen-activated protein kinase family on Ser-25 (22-24), by the Ca21/calmodulin-dependent kinase IV/Gr (CaMK IV/Gr) on Ser-16 (25), and by the cyclic AMP-dependent protein kinase (PKA) on Ser-16 and Ser-63 (4).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1997 Sep 17(9) 5530-9",
                "id": "9271428"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c40"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "ecause smoke exposure in vivo affects a variety of cell types in the lung, and because cell culture studies cannot mimic the complexity of animal physiology, we performed in vivo studies to examine the signaling pathways activated in murine lung after exposure to cigarette smoke. Western blotting of normal mouse lung homogenates showed increased p-ERK at 10 days of smoke exposure compared with lungs from control (unexposed) mice (Fig. 4A). Immunohistochemistry of lung tissue sections revealed nominal p-ERK staining in airway lining cells and red blood cells in control mice, with no staining in alveolar cells (Figs. 4, B and C). Robust expression of p-ERK is observed in airway lining cells, as well as in macrophages in the alveolar spaces at 10 days of smoke exposure (Figs. 4, D and E).Strong airway and alveolar p-ERK staining was still present at 6 months of exposure (Fig. 4, F and G).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Apr 23 279(17) 17690-6",
                "id": "14764579"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c3f"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "active forms of ERK- 1 (p44mapk) and ERK-2 (p42mapk) were detected by Western blotting using an antibody that recognizes the dually phosphorylated forms of these enzymes. As illustrated by Figure 5A, addition of CCK-8 to quiescent cultures of Swiss 3T3 CCKBRGFP cells induced a striking ERK activation, comparable to that promoted by bombesin or EGF in parallel cultures of these cells. ERK activation in response to CCKB/gastrin receptor activation was virtually abolished by treatment with the selective MEK inhibitor PD 98059.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Physiol 2001 Dec 189(3) 291-305",
                "id": "11748587"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c3e"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "The extracellular signal-regulated kinases 1 and 2 (ERK1/2), also known as p44(MAPK) and p42(MAPK), respectively, are two of the kinases associated with HDAC4. ERK1/2 are components of the Ras-mitogen-activated protein kinase (MAPK) signal transduction pathway. Activation of the Ras-MAPK pathway by expression of oncogenic Ras or constitutively active MAPK/ERK kinase 1 results in an increased percentage of cells (from approximately 10% to approximately 70%) that express HDAC4 in the nucleus in C2C12 myoblast cells.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2000 Dec 19 97(26) 14329-33",
                "id": "11114188"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c3d"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "MafB/Kreisler is induced in response to ERK and synergizes with GATA and Ets to enhance transcription from the proximal promoter. The requirement for MafB in promoter regulation is demonstrated by inhibition of transactivation following dominant-negative or antisense suppression of MafB function. Thus, ERK promotes megakaryocyte differentiation by coordinate regulation of nuclear factors that synergize in GPIIb promoter regulation. These results establish a novel role for MafB as a regulator of ERK-induced gene expression.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 May 24(10) 4534-45",
                "id": "15121870"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c3c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Treating TMK-1 cells with IL-1beta increased VEGF mRNA levels and activated extracellular signal-regulated kinases 1 and 2 (Erk 1/2) and p38, but not Akt. Inhibitors of the Erk and p38 pathways blocked IL-1beta induction of VEGF mRNA. Treating TMK-1 cells with IL-1beta also increased VEGF promoter activity. VEGF transcriptional activity was found to depend on a 120-bp region just proximal to the transcription start site.",
              "citation": {
                "type": "PubMed",
                "name": "Surgery 2004 Sep 136(3) 686-92",
                "id": "15349119"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c3b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Carcinoma of gastrointestinal tract",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": " As might be expected from the wide array of hormones, cytokines, and growth factors that can affect adipogenesis, several different signal transduction pathways have been implicated in the process as well. There has been quite a bit of interest in the MAP kinase family of intracellular protein kinases. As just described, many growth factors that exert their influence through tyrosine kinase receptors inhibit fat cell differentiation. It is now clear that much of this inhibition occurs through activation of the \\\"classic\\\" MAP kinases, Erk 1 and 2. These kinases directly phosphorylate PPARg (see subsequent text), and inhibit its adipogenic activity.33",
              "citation": {
                "type": "PubMed",
                "name": "Ann N Y Acad Sci 2002 Dec 979 143-58; discussion 188-96",
                "id": "12543724"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c3a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "In brief, p210BCR/ABL activates signal transduction pathways such as RAS/MAPK, PI-3 kinase, c-CBL and CRKL pathways, JAK-STAT and the Src pathway. Of these, the ras, Jun-kinase, and PI-3 kinase pathways have been demonstrated to play a major role in transformation and proliferation (Raitano et al., 1995; Sawyers et al., 1995; Skorski et al., 1995, 1997a). Inhibition of apoptosis is thought to result from activation of the PI-3 kinase and RAS pathways, with induction through AKT of c-myc and BCL-2 (Raitano et al., 1995; Sawyers et al., 1995; Skorski et al., 1995, 1997a; Warmuth et al., 1999)",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2002 Dec 9 21(56) 8547-59",
                "id": "12476301"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c39"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Treatment of glEND.2 cells with vascular endothelial growth factor (VEGF, 10 ng/ml) induced a time dependent phosphorylation of ERK1/2, which was significant at 2 minutes of VEGF exposure (3.7 fold), peaking at 10 minutes, and thereafter tapering off. VEGF also induced activation of VEGFR-2. VEGF induced ERK1/2 activation was totally blocked by pretreatment with specific ERK1/2 inhibitor U0126. Inhibition of ERK1/2 activation also inhibited VEGF induced proliferation, where as inhibition of PKC or PI3K had no effect, suggesting that VEGF induces receptor mediated activation of ERK1/2 leading to proliferation in glEND.2 cells.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2005 Sep 9 334(4) 1049-60",
                "id": "16039615"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c38"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "The proliferative effect of C-peptide on VSMCs was inhibited by Src short interference RNA transfection, PP2, an inhibitor of Src-kinase, LY294002, an inhibitor of PI-3 kinase, and the ERK1/2 inhibitor PD98059. Moreover, C-peptide induced phosphorylation of Src, as well as activation of PI-3 kinase and ERK1/2, suggesting that these signaling molecules are involved in C-peptide-induced VSMC proliferation. Finally, C-peptide induced cyclin D1 expression as well as phosphorylation of Rb in VSMCs. Our results demonstrate that C-peptide induces VSMC proliferation through activation of Src- and PI-3 kinase as well as ERK1/2.",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 2006 Nov 24 99(11) 1181-7",
                "id": "17068290"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c37"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": "vascular smooth muscle"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Furthermore, in mast cells lacking group V secretory PLA(2), the time course of phosphorylation of ERK1/2 and of cPLA(2)alpha was markedly truncated, leading to attenuation of eicosanoid generation in response to stimulation through TLR2, but not through c-kit or FcepsilonRI. These findings provide the first dissection of the mechanisms of TLR-dependent rapid eicosanoid generation, which is MyD88-dependent, requires cPLA(2)alpha, and is amplified by group V sPLA(2) through its regulation of the sequential phosphorylation and activation of ERK1/2 and cPLA(2)alpha.",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2007 Jul 15 110(2) 561-7",
                "id": "17369491"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c36"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "mast cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "However, using an inhibitor of ERK activation, U0126, we show that Alb-AGE stimulates VEGF expression through an ERK-dependent pathway. Accordingly, we found that Alb-AGE activated mitogen-activate protein kinase, ERK1/2, JNK1/2, but not p38, and that Alb-AGE did not activate PI3K and PKB. Moreover, Alb-AGE activated the transcription factor, hypoxia inducible factor-1 (HIF-1) DNA binding activity. This activation is mediated by an increase in accumulation of the HIF-1alpha protein through an ERK-dependent pathway.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Nov 23 276(47) 43836-41",
                "id": "11571295"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c35"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Moreover, IL-22 (100 ng/ml) induced a transient activation of ERK1/2 (Fig. 3A). During the observed time interval, total ERK1 and ERK2 levels remained unchanged (Fig. 3A). To identify upstream signaling events, we investigated the effect of the MEK-1 inhibitor PD98059 on the IL-22-mediated ERK regulation. PD98059 downregulated ERK1/2 phosphorylation after IL-22 stimulation significantly (Fig. 3B), suggesting MEK-1 as an upstream signal transducer of the IL-22-induced ERK activation. Cross talk between the PI3-kinase and the MEK-ERK pathway has been proposed (43). However, ERK activation after IL-22 stimulation was not significantly affected by pretreatment with wortmannin (Fig. 3C), suggesting a PI3-kinase-independent activation of ERK-MAP kinases by IL-22.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Gastrointest Liver Physiol 2006 Apr 290(4) G827-38",
                "id": "16537974"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c34"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Simultaneous overexpression of selenophosphate synthetase and phospholipid-hydroperoxide GSH peroxidase (PHGPx) [250] blocks activation of NF-kB by IL-1. Overexpression of SOD [84] or GSH peroxidase [81, 211] abolished NF-kB activation by preventing degradation of IkB after stimulation with TNF-a. The precise mechanism(s) through which oxidants and reductants influence activation of NF-kB is presently unknown; however, there is evidence that antioxidant enzyme (AOE372), a redox-sensitive thioredoxin peroxidase, regulates IkB phosphorylation [246]. Phosphatases The phosphatases are an important component of most signal transduction pathways, because failure to reverse kinase actions can disrupt normal cellular functions. For example, transfection of human fibroblasts with constitutively active ras (hRasV12) inhibits cell growth and ultimately results in a senescentlike phenotype [441]. Similarly, constitutive ERK activation has an inhibitory effect on cell cycle progression [442,443]. Both the serine/threonine phosphatases and the PTPs are known to be redox-sensitive [82,144,153,156,271,281, 444-449]. The mechanism of redox effects on activity is probably best understood for the PTPs. Without exception, the PTPs contain a highly conserved region of 11 amino acid residues in their catalytic domain; specifi- cally, (Ile/Val)-His-Cys-X-Ala-Gly-X-X-Arg-(Ser/Thr)- Gly, where X is a nonconserved amino acid [17]. Either oxidation or mutation of the cysteine renders these molecules inactive [17,281]. H2O2 is a potent inhibitor of PTPs. As in the case of other oxidants, H2O2 probably oxidizes the thiolate anion at the catalytic site [280]. Because formation of a phosphorylcysteine intermediate seems to be critical to PTP activity [450-452], blocking it through oxidation of the cysteine inactivates the molecules. In many cases, treatment of cells with H2O2 stimulates increases in protein phosphorylation by inhibiting phosphatase-catalyzed removal of phosphate groups. Furthermore, mitogens that increase cellular ox- idant production may stimulate phosphorylation indirectly by decreasing phosphatase activity. Additional mechanisms are involved in stimulation of pathways activated by growth factors that increase oxidant production, however, because there are known instances in which the oxidants they produce have no effect on protein phosphorylation. For example, TGF-b1 stimulates phosphorylation of numerous proteins and has been shown to cause a large increase in H2O2 production; however, its effects on protein phosphorylation are not blocked by catalase [453]. Furthermore, H2O2 is effective in promoting phosphorylation of phospholipase D, the PDGF receptor, and PKC-a even after pretreatment of Swiss 3T3 fibroblasts with orthovanadate to inhibit phosphatases [454]. Thus, although diminished phosphatase activity may partially account for increased phosphorylation in some cases, it cannot totally account for oxidation effects on phosphorylation in every case. SPECIFICITY In general, there is good agreement between studies on redox effects on any given gene; albeit, not all oxidizing or reducing treatments exert equivalent effects. This is clearly demonstrated in studies of pag , which encodes a protein associated with cellular proliferation. Pag protein inhibits the tyrosine kinase activity of the Abelson (abl ) protein by binding to its SH3-binding domain [455]. BSO, menadione, sodium arsenate, and diethyl maleate all stimulate pag expression, but H2O2 does not [269]. Conversely, H2O2 stimulates c-fos expression (Table 1), although 4-hydroynonenal (a product of v-6-polyunsaturated fatty acid peroxidation) not only fails to induce c-fos expression but is actually inhibitory to c-fos induction by EGF and PDGF [185]. Similarly, some oxidants such as diamide decrease hypoxia-induced signals [201], although others such as H2O2 increase them [124]. As might be expected, the effects of any stimu...",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2000 Feb 1 28(3) 463-99",
                "id": "10699758"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c33"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Simultaneous overexpression of selenophosphate synthetase and phospholipid-hydroperoxide GSH peroxidase (PHGPx) [250] blocks activation of NF-kB by IL-1. Overexpression of SOD [84] or GSH peroxidase [81, 211] abolished NF-kB activation by preventing degradation of IkB after stimulation with TNF-a. The precise mechanism(s) through which oxidants and reductants influence activation of NF-kB is presently unknown; however, there is evidence that antioxidant enzyme (AOE372), a redox-sensitive thioredoxin peroxidase, regulates IkB phosphorylation [246]. Phosphatases The phosphatases are an important component of most signal transduction pathways, because failure to reverse kinase actions can disrupt normal cellular functions. For example, transfection of human fibroblasts with constitutively active ras (hRasV12) inhibits cell growth and ultimately results in a senescentlike phenotype [441]. Similarly, constitutive ERK activation has an inhibitory effect on cell cycle progression [442,443]. Both the serine/threonine phosphatases and the PTPs are known to be redox-sensitive [82,144,153,156,271,281, 444-449]. The mechanism of redox effects on activity is probably best understood for the PTPs. Without exception, the PTPs contain a highly conserved region of 11 amino acid residues in their catalytic domain; specifi- cally, (Ile/Val)-His-Cys-X-Ala-Gly-X-X-Arg-(Ser/Thr)- Gly, where X is a nonconserved amino acid [17]. Either oxidation or mutation of the cysteine renders these molecules inactive [17,281]. H2O2 is a potent inhibitor of PTPs. As in the case of other oxidants, H2O2 probably oxidizes the thiolate anion at the catalytic site [280]. Because formation of a phosphorylcysteine intermediate seems to be critical to PTP activity [450-452], blocking it through oxidation of the cysteine inactivates the molecules. In many cases, treatment of cells with H2O2 stimulates increases in protein phosphorylation by inhibiting phosphatase-catalyzed removal of phosphate groups. Furthermore, mitogens that increase cellular ox- idant production may stimulate phosphorylation indirectly by decreasing phosphatase activity. Additional mechanisms are involved in stimulation of pathways activated by growth factors that increase oxidant production, however, because there are known instances in which the oxidants they produce have no effect on protein phosphorylation. For example, TGF-b1 stimulates phosphorylation of numerous proteins and has been shown to cause a large increase in H2O2 production; however, its effects on protein phosphorylation are not blocked by catalase [453]. Furthermore, H2O2 is effective in promoting phosphorylation of phospholipase D, the PDGF receptor, and PKC-a even after pretreatment of Swiss 3T3 fibroblasts with orthovanadate to inhibit phosphatases [454]. Thus, although diminished phosphatase activity may partially account for increased phosphorylation in some cases, it cannot totally account for oxidation effects on phosphorylation in every case. SPECIFICITY In general, there is good agreement between studies on redox effects on any given gene; albeit, not all oxidizing or reducing treatments exert equivalent effects. This is clearly demonstrated in studies of pag , which encodes a protein associated with cellular proliferation. Pag protein inhibits the tyrosine kinase activity of the Abelson (abl ) protein by binding to its SH3-binding domain [455]. BSO, menadione, sodium arsenate, and diethyl maleate all stimulate pag expression, but H2O2 does not [269]. Conversely, H2O2 stimulates c-fos expression (Table 1), although 4-hydroynonenal (a product of v-6-polyunsaturated fatty acid peroxidation) not only fails to induce c-fos expression but is actually inhibitory to c-fos induction by EGF and PDGF [185]. Similarly, some oxidants such as diamide decrease hypoxia-induced signals [201], although others such as H2O2 increase them [124]. As might be expected, the effects of any stimu...",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2000 Feb 1 28(3) 463-99",
                "id": "10699758"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c32"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "cardiomyocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "LPS-induced IL-8 production also depends on CS-induced phosphorylation and activation of ERK-1, ERK-2 and P38MAPK. CS has been found to have a profound modulatory effect on ERK-1 and ERK-2. Both basal and LPS induced phosphorylation of ERK-2 was higher in AM from healthy smokers than those from non-smokers. CS has been shown to enhance mitogenactivated protein-kinase activation more than NF-kB activation to increase LPS-induced IL-8 production in AM [76].",
              "citation": {
                "type": "PubMed",
                "name": "Exp Lung Res 2009 Aug 35(6) 439-85",
                "id": "19842832"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c31"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Despite remarkable progress in dissecting the signaling pathways that are crucial for the metabolic effects of insulin, the molecular basis for the specificity of its cellular actions is not fully understood. One clue might lie in the spatial and temporal aspects of signaling. Recent evidence suggests that signaling molecules and pathways are localized to discrete compartments in cells by specific protein interactions. Also, the rapid termination of tyrosine or lipid phosphorylation by phosphatases or serine kinases might tightly control the strength of a signaling pathway, thus determining its effect on growth, differentiation and metabolism. Insulin is the most potent anabolic hormone known, promoting the synthesis and storage of carbohydrates, lipids and proteins and inhibiting their degradation and release back into the circulation. Decreased secretion of insulin, coupled with resistance to its actions, results in type 2 diabetes, a devastating disease that is reaching epidemic proportions [1]. Even in the absence of diabetes, insulin resistance is often associated with central obesity, hypertension, polycystic ovarian syndrome, dyslipidemia and atherosclerosis. At the cellular level, insulin action is characterized by diverse effects, including changes in vesicle trafficking, stimulation of protein kinases and phosphatases, promotion of cellular growth and differentiation and activation or repression of transcription. This complexity suggests that insulin action must involve multiple signaling pathways that diverge at or near the activation of its tyrosine kinase receptor. In fact, it is likely that even individual effects of the hormone require multiple signaling inputs. Evidence is emerging that the coordination of these pathways might be governed by their intracellular compartmentalization or duration of action. Here, we consider how temporal and spatial aspects of signal transduction play a crucial role in determining the specificity of insulin action, focusing on signal initiation from the receptor that is spatially segregated into discrete domains of the plasma membrane, as well as the mechanisms that determine the duration of individual signaling pathways. Together, these factors help to differentiate insulin from other hormones that share some of the same overall signaling properties. Divergent signaling pathways are initiated by insulin receptor substrates. The insulin receptor is a tyrosine kinase that catalyzes the phosphorylation of several intracellular substrates, including the insulin receptor substrate (IRS) proteins [2], GAB-1 [3], Shc [4], APS [5], p60DOK [6], SIRPS [7] and c-Cbl [8] (Fig. 1). Each of these substrates recruits a distinct subset of signaling proteins containing Src homology 2 (SH2) domains, which interact specifically with sequences surrounding the phosphotyrosine residue. Moreover, each of these substrates can be confined to distinct locations in the cell by specific sequences that direct interactions with other proteins or lipids. Most attention in the field of insulin receptor substrates has focused on the IRS family of proteins. Mice lacking the IRS-1 protein are insulin resistant but do not develop overt diabetes [9,10]. By contrast, animals lacking IRS-2 exhibit both impaired glucose tolerance and diabetes [11], which appears to result from a defect in insulin secretion as well as insulin resistance, presumably owing to decreased b-cell proliferation in the pancreas in the face of increased demand for insulin. Despite the similarity in structure and function, the apparent differences in phenotype between IRS1 and IRS2 knockout mice underscore a specific signaling specificity that probably results from their tissue distribution, subcellular location, activation&ndash;inactivation kinetics and combinatorial interactions with downstream effectors [12]. The tyrosine phosphorylation of IRS family members generates docking sites for sev...",
              "citation": {
                "type": "PubMed",
                "name": "Trends Cell Biol 2002 Feb 12(2) 65-71",
                "id": "11849969"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c30"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Activation of PKC-a mediated the sustained decrease in mitochondrial membrane hyperpolarisation and oxidative phosphorylation but not the decrease in electron transfer rate. Sustained mitochondrial dysfunction was also affected by ERK1/2, through a PKC-independent pathway. These findings suggest that activation of PKC-a and/or ERK1/2 lead to decreased activity of ATP synthase, rather than affecting OXPHOS system complexes [40]. Indeed, the a, b, and e subunits of F(1)F(0)- ATPase have PKC consensus motifs [41]. PKC-a phosphorylated the b subunit of F(1)F(0)-ATPase on a serine residue and decreased F(0)F(1)-ATPase activity, oxidative phosphorylation and ATP production [41].",
              "citation": {
                "type": "PubMed",
                "name": "Cell Mol Life Sci 2006 Jun 63(11) 1236-48",
                "id": "16568236"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c2f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "we examined the requirement for PKCs in the PMA-induced activation of ERKs by using different PKC inhibitors. Treatment with GF109203X resulted in a total inhibition of ERKs activation, whereas rottlerin had no effect (Figure 8). Because rottlerin is unable to block the activation of ERKs by PMA, PKC-d is not implicated in this process. Given that atypical PKCs were not activated by PMA on the XG-6 cells, these results suggest that PKC-z was not involved...Finally, because XG-6 cells express PKC-nu and PKC-d as novel PKC isoforms, we can assume that the novel PKC, namely PCK-nu, is involved in the activation of ERKs by PMA.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2001 Aug 15 358(Pt 1) 193-200",
                "id": "11485567"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c2e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Multiple Myeloma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "we tested whether ERK1 and ERK2 (ERK1/2) were activated by conjugation of NK92 cells with Raji target cells. ERK1/2 activation peaked at 2 min, dropping back to basal levels by 10 min. PD98059, a specific MEK inhibitor, effectively suppressed this activation as well as NK lytic function against tumor cells (data not shown). More significantly, PD98059 blocked perforin and granzyme B movement in NK92 cells towards target cells (Fig. 1a,b). These results confirm that ERK1/2 are responsible for the mobilization and redistribution of perforin and granzyme B to effect lysis6.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Immunol 2000 Nov 1(5) 419-25",
                "id": "11062502"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c2d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "natural killer cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "ERK phosphorylation that was constitutive in mutant ras MM cells was completely abolished by the MEK inhibitor PD98059 (Figure 2C, left panels), as was the ERK phosphorylation reinduced in wild-type cells by readdition of IL-6 (Figure 2C, right panel).......In addition, re-exposure to IL-6 could reinduce AKT phosphorylation in wild-type cells in a wortmannin-sensitive fashion. Moreover, the constitutively maintained AKT phosphorylation in the mutation-containing cells was also sensitive to wortmannin. These data indicate the PI3-K/AKT cascade is a ras effector in these mutant rascontaining MM cells.",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2003 Apr 15 101(8) 3126-35",
                "id": "12515720"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c2c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Studies to date suggest that, in these cancers, several (if not all) of the critical downstream signaling pathways, including the phosphoinositide 3-kinase (PI3K)/Akt, signal transducers and activators of transcription, and extracellular signal-regulated kinase 1 and 2 pathways, are solely controlled by EGFR. Thus, when the tumors are exposed to EGFR inhibitors, these intracellular pathways are turned off and the cancer cells undergo apoptosis (21, 22, 24, 25).",
              "citation": {
                "type": "PubMed",
                "name": "Clin Cancer Res 2008 May 15 14(10) 2895-9",
                "id": "18483355"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c2b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Carcinoma, Non-Small-Cell Lung",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "The ability of CXCL12 to stimulate proliferation and survival is mediated by activation of the Erk 1/2 and phosphatidylinositol 3-kinase pathways in many cell types Taken together these data indicate that the ability of AMD 3100 to decrease tumor growth in animal models reflects direct inactivation of CXCR4 in tumor cells and consequent inhibition of Erk 1/2 and phosphatidylinositol 3-kinase pathways, resulting in increased tumor cell apoptosis and decreased proliferation.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2003 Nov 11 100(23) 13513-8",
                "id": "14595012"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c2a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Simultaneous overexpression of selenophosphate synthetase and phospholipid-hydroperoxide GSH peroxidase (PHGPx) [250] blocks activation of NF-kB by IL-1. Overexpression of SOD [84] or GSH peroxidase [81, 211] abolished NF-kB activation by preventing degradation of IkB after stimulation with TNF-a. The precise mechanism(s) through which oxidants and reductants influence activation of NF-kB is presently unknown; however, there is evidence that antioxidant enzyme (AOE372), a redox-sensitive thioredoxin peroxidase, regulates IkB phosphorylation [246]. Phosphatases The phosphatases are an important component of most signal transduction pathways, because failure to reverse kinase actions can disrupt normal cellular functions. For example, transfection of human fibroblasts with constitutively active ras (hRasV12) inhibits cell growth and ultimately results in a senescentlike phenotype [441]. Similarly, constitutive ERK activation has an inhibitory effect on cell cycle progression [442,443]. Both the serine/threonine phosphatases and the PTPs are known to be redox-sensitive [82,144,153,156,271,281, 444-449]. The mechanism of redox effects on activity is probably best understood for the PTPs. Without exception, the PTPs contain a highly conserved region of 11 amino acid residues in their catalytic domain; specifi- cally, (Ile/Val)-His-Cys-X-Ala-Gly-X-X-Arg-(Ser/Thr)- Gly, where X is a nonconserved amino acid [17]. Either oxidation or mutation of the cysteine renders these molecules inactive [17,281]. H2O2 is a potent inhibitor of PTPs. As in the case of other oxidants, H2O2 probably oxidizes the thiolate anion at the catalytic site [280]. Because formation of a phosphorylcysteine intermediate seems to be critical to PTP activity [450-452], blocking it through oxidation of the cysteine inactivates the molecules. In many cases, treatment of cells with H2O2 stimulates increases in protein phosphorylation by inhibiting phosphatase-catalyzed removal of phosphate groups. Furthermore, mitogens that increase cellular ox- idant production may stimulate phosphorylation indirectly by decreasing phosphatase activity. Additional mechanisms are involved in stimulation of pathways activated by growth factors that increase oxidant production, however, because there are known instances in which the oxidants they produce have no effect on protein phosphorylation. For example, TGF-b1 stimulates phosphorylation of numerous proteins and has been shown to cause a large increase in H2O2 production; however, its effects on protein phosphorylation are not blocked by catalase [453]. Furthermore, H2O2 is effective in promoting phosphorylation of phospholipase D, the PDGF receptor, and PKC-a even after pretreatment of Swiss 3T3 fibroblasts with orthovanadate to inhibit phosphatases [454]. Thus, although diminished phosphatase activity may partially account for increased phosphorylation in some cases, it cannot totally account for oxidation effects on phosphorylation in every case. SPECIFICITY In general, there is good agreement between studies on redox effects on any given gene; albeit, not all oxidizing or reducing treatments exert equivalent effects. This is clearly demonstrated in studies of pag , which encodes a protein associated with cellular proliferation. Pag protein inhibits the tyrosine kinase activity of the Abelson (abl ) protein by binding to its SH3-binding domain [455]. BSO, menadione, sodium arsenate, and diethyl maleate all stimulate pag expression, but H2O2 does not [269]. Conversely, H2O2 stimulates c-fos expression (Table 1), although 4-hydroynonenal (a product of v-6-polyunsaturated fatty acid peroxidation) not only fails to induce c-fos expression but is actually inhibitory to c-fos induction by EGF and PDGF [185]. Similarly, some oxidants such as diamide decrease hypoxia-induced signals [201], although others such as H2O2 increase them [124]. As might be expected, the effects of any stimu...",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2000 Feb 1 28(3) 463-99",
                "id": "10699758"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c29"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "This substrate (ELK1) could be phosphorylated to a stoichiometry of 3.3 mol of phosphate by incubation with homogeneous ERKI, consistent with the presence of at least four phosphorylation sites....Peptide B contained only one serine, thus pinpointing the phosphorylation site S389.....S324 and S422 are inferred as the phosphorylated sites in peptides D and E, respectively. These peptides were highly purified and each contained exclusively serine phosphate. C appeared to contain only one serine, thus strongly suggesting that S383 is also a site.....The phosphopeptide maps also demonstrate phosphorylation of T336, not identified previously by peptide sequencing.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1995 Mar 1 14(5) 951-62",
                "id": "7889942"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c28"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "The results showed that transcriptional activation of the SRE by E2 was due to ERalpha activation of the MAPK pathway...The role of ERalpha  expression in mediating increased reporter gene activity was further investigated and shown to be related to enhanced ERK1/2 activation...in cells transfected with pSS and ERalpha  or HE11 (DNA binding domain deletion), E2 induced CAT activity; similar results were observed for CHO cells using pSRE (Fig. 3E), suggesting that this kinase-dependent response is not associated with nuclear ERalpha  action. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Apr 13 276(15) 11590-8",
                "id": "11145955"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c27"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "It is known that there are two isoforms of ERK, ERK1 and ERK2, and they phosphorylate and activate various transcription factors, such as Elk-1 and Elk-2. These transcription factors regulate expression of diverse genes that relates to the proliferation and growth of the cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Jan 20 281(3) 1332-7",
                "id": "16287813"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86c2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "E2 sensitivity is regulated by acetylation of lysines 302 and 303, by CREB-binding protein (CBP).",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2002 Feb 2(2) 101-12",
                "id": "12635173"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86c1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Integrin signaling may be needed for the transcription of cyclin D1, because the cyclin D1 promoter is coordinately regulated by JNK and ERK (37) (Fig. 4).",
              "citation": {
                "type": "PubMed",
                "name": "Science 1999 Aug 13 285(5430) 1028-32",
                "id": "10446041"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86c0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": " We show here that neither BAFF nor APRIL was able to induce STAT3 phosphorylation but did activate ERK1/2 and PI3K/Akt pathways.",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2004 Apr 15 103(8) 3148-57",
                "id": "15070697"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86bf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Multiple Myeloma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Tyrosine 759 of gp130 is also essential for the activation of the MAPK cascade. Mutation of tyrosine 759 to phenylalanine was shown to abolish IL-6-mediated activation of Erk1/Erk2 (55). ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Jan 3 278(1) 661-71",
                "id": "12403768"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86be"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "The second subfamily comprises DUSP6, DUSP7 and DUSP9. They consist of 3 exons, are cytoplasmic in their subcellular localization and preferentially recognize ERK1 and ERK2 in vitro.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Drug Discov 2007 May 6(5) 391-403",
                "id": "17473844"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86bd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Estrogen rapidly activates the mitogen-activated protein kinases, Erk-1 and Erk-2, via an as yet unknown mechanism. requires the expression of the G protein-coupled receptor homolog, GPR30. We show that 17beta-estradiol activates Erk-1/-2 not only in MCF-7 cells, which express both estrogen receptor alpha (ER alpha) and ER beta, but",
              "citation": {
                "type": "PubMed",
                "name": "Mol Endocrinol 2000 Oct 14(10) 1649-60",
                "id": "11043579"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86bc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Furthermore, activation of phosphorylation of IRE1a and ERK was also repressed, indicating that CIM is required for transduction of the adaptive signals in UPR (Fig. 5D upper panel).",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2010 Dec 1 70(23) 9949-58",
                "id": "21118962"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86bb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Fig. 7. (A and B) Simultaneous signalling via VEGFR-2 and VEGFR-3 upon VEGF-C stimulation leads to sustained p42/p44 MAPK activation in HMVECs.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2001 Sep 3 20(17) 4762-73",
                "id": "11532940"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86ba"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "As shown in Fig. 1A, the phosphorylation level of type 1 and type 2 JNKs was significantly increased within 60 min after H2O2 treatment, peaking (?5.5-fold, compared with the no treatment sample) at 2 h. The p38 and ERK proteins were also phosphorylated and activated in response to oxidative stress but to a substantially lesser than was JNK (Fig. 1B).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 Sep 28 282(39) 28395-407",
                "id": "17681939"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86b9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "M-CSF triggers the activation of extracellular signal-regulated protein kinases (ERK)-1/2.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 1999 Sep 1 163(5) 2452-62",
                "id": "10452980"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86b8"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Sodium salicylate activated p38MAPK through phosphorylation at Thr 180/Tyr 182 and Akt/PKB at Ser 473, whereas it partially activated ERK1/2 through its phosphorylation at Thr 202/Tyr 204.",
              "citation": {
                "type": "PubMed",
                "name": "Int J Oncol 2003 Aug 23(2) 503-8",
                "id": "12851702"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86b7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "ERK activated upon peroxynitrite exposure triggered the upregulation of beta2-integrin CD11b/CD18 in human PMNs, increased their adhesion to the endothelium (58), and enhanced their production of oxygen free radicals (57).",
              "citation": {
                "type": "PubMed",
                "name": "Front Biosci 2009 14 4809-14",
                "id": "19273391"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86b6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "granulocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "UA strikingly induced both Raf-1 and MEK1/2 activation within 2 min and that of ERK1/2 within 5 min, as compared with the nontreated cells (Fig. 2). Similarly, both MKK3/6 and p38 MAPK were activated within 2 min, whereas phosphorylation of JNK1/2 was not observed.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2007 Apr 15 178(8) 4854-64",
                "id": "17404266"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86b5"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Analysis of embryonic fibroblasts from single KO mice revealed that Mnk1 is responsible for the inducible phosphorylation of eIF4E in response to MAP kinase activation, whereas Mnk2 mainly contributes to eIF4E's basal, constitutive phosphorylation.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Aug 24(15) 6539-49",
                "id": "15254222"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86b4"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "ERK 1/2 signaling pathway negatively controls claudin-2 expression",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Feb 4 280(5) 3780-8",
                "id": "15569684"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86b3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "we remark the role of PKC, probably isoform epsilon, in the negative control of ERK-1/2",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 1999 Sep 1 163(5) 2452-62",
                "id": "10452980"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86b2"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "In this study, we have shown that E(2) induces a slow but persistent activation of Erk in MCF-7 breast carcinoma cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Jun 21 277(25) 22558-65",
                "id": "11960991"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86b1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "TGF-beta1 treatment activated the MAPK pathway, as shown by an increased phosphorylation of extracellular-regulated kinases (ERK)1/2 after 30 min of exposure.",
              "citation": {
                "type": "PubMed",
                "name": "Pharmacol Res 2008 Apr 57(4) 274-82",
                "id": "18346908"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86b0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Endocrinol 2004 Dec 183(3) 561-7",
                "id": "15590982"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86af"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "As shown in Fig. 3A and B, exposure to eckol caused an increase in the phosphorylation of Erk, and Akt in a time-dependent manner.",
              "citation": {
                "type": "PubMed",
                "name": "Int J Biochem Cell Biol 2010 Feb 42(2) 297-305",
                "id": "19931411"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86ae"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "The activation of Erk1/2 by Mos, but not by MosKD, was shown by immunoblotting using antibodies specific to residues phosphorylated by Mek1/2 (34, 48) (Fig. 3B).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2007 Jun 27(11) 3936-50",
                "id": "17371847"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86ad"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Here, we report that in BCR/ABL+ cell lines and in patient-derived CML blast crisis mononuclear and CD34+ cells, p210(BCR/ABL) increases expression and activity of the transcriptional-inducer and translational-regulator heterogeneous nuclear ribonucleoprotein K (hnRNP K or HNRPK) in a dose- and kinase-dependent manner through the activation of the MAPK(ERK1/2) pathway.",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2006 Mar 15 107(6) 2507-16",
                "id": "16293596"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86ac"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Cytosolic b-arrestins are phosphorylated: S412 in b-arrestin1 by the extracellular regulated kinase (ERK) mitogen-activated protein (MAP) kinase (Lin et al., 1999), T383 in rat (Lin et al., 2002) or T382 in bovine b-arrestin2 by casein kinase II (Kim et al., 2002).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2006 Dec 8 24(5) 643-52",
                "id": "17157248"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86ab"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "The haematopoietic protein tyrosine phosphatase (HePTP) is a negative regulator of the MAP kinases Erk1, Erk2 and p38.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 1999 Sep 1(5) 305-11",
                "id": "10559944"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86aa"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "These results suggest that CpG ODN activates the TLR9-MyD88-ERK1/2 pathway causing expression of Egr-1 and its target genes such as TF and Nab2, thus inducing foam cell formation.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2009 Dec 11 390(2) 196-200",
                "id": "19737531"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86a9"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "8631994;9535909;12637502",
              "citation": {
                "type": "PubMed",
                "name": "BMC Bioinformatics 2004 Jun 22 5 79",
                "id": "15212693"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86a8"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Moreover, CXCR4-evoked activation of extracellular signal-regulated kinase 1/2 (ERK1/2) was attenuated by CyPA RNAi, by overexpression of a PPIase-deficient mutant of CyPA (CyPA-R55A), and by pretreatment of the immunosuppressive drugs, cyclosporine A and sanglifehrin A.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2008 Jan 4 283(1) 623-37",
                "id": "17991743"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86a7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "rac2-/- neutrophils displayed significant defects in... and p38 and, unexpectedly, p42/p44 MAP kinase activation",
              "citation": {
                "type": "PubMed",
                "name": "Immunity 1999 Feb 10(2) 183-96",
                "id": "10072071"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86a6"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "from full text - As shown in Fig. 1A, ERK1/2 in wild-type MEFs is phosphorylated after IGF-1 stimulation with a peak at 510 min, after which pERK declined substantially. In b-arrestin1 KO MEFs, on the other hand, ERK1/2 remained essentially inactivated upon IGF-1 stimulation (Fig. 1A).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 Apr 13 282(15) 11329-38",
                "id": "17303558"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86a5"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "The human beta-defensins (-1, -2, -3, -4) and cathelicidin LL-37 induce IL-18 secretion through p38 and ERK MAPK activation in primary human keratinocytes.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2005 Aug 1 175(3) 1776-84",
                "id": "16034119"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86a4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "(c) the phosphorylation of the extracellular signal-regulated protein kinases 1 and 2 (ERK1/2);",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Physiol 2004 Sep 200(3) 428-39",
                "id": "15254971"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86a3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "NGF promotes VEGF production in cultured hGCs. Blockade of trkA receptor tyrosine kinase activity blocks this effect. NGF induces MAPK-ERK2 phosphorylation, and blockade of this signaling pathway prevents the NGF-induced increase in VEGF production.",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Endocrinol Metab 2009 Aug 94(8) 3065-71",
                "id": "19454577"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86a2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "ovarian granulosa cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "In HepG2 cells, ectopic expression of miR-34a potently inhibited tumor cell migration and invasion in a c-Met-dependent manner. miR-34a directly targeted c-Met and reduced both mRNA and protein levels of c-Met; thus, decreased c-Met-induced phosphorylation of extracellular signal-regulated kinases 1 and 2 (ERK1/2). ",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Lett 2009 Mar 8 275(1) 44-53",
                "id": "19006648"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86a1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "These stimulatory effects of IL-6 were paralleled by time-dependent increases in the phosphorylation of JNK and ERK1/2, respectively (Fig. 1b and d).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2007 Mar 27(6) 2372-83",
                "id": "17242212"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86a0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "umbilical vein endothelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Stimulation of FPR by f-MLF produced a further 8- to 10-fold increase in HA-Erk-2 activity over the basal (non-ligand-stimulated) state, and this ligand-dependent activity was attenuated at the time points of maximal activity by co-expression of Dexras1 (reduced 31 +/- 6.8% in COS-7 at 10 min and 86 +/- 9.2% in HEK-293 at 5 min, p < 0.01 for each).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Mar 29 277(13) 10876-82",
                "id": "11751935"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad869f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "CD2AP was required for early activation of anti-apoptotic phosphatidylinositol 3-kinase (PI3K)/AKT and extracellular signal-regulated kinase 1/2 by TGF-beta",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem. 2004 Aug 27;279(35):37004-12",
                "id": "15213232"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad869e"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Eur J Immunol 2004 Feb 34(2) 587-97",
                "id": "14768064"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad869d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "from full text - introduction of the specific antisense morpholino oligonucleotide against ADAM10 inhibited the bombesin-mediated transactivation of Erk1/2",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2002 Jul 22 158(2) 221-6",
                "id": "12119356"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad869c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Cholesterol has been recently suggested to regulate the early steps of keratinocyte differentiation through lipid rafts. In many cell types, depletion of cholesterol activates signaling proteins like epidermal growth factor receptor (EGFR), human epidermal growth factor receptor 2 (HER2), or extracellular signal-regulated kinase (ERK) known to affect cell differentiation",
              "citation": {
                "type": "PubMed",
                "name": "J Invest Dermatol 2004 Sep 123(3) 564-73",
                "id": "15304097"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad869b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "XFLRT3 signalling results in phosphorylation of ERK and is blocked by MAPK phosphatase 1, but not by expression of a dominant-negative phosphatidyl inositol 3-OH kinase (PI(3)K) mutant.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2004 Jan 6(1) 38-44",
                "id": "14688794"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad869a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "EGF activated the epidermal growth factor receptor to the same extent in SPP-1-expressing cells, yet ERK1/2 activation was impaired.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Aug 13 279(33) 34290-7",
                "id": "15180992"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8699"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Inhibiting TSP1 activity reduced the elevated activation of MEK/ERK and expression of key fibrogenic proteins. TSP1 also blocked platelet-derived growth factor (PDGF)-induced contractile activity and MEK/ERK activation.",
              "citation": {
                "type": "PubMed",
                "name": "Fibrogenesis Tissue Repair 2011 4(1) 9",
                "id": "21453480"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8698"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "siRNA-mediated depletion of B-Raf reduced cell proliferation by up to 65% through the inhibition of ERK1/2 activation, irrespective of the mutational status of B-Raf.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Apr 7 281(14) 9238-50",
                "id": "16452469"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8697"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "The recombinant N-terminal domain of ADD1/SREBP-1c was phosphorylated predominantly on serine and slightly on threonine residues by MAP kinases ERK1 and ERK2 in vitro",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 1998 Aug 19 249(2) 375-9",
                "id": "9712704"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8696"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "S100A1-mediated anti-apoptotic effects involve specific activation of the extracellular signal-regulated kinase 1/2 (ERK1/2) pro-survival pathway, including activation of phospholipase C, protein kinase C, mitogen-activated protein kinase kinase 1, and ERK1/2.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Nov 28 278(48) 48404-12",
                "id": "12960148"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8695"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "cardiomyocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Activation of p44/42 appeared to be antiapoptotic, since MAPK stimulation with epidermal growth factor or a dominant-positive p42 construct inhibited apoptosis.",
              "citation": {
                "type": "PubMed",
                "name": "J Pharmacol Exp Ther 2003 Dec 307(3) 861-9",
                "id": "14557375"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8694"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Aug 30 277(35) 32360-8",
                "id": "12060661"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8693"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "LPA mediated Akt activation was inhibited by pertussis toxin (PTX), whereas Erk1/2 activation was completely inhibited by a blocker of phospholipase Cbeta, U-73122.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2005 Jul 289(1) C2-11",
                "id": "15728708"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8692"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "We find that although pretreatment of BMMs with IL-4 does not alter M-CSF signaling, it reversibly blocks RANKL-dependent activation of the NF-kappa B, JNK, p38, and ERK signals.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Feb 22 277(8) 6622-30",
                "id": "11719504"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8691"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Previous study carried out on PC12 cells expressing each alpha(2)-adrenergic receptor subtype individually (PC12/alpha(2A), /alpha(2B) or /alpha(2C)) have shown that epinephrine causes activation of PI3K and phosphorylation of Erk 1/2",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2006 May 18(5) 729-39",
                "id": "16098714"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8690"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "The ability of TNF-alpha to activate ERKs was also confirmed by the ability of the MEK inhibitor, PD098059 [43], to attenuate both in vitro kinase activity and ERK phosphorylation in a concentration-dependent manner",
              "citation": {
                "type": "PubMed",
                "name": "J Leukoc Biol 1998 Oct 64(4) 537-45",
                "id": "9766635"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad868f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "After bFGF was added to pulmonary fibroblasts, the kinase activities of p44/p42 ERK1/2 were determined by an in-gel assay at various times after exposure (Fig. 1). The data demonstrate that the addition of bFGF results in activation of ERK1/2 within 5 min, with the highest activity at 30 min, followed by a lower level of activity that persists for 8-12 h. ",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2001 Oct 281(4) L766-75",
                "id": "11557580"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad868e"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Furthermore, BMP4 stimulated phosphorylation of Smad1 and ERK1/2 in HSCs.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Physiol 2006 May 207(2) 499-505",
                "id": "16447265"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad868d"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "hepatic stellate cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2004 Jul 8 23(31) 5301-15",
                "id": "15241487"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad868c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2002 Nov 22(22) 7929-41",
                "id": "12391160"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad868b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "ANG II activates Src leading to an increase in ERK1/ERK2 phosphorylation and an increase in NOS protein in PAECs",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2007 Jun 292(6) C2185-96",
                "id": "17329403"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad868a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 2004 Jun 145(6) 2845-57",
                "id": "15001544"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8689"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Significant and specific knockdown of endogenous M-BAR mRNA levels was observed (Fig. 3b), and the cells treated with M-BAR siRNAs also showed potent suppression of DC-induced EGFR tyrosine phosphorylation and ERK1/2 activation (Fig. 3c). These results suggest that DC-induced activation of EGFR in AGS cells involves the activity of M-BAR/TGR5.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2007 Mar 2 354(1) 154-9",
                "id": "17214962"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8688"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "This interaction between HIF-1alpha and p42/p44 MAPK suggests a cooperation between hypoxic and growth factor signals that ultimately leads to the increase in HIF-1-mediated gene expression.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Nov 12 274(46) 32631-7",
                "id": "10551817"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8687"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "completely abolished by pretreatment of the cells with PD 98059, an inhibitor of MEK and GF 109203X, an inhibitor of PKC. These results demonstrated that the PKC/ERK1/2 cascade is the essential signaling pathway by which VLDL activates VLDL receptor mRNA expression.",
              "citation": {
                "type": "PubMed",
                "name": "J Huazhong Univ Sci Technolog Med Sci 2003 23(2) 97-100",
                "id": "12973919"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8686"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "An increase in c-Jun phosphorylation by ERK was also found to accompany the increased AP-1 activity as detected by Western blot.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2002 May 17 293(4) 1248-53",
                "id": "12054510"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8685"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Jan 24(2) 675-86",
                "id": "14701740"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8684"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "n a mammalian cell line, ERK1/2 interacts with Cdc25C in interphase and phosphorylates Cdc25C at T48 in mitosis. Inhibition of ERK activation partially inhibits T48 phosphorylation, Cdc25C activation, and mitotic induction.",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2007 Mar 23 128(6) 1119-32",
                "id": "17382881"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8683"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Thus, insulin stimulation of MAP kinase activation occurred more rapidly and was prolonged in WT-Shc cells, while the activation was delayed and transient in 317Y/F-Shc cells compared with that in HIRc cells. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1997 Apr 4 272(14) 9581-6",
                "id": "9083103"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8682"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "PD098059, a specific inhibitor of p42/44(MAPK) phosphorylation, inhibited FGF-2-stimulated DNA synthesis, phosphorylation of p42/44(MAPK) and p90(RSK), and degradation of IkappaBbeta",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Oct 27 275(43) 33905-10",
                "id": "10944532"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8681"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "In cells stably transfected with empty vector, AVP rapidly stimulated ERK, JNK, and p38 activity (Fig. 7A), similar to what we have previously reported (11). ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Oct 10 278(41) 39830-8",
                "id": "12882977"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8680"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Immunoblot analysis of lysates of mesangial cells with a phospho-Erk1/2-specific antibody that specifically recognizes the activated form of Erk1/2 type MAPK showed a time-dependent increase in activation of MAPK in response to EGF (Fig. 5A).",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Renal Physiol 2005 Jul 289(1) F72-82",
                "id": "15701816"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad867f"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "mesangial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "ERK1/2 activation via adenosine A3 receptors may be an important mechanism for the regulation of the receptor itself, regulating its desensitisation and internalisation in a GRK2-dependent manner [138].",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2003 Sep 15(9) 813-27",
                "id": "12834807"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad867e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Here we demonstrate that activated EphB1 recruits the adaptor proteins Grb2 and p52Shc and promotes p52Shc and c-Src tyrosine phosphorylation as well as MAPK/extracellular signal-regulated kinase (ERK) activation. ",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2003 Aug 18 162(4) 661-71",
                "id": "12925710"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad867d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "TRAF6 activates the extracellular signalregulated kinases (ERK) 1 and 2 as well as p38 mitogen-activated protein kinase (MAPK),11,118125",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 2001 Dec 7 89(12) 1092-103",
                "id": "11739273"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad867c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "We show that expression of cyt-PTP significantly reduces kinase activity of ERK1 and ERK2. Presence of PTP also reduces phosphorylation of ERK proteins at both Thr and Tyr residues of their activating TEY motif in NIH3T3 cells and in mammary tumor cells.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cancer Res 2003 May 1(7) 541-50",
                "id": "12754301"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad867b"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "The Raf-1 inhibitor, GW5074, dose-dependently blocked strain-induced Erk activation and Raf-1 phosphorylation. ",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2005 Mar 17(3) 311-20",
                "id": "15567062"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad867a"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "mesangial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "CCL3- and CCL4-triggered migration of GM-CSF-primed neutrophils was inhibited by the CCR5 antagonist TAK-779. Accordingly, freshly isolated neutrophils express CCR5. Extracellular signal-regulated kinases (ERK)-1/2 and p38 mitogen-activated protein kinase (MAPK) inhibitors blocked CCL3-induced migration of GM-CSF-primed neutrophils.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2005 Mar 17(3) 355-63",
                "id": "15567066"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8679"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Figure 1 | The ErbB signalling network.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Mol Cell Biol 2001 Feb 2(2) 127-37",
                "id": "11252954"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8678"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Adenovirus-mediated expression of mSef but not GFP resulted in a reduction in the levels of activated ERK1/2, whereas overall levels of ERK1/2 were unaffected (Fig. 2  A). ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Apr 18 278(16) 14087-91",
                "id": "12604616"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8677"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Recombinant human (rh) CyPA activated ERK1/2, p38MAPK, SAPKs, and Akt in cultured cardiac myocytes. Furthermore, CyPA significantly increased Bcl-2 in cardiac myocytes.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2004 Apr 23 317(1) 162-8",
                "id": "15047162"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8676"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "cardiomyocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Inhibition of ERK1/2 signaling using U0126 enhanced HIF-1alpha stabilization.  Inhibition of ERK1/2 phosphorylation using the MEK1/2 inhibitor U0126 slightly increased HIF-1{alpha} protein levels after 4 h {Western blot analysis}",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2008 Jun 27 283(26) 17919-28",
                "id": "18424783"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8675"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": "Epithelium"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "The NADPH oxidase subunits p67 and p47 undergo phosphorylation by ERK1/2 and stimulate the production of reactive oxygen species.95 ##phosphorylation of p67 and p47 is scripted as increased activity of NADPH oxidase##",
              "citation": {
                "type": "PubMed",
                "name": "N Engl J Med 2009 May 7 360(19) 1989-2003",
                "id": "19420368"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8674"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1999 Oct 19(10) 7203-15",
                "id": "10490655"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8673"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "# Pubmed:gene: Erk1/2-dependent phosphorylation of Galpha-interacting protein stimulates its GTPase accelerating activity and autophagy in human colon cancer cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Dec 15 275(50) 39090-5",
                "id": "10993892"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8672"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "The nuclear export of Bach1 was dependent on Crm1/Exportin-1 as well as the extracellular signal-regulated kinase-1/2 (ERK1/2) activity.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Dec 5 278(49) 49246-53",
                "id": "14504288"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8671"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "p44MAPK/extracellular signal-regulated kinase 1 (ERK1) and p42 MAPK/ERK2 are activated by IL-3, colocalize with mitochondrial Bcl2, and can directly phosphorylate Bcl2 on Ser-70 in a stauro-resistant manner both in vitro and in vivo",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2000 Feb 15 97(4) 1578-83",
                "id": "10677502"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8670"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Ang II-stimulated StAR transcription in H295R cells is dependent upon both influx of external Ca2+ and tyrosine kinase signaling and is enhanced by protein kinase C and mitogen-activated protein kinase (ERK1/2) activation. In particular, Janus tyrosine kinase-2 (Jak2) activation was increased with Ang-II treatment of H295R cells",
              "citation": {
                "type": "PubMed",
                "name": "Endocr Res 2004 Nov 30(4) 685-93",
                "id": "15666812"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad866f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "The inhibition of ERK1/2 increases the activity of STAT3, which, in turn, enhances the hypertrophic effect of CT-1.",
              "citation": {
                "type": "PubMed",
                "name": "Chin Med J (Engl) 2004 Aug 117(8) 1135-42",
                "id": "15361284"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad866e"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "% The ligation-associated induction of Homer1a was dependent on activation of NMDA receptors and the extracellular signal-regulated kinase 1 and 2 (ERK1/2) pathway. The non-competitive NMDA-receptor antagonist, MK-801, and a specific inhibitor of the ERK1/2 pathway, U0126, significantly attenuated the injury-elicited increases in Homer1a mRNA when compared to saline-treated animals.",
              "citation": {
                "type": "PubMed",
                "name": "Neurosci Lett 2006 May 8 398(3) 296-9",
                "id": "16448751"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad866d"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "neuron",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Moreover, molecular mechanism studies indicated that NOK could concomitantly activate both MAP kinase and phosphatidylinositol 3'-kinases (PI3K) pathways in stable BaF3 cells.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2004 May 15 64(10) 3491-9",
                "id": "15150103"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad866c"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Rapid ERK1/2 activation that preceded FAK and paxillin activation was detected",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2005 Nov 289(5) C1343-50",
                "id": "15944210"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad866b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "vascular smooth muscle"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "It was observed that the stimulatory effect of nicotine was associated with activation of protein kinase C and mitogen-activated protein kinases, increased levels of intracellular cAMP, and phosphorylation and DNA binding of the transcription factor CREB. Increased transcription of the gene was dependent on cAMP-response elements (CREs) present on the 50 end of its gene promoter.",
              "citation": {
                "type": "PubMed",
                "name": "Mutat Res 659(3) 221-31",
                "id": "18495523"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad866a"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1998 Jun 12 273(24) 15294-300",
                "id": "9614146"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8669"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "The present study indicated that TGF-beta-responsive ERK1/2 and JNK cascades negatively regulate Smad3-induced transcriptional activity as well as ALP activity and mineralization in osteoblasts",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Sep 27 277(39) 36024-31",
                "id": "12130649"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8668"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2005 Jul 22 19(2) 159-70",
                "id": "16039586"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8667"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Raf-1 phosphorylates and activates MEK-1, a kinase that activates the extracellular signal regulated kinases (ERK)",
              "citation": {
                "type": "PubMed",
                "name": "Nature 1999 Sep 9 401(6749) 173-7",
                "id": "10490027"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8666"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Oct 24(19) 8671-80",
                "id": "15367685"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8665"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Jan 29 274(5) 2893-8",
                "id": "9915826"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8664"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Knockdown of beta-arrestins also eliminated generation of a nuclear signal for phospho-ERK.",
              "citation": {
                "type": "PubMed",
                "name": "Environ Health Perspect 2009 Mar 117(3) 400-9",
                "id": "19337515"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8663"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Stimulation by IL-18 strongly enhanced tyrosine phosphorylation of STAT3 and of the mitogen-activated protein kinases (MAPK) p44erk-1and p42erk-2.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2000 Aug 1 165(3) 1307-13",
                "id": "10903731"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8662"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "natural killer cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1997 Oct 24 272(43) 27015-24",
                "id": "9341140"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8661"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "On the other hand, transfection of the dominant  negative forms of raf-1 , MEK1 , or ERK1 / 2 markedly stimulated basal cystatin  A promoter activity.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Sep 28 276(39) 36632-8",
                "id": "11451947"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8660"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Hydrogen peroxide treatment of AGS-B cells increased the phosphorylation and kinase activity of ERK-1 and ERK-2, but did not affect Jun kinase tyrosine phosphorylation or kinase activity.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1998 Sep 4 273(36) 23046-54",
                "id": "9722530"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad865f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2001 Feb 1 97(3) 692-9",
                "id": "11157486"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad865e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "On the other hand the cell survival effects of Ras were accompanied by a strong upregulation of ERK activity (represented by phosphorylated ERK1/2 Thr202/Tyr204) and by upregulation of the activity of p70S6K (represented by the phosphorylation status of the major p70S6K target S6) (Figures 3b and c)",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2008 Mar 27 27(14) 2072-83",
                "id": "17922028"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad865d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "To determine if other receptor-associated cofactors were targets of cAMP-dependent signaling pathways, we examined the phosphorylation of steroid receptor coactivator 1 (SRC-1). We detected a 1.8-fold increase in SRC-1 phosphorylation in transfected COS-1 cells incubated with 8-bromo-cAMP. Phosphorylation was increased on two mitogen-activated protein kinase (MAPK) sites, threonine 1179 and serine 1185.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2000 Dec 20(23) 8720-30",
                "id": "11073973"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad865c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "FROM FULL TEXT: VES induces early and sustained activation of ERK1/2 starting at 1 h, peaking at 2 h, and returning to barely detectable levels by 6 h after treatment (Fig. 1A, top panel). Levels of ERK1/2 proteins were not increased by VES treatment (Fig. 1A, bottom panel).",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2001 Sep 1 61(17) 6569-76",
                "id": "11522656"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad865b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2004 Jul 16 320(1) 108-15",
                "id": "15207709"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad865a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Apr 5 277(14) 12144-50",
                "id": "11823472"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8659"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Upstream proteins known to phosphorylate BAD include Akt, extracellular signal-regulated kinase/mitogen-activated protein kinase (Erk/ MAPK), Pim-1 and Pim-2.",
              "citation": {
                "type": "PubMed",
                "name": "Br J Haematol 2006 Sep 134(5) 500-9",
                "id": "16869825"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8658"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "These results suggest that high glucose suppresses apoptosis via upregulation of bcl-xL and bfl-1/A1 levels through PI 3-K and ERK1/2 pathways in CASMC.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2002 Aug 283(2) C422-8",
                "id": "12107051"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8657"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Oct 27 275(43) 33302-7",
                "id": "10915800"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8656"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "gAd induced the phosphorylation of MEK1/2 and ERK1/2 in RAW264 cells. In addition, the gAd-induced phosphorylation of MEK1/2 and ERK1/2 was dramatically reduced by PD98059 and U0126, respectively. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Endocrinol 2008 Sep 24 292(1-2) 20-5",
                "id": "18555587"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8655"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "RAGE-mediated NF-kappaB activation was suppressed by the selective p38 MAPK inhibitor SB203580 and by coexpression of a kinase-dead p38 dominant-negative mutant.",
              "citation": {
                "type": "PubMed",
                "name": "Diabetes 2001 Jun 50(6) 1495-504",
                "id": "11375353"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8654"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Monocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Biol Chem 1996 Nov 377(11) 721-30",
                "id": "8960373"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8653"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": " As can be seen in Figure 5B, VEGF-induced ERK phosphorylation in MM.1S and patient MM cells (Figure 5A) was inhibited by 60-minute pretreatment with anti-VEGF antibody (Figure 5A), confirming specific VEGF signaling.",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2001 Jul 15 98(2) 428-35",
                "id": "11435313"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8652"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Multiple Myeloma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "We show that expression of cyt-PTP significantly reduces kinase activity of ERK1 and ERK2. Presence of PTP also reduces phosphorylation of ERK proteins at both Thr and Tyr residues of their activating TEY motif in NIH3T3 cells and in mammary tumor cells.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cancer Res 2003 May 1(7) 541-50",
                "id": "12754301"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8651"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "Neoplasms",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "As shown in Fig. 3A, upon NGF treatment, TrkA phosphorylation was increased within 10 minutes. Concomitantly, the levels of phospho Akt (pAkt) and phospho ERK (pERK) were increased within 10 minutes and remained high even after 2 h of treatment with NGF. Furthermore, pharmacological inhibition of TrkA (K252a), PI3K (LY294002) and MEK 1/2 (PD98059) (Fig. 3B) totally abolished NGF stimulated invasion (Fig. 3C).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cancer 2010 9 157",
                "id": "20569463"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8650"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "The results support the conclusion that PRL1 enhances the invasiveness of lung cancer cells by increasing MMP2/9 expression through the Src and ERK1/2 pathways.",
              "citation": {
                "type": "PubMed",
                "name": "Biochemistry 2009 Mar 3 48(8) 1838-46",
                "id": "19199380"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad864f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Carcinoma, Non-Small-Cell Lung",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "The inhibition of CTGF-induced p42/44 MAPK or phosphatidylinositol 3-kinase (PI3K)/protein kinase B pathway activities abrogated the induction of fibronectin expression.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Nov 15 277(46) 44187-94",
                "id": "12218048"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad864e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "mesangial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Rapid activation of mitogen-activated protein kinases (Erk1/2, p38, and JNK MAPK) were observed in CSE-treated NL cells.  ",
              "citation": {
                "type": "PubMed",
                "name": "Proc Am Thorac Soc 2006 Aug 3(6) 466",
                "id": "16921106"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad864d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Data in isolated fibroblasts (26,56), neutrophils (57,58), endothelial and vascular smooth muscle cells (5961), neural cells (31,62), cardiomyocytes (63) and whole lung tissue (64) showed that, in addition to other known oxidants, peroxynitrite is also a powerful activator of ERK.",
              "citation": {
                "type": "PubMed",
                "name": "Front Biosci 2009 14 4809-14",
                "id": "19273391"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad864c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 1997 Mar 27 232(3) 637-42",
                "id": "9126327"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad864b"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "MAP kinase phosphatase (MKP)-3 is a cytoplasmic dual specificity protein phosphatase that specifically binds to and inactivates the ERK1/2 MAP kinases in mammalian cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Oct 1 279(40) 41882-91",
                "id": "15269220"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad864a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2003 May 15 170(10) 5281-94",
                "id": "12734378"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8649"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Western blot analysis using phospho-ERK antibodies indicated that serum and PMA rapidly activated ERKs by 0.5-1 min in IMLF+/+  (Fig. 2A).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2009 Apr 3 284(14) 9596-611",
                "id": "19176526"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8648"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "These results indicate that ERK-1/ ERK-2 signaling and transcriptional activation through AP-1 and NF-kappaB are essential for the induction of IL-8 expression in mononuclear phagocytes in response to CPPD and MSU crystals.",
              "citation": {
                "type": "PubMed",
                "name": "Arthritis Rheum 2000 May 43(5) 1145-55",
                "id": "10817569"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8647"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Cardiomyocyte-derived cell lines deficient in p38alpha are more resistant to apoptosis owing to lower expression of the pro-apoptotic proteins Bax and Fas and upregulation of the ERK survival pathway",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2007 Jan 19(1) 62-74",
                "id": "16844343"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8646"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "cardiomyocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "ndeed, p75/p85 S6 kinase (S6K), a downstream target of cytosolic P-ERK, is phosphorylated in response to both catecholamine and EGF stimulation in an AG 1478-sensitive (sp) manner (Fig. 1E).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2009 Jul 24 284(30) 20375-86",
                "id": "19509284"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8645"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Jul 20 276(29) 26753-61",
                "id": "11342557"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8644"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Western blot analysis showed that HMGb1 activates ERK1/2, while the use of an anti-RAGE receptor-blocking antibody and of the selective MEK1/2 inhibitor PD98059 blocked ERK1/2 activation and wound healing responses to HMGb1.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Biochem Biophys 2010 May 57(1) 9-17",
                "id": "20361273"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8643"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "We show that the type I neurotensin receptor-3 (also called sortilin) is the only known neurotensin receptor expressed in a murine microglial cell line and that its activation leads to phosphorylation of both extracellular signaling-regulated (Erk1/2) and Akt kinases.",
              "citation": {
                "type": "PubMed",
                "name": "J Neurosci Res 2004 Oct 1 78(1) 92-9",
                "id": "15372498"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8642"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Insulin-induced VEGF expression requires p38 MAPK and PI 3-kinase, whereas hyperglycemia-induced VEGF expression is HIF-1alpha-independent and requires PKC and p42/p44 MAPK.",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Invest 2002 Mar 109(6) 805-15",
                "id": "11901189"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8641"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "beta 2 receptors can also couple to Gi proteins, resulting in stimulation of of the ERK and p38 MAPK pathways.  Activation of this pathway by the beta 2 receptor requires that the receptor be phosphorylated by PKA",
              "citation": {
                "type": "PubMed",
                "name": "J Allergy Clin Immunol 2006 Jan 117(1) 18-24; quiz 25",
                "id": "16387578"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8640"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Such action of HGF was dependent on the activation of extracellular signal-regulated kinase-1 and -2",
              "citation": {
                "type": "PubMed",
                "name": "J Am Soc Nephrol 2004 Jun 15(6) 1402-12",
                "id": "15153551"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad863f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cell Growth Differ 2001 Jul 12(7) 379-86",
                "id": "11457735"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad863e"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "This inhibitory effect was further substantiated by the inhibition of NO on both the shear stress-induced transcriptional activity of Elk-1 (an ERK substrate)",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 1999 Aug 6 85(3) 238-46",
                "id": "10436166"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad863d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Interestingly, in our study, PAC1 gene expression in acute leukemias showing constitutive ERK activation was significantly lower",
              "citation": {
                "type": "PubMed",
                "name": "Blood 1999 Jun 1 93(11) 3893-9",
                "id": "10339498"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad863c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "lymphocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "acrolein exclusively increased the phosphorylation of ERK among these MAPK, suggesting a role for the ERK pathway in acrolein-induced 5-LO expression with subsequent production of LTB(4).",
              "citation": {
                "type": "PubMed",
                "name": "Toxicol Appl Pharmacol 2010 May 15 245(1) 76-82",
                "id": "20153347"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad863b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "# Ariadne: Sod2 regulates MMP-1 transcription by activating ERK1/2. [Expression]",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Apr 27 276(17) 14264-70",
                "id": "11297530"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad863a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "In macrophages, CD74 demonstrates high-affinity binding to MIF. MIF binds to the extracellular domain of CD74; this complex is required for MIF-mediated MAPK activation and cell proliferation [16] .",
              "citation": {
                "type": "PubMed",
                "name": "Oncology 2008 75(3-4) 127-33",
                "id": "18791328"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8639"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "ITSN-1 knockdown acts as a proapoptotic signal that causes mitochondrial outer membrane permeabilization, dissipation of the mitochondrial membrane potential, and generation of reactive oxygen species.These effects were secondary to decreased activation of Erk1/2 and its direct activator MEK. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 Jun 8 282(23) 17166-78",
                "id": "17405881"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8638"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "hyperoxia stimulated ERK-1 and ERK-2 phosphorylation {SE: Canonical ERK phosphorylation leading directly to activation}",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Oct 1 279(40) 42302-12",
                "id": "15292179"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8637"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": "Epithelium"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1995 Sep 29 270(39) 23007-12",
                "id": "7559439"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8636"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Evidence is provided that attenuation of Erk-1/-2 activity by estrogen occurs via GPR30-dependent stimulation of adenylyl cyclase and cAMP-dependent signaling that results in Raf-1 inactivation.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Endocrinol 2002 Jan 16(1) 70-84",
                "id": "11773440"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8635"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 May 25 276(21) 18075-81",
                "id": "11278548"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8634"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "the extracellular signal-regulated kinases (ERK1/2) were shown to beinhibited in both phosphorylation status and enzymatic activity afteroverexpression of PTPepsilon.",
              "citation": {
                "type": "PubMed",
                "name": "Scand J Immunol 2002 Aug 56(2) 195-203",
                "id": "12121439"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8633"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "When HEMEC were exposed to acidic pH for various time periods, there was a rapid and significant activation of JNK which was seen as early as 1 min. Activation of p44/42 MAPK was first detected at 15 min and maximized by 30 min, while activation of p38 MAPK was delayed, appearing at 60 min (Fig. 3A).",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2006 Nov 291(5) C931-45",
                "id": "16790501"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8632"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": "vascular tissue"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "We isolated by two-dimensional gel electrophoresis a PD098059-sensitive phosphoprotein of 38 kDa that we identified, by mass spectrometry, as tropomyosin-1. In fact, H(2)O(2) induced a time-dependent phosphorylation of tropomyosin that was sensitive to inhibition by PD098059 and UO126",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 2003 Apr 14(4) 1418-32",
                "id": "12686598"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8631"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "siRNA-mediated RPTP-kappa knockdown resulted in a 2-fold increase of basal phosphorylation of p44 and p42 Erk, in primary human keratinocytes (Fig. 9C). Similarly, RPTP-kappa knockdown resulted in a further 2-fold increase of EGF-induced phosphorylation of Erk (Fig. 9C).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Dec 30 280(52) 42694-700",
                "id": "16263724"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8630"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Furthermore, carrageenan induced lung apoptosis (Bax and Bcl-2 expression) as well as nitrotyrosine formation, NF-kB activation, and pJNK expression, as determined by immunohistochemical analysis of lung tissues and the degree of lung inflammation and tissue injury (histological score). Administration of PD98059, an inhibitor of MAPK3/MAPK1 (10 mg/kg) 1 h after carrageenan caused a reduction in all the parameters of inflammation measured.",
              "citation": {
                "type": "PubMed",
                "name": "Int J Immunopathol Pharmacol 22(4) 937-50",
                "id": "20074457"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad862f"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "In T cells CD137-induced signals lead to the recruitment of TRAF family members and activation of several kinases, including ASK-1, MKK, MAPK3/ MAPK4, p38, and JNK/SAPK  CD137 = TNFRSF9 ASK1 = MAP3K5",
              "citation": {
                "type": "PubMed",
                "name": "Immunol Res 2004 29(1-3) 197-208",
                "id": "15181282"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad862e"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Together, the results show that K/E-FR3 is transforming and that the Ras-ERK and the PI3K-Akt signaling pathways, which are positively regulated by SHP2, are important for K/E-FR3-induced transformation.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2003 Oct 9 22(44) 6909-18",
                "id": "14534538"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad862d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Sorbitol resulted in activation of the extracellular signal-regulated kinase (ERK), p54 c-Jun N-terminal kinase (JNK), and protein kinase B",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Oct 3 278(40) 38484-94",
                "id": "12881532"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad862c"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "myocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "IL3 induced ERK1/2 MAP kinase activation, which peaked after 10 mins of IL3 stimulation.",
              "citation": {
                "type": "PubMed",
                "name": "Circulation 2001 Jan 30 103(4) 549-54",
                "id": "11157721"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad862b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": "vascular tissue"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "The adapter protein Grb2 can directly associate with phosphorylated Y703 and Y936 in c-Kit",
              "citation": {
                "type": "PubMed",
                "name": "Cell Mol Life Sci 2004 Oct 61(19-20) 2535-48",
                "id": "15526160"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad862a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "In human bronchial airway epithelial (BEAS-2B) cells, Ni-induced VEGFA transcription by stimulating an extracellular regulated kinase (ERK) signaling cascade that involved Src kinase-activated Sp1 transactivation, as well as increased hypoxia-inducible factor-1a (HIF-1a) stabilization and DNA binding",
              "citation": {
                "type": "PubMed",
                "name": "Toxicol Sci 2009 Jul 110(1) 212-23",
                "id": "19403854"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8629"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "In addition to NF-?B, among the known pathways that can be activated by RAGE are phosphoinositide 3-kinases (PI3K)/Akt (also termed as protein kinase B), and mitogen-activated protein kinase members (MAPKs) (52,53). The latter group includes Jun-N-terminal kinase (JNK), p38, and extracellular signal-regulated kinases (ERK) (54,55) (Figure 2).",
              "citation": {
                "type": "PubMed",
                "name": "Front Biosci 2009 14 1403-13",
                "id": "19273137"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8628"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "vascular tissue"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "This indicates that ERK1/2, reported to be located downstream of PKA, participates in the PKA-mediated CREB phosphorylation elicited by glucose. In ERK1/2-downregulated MIN6 cells by siRNA, glucose-stimulated CREB phosphorylation was highly reduced and CREB protein content was decreased by 60%.% blockade of ERK1/2 activity with PD98059 caused a significant decrease in CREB protein level",
              "citation": {
                "type": "PubMed",
                "name": "Diabetes 2006 Aug 55(8) 2220-30",
                "id": "16873684"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8627"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Furthermore, both forskolin and EGF induced ERK1/2 phosphorylation, but only forskolin-mediated CREB phosphorylation was inhibited by H89, suggesting that PKA regulates CREB indirectly through the MAPK/ERK1/2 pathway. ",
              "citation": {
                "type": "PubMed",
                "name": "Apoptosis 2008 May 13(5) 681-92",
                "id": "18392938"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8626"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 May 14 279(20) 20927-34",
                "id": "15010475"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8625"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Finally, Ark-mediated repression was significantly attenuated by a dominant negative MEF2C, whereas repression induced by constitutively active Rac was unaffected, indicating that MEF2 proteins are not targets of the Ark -- Rac -- MEK -- ERK cascade.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Oct 11 277(41) 38133-40",
                "id": "12138087"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8624"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Furthermore, GH induced rapid, time- and dose-dependent signaling events in LNCaP cells, including phosphorylation of JAK2 tyrosine kinase, of GHR itself and of STAT5A (JAK2-STAT5A pathway), of p42/p44 MAPK and of Akt/PKB.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Endocrinol 2004 May 31 220(1-2) 109-23",
                "id": "15196705"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8623"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Inhibition of MEK1 significantly inhibited extracellularly regulated kinase (ERK)1/2 activation and insulin-regulated Gene33 transcription and protein",
              "citation": {
                "type": "PubMed",
                "name": "Biochim Biophys Acta 2004 Sep 17 1679(3) 248-55",
                "id": "15358516"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8622"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "NGF activates Erk1/Erk2 and JNK but not p38MAPK in J774 cells",
              "citation": {
                "type": "PubMed",
                "name": "Blood 1996 Dec 15 88(12) 4630-7",
                "id": "8977255"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8621"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Both the growth-stimulating activity of low-dose NO for endothelial cells and suppression of TSP1 expression were ERK-dependent. Conversely, exogenous TSP1 suppressed NO-mediated pERK",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2005 Sep 13 102(37) 13147-52",
                "id": "16141331"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8620"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "These results suggested that Ang II enhances foam cell formation by upregulating ACAT1 expression predominantly through the actions of AT(1) receptor via the G protein/c-Src/PKC/MAPK pathway in human monocyte-macrophages.",
              "citation": {
                "type": "PubMed",
                "name": "Hypertens Res 2008 Sep 31(9) 1801-10",
                "id": "18971559"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad861f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Monocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "We found increased Erk-1/2 and p38 MAP kinase activities to be important components of ROS-mediated signaling. The pro-oxidant state also contributed to constitutive elevation of AP-1, NFkappaB and cAMP response element transactivation in the malignant phenotype. ",
              "citation": {
                "type": "PubMed",
                "name": "Carcinogenesis 1999 Nov 20(11) 2063-73",
                "id": "10545407"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad861e"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": " Furthermore, TNF-alpha activity was found to be strictly dependent on the activation of ERK 1/2 p44, cooperating with the intracellular pathways involving Src kinases, PI3K/Akt, p38 MAPK, well known as activated in response to classical chemoattractants (CXCL8) or priming agents (GM-CSF).",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2008 Mar 20(3) 557-68",
                "id": "18164590"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad861d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "In addition, we have shown that the EP(4) receptor, but not the EP(2), can activate the extracellular signal-regulated kinases (ERKs) 1 and 2 by way of PI3K leading to the induction of early growth response factor-1 (EGR-1), a transcription factor traditionally associated with wound healing",
              "citation": {
                "type": "PubMed",
                "name": "Life Sci 2003 Dec 5 74(2-3) 143-53",
                "id": "14607241"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad861c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "These observations indicate that phosphorylation of Ser 362 and Ser 374 prime c-Fos for additional growth factor-regulated phosphorylation... ERK phosphorylates Thr 325 and Thr 331 in primed c-Fos.   [Figure 2c shows the experimental results, done with ERK 1/2.]",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2002 Aug 4(8) 556-64",
                "id": "12134156"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad861b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "endogenous GMF is rapidly phosphorylated upon stimulation of astrocytes by phorbol 12-myristate 13-acetate We further observed that protein kinase A (PKA)-phosphorylated GMF is a potent inhibitor (IC50 = 3 nM) of the ERK1/ERK2 (p44/p42) subfamily of mitogen-activated protein (MAP) kinase.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1996 Sep 20 271(38) 22953-6",
                "id": "8798479"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad861a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "astrocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Downstream of EGF-R activation, Srcasm was shown to block ERK1/2 and STAT3 in addition to PDK- 1, the latter being a crucial activator of the PI3K/Akt axis (Vivanco and Sawyers, 2002).",
              "citation": {
                "type": "PubMed",
                "name": "J Invest Dermatol 2008 Mar 128(3) 501-16",
                "id": "18268536"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8619"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Ligation of this receptor by EGF activates Erk1 and Erk2, members of the mitogen-activated protein (MAP) kinase family, through a Ras-dependent signal transduction pathway. ",
              "citation": {
                "type": "PubMed",
                "name": "Nature 1998 Oct 15 395(6703) 713-6",
                "id": "9790194"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8618"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Taken together, our data suggest that hyperoxia, by virtue of activating NADPH oxidase, generates reactive oxygen species (ROS), which mediates cell death of lung epithelium via ERK1/2 MAPK activation, and functions upstream of caspase activation in lung epithelial cells.  ",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2003 Mar 28(3) 305-15",
                "id": "12594056"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8617"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "We show that phospholipase C gamma, phosphatidylinositol 3-kinase/p70 S6 kinase, Shc, Grb2, Raf-1, and mitogen-activated protein kinase are downstream components of the Nyk/Mer signal transduction pathways. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1995 Dec 15(12) 6582-92",
                "id": "8524223"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8616"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Phosphorylated ERK1/2, JNK, p38 and ERK5 were significantly increased by exposure to TS, indicating the activation of these MAPK pathways.",
              "citation": {
                "type": "PubMed",
                "name": "Carcinogenesis 2005 Dec 26(12) 2187-95",
                "id": "16051644"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8615"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Diabetologia 2001 Mar 44(3) 325-32",
                "id": "11317664"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8614"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "CD40 lacks intrinsic catalytic activity, but the cytoplasmic domain of CD40 has two binding sites for TRAF...TRAFs 1, 2, 3, 5, and 6 have been found in association with CD40, and these adaptors couple CD40 to the phosphoinositide 3-kinase (PI3K), phospholipase C (PLC-), mitogen-activated protein kinase (MAPK-ERK, p38, and JNK), and nuclear factor B (NF-B) signaling pathways",
              "citation": {
                "type": "PubMed",
                "name": "Sci STKE 2004 Jun 15 2004(237) pe25",
                "id": "15199223"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8613"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "MEK specific inhibitors U0126 and PD98059...which inhibit the activation of ERK1/2 and ERK5",
              "citation": {
                "type": "PubMed",
                "name": "Development 2005 Apr 132(8) 1773-83",
                "id": "15772134"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8612"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "ANGPTL3 bound to alpha(v)beta(3) and induced integrin alpha(v)beta(3)-dependent haptotactic endothelial cell adhesion and migration and stimulated signal transduction pathways characteristic for integrin activation, including phosphorylation of Akt, mitogen-activated protein kinase, and focal adhesion kinase",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 May 10 277(19) 17281-90",
                "id": "11877390"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8611"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "IL-4 can inhibit the p44/42 pathway in stimulated monocytes [47].",
              "citation": {
                "type": "PubMed",
                "name": "Curr Vasc Pharmacol 2009 Jul 7(3) 267-76",
                "id": "19601851"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8610"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Monocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Jan 8 274(2) 801-13",
                "id": "9873019"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad860f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Insulin-stimulated Na(+),K(+)-ATPase activation, phosphorylation, and translocation of alpha-subunits to the plasma membrane were abolished by 20 microm PD98059, which is an inhibitor of MEK1/2, an upstream kinase of ERK1/2. Furthermore, inhibitors of phosphatidylinositol 3-kinase (100 nm wortmannin) and protein kinase C (10 microm GF109203X) had similar effects.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jun 11 279(24) 25211-8",
                "id": "15069082"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad860e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Muscle, Skeletal"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Restoration of phosphorylation at S338, either by expression of highly active PAK or by expression of an S338 phospho-mimetic Raf-1 mutation, led to a partial rescue of ERK activation in suspended cells. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2005 Jun 25(11) 4466-75",
                "id": "15899852"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad860d"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Phosphopeptide analysis of Elk-1 indicated that phosphorylation at Ser383 and Ser389 (peptides 16), which are homologous to Ser381 and Ser387 in Sap-1a, as well as within the unidentified peptides f and g was much less efficiently catalyzed by p38 MAPK than by ERK-1 in vitro (compare with peptides ad in Figure 6D).",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1997 Apr 1 16(7) 1620-7",
                "id": "9130707"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad860c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "D2R stimulation activated ERK",
              "citation": {
                "type": "PubMed",
                "name": "J Neurochem 2003 May 85(3) 729-39",
                "id": "12694399"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad860b"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Furthermore, we found that melanoma cell integrin alphav was required for MAPK kinase (MEK) 1 and extracellular signal-regulated kinase (ERK)1/2 activity in 3D-collagen",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2004 Nov 22 167(4) 745-56",
                "id": "15557124"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad860a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Erk phosphorylates serine residues in the linker regions of Smad1 (Kretzschmar et al., 1997), Smad2 and Smad3 (Kretzschmar et al., 1999), and substitution of these serines by negatively charged residues inhibits nuclear translocation of Smads and thus signalling.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 2001 Dec 114(Pt 24) 4359-69",
                "id": "11792802"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8609"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Cell attachment to fibronectin through ITGAV.ITGB3 activated the phosphorylation of ERK-1 within 60 minutes. ERK-1 activation was detected even in the presence of dn Cdc42 or dn Rac1 after attachment to fibronectin, indicating that these integrin-induced signaling components are still activated by attachment when Cdc42 and Rac1 are blocked.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2002 Jul 22(13) 4587-97",
                "id": "12052868"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8608"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Here we show that upon Fas, tumor necrosis factor alpha receptor, or tumor necrosis factor alpha-related apoptosis-inducing ligand receptor stimulation, an inhibition of extracellular signal-regulated kinase 1 and 2 (ERK1/2) activation sensitizes wild-type but not K8-null mouse hepatocytes to apoptosis and that a much weaker ERK1/2 activation occurs in K8-null hepatocytes.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Aug 24(16) 7072-81",
                "id": "15282307"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8607"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "hepatocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "97207326;9524113;9054461",
              "citation": {
                "type": "PubMed",
                "name": "BMC Bioinformatics 2004 Jun 22 5 79",
                "id": "15212693"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8606"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Mar 24(6) 2499-512",
                "id": "14993287"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8605"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "By contrast, serum- and glucocorticoid-inducible kinase 1 (SGK1) was significantly induced in a p53-dependent manner after DNA damage, and this induction was through extracellular signal-regulated kinase 1/2-mediated posttranslational regulation.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2004 Sep 28 101(39) 14057-62",
                "id": "15383658"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8604"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "the presence of an anti-CD14 Ab completely abolished the phosphorylation of ERK proteins after stimulation with LPS",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2006 Sep 15 177(6) 4086-93",
                "id": "16951373"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8603"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "PD-98059, an inhibitor of phosphorylation of ERK1/2, caused a marked inhibition of HSP60-induced COX-2 and NOS-2 expression.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2002 Oct 283(4) C1267-77",
                "id": "12225989"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8602"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "H2320 was transfected (together with pRlSV40) into MCT cells, together with empty expression vector (vector), expression vectors for WT c-Ets2 a mutant c-Ets2 that cannot be phosphorylated by ERK1/2",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Oct 15 274(42) 30273-9",
                "id": "10514521"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8601"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "This assay is specific for the ERK 1 isoform of MAPK [14,19]. As shown in Figure 4, cholic acid at 50 mM caused a rapid 34-fold activation of MAPK",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 1996 Jun 15 316 ( Pt 3) 765-9",
                "id": "8670150"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8600"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "hepatic stellate cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "MEK1/2 inhibitors, such as PD98059 and U0126, reduced RA-induced ERK1/2 activity, but could not block the genistein effects.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biochem 2005 Dec 1 96(5) 1061-70",
                "id": "16149052"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85ff"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Culture with CCL2 enhanced phosphorylation of extracellular signal-related kinase 1 (ERK1) and ERK2, but not phosphorylation of p38 or Src.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2001 Nov 1 167(9) 5381-5",
                "id": "11673556"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85fe"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "In parental Fr3T3 cells only the phosphorylated inactive forms of ERK1 and ERK2 were detected as determined by shift in EMSA. In contrast, Met-transformed cells (Met activated) a significant portion of ERK1 and ERK2 was seen to have a retarded mobility in SDS-PAGE indicative of phosphorylation. There was increase in the MAP kinase activity.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1997 May 15 16(10) 2634-45",
                "id": "9184210"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85fd"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Finally, we demonstrated that CXCL5 mediates pancreatic cancer-derived angiogenesis through activation of several signaling pathways, including protein kinase B (Akt), extracellular signal-regulated kinase (ERK), and signal transducer and activator of transcription (STAT) in human endothelial cells",
              "citation": {
                "type": "PubMed",
                "name": "Am J Pathol 2011 Mar 178(3) 1340-9",
                "id": "21356384"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85fc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1991 Nov 25 266(33) 22159-63",
                "id": "1939237"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85fb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2001 Apr 21(8) 2659-70",
                "id": "11283246"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85fa"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Leptin-induced MUC5B expression was blocked by the ERK1/2 and p38 pathway inhibitors, but not by the JAK2/STAT3 pathway inhibitor.",
              "citation": {
                "type": "PubMed",
                "name": "Exp Lung Res 2010 Jun 36(5) 262-9",
                "id": "20497020"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85f9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Lung airway"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "this pathway has been shown to activate HIF2A",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2002 Jan 2(1) 38-47",
                "id": "11902584"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85f8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Although it interacts with the ErbB2 C terminus through the PDZ domain, Erbin has no effect on ErbB2 tyrosine phosphorylation or binding to the adaptor proteins Shc and Grb2. In contrast, expression of Erbin greatly impairs activation of Erk, but not Akt, by ligands that activate receptor tyrosine kinases.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Jan 10 278(2) 1108-14",
                "id": "12379659"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85f7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Hypoxia and PDGF-BB induced synthesis of soluble collagen type I via Erk1/2 and p38 MAP kinase",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 Jan 12 282(2) 908-15",
                "id": "17099219"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85f6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "The activated GST-MEK1 was then used to activate the purified recombinant extracellular signal-regulated kinase 1, whose activity was measured by the [32P-g]ATP incorporation into MBP, an extracellular signal-regulated kinase 1 substrate.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1996 Feb 9 271(6) 3265-71",
                "id": "8621729"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85f5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "In addition, introduction of B-Raf enhances and sustains integrin-mediated activation of ERK in wild-type primary fibroblasts",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Nov 24 275(47) 36532-40",
                "id": "10976102"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85f4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "The ER coactivator AIB1, like ER itself, is phosphorylated and activated by different signaling kinases, including the p42/44 MAPK, which can be activated by HER2 (64)",
              "citation": {
                "type": "PubMed",
                "name": "Clin Cancer Res 2003 Jan 9(1 Pt 2) 447S-54S",
                "id": "12538499"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85f3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Western blot with phosphospecific antibodies for each of the respective MAPK (JNK, ERK, and p38)...Phosphorylation of all three MAPK increased during this time, with ERK MAPK showing the most profound increase (Fig. 4).",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2005 Aug 1 39(3) 355-64",
                "id": "15993334"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85f2"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "We found that BMPs/Smad1 signaling inhibits the growth of androgen-sensitive prostate cancer cells.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2007 Jan 24 26(2) 346-57",
                "id": "17183365"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85f1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Prostatic Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Cyclic stretch of NRVMs induced rapid (10 min) and sustained (up to 120 min) FAK and ERK1/2 activation (Fig. 1A), as indicated by increases in the amount of FAK andERK1/2 detected by specific antibodies against FAK phosphorylated at Tyr397 and ERK1/2 phosphorylated at Thr202/Tyr204",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Heart Circ Physiol 2005 Oct 289(4) H1488-96",
                "id": "15923313"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85f0"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "myocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "In contrast to ERK, the activities of p38 and SAPK/JNK are very low in insulin- or EGF-stimulated fibroblasts and, therefore, insufficient to phosphorylate ATF2 Thr71 and/or Thr69 efficiently by themselves (Figures 1D and 4A). However, these low levels of active p38 are essential and appear to be sufficient to phosphorylate Thr69 when ATF2 Thr71 is already mono-phosphorylated by ERK (see the model in Figure 7).",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2002 Jul 15 21(14) 3782-93",
                "id": "12110590"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85ef"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Activated ERK can translocate into the nucleus, where it catalyses the phosphorylation of transcription factors such as p62TCF, initiating a transcriptional programme that leads to cellular proliferation or differentiation.",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2001 Dec 13 414(6865) 799-806",
                "id": "11742412"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85ee"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "These demonstrate that Ang II is capable of inducing CRP generation in macrophages via AT(1)-ROS-ERK1/2/p38MAPK-NF-kB signal pathway, which contributes to better understanding of the proinflammatory and proatherosclerotic actions of Ang II.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Physiol Biochem 2011 27(1) 63-70",
                "id": "21325823"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85ed"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 1995 Jun 6 92(12) 5361-5",
                "id": "7777512"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85ec"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "It underwent further autophosphorylation in vitro (up to 0.01 mol of P per mol) at the regulatory Tyr-204 site and at additional tyrosine and serine residues",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1993 Aug 13(8) 4679-90",
                "id": "7687743"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85eb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Histamine induced a time-dependent, H1 receptor-mediated activation of p38 MAP kinase (p38), p44/42 MAP kinase (ERK), and c-jun terminal NH2 kinase (JNK).",
              "citation": {
                "type": "PubMed",
                "name": "Circulation 2005 Jul 19 112(3) 341-9",
                "id": "16009787"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85ea"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "The hypertrophic effect of CT-1 was essentially mediated by STAT3, independent of PI3-K, and negatively regulated by ERK1/2 via inhibiting the phosphorylation of STAT3.",
              "citation": {
                "type": "PubMed",
                "name": "Acta Pharmacol Sin 2004 Sep 25(9) 1157-64",
                "id": "15339391"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85e9"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Pak4-induced arrest appears to be mediated by a pathway that requires the ERK mitogen-activated protein kinase, as well as the cell cycle inhibitors p16(INK4) and p19(ARF).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2005 Nov 25(21) 9532-42",
                "id": "16227603"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85e8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "The MAP kinase phosphorylation and cell proliferation were suppressed by diphenylene iodonium chloride, an NADPH oxidase inhibitor, and by calphostin C, a protein kinase C (PKC)-specific inhibitor.",
              "citation": {
                "type": "PubMed",
                "name": "Liver Int 2005 Oct 25(5) 1018-26",
                "id": "16162162"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85e7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "hepatic stellate cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Cot expression has been shown to induce ERK and JNK activation",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Nov 21 278(47) 47089-97",
                "id": "12975377"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85e6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "In summary, PKCalpha, which was activated in senescent cells by ROS strongly activated Erk1/2, and the SA-pErk1/2 in turn phosphorylated Sp1 on Ser(59). Sp1-enhanced transcription of p21(Sdi1) resulted in regulation of cellular senescence in primary human diploid fibroblast cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2009 Jun 5 284(23) 15475-86",
                "id": "19318349"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85e5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2004 Sep 15 173(6) 3962-71",
                "id": "15356145"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85e4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "These effects were completely prevented by calphostin C, a protein kinase C inhibitor.",
              "citation": {
                "type": "PubMed",
                "name": "Hepatology 2001 May 33(5) 1130-40",
                "id": "11343241"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85e3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "over-expression of gamma-synuclein leads to constitutive activation of ERK1/2 and down-regulation of JNK1",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Sep 20 277(38) 35050-60",
                "id": "12121974"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85e2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cancer 2003 Aug 15 98(4) 720-9",
                "id": "12910515"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85e1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "SpD, a substance P analogue, stimulates Erk1 and Erk2 activation in H345 SCLC cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Jul 27 276(30) 28083-91",
                "id": "11323408"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85e0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Lung Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Components of these pathways (Shc, p44/42 MAPK kinase, Akt/protein kinase B and p70s6k) are phosphorylated in response to progranulin7,10 and have been previously implicated in the ability of progranulin to stimulate cell division.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Med 2003 Feb 9(2) 225-9",
                "id": "12524533"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85df"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "In mice treated for 1 h with IL-6, phosphorylation of ERK1/2 and JNK in the aortas was increased 4.0- and 3.0-fold, respectively (levels in aortas of IL-6 treated, insulin-stimulated mice versus levels in aortas of non-IL-6-treated, insulin-stimulated mice; P < 0.01) (Fig. 9a and b)....IL-6 effects were reversed by treatment with PD98059 and JNK inhibitor I, respectively (Fig. 9a, b, c, and d).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2007 Mar 27(6) 2372-83",
                "id": "17242212"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85de"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "KGF treatment increased phosphorylation of ERK1/2",
              "citation": {
                "type": "PubMed",
                "name": "Exp Hematol 2002 Apr 30(4) 297-305",
                "id": "11937263"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85dd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1996 Feb 15 12(4) 863-73",
                "id": "8632909"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85dc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "NIH3T3/MUC4 cells also showed an increased phosphorylation of ERKs (p42/44 MAPK) as compared to the control NIH3T3/ pSecTag cells.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2008 Nov 15 68(22) 9231-8",
                "id": "19010895"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85db"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "PPAR gamma agonists 15-d-PGJ2 and thiazolidinediones such as pioglitazone and troglitazone elicited rapid activation of ERK within 15 min and induced c-fos mRNA expression within 30 min",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Dec 28 276(52) 48950-5",
                "id": "11687581"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85da"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "We found that tuberin expression increases p42/44 MAPK phosphorylation and B-Raf kinase activity. Short interfering RNA down-regulation of tuberin decreased the p42/44 MAPK phosphorylation and B-Raf activity. Expression of Rheb, the target of the GTPase-activating domain of tuberin, inhibited wild-type B-Raf kinase but not activated forms of B-Raf.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jul 16 279(29) 29930-7",
                "id": "15150271"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85d9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2003 Oct 285(4) C823-30",
                "id": "12801888"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85d8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "FIGURE 8. Model for neutrophil signaling mechanisms triggered by bacterial DNA. Although the activation of the intermediates indicated in the figure have been probed, a causal relationship between TIR pathway activation and MAPKs, AP-1 and NF-kB, has not been directly determined. ",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2006 Sep 15 177(6) 4037-46",
                "id": "16951367"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85d7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "In addition to chemotaxis, Fprs also mediate neutrophil activation by Listeria lysate as shown by increased phosphorylation of extracellular regulatory kinase (Erk) 1/2 in WT mouse neutrophils, which was reduced by Fpr1 or Fpr2 antagonist.",
              "citation": {
                "type": "PubMed",
                "name": "Sci Rep 2012 2 786",
                "id": "23139859"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85d6"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "AGTR2 inhibition with PD diminished p38 and p42/44 phosphorylation in fibroblast isolated from bleomycin-, but not saline-treated mouse lungs (Figures 6A?6D).",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2007 Dec 37(6) 640-50",
                "id": "17630322"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85d5"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 1999 Nov 12 461(1-2) 120-4",
                "id": "10561508"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85d4"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Br J Cancer 2003 Jul 21 89(2) 374-84",
                "id": "12865932"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85d3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Immunoblotting with antibodies that detect only the phosphorylated and active forms of these kinases indicated that oxLDL activated both ERK1/2 and PKB in BMDM whereas n-LDL or ac-LDL had no effect (Fig. 8A). ",
              "citation": {
                "type": "PubMed",
                "name": "J Lipid Res 2001 Sep 42(9) 1483-91",
                "id": "11518769"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85d2"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "In tumor cells, activation of extracellular-regulated kinase (ERK) 1/2 results in phosphorylation of several ERK1/2 effectors, including the proapoptotic protein Bad. Phosphorylation of Ser112 by ERK1/2 inactivates Bad and protects the tumor cell from apoptosis.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2003 Feb 1 63(3) 616-20",
                "id": "12566304"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85d1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "the phosphorylation of BAD at Ser-112 was blocked by PD98059 (MAPKK inhibitor) phosphorylation of  BAD Ser-136 via the PI-3K-Akt cascade paclitaxel induces the phosphorylation of BAD Ser-112 via the ERK cascade, and the phosphorylation of both BAD Ser-136 Ser-136 and Raf-1 Ser-259 via the PI-3K-Akt",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Sep 6 277(36) 33490-500",
                "id": "12087097"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85d0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Endocrinol 2000 Oct 14(10) 1557-69",
                "id": "11043572"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85cf"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2005 Jan 25(2) 854-64",
                "id": "15632084"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85ce"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "we found that MLK3 consistently caused a moderate activation of the ERK kinase",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 1999 May 1 59(9) 2195-202",
                "id": "10232608"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85cd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 2002 Jun 13(6) 2031-44",
                "id": "12058067"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85cc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "The role of the mitogen-activated protein kinase cascade in the regulation of HGL expression was highlighted by the use of MAP kinase kinase-1/2 inhibitor \\\"PD 98,059\\\", which blunted both the activation of p42/p44(mapk) and the down-regulation of HGL mRNA induced by EGF and/or TGF-alpha.",
              "citation": {
                "type": "PubMed",
                "name": "Gastroenterology 1999 Apr 116(4) 831-41",
                "id": "10092305"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85cb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Human recombinant CyPA can mimic the effects of secreted CyPA to stimulate ERK1/2 and cell growth. The peptidyl-prolyl isomerase activity is required for ERK1/2 activation by CyPA.",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 2000 Oct 27 87(9) 789-96",
                "id": "11055983"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85ca"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": "vascular smooth muscle"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Additionally, Mig and SDF-1alpha activated MAPKs p44/42 and p38 on melanoma cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Nov 30 276(48) 45098-105",
                "id": "11571298"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85c9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "simultaneously western blotting showed that the expression of p-ERK1/2 was increased significantly in CCR7-BE1 cells, while exhibiting no effect on the total protein levels of ERK1/2 (Fig. 7C).",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Biol Ther 2009 Feb 8(4) 322-30",
                "id": "19305150"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85c8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Carcinoma, Non-Small-Cell Lung",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "PRL is shown to stimulate the differential tyrosyl phosphorylation of three isoforms (ERK-1, 2, and 4) of mitogen-activated protein kinases (MAP kinase) in a rat pre-T lymphoma cell line (Nb2)",
              "citation": {
                "type": "PubMed",
                "name": "Proc Soc Exp Biol Med 1997 Jun 215(2) 198-202",
                "id": "9160049"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85c7"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Glucose stimulates nuclear USF2 protein accumulation through protein kinase C, p38 MAPK, and extracellular signal-regulated kinase pathways. Increased PKG activity down-regulates USF2 protein levels and its DNA binding activity under high glucose conditions, resulting in inhibition of glucose-induced TSP1 transcription and TGF-beta",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Aug 13 279(33) 34311-22",
                "id": "15184388"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85c6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "calcimycin, a calcium mobilizer, activates the RAF/MEK/ERK pathway through RAS,",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 2005 Sep 16(9) 4437-53",
                "id": "16000378"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85c5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "The formed transductosome mediates the activation of MAP kinase, PI 3-kinase, Jun kinase, cGMP-dependent kinase and focal adhesion kinase",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1999 Feb 15 18(4) 882-92",
                "id": "10022831"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85c4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Endostatin blocked VEGF-induced tyrosine phosphorylation of KDR/Flk-1 and activation of ERK, p38 MAPK, and p125(FAK) in human umbilical vein endothelial cells",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Aug 2 277(31) 27872-9",
                "id": "12029087"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85c3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "alpha2-AR-mediated activation of either endogenous or cotransfected p42/p44 mitogen-activated protein (MAP) kinase",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Apr 16 274(16) 11253-9",
                "id": "10196213"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85c2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Mitogen-activated protein kinases such as ERK phosphorylate and activate MNK1, which in turn is able to phosphorylate eIF4E",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2001 Dec 1(3) 222-31",
                "id": "11902577"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85c1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 May 9 278(19) 16713-9",
                "id": "12609980"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85c0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": ": In vitro, gefitinib inhibited cell proliferation with differing IC(50), and suppressed activation of EGFR and downstream signaling molecules protein kinase B (AKT), extracellular signal-regulated kinase 1/2, signal transducer and activator of transcription 3 (STAT3), and nuclear factor kappaB. ",
              "citation": {
                "type": "PubMed",
                "name": "Clin Cancer Res 2009 Apr 1 15(7) 2361-72",
                "id": "19318490"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85bf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "H2O2 used as a positive control to induce oxidative stress also resulted in a reduction of ERK activation in PLD1 siRNA-transfected cells when compared to control siRNA-transfected cells (Figures 4E).",
              "citation": {
                "type": "PubMed",
                "name": "PLoS One 2010 5(3) e9600",
                "id": "20231899"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85be"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "CT-1 simultaneously activated both ERK1/2 and STAT3 in rat cardiomyocytes.",
              "citation": {
                "type": "PubMed",
                "name": "Chin Med J (Engl) 2004 Aug 117(8) 1135-42",
                "id": "15361284"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85bd"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "cardiomyocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Furthermore, expression of VACM-1 but not S730AVACM-1 protein retarded cytokinesis and prevented MAPK phosphorylation.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2003 Dec 285(6) C1386-96",
                "id": "12917106"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85bc"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "The amounts of IL-1Ra stimulated by WPE or beta-LG + alpha-LA significantly reduced the IL-1 activity in EL4 cells. Inhibitors of p38 and extracellular signal-regulated kinases (ERK)1/2 mitogen-activated protein kinase, and nuclear factor-kappaB cascades reduced neutrophil production of IL-1Ra.",
              "citation": {
                "type": "PubMed",
                "name": "J Nutr 2010 Feb 140(2) 382-91",
                "id": "20032479"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85bb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Lipid Res 2002 Mar 43(3) 463-76",
                "id": "11893783"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85ba"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "the recruitment of c-Jun was strongly enhanced following TNF-a treatment (Fig. 10B, lanes 3 and 4). In contrast, the binding of c-Jun to the fra-1 promoter was significantly diminished in MEFS lacking the erk1-/- signaling (cf lanes 7 and 8 with lanes 3 and 4).",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2006 Nov 15 177(10) 7193-202",
                "id": "17082637"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85b9"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "To determine if the ERK-MAPK pathway was also activated by TLR2 in megakaryocytes, lysates of Meg-01 cells were treated with 1 ?g/mL Pam3CSK4 for up to 1 hour and were immunoblotted for phosphorylated ERK1/2. As shown in Figure 1A, there was an increase in the phosphorylation of ERK beginning at 5 minutes that peaks at 30 minutes (105.8% 3.9).",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2011 Mar 31",
                "id": "21454454"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85b8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Depletion of cholesterol from the cells using beta-cyclodextrin blocked insulin stimulation of glucose uptake, insulin inhibition of perilipin phosphorylation in response to isoproterenol, and insulin stimulation of protein kinase B and Map-kinases extracellular signal-related kinase (ERK)1/2 phosphorylation",
              "citation": {
                "type": "PubMed",
                "name": "Eur J Biochem 2004 Jun 271(12) 2471-9",
                "id": "15182363"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85b7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Adipocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "JAK1 activity may be involved in activation of Raf-1 and ERK1",
              "citation": {
                "type": "PubMed",
                "name": "Immunopharmacology 1999 May 42(1-3) 187-93",
                "id": "10408379"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85b6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "TGF-b was also shown to induce Egr-1 expression in normal dermal fibroblasts [32]. The response was rapid and transient, occurred via an ERK1/2- dependent and Smad-independent mechanism, and involved transcriptional stimulation.",
              "citation": {
                "type": "PubMed",
                "name": "Curr Opin Rheumatol 2007 Nov 19(6) 568-73",
                "id": "17917537"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85b5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "S118 can be phosphorylated by the ERK1/2 mitogen activated protein kinases (MAPK) and by the cyclin-dependent protein kinase Cdk7",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2002 Jul 25 21(32) 4921-31",
                "id": "12118371"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85b4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "The Akt kinase substrate was GSK3, and the ERKs substrate was Elk1. Our results indicated that phosphorylation of GSK3-a and -b decreased in UVB-treated DNMFyn- JB6 cells (Fig. 9A)....Phosphorylation of Elk1 dramatically decreased in UVB-treated DNM-Fyn-JB6 cells com-pared with WT-Fyn-JB6 cells (Fig. 9C)",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Jan 28 280(4) 2446-54",
                "id": "15537652"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85b3"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Our cellular and molecular dissection showed that the PDGF-BB/PDGFRbeta kinase axis promoted MM tumor growth and vessel sprouting by activating ERK1/2, AKT, and the transcription of MMEC-released proangiogenic factors, such as vascular endothelial growth factor (VEGF) and interleukin-8 (IL-8)",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2008 Aug 15 112(4) 1346-56",
                "id": "18524994"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85b2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Multiple Myeloma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Treatment with 1% CSE for 15 min activated ERK1/2 (Fig. 8A, panel 1).",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2008 Oct 295(4) L624-36",
                "id": "18689604"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85b1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Sep 27 277(39) 36181-7",
                "id": "12110689"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85b0"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Here, we demonstrate that extracellular signal-regulated kinases (ERKs) can phosphorylate 5-LO in vitro",
              "citation": {
                "type": "PubMed",
                "name": "FASEB J 2002 Sep 16(11) 1441-3",
                "id": "12205041"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85af"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Engagement of Gi- and Gq-protein-coupled ETB receptors by ET-1 led to phosphorylation of ERK1/2, p38 MAPK, and JNK1/2 and then activated transcription factor NF-?B. ",
              "citation": {
                "type": "PubMed",
                "name": "Cell Commun Signal 2013 11(1) 8",
                "id": "23343326"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85ae"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Science 1999 Dec 24 286(5449) 2514-7",
                "id": "10617468"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85ad"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Expression of Dual specificity phosphatase 4 or MAP kinase phosphatase-2 (MKP-2) was maintained in cells upon loss of adhesion over the 9 hours time period but was dramatically down-regulated upon inhibition of MEK, suggesting that the expression of MKP-2 was regulated at transcriptional level by activated ERK1 in mutant V599E B-Raf cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Sep 5 278(36) 34548-54",
                "id": "12821662"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85ac"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "For instance, activation of epidermal growth factor receptor (EGFR) by EGF leads to phosphorylation of the Ser118 residue in the ERalpha AF-1 domain by p44/42 mitogen-activated protein kinase (MAPK), which in turn recruits the coactivator p68/p72 and activates target gene transcription in a ligand-independent manner [80,81].",
              "citation": {
                "type": "PubMed",
                "name": "Breast Cancer Res 2004 6(1) 39-52",
                "id": "14680484"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85ab"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Phosphorylation at Thr 125 is sufficient to block caspase-9 processing and subsequent caspase-3 activation",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2003 Jul 5(7) 647-54",
                "id": "12792650"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85aa"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "We found that KGF induced rapid activation of Akt, p70 S6K, JNK, and extracellular signal-regulated (ERK) ",
              "citation": {
                "type": "PubMed",
                "name": "J Lipid Res 2005 Dec 46(12) 2624-35",
                "id": "16162944"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85a9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Stimulation of EGFR and mitogen-activated protein kinase signaling by GM3 depletion involves the phosphorylation of EGFR at tyrosine residues 845, 1068, and 1148 but not 1086 or 1173. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Dec 5 278(49) 48770-8",
                "id": "14512423"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85a8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Active FOXO3a rapidly increased the level of Bcl-2-interacting mediator (bim) in differentiated SH-SY5Y cells, and BDNF decreased the FOXO3a-induced increase of bim through activation of both PI3K/Akt and Erk signaling pathways.",
              "citation": {
                "type": "PubMed",
                "name": "Brain Res Mol Brain Res 2004 Jul 5 126(1) 45-56",
                "id": "15207915"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85a7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": " In human macrophages fibrinogen stimulated interleukin (IL)6 expression and ERK (extracellular signal-related kinase) phosphorylation.",
              "citation": {
                "type": "PubMed",
                "name": "Thromb Haemost 2008 Aug 100(2) 301-7",
                "id": "18690351"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85a6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Oct 24 278(43) 42409-18",
                "id": "12917419"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85a5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2003 Dec 1 63(23) 8330-7",
                "id": "14678993"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85a4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Pharmacologic and genetic inhibition of alpha-CaMKII by using trifluoperazine, KN93, and alpha-CaMKII small interfering RNA decreases the phosphorylation of ERK and of cAMP-response element-binding protein, leading to a significant decrease in the transactivation of serum response element and cAMP-response element. Inhibition of alpha-CaMKII decreases the expression of c-fos, AP-1 transactivation, and AP-1 DNA binding activity.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Feb 25 280(8) 7049-59",
                "id": "15590632"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85a3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "osteoblast",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Subsequent kinetic analyses and transfection studies demonstrated that VHR specifically dephosphorylates and inactivates ERK1 and ERK2 in vitro and in vivo.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 May 7 274(19) 13271-80",
                "id": "10224087"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85a2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Ang II dramatically increased the phosphorylation of ERK1/2, JNK1/2 and p38 (Figure 2 A-C).",
              "citation": {
                "type": "PubMed",
                "name": "Exp Mol Med 2006 Oct 31 38(5) 525-34",
                "id": "17079869"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85a1"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "The differentially expressed gene set was integrated with the set of signaling proteins previously shown to be activated by TS: ADAM17 (37), AhR (36, 38), cyclic AMP responsive element binding protein 1 (CREB1; ref. 36), mitogen- activated protein kinase [extracellular signalregulated kinase (ERK)-1/2; ref. 39], protein kinase A catalytic subunit (PRKACA; ref. 36), and SRC.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Prev Res (Phila Pa) 2008 Jul 1(2) 100-11",
                "id": "19138943"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad85a0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "We show that both HSP60s activate the stress-activated protein kinases p38 and JNK1/2, the mitogen-activated protein kinases ERK1/2, and the I-kappaB kinase (IKK).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Aug 17 276(33) 31332-9",
                "id": "11402040"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad859f"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "IL-33 rapidly activated ERK1/2, JNK, p38, and NF-kB signaling cascades, as evidenced by phosphorylation of MAP kinases and phosphorylation and degradation of the NF-kB inhibitor IkB-a.",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2009 Feb 12 113(7) 1526-34",
                "id": "18955562"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad859e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "basophil",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "we found that both ERK1 and ERK2 were expressed in SK-OV-3.ipl cells incubated under various conditions (e.g. untreated (Fig. 2A, panel b, lane 1), treated with HA (lane 2), or pretreated with anti-CD44 antibody, followed by HA treatment (lane 3)). We also observed that ERK2 (and to a lesser extent, ERK1) phosphorylation was significantly up-regulated by HA treatment",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Mar 25 280(12) 11961-72",
                "id": "15655247"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad859d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Treatment with a specific inhibitor of mitogen-activated protein (MAP) kinase, but not with other inhibitors, abolished the stimulation of apoA-I gene expression by E2 and genistein.",
              "citation": {
                "type": "PubMed",
                "name": "J Lipid Res 2004 Jan 45(1) 106-12",
                "id": "14563824"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad859c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2003 Feb 11(2) 405-13",
                "id": "12620228"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad859b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "We previously reported that MAPK activation by GRP occurs via EGFR phosphorylation in HNSCC (15).",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2004 Sep 1 64(17) 6166-73",
                "id": "15342401"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad859a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Head and Neck Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Here we show that upon Fas, tumor necrosis factor alpha receptor, or tumor necrosis factor alpha-related apoptosis-inducing ligand receptor stimulation, an inhibition of extracellular signal-regulated kinase 1 and 2 (ERK1/2) activation sensitizes wild-type but not K8-null mouse hepatocytes to apoptosis and that a much weaker ERK1/2 activation occurs in K8-null hepatocytes.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Aug 24(16) 7072-81",
                "id": "15282307"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8599"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "hepatocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Ras acting via Erk MAP kinases causes phosphorylation of Smad2 and Smad3 at specific sites in the region linking the DNA-binding domain and the transcriptional activation domain.",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 1999 Apr 1 13(7) 804-16",
                "id": "10197981"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8598"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "carcinoma of breast",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "from full text - isoprenaline challenge also increases ERK1/2 phosphorylation (Fig. 4c). This effect increases dramatically after the addition of rolipram through a process attenuated in cells treated with either pertussis toxin or H89 (Fig. 4 c and d),",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2003 Feb 4 100(3) 940-5",
                "id": "12552097"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8597"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "cardiomyocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Further results showed that VEGFA induced the activation of JNK/SAPK, p38 kinase and extracellular signal-regulated kinases 1 and 2 (ERK1/2), while JNK/SAPK inhibitor SP600125 and specific siRNA both blocked all those angiogenic effects induced by VEGFA. ",
              "citation": {
                "type": "PubMed",
                "name": "Cell Biochem Biophys 2012 May 17",
                "id": "22592917"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8596"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Exposure of SCLC or PNECs to NNK or nicotine increased expression of the a7nAChR and caused influx of Ca2+, activation of PKC, Raf-1, ERK1/2, and c-myc, resulting in the stimulation of cell proliferation.",
              "citation": {
                "type": "PubMed",
                "name": "Mutat Res 659(3) 221-31",
                "id": "18495523"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8595"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasm",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "PEA-15 is a widely expressed death effector domain-containing phosphoprotein involved in signal transduction, apoptosis, ERK activation, and glucose transport.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Nov 10 275(45) 35224-32",
                "id": "10926929"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8594"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Hum Mol Genet 2001 Mar 15 10(6) 605-16",
                "id": "11230180"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8593"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "We show that Cdc2 inhibits EGF-mediated ERK activation through direct interaction and phosphorylation of several ERK pathway proteins, including the guanine nucleotide exchange factor, Sos-1, and Raf-1 kinase.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Jul 1 280(26) 24524-31",
                "id": "15888452"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8592"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Recombinant galectin-1 and galectin-3 stimulated the proliferation of cultured HSCs via the MEK1/2-ERK1/2 signaling pathway.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 May 23 278(21) 18938-44",
                "id": "12646584"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8591"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Depletion of cholesterol from the cells using beta-cyclodextrin blocked insulin stimulation of glucose uptake, insulin inhibition of perilipin phosphorylation in response to isoproterenol, and insulin stimulation of protein kinase B and Map-kinases extracellular signal-related kinase (ERK)1/2 phosphorylation",
              "citation": {
                "type": "PubMed",
                "name": "Eur J Biochem 2004 Jun 271(12) 2471-9",
                "id": "15182363"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8590"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "These data indicate that ROS was generated before the ERK activation and ERK was activated before NFATc activation, clarifying the sequence of ROS generation, ERK and NFATc activation.",
              "citation": {
                "type": "PubMed",
                "name": "J Hypertens 2008 Dec 26(12) 2349-60",
                "id": "19008713"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad858f"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "The P-1 domain mediates a constitutive interaction of SLP-76 with the SH3 domain of PLC-gamma1 and is required for TCR-mediated activation of Erk, PLC-gamma1, and NFAT (nuclear factor of activated T cells).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2001 Jul 21(13) 4208-18",
                "id": "11390650"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad858e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Importantly, CA-MEK1 rescued TNF-stimulated IL-6 expression in A549 FAK shRNA cells without effects on basal IL-6 production (Fig. 8D). Together, these results support the conclusion that TNF-stimulated FAK activity promotes signals leading to ERK/MAPK activation necessary for efficient IL-6 production in fibroblasts and carcinoma cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 Jun 15 282(24) 17450-9",
                "id": "17438336"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad858d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Carcinoma, Non-Small-Cell Lung",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Here, we demonstrate that stimulation of Rat-2 or embryonic stem cells with activators of ERK1/2 or of cAMP-dependent protein kinase induced phosphorylation of endogenously expressed LKB1 at Ser(431).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Jun 1 276(22) 19469-82",
                "id": "11297520"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad858c"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "embryonic stem cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "In the present study, we show that, in addition to being phosphorylated on Thr-581 and Ser-360 by ERK1/2 or p38,",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2005 Apr 15 387(Pt 2) 507-17",
                "id": "15568999"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad858b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2004 Oct 15 64(20) 7439-46",
                "id": "15492268"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad858a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Sep 10 274(37) 26485-92",
                "id": "10473609"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8589"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "since in PKR-null MEFs there is a marked defect in Erk1 and Erk2 activation by PDGF (Figure1D), it appears that PKR is involved in serine phosphorylation of Stat3 through the activation of Erks.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2001 May 15 20(10) 2487-96",
                "id": "11350938"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8588"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "in embryonic kidney cells expressing full-length DCC, NTN1 causes increased transient phosphorylation and activity of ERK1 and ERK2 but not of JNK1, JNK2 or MAPK14 this phosphorylation was mediated by MAP2K1 (aka MEK1) and/or MAP2K2 (aka MEK2)",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2002 May 23 417(6887) 443-7",
                "id": "11986622"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8587"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "embryonic kidney cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Expression of Edg-2 dramatically potentiated LPA-induced phosphorylation of cotransfected HA-Erk1 (Fig. 2C).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2002 Apr 22(7) 2099-110",
                "id": "11884598"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8586"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Stimulation of VSMCs with MCP-1 induced proliferation and resulted in a concentration- and time-dependent release of the proinflammatory cytokine interleukin-6 (IL-6). MCP-1 also induced extracellular signal-regulated kinase, which, along with IL-6 release, was inhibited by pertussis toxin.",
              "citation": {
                "type": "PubMed",
                "name": "Arterioscler Thromb Vasc Biol 2002 Jun 1 22(6) 914-20",
                "id": "12067898"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8585"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "MAPK3 and MAPK1 was activated and phosphorylated in response to both OSM and EGF. Kinetics of phosphorylation were different with EGF and OSM.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2001 Mar 1 166(5) 3491-8",
                "id": "11207308"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8584"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "The sarcoendoplasmic reticulum Ca2+ ATPase (SERCA) inhibitor thapsigargin (Tg), as well as the Ca2+ ionophores ionomycin (Io) and A23187 (A2), each increased Akt and ERK1/2- phosphorylation, and this activity was similarly inhibited by AG1478 (Figure 2C).",
              "citation": {
                "type": "PubMed",
                "name": "Carcinogenesis 2006 Nov 27(11) 2331-40",
                "id": "16774943"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8583"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Fibronectin increased Rho protein expression that was detected at 60 min and stimulated the phosphorylation of Erk1/2 which was detected at both 15 and 60 min in H1838 cells (Fig. 4).",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Lett 2005 Feb 28 219(1) 71-81",
                "id": "15694666"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8582"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Carcinoma, Non-Small-Cell Lung",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Fig.1",
              "citation": {
                "type": "PubMed",
                "name": "Science 2004 Nov 26 306(5701) 1506-7",
                "id": "15567848"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8581"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "We further show that p42/p44 MAPK is critical for the hypoxia-induced transactivation of endothelial PAS-domain protein 1 (EPAS1),",
              "citation": {
                "type": "PubMed",
                "name": "Comp Biochem Physiol B Biochem Mol Biol 2001 Feb 128(2) 187-204",
                "id": "11207433"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8580"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Inhibition of Duox1 activation with DPI or after siRNA-mediated specific Duox1 silencing significantly inhibited localized ERK activation in wounded HBE1 monolayers (Fig. 4, C and D), ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 Feb 2 282(5) 3213-20",
                "id": "17135261"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad857f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Arterioscler Thromb Vasc Biol 2002 Nov 1 22(11) 1811-6",
                "id": "12426209"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad857e"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "FGF-2 (/=10(-12) m) also increased cathepsin K and MMP-9 mRNA levels in mouse and rabbit osteoclasts. FGF-2 acts directly on mature osteoclasts through activation of FGFR1 and p42/p44 MAP kinase, causing the stimulation of bone resorption at physiological or pathological concentrations.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Oct 6 275(40) 31444-50",
                "id": "10896947"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad857d"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Enzastaurin specifically inhibits TPA-triggered phosphorylation of signaling molecules downstream of PKC...enzastaurin inhibited TPA-induced phosphorylation of downstream PKCu/ PKD, MARCKS, GSK3b, JNK1/2, ERK1/2, and c-Myc, but did not inhibit phosphorylation of PDK-1, a signaling molecule upstream of PKC, which triggers activation loop phosphorylation of cPKCs and nPKCs",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2007 Feb 15 109(4) 1669-77",
                "id": "17023575"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad857c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "HGF induced activation of ERK1 and ERK2 was shown to be dependent on the presence of HS moieties.",
              "citation": {
                "type": "PubMed",
                "name": "Arterioscler Thromb Vasc Biol 2003 Jan 1 23(1) 69-75",
                "id": "12524227"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad857b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Results reveal that nicotine induces phosphorylation and activation of ERK1/2 in a dose-dependent manner (Fig. 2A).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cancer Res 2009 Dec 7(12) 1954-61",
                "id": "19903766"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad857a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "insulin significantly increased MAP kinase [isoforms p42(MAPK) and p44(MAPK) (ERK1 and ERK2)] phosphorylation and activity, and the activity of its upstream activator MEK1. Insulin also increased the activity of the MAP kinase downstream substrate, the p90 ribosomal S6 kinase 2 (RSK2) almost twofold",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Endocrinol Metab 2000 Jun 278(6) E992-9",
                "id": "10827000"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8579"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "For the PAR2 receptor expressed in NIH3T3 cells, b-arrestin-mediated ERK activation leads to reorganization of the actin cytoskeleton, polarized pseudopod extension, and chemotaxis with enrichment of a PAR2/b-arrestin scaffolding complex in the pseudopodia (Ge et al., 2003).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2006 Dec 8 24(5) 643-52",
                "id": "17157248"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8578"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "The mechanism by which CCL19 activates ERK1/2 was determined to be beta-arrestin-dependent, because it is reduced both by depletion of beta-arrestin-2 with small interfering RNA and by elimination of the phosphorylation sites in the tail of the receptor",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 May 28 279(22) 23214-22",
                "id": "15054093"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8577"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Biol Psychiatry 2004 Jan 15 55(2) 118-25",
                "id": "14732590"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8576"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "This survival-promoting activity is totally due to IL-10 stimulating the insulin receptor substrate-2/PI 3-kinase/Akt pathway, which increases the anti-apoptotic activity of ERK1/2.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2001 Oct 15 167(8) 4436-42",
                "id": "11591769"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8575"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Endocrinol 2003 Mar 17(3) 487-97",
                "id": "12554784"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8574"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Expression of wild-type (wt) Cbp remarkably suppressed EGF-induced activation of Src, ERK1/2, and Akt-1 enzymes, and NIH3T3 cell transformation, as well as colony formation of a breast cancer cell line (MDA-MB-468) in soft agar.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2006 Sep 7 25(40) 5495-506",
                "id": "16636672"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8573"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2003 Aug 15 102(4) 1169-77",
                "id": "12714503"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8572"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Cytosolic b-arrestins are phosphorylated: S412 in b-arrestin1 by the extracellular regulated kinase (ERK) mitogen-activated protein (MAP) kinase (Lin et al., 1999), T383 in rat (Lin et al., 2002) or T382 in bovine b-arrestin2 by casein kinase II (Kim et al., 2002).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2006 Dec 8 24(5) 643-52",
                "id": "17157248"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8571"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Brain Res Mol Brain Res 1997 Nov 51(1-2) 220-8",
                "id": "9427524"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8570"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Western blotting showed that both types of flows induced ERK1/2 activation that was inhibited by disruption of heparan sulfate proteoglycans (HSPGs). ",
              "citation": {
                "type": "PubMed",
                "name": "PLoS One 2010 5(8)",
                "id": "20808940"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad856f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Pretreatment with inhibitors for MEK1/2, Raf1 and MSK1, and overexpression of a Raf1 dominant-negative mutant significantly diminished IL-17F-induced CCL20 production.",
              "citation": {
                "type": "PubMed",
                "name": "J Allergy (Cairo) 2011 2011 587204",
                "id": "22013453"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad856e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "PD-98059, an inhibitor of phosphorylation of ERK1/2, caused a marked inhibition of HSP60-induced COX-2 and NOS-2 expression.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2002 Oct 283(4) C1267-77",
                "id": "12225989"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad856d"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "induction of MKP-1 correlated with the inhibition of extracellular signal- regulated kinase (ERK1/2) and c-Jun N-terminal kinase (JNK) activity",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Feb 11 280(6) 4117-24",
                "id": "15590693"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad856c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Reconstitution of PKCbetaI expression in these cells by retroviral transfection increased Ras/ERK activation by 3050%, indicating full restoration of Ras/ERK activation (Fig. 2 D and E). ",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2003 Aug 5 100(16) 9470-5",
                "id": "12881490"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad856b"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "mast cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "the Grb2/Sos complex connects Pyk2 to the activation of ERK, whereas adaptor proteins p130Cas and Crk link Pyk2 with the JNK pathway.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 May 21 274(21) 14893-901",
                "id": "10329689"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad856a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Furthermore, oncogenic HER2/Neu, which induces phosphorylation and thereby activation of ER81, was less able to activate acetylation-deficient ER81 mutants, indicating that both acetyltransferase and protein kinase-specific regulatory mechanisms control ER81 activity. Importantly, HER2/Neu overexpression stimulates the ability of p300 to acetylate ER81, likely by inducing phosphorylation of p300 through the Ras-->Raf-->mitogen-activated protein kinase pathway.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2003 Sep 23(17) 6243-54",
                "id": "12917345"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8569"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "MAPK. Stimulation of ERK by endothelial-cell integrins is mediated by either FAK, or the Src-family kinases Fyn and Yes.",
              "citation": {
                "type": "PubMed",
                "name": "Biochim Biophys Acta 2004 Mar 4 1654(1) 51-67",
                "id": "14984767"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8568"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "ERK directly phosphorylates SGK at Ser78 and indirectly activates SGK at Thr256 and Ser422 through unknown intermediate molecules. ",
              "citation": {
                "type": "PubMed",
                "name": "Eur J Neurosci 2006 Mar 23(5) 1311-20",
                "id": "16553792"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8567"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Here we show that the angiotensin II type 1A receptor-mediated activation of extracellular signal-regulated kinases 1 and 2 (ERK1/2) in HEK-293 cells is increased when the cellular level of beta-arrestin1 is down-regulated by RNA interference but is decreased or eliminated when the cellular level of beta-arrestin2 is diminished",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Feb 27 279(9) 7807-11",
                "id": "14711824"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8566"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Moreover, mitogen-activated protein kinase (MEK) /extracellular-signal-regulated kinase (ERK) pathway inhibitors; U0126 (1.4-diamino-2, 3-dicyano-1, 4-bis [2-amino-phenylthio] butadiene) and PD98059 (2'-Amino-3'-methoxyflavone) inhibited inducible Glvr-2 mRNA expression,",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Physiol 2004 Jan 198(1) 40-7",
                "id": "14584042"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8565"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Jul 18 278(29) 27096-104",
                "id": "12734206"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8564"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "As shown in Fig. 1A, POVPC treatment at 10 ug/ml induced ERK1/2 phosphorylation at 30 min, 2 h, and 6 h, but not at 24 h, suggesting that POVPC elicits a transient activation of the MEK-ERK1/2 pathway. ",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2008 Nov 295(5) C1175-82",
                "id": "18768922"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8563"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2004 May 14 317(4) 972-9",
                "id": "15094364"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8562"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Transfection of the native Src inhibitor, C-terminal Src kinase (Csk), also suppressed crystal-induced c-Src, ERK1/2, and IkappaBalpha phosphorylation and IL-8 expression.",
              "citation": {
                "type": "PubMed",
                "name": "J Leukoc Biol 2001 Dec 70(6) 961-8",
                "id": "11739559"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8561"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Pretreatment of LNCaP cells with SB202190, PD98059, or tyrphostin AG879 [p38 mitogen-activated protein kinase (MAPK), MAP/extracellular signal-regulated protein kinase kinase 1/2, and ErbB2 MAPK inhibitors, respectively) but not wortmannin (PI3-kinase inhibitor) blocked IL-6-mediated induction of the PSA promoter, which demonstrates that IL-6 activity is dependent on a MAPK pathway.",
              "citation": {
                "type": "PubMed",
                "name": "Clin Cancer Res 2001 Jun 7(6) 1773-81",
                "id": "11410519"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8560"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Rb is directly phosphorylated by active ERK1/2",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Oct 28 280(43) 35992-8",
                "id": "16126730"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad855f"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "ERK1/2 are the Raf effectors for suppression of integrin activation, and PEA-15 reverses suppression by binding ERK1/2.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Dec 26 278(52) 52587-97",
                "id": "14506247"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad855e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "V12S35 transformed NIH-3T3 cells showed enhanced Erk1/2 activity which led to increase in tumorigenicity and metastasis.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 1998 Jul 21 95(15) 8773-8",
                "id": "9671754"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad855d"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Endocrinol 2003 Nov 17(11) 2268-82",
                "id": "12907754"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad855c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "\\\"Erythropoietin-induced serine 727 phosphorylation of STAT3 in erythroid cells is mediated by a MEK-, ERK-, and MSK1-dependent pathway.\\\"",
              "citation": {
                "type": "PubMed",
                "name": "Exp Hematol 2003 May 31(5) 398-405",
                "id": "12763138"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad855b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "erythrocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "S100A4 is a direct target of ERBB2 signaling in medulloblastoma cells via a pathway involving phosphatidylinositol 3-kinase, AKT1, and extracellular signal-regulated kinase 1/2",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2003 Jan 1 63(1) 140-8",
                "id": "12517790"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad855a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "ER81 is activated by many signals through phosphorylation directly mediated by mitogen-activated protein kinases (MAPKs), but also by an unknown protein kinase",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2003 Feb 6 22(5) 746-55",
                "id": "12569367"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8559"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "inhibition of ERK1/2 signaling resulted in marked attenuation in IR-induced ATR activity with little, if any, effect on IR-induced ATM activation. Furthermore, inhibition of ERK1/2 signaling resulted in >/=85% attenuation in IR-induced G2/M arrest and concomitant diminution of IR-induced activation of ataxia telangiectasia mutated- and rad3-related (ATR), Chk1 and Wee1 kinases as well as phosphorylation of Cdc25A-Thr506, Cdc25C-Ser216 and Cdc2-Tyr15.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2007 Jul 12 26(32) 4689-98",
                "id": "17297454"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8558"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Data in isolated fibroblasts (26,56), neutrophils (57,58), endothelial and vascular smooth muscle cells (5961), neural cells (31,62), cardiomyocytes (63) and whole lung tissue (64) showed that, in addition to other known oxidants, peroxynitrite is also a powerful activator of ERK.",
              "citation": {
                "type": "PubMed",
                "name": "Front Biosci 2009 14 4809-14",
                "id": "19273391"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8557"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Neural Stem Cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2000 Aug 31 19(37) 4221-9",
                "id": "10980595"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8556"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "SOCS6 reduced SCF-induced activation of ERK1/2 and p38",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jan 5",
                "id": "14707129"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8555"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Apr 27 276(17) 14466-73",
                "id": "11278290"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8554"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "PTPD1 activates src tyrosine kinase and increases the magnitude and duration of epidermal growth factor (EGF) signaling. EGF receptor phosphorylation and downstream activation of ERK 1/2 and Elk1-dependent gene transcription are enhanced by PTPD1.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Jun 24(11) 4613-26",
                "id": "15143158"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8553"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "when G-CSF-induced signaling was examined (Figure 1C-D), Erk1/2 phosphorylation was found reproducibly reduced in Gfi1 -/- bone marrow mononuclear cells  (MNCs)",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2010 May 13 115(19) 3970-9",
                "id": "20203268"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8552"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Monocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "In prostate DU145 cells, both FGF1 and FGF2 activated ERK1/2 potently and p38 moderately.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2001 Aug 30 20(38) 5359-65",
                "id": "11536048"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8551"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Pretreatment with the ICAM-1peptide increased TGF-alpha-induced phospho-ERK1/2; the peptide alone had no significant effect (Fig. 3C). Addition of exogenous fibrinogen or the fibrinogen peptide prevented the ICAM-1peptide-dependent increase in phospho-ERK1/2 (Fig. 3C), while the control fibrinogen(scrambled) peptide had no effect on this increase (Fig. 3C). ",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2009 Jul 297(1) L174-83",
                "id": "19429776"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8550"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "In parallel, stimulation of the wild-type angiotensin type 1A receptor with Ang II robustly stimulates ERK1/2 activation with approximately 60% of the response blocked by the PKC inhibitor (G protein dependent)",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2003 Sep 16 100(19) 10782-7",
                "id": "12949261"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad854f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "VEGF-A expression is regulated at all steps of its synthesis including transcription, mRNA stability, an under estimated way of VEGF regulation and translation. In this chapter, we present the link between VEGF mRNA stability through AU-rich sequences present in its 3'-untranslated region (3'-UTR) and the ERK pathway. We present several methods that have been used to demonstrate that ERKs increase VEGF mRNA half-life.",
              "citation": {
                "type": "PubMed",
                "name": "Methods Mol Biol 2010 661 451-69",
                "id": "20812001"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad854e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "The B cell adaptor molecule of 32 kDa (Bam32) is an adaptor that links the B cell antigen receptor (BCR) to ERK and JNK activation and ultimately to mitogenesis. After BCR cross-linking, Bam32 is recruited to the plasma membrane and accumulates within F-actin-rich membrane ruffles.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Sep 17 279(38) 39775-82",
                "id": "15247305"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad854d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "B cell lymphoma",
                "cell": "b-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2003 Jul 5(7) 647-54",
                "id": "12792650"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad854c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Nov 23 276(47) 44315-22",
                "id": "11551923"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad854b"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2003 Feb 23(3) 1095-111",
                "id": "12529413"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad854a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Subsequent studies showed that PDGF activated extracellular signal-regulated kinase, Jun N-terminal protein kinase, and phosphatidylinositol 3 (PI3)-kinase pathways in SMCs.  Inhibition of these pathways blocked SMC proliferation in response to PDGF, but only inhibition of PI3-kinase or its effector, Akt, blocked PDGF-induced CREB loss.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2006 Jul 26(13) 4934-48",
                "id": "16782881"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8549"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Muscle, Smooth"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "S100-A9 binds the transcription factors NF-kB and P53, and activates the P38 and ERK MAPK kinases and the receptor for advanced glycated end products (RAGE) (50).",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2008 May 38(5) 541-50",
                "id": "18079489"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8548"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "LDL, in pathophysiological concentrations, affect the IGF-I signaling pathway at multiple levels: 1) they induce phosphorylation of IGF-I receptor beta and IRS-1 in a time- and dose-dependent manner; 2) they up-regulate IRS-1-associated PI3 kinase/Akt activation in response to IGF-I at early times; and 3) they show additive effects with IGF-I on extracellular signal-regulated MAPK 1/2 phosphorylation.",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 2001 Nov 142(11) 4852-60",
                "id": "11606453"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8547"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "UVBcaused phosphorylation of ERK1/2 (Fig. 1A) and Akt (Fig. 1D) was strongly enhanced by silibinin pre-treatment at 100 M dose without any change in their total protein levels.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 May 27 280(21) 20375-83",
                "id": "15792956"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8546"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Erk and p38 phosphorylate MNK1 and MNK2, which stimulates their in vitro kinase activity towards a substrate, EIF-4E",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1997 Apr 15 16(8) 1909-20",
                "id": "9155017"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8545"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "activation of extracellular signal-regulated kinase 1/2 (ERK1/2) and matrix metalloproteinase-9 (MMP-9) by thrombin was inhibited by the EGFR inhibitor AG1478 and in Nox1 KO SMCs",
              "citation": {
                "type": "PubMed",
                "name": "Cardiovasc Res 2012 Mar 1 93(3) 406-13",
                "id": "22102727"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8544"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "These findings indicate that G-CSF induces human neutrophil migration via activation of MEK/ERK and PI3K.",
              "citation": {
                "type": "PubMed",
                "name": "Immunology 2006 Nov 119(3) 393-403",
                "id": "16903868"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8543"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jun 11 279(24) 25211-8",
                "id": "15069082"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8542"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "the augmentation of kinase activity of RAGE-bound ERK upon the stimulation of cells with amphoterin was demonstrated by determining the phosphorylation level of myelin basic protein, an ERK substrate.....In vitro binding studies using a series of C-terminal deletion mutants of human RAGE revealed the importance of the membrane-proximal cytoplasmic region of RAGE for the direct ERK-RAGE interaction",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 2003 Aug 28 550(1-3) 107-13",
                "id": "12935895"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8541"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2001 May 3(5) 453-9",
                "id": "11331872"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8540"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Feb 24(3) 1081-95",
                "id": "14729955"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad853f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Stimulation of MCF-7 cells with 10 nM of EGF and progestin resulted in activation of extracellular signal-regulated protein kinase (ERK)1/2 within 5 min.",
              "citation": {
                "type": "PubMed",
                "name": "Breast Cancer Res 2004 6(3) R239-45",
                "id": "15084247"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad853e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Stimulation of G1E-ER2 cells by SCF resulted in significant but only transient activation of ERK-1 and ERK2. Activation peaked 10 minutes after SCF stimulation and dropped to baseline thereafter. When alpha5beta1 integrin was activated by fibronectin peptide, SCF strongly induced ERK-1 and ERK-2 activation as early as 10 minutes after stimulation that persisted and reached maximum levels at 120 minutes.",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2001 Apr 1 97(7) 1975-81",
                "id": "11264161"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad853d"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Interestingly, each of the individual MAPKs evaluated was found to promote Lox-1 expression to varying degrees. As we expected, CpG ODN treatment of macrophages increased three MAPKs phosphorylation, and each inhibitor of three MAPKs significantly attenuated the CpG ODN-induced phosphorylation of the MAPKs (Fig. 7A). ",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2008 Dec 20(12) 2266-75",
                "id": "18817866"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad853c"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "U0126 (the inhibitor for MAP/ERK kinase) suppressed chymase-induced migration of EoL-1 cells and mouse eosinophils.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2005 Jul 15 332(4) 969-75",
                "id": "15919053"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad853b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "p38 MAPK was required for the IL-33-mediated responses of endothelial cells, whereas ERK was required for IL-33-mediated IL-8 production by epithelial cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2010 Nov 15 185(10) 5743-50",
                "id": "20926795"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad853a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "The activation of ERK1/2 was considerably higher in alpha-synuclein overexpressing cells, 5 min after adding serum, compared with the non-induced (Dox+) condition.",
              "citation": {
                "type": "PubMed",
                "name": "Neurobiol Aging 2003 Sep 24(5) 687-96",
                "id": "12885576"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8539"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "TPA stimulates increased generation of ROS and initiates the stress-activated protein kinase (SAPK) pathway via protein kinase C (PKC) bII activation (Datta et al., 2000), representing typical characteristics of STASIS...Activation of stress kinases (JNK, MAPK, p38) (Day 2008;  Gao et al., 2008; Kirkham and Rahman, 2006;  Kliment et al., 2008; Koli et al., 2008) ",
              "citation": {
                "type": "PubMed",
                "name": "Biol Chem 2008 Mar 389(3) 211-20",
                "id": "18208352"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8538"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Epo induced tyrosine phosphorylation of ERK1 and ERK2 was markedly reduced in cells expressing mutant Epor.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1994 Nov 25 269(47) 29962-9",
                "id": "7961995"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8537"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Wild type as well as substrate-trapping DA forms of PTPepsilonM suppressed phosphorylation of IR downstream enzymes such as Akt, extracellular regulated kinase (ERK) and glycogen synthase kinase 3 (GSK3).",
              "citation": {
                "type": "PubMed",
                "name": "Zoolog Sci 2005 Feb 22(2) 169-75",
                "id": "15738637"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8536"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2005 Feb 25(3) 907-20",
                "id": "15657420"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8535"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "In vitro kinase assays using the combined STAT1 proteins as substrates from immunoprecipitation and glutathione S-transferase pull down show that active ERK1, JNK1, p38 kinase, MEK1 and MSK1 stimulated phosphorylation of STAT1 (Ser727) indirectly through an unidentified factor or a downstream kinase.",
              "citation": {
                "type": "PubMed",
                "name": "Carcinogenesis 2004 Jul 25(7) 1165-75",
                "id": "14963018"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8534"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "we reported in H9C2 cardiomyocytes that peroxynitritemediated activation of ERK, although dependent on Raf-1 and MEK, was not due to upstream activation of p21ras (63).",
              "citation": {
                "type": "PubMed",
                "name": "Front Biosci 2009 14 4809-14",
                "id": "19273391"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8533"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "cardiomyocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Here we show that RIP2 activates the extracellular signal-regulated kinase (ERK) pathway and that the kinase activity of RIP2 appears to be important in this process.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Nov 19 274(47) 33684-90",
                "id": "10559258"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8532"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "These results reveal selective signaling differences between NK cells and T lymphocytes; in NK cells, the MKK/ERK pathway and not p38 MAPK plays a critical positive regulatory role during activation by IL-2.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2000 Jun 15 164(12) 6244-51",
                "id": "10843677"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8531"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "natural killer cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Preincubation with GF109203X, a PKC inhibitor, significantly reduced the level of early (3 min) IL-8-induced p47phox phosphorylation (Fig. 4A), but had no effect on the level of later (15 min) IL-8-induced p67phox phosphorylation (Fig. 4B). Furthermore, ERK1/2 and Akt/PKB phosphorylation transiently peaked after exposure to IL-8 for 3min (Fig. 4C).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Nov 4 280(44) 37021-32",
                "id": "16115878"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8530"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Sep 20 277(38) 35282-8",
                "id": "12084708"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad852f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "The major phosphopeptide detected with p46SAPK and with p54SAPK is similar in mobility to a major phosphopeptide in the ERK1 map (Fig. 4b). This peptide was previously demonstrated to contain phosphoserine at position 383 [8].",
              "citation": {
                "type": "PubMed",
                "name": "Curr Biol 1995 Oct 1 5(10) 1191-200",
                "id": "8548291"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad852e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Accordingly, NOX4 activation was associated with intracellular ERK1/2 signaling and phosphorylation of nuclear or ER proteins, such as retinoblastoma protein and eukaryotic translation initiation factor 4E binding protein-1, thereby mediating smooth muscle cell proliferation and hypertrophy (186,193).",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2008 Mar 15 44(6) 938-55",
                "id": "18164271"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad852d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Oct 26 276(43) 39892-7",
                "id": "11518717"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad852c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Consistent with EGFR activation, AKT and ERK phosphorylation was also observed during the course of ATP-?-S stimulation. Furthermore, ATP-?-S also elicited a similar response in primary HCE cells and BEAS 2B cells, although its effect on signaling in BEAS 2B cells was more transient than that in THCE cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 2007 Mar 1 120(Pt 5) 815-25",
                "id": "17284517"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad852b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Both early passage and immortalized MEF cells from GSTpi(-/-) animals expressed significantly elevated activity of extracellular signal-regulated kinases ERK1/ERK2, kinases linked to cell proliferation pathways",
              "citation": {
                "type": "PubMed",
                "name": "J Pharmacol Exp Ther 2001 Jul 298(1) 339-45",
                "id": "11408560"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad852a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "In this paper, we present a comprehensive pathway map of EGFR signaling and other related pathways. The map reveals that the overall architecture of the pathway is a bow-tie (or hourglass) structure with several feedback loops.  See figure 2: The bow-tie architecture of the EGFR signaling pathway.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Syst Biol 2005 1 2005.0010",
                "id": "16729045"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8529"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Here, we show that exposure to 100 ng/ml EGF for 15 min, 1 U/ml GO for 30 min, or smoke from one cigarette for 45 min activates downstream ERK1/2 and Akt signaling (Fig. 7A) ",
              "citation": {
                "type": "PubMed",
                "name": "FASEB J 2008 Mar 22(3) 910-7",
                "id": "17971399"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8528"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 May 17 277(20) 18111-7",
                "id": "11877445"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8527"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Aug 23 277(34) 31099-106",
                "id": "12048182"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8526"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "activation of ERK depended on EGFR, Src tyrosine kinase and calcium calmodulin in PC12 cells (31), while requiring ras/Raf-1/MEK activation in human neutrophils (58).",
              "citation": {
                "type": "PubMed",
                "name": "Front Biosci 2009 14 4809-14",
                "id": "19273391"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8525"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "inhibition of extracellular signal regulated kinase (ERK) phosphorylation and p38 mitogen-activated protein kinase (MAPK) activation in response to fMLP by CYL-26z up to 30microM was obtained",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Pharmacol 2006 Sep 14 72(6) 749-60",
                "id": "16887102"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8524"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "PAFR promoter 2 contained AP-2 and Sp-1 binding sites we demonstrated that PAF activates p44ERK1/p42ERK2 in CHO cells stably expressing PAF receptor",
              "citation": {
                "type": "PubMed",
                "name": "Prog Lipid Res 2000 Jan 39(1) 41-82",
                "id": "10729607"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8523"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Elk-1 is phosphorylated by upstream MAPK kinases including the MEK-ERK-1/2 pathway. LPS induced phosphorylation of ERK-1/2 and MEK1/2 occurred within 15 minutes of LPS treatment (data not shown). Phosphorylation of both ERK1/2 and MEK1/2 was inhibited by IL-10 pretreatment (Figure 6C and 6D).",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 2005 Aug 19 97(4) 305-13",
                "id": "16037570"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8522"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2004 Oct 29 323(4) 1241-5",
                "id": "15451430"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8521"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Neutrophils stimulated with FMLP exhibited phosphorylation of the cAMP response element binding protein (CREB), and this reaction was inhibited by SB 203580 and PD 98059.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 1999 Oct 15 163(8) 4527-36",
                "id": "10510396"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8520"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Autocrine Wnt signalling through the GPCR frizzled 1 contributes to breast cancer cell proliferation in part through EGFR transactivation92. To add another layer of complexity, progesterone receptor signalling through WnT1 induced EGFR transactivation and SRCdependent sustained activation of ErkMAPK signalling in breast cancer cells93",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2008 Dec 8(12) 929-41",
                "id": "19005493"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad851f"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "Neoplasm",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2003 Dec 23(24) 9389-404",
                "id": "14645548"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad851e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Neurosci 1999 Feb 1 19(3) 928-39",
                "id": "9920656"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad851d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Ariadne: However, tenascin-C, another member  of the matricellular family of extracellular matrix proteins that does not  utilize CRT-dependent signaling, also induces ERK phosphorylation (Fig. 7 C )  and stimulates focal adhesion disassembly through a MEK-dependent process.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Jun 7 277(23) 20453-60",
                "id": "11923291"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad851c"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Exp Mol Med 2002 Dec 31 34(6) 451-61",
                "id": "12526087"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad851b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Data in isolated fibroblasts (26,56), neutrophils (57,58), endothelial and vascular smooth muscle cells (5961), neural cells (31,62), cardiomyocytes (63) and whole lung tissue (64) showed that, in addition to other known oxidants, peroxynitrite is also a powerful activator of ERK.",
              "citation": {
                "type": "PubMed",
                "name": "Front Biosci 2009 14 4809-14",
                "id": "19273391"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad851a"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Neurofibromin expression was significantly decreased within 2 days after infection (Figure 3A). Concomitant with this decrease was an increase in ERK and AKT activity as assessed by their phosphorylation status....Ras-GTP levels were elevated 2 days after infection",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Cell 2006 Dec 10(6) 459-72",
                "id": "17157787"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8519"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Oct 29 274(44) 31223-8",
                "id": "10531317"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8518"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "In the presence of an inhibitor of farnesly transferase (Ftase-1), which prevent the maturation of Ras, both Estradiol and TGF alpha induced ERK activation was significantly inhibited.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 May 3 277(18) 15514-22",
                "id": "11854297"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8517"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Together, the results demonstrate that OxPAPC induces TF expression in HUVECs through activation of PKC/ERK/EGR-1 and Ca(++)/calcineurin/NFAT pathways rather than by NF-kappa B-mediated transcription",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2002 Jan 1 99(1) 199-206",
                "id": "11756172"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8516"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "umbilical vein endothelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Platelet-derived growth factor (PDGF) is an important regulator of vascular smooth muscle (VSM) cell growth and migration and has been identified as a key mediator of neointima formation resulting from vascular injury. PDGF exerts its effects, in part, through activation of ERK1/2. ",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2005 Jun 288(6) C1193-201",
                "id": "15677375"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8515"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": "vascular smooth muscle"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Insulin induced phosphorylation IRS-1 followed by complex formation with Grb2 and SOS, activation of RAS/Raf/MEK1/ERK and finally cyclin D expression. MEK inhibitor PD980059 inhibited insulin induced downstream signaling.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Oct 22 279(43) 44344-54",
                "id": "15294900"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8514"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Whereas overexpression of wild-type Epac1 enhanced the phosphorylation of ERK1/2 induced by the beta2-AR, the receptor response was almost fully blunted (n = 4; p < 0.003) by expression of R279K Epac1 (Fig. 5A).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Nov 5 279(45) 46497-508",
                "id": "15319437"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8513"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Binding of (pro)renin to the receptor mediates (pro)renin cellular effects by activating MAP kinases ERK1/2.",
              "citation": {
                "type": "PubMed",
                "name": "Bull Acad Natl Med 2004 188(4) 621-8; discussion 628-9",
                "id": "15587681"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8512"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "We report that in the CML cell line K562 Ras induces p21Cip1 expression through the Raf-MEK-ERK pathway.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Jan 14 280(2) 1112-22",
                "id": "15528212"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8511"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Wy-L4,643 increases phosphorylation of ERK and p38",
              "citation": {
                "type": "PubMed",
                "name": "Thromb Haemost 2003 Oct 90(4) 611-9",
                "id": "14515181"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8510"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Ang II and H2O2 induced marked activation of extracellular signal-responsive kinase1/2 (ERK1/2), which was blocked by NAC. Ang II and H2O2 also activated p38MAPK, and they were blocked by pre-treatment with NAC. However, the level of activated p38MAPK was quite low in comparison with ERK1/2. Ang II- or H2O2 -induced Gax down-regulation was significantly inhibited by PD98059, an ERK1/2 inhibitor but not SB203580, a p38MAPK inhibitor",
              "citation": {
                "type": "PubMed",
                "name": "Regul Pept 2005 Apr 15 127(1-3) 159-67",
                "id": "15680482"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad850f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Muscle, Smooth"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "These events have been detected in primary scleroderma fibroblasts, which generate reactive oxygen species-Ras-ERK1/2",
              "citation": {
                "type": "PubMed",
                "name": "N Engl J Med 2009 May 7 360(19) 1989-2003",
                "id": "19420368"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad850e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "The inhibitor U0126 completely blocked TNF-? release, indicating that TNF-? release in response to CSM exposure is dependent on the activation of erk1/2 (Fig. 3). In contrast, PI3-K inhibitor LY294002 and EGFR-specific inhibitor AG1478 had no effect on CSM-induced TNF-? release by macrophages (",
              "citation": {
                "type": "PubMed",
                "name": "Biochim Biophys Acta 2006 Jun 1762(6) 592-7",
                "id": "16777389"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad850d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "VEGF-induced Erk activation was not dependent on phosphoinositide (PI) 3-kinase activation but required sequential phosphorylation of type 2 VEGF receptor, PLCgamma and c-Src, as demonstrated by inhibitors SU1498, U73122, and PP1, respectively.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Aug 5 280(31) 28402-11",
                "id": "15919658"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad850c"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "In addition, ERK1 and ERK2 activation by phosphorylation occurred following CD53 antigen ligation.",
              "citation": {
                "type": "PubMed",
                "name": "Kidney Int 2003 Feb 63(2) 534-42",
                "id": "12631118"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad850b"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "mesangial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "from full text - Exposure of serum-starved cells to the calcium ionophore, A23187, was sufficient to induce detectable tyrosine phosphorylation of FAK but failed to increase either Shc phosphotyrosine content or Erk 1/2 phosphorylation. Stimulation of cells with phorbol ester modestly increased both FAK and Shc phosphotyrosine content and caused weak Erk 1/2 activation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1997 Dec 12 272(50) 31648-56",
                "id": "9395506"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad850a"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 1996 Jun 133(6) 1383-90",
                "id": "8682872"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8509"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Exposure of cells to alpha2M* (50 pM) induced phosphatidylinositol 3-kinase-dependent activation of Akt by phosphorylation at Thr-308 and Ser-473 with a concomitant 60-80% increase in Akt-associated kinase activity. ERK1/2 and p38 MAPK were also activated",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 May 12 281(19) 13694-707",
                "id": "16543232"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8508"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Prostatic Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 May 21 279(21) 22404-11",
                "id": "14988395"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8507"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "p90Rsk (Rsk1) is a well known downstream substrate for ERKs. Upon serum stimulation, phosphorylation of p90Rsk at Ser-369 (corresponding to Ser-380 of human p90Rsk) was detected in all ES lines examined",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2003 Oct 28 100(22) 12759-64",
                "id": "14566055"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8506"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Additionally, over-expression of CREG dampened the stretched cardiomyocyte hypertrophy through ERK1/2.",
              "citation": {
                "type": "PubMed",
                "name": "J Hypertens 2004 Aug 22(8) 1579-87",
                "id": "15257182"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8505"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "cardiomyocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1997 Apr 15 16(8) 1921-33",
                "id": "9155018"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8504"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "GSTP1 overexpression in SAOS-2 osteosarcoma cells caused the cells to be more resistant to doxorubicin and cisplatin. GSTP1 suppression in HOS cells caused more apoptosis and extensive DNA damage in response to doxorubicin and cisplatin. GSTP1 contributes to doxorubicin and cisplatin resistance in osteosarcoma, which may be mediated in part by the activation of extracellular signal-regulated kinase 1/2.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cancer Ther 2007 May 6(5) 1610-9",
                "id": "17513610"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8503"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "osteosarcoma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Nat Immunol 2002 Apr 3(4) 392-8",
                "id": "11896392"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8502"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "we found that IL-33R signaling induced a time-dependent activation of Erk1/2, protein kinase B (PKB), JNK1/2, NF-kB, and p38, and degradation of IkB (supplemental Figure 1B).",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2010 May 13 115(19) 3899-906",
                "id": "20200353"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8501"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "mast cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Overexpression of PLCdelta4 selectively activates protein kinase C-phi and upregulates the expression of epidermal growth factor receptors EGFR/erbB1 and HER2/erbB2, leading to constitutive activation of extracellular signal-regulated kinases 1 and 2 (ERK1/2) pathway in MCF-7 cells. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cancer 2004 May 13 3 15",
                "id": "15140260"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8500"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "human endostatin binding to alpha 5 beta 1 integrin leads to the inhibition of focal adhesion kinase/c-Raf/MEK1/2/p38/ERK1 mitogen-activated protein kinase pathway",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2003 Apr 15 100(8) 4766-71",
                "id": "12682293"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84ff"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "p90rsk (MAPKAP-K1), one of the main substrates activated by phosphorylated ERK1/2, may be involved in the phosphorylation and inactivation of GSK3 (29-31). Tungstate treatment strongly stimulated the phosphorylation of p90rsk at consensus serine 380, both in CHO-R cells and in primary cultured hepatocytes",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Oct 31 278(44) 42785-94",
                "id": "12925525"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84fe"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "These data suggest that Spred-1 negatively regulates hematopoiesis by suppressing not only SCF-induced but also IL-3-induced ERK activation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Dec 10 279(50) 52543-51",
                "id": "15465815"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84fd"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Inhibition of protein tyrosine kinases and MAPK kinase (MEK1/2, upstream activator of p42/44MAPK) abolished A2a purinoceptor-stimulated increases in L-arginine transport, NO production, and p42/44MAPK phosphorylation.",
              "citation": {
                "type": "PubMed",
                "name": "FASEB J 2002 Oct 16(12) 1584-94",
                "id": "12374781"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84fc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "inhibition of the ERK kinases 1 and 2 (MEK1 and 2) by PD098059 (2'-amino-3'-methoxyflavone)",
              "citation": {
                "type": "PubMed",
                "name": "J Physiol 2003 Jan 15 546(Pt 2) 461-70",
                "id": "12527732"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84fb"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Induction of TGF-alpha caused increased pERK1/2 as measured by Western blot of whole-lung homogenate (Figures 1A) ",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2012 Mar 46(3) 380-8",
                "id": "22021337"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84fa"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "After stimulation with the mitogen phorbol 12-myristate 13- acetate (PMA) or serum, conditionally expressed RASSF1A specifically enhanced the activating phosphorylation of ERK, but not of p38 kinase or c-Jun NH2 kinase (Fig. 5A).",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2009 Mar 1 69(5) 1748-57",
                "id": "19223555"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84f9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "In addition to inducing G protein- and non-G protein-related signaling pathways, ANG II, via AT(1) receptors, carries out its functions via MAP kinases (ERK 1/2, JNK, p38MAPK), receptor tyrosine kinases [PDGF, EGFR, insulin receptor], and nonreceptor tyrosine kinases [Src, JAK/STAT, focal adhesion kinase (FAK)].",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2007 Jan 292(1) C82-97",
                "id": "16870827"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84f8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cell Growth Differ 2000 Jun 11(6) 305-14",
                "id": "10910097"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84f7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Clin Cancer Res 2003 Jun 9(6) 2342-9",
                "id": "12796404"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84f6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Jun 22 276(25) 23028-33",
                "id": "11292833"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84f5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Figure 1. Pathways to MUC5AC expression in COPD",
              "citation": {
                "type": "PubMed",
                "name": "Physiol Rev 2007 Jul 87(3) 1047-82",
                "id": "17615396"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84f4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "GRP induced rapid activation of p44/42 MAPK in lung cancer cells through EGFR.",
              "citation": {
                "type": "PubMed",
                "name": "Neoplasia 2005 Apr 7(4) 426-31",
                "id": "15967120"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84f3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Carcinoma, Non-Small-Cell Lung",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "from full text - Furthermore, the decreased expression of either b-arrestin 1 or b-arrestin 2 (via siRNA) resulted in a decrease in ERK1/2 activity",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Apr 21 281(16) 10856-64",
                "id": "16492667"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84f2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "we found that activation of Ras and extracellular signal-regulated kinase (ERK) is necessary for colony-stimulating factor-1 (CSF-1)-mediated c-Myc expression and DNA synthetic (S) phase entry.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Mar 5 274(10) 6553-8",
                "id": "10037749"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84f1"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "On the contrary, D-tubocurarine reduced the levels of phospho- ERK (Fig. 9, panel A, Lanes 4 and 5).",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2004 Jan 1 64(1) 135-45",
                "id": "14729617"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84f0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasm",
                "cell": "",
                "tissue": "mesothelium"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 1995 Nov 108 ( Pt 11) 3599-609",
                "id": "8586671"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84ef"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "The phosphorylation of MAPKs including ERK1/2, p38, and JNK was measured by immunoblot analysis using specific Abs. LPS-induced phosphorylation of ERK1/2, p38, and JNK was inhibited by EGCG (Fig. 4A?C). However, in 67LR-ablated cells, the inhibitory effect of EGCG on LPSinduced upregulation of phosphorylation was attenuated (Fig. 4A?C).",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2010 Jul 1 185(1) 33-45",
                "id": "20511545"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84ee"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "leukemia",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2003 Feb 23(3) 1095-111",
                "id": "12529413"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84ed"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Pretreatment of THP-1 cells with pharmacological inhibitors of PI3K (LY294002), MAPK (PD98059), p38 MAPK (SB203580), and JNK (SP600125) inhibited ET-1-mediated MIP-1b mRNA expression by 89 6 5%, 104 6 7%, 102 6 8%, and 118 6 1%, respectively, when compared with that of untreated cells (Fig.1B).",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2010 Oct 15",
                "id": "20952681"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84ec"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Menshikov, M., Torosyan, N., Elizarova, E., Plakida, K., Vorotnikov, A., Parfyonova, Y., et al. 2006b. Urokinase induces matrix metalloproteinase-9/gelatinase B expression in THP-1 monocytes via ERK1/2 and cytosolic phospholipase A2 activation and eicosanoid production. J. Vasc. Res. 43: 482490. doi:10. 1159/000095248. PMID:16926552.",
              "citation": {
                "type": "PubMed",
                "name": "J Lipid Res 2009 Apr 50 Suppl S189-94",
                "id": "19064999"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84eb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "The elevation of secreted PSA level by the forced expression of ErbB-2 was inhibited by an MEK inhibitor, PD98059. In C-81 cells, the expression of a dominant negative mutant of ErbB-2 reduced the secreted level of PSA. ErbB-2 signal pathway via MAP kinases (ERK1/2) is involved in regulating the secretion of PSA by androgen-independent human prostate cancer LNCaP C-81 cells in an androgen-depleted environment.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2003 Feb 6 22(5) 781-96",
                "id": "12569372"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84ea"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "The present study confirmed that Ang II elicits a rapid and robust phosphorylation of ERK1/2 with a peak at 10 min in HSCs in a time-dependent manner, as demonstrated byWestern blot (Fig. 8A,B).",
              "citation": {
                "type": "PubMed",
                "name": "Regul Pept 2007 Jan 10 138(1) 15-25",
                "id": "16971004"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84e9"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "hepatic stellate cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Hypertension 2003 Mar 41(3) 546-52",
                "id": "12623957"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84e8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2001 Nov 15 20(52) 7658-67",
                "id": "11753643"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84e7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "stimulation of Erk by alpha6beta4 was suppressed by dominant-negative Shc, Ras and RhoA",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1997 May 1 16(9) 2365-75",
                "id": "9171350"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84e6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "MEKK3-dependent activation of an NF-kappaB reporter gene as well as ERK, JNK, and p38 MAP kinases correlated with a requirement for serine at position 526. Constitutively active mutants of MEKK3, consisting of S526D and S526E, were capable of activating a NF-kappaB luciferase reporter gene as well as ERK and MEK, suggesting that a negative charge at Ser526 was necessary for MEKK3 activity and implicating Ser526 as a phosphorylation site.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Mar 10 281(10) 6236-45",
                "id": "16407301"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84e5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "This migration shift of FRS2 is completely abrogated by U0126, a specific MAPK kinase 1 (MEK1) inhibitor, suggesting that ERK1/2 acts as serine/threonine kinase upstream of FRS2.",
              "citation": {
                "type": "PubMed",
                "name": "Biol Chem 2003 Aug 384(8) 1215-26",
                "id": "12974390"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84e4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "We show that the sustained ERK-MAP kinase signalling resulting from transformation by oncogenic Ras down-regulates ROCK1 and Rho-kinase, two Rho effectors required for actin stress fibre formation. The repression of Rho- dependent stress fibre formation by ERK-MAP kinase signalling",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2001 Feb 15 20(4) 755-66",
                "id": "11179220"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84e3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Hypertens 2001 Mar 19(3 Pt 2) 553-9",
                "id": "11327629"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84e2"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Second, 1 uM apelin (65-77) promoted a time-dependent phosphorylation of ERKs in HUVECs, which peaked at 40 s (Fig. 6B).",
              "citation": {
                "type": "PubMed",
                "name": "FASEB J 2004 Dec 18(15) 1909-11",
                "id": "15385434"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84e1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "umbilical vein endothelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "reduction in CD45 expression caused the duration of peak PMA-induced MEK and extracellular signal-regulated kinase (ERK) 1/2 activity to increase from 5 min to 30 min while leading to a 4-fold increase in PMA-dependent PKCdelta activation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Mar 30 276(13) 10212-7",
                "id": "11124968"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84e0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "stimulation with the PAR-2 peptide produced a rapid increase in ERK1/2 activation that did not significantly decline even after 4 h of exposure. SLIGKV also activated p38MAPK with similar levels of activation evident at both early and late time points (Fig. 4B).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Apr 28 281(17) 11792-804",
                "id": "16467309"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84df"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "umbilical vein endothelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cell Prolif 2003 Apr 36(2) 75-86",
                "id": "12680875"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84de"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Similar to cell proliferation, the chemotactic effect of FGF2 requires the activation of the MAPK signaling pathway [30] and is abolished by PKC down-regulation [31].",
              "citation": {
                "type": "PubMed",
                "name": "Cytokine Growth Factor Rev 2005 Apr 16(2) 159-78",
                "id": "15863032"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84dd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "PD 098059, an antagonist of MEK (MAP kinase/ERK kinase), the upstream kinase of ERK, significantly reduced the PDGF-induced activation of ERK and potently inhibited the expression of MKP-1 after stimulation with PDGF",
              "citation": {
                "type": "PubMed",
                "name": "Hypertension 1998 Oct 32(4) 661-7",
                "id": "9774360"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84dc"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "addition of AG1478 also suppressed ATP-mediated phosphorylation of ERK1/2 and I-?B? (Fig. 4A), indicating the involvement of EGFR activation in these signaling events. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2009 Jun 26 284(26) 17858-67",
                "id": "19386603"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84db"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Activation of IL-4Ralpha by IL-13 or IL-4 induced signal transducer and activation of transcription-6 (STAT6), p42/ p44 ERK, p38, and to a lesser extent, SAPK/JNK mitogen-activated protein kinase phosphorylation.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Crit Care Med 2002 Apr 15 165(8) 1161-71",
                "id": "11956062"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84da"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Mol Endocrinol 1999 Apr 13(4) 555-65",
                "id": "10194762"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84d9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "exercise leads to the activation of at least three MAPK signalling pathways, i.e. ERK1/2, p38 MAPK and JNK, in skeletal muscle (Zierath, 2002).",
              "citation": {
                "type": "PubMed",
                "name": "Proc Nutr Soc 2004 May 63(2) 227-32",
                "id": "15294035"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84d8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Muscle, Skeletal"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "VEGF-induced PGI2 production is mediated via ERK1/2-dependent activation of cytosolic phospholipase A2",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2001 Jun 280(6) C1375-86",
                "id": "11350732"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84d7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "in embryonic kidney cells expressing full-length DCC, NTN1 causes increased transient phosphorylation and activity of ERK1 and ERK2 but not of JNK1, JNK2 or MAPK14 this phosphorylation was mediated by MAP2K1 (aka MEK1) and/or MAP2K2 (aka MEK2)",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2002 May 23 417(6887) 443-7",
                "id": "11986622"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84d6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "In VSMCs, ERK1/2 phosphorylation induced by Ang II was abrogated in cells pretreated with AG 1024, a highly selective inhibitor of IGF-1R-PTK (46) ",
              "citation": {
                "type": "PubMed",
                "name": "Cell Biochem Biophys 2007 47(1) 1-10",
                "id": "17406055"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84d5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "We found that activation of the MAPK pathway was responsible for motility, invasion and production of angiogenic factors.",
              "citation": {
                "type": "PubMed",
                "name": "Clin Exp Metastasis 2002 19(4) 301-11",
                "id": "12090470"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84d4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "# Ariadne: Indeed, ERK and RSK (ribosomal S6 kinase), which is activated by ERK , phosphorylate MITF and promote its degradation, thereby leading to an inhibition of tyrosinase expression and melanogenesis ( 25 , 26 ). [ProtModification]",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Sep 13 277(37) 33690-7",
                "id": "12093801"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84d3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Genetic and biochemical experiments have demonstrated that kaposin A activates the ERK1/2 pathway by recruiting the guanine nucleotide exchange factor cytohesin-1 to membranes, leading to enhanced GTP binding of the GTPase, ARF1",
              "citation": {
                "type": "PubMed",
                "name": "Microbiol Mol Biol Rev 2003 Jun 67(2) 175-212, table of contents",
                "id": "12794189"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84d2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Interestingly, although the ERK1/2, p38 and JNK MAPKs were still induced in the Mekk3 knockdown cells, their levels were consistently lower than those in the control cells with similar kinetics at early time-points",
              "citation": {
                "type": "PubMed",
                "name": "Immunology 2007 Feb 120(2) 242-50",
                "id": "17116170"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84d1"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "3 independent signaling pathways, STAT3, MEK1-ERK1/2, and AKT activation, that are coinduced by Lif stimulation were completely suppressed by SOCS3 overexpression",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Invest 2001 Nov 108(10) 1459-67",
                "id": "11714737"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84d0"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "The ERK pathway is the best characterized of the MAPK pathways. Binding of ANG II to AT1Rs activates ERK1/2 within 5 minutes, and in VSMCs ERK 1/2 activity is blocked by inhibition of PLC, suggesting its dependency on calcium (42).",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2007 Jan 292(1) C82-97",
                "id": "16870827"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84cf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "vascular smooth muscle"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Consistent with EGFR activation, AKT and ERK phosphorylation was also observed during the course of ATP-?-S stimulation. Furthermore, ATP-?-S also elicited a similar response in primary HCE cells and BEAS 2B cells, although its effect on signaling in BEAS 2B cells was more transient than that in THCE cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 2007 Mar 1 120(Pt 5) 815-25",
                "id": "17284517"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84ce"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "bronchial epithelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "We found that CCR7 induced a Gi-dependent activation of MAPK members ERK1/2, JNK, and p38, with ERK1/2 and p38 controlling JNK. MAPK members regulated chemotaxis, but not the migratory speed, of DCs.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2005 Apr 1 174(7) 4070-80",
                "id": "15778365"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84cd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "dendritic cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "expression of a catalytically inactive mutant of SHP-2 in COS cells was shown to block ERK phosphorylation in response to leptin studies in COS cells coexpressing ERK1 and obRa or obRb suggested that the magnitude of ERK phosphorylation in response to leptin was significantly greater in cells transfected with obRb Consequences of ERK activation by leptin are many and include induction of specific gene expression, activating c-fos",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2002 Aug 14(8) 655-63",
                "id": "12020765"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84cc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "GKLF induction by H-Fe is mediated through hydroxyl radicals, p38MAP kinase-, calcium-, and protein synthesis-dependent pathways.",
              "citation": {
                "type": "PubMed",
                "name": "FASEB J 2002 Jul 16(9) 1077-86",
                "id": "12087069"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84cb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "In addition, NHERF2 increases LPA-induced ERK activation, which is followed by cyclooxygenase-2 induction via a PLC-dependent pathway.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Jun 24(11) 5069-79",
                "id": "15143197"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84ca"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Exposure to H2O2 enhances c-Myc recruitment to gamma-GCS regulatory regions through ERK-dependent phosphorylation. Phosphorylation at Ser-62 is required for c-Myc recruitment to gamma-GCS promoters and determines the cellular response to oxidative stress induced by different stimuli.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2006 Feb 17 21(4) 509-19",
                "id": "16483932"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84c9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2003 Oct 23(19) 7030-43",
                "id": "12972619"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84c8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Smoke exposure of GM-Ms also resulted in the rapid activation of the MAP kinases ERK and p38 (Figure 4).",
              "citation": {
                "type": "PubMed",
                "name": "Exp Lung Res 2008 Nov 34(9) 599-629",
                "id": "19005923"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84c7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "we stimulated murine satellite cells (the C2C12 cell line) with SDF-1 and demonstrated the phosphorylation of p42/44 MAPK and AKT serine-threonine kinase in these cells.",
              "citation": {
                "type": "PubMed",
                "name": "Folia Histochem Cytobiol 2003 41(1) 13-21",
                "id": "12705474"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84c6"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Satellite Cells, Skeletal Muscle",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "A mutant ErbB3 protein was generated in which Tyr-1325 in a consensus Shc phosphotyrosine-binding domain recognition site was mutated to Phe (ErbB3-Y/F). This mutation abolished the association of Shc with ErbB3 and blocked the activation of mitogen-activated protein kinase by heregulin.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1998 Aug 14 273(33) 20996-1002",
                "id": "9694850"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84c5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2002 Jun 1 16(11) 1356-70",
                "id": "12050114"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84c4"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "jubilant",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2000 Jun 15 164(12) 6244-51",
                "id": "10843677"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84c3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "The FAK-ERK1/2 pathway, a genistein-sensitive tyrosine kinase, and a distinct classical/novel PKC appear selectively required for increased production of collagen XII in cells under tensile stress,",
              "citation": {
                "type": "PubMed",
                "name": "Biochim Biophys Acta 2003 Feb 17 1593(2-3) 239-48",
                "id": "12581868"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84c2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Feb 25 275(8) 5613-9",
                "id": "10681543"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84c1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2002 Feb 22(4) 1027-35",
                "id": "11809795"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84c0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "It was not affected by an inhibitor of protein tyrosine kinase and was reduced by mitogen-activated protein kinase inhibitors.",
              "citation": {
                "type": "PubMed",
                "name": "Naunyn Schmiedebergs Arch Pharmacol 2001 Dec 364(6) 487-95",
                "id": "11770002"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84bf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Clin Exp Immunol 2002 Mar 127(3) 539-46",
                "id": "11966773"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84be"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "epidermal growth factor induces immediate, ERK1/ERK2-dependent activation of endogenous ribosomal transcription inactivation of ERK1/ERK2 causes an equally immediate reversion to the basal transcription level",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2001 Nov 8(5) 1063-73",
                "id": "11741541"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84bd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "The up-regulation of CBP transcriptional activity in response to NGF was, however, prevented by the specific inhibitor of mitogen-activated protein kinase (p42/44(MAPK)) activation, PD98059, which had no effect on the up-regulation induced by cyclic AMP, indicating that activation of the mitogen-activated protein kinase signal pathway is specifically involved in the NGF-induced activation of CBP.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1998 Dec 4 273(49) 32400-7",
                "id": "9829969"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84bc"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "We now show that the phosphorylation of these two residues is critical for determining the stability of Myc. Phosphorylation of Ser 62 is required for Ras-induced stabilization of Myc, likely mediated through the action of ERK.",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2000 Oct 1 14(19) 2501-14",
                "id": "11018017"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84bb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "In human HaCaT keratinocytes for instance, ERK1/2 phosphorylation increases in dependence of EGF-R recruitment to transadhering E-cadherin, and E-cadherin-mediated activation of MAPK was also reported in intestinal epithelial cells (Pece and Gutkind, 2000; Laprise et al., 2004).    ",
              "citation": {
                "type": "PubMed",
                "name": "J Invest Dermatol 2008 Mar 128(3) 501-16",
                "id": "18268536"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84ba"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "transient knockdown of cortactin in serum-supplemented FaDu cells led to decreased activation of Erk and Akt (49).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2010 Nov 30(21) 5057-70",
                "id": "20805359"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84b9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Head and Neck Neoplasms",
                "cell": "squamous cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Using sequence-specific peptides, we found that the second proline-rich domain of DOC-2/DAB2 is the key binding site to Grb2 in the presence of growth factors. Such elevated binding interrupts the binding between SOS and Grb2, which consequently suppresses downstream ERK phosphorylation. Reduced ERK phosphorylation was restored when the binding between DOC-2/DAB2 and Grb2 was interrupted by a specific peptide or by increasing the expression of Grb2.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Jul 27 276(30) 27793-8",
                "id": "11371563"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84b8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "To elucidate the Gab1-dependent signals required for epithelial morphogenesis, we undertook a structure-function approach and demonstrate that association of Gab1 with the tyrosine phosphatase SHP-2 is required for sustained Erk activation and for epithelial morphogenesis downstream from the Met receptor.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2000 Nov 20(22) 8513-25",
                "id": "11046147"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84b7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "This loading of macrophages with free cholesterol activates NF-?B and the MAPKs p38, extracellular-signal-regulated kinase 1 (ERK1) and ERK2, and JNK, thereby inducing the expression of genes encoding inflammatory cytokines (including TNF-? and IL-6)66",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2008 Jul 24 454(7203) 455-62",
                "id": "18650916"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84b6"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "whereas the inhibition of MAPK was able to block the invasive phenomena in both cell types.",
              "citation": {
                "type": "PubMed",
                "name": "Thromb Haemost 2005 May 93(5) 964-75",
                "id": "15886816"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84b5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2001 Mar 1 61(5) 1855-61",
                "id": "11280738"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84b4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Virol 2002 Mar 76(5) 2245-54",
                "id": "11836402"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84b3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "We propose that the FGF-1-induced signaling pathway that leads to promatrilysin expression is ERK-dependent and leads to phosphorylation of Ser-727 on STAT3, phosphorylated STAT3, then binds and transactivates the matrilysin promoter",
              "citation": {
                "type": "PubMed",
                "name": "Neoplasia 4(1) 60-7",
                "id": "11922392"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84b2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "C2-ceramide was found to inhibit the growth of Bel7402 cells by inducing cell cycle arrest. During the process, the expression of p21 protein increased, while that of cyclinD1, phospho-ERK1/2 and c-myc decreased. Furthermore, the level of CDK7 was downregulated, while the transcriptional activity of PPARgamma was upregulated. ",
              "citation": {
                "type": "PubMed",
                "name": "World J Gastroenterol 2007 Feb 21 13(7) 1129-34",
                "id": "17373752"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84b1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Nicotine can also activate the MAP kinase pathway and increase levels of Raf-1, ERK1/2 and MEK1 in a a7-nAChR-dependent manner [16,19,39].",
              "citation": {
                "type": "PubMed",
                "name": "Trends Pharmacol Sci 2008 Mar 29(3) 151-8",
                "id": "18262664"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84b0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasm",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "DFMO increased ERK1/2 and Src activity within 30 min [24],",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2007 Aug 15",
                "id": "17825525"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84af"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "intestinal epithelium"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "At the gene transcriptional level, both IL-6 and Stat3 mRNA levelswere up-regulated in response to MMP12 overexpression (Fig. 4C). Other intracellular oncogenic moleculeswere also analyzed (Supplementary Fig. S2). NFnB, extracellular signal-regulated kinase (ERK), p38, and AKT were all significantly activated in doxycycline-treated bitransgenic mice compared with untreated bitransgenic mice.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2009 Sep 15 69(18) 7252-61",
                "id": "19706765"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84ae"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Alveolar type II cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Neurosci 2003 Jul 2 23(13) 5877-86",
                "id": "12843292"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84ad"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "We report that EphB1 receptors are localized in caveolae, and directly interact with caveolin-1 upon ligand stimulation. This interaction, as well as EphB1-mediated activation of extracellular-signal-regulated kinase (ERK), was abrogated by overexpression of a caveolin-1 mutant lacking a functional scaffolding domain.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 2006 Jun 1 119(Pt 11) 2299-309",
                "id": "16723736"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84ac"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "NNKmediated ERK activation was prevented by U0126 but not by SN50 (fig. 8d).",
              "citation": {
                "type": "PubMed",
                "name": "Eur Respir J 2008 Oct 32(4) 911-23",
                "id": "18508827"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84ab"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Two activities that could phosphorylate MBP were induced -5- fold by NGF treatment of PC12 cells. These activities corresponded to the MAP kinases ERK2 and ERK1, as demonstrated previously (Boulton et al., 199 lb), and were confirmed by immunoblotting (data not shown).",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1995 Mar 1 14(5) 951-62",
                "id": "7889942"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84aa"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "PD98059 (MAPK/ERK1 inhibitor) and SB203580 (p38 MAPK inhibitor) respectively. In isolated rat skeletal muscle specific inhibition of ERK1/2 by PD98059 completely abolishes contraction-mediated p90rsk activity (Ryder et al. 2000).",
              "citation": {
                "type": "PubMed",
                "name": "Proc Nutr Soc 2004 May 63(2) 227-32",
                "id": "15294035"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84a9"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Sep 26 278(39) 37681-9",
                "id": "12821672"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84a8"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "As single agents, FAS blocker C75 and Taxol induced a significant stimulation of the proliferation and cell survival mitogen-activated protein kinase extracellular signal-regulated kinase (ERK1/ERK2 MAPK) activity, whereas, in combination, they interfered with ERK1/ERK2 activation",
              "citation": {
                "type": "PubMed",
                "name": "Int J Cancer 2005 May 20 115(1) 19-35",
                "id": "15657900"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84a7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Time course experiments clearly indicated NGF-induced transient phosphorylation in ECs of all three major signaling molecules Erk1/2, Akt and PLCg. The NGF-induced phosphorylation of these signaling molecules was blocked by K252a, a TrkA inhibitor, confirming that these signaling pathways are initiated by NGF-stimulated TrkA receptors in ECs. ",
              "citation": {
                "type": "PubMed",
                "name": "Vascul Pharmacol 53(3-4) 107-14",
                "id": "20434587"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84a6"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1993 Feb 13(2) 801-8",
                "id": "8423803"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84a5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "treatment of A549 cells with SU6656 caused considerable reduction in ERK1/2 activity and significantly reduced MMP2 and MMP9 expression (Figure 6BFigure 6). ",
              "citation": {
                "type": "PubMed",
                "name": "Biochemistry 2009 Mar 3 48(8) 1838-46",
                "id": "19199380"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84a4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Overexpression of the ERK-1 mutant, but not the ERK-2 mutant, significantly inhibited hyperoxia-induced ARE transcription, suggesting that ERK-1 at least in part mediates Nrf2 translocation and its downstream target expression (Fig. 7B).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Oct 1 279(40) 42302-12",
                "id": "15292179"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84a3"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "In cycling cells, the effects of Nox1 were dose dependent: levels of Nox1 that induced 3- to 10-fold increases in ROS promoted phosphorylation of ERK1/2 and expression of cyclin D1,",
              "citation": {
                "type": "PubMed",
                "name": "Antioxid Redox Signal 8(9-10) 1447-59",
                "id": "16987002"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84a2"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "# Ariadne: Erk has also been shown to induce expression of Fra-1 and Fra-2  ( 42 , 44 ). [Expression]",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2003 Mar 1 170(5) 2427-34",
                "id": "12594266"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84a1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Arterioscler Thromb Vasc Biol 1999 Jan 19(1) 73-82",
                "id": "9888869"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad84a0"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Oct 15 274(42) 30115-21",
                "id": "10514499"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad849f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": " Human ASM cells exposed to the primary proasthmatic T helper type 2 (Th2) cytokine, IL-13, exhibited upregulated expression of 11beta-HSD1, an effect that was attributed to activation of the transcription factor, AP-1, coupled to MAPK signaling via the ERK1/2 and JNK pathways.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2009 May 296(5) L790-803",
                "id": "19251840"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad849e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Muscle, Smooth"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Clin Cancer Res 2002 Jul 8(7) 2356-61",
                "id": "12114440"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad849d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "PK1 induced a time-dependent increase in expression of IL-8 and COX-2, which was significantly reduced by inhibitors of Gq, cSrc, epidermal growth factor receptor (EGFR), and MAPK kinase. Treatment of third-trimester placenta with 40 nm PK1 induced a rapid phosphorylation of cSrc, EGFR, and ERK1/2. Phosphorylation of ERK1/2 in response to PK1 was dependent on sequential phosphorylation of cSrc and EGFR.",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 2008 Jul 149(7) 3470-7",
                "id": "18372330"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad849c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "In addition, immune-complex kinase assays (Fig. lb, lower panels) revealed the stimulation of both epitope-tagged ERK1 and epitope-tagged ERK2 by TPA but not by anisomycin.",
              "citation": {
                "type": "PubMed",
                "name": "Curr Biol 1995 Oct 1 5(10) 1191-200",
                "id": "8548291"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad849b"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "The E2-ER alpha complex rapidly activated multiple signal transduction pathways (i.e., ERK/MAPK, PI3K/AKT) committed to both cell cycle progression and apoptotic cascade prevention.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Physiol 2005 Apr 203(1) 193-201",
                "id": "15389627"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad849a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Bcl-2 positively regulates Sox9-dependent chondrocyte gene expression by suppressing the MEK-ERK1/2 signaling pathway.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Aug 26 280(34) 30517-25",
                "id": "15975921"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8499"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "In both cell types, ERK phosphorylation was suppressed by MKK inhibitors U-0126 or PD-98059 (3, 5, 17), indicating that the mechanism of phosphorylation requires active MKK1/2 (Fig. 1).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2002 Oct 22(20) 7226-41",
                "id": "12242299"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8498"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Acute stimulation of NO production by adenosine occurred independent of changes in intracellular Ca2+, pH, or cAMP but was associated with phosphorylation of p42/p44MAPK.",
              "citation": {
                "type": "PubMed",
                "name": "FASEB J 2002 Oct 16(12) 1584-94",
                "id": "12374781"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8497"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Consistent with the earlier results, p42/44 MAPK and its upstream kinase MEK1/2 were activated in a time-dependent manner by the induction of Pak1 (Fig. 3C).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Nov 17 275(46) 36238-44",
                "id": "10945974"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8496"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Previously, we have shown that phosphorylation of beta-arrestin1 by ERKs at Ser-412",
              "citation": {
                "type": "PubMed",
                "name": "Biochemistry 2002 Aug 27 41(34) 10692-9",
                "id": "12186555"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8495"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Low level expression of MKP-3 blocks totally epidermal growth factor-stimulated ERK1",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1996 Nov 1 271(44) 27205-8",
                "id": "8910287"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8494"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "inhibition of CaMKII activity by specific inhibitors inhibited Erk-1/2 phosphorylation. Whereas CaMK inhibition affected neither integrin-stimulated Akt phosphorylation nor p21Ras or Mek-1 activity, it was necessary for Raf-1 activity...Active CaMKII phosphorylated Raf-1 in vitro. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Nov 14 278(46) 45101-8",
                "id": "12954639"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8493"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "HGF activates P42/P44MAPK (extracellular signal regulated kinase 2/1) and P38 MAPK two and three-fold respectively compared to basal level in a PKC independent manner. The phosphorylation level peaked within 5-10 minutes of HGF treatment.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2001 Dec 6 20(56) 8125-35",
                "id": "11781826"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8492"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "melanocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 May 3 277(18) 15376-84",
                "id": "11859076"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8491"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": " PD0325901 is a selective inhibitor of MEK1 and MEK2 kinases that rapidly abrogates ERK signaling",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2009 Mar 17 106(11) 4519-24",
                "id": "19251651"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8490"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "In summary, these data demonstrate that adiponectin initially increases TNF alpha production by macrophages via ERK1/2 Egr-1 and NFkB-dependent mechanisms; these increases in TNF-alpha in turn lead to increased expression of interleukin-10 and an eventual dampening of LPS-mediated cytokine production in macrophages. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 Jul 27 282(30) 21695-703",
                "id": "17537727"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad848f"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "he independent signaling competence of Tnfr1 and Tnfr2 was further confirmed in the studies of various kinases of the Erk/Mapk signal transduction cascade; Erk1, Erk2, Raf-1, Raf-B, Mek-1, Mekk, and p90rsk all were found to be activated independently by Tnfr1 as well as Tnfr2. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1996 Nov 8 271(45) 28097-104",
                "id": "8910423"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad848e"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Biochemistry 2003 Jun 24 42(24) 7571-9",
                "id": "12809513"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad848d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Using phosphoinositide 3-kinase (PI3-kinase) inhibitor LY294002 and Src inhibitor PP2, we show that interleukin (IL)-18-induced ERK1/2 activation is Src kinase-dependent.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Sep 20 277(38) 34679-91",
                "id": "12105209"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad848c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "TGF-alpha exerts a neuroprotective action against NMDA toxicity, in which Erk1/2 activation plays a key role, and suggest that the underlying mechanisms involve recovery of translation inhibition, mediated at least in part by eIF4E phosphorylation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Aug 8 278(32) 29552-9",
                "id": "12771152"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad848b"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2004 Jun 1 172(11) 7053-9",
                "id": "15153527"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad848a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Figure 4.  T1/ST2 activates MAP kinases p42/44 and p38",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Dec 20 277(51) 49205-11",
                "id": "12368275"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8489"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Determination of kinase activity in immunoprecipitates of the ERKI isoform, that were prepared from NDF- (Figure 6A) or EGF-treated cells (Figure 6B), revealed that the absence of ErbB-2 at the cell surface caused significant reduction in the extent and duration of kinase activation by either growth factor.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1996 Jan 15 15(2) 254-64",
                "id": "8617201"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8488"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "These data demonstrate that it is the hemin-induced surge in cellular ROS levels, in particular the superoxide generated most likely from NADPH oxidase activity, and consequent oxidative stress which mediates Egr-1 upregulation via ERK-1/2 activation.",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 2008 Jan 4 102(1) 42-50",
                "id": "17967787"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8487"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "DAPK interacts with ERK through a docking sequence within its death domain and is a substrate of ERK. Phosphorylation of DAPK at Ser 735 by ERK increases the catalytic activity of DAPK both in vitro and in vivo.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2005 Jan 26 24(2) 294-304",
                "id": "15616583"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8486"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Also, inhibitors of Src and of Erk1/2 kinases markedly reduced NE-stimulated R2 expression.",
              "citation": {
                "type": "PubMed",
                "name": "Exp Cell Res 2002 Apr 1 274(2) 207-15",
                "id": "11900481"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8485"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "brown adipocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "inhibition of the activation of ERK by specific inhibitors of MEK1 blocks the up-regulation of VEGF by low pH",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem. 2002 Mar 29;277(13):11368-74",
                "id": "11741977"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8484"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Overexpression of gene 33 protein in mouse fibroblasts inhibited (i) cell proliferation driven by ErbB-2 but not by serum and sustained activation of ERK 1 and 2 by ErbB-2 but not by serum.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2000 Oct 20(20) 7735-50",
                "id": "11003669"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8483"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "LCK activates Erk1 and Erk2, the activation of Erk2 was greater than Erk1.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Nov 24 275(47) 37224-31",
                "id": "10978311"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8482"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Figure 3 Activation of ERKs by IL-1b and TNFa in ventricular myocytes. ",
              "citation": {
                "type": "PubMed",
                "name": "J Mol Cell Cardiol 1999 Dec 31(12) 2087-99",
                "id": "10640438"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8481"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "myocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Activation of ERK1/2 and NF-kB was seen after exposure to DSPs.",
              "citation": {
                "type": "PubMed",
                "name": "ScientificWorldJournal 2010 10 2139-56",
                "id": "21057728"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8480"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "In macrophages, CD74 demonstrates high-affinity binding to MIF. MIF binds to the extracellular domain of CD74; this complex is required for MIF-mediated MAPK activation and cell proliferation [16] .",
              "citation": {
                "type": "PubMed",
                "name": "Oncology 2008 75(3-4) 127-33",
                "id": "18791328"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad847f"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "nduction of IL-1beta caused by CSE was dependent on ERK1/2 and NF-{kappa}B in the human alveolar type II-like epithelial cell line A549 and HBEC. Surprisingly, phosphorylated I{kappa}B levels were decreased in a dose-dependent manner in spite of sustained activation of NF-{kappa}B (113).",
              "citation": {
                "type": "PubMed",
                "name": "Physiol Rev 2007 Jul 87(3) 1047-82",
                "id": "17615396"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad847e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "bronchial epithelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Gal-9 induced phosphorylation of the MAPK p38 and ERK1/2 in DCs, and an inhibitor of p38 signaling, but not inhibitors of signaling by either ERK1/2 or PI3K, blocked Gal-9-induced up-regulation of costimulatory molecule expression and IL-12 production.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2005 Sep 1 175(5) 2974-81",
                "id": "16116184"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad847d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "dendritic cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "overexpression of wild-type PTEN in the MCF-7 breast cancer line results in phosphatase activity-dependent decreases in the phosphorylation of ETS-2 PTEN blocks insulin-stimulated ETS-2 phosphorylation Our observations, therefore, suggest that PTEN blocks insulin-stimulated ETS-2 phosphorylation through inhibition of the ERK members of the MAP kinase family",
              "citation": {
                "type": "PubMed",
                "name": "Hum Mol Genet 2002 Jul 15 11(15) 1687-96",
                "id": "12095911"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad847c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "diethylmaleate, an intracellular ROS inducer of H2O2 was found to increase ERK1/2 phosphorylation in a Src-independent manner in rat-2 fibroblasts (36).",
              "citation": {
                "type": "PubMed",
                "name": "Cell Biochem Biophys 2007 47(1) 1-10",
                "id": "17406055"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad847b"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Nucleic Acids Res 1994 Dec 11 22(24) 5173-6",
                "id": "7816602"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad847a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "HGF can induce serine/threonine phosphorylation of paxillin most probably mediated directly by ERK",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Mar 22 277(12) 10452-8",
                "id": "11784715"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8479"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Moreover, calpain, which is increased in Parkinson's disease neurons [66], appears to be a direct cytoplasmic target of ERK1/2 [67].",
              "citation": {
                "type": "PubMed",
                "name": "Eur J Biochem 2004 Jun 271(11) 2060-6",
                "id": "15153095"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8478"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "the phosphorylation of extracellular signal-regulated kinase, c-Jun NH(2)-terminal protein kinase, and p38 was significantly higher in the cell lines expressing reduced laminin receptor, regardless of the exposure to exogenous laminin.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2004 May 15 64(10) 3572-9",
                "id": "15150114"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8477"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "In hyperplastic lung tissues and in tumors induced at early times after BRafVE expression, a high percentage of cells stain positive for Ki67 (Fig. 4E,F), phospho-histone H3, and BrdU incorporation. However, in tumors observed at later times, the percentage of Ki67-positive cells is dramatically decreased even though the BRafVEMEKERK signaling pathway remains active in these cells (Figs. 3A,B, 4G).",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2007 Feb 15 21(4) 379-84",
                "id": "17299132"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8476"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "TamR-1 cells also showed a concomitant increase in total ERBB3 but no change in EGFR was noted (Fig. 2A). Most noteworthy, IGF1R appeared down-regulated. Increases in activated AKT, MAPK3/1 and its downstream partner RPS6KA2 were also detected (Fig. 2B and C).",
              "citation": {
                "type": "PubMed",
                "name": "Endocr Relat Cancer 2008 Dec 15(4) 985-1002",
                "id": "18824559"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8475"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "In asbestos-associated transformation of rodent mesothelial cells, the use of dominant negative ERK1 or Fra-1 constructs reverses the phenotype of mesothelioma cells to that of normal mesothelial cells (12). Moreover, Fra-1 expression is increased in human mesotheliomas and in other tumor types. ",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2006 Jun 34(6) 666-9",
                "id": "16484683"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8474"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "mesothelioma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Pretreatment with PP2, a specific inhibitor of Src family tyrosine kinase, completely blocked the NHERF2-dependent increase of the phosphorylation of ERK and Akt, suggesting that NHERF2 up-regulates Erk phosphorylation through a Src family kinase-dependent pathway.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2004 Jul 16(7) 791-800",
                "id": "15115658"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8473"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Stem cell factor (SCF) induced activation of Erk1 and 2.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2002 Oct 1 21(19) 5097-108",
                "id": "12356726"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8472"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Lung Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Jul 8 280(27) 25611-20",
                "id": "15890648"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8471"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Sp1, SRE-1 binding protein, and CBP are part of the transcriptional complex resulting in induction of LDL receptor expression in response to activation of the Raf/MEK/p42/44MAPK cascade. MEK=MAP2K1,2 p42=MAPK1 44MAP=MAPK3",
              "citation": {
                "type": "PubMed",
                "name": "J Lipid Res 2003 Mar 44(3) 584-93",
                "id": "12562867"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8470"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "The 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced activation of ERK1/2 through the phosphorylation of threonine and tyrosine at 202 and 204, respectively",
              "citation": {
                "type": "PubMed",
                "name": "Mol Carcinog 2006 Jan 45(1) 26-37",
                "id": "16267831"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad846f"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Plasminogen, fibrinogen, and P2-C suppressed apoptosis via activation of Akt and ERK1/2 kinases, while angiostatin and P1 failed to activate these prosurvival pathways and did not prevent neutrophil apoptosis. ",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2008 Sep 1 181(5) 3609-19",
                "id": "18714035"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad846e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "The NFIL3 (E4BP4) transcription factor, Bcl-xL, and constitutively active mutants of components in Ras signal transduction pathways have been identified as key regulation proteins affecting murine interleukin-3 (IL-3)-dependent cell survival. expression of Nfil3 is regulated by oncogenic Ras mutants through both the Raf-mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1999 Apr 19(4) 2754-62",
                "id": "10082541"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad846d"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Nevertheless, we confirmed that VEGFR-1 mediated signaling by utilizing the VEGFR-1-specific ligand VEGF-B. Activated Erk-1/2 signaling was again observed in both L3.6pl and Panc-1 cells, with maximal stimulation at 3 minutes that decreased to baseline levels by 30 minutes (Fig. 3). No activation of Akt or JNK/SAPK signaling was detected (data not shown).",
              "citation": {
                "type": "PubMed",
                "name": "Cancer 2005 Jul 15 104(2) 427-38",
                "id": "15952180"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad846c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "SDF-1alpha-induced chemokine expression was abrogated upon inclusion of U0126, a pharmacological inhibitor of ERK1/2, indicating that the ERK signaling cascade is involved in this response.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2001 Feb 15 166(4) 2695-704",
                "id": "11160334"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad846b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "We found that inhibiting ERK1/2 reduced DISC formation relative to JNK, p38 inhibition, suggesing that ERK1/2 pathway may participate in apoptosis (Fig. 3).",
              "citation": {
                "type": "PubMed",
                "name": "J Toxicol Sci 2010 35(1) 33-9",
                "id": "20118622"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad846a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "AG 1478 (EGF receptor tyrosine kinase inhibitor), PD 98059 (ERK1/2 inhibitor), and SB 203580 (p38 inhibitor) significantly inhibited EGF-induced p11 expression.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Oct 11 277(41) 38431-40",
                "id": "12163506"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8469"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Exp Cell Res 2002 Oct 1 279(2) 219-26",
                "id": "12243747"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8468"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Dec 6 277(49) 47373-9",
                "id": "12239221"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8467"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Loss of b-catenin expression leads to a dramatic reduction in ERK1/2 activity (Figs. 6C and D).",
              "citation": {
                "type": "PubMed",
                "name": "Dev Biol 2005 Jul 1 283(1) 226-39",
                "id": "15907834"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8466"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": "Epithelium"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Expression of N17Ras attenuated activation of ERK (Figure 4A) and JNK (Figure 4B). In contrast, selective activation of Ras was sufficient for ERK but not JNK activation.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2003 Jun 28(6) 762-9",
                "id": "12600818"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8465"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "bronchial epithelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "In turn, this impaired ERK1/2 activation in K8-null hepatocytes is associated with a drastic reduction in c-Flip protein, an event that also holds in a K8-null mouse mammary cell line.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Aug 24(16) 7072-81",
                "id": "15282307"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8464"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "U0126 indeed inhibited the insulin-induced phosphorylation of ERK1/2",
              "citation": {
                "type": "PubMed",
                "name": "Diabetes 2003 May 52(5) 1073-80",
                "id": "12716735"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8463"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "We previously showed that ERK1 phosphorylates HSF1 on serine 307 and leads to secondary phosphorylation by glycogen synthase kinase 3 (GSK3) on serine 303",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2003 Sep 23(17) 6013-26",
                "id": "12917326"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8462"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Re-expression of HSulf-1 in ovarian cancer cell lines resulted in diminished HSPG sulfation, diminished phosphorylation of receptor tyrosine kinases that require sulfated HSPGs as co-receptors for their cognate ligands, and diminished downstream signaling through the extracellular signal-regulated kinase pathway after treatment with fibroblast growth factor-2 or heparin-binding epidermal growth factor.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Jun 20 278(25) 23107-17",
                "id": "12686563"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8461"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "NNK has been found to promote Ca2+ influx, to release serotonin and to activate both protein kinase C (PKC) and the MAP kinase pathway to stimulate the proliferation of SCLC cells [42,45].",
              "citation": {
                "type": "PubMed",
                "name": "Trends Pharmacol Sci 2008 Mar 29(3) 151-8",
                "id": "18262664"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8460"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Carcinoma, Small Cell",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "from full text - we found that in turn, ectopic expression of WT and Foxo1 mutants in primary cultures of rat hepatocytes increased the phosphorylation of ERK1/2, JNK1/2, and p38",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 2007 Feb 15",
                "id": "17303659"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad845f"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "hepatocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Phosphorylation of both ERKs remained high for 2 h in the T47D/puro cells, whereas it decreased to the basal level in the T47D/5R cells after 2 h.....More striking differences between the two cell lines were observed when cells were stimulated with NDF (Fig. 4B).....Therefore, we conclude that both EGF- and NDF-induced MAPK activation is impaired by the absence of cell surface ErbB-2.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1995 Mar 15(3) 1182-91",
                "id": "7532277"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad845e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "PMA and granulocyte/macrophage colony-stimulating factor induce Egr-1 expression through ERK and p38 activation, respectively.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 May 23 278(21) 18859-67",
                "id": "12618431"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad845d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Stem Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Pretreatment of the cells with PD 98059 and U-126 (MEK1/MEK2 inhibitor) reduced IL1B-induced increases in Erk activity.",
              "citation": {
                "type": "PubMed",
                "name": "J Pharmacol Exp Ther 2003 Jun 305(3) 981-8",
                "id": "12626640"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad845c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "SSB-1 also enhanced HGF-induced Erk phosphorylation",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Apr 22 280(16) 16393-401",
                "id": "15713673"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad845b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Recombinant HVH2 phosphatase exhibited a high substrate specificity toward activated ERK and dephosphorylated both threonine and tyrosine residues of activated ERK1 and ERK2",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1995 Mar 31 270(13) 7197-203",
                "id": "7535768"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad845a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "In many cells PKA inhibits the extracellular receptor kinase (ERK1/2) cascade of the mitogen-activated protein kinase (MAPK) pathway leading to inhibition of cell proliferation.",
              "citation": {
                "type": "PubMed",
                "name": "Hum Mol Genet 2003 Jul 1 12(13) 1475-84",
                "id": "12812976"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8459"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "activation of ERK depended on EGFR, Src tyrosine kinase and calcium calmodulin in PC12 cells (31), while requiring ras/Raf-1/MEK activation in human neutrophils (58).",
              "citation": {
                "type": "PubMed",
                "name": "Front Biosci 2009 14 4809-14",
                "id": "19273391"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8458"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "from full text - we used the dominant negative approach by transfecting the HEK 293 cell line with D556A-PDE4D5. Challenge of these cells with isoprenaline causes a marked potentiation of ERK1/2 phosphorylation (Fig. 3 d and e)",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2003 Feb 4 100(3) 940-5",
                "id": "12552097"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8457"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "inflammatory fluids. Chemerin is secreted as a precursor of low biological activity, which upon proteolytic cleavage of its COOH-terminal domain, is converted into a potent and highly specific agonist of ChemR23, the chemerin receptor. Activation of chemerin receptor results in intracellular calcium release, inhibition of cAMP accumulation, and phosphorylation of p42-p44 MAP kinases, through the Gi class of heterotrimeric G proteins.",
              "citation": {
                "type": "PubMed",
                "name": "J Exp Med 2003 Oct 6 198(7) 977-85",
                "id": "14530373"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8456"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "a study from our group has recently shown that ERK can also directly phosphorylate TSC2 on Ser664, leading to the inhibition of the complex (Ma et al., 2005a).",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2008 Sep 18 27(41) 5527-41",
                "id": "18794886"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8455"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasm",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "lyn kinase is activated and physically associated with MAP kinase/ERK1.",
              "citation": {
                "type": "PubMed",
                "name": "Immunobiology 2000 Nov 202(4) 363-82",
                "id": "11131153"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8454"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Treatment with LPS resulted in significant increases in ERK, JNK, and p38 phosphorylation compared with control, and these events were not inhibited by cotreatment with lutein (Fig. 4D).",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2008 Sep 15 45(6) 885-96",
                "id": "18620044"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8453"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "leukemia",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Data in isolated fibroblasts (26,56), neutrophils (57,58), endothelial and vascular smooth muscle cells (5961), neural cells (31,62), cardiomyocytes (63) and whole lung tissue (64) showed that, in addition to other known oxidants, peroxynitrite is also a powerful activator of ERK.",
              "citation": {
                "type": "PubMed",
                "name": "Front Biosci 2009 14 4809-14",
                "id": "19273391"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8452"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": "vascular smooth muscle"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Human recombinant CyPA can mimic the effects of secreted CyPA to stimulate ERK1/2 and cell growth. The peptidyl-prolyl isomerase activity is required for ERK1/2 activation by CyPA.",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 2000 Oct 27 87(9) 789-96",
                "id": "11055983"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8451"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "NAC treatment markedly suppressed ERK phosphorylation. It inhibited ERK activation",
              "citation": {
                "type": "PubMed",
                "name": "Int Immunopharmacol 2005 Oct 5(11) 1641-51",
                "id": "16039554"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8450"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "umbilical vein endothelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": " Our results show that both Gab protein-associated IL-6-induced complex formation and phosphorylation of SHP2-Grb2 are decreased in the presence of inactive Hck. Consequently, Gab-associated activation of downstream signaling molecules ERK and AKT-1 mediating MM cell growth and survival are significantly decreased.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 May 14 279(20) 21658-65",
                "id": "15010462"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad844f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Multiple Myeloma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "The redox-dependent enhancement of Grb2 recruitment to LMW-PTP ultimately leads to an improvement of ERK activation, likely triggering a prosurvival signal against the oxidant environment.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2006 Sep 22 348(2) 367-73",
                "id": "16890200"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad844e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "We report that inhibition of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase (MEK)-1/2 blocked BCR-induced activation of extracellular signal-regulated kinase (ERK).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Apr 5 277(14) 12144-50",
                "id": "11823472"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad844d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "b-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "We investigated the possibility that the induction of CD13/APN is mediated by phosphorylation of Ets-2 via RAS/MAPK. A phosphorylation-defective Ets-2 mutant, T72A, failed to transactivate CD13/APN, suggesting that Ets-2 phosphorylation is obligatory for CD13/APN induction.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Dec 5 278(49) 49358-68",
                "id": "14507917"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad844c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "1) STAT proteins play an essential role in angiotensin II-induced vascular smooth muscle cell proliferation, 2) JAK2 plays an essential role in the tyrosine phosphorylation of Raf-1, and 3) convergent mitogenic signaling cascades involving the cytosolic kinases JAK2, MEK1, and ERK1 mediate vascular smooth muscle cell proliferation ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1997 Sep 26 272(39) 24684-90",
                "id": "9305939"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad844b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "DFMO leads to inactivation of p42/p44 MAPK and induction of p21Waf/CIP1(CDKN1A)",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Mol Med 7(2) 113-26",
                "id": "12927050"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad844a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Inhibition of I kappa B-alpha phosphorylation, PI3-kinase or ERK1/2 activation blocked IL-8 release",
              "citation": {
                "type": "PubMed",
                "name": "Eur J Immunol 2004 Jun 34(6) 1733-43",
                "id": "15162444"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8449"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "TPO induced strong and sustained activation of ERK1/2. The TPO induced activation of ERK started around 15 minutes of stimulation and reached a maximum around 2 hours of treatment.",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2005 Jun 1 105(11) 4258-63",
                "id": "15705785"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8448"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "hematopoietic",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Both PD98059 and SB203580, inhibitors of ERK1/ERK2 and p38 strongly suppressed IL-1beta induced COX-2 expression in a dose dependent manner, indicating that they mediate IL-1beta induced COX-2 expression.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Pharmacol 2002 Nov 62(5) 1112-8",
                "id": "12391274"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8447"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol 1999 Dec 277(6 Pt 1) E1046-54",
                "id": "10600794"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8446"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "hKSR-2 also regulates the activity of MEKK3 (another MAP3K family member) in HEK-293T cells. We demonstrate that hKSR-2 is a negative regulator of MEKK3-mediated activation of MAP kinase (specifically ERK and JNK) and NF-kappaB pathways, and concurrently inhibits MEKK3-mediated interleukin-8 production.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2005 Sep 9 334(4) 1214-8",
                "id": "16039990"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8445"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "In human HaCaT keratinocytes for instance, ERK1/2 phosphorylation increases in dependence of EGF-R recruitment to transadhering E-cadherin, and E-cadherin-mediated activation of MAPK was also reported in intestinal epithelial cells (Pece and Gutkind, 2000; Laprise et al., 2004).    ",
              "citation": {
                "type": "PubMed",
                "name": "J Invest Dermatol 2008 Mar 128(3) 501-16",
                "id": "18268536"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8444"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": "Epithelium"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "indicating that this pathway seems to be more specialized in proliferation of foetal brown adipocytes (Valverde et al. 1995). The chemical compound PD98059 is a selective and cell permeable inhibitor of MAPK kinase that acts by inhibiting the activation of MAPK (Alessi et al. 1995). When brown adipocytes were cultured with PD98059 together with insulin or IGF-I, an enhanced FAS mRNA expression was observed (Porras et al. 1998).",
              "citation": {
                "type": "PubMed",
                "name": "Mini Rev Med Chem 2005 Mar 5(3) 269-78",
                "id": "15777261"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8443"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "TNF-a induced minimal activation of MAPKerk after brief periods of exposure (515 min); however, phosphoactivation of MAPKerk was observed by 60 min.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2000 Aug 1 165(3) 1618-25",
                "id": "10903772"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8442"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "bronchial epithelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Stimulation of TLRs leads to activation of NF-?B, MAPKs, JuN N-terminal kinases (JNKs), p38 and ERKs, and interferon regulatory factor (IRF3, IRF5 and IRF7) signalling pathways5.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2009 Jan 9(1) 57-63",
                "id": "19052556"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8441"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "CO activated p38 MAPK, pERK1/2 and Akt at 30 min as determined by phosphorylation in a dose (Figure 4A) and time (Figure 4B) dependent manner.",
              "citation": {
                "type": "PubMed",
                "name": "PLoS One 2009 4(12) e8139",
                "id": "19956541"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8440"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "ErbB2 over-expression was functional since we observed an approximately 6-fold increase in P-Ser 473 of Akt, and a 2.4 fold increase in P-Erk 1/2 levels in CAErbB2 cells compared to vector control (Fig. 1B)",
              "citation": {
                "type": "PubMed",
                "name": "BMC Cell Biol 2009 10 64",
                "id": "19754954"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad843f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "We have shown that H2O2 increases ERK1/2 phosphorylation, which has also been recently shown to be important in H2O2 -induced neutrophil chemotaxis.",
              "citation": {
                "type": "PubMed",
                "name": "PLoS One 2012 7(11) e49215",
                "id": "23152875"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad843e"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "miR-155 transfected cells showed a significant reduction in angiotensin II-induced extracellular signal-related kinase 1/2 (ERK1/2) activation. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Jul 7 281(27) 18277-84",
                "id": "16675453"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad843d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "IGF-1 stimulation of MEK, Erk, p90Rsk, and Akt were accordingly augmented.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Nov 14 278(46) 45492-8",
                "id": "12970367"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad843c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biochem 2000 Sep 7 79(3) 355-69",
                "id": "10972974"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad843b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "NGF activates Erk1/Erk2 and JNK but not p38MAPK in J774 cells... NGF also induced phosphorylation of JNK",
              "citation": {
                "type": "PubMed",
                "name": "J Leukoc Biol 2001 Jun 69(6) 1019-26",
                "id": "11404390"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad843a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "several downstream substrates of ERK1/2 kinase have been identified (Brunet & Pouyssegur, 1997), including p90 ribosomal S6 kinase (p90rsk, also known as MAPK-activated protein kinase (MAPKAP-K) 1; Zhao et al. 1996) and mitogen- and stress-activated kinases (MSK) 1 and 2 (Deak et al. 1998).",
              "citation": {
                "type": "PubMed",
                "name": "Proc Nutr Soc 2004 May 63(2) 227-32",
                "id": "15294035"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8439"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "AVP induces extracellular signal-related kinase, ERK1 [p44mapk] and ERK2 [p42mapk] activation, a response prevented by treatment with mitogen-activated protein kinase kinase",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2002 Mar 282(3) C434-50",
                "id": "11832328"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8438"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2001 May 21(9) 2981-90",
                "id": "11287604"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8437"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Biochemistry 2005 Jun 21 44(24) 8890-7",
                "id": "15952796"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8436"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2002 Jun 15 62(12) 3530-7",
                "id": "12068000"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8435"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "It is known that LPS stimulation leads to increased activation of three subgroups of MAPKs, i.e., ERK, JNK, and p38, in murine macrophages and human monocytes (38, 39).",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2002 Aug 1 169(3) 1401-9",
                "id": "12133965"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8434"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "TRAIL-induced Erk activation was observed in both control and cytokine-pretreated cells (Fig. 6AGo), but the kinetics of Erk activation was delayed in IL-1/TNF{alpha}-treated cells (Fig. 6AGo). ",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Endocrinol Metab 2004 Jan 89(1) 250-7",
                "id": "14715858"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8433"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "thymic epithelium",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Thus, thrombin suppresses eNOS and upregulates ECE-1 expression via Rho/ROCK and ERK pathway, respectively.",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 2001 Sep 28 89(7) 583-90",
                "id": "11577023"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8432"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Here we have identified a novel MAP kinase kinase kinase (MAPKKK), termed MLTK (for MLK-like mitogen-activated protein triple kinase), whose expression is increased by activation of the ERK/MAPK pathway.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Feb 9 276(6) 4276-86",
                "id": "11042189"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8431"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "In Rac2(-/-) T cells, proliferation was reduced upon stimulation with either plate-bound anti-CD3 or T cell receptor-specific antigen. This defect is accompanied with decreased activation of mitogen activated protein kinase extracellular signal-regulated kinase (ERK)1/2 and p38, and reduced Ca(2)+ mobilization. TCR stimulation-induced actin polymerization is also reduced",
              "citation": {
                "type": "PubMed",
                "name": "J Exp Med 2001 Oct 1 194(7) 915-26",
                "id": "11581314"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8430"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "PMA (100 nM) and EGF (25 ng/ml) induced the activation of ERK1/ ERK2 in glioblastoma cell lines ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Mar 4 280(9) 7729-38",
                "id": "15618223"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad842f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Therefore, PDGF beta receptor, ERK1/2, PLC and PKC are involved in the signal transduction of PDGF-induced growth response of rat cardiac myocytes.",
              "citation": {
                "type": "PubMed",
                "name": "Regul Pept 2005 Apr 15 127(1-3) 11-8",
                "id": "15680465"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad842e"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "cardiomyocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "the phosphorylation of and protein levels of p42/44 mitogen-activated protein kinase (p42/44MAP kinase) were increased about 3.9- and 3.2-fold in ALD livers",
              "citation": {
                "type": "PubMed",
                "name": "Hepatology 2002 Feb 35(2) 425-32",
                "id": "11826419"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad842d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Phosphorylation of SRC-1 by MAPK was required for optimal ligand-independent activation of the AR by IL-6.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Oct 11 277(41) 38087-94",
                "id": "12163482"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad842c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "the Mek1/2-specific inhibitors, PD98059 and U0126, both completely abolished forskolin, PMA, and GIP-mediated ERK1/2 phosphorylation, supporting a role for Mek1/2 in the cascade (Fig. 4  C).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Oct 4 277(40) 37088-97",
                "id": "12138104"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad842b"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "HCA furthermore activated ERK pathway, and ERK inhibitor reversed inhibitory effect of HCA on cell growth and transcriptional activation of NF-kappaB. ",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Pharmacol 2005 Oct 15 70(8) 1147-57",
                "id": "16143316"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad842a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "It is known that LPS stimulation leads to increased activation of three subgroups of MAPKs, i.e., ERK, JNK, and p38, in murine macrophages and human monocytes (38, 39).",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2002 Aug 1 169(3) 1401-9",
                "id": "12133965"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8429"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Monocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "In response to mitogenic stimulation with platelet-derived growth factor (PDGF), SMC rapidly express NOR1 through an ERK-MAPK-dependent signaling pathway. 5'-deletion analysis, site-directed mutagenesis, and transactivation experiments demonstrate that PDGF-induced NOR1 expression is mediated through a cAMP-response element-binding protein (CREB)-dependent transactivation of the NOR1 promoter.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Nov 3 281(44) 33467-76",
                "id": "16945922"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8428"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Apr 24(8) 3227-37",
                "id": "15060146"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8427"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "siRNA-mediated depletion of B-Raf reduced cell proliferation by up to 65% through the inhibition of ERK1/2 activation, irrespective of the mutational status of B-Raf.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Apr 7 281(14) 9238-50",
                "id": "16452469"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8426"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Cells were treated with LY294002 prior to CS exposure, and CS-induced ERK1/2 kinase activation was assayed by immunoblot analysis (Fig. 4A). PI3K inhibitor completely blocked CS-stimulated ERK1/2 activation.  # from full text",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Apr 14 281(15) 10174-81",
                "id": "16490785"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8425"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "respiratory epithelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Because PDGFRb activation, through transphosphorylation of tyrosine residues in its cytoplasmic domain, triggers a cascade of phosphorylation events which eventually lead to the activation of extracellular regulated-protein kinases (Erks), phosphorylated- Erk1/2 was used as an indicator of PDGFRb activation [7].",
              "citation": {
                "type": "PubMed",
                "name": "PLoS One 2009 4(9) e6922",
                "id": "19742316"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8424"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "The kinase activity of RSK1 or RSK2 was enhanced by in vitro incubation with ERK1",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1996 Nov 22 271(47) 29773-9",
                "id": "8939914"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8423"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Figure 4 shows the inhibitory effect of gefitinib on EGFinduced autophosphorylation of EGFR, and phophorylation of Akt and ERK1/2 in three of the NSCLC cell lines. EGF stimulated EGFR autophosphorylation and activation of Akt and ERK1/2 in PC9 (A), A549 (B), and QG56 (C) cells, and activation was blocked to different extents by gefitinib.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cancer Ther 2004 Apr 3(4) 465-72",
                "id": "15078990"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8422"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "ERK/Ets-1 pathway",
              "citation": {
                "type": "PubMed",
                "name": "PLoS Pathog 2007 Mar 3(3) e44",
                "id": "17397260"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8421"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "ATF1 and CREB can be phosphorylated by Rsk2 which is a protein kinase directly activated by Erk MAP kinase.  These results suggest a signaling pathway in which Erk MAP kinase activates the c-fos enhancer by direct phosphorylation of p62TCF and by activation of Rsk related kinases that phosphorylate ATF1 and CREB.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2000 Mar 9 19(11) 1379-85",
                "id": "10723128"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8420"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Pretreatment with Triptorelin or [d-Lys(6)]GnRH-II blocked EGF-induced autophosphoryla-tion of EGF receptor and activation of mitogen-activated protein kinase (extracellular-signal-regulated kinase 1/2 (ERK1/2)) in these cells.",
              "citation": {
                "type": "PubMed",
                "name": "Eur J Endocrinol 2005 Oct 153(4) 613-25",
                "id": "16189183"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad841f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Taken together, RhoA, ROCK, p38MAPK, ERK1/2, and p47(PHOX) may be subsequently activated, leading to activation of NADPH oxidase to produce superoxide. ",
              "citation": {
                "type": "PubMed",
                "name": "Exp Mol Med 2005 Dec 31 37(6) 575-87",
                "id": "16391519"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad841e"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "PD98059, a specific inhibitor of ERK kinase (MEK1), reduced H2O2-induced AR expression. EGF alone elicited activation of ERK and induction of AR expression",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2001 Jul 15 31(2) 205-16",
                "id": "11440832"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad841d"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": "Muscle, Smooth"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2005 Jul 22 333(1) 110-5",
                "id": "15950189"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad841c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Membrane array analysis suggested that both extracellular signal-regulated kinase (ERK) 1/2 and c-Jun- NH2-terminal kinase (JNK) signal but not p38 MAPK signaling was activated in response to nicotine",
              "citation": {
                "type": "PubMed",
                "name": "Mutat Res 659(3) 221-31",
                "id": "18495523"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad841b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "bronchial epithelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "RKIP has been shown to disrupt the Raf-1-MEK1/2 [mitogen-activated protein kinase-ERK (extracellular signal-regulated kinase) kinase-1/2]-ERK1/2 and NF-kappaB signaling pathways, via physical interaction with Raf-1-MEK1/2 and NF-kappaB-inducing kinase or transforming growth factor beta-activated kinase-1, respectively, thereby abrogating the survival and antiapoptotic properties of these signaling pathways.",
              "citation": {
                "type": "PubMed",
                "name": "Adv Cancer Res 2004 91 169-200",
                "id": "15327891"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad841a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "prolong treatment (16?18 h) with PMA (Fig. 5A), or with dequalinium (Fig. 2C and D), blocked both PKB and ERK1-2 phosphorylation (Fig. 5B?E). In addition, the SMS inhibitor D609 blocked phosphorylation of PKB and ERK1-2 (Fig. 6),",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 2010 Feb 5 584(3) 517-24",
                "id": "19948174"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8419"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "A direct serine phosphorylation and activation of Syk by ERK was observed in in vitro experiments.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 1999 Aug 1 163(3) 1110-4",
                "id": "10415002"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8418"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "from full text - IEC-18 cells were stimulated with Ang II or EGF. These stimuli promoted a marked increase in ERK phosphorylation but with different kinetics (Fig. 5A).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Jan 14 280(2) 1582-93",
                "id": "15525649"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8417"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "\\\"SB-202190\\\"-dependent increase in LDL receptor expression was accompanied by induction of p42/44(MAPK)",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Jul 9 274(28) 19593-600",
                "id": "10391894"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8416"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "PD-98059, a selective inhibitor of the mitogen-activated protein kinase kinase-1 (MEK-1)-ERK-1/2 pathway, abolished ERK-1/2 and NF-kappaB activation and ET(B) upregulation. NF-kappaB inhibition also prevented RLX-mediated ET(B) stimulation",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 2003 Jan 10 92(1) 32-40",
                "id": "12522118"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8415"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "cells exposed to 10 J/m2 of UV showed phosphorylation of not only ERK1 and ERK2 but also JNK1/2 and p38 (Fig. 3).",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2001 Jul 15 61(14) 5396-401",
                "id": "11454682"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8414"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "FGF-2 (>/=10(-12) m) up-regulated the phosphorylation of cellular proteins, including p42/p44 mitogen-activated protein (MAP) kinase, and increased the kinase activity of immunoprecipitated FGFR1 in mouse osteoclasts.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Oct 6 275(40) 31444-50",
                "id": "10896947"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8413"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "osteoclast",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "IGF-1 increased active ERK1/2 within 5 min, a response that was ablated by pretreatment with LY294002.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Oct 8 279(41) 42709-18",
                "id": "15304489"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8412"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "S1P greatly enhances the activity of ERK1/2 via a S1P1/Gi-dependent pathway (Lee et al., 1998).",
              "citation": {
                "type": "PubMed",
                "name": "Microvasc Res 2009 Jan 77(1) 39-45",
                "id": "18973762"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8411"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "LOX metabolites 5-HETE and 12-HETE stimulate cancer growth through activation of p44/42 mitogen-activated protein kinase and PI3/Akt kinase pathways",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cancer Ther 2002 Sep 1(11) 929-35",
                "id": "12481414"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8410"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Nov 2 276(44) 41014-22",
                "id": "11535599"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad840f"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "8-isoprostane significantly (P=0.03) activated ERK 1/2 and the peak of phosphorylation was reached after 15 min of stimulation (Fig. 4A). Similarly, 8-isoprostane induced significantly (P=0.03) p38 MAPK phosphorylation, but with a peak of phosphorylation after 30 min (Fig. 4B) and the 8-isoprostane induced phosphorylation of both MAP kinases sustained for up to 60 min. ",
              "citation": {
                "type": "PubMed",
                "name": "Cardiovasc Res 2003 Oct 1 59(4) 945-54",
                "id": "14553834"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad840e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "The treatment of NCI-N87 cells with EGF resulted in increases in phosphorylation of Erk1/2, Akt, and P38. Blockade of the Erk, phosphatidylinositol-3 kinase/Akt, or P38 pathways in this cell line",
              "citation": {
                "type": "PubMed",
                "name": "Br J Cancer 2003 Mar 10 88(5) 796-802",
                "id": "12618892"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad840d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "HDGF also activated specific ERK1/2 signaling",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2004 Jun 286(6) L1194-201",
                "id": "14751852"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad840c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK3) actsIn kin(p(HGNC:MAPK3))",
              "summary_text": "Inhibitor experiments suggested that nuclear factor kappaB and p 44/42 mitogen-activated protein kinase are involved in both, basal and adipocytokine-induced TIMP-1 expression.",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 2005 Nov 21 579(28) 6417-22",
                "id": "16288749"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad840b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:NFE2L2,pmod(U,K))",
        "relation": "increases",
        "target": "deg(p(HGNC:NFE2L2))",
        "directed": false,
        "label": "p(HGNC:NFE2L2,pmod(U,K)) increases deg(p(HGNC:NFE2L2))",
        "metadata": {
          "casual": true,
          "createdBy": "Jamboree2014",
          "edgeId": "55775dd92f9e241f18ad8db6",
          "evidences": [
            {
              "bel_statement": "p(HGNC:NFE2L2,pmod(U,K)) increases deg(p(HGNC:NFE2L2))",
              "summary_text": "We propose that exposure of cells to sulforaphane or oxidative stress, by altering the redox state of Cys 151, reduces the ability of Nrf2-bound Keap1 proteins to associate with the Cul3-Rbx1 core complex. As a result, fewer Nrf2 molecules will be targeted for ubiquitination and subsequent degradation, leading to increased accumulation of Nrf2.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "15572695"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86c3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "COS cell line"
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:NFE2L2)",
        "relation": "hasModification",
        "target": "p(HGNC:NFE2L2,pmod(U,K))",
        "directed": false,
        "label": "p(HGNC:NFE2L2) hasModification p(HGNC:NFE2L2,pmod(U,K))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8db7",
          "evidences": [

          ]
        }
      },
      {
        "source": "p(HGNC:EIF2AK3,pmod(P))",
        "relation": "directlyIncreases",
        "target": "kin(p(HGNC:EIF2AK3))",
        "directed": false,
        "label": "p(HGNC:EIF2AK3,pmod(P)) directlyIncreases kin(p(HGNC:EIF2AK3))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8db8",
          "evidences": [
            {
              "bel_statement": "p(HGNC:EIF2AK3,pmod(P)) directlyIncreases kin(p(HGNC:EIF2AK3))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86c4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:EIF2AK3)",
        "relation": "hasModification",
        "target": "p(HGNC:EIF2AK3,pmod(P))",
        "directed": false,
        "label": "p(HGNC:EIF2AK3) hasModification p(HGNC:EIF2AK3,pmod(P))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8db9",
          "evidences": [
            {
              "bel_statement": "p(HGNC:EIF2AK3) hasModification p(HGNC:EIF2AK3,pmod(P))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86c5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "tloc(p(MGI:Keap1),GOCC:cytoplasm,GOCC:nucleus)",
        "relation": "translocates",
        "target": "p(HGNC:KEAP1)",
        "directed": false,
        "label": "tloc(p(MGI:Keap1),GOCC:cytoplasm,GOCC:nucleus) translocates p(HGNC:KEAP1)",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8dba",
          "evidences": [
            {
              "bel_statement": "tloc(p(MGI:Keap1),GOCC:cytoplasm,GOCC:nucleus) translocates p(HGNC:KEAP1)",
              "summary_text": "However, after oxidative stress induced by a variety of agents, Keap1 redistributed and accumulated in the nucleus (Fig. 1A and D). This redistribution was not unique to NIH 3T3 fibroblasts. In the human hepatoblastoma cell line HepG2 (Fig. 1B), as well as in Cos7 fibroblasts (Fig. 1C), endogenous Keap1 also accumulated in the nucleus after DEM treatment. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2005 Jun 25(11) 4501-13",
                "id": "15899855"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86c6"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "tloc(p(HGNC:NFE2L2),GOCC:cytoplasm,GOCC:nucleus)",
        "relation": "translocates",
        "target": "p(HGNC:NFE2L2)",
        "directed": false,
        "label": "tloc(p(HGNC:NFE2L2),GOCC:cytoplasm,GOCC:nucleus) translocates p(HGNC:NFE2L2)",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8dbb",
          "evidences": [
            {
              "bel_statement": "tloc(p(HGNC:NFE2L2),GOCC:cytoplasm,GOCC:nucleus) translocates p(HGNC:NFE2L2)",
              "summary_text": "Interestingly, mouse keratinocytes also showed a similar response to low and high dose UVB as mouse Hepa-1 and human fibroblast cells. The exposure of cells to 7.5 J/m2  UVB led to nuclear import and accumulation of Nrf2. ",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2006 Sep 1 66(17) 8421-9",
                "id": "16951152"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86d7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "tloc(p(HGNC:NFE2L2),GOCC:cytoplasm,GOCC:nucleus) translocates p(HGNC:NFE2L2)",
              "summary_text": "Transfection of Nrf2-siRNA diminished, albeit not completely, the L-flow-induced nuclear accumulation of Nrf2 (Fig. 2A) and the gene expressions of both NQO1 and HO-1  (Fig. 2B). These results demonstrate that Nrf2 activity is indispensable for the inducible expression of ARE-regulated genes in response to L-flow in HAECs. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Jul 22 280(29) 27244-50",
                "id": "15917255"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86d6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "tloc(p(HGNC:NFE2L2),GOCC:cytoplasm,GOCC:nucleus) translocates p(HGNC:NFE2L2)",
              "summary_text": "In Fig. 2, immunoblots of nuclear and cytosolic extracts showed a marked decrease in nuclear levels of BACH1 with concentrations of arsenite as low as 0.1 um, whereas the lowest concentration of arsenite to elicit nuclear accumulation of NFE2L2 was 5 um, with significantly greater accumulation at 25 um treatment.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2008 Aug 15 283(33) 22363-70",
                "id": "18550526"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86d5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "tloc(p(HGNC:NFE2L2),GOCC:cytoplasm,GOCC:nucleus) translocates p(HGNC:NFE2L2)",
              "summary_text": "treatment with CSE resulted in no nuclear translocation of Nrf2, resveratrol induced significant nuclear accumulation of Nrf2, and resveratrol plus CSE induced significant nuclear translocation of Nrf2",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2008 Mar 294(3) L478-88",
                "id": "18162601"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86d4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasm",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "tloc(p(HGNC:NFE2L2),GOCC:cytoplasm,GOCC:nucleus) translocates p(HGNC:NFE2L2)",
              "summary_text": "The findings demonstrated that phosphorylation of Nrf2 at the TA domains by CK2 is an integral component of Nrf2 activation necessary for the nuclear localization and transcription activation function of Nrf2 in neuroblastoma cells.  \t ",
              "citation": {
                "type": "PubMed",
                "name": "J Biochem Mol Toxicol 2008 Feb 22(1) 63-76",
                "id": "18273910"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86d3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "neuroblastoma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "tloc(p(HGNC:NFE2L2),GOCC:cytoplasm,GOCC:nucleus) translocates p(HGNC:NFE2L2)",
              "summary_text": "Phosphorylated Fyn accumulates in the nucleus and phosphorylates Nrf2 at tyrosine 568. This leads to nuclear export, ubiquitination, and degradation of Nrf2",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 Jun 1 282(22) 16502-10",
                "id": "17403689"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86d2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "tloc(p(HGNC:NFE2L2),GOCC:cytoplasm,GOCC:nucleus) translocates p(HGNC:NFE2L2)",
              "summary_text": "Figure 1 Shear stress increases Nrf2 protein expression and induces Nrf2 translocation into nuclei. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biomed Sci 2009 16 12",
                "id": "19272177"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86d1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "tloc(p(HGNC:NFE2L2),GOCC:cytoplasm,GOCC:nucleus) translocates p(HGNC:NFE2L2)",
              "summary_text": "In HUVECs, the CO donor RuCO induced Nrf2 nuclear translocation and HO-1 expression in a dose-dependent manner (Figure 1A)",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 2007 Oct 26 101(9) 919-27",
                "id": "17823375"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86d0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "tloc(p(HGNC:NFE2L2),GOCC:cytoplasm,GOCC:nucleus) translocates p(HGNC:NFE2L2)",
              "summary_text": "After treatment with t- BHQ, Nrf2 accumulated in the nucleus, resulting in a much stronger signal. The PKC inhibitor staurosporine was able to block the t-BHQ-induced nuclear accumulation of Nrf2.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Nov 7 278(45) 44675-82",
                "id": "12947090"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86cf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "hepatocellular carcinoma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "tloc(p(HGNC:NFE2L2),GOCC:cytoplasm,GOCC:nucleus) translocates p(HGNC:NFE2L2)",
              "summary_text": "As shown in Figure 5, 1 hour of treatment with 20 mM acrolein increased nuclear Nrf2 significantly (z 2.5-fold) compared with nontreatment in HBE1 cells.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2008 Apr 38(4) 483-90",
                "id": "18048804"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86ce"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "bronchial epithelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "tloc(p(HGNC:NFE2L2),GOCC:cytoplasm,GOCC:nucleus) translocates p(HGNC:NFE2L2)",
              "summary_text": "Nuclear Nrf2 protein was increased by 50% in BEAS-2B cells treated with 10 uM of apo-10'-lycopenoic acid for 3 hr, as compared to control.",
              "citation": {
                "type": "PubMed",
                "name": "Int J Cancer 2008 Sep 15 123(6) 1262-8",
                "id": "18566994"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86cd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "tloc(p(HGNC:NFE2L2),GOCC:cytoplasm,GOCC:nucleus) translocates p(HGNC:NFE2L2)",
              "summary_text": "The electrophilic lipid peroxidation product 4-hydroxy-2-nonenal (HNE) has been shown to modify Keap1, allowing Nrf2 to enter the nucleus",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2009 Jun 15 46(12) 1650-7",
                "id": "19345732"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86cc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "tloc(p(HGNC:NFE2L2),GOCC:cytoplasm,GOCC:nucleus) translocates p(HGNC:NFE2L2)",
              "summary_text": "Collectively, these data support the conclusion that Keap1 dimerization is required for Nrf2 sequestration and transcriptional repression. Furthermore, exposure to inducing agents disrupts the Keap1 dimerization function and results in Nrf2 release.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Sep 27 277(39) 36544-52",
                "id": "12145307"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86cb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "tloc(p(HGNC:NFE2L2),GOCC:cytoplasm,GOCC:nucleus) translocates p(HGNC:NFE2L2)",
              "summary_text": "Wild-type Nrf2 predominantly localized in the nucleus (Fig. 6A). By contrast, Nrf2S40A mutant failed to localize in the nucleus (Fig. 6A).",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 2009 Dec 15 122(Pt 24) 4452-64",
                "id": "19920073"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86ca"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Carcinoma of liver",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "tloc(p(HGNC:NFE2L2),GOCC:cytoplasm,GOCC:nucleus) translocates p(HGNC:NFE2L2)",
              "summary_text": "In related experiments, the majority of the Nrf2S40-phosphorylated protein was found localized in the nucleus (Fig. 5D, lower panel).",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 2009 Dec 15 122(Pt 24) 4452-64",
                "id": "19920073"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86c9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "tloc(p(HGNC:NFE2L2),GOCC:cytoplasm,GOCC:nucleus) translocates p(HGNC:NFE2L2)",
              "summary_text": "However, a high proportion of Nrf2 accumulated in the nucleus of both cell types following the exposure of cells to hyperoxia (Fig. 1A, right panels).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Oct 1 279(40) 42302-12",
                "id": "15292179"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86c8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "tloc(p(HGNC:NFE2L2),GOCC:cytoplasm,GOCC:nucleus) translocates p(HGNC:NFE2L2)",
              "summary_text": "Coexpression of aPKC{iota} with Nrf2-GFP and Keap1 induced the nuclear  accumulation of the fusion protein; however, the kinase inactive mutant aPKC{iota}(K274W) did not affect the cytoplasmic localization of Nrf2-GFP (Fig. 5A).",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2003 Aug 285(2) C334-42",
                "id": "12700136"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86c7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "tloc(p(HGNC:NFE2L2),GOCC:cytoplasm,GOCC:nucleus)",
        "relation": "increases",
        "target": "tscript(p(HGNC:NFE2L2))",
        "directed": false,
        "label": "tloc(p(HGNC:NFE2L2),GOCC:cytoplasm,GOCC:nucleus) increases tscript(p(HGNC:NFE2L2))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8dbc",
          "evidences": [
            {
              "bel_statement": "tloc(p(HGNC:NFE2L2),GOCC:cytoplasm,GOCC:nucleus) increases tscript(p(HGNC:NFE2L2))",
              "summary_text": "Collectively, these data support the conclusion that Keap1 dimerization is required for Nrf2 sequestration and transcriptional repression. Furthermore, exposure to inducing agents disrupts the Keap1 dimerization function and results in Nrf2 release.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Sep 27 277(39) 36544-52",
                "id": "12145307"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86d9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "tloc(p(HGNC:NFE2L2),GOCC:cytoplasm,GOCC:nucleus) increases tscript(p(HGNC:NFE2L2))",
              "summary_text": "Transfection of Nrf2-siRNA diminished, albeit not completely, the L-flow-induced nuclear accumulation of Nrf2 (Fig. 2A) and the gene expressions of both NQO1 and HO-1  (Fig. 2B). These results demonstrate that Nrf2 activity is indispensable for the inducible expression of ARE-regulated genes in response to L-flow in HAECs. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Jul 22 280(29) 27244-50",
                "id": "15917255"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86d8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "tloc(p(HGNC:NFE2L2),GOCC:cytoplasm,GOCC:nucleus)",
        "relation": "decreases",
        "target": "p(HGNC:NFE2L2,pmod(U,K))",
        "directed": false,
        "label": "tloc(p(HGNC:NFE2L2),GOCC:cytoplasm,GOCC:nucleus) decreases p(HGNC:NFE2L2,pmod(U,K))",
        "metadata": {
          "casual": true,
          "createdBy": "Jamboree2014",
          "edgeId": "55775dd92f9e241f18ad8dbd",
          "evidences": [
            {
              "bel_statement": "tloc(p(HGNC:NFE2L2),GOCC:cytoplasm,GOCC:nucleus) decreases p(HGNC:NFE2L2,pmod(U,K))",
              "summary_text": "Phosphorylated Fyn accumulates in the nucleus and phosphorylates Nrf2 at tyrosine 568. This leads to nuclear export, ubiquitination, and degradation of Nrf2",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "17403689"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86da"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "HepG2 cell line",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:NFE2L2)",
        "relation": "hasModification",
        "target": "p(HGNC:NFE2L2,pmod(P,S,40))",
        "directed": false,
        "label": "p(HGNC:NFE2L2) hasModification p(HGNC:NFE2L2,pmod(P,S,40))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8dbe",
          "evidences": [
            {
              "bel_statement": "p(HGNC:NFE2L2) hasModification p(HGNC:NFE2L2,pmod(P,S,40))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86db"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:NFE2L2,pmod(P,S,40))",
        "relation": "directlyDecreases",
        "target": "complex(p(HGNC:KEAP1),p(HGNC:NFE2L2))",
        "directed": false,
        "label": "p(HGNC:NFE2L2,pmod(P,S,40)) directlyDecreases complex(p(HGNC:KEAP1),p(HGNC:NFE2L2))",
        "metadata": {
          "casual": true,
          "createdBy": "Jamboree2014",
          "edgeId": "55775dd92f9e241f18ad8dbf",
          "evidences": [
            {
              "bel_statement": "p(HGNC:NFE2L2,pmod(P,S,40)) directlyDecreases complex(p(HGNC:KEAP1),p(HGNC:NFE2L2))",
              "summary_text": "Here, we demonstrate that antioxidant-induced PKC-delta-mediated phosphorylation of Nrf2S40 leads to release of Nrf2 from INrf2. This was evident from specific chemical inhibitors of PKC isoenzymes in reporter assays, in vitro kinase assays with purified Nrf2 and PKC isoenzymes, in vivo analysis with dominant-negative mutants and siRNA against PKC isoforms, use of PKC-delta(+/+) and PKC-delta(-/-) cells, and use of Nrf2S40 phospho-specific antibody.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "19920073"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c74"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Hepa-1 cell line",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2,pmod(P,S,40)) directlyDecreases complex(p(HGNC:KEAP1),p(HGNC:NFE2L2))",
              "summary_text": "Here, we demonstrate that antioxidant-induced PKC-delta-mediated phosphorylation of Nrf2S40 leads to release of Nrf2 from INrf2. This was evident from specific chemical inhibitors of PKC isoenzymes in reporter assays, in vitro kinase assays with purified Nrf2 and PKC isoenzymes, in vivo analysis with dominant-negative mutants and siRNA against PKC isoforms, use of PKC-delta(+/+) and PKC-delta(-/-) cells, and use of Nrf2S40 phospho-specific antibody.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 2009 Dec 15 122(Pt 24) 4452-64",
                "id": "19920073"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c73"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2,pmod(P,S,40)) directlyDecreases complex(p(HGNC:KEAP1),p(HGNC:NFE2L2))",
              "summary_text": "Here, we demonstrate that antioxidant-induced PKC-delta-mediated phosphorylation of Nrf2S40 leads to release of Nrf2 from INrf2. This was evident from specific chemical inhibitors of PKC isoenzymes in reporter assays, in vitro kinase assays with purified Nrf2 and PKC isoenzymes, in vivo analysis with dominant-negative mutants and siRNA against PKC isoforms, use of PKC-delta(+/+) and PKC-delta(-/-) cells, and use of Nrf2S40 phospho-specific antibody.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "19920073"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c72"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2,pmod(P,S,40)) directlyDecreases complex(p(HGNC:KEAP1),p(HGNC:NFE2L2))",
              "summary_text": "Moreover, Keap1 was unable to sequester the Nrf2(S40E) mutant, which mimics constitutive phosphorylation, suggesting that phosphorylation of the Ser40 residue affected the stability of the Nrf2-Keap1 complex.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2003 Aug 285(2) C334-42",
                "id": "12700136"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86e1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2,pmod(P,S,40)) directlyDecreases complex(p(HGNC:KEAP1),p(HGNC:NFE2L2))",
              "summary_text": "Moreover, Keap1 was unable to sequester the Nrf2(S40E) mutant, which mimics constitutive phosphorylation, suggesting that phosphorylation of the Ser40 residue affected the stability of the Nrf2-Keap1 complex.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "12700136"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86e0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "COS cell line",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2,pmod(P,S,40)) directlyDecreases complex(p(HGNC:KEAP1),p(HGNC:NFE2L2))",
              "summary_text": "The Keap1-mediated control of Nrf2 protein levels was not affected by Nrf2 phosphorylation in vivo under both basal and induced conditions, nor was the interaction between Nrf2 and Keap1.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "19668370"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86df"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2,pmod(P,S,40)) directlyDecreases complex(p(HGNC:KEAP1),p(HGNC:NFE2L2))",
              "summary_text": "The Keap1-mediated control of Nrf2 protein levels was not affected by Nrf2 phosphorylation in vivo under both basal and induced conditions, nor was the interaction between Nrf2 and Keap1.",
              "citation": {
                "type": "Other",
                "name": "",
                "id": "19668370"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86de"
              },
              "experiment_context": {
                "species_common_name": "mouse",
                "disease": "",
                "cell": "fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2,pmod(P,S,40)) directlyDecreases complex(p(HGNC:KEAP1),p(HGNC:NFE2L2))",
              "summary_text": "Moreover, Keap1 was unable to sequester the Nrf2(S40E) mutant, which mimics constitutive phosphorylation, suggesting that phosphorylation of the Ser40 residue affected the stability of the Nrf2-Keap1 complex.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "12700136"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86dd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2,pmod(P,S,40)) directlyDecreases complex(p(HGNC:KEAP1),p(HGNC:NFE2L2))",
              "summary_text": "The Keap1-mediated control of Nrf2 protein levels was not affected by Nrf2 phosphorylation in vivo under both basal and induced conditions, nor was the interaction between Nrf2 and Keap1.",
              "citation": {
                "type": "Other",
                "name": "",
                "id": "19668370"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86dc"
              },
              "experiment_context": {
                "species_common_name": "human",
                "disease": "",
                "cell": "hek293",
                "tissue": "kidney"
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:NFE2L2,pmod(P,S,40))",
        "relation": "directlyIncreases",
        "target": "tloc(p(HGNC:NFE2L2),GOCC:cytoplasm,GOCC:nucleus)",
        "directed": false,
        "label": "p(HGNC:NFE2L2,pmod(P,S,40)) directlyIncreases tloc(p(HGNC:NFE2L2),GOCC:cytoplasm,GOCC:nucleus)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8dc0",
          "evidences": [
            {
              "bel_statement": "p(HGNC:NFE2L2,pmod(P,S,40)) directlyIncreases tloc(p(HGNC:NFE2L2),GOCC:cytoplasm,GOCC:nucleus)",
              "summary_text": "In related experiments, the majority of the Nrf2S40-phosphorylated protein was found localized in the nucleus (Fig. 5D, lower panel).",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 2009 Dec 15 122(Pt 24) 4452-64",
                "id": "19920073"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86e3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L2,pmod(P,S,40)) directlyIncreases tloc(p(HGNC:NFE2L2),GOCC:cytoplasm,GOCC:nucleus)",
              "summary_text": "## from full text ## coexpression of the GFP fusion protein with Keap1 and the Nrf2(S40E) mutant, in which Ser40 was replaced with Glu to mimic constitutive phosphorylation, showed nuclear  accumulation in the absence of stimulus (Fig. 4, B and C), ",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2003 Aug 285(2) C334-42",
                "id": "12700136"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86e2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "a(CHEBI:quercetin)",
        "relation": "increases",
        "target": "p(HGNC:NFE2L2)",
        "directed": false,
        "label": "a(CHEBI:quercetin) increases p(HGNC:NFE2L2)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8dc1",
          "evidences": [
            {
              "bel_statement": "a(CHEBI:quercetin) increases p(HGNC:NFE2L2)",
              "summary_text": "Quercetin pretreatment strongly suppressed UVA-induced apoptosis in human keratinocyte HaCaT cells, markedly increased protein levels of the transcription factor Nrf2, induced the expression of antioxidative genes, and dramatically reduced the production of reactive oxygen species following UVA irradiation.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2009 Sep 11 387(1) 109-14",
                "id": "19576171"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86e4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:NFE2L2),p(HGNC:ATF4))",
        "relation": "hasComponent",
        "target": "p(HGNC:ATF4)",
        "directed": false,
        "label": "complex(p(HGNC:NFE2L2),p(HGNC:ATF4)) hasComponent p(HGNC:ATF4)",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8dc2",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:NFE2L2),p(HGNC:ATF4)) hasComponent p(HGNC:ATF4)",
              "summary_text": "hprd",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Jun 15 276(24) 20858-65",
                "id": "11274184"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86e5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:NFE2L2),p(HGNC:ATF4))",
        "relation": "hasComponent",
        "target": "p(HGNC:NFE2L2)",
        "directed": false,
        "label": "complex(p(HGNC:NFE2L2),p(HGNC:ATF4)) hasComponent p(HGNC:NFE2L2)",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8dc3",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:NFE2L2),p(HGNC:ATF4)) hasComponent p(HGNC:NFE2L2)",
              "summary_text": "hprd",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Jun 15 276(24) 20858-65",
                "id": "11274184"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86e6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:NFE2L2),p(HGNC:MAFG))",
        "relation": "increases",
        "target": "p(HGNC:HMOX1)",
        "directed": false,
        "label": "complex(p(HGNC:NFE2L2),p(HGNC:MAFG)) increases p(HGNC:HMOX1)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8dc4",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:NFE2L2),p(HGNC:MAFG)) increases p(HGNC:HMOX1)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86e8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:NFE2L2),p(HGNC:MAFG)) increases p(HGNC:HMOX1)",
              "summary_text": "These results indicate that heme promotes stabilization of Nrf2, leading to accumulation of Nrf2. MafG dimers that bind to StREs to activate the ho-1 gene.",
              "citation": {
                "type": "Other",
                "name": "",
                "id": "12453873"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86e7"
              },
              "experiment_context": {
                "species_common_name": "rat",
                "disease": "",
                "cell": "proximal epithelial",
                "tissue": "kidney"
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:NFE2L2),p(HGNC:MAFG))",
        "relation": "hasComponent",
        "target": "p(HGNC:NFE2L2)",
        "directed": false,
        "label": "complex(p(HGNC:NFE2L2),p(HGNC:MAFG)) hasComponent p(HGNC:NFE2L2)",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8dc5",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:NFE2L2),p(HGNC:MAFG)) hasComponent p(HGNC:NFE2L2)",
              "summary_text": "As shown in Fig. 3, the level of iNOS mRNA significantly increased in the presence of the transfected decoy vector but not in the presence of a decoy vector with the mutation in the TCF11/MafG binding site that could not compete at the iNOS site. As competition for the native binding sequence resulted in an increase in iNOS mRNA expression, the data suggest that TCF11/MafG binding is a negative regulator of iNOS. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 Dec 21 282(51) 36837-44",
                "id": "17928287"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c77"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:NFE2L2),p(HGNC:MAFG)) hasComponent p(HGNC:NFE2L2)",
              "summary_text": "The antioxidant response element (ARE) is known to regulate expression and induction of NQO1 and GST Ya genes. EMSA studies with HepG2 cells using anti-NRF2 and anti-MAFG antibodies demonstrated the binding of NRF2/MAFG heterodimer to the ARE of NQO1 gene. Overexpression of NRF2 led to increased expression of NQO1 gene ARE-mediated luciferase gene and overexpression of MAFG repressed the NRF2-mediated upregulation of the luciferase gene expression. The results thus demonstrated that Maf-Nrf2 heterodimers play a role in the negative regulation of ARE-mediated transcription and antioxidant induction of NQO1 and other detoxifying enzyme genes.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Dec 22 275(51) 40134-41",
                "id": "11013233"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c76"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:NFE2L2),p(HGNC:MAFG)) hasComponent p(HGNC:NFE2L2)",
              "summary_text": "When MafG was co-expressed with Nrf2 in HeLa cells, MafG exerted a bi-directional transcription regulatory effect. At low concentrations, MafG amplified Nrf2 induced ARE-Luciferase activities in a dose-dependent manner (Fig. 5A). At higher concentrations, the amplification effect of MafG was attenuated and even reversed (Fig. 5A). This observation is consistent with previous reports [48, 49], probably due to the reason that overexpressing MafG may favor the formation of MafG/MafG homodimer.",
              "citation": {
                "type": "PubMed",
                "name": "Biochim Biophys Acta 2008 Oct 1783(10) 1847-56",
                "id": "18585411"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c75"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:NFE2L2),p(HGNC:MAFG)) hasComponent p(HGNC:NFE2L2)",
              "summary_text": "hprd",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1997 Apr 24 14(16) 1901-10",
                "id": "9150357"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86ea"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:NFE2L2),p(HGNC:MAFG)) hasComponent p(HGNC:NFE2L2)",
              "summary_text": "By contrast, mixtures containing equal amounts of either Nrf2MafG or Nrf2MafK showed substantial nqo1 ARE-binding activity (Figure 7A)",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2003 Sep 1 374(Pt 2) 337-48",
                "id": "12816537"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86e9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:NFE2L2),p(HGNC:MAFG))",
        "relation": "hasComponent",
        "target": "p(HGNC:MAFG)",
        "directed": false,
        "label": "complex(p(HGNC:NFE2L2),p(HGNC:MAFG)) hasComponent p(HGNC:MAFG)",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8dc6",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:NFE2L2),p(HGNC:MAFG)) hasComponent p(HGNC:MAFG)",
              "summary_text": "The antioxidant response element (ARE) is known to regulate expression and induction of NQO1 and GST Ya genes. EMSA studies with HepG2 cells using anti-NRF2 and anti-MAFG antibodies demonstrated the binding of NRF2/MAFG heterodimer to the ARE of NQO1 gene. Overexpression of NRF2 led to increased expression of NQO1 gene ARE-mediated luciferase gene and overexpression of MAFG repressed the NRF2-mediated upregulation of the luciferase gene expression. The results thus demonstrated that Maf-Nrf2 heterodimers play a role in the negative regulation of ARE-mediated transcription and antioxidant induction of NQO1 and other detoxifying enzyme genes.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Dec 22 275(51) 40134-41",
                "id": "11013233"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c7a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:NFE2L2),p(HGNC:MAFG)) hasComponent p(HGNC:MAFG)",
              "summary_text": "As shown in Fig. 3, the level of iNOS mRNA significantly increased in the presence of the transfected decoy vector but not in the presence of a decoy vector with the mutation in the TCF11/MafG binding site that could not compete at the iNOS site. As competition for the native binding sequence resulted in an increase in iNOS mRNA expression, the data suggest that TCF11/MafG binding is a negative regulator of iNOS. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 Dec 21 282(51) 36837-44",
                "id": "17928287"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c79"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:NFE2L2),p(HGNC:MAFG)) hasComponent p(HGNC:MAFG)",
              "summary_text": "When MafG was co-expressed with Nrf2 in HeLa cells, MafG exerted a bi-directional transcription regulatory effect. At low concentrations, MafG amplified Nrf2 induced ARE-Luciferase activities in a dose-dependent manner (Fig. 5A). At higher concentrations, the amplification effect of MafG was attenuated and even reversed (Fig. 5A). This observation is consistent with previous reports [48, 49], probably due to the reason that overexpressing MafG may favor the formation of MafG/MafG homodimer.",
              "citation": {
                "type": "PubMed",
                "name": "Biochim Biophys Acta 2008 Oct 1783(10) 1847-56",
                "id": "18585411"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c78"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:NFE2L2),p(HGNC:MAFG)) hasComponent p(HGNC:MAFG)",
              "summary_text": "By contrast, mixtures containing equal amounts of either Nrf2MafG or Nrf2MafK showed substantial nqo1 ARE-binding activity (Figure 7A)",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2003 Sep 1 374(Pt 2) 337-48",
                "id": "12816537"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86ec"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:NFE2L2),p(HGNC:MAFG)) hasComponent p(HGNC:MAFG)",
              "summary_text": "hprd",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1997 Apr 24 14(16) 1901-10",
                "id": "9150357"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86eb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:NFE2L2),p(HGNC:MAFK))",
        "relation": "increases",
        "target": "p(HGNC:HMOX1)",
        "directed": false,
        "label": "complex(p(HGNC:NFE2L2),p(HGNC:MAFK)) increases p(HGNC:HMOX1)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8dc7",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:NFE2L2),p(HGNC:MAFK)) increases p(HGNC:HMOX1)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86ed"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:NFE2L2),p(HGNC:MAFK))",
        "relation": "hasComponent",
        "target": "p(HGNC:MAFK)",
        "directed": false,
        "label": "complex(p(HGNC:NFE2L2),p(HGNC:MAFK)) hasComponent p(HGNC:MAFK)",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8dc8",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:NFE2L2),p(HGNC:MAFK)) hasComponent p(HGNC:MAFK)",
              "summary_text": "in vitro; in vivo",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1997 Apr 24 14(16) 1901-10",
                "id": "9150357"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86ef"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:NFE2L2),p(HGNC:MAFK)) hasComponent p(HGNC:MAFK)",
              "summary_text": "By contrast, mixtures containing equal amounts of either Nrf2MafG or Nrf2MafK showed substantial nqo1 ARE-binding activity (Figure 7A)",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2003 Sep 1 374(Pt 2) 337-48",
                "id": "12816537"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86ee"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:NFE2L2),p(HGNC:MAFK))",
        "relation": "hasComponent",
        "target": "p(HGNC:NFE2L2)",
        "directed": false,
        "label": "complex(p(HGNC:NFE2L2),p(HGNC:MAFK)) hasComponent p(HGNC:NFE2L2)",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8dc9",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:NFE2L2),p(HGNC:MAFK)) hasComponent p(HGNC:NFE2L2)",
              "summary_text": "By contrast, mixtures containing equal amounts of either Nrf2MafG or Nrf2MafK showed substantial nqo1 ARE-binding activity (Figure 7A)",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2003 Sep 1 374(Pt 2) 337-48",
                "id": "12816537"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86f1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:NFE2L2),p(HGNC:MAFK)) hasComponent p(HGNC:NFE2L2)",
              "summary_text": "in vitro; in vivo",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1997 Apr 24 14(16) 1901-10",
                "id": "9150357"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86f0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(SFAM:\"MAPK p38 Family\")",
        "relation": "actsIn",
        "target": "kin(p(SFAM:\"MAPK p38 Family\"))",
        "directed": false,
        "label": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8dca",
          "evidences": [
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "To determine whether this activation by NE was mediated by the TGF-beta1 receptor, we used a dominant negative vector of the TGF-beta1 type II receptor, and the synergistic effects were inhibited. Furthermore, this synergistic effect was attenuated by a specific inhibitor of p38, SB203680. These data indicate that NE enhances cardiac fibrosis through TGF-beta1 post-receptor signaling, predominantly via the p38 MAP kinase pathway.",
              "citation": {
                "type": "PubMed",
                "name": "Hypertension 2002 Aug 40(2) 148-54",
                "id": "12154105"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8ca8"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "myogenin as an important transcriptional target under the control of three intracellular signaling pathways, namely, the p38 mitogen-activated protein kinase- (MAPK), calcium-calmodulin-dependent protein kinase- (CaMK), and calcineurin-mediated pathways,... Three cis-elements (i.e., the E box, myocyte enhancer factor [MEF] 2, and MEF3 sites) in the proximal myogenin promoter in response to these three pathways are defined. MyoD, MEF2s, and Six proteins, the trans-activators bound to these cis-elements, are shown to be activated by these signaling pathways.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 2002 Jun 13(6) 1940-52",
                "id": "12058061"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8ca7"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": "Muscle, Skeletal"
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "from full text - We previously showed that TL1A is induced by the Fc?R signaling pathway [45]. Recently, the potential interaction of TL1A in microbial-host interaction was illustrated by a report showing microbial organisms can induce TL1A in APCs [46]. Microbial-activated TL1A was in part mediated by TLR 1, 2, 4, and 9 signaling pathways and dependent on downstream p38 MAP kinase and NF-kappaB activation (Fig. 1) [46]. Negative regulators of the TL1A signaling pathway also exist and may serve to maintain gut immune homeostasis. Our group showed that TLR8 or TLR7/8 ligand (R848) can inhibit TL1A production in a dose dependent manner [47].",
              "citation": {
                "type": "PubMed",
                "name": "Curr Gastroenterol Rep 2009 Dec 11(6) 473-80",
                "id": "19903423"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8ca6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "antigen presenting cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "We showed that the fast-releasing NO donor DPTA-NO significantly enhanced the phosphorylation levels of the MAP kinases JNK and p38, which increased to a peak within 3 h (about six- and ninefold, respectively), but did not affect the high basal level of ERK1/2 kinase phosphorylation in U937 cells (Figs. 6A, B, and D)",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2010 Jan 15 48(2) 298-305",
                "id": "19892011"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8ca5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "TGF-beta led to activation of Smad2/3, p38, p42/44, and c-Jun NH2-terminal kinase (JNK) pathways, assessed by phosphorylation, immunofluorescence, and reporter gene analysis. TGF-beta-dependent growth inhibition was specifically attenuated by pharmacological blockade of the TGF-beta type I receptor (TbetaRI) kinase or p38 mitogen-activated protein kinase pathways, whereas blockade of p42/44 or JNK kinases did not influence the effect of TGF-beta. TbetaRI kinase inhibition blocked all downstream pathways including Smad and p38 phosphorylation",
              "citation": {
                "type": "PubMed",
                "name": "J Pharmacol Exp Ther 2005 Dec 315(3) 1005-12",
                "id": "16120811"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8ca4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Interestingly, recent in vitro kinetic studies using recombinant active p38a expressed in Escherichia coli showed that p38 phosphorylates GST-ATF2 (amino acids 1-115) via a two-step (double collision) mechanism, involving the dissociation of mono-phosphorylated ATF2 Thr71 or Thr69 from the enzyme after the first phosphorylation step (Waas et al., 2001). Moreover, these authors found that mono-phosphorylation of ATF2 Thr69 strongly reduces the phosphorylation rate of Thr71, whereas, in contrast, mono-phosphorylation of Thr71 does not reduce the rate of Thr69 phosphorylation. Thus, efficient phosphorylation of ATF2 by recombinant E.coli-expressed active p38 only occurs in the order Thr71-> Thr69 + 71 (Figure 7). ",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2002 Jul 15 21(14) 3782-93",
                "id": "12110590"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8ca3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "In 1F6-18kD and 1F6-ALL clones VEGF mRNA was increased 4- to 5-fold and VEGF protein secretion was highly stimulated due to activation of the VEGF promotor. PI-3K, p38 MAPK and ERK1/2 MAPK pathways were activated, while inhibition of PI-3K or p38 resulted in, respectively, 55% and up to 70% reduction of VEGF mRNA overexpression. A concurrent 60% decrease in VEGF protein secretion was mostly apparent upon inhibition of PI-3K. Inhibition of ERK1/2 hardly affected VEGF mRNA or protein secretion. ",
              "citation": {
                "type": "PubMed",
                "name": "Cell Oncol 2009 31(3) 179-90",
                "id": "19478386"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8ca2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "melanoma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "In vitro treatment with activin A increased VEGF secretion, as well as p38 and p42/44 MAPK activity in corneal epithelial cells, whereas concurrent administration of specific inhibitors of p38 or p42/44 MAPK abolished the stimulatory effect of activin A on VEGF production. We conclude that activin A stimulates inflammatory corneal angiogenesis by increasing VEGF levels through a p38 and p42/44 MAPK-dependent mechanism.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Pathol 2004 Apr 164(4) 1293-302",
                "id": "15039217"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8ca1"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "We have observed that activation of p38 kinase accompanies receptor-mediated events in platelets and coincides with cPLA2 phosphorylation. Furthermore, in the presence of inhibitors of p38 kinase, the proline-directed phosphorylation of cPLA2 was completely blocked in platelets stimulated with the thrombin receptor agonist peptide SFLLRN and was suppressed during the early (up to 2 min) phase of platelet stimulation caused by thrombin.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1996 Nov 1 271(44) 27723-9",
                "id": "8910365"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8ca0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Blood Platelets",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "In addition, TNF-alpha was shown to induce the expression of VCAM-1 in a p38 kinase-dependent manner; also, TNF-alpha-induced p38 kinase activation was blocked by inhibition of PKCdelta, suggesting that p38 kinase is apparently situated downstream of PKCdelta in the TNF-alpha-signaling pathway to VCAM-1 expression.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2005 Feb 288(2) L307-16",
                "id": "15489375"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c9f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "TTP can be phosphorylated in vitro by p38 MAPK itself (8, 10) or by MK2 (47). Two major sites of MK2-mediated phosphorylation of mouse TTP in vitro and in vivo were identified as serines 52 and 178 (15; T. Santalucia, M. Brook, E. Hitti, G. Sully, R. Wait, C. R. Tchen, C. J. A. Asensio, M. Gaestel, J. Saklavala, and A. R. Clark, unpublished data). ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2006 Mar 26(6) 2408-18",
                "id": "16508015"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c9e"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "periodically stretched them for 6 h (15% elongation, 0.5 Hz). The cells responded with an increase both in ET(B)-R mRNA (12-fold compared with control) and protein (4-fold). Among various kinase pathways, Rho kinase (ROCK) and p38 mitogen-activated protein kinase (p38 MAPK) mediated part of the deformation-induced increase in ET(B)-R expression, as judged by the inhibitory effect of Y27632 (1 microm, 38% inhibition) and SB202190 (10 microm, 44% inhibition), respectively.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Oct 5 276(40) 36999-7003",
                "id": "11457849"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c9d"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "we show here that there exists a dynamic feedback loop that is triggered by a DNA damage response (DDR) and, which after a delay of several days, locks the cell into an actively maintained state of 'deep' cellular senescence. The essential feature of the loop is that long-term activation of the checkpoint gene CDKN1A (p21) induces mitochondrial dysfunction and production of reactive oxygen species (ROS) through serial signalling through GADD45-MAPK14(p38MAPK)-GRB2-TGFBR2-TGFbeta. These ROS in turn replenish short-lived DNA damage foci and maintain an ongoing DDR.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Syst Biol 2010 6 347",
                "id": "20160708"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c9c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "stimulation with the PAR-2 peptide produced a rapid increase in ERK1/2 activation that did not significantly decline even after 4 h of exposure. SLIGKV also activated p38MAPK with similar levels of activation evident at both early and late time points (Fig. 4B).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Apr 28 281(17) 11792-804",
                "id": "16467309"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c9b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "umbilical vein endothelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "We show that Crry increases early TCR-dependent activation signals, including p56lck-, zeta-associated protein-70 (ZAP-70), Vav-1, Akt, and extracellular signal-regulated kinase (ERK) phosphorylation but also costimulation-dependent mitogen-activated protein kinases (MAPK), such as the stress-activated c-Jun N-terminal kinase (JNK). It is intriguing that Crry costimulus enhanced p38 MAPK activation in T helper cell type 1 (Th1) but not in Th2 cells. ",
              "citation": {
                "type": "PubMed",
                "name": "J Leukoc Biol 2005 Dec 78(6) 1386-96",
                "id": "16301324"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c9a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Th1 cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Activation of the tyrosine kinase receptor vascular endothelial growth factor receptor 2 (VEGFR2) by VEGF leads to the activation of stress-activated protein kinase (SAPK)2/p38 and then to actin polymerization and reorganization into stress fibers in endothelial cells. In turn, this triggers endothelial cell migration",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2004 Jan 15 23(2) 434-45",
                "id": "14724572"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c99"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "In addition to inducing G protein- and non-G protein-related signaling pathways, ANG II, via AT(1) receptors, carries out its functions via MAP kinases (ERK 1/2, JNK, p38MAPK), receptor tyrosine kinases [PDGF, EGFR, insulin receptor], and nonreceptor tyrosine kinases [Src, JAK/STAT, focal adhesion kinase (FAK)].",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2007 Jan 292(1) C82-97",
                "id": "16870827"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c98"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Recent studies show that TLR4 serves as a previously unrecognized environmental sensor for autophagy. The studies defined a new molecular pathway in which LPS induces autophagy in human and murine macrophages by a pathway regulated through a TRIF-dependent, myeloid differentiation factor 88 (MyD88)-independent TLR4 signaling. Receptor-interacting protein 1 and p38 mitogen-activated protein kinase are downstream components of this pathway (Figure 1).",
              "citation": {
                "type": "PubMed",
                "name": "Proc Am Thorac Soc 2010 Feb 7(1) 22-8",
                "id": "20160145"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c97"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Here, we demonstrate that the HBP1 transcriptional repressor participates in RAS- and p38 MAPK-induced premature senescence. In cell lines, we had previously isolated HBP1 as a retinoblastoma (RB) target but have determined that it functions as a proliferation regulator by inhibiting oncogenic pathways as a transcriptional repressor. In primary cells, the results indicate that HBP1 is a necessary component of premature senescence by RAS and p38 MAPK. Similarly, a knockdown of WIP1 (a p38 MAPK phosphatase) induced premature senescence that also required HBP1.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2006 Nov 26(22) 8252-66",
                "id": "16966377"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c96"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Here we describe a role for PRAK in tumor suppression by demonstrating that PRAK mediates senescence upon activation by p38 in response to oncogenic ras ... Furthermore, we show that PRAK activates p53 by direct phosphorylation. We propose that phosphorylation of p53 by PRAK following activation of p38 MAPK by ras plays an important role in ras-induced senescence and tumor suppression ... from full text, oncogenic ras is HRAS G12V and TP53 is phosphorylated at S37 ... human primary BJ fibroblasts",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2007 Jan 26 128(2) 295-308",
                "id": "17254968"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c95"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Transfection studies with luciferase reporter gene constructs indicate that increased HO-1 gene expression via inhibition of p38 was mediated by the transcription factor Nrf2, which is a central regulator of the cellular oxidative stress response. Accordingly, inhibitors of p38 induced binding of nuclear proteins to a Nrf2 target sequence of the HO-1 promoter, but did not affect HO-1 protein expression and promoter activity in Nrf2(-/-) MEF.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2009 Jun 1 182(11) 7048-57",
                "id": "19454702"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c94"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Monocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "n addition, in vitro stimulation of PMN with recombinant HMGB1 caused TLR4-dependent activation of NAD(P)H oxidase as well as increased ROS production through both MyD88-IRAK4-p38 MAPK and MyD88-IRAK4-Akt signaling pathways. Thus, PMN NAD(P)H oxidase activation, induced by HS/R and as mediated by HMGB1/TLR4 signaling, is an important mechanism responsible for PMN-mediated inflammation and organ injury after hemorrhage...PMN isolated from the mice ",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2007 May 15 178(10) 6573-80",
                "id": "17475888"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c93"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Although phosphatidylinositol 3-kinase pathway inhibition by LY294004 blocked both PHAS-1 Ser-65 and Thr-70 phosphorylation (3.8 +/- 0.1 versus 0.8 +/- 0.1 and 3.2 +/- 0.2 versus 1.0 +/- 0.01, respectively), protein phosphatase 2A inhibition by okadaic acid selectively increased (3.3 +/- 0.1 versus 5.2 +/- 0.1) and p38 mitogen-activated protein kinase inhibition by SB203580 selectively decreased (3.8 +/- 0.1 versus 1.4 +/- 0.3) Ser-65 phosphorylation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Sep 19 278(38) 36973-9",
                "id": "12860993"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c92"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "In the present study, we show that besides STAT1 also the tyrosine phosphatase SHP2 became tyrosine-phosphorylated upon hyperosmolarity. SB 202190 and SB 203580 (specific inhibitors of p38) inhibited both STAT activation and tyrosine phosphorylation of SHP2 induced by hyperosmotic stress. Overexpression of wild-type p38 mitogen-activated protein kinase and its upstream activator mitogen-activated protein kinase kinase 6 (MKK6) resulted in an enhanced STAT1 tyrosine phosphorylation upon osmotic shock.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Oct 15 274(42) 30222-7",
                "id": "10514514"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c91"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "The recent observation that diesel exhaust, a known source of particles and other agents that induce oxidative stress, activates redox-sensitive transcription factors and kinases in human airways (31) [From primary paper: DE induced a significant increase in the nuclear translocation of NF-{kappa}B (P = 0.02), AP-1 (P = 0.02), phosphorylated JNK (P = 0.04), and phosphorylated p38 (P = 0.01), as well as an increase in total (cytoplasmic + nuclear) immunostaining of phosphorylated p38 (P = 0.03). ]",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2006 Jun 34(6) 666-9",
                "id": "16484683"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c90"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Alveolar type II cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "In order to investigate the role of IRAK-4 kinase function in vivo, we generated \\\"knock-in\\\" mice where the wild-type IRAK-4 gene is replaced with a mutant gene encoding kinase-deficient IRAK-4 protein (IRAK-4 KD). IRAK-4 kinase is rendered inactive by mutating the conserved lysine residues in the ATP pocket essential for coordinating ATP. Analyses of embryonic fibroblasts and macrophages obtained from IRAK-4 KD mice demonstrated lack of cellular responsiveness to stimulation with IL-1beta or Toll-like receptor 4 (TLR4) and TLR7 agonists. IRAK-4 KD cells were severely impaired in NF-kappaB, JNK, and p38 activation in response to IL-1beta or TLR7 ligand.",
              "citation": {
                "type": "PubMed",
                "name": "Ernst Schering Found Symp Proc 2007 (3) 63-82",
                "id": "18510099"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c8f"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "ERK1/2-phosphorylation peaked around 3 minutes after Pam3CSK4-activation and then abated, while thrombin-activation caused a quick increase, which remained constant after 10 minutes (Figure 2B). For p38, thrombin caused an almost immediate increase in phosphorylation, reaching a plateau after 3 minutes, while Pam3CSK4  led to only 60-70% of phosphorylation relative to thrombin (Figure 2C). (anti-phospho-ERK1/2(Thr202/Tyr204))",
              "citation": {
                "type": "PubMed",
                "name": "Thromb Haemost 2009 Jul 102(1) 97-110",
                "id": "19572074"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c8e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Blood Platelets",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "IL-18 treatment markedly increased phospho-ATF-2 (Thr71) levels in HCMEC, and this effect was blocked by the IL-18BPa/Fc chimera (Fig. 5A). Furthermore, treatment with the p38PMAPK inhibitor SB203580 strongly inhibited IL-18-mediated ATF-2 phosphorylation (Fig. 5B). Inhibition of p38MAPK also attenuated p65 phosphorylation (Fig. 5C) and NF-?B-driven reporter gene activity (Fig. 5D). Together, these results demonstrate that IL-18 induced NF-?B activation via p38MAPK activation (Fig. 5).",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2006 Jan 20 339(3) 956-63",
                "id": "16325763"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c8d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": "vascular tissue"
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "In parallel with the upregulation of TGF-{beta}1, the protein levels of TAK1 were significantly increased 1.66  0.14-, 1.97  0.16-, and 1.57  0.07-fold (P < 0.01) at 1, 3, and 7 days post-MI compared with sham-operated rats (Fig. 2, A and B). Although there was no change in the protein levels of MKK3/6 and p38 MAPK levels throughout the time course, P-MKK3/6 and P-p38 MAPK were increased significantly (P-MKK3/6: 2.20  0.19-, 2.55  0.47-, and 3.29  0.32-fold; P-p38 MAPK: 1.90  0.03-, 2.03  0.06-, and 2.35  0.06-fold at 1, 3, and 7 days after MI), indicating the activation of the TGF-{beta}1-TAK1-MKK3/6-p38 MAPK pathway.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Heart Circ Physiol 2006 Feb 290(2) H709-15",
                "id": "16183734"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c8c"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "cardiomyocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "DCs isolated from E-FABP-null spleen showed enhanced production of IL-12p70, a key cytokine for innate immune responses, in response to appropriate stimuli as compared with wild-type. In real-time PCR, the expression level of IL-12p35 mRNA after LPS stimuli was much higher in mutant DCs when compared with wild-type, while no apparent change of IL-12p40 mRNA level was detected. Phosphorylated forms of p38 mitogen-activated protein kinase (p38MAPK) and IkappaB-alpha, molecules critical for IL-12 production, were detected at higher levels in E-FABP-null-mutant DCs after LPS stimuli when compared with wild-type counterparts",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2006 Jun 23 345(1) 459-66",
                "id": "16684508"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c8b"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "dendritic cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "To determine whether the p38MAPK was involved in HSP70-induced phagocytosis, RAW264.7 macrophages were treated with either SB203580 (a specific p38MAPK-inhibitor) at the dose of 20 mM in DMEM for 20 h or cultured in medium alone. Further, the vehicle in which the SB203580 was suspended (DMSO) was mixed in equivalent volume of medium (as for SB203580) and used as a control.As seen in Fig. 5C, SB203580 is able to abrogate HSP70-induced phagocytosis whereas controls were unable to do so (P  0.05). Together, these data indicate that HSP70-induced phagocytosis is mediated via involvement of p38MAPK.",
              "citation": {
                "type": "PubMed",
                "name": "J Surg Res 2006 Nov 136(1) 58-69",
                "id": "16979664"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c8a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Proper H(2)O to mucin ratio of airway mucus is important for mucociliary clearance. Recent studies suggest that decreased aquaporin 5 (AQP5) is correlated with increased staining of MUC5AC in submucosal glands of COPD patients. Lipopolysaccharide (LPS) is one of the major insults in airway mucin secretion in COPD. In this study, changes in both AQP5 and MUC5AC expression levels in SPC-A1, a human airway submucosal gland cell line, were quantified after exposure of the cells to LPS. AQP5 transcription and protein expression were decreased while MUC5AC expression was increased by LPS exposure in SPC-A1 cells. Further studies revealed that AQP5 expression was down-regulated via the p38/JNK signaling pathway, while MUC5AC was up-regulated through the EGFR-p38/JNK pathway. Therefore, p38 and JNK may become promising targets to preserve AQP5 expression and prevent MUC5AC over-expression to restore proper H(2)O to mucin ratio of the airway mucus, which may be beneficial to the clinical management of COPD patients.",
              "citation": {
                "type": "PubMed",
                "name": "Respir Physiol Neurobiol 2010 May 31 171(3) 212-7",
                "id": "20362698"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c89"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Chronic Obstructive Pulmonary Disease",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "In this study, we demonstrated that high glucose significantly increased intracellular ROS levels in human aortic endothelial cells (HAECs). Additionally, high glucose reduced the antioxidant activity of thioredoxin. To investigate the mechanisms involved, we found that glucose enhanced the expression of thioredoxin interacting protein (Txnip), a Trx inhibitory protein, through p38 mitogen-activated protein kinase (MAPK). We also showed that glucose regulated Txnip at transcription level and p38 MAPK and forkhead box O1 transcriptional factor (FOXO1) were involved in the process.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2009 Apr 17 381(4) 660-5",
                "id": "19254690"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c88"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Proliferation of retinal endothelial cells in situ and in vitro migration of lung endothelial cells isolated from Rap1b-deficient mice were inhibited. At the molecular level, activation of 2 MAP kinases, p38 MAPK and p42/44 ERK, important regulators of endothelial migration and proliferation, was decreased in Rap1b-deficient endothelial cells in response to VEGF stimulation. These studies provide evidence that Rap1b is required for normal angiogenesis",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2008 Mar 1 111(5) 2647-56",
                "id": "17993608"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c87"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "The PTEN gene (phosphatase and tensin homologous on chromosome 10) is frequently mutated or deleted in a number of malignancies including human hepatocellular carcinoma (HCC). We reported previously that the hepatitis B virus X (HBx) protein, known to be a causative agent in the formation of HCC, activates insulin-like growth factor II (IGF-II) expression through Sp1 phosphorylation by protein kinase C (PKC) or mitogen-activated protein kinase (MAPK) signaling. In this report we demonstrate that the PTEN effect on HBx induced IGF-II activation in a hepatoma cell line. Expression of PTEN and IGF-II was inversely related in different hepatoma cell lines. PTEN expression induced decreased Sp1 DNA binding by dephosphorylating Sp1 and interfered with transcriptional transactivation of IGF-II by HBx in hepatoma cells. The protein phosphatase activity was involved in PTEN downregulation of IGF-II transcription through downregulation of MAPK, MAPK kinase phosphorylation and PKC translocation. Our data suggest that PTEN blocks Sp1 phosphorylation in response to HBx, by inactivating PKC, MAPK and MAPK kinase which eventually downregulate IGF-II expression, during the formation of HCC.",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 2003 Jun 19 545(2-3) 203-8",
                "id": "12804776"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c86"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Our data further demonstrated that AMs exposed to CSE trigger an intracellular signaling pathway mediated by MAPKs and NF-B. Specifically, p38 MAPK activity peaked in AMs from wild-type mice after just 30 min of CSE exposure (Fig. 4). Whereas p38 MAPK activation was also observed in RAGE KO AMs, there was a significant decrease in p38 MAPK activity after 60 min of CSE exposure compared with wild-type AMs (Fig. 4).We also demonstrated that, after 4 h, nuclear translocation of active NF-B was significantly diminished in smoke-exposed RAGE KO AMs compared with smoke-exposed AMs from control mice (Fig. 5).",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2012 Jun 1 302(11) L1192-9",
                "id": "22505673"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c85"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages, Alveolar",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "In order to investigate the role of IRAK-4 kinase function in vivo, we generated \\\"knock-in\\\" mice where the wild-type IRAK-4 gene is replaced with a mutant gene encoding kinase-deficient IRAK-4 protein (IRAK-4 KD). IRAK-4 kinase is rendered inactive by mutating the conserved lysine residues in the ATP pocket essential for coordinating ATP. Analyses of embryonic fibroblasts and macrophages obtained from IRAK-4 KD mice demonstrated lack of cellular responsiveness to stimulation with IL-1beta or Toll-like receptor 4 (TLR4) and TLR7 agonists. IRAK-4 KD cells were severely impaired in NF-kappaB, JNK, and p38 activation in response to IL-1beta or TLR7 ligand.",
              "citation": {
                "type": "PubMed",
                "name": "Ernst Schering Found Symp Proc 2007 (3) 63-82",
                "id": "18510099"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c84"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "The mRNA and protein levels of VEGF in CRH-treated HaCaT cells were significantly attenuated. However, this downregulation was abrogated by pretreatment with antalarmin, SB203580 and SP600125; pretreatment with PD98059 did not attenuate the effects of CRH on the expression of VEGF. In addition, CRH treatment induced rapid phosphorylation of p38 MAPK and JNK1/2, and antalarmin, SB203580 and SP600125 inhibited CRH-induced phosphorylation of p38 MAPK and JNK1/2. ",
              "citation": {
                "type": "PubMed",
                "name": "Regul Pept 2010 Feb 25 160(1-3) 115-20",
                "id": "19852986"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c83"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "HNE was able to induce phosphorylation of ERK and p38 MAPK, but not JNK, in a time-dependent manner up to 120min (Fig. 3). Moreover, nuclear translocation of 5-LO induced by HNE was markedly attenuated by PD98059, an ERK inhibitor as well as by SB203580, a p38 MAPK inhibitor, but not by SP600125, a JNK inhibitor (Fig. 4A?D). Linked to these results, LTB4 production by HNE was also significantly attenuated by PD98059 as well as by SB203580 in a dose-dependent manner, but not by SP600125 (Fig. 4E). ",
              "citation": {
                "type": "PubMed",
                "name": "Atherosclerosis 2010 Jan 208(1) 56-61",
                "id": "19586628"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c82"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": "vascular smooth muscle"
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": " In the present investigation, we find that SB203580, a specific inhibitor of p38, blocks oxLDL-exposed J774 cells from becoming foam cells. Inhibition of foam cell formation by blockade of the p38 pathway is, at least in part, due to inhibition of oxLDL-induced up-regulation of the scavenger receptor CD36. Using pharmaceutical inhibitors and dominant active MAP kinase kinases, we demonstrated that activation of the p38 pathway, but not the ERK or JNK pathways, is necessary and sufficient to transactivate PPARgamma, a nuclear receptor that has recently been shown to play a pivotal role in oxLDL-induced CD36 expression. Our results for the first time demonstrate a regulation of CD36 by p38, and the importance of the p38 pathway in regulation of foam cell formation.",
              "citation": {
                "type": "PubMed",
                "name": "APMIS 2002 Jun 110(6) 458-68",
                "id": "12193207"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c81"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "These effects of high glucose were blocked by antioxidants (taurine and tiron), inhibitors of mitochondrial electron transport chain complex I (rotenone) and II (thenoyltrifluoroacetone), an inhibitor of glycolysis-derived pyruvate transport into mitochondria (alpha-cyano-4-hydroxycinnamic acid), an uncoupler of oxidative phosphorylation (carbonyl cyanide m-chlorophenylhydrazone), a manganese superoxide dismutase mimetic, catalase, and a specific inhibitor of p38 MAPK (SB 203580), but were not affected by an inhibitor of the malate-aspartate shuttle (aminooxyacetate acid). Hydrogen peroxide (>/=10(-5) M) also stimulated p38 MAPK phosphorylation, ANG secretion, and ANG mRNA gene expression, but its stimulatory effect was blocked by catalase and SB 203580.",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 2002 Aug 143(8) 2975-85",
                "id": "12130563"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c80"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Tube Cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Using isolated human platelets, we report that PKCdelta, but not PKCalpha or PKCbeta, is required for collagen-induced phospholipase C-dependent signaling, activation of alpha(IIb)beta(3), and platelet aggregation. Analysis of PKCdelta phosphorylation and translocation to the membrane following activation by both collagen and thrombin indicates that it is positively regulated by alpha(IIb)beta(3) outside-in signaling. Moreover, PKCdelta triggers activation of the mitogen-activated protein kinase-kinase (MEK)/extracellular-signal regulated kinase (ERK) and the p38 MAPK signaling. This leads to the subsequent release of thromboxane A(2), ##Phospho-specific antibodies for PKC?, MEK1/2, ERK1/2, and p38 MAPK came from Cell Signaling Technologies (Beverly, MA) and Santa Cruz Biotechnologies (Santa Cruz, CA).##",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Oct 6 281(40) 30024-35",
                "id": "16895913"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c7f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Blood Platelets",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Analysis of ubiquitination and degradation of the constitutively dimerized ATF2 mutant (ATF2(Delta150-248)) showed that activation of JNK or p38 kinase renders ATF2 resistant to ubiquitination and degradation. This effect is mediated by JNK/p38-dependent phosphorylation of ATF2 at Thr-69 and Thr-71, because the phosphorylation-deficient mutant (ATF2(Delta150-248-T69A,T71A)) was not protected from ubiquitination and degradation by the activation of SAPK.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Apr 28 275(17) 12560-4",
                "id": "10777545"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c7e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "the transcriptional activity of the ATF-2 transcription factor, as a direct p38 and JNK target in syndecan-4-null and wild type cells. In the absence of syndecan-4, both ATF-2 phosphorylation and transcriptional activity were significantly more elevated compared with wild type cells, and both activities were decreased either by the re-expression of syndecan-4 or by the expression of RacN17.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Nov 5 279(45) 47172-6",
                "id": "15371457"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c7d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "control and Sod2-overexpressing cells were treated with the specific inhibitors of ERK1/2 (PD98059) and p38 (SB203580) (Fig. 4B, inset). Northern blotting demonstrated that the ERK1/2 inhibitor blocked basal MMP-1 expression and dramatically decreased MMP-1 mRNA levels in the HT15 cell lines. The p38 inhibitor increased MMP-1 expression in both control and HT15 cell lines......the inductive properties of SB203580 could be blocked by PD98059.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Apr 27 276(17) 14264-70",
                "id": "11297530"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c7c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "fibrosarcoma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "HeLa S3 cells were radiolabeled with 32Pi in the presence and absence of 1,000 units/ml interferon-a. HeLa cells were also stimulated with sodium arsenite, which is a known activator of stress-activated protein kinases such as p38mapk. As shown in Fig. 8A, two radioactive tryptic peptides were detected with both stimulants. The earlier peak eluted with the S727-PP standard, and the later peak eluted in the region expected for the Ser-505 phosphopeptide.....Interferon-a treatment led to a 2-fold increase in phosphorylation at Ser-727 and a 1.6-fold increase in phosphorylation at Ser-505, and the corresponding increases with arsenite treatment were 6.5-fold for Ser-727 and 1.9-fold for Ser-505 (Fig. 8A).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1998 Feb 20 273(8) 4449-58",
                "id": "9468497"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8c7b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "NGF was also found to stimulate p38 MAPK activity, as measured in an immune complex kinase assay (Fig. 5B).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1998 Apr 18(4) 1946-55",
                "id": "9528766"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8802"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Phospho-Y705-STAT3, phospho-S727-STAT1, and phospho-p38 protein levels were also significantly higher in IRF-2(-/-) than control macrophages. ",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2007 Mar 15 178(6) 3602-11",
                "id": "17339457"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8801"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "VEGF-C/Flt-4 signaling-induced activation of p38 MAPK and upregulation of CNTN-1 were both abolished by transfection with p38AF-dominant negative form of p38 MAPK (Figure 4B)",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Cell 2006 Mar 9(3) 209-23",
                "id": "16530705"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8800"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Moreover, release of arachidonic acid induced by VWF was strongly impaired by inhibition of p38MAPK. We also found that VWF induced phosphorylation of cytosolic phospholipase A(2), and that this process was prevented by the p38MAPK inhibitor SB203580.",
              "citation": {
                "type": "PubMed",
                "name": "Thromb Haemost 2004 Jan 91(1) 102-10",
                "id": "14691575"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87ff"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Blood Platelets",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Here, we show that ADP secreted from platelet-dense granules, and subsequent activation of P2Y12 receptors, as well as TxA2 release are important upstream mediators of p38 MAP kinase activation by thrombin.",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2007 Jan 15 109(2) 616-8",
                "id": "16990590"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87fe"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Blood Platelets",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "One report has claimed that phosphorylation of GATA-3 occurs in Th2 cells and that this phosphorylation was mediated by p38 MAPK [66].",
              "citation": {
                "type": "PubMed",
                "name": "Arthritis Res Ther 2006 8(2) 205",
                "id": "16542479"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87fd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Th2 cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "The superoxide donor menadione activated p38 MAPK and phosphorylation of STAT1 at serine 727, but not at tyrosine 701 (Fig. 8B),",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2005 Aug 25(15) 6821-33",
                "id": "16024814"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87fc"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Mice with haploinsufficiency of the Grb2 gene (Grb2(+/-) mice) appear normal at birth but have defective T cell signaling. In response to pressure overload, cardiac p38 MAPK and JNK activation was inhibited and cardiac hypertrophy and fibrosis was blocked in Grb2(+/-) mice.",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Invest 2003 Mar 111(6) 833-41",
                "id": "12639989"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87fb"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "ERK and p38 play a role in alpha-adrenergic-stimulated NCX1 upregulation, and (3) p38 activation alone is sufficient for NCX1 upregulation.",
              "citation": {
                "type": "PubMed",
                "name": "Ann N Y Acad Sci 2002 Nov 976 237-47",
                "id": "12502566"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87fa"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "cardiomyocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "HGF activates P42/P44MAPK (extracellular signal regulated kinase 2/1) and P38 MAPK two and three-fold respectively compared to basal level in a PKC independent manner. The phosphorylation level peaked within 5-10 minutes of HGF treatment.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2001 Dec 6 20(56) 8125-35",
                "id": "11781826"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87f9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "melanocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "We propose that Foxo1 turns on a feed-forward loop, relayed by p38 and acting to amplify both PKB activation and Foxo1 inhibition",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 2007 Feb 15",
                "id": "17303659"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87f8"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "hepatocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "IL-8 treatment lasting 15 min failed to recruit flavocytochrome b(558), p47(phox), or Rac2, but did enhance the Btk- and p38 MAPK-dependent phosphorylation and the translocation of p67(phox) into detergent-resistant microdomains. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Nov 4 280(44) 37021-32",
                "id": "16115878"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87f7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Inhibition of p38, which is known to stimulate TonEBP/OREBP transcriptional activity",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2008 Feb 1 283(5) 2554-63",
                "id": "18056707"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87f6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Taken together, RhoA, ROCK, p38MAPK, ERK1/2, and p47(PHOX) may be subsequently activated, leading to activation of NADPH oxidase to produce superoxide. ",
              "citation": {
                "type": "PubMed",
                "name": "Exp Mol Med 2005 Dec 31 37(6) 575-87",
                "id": "16391519"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87f5"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Figure 4.  p38 MAPK and its downstream effector, MAPKAPK2, regulates MMP-2 and MMP-9 by stabilizing their mRNA transcripts in bladder cancer cells. ",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2010 Jan 15 70(2) 832-41",
                "id": "20068172"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87f4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "RAGE-mediated NF-kappaB activation was suppressed by the selective p38 MAPK inhibitor SB203580 and by coexpression of a kinase-dead p38 dominant-negative mutant.",
              "citation": {
                "type": "PubMed",
                "name": "Diabetes 2001 Jun 50(6) 1495-504",
                "id": "11375353"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87f3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Monocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "p38 MAPK can positively and negatively modulate NFAT activity by several mechanisms. p38 MAPK can induce NFAT expression at the transcriptional and post-transcriptional levels and can promote the interaction of NFAT with the coactivator CREB-binding protein (CBP). In contrast, p38 MAPK can inhibit NFAT transcriptional activity by phosphorylation of NFAT and by activation of NFAT nuclear export [73,74].",
              "citation": {
                "type": "PubMed",
                "name": "Arthritis Res Ther 2006 8(2) 205",
                "id": "16542479"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87f2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Degterev, Yuan, and others identified chemical compounds named necrostatins that allosterically inhibit the kinase activity of RIP1 and that can block necrosis without affecting RIP1-mediated activation of nuclear factor {kappa}B (NF-{kappa}B), p38 mitogen?activated protein kinase (MAPK), or c-Jun N-terminal kinase (JNK) (2, 15).",
              "citation": {
                "type": "PubMed",
                "name": "Sci Signal 2010 3(115) re4",
                "id": "20354226"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87f1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "CaMKIV, and p38 MAPK were also the kinases involved in CREB Ser(133) phosphorylation induced by CD3/CD28.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2001 Jan 1 166(1) 284-92",
                "id": "11123304"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87f0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "ET-1-induced transcription of the immediate early gene c-fos requires the concomitant activation of both the PKC/ERK- and p38MAPK-dependent pathways, because inhibitors of either pathway block the ET-1-induced increase of c-fos mRNA.",
              "citation": {
                "type": "PubMed",
                "name": "J Neurosci 2001 Nov 15 21(22) 8842-53",
                "id": "11698596"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87ef"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "2 hours after the LPS stimulation, the phosphorylation levels of ERK1/2, p38 MAPK and JNK all increased.  ",
              "citation": {
                "type": "PubMed",
                "name": "Chin Med J (Engl) 2007 Jun 20 120(12) 1075-81",
                "id": "17637225"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87ee"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "TNF activates NFKB transcriptional activity in macrophages and epithelial cells . TNF similarly activates p38 MAPK.",
              "citation": {
                "type": "PubMed",
                "name": "Pharmacol Rev 2004 Dec 56(4) 515-48",
                "id": "15602009"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87ed"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": "Epithelium"
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Fig. 3. CREB phosphorylation is induced by OxPAPC via PKA, PKC, p38MAPK, and ERK1/2.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Dec 19 278(51) 51006-14",
                "id": "14523007"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87ec"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Treatment of the cells concurrently with SB203580, a specific p38MAPK inhibitor, robustly blocked activation of NFkappaB transcriptional activity",
              "citation": {
                "type": "PubMed",
                "name": "Biochim Biophys Acta 2007 Mar 1773(3) 367-74",
                "id": "17196679"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87eb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "To verify the effect of SB 203580 on p38mapk activity in platelets, the activity of MAPKAP-K2, an in vivo substrate of p38mapk, was determined. SB 203580 inhibited activation of MAPKAP-K2 by thrombin in a concentration dependent manner with an IC50 of 0.2 mM, and inhibition was complete with 10 mM inhibitor (not shown).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1998 Feb 20 273(8) 4449-58",
                "id": "9468497"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87ea"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Blood Platelets",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Phospho-p38+ alveolar macrophages and phospho-p38+ cells in alveolar walls were increased in patients with severe and mild/moderate COPD, compared with smoking and nonsmoking controls. ",
              "citation": {
                "type": "PubMed",
                "name": "Eur Respir J 2008 Jan 31(1) 62-9",
                "id": "17959643"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87e9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "The downregulated connexin32 expression was inhibited by treatment with a MAP-kinase inhibitor (PD98059), whereas the upregulated claudin-2 expression was blocked by p38 MAP and PI3-kinase inhibitors (SB203580 and LY294002)",
              "citation": {
                "type": "PubMed",
                "name": "Exp Cell Res 2004 Oct 1 299(2) 427-41",
                "id": "15350541"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87e8"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "hepatocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "These results suggest that p38 mitogen-activated protein kinase regulates LPS-induced activation of Sp1, which in turn regulates transcription of the hIL-10 gene",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Apr 27 276(17) 13664-74",
                "id": "11278848"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87e7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Using pharmacological inhibitors, we further show that p38 MAPK and Akt signaling pathways are crucial for the ErbB2-induced MMP-9 up-regulation, invasion and migration of MCF10A cells",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Lett 2009 Mar 18 275(2) 227-33",
                "id": "19022565"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87e6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "TNFR1-stimulated p42/44 MAPK and p38 MAPK activities were insensitive to pharmacological caspase inhibition or CrmA.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2002 Aug 15 366(Pt 1) 145-55",
                "id": "11996667"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87e5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "jubilant",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2003 Jul 1 63(13) 3632-6",
                "id": "12839952"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87e4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "neutrophils predominantly migrated toward end target chemoattractants via p38 MAPK, whereas intermediary chemoattractant-induced migration was phosphoinositide 3-kinase (PI3K)/Akt dependent. ",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2002 Oct 14 159(1) 91-102",
                "id": "12370241"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87e3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "ER81 is not only activated by ERK MAPK but also by p38 MAPK (42, 68). TAK1 is an MAPK kinase kinase that is capable of activating the p38 MAPK pathway (39, 69-73),",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Nov 7 278(45) 44377-84",
                "id": "12947087"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87e2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": " In addition, inhibition of JNK and p38 suppressed TGFbeta induction of TGFbeta3 transactivation",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Oct 6 281(40) 29479-90",
                "id": "16891311"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87e1"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "CaMKIV, and p38 MAPK were also the kinases involved in CREB Ser(133) phosphorylation induced by CD3/CD28.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2001 Jan 1 166(1) 284-92",
                "id": "11123304"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87e0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Co-stimulation of TF1-KDR cells with both GM-CSF and VEGF-A resulted in massive migration of both the common GM-CSFR beta-chain and VEGF-R2 to lipid rafts and sustained p38 mitogen-activated protein kinase activation.",
              "citation": {
                "type": "PubMed",
                "name": "Br J Haematol 2009 May 145(3) 399-411",
                "id": "19245429"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87df"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "leukemia",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "BMP-2 and TGF-beta stimulated Ras, MAPK, and AP-1 activities (note: Ras is upstream of the otehr two)",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 May 3 277(18) 15514-22",
                "id": "11854297"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87de"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "This loading of macrophages with free cholesterol activates NF-?B and the MAPKs p38, extracellular-signal-regulated kinase 1 (ERK1) and ERK2, and JNK, thereby inducing the expression of genes encoding inflammatory cytokines (including TNF-? and IL-6)66",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2008 Jul 24 454(7203) 455-62",
                "id": "18650916"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87dd"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Western blotting showed enhanced phosphorylation of p38 MAPK in the cremasteric tissue after stimulation with KC but not with MIP-2.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2012 Jul 6 423(3) 484-9",
                "id": "22683630"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87dc"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": "Muscles"
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "p38 MAPK is activated in a ERK-dependent fashion, thus indicating that Ras promotes premature senescence by sequentially activating the ERK and p38 MAPK pathway [68].",
              "citation": {
                "type": "PubMed",
                "name": "J Mol Cell Cardiol 2004 Feb 36(2) 175-83",
                "id": "14871544"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87db"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "IL-22 induces the activation of the ERK, JNK, and p38 MAPK pathways that are not activated by IL-10 ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Sep 13 277(37) 33676-82",
                "id": "12087100"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87da"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "hepatoblastoma cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "In parallel, after stimulation with 10 ?M HNE, p38 MAPK was rapidly and strongly phosphorylated within 5 min, and this phosphorylation was maintained up to 45 min (Fig. 6B), suggesting a possible role of p38 MAPK in HNE-induced 5-LO activation.",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2009 Mar 1 46(5) 692-8",
                "id": "19135147"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87d9"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Inhibition of ERKs with PD98059 or of p38 with SB203580 significantly inhibited silica-induced AP-1 activation....These findings demonstrate for the first time that freshly fractured silica induces AP-1 activation, which may be mediated through p38 MAPK and ERK pathways.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Oct 22 274(43) 30611-6",
                "id": "10521445"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87d8"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "IL-18 activated p38 MAP kinase, jun kinase, and beta casein kinase (TIP kinase), an apparently novel kinase previously thought to be specifically activated by IL-1 and tumor necrosis factor (TNF)",
              "citation": {
                "type": "PubMed",
                "name": "J Interferon Cytokine Res 1998 Dec 18(12) 1077-88",
                "id": "9877452"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87d7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "It is known that LPS stimulation leads to increased activation of three subgroups of MAPKs, i.e., ERK, JNK, and p38, in murine macrophages and human monocytes (38, 39).",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2002 Aug 1 169(3) 1401-9",
                "id": "12133965"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87d6"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "As shown in Figure 6A, the basal level of phospho-p38 MAPK was elevated in cav-1/- mice but not detectable in wild-type mice.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2008 Aug 39(2) 171-9",
                "id": "18323531"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87d5"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Blocking ERK1/2 with PD98059 or p38 MAPK with SB203580 reduced BK-induced IL-6 expression.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2003 Mar 28(3) 330-8",
                "id": "12594059"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87d4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Kumagai et al. [40] examined the relation between COX-2 mRNA stability and HNE-activated p38 MAPK pathway and found that the p38 MAPKspecific inhibitor accelerated COX-2 mRNA degradation [15,43].",
              "citation": {
                "type": "PubMed",
                "name": "Curr Atheroscler Rep 2007 Sep 9(3) 216-21",
                "id": "18241616"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87d3"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Figure 1C shows that LPS activates and phosphorylates p38 by 15 min (lane 2), which returns toward control (lane 1)  at 2 h (lane 3).",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2004 Jan 286(1) C145-52",
                "id": "14522818"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87d2"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Monocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Here we show that untimely proteolysis of cyclin B1 following p38 activation contributes to G(2) checkpoint. ",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Physiol 2007 Aug 212(2) 481-8",
                "id": "17373649"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87d1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "This analysis demonstrated that MKK6 caused p38 MAP kinase activation (Fig. 6C).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1996 Mar 16(3) 1247-55",
                "id": "8622669"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87d0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "p38 kinase, a stress-activated kinase, becomes activated in response to hypoxia",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Apr 27 276(17) 14359-65",
                "id": "11278616"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87cf"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium"
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "VEGF-C/Flt-4 signaling-induced activation of p38 MAPK and upregulation of CNTN-1 were both abolished by transfection with p38AF-dominant negative form of p38 MAPK (Figure 4B)",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Cell 2006 Mar 9(3) 209-23",
                "id": "16530705"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87ce"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Lung Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Most surprisingly, b-Raf also enhanced Rin-mediated activation of p38 (Fig. 6, F  and G), suggesting that b-Raf participates in a Rin-dependent p38 activation pathway. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Nov 11 280(45) 37599-609",
                "id": "16157584"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87cd"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "In cultured myoblasts evidence has been presented that MEF2 binding is necessary for p38 MAPK regulation of muscle creatine kinase promoter-driven reporter gene expression (Zetser et al. 1999).",
              "citation": {
                "type": "PubMed",
                "name": "Proc Nutr Soc 2004 May 63(2) 227-32",
                "id": "15294035"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87cc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "myoblast",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Of the LPS-regulated proteins identified by peptide mass fingerprinting for which probes were present on the oligonucleotide microarray... Similarly, CAP1, Rho-GAP1, and ficolin 1 were down-regulated at both the mRNA transcript and protein levels",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Aug 30 277(35) 31291-302",
                "id": "11943771"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87cb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "TAK1 is thought to activate two divergent pathways that lead to the transcription factors NF-kB and AP-1 through kinase cascades involving the canonical I?B kinase complex (IKK-a, IKK-b, and IKK-g) and MAP kinases (ERK, JNK, p38), respectively, to induce the expression of target genes.  ",
              "citation": {
                "type": "PubMed",
                "name": "Arthritis Res Ther 2005 7(1) 12-9",
                "id": "15642149"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87ca"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "dendritic cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "p38 activation is necessary for shear stress-dependent angiogenesis.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Physiol 2010 Jan 222(1) 120-6",
                "id": "19774558"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87c9"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": "Muscle, Skeletal"
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "we found that IL-33R signaling induced a time-dependent activation of Erk1/2, protein kinase B (PKB), JNK1/2, NF-kB, and p38, and degradation of IkB (supplemental Figure 1B).",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2010 May 13 115(19) 3899-906",
                "id": "20200353"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87c8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "mast cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "cyclosporin A blocks angiotensin II-induced mitogen-activated protein kinase activation in cultured primary cardiomyocytes and in the heart of hypertensive mice.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Dec 29 275(52) 40867-73",
                "id": "11016940"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87c7"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "cardiomyocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Pretreatment of NHBECs with the MEK-1 inhibitor PD98059 abolished the V2O5-induced increase in HB-EGF mRNA expression, whereas pretreatment with the p38 MAP kinase inhibitor SB203580 blocked the V2O5-induced increase in HB-EGF mRNA by ~ 80% (Figure 8 ).",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2001 Feb 24(2) 123-31",
                "id": "11159045"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87c6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Inhibitors of ERK (U0126, PD98059, and ERK1/2 antisense phosphorothioate oligonucleotide), JNK (SB203580, SP600125, and curcumin), and p38 (SB203580 and SB202190) pathways down-regulated the TNF-stimulated expression of MMP-13.",
              "citation": {
                "type": "PubMed",
                "name": "Exp Cell Res 2003 Aug 1 288(1) 208-17",
                "id": "12878172"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87c5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "chondrocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "IgE triggers the activation of three members of the mitogen-activated protein (MAP) kinase family, c-Jun amino-terminal kinase (JNK), p38 MAP kinase (p38), and extracellular signal-regulated kinases. SCF similarly activates all three MAP kinases.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 1999 Feb 15 162(4) 2087-94",
                "id": "9973482"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87c4"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Signal transduction pathway inhibitors (SB203580, curcumin, and PD98059) implicated p38 and JNK",
              "citation": {
                "type": "PubMed",
                "name": "FASEB J 2005 Mar 19(3) 443-5",
                "id": "15640282"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87c3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Treatment with LPS resulted in significant increases in ERK, JNK, and p38 phosphorylation compared with control, and these events were not inhibited by cotreatment with lutein (Fig. 4D).",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2008 Sep 15 45(6) 885-96",
                "id": "18620044"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87c2"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "leukemia",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Phosphorylation of MEF2A by p38 MAPK strongly increases the transcriptional activity of MEF2A",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Apr 25 278(17) 15297-303",
                "id": "12586839"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87c1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Inhibition of p38 MAPK selectively blocks the accumulation of neutrophils into the airspaces",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2000 Feb 15 164(4) 2151-9",
                "id": "10657669"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87c0"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Here we have shown that UV-induced activation of the POMC and MC1R promoters is mediated by p38 stress-activated kinase signaling to the transcription factor, upstream stimulating factor-1 (USF-1).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Dec 3 279(49) 51226-33",
                "id": "15358786"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87bf"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "melanocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "AG1478 inhibited ERK, JNK, and p38 kinase signaling pathways stimulated by cigarette smoke. ",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2006 Jun 34(6) 666-9",
                "id": "16484683"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87be"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "CO activated p38 MAPK, pERK1/2 and Akt at 30 min as determined by phosphorylation in a dose (Figure 4A) and time (Figure 4B) dependent manner.",
              "citation": {
                "type": "PubMed",
                "name": "PLoS One 2009 4(12) e8139",
                "id": "19956541"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87bd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "S1P stimulated expression of the transcription factor KLF5 in manners dependent on G(i), Ras, and ERK/p38 MAPK",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Mar 26 279(13) 12300-11",
                "id": "14711826"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87bc"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": "vascular smooth muscle"
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Cadmium rapidly activates p38 and ERK1/2",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Dec 5 278(49) 49246-53",
                "id": "14504288"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87bb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Treatment with p38 inhibitors, such as SB202190, SB203580, and PD169316, substantially reduced LPS-induced p62 mRNA expression, as well as IL-6 mRNA (Fig. 4D and Fig. S4C).",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2011 Jan 25 108(4) 1427-32",
                "id": "21220332"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87ba"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "This proapoptotic effect was blocked by inhibition of the p38 MAPK kinase signaling with the inhibitor SB-203580 and was associated with an increase in p38 activity as measured by a kinase assay.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2004 Sep 287(3) L515-24",
                "id": "15132952"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87b9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": " Inhibition of the p38 mitogen-activated protein kinase pathway blocked the induction of p16(INK4a) and cellular senescence",
              "citation": {
                "type": "PubMed",
                "name": "FASEB J 2009 May 23(5) 1358-65",
                "id": "19124561"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87b8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "erythroid progenitor",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "In 2005, Yuan and colleagues identified necrostatin 1 and necrostatin 3, small molecules that allosterically block the kinase activity of RIP1, thereby inhibiting necroptosis but leaving RIP1-mediated activation of NF-kB, mitogen-activated protein kinase p38 and JUN N-terminal kinase 1 (JNK1) unaffected7,63.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Mol Cell Biol 2010 Oct 11(10) 700-14",
                "id": "20823910"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87b7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "The cytoplasmic tail of the endothelin B receptor was found to be required for activation of all three mitogen-activated protein kinases and stimulation of intracellular calcium levels.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1996 Dec 6 271(49) 31572-9",
                "id": "8940174"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87b6"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "PMA stimulation resulted in translocation of NF?B and this translocation was inhibited by both SB-202190 and bis I (Fig. 6). (SB-202190 is a p38 inhibitor)",
              "citation": {
                "type": "PubMed",
                "name": "J Surg Res 2008 Mar 18",
                "id": "18675993"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87b5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Monocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Addition of CHA, CGS 21680, and Compound 24 induced a concentration-dependent increase of pERK1/2, pp38, and pAkt, whereas Cl-IB-MECA was involved only in ERK1/2 phosphorylation",
              "citation": {
                "type": "PubMed",
                "name": "Arterioscler Thromb Vasc Biol 2010 Jan 30(1) 90-7",
                "id": "19834107"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87b4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Foam Cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "We show that Siah2 is subject to phosphorylation by p38 MAPK, which increases Siah2-mediated degradation of PHD3. .... Phosphopeptide mapping identified T24 and S29 as the primary phospho-acceptor sites.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Nov 17 281(46) 35316-26",
                "id": "17003045"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87b3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Two-dimensional phosphopeptide mapping using mutation of phosphorylation sites for MAPK revealed that the nine serine residues in Foxo1 are specifically phosphorylated by Erk and that five of the nine residues are phosphorylated by p38 in vivo. ",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2007 Mar 19(3) 519-27",
                "id": "17113751"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87b2"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "The exact role of P38MAPK in TLR-4-induced IL-8 production/release remains unclear, although P38MAPK has been shown to play a key role in increasing the mRNA stability of IL-8, GM-CSF, and TNF-a in LPS-treated lung macrophages [54].",
              "citation": {
                "type": "PubMed",
                "name": "Exp Lung Res 2009 Aug 35(6) 439-85",
                "id": "19842832"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87b1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "we incubated NIH-3T3 cells in amino acid-deficient medium with increasing concentrations of SB203580. As shown in Fig. 7Go, inclusion of the p38MAPK inhibitor was able to block CA-VI expression by amino acid deprivation, with partial inhibition occurring at 1020 M and full inhibition at 100 M.",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 2001 Jan 142(1) 221-8",
                "id": "11145585"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87b0"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Next, we incubated the cells with p38 MAP kinase inhibitor SB 203580. SB 203580 at concentration of 5 ?M inhibited the IL-8 generation by macrophages. The amounts of IL-8 produced and released by the cells were diminished by 42% (from ~52.5  7 ng/ml to ~22.0  5.1 ng/ml).",
              "citation": {
                "type": "PubMed",
                "name": "Respir Res 2006 7 66",
                "id": "16620395"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87af"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Macrophages, Alveolar",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "At the transcription level, inhibition of p38 MAPK inhibits CCR7 mRNA expression. Finally, we demonstrated that transcription factors CREB-1 and C/EBPalpha and C/EBPbeta are translocated to the nucleus following PGE(2) stimulation and bind the potent CCR7 promoter region. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Immunol 2009 Aug 46(13) 2682-93",
                "id": "19545899"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87ae"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "IL-4 induces p38 MAPK activation in human dermal fibroblasts Since inhibition  of p38 MAPK significantly decreased IL-4-induced TIMP-2 expression, we  determined the activation of p38 MAPK by immunoblotting using Abs specific for  phosphorylated, activated forms of p38 MAPK (Thr 180 /Tyr 182 ).",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2002 Feb 15 168(4) 1895-902",
                "id": "11823524"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87ad"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "In C3H/HeOuJ mice treated with ETX, activation of p38 MAP kinase was also evident in macrophages and endothelial cells, and JNK kinase in macrophages. In contrast, reduced protein kinase B (AKT) was noted in macrophages.",
              "citation": {
                "type": "PubMed",
                "name": "Exp Mol Pathol 2007 Dec 83(3) 311-26",
                "id": "17996232"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87ac"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Recombinant TTP was phosphorylated by three members of the mitogen-activated protein (MAP) kinase family, p42, p38, and JNK, with half-maximal phosphorylation occurring at approximately 0.5, 0.25, and 0.25 microM protein, respectively....we expressed human and mouse TTP as glutathione S-transferase and maltose-binding protein (MBP) fusion proteins in Escherichia coli, and purified them by affinity resins and Mono Q chromatography. ",
              "citation": {
                "type": "PubMed",
                "name": "Arch Biochem Biophys 2003 Apr 1 412(1) 106-20",
                "id": "12646273"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87ab"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "p38 mitogen-activated protein kinase was activated by HSA and was involved in NF-kappaB-dependent transcription of fractalkine.",
              "citation": {
                "type": "PubMed",
                "name": "J Am Soc Nephrol 2003 Oct 14(10) 2436-46",
                "id": "14514721"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87aa"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Leptin-induced MUC5B expression was blocked by the ERK1/2 and p38 pathway inhibitors, but not by the JAK2/STAT3 pathway inhibitor.",
              "citation": {
                "type": "PubMed",
                "name": "Exp Lung Res 2010 Jun 36(5) 262-9",
                "id": "20497020"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87a9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Lung airway"
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Oxidants also activate mitogen-activated protein (MAP) kinase pathways. H2O2 is a potent activator of extracellular regulated kinases (ERK) and p38 MAP kinase",
              "citation": {
                "type": "PubMed",
                "name": "Pharmacol Rev 2004 Dec 56(4) 515-48",
                "id": "15602009"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87a8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Figure 1B shows that MKK3(Glu) caused marked activation of p38 MAP kinase.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1996 Mar 16(3) 1247-55",
                "id": "8622669"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87a7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "p38 activity was required to enhance the accessibility of the cryptic NF-kappa B binding sites contained in H3 phosphorylated promoters, which indicated that p38-dependent H3 phosphorylation may mark promoters for increased NF-kappa B recruitment.  ",
              "citation": {
                "type": "PubMed",
                "name": "Nat Immunol 2002 Jan 3(1) 69-75",
                "id": "11743587"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87a6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "dendritic cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Thus, stimuli that activate these kinases, including exposure to pro-inflammatory cytokines, UV irradiation, DNA damage or change in ROS, are among the classic inducers of ATF2 transcriptional activity (van Dam et al., 1995).ATF2 mediates both transcription and DNA damage control, through its phosphorylation by JNK/p38 or ATM/ATR respectively. ",
              "citation": {
                "type": "PubMed",
                "name": "Pigment Cell Res 2007 Dec 20(6) 498-506",
                "id": "17935492"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87a5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Mobilization of receptors to the cell surface and phosphorylation of p38 MAPK by LOS were both impaired in PMN with the NADPH oxidase chemically inhibited or genetically absent and in cells lacking functional ClC-3.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 Nov 23 282(47) 33958-67",
                "id": "17908687"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87a4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "NO* dose dependently activated p38 MAPK, and p38 MAPK inhibition with SB202190 or knockdown with siRNA was shown to block NO* activation of PPARgamma.",
              "citation": {
                "type": "PubMed",
                "name": "FASEB J 2007 Mar 21(3) 950-61",
                "id": "17197391"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87a3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Omeprazole is able to inhibit neutrophil chemotaxis to fMLP and IL-8... The addition of a potassium ionophore, nigericin, restored the migratory ability, as well as the intracellular calcium levels. The activity of p38 MAP Kinase was decreased in neutrophils pretreated with omeprazole.",
              "citation": {
                "type": "PubMed",
                "name": "Inflamm Res 2007 Mar 56(3) 105-11",
                "id": "17406807"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87a2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "We inhibited p38alpha MAPK by mating beta(1)-AR Tg and beta(2)-AR Tg mice with DNp38alpha MAPK mice, which rescued the depressed LVEF and reduced apoptosis and fibrosis in bigenic beta(2)-AR x DNp38alpha MAPK mice",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Invest 2007 May 117(5) 1335-43",
                "id": "17446930"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87a1"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "The epithelial senescence was accompanied by p38 MAPK-dependent airway inflammation. Senescent NCI-H441 cells impaired epithelial wound repair and secreted increased amounts of pro-inflammatory cytokines in a p38 MAPK-dependent manner. Clara cell senescence in COPD patients was accelerated and accompanied by p38 MAPK activation",
              "citation": {
                "type": "PubMed",
                "name": "Respir Res 2011 12 78",
                "id": "21663649"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad87a0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Clara cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "from full text - blockade of p38 MAPK suppresses TNF production. 73,74",
              "citation": {
                "type": "PubMed",
                "name": "Inflamm Bowel Dis 2006 Nov 12(11) 1068-83",
                "id": "17075348"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad879f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "insulin-dependent p38 MAPK phosphorylation was efficiently reduced in cells pretreated with wortmannin",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Dec 7 276(49) 46079-87",
                "id": "11598141"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad879e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Kinases that were inhibited by low levels of GSTp expression included JNK, MKK3, p38, and MKK7.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2000 Aug 1 60(15) 4053-7",
                "id": "10945608"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad879d"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Endostatin blocked VEGF-induced tyrosine phosphorylation of KDR/Flk-1 and activation of ERK, p38 MAPK, and p125(FAK) in human umbilical vein endothelial cells",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Aug 2 277(31) 27872-9",
                "id": "12029087"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad879c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "The phosphorylation of p38 mitogen-activated protein kinase (p38 MAPK), which mediates signaling that leads to senescence, was also detected in both IR- or H(2)O(2)-treated AT and normal fibroblasts expressing hTERT.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jan 16 279(3) 2030-7",
                "id": "14570874"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad879b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Intraperitoneal administration of rottlerin or SB-203580 at least 1 h before TNF-? clearly diminished the level of VCAM-1 expression in lung tissue, suggesting that PKC? and p38 kinase do indeed play a role in the TNF-? signaling to VCAM-1 expression in vivo",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2005 Feb 288(2) L307-16",
                "id": "15489375"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad879a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Studies of IL-24 mRNA stability in anisomycin-treated keratinocytes reveal that the p38 MAPK inhibitor SB 202190 accelerates IL-24 mRNA decay suggesting p38 MAPK to regulate IL-24 expression by mRNA-stabilizing mechanisms.",
              "citation": {
                "type": "PubMed",
                "name": "PLoS One 2010 5(1) e8671",
                "id": "20072629"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8799"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "We confirmed p38 MAPK activity activation by PM in a time-dependent manner (Cell Signaling) (Figure E3A) and subsequently determined that a prominent p38 MAPK target, the Ser/Thr kinase MAPKAP2, is also activated by PM, as evidenced by phosphorylation of the actin-binding protein, HSP27.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2010 Apr 42(4) 442-9",
                "id": "19520919"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8798"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Pretreatment of THP-1 cells with pharmacological inhibitors of PI3K (LY294002), MAPK (PD98059), p38 MAPK (SB203580), and JNK (SP600125) inhibited ET-1-mediated MIP-1b mRNA expression by 89 6 5%, 104 6 7%, 102 6 8%, and 118 6 1%, respectively, when compared with that of untreated cells (Fig.1B).",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2010 Oct 15",
                "id": "20952681"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8797"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "In addition, SB202190 and U0126 both inhibited the induction of MUC5AC mRNA expression by IL-13 (Fig. 4c).",
              "citation": {
                "type": "PubMed",
                "name": "Respirology 2008 Mar 13(2) 191-202",
                "id": "18339016"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8796"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "TRAF6 activates the extracellular signalregulated kinases (ERK) 1 and 2 as well as p38 mitogen-activated protein kinase (MAPK),11,118125",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 2001 Dec 7 89(12) 1092-103",
                "id": "11739273"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8795"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "The p38 mitogen-activated protein kinase (MAPK) signaling pathway is also activated in response to IL-12, followed by phosphorylation of STAT4 on serine 721, which is required for STAT4 full transcriptional activity. ",
              "citation": {
                "type": "PubMed",
                "name": "Genes Cells 2005 Dec 10(12) 1153-62",
                "id": "16324152"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8794"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "LPS induces autophagy through TRIF/RIP1/p38MAPK dependent TLR4 signaling pathway that maintains cell survival.",
              "citation": {
                "type": "PubMed",
                "name": "Immunity 2007 Jul 27(1) 135-44",
                "id": "17658277"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8793"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Phosphorylation status of the three key MAPKs (ERK, JNK, and p38) and AKT in FIZZ2-treated MLFs were analyzed by Western blotting. The results showed rapid (10 min) marked activation of ERK by FIZZ2, with lesser effects on AKT and p38 (Fig. 5B). JNK was not activated by FIZZ2 treatment. ",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2011 Jul 1 187(1) 450-61",
                "id": "21602491"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8792"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "p38 is one of the substrates of MEKs. MEK3 and MEK6 both strongly activate p38 kinase, however MEK3 is more active on p38?, while MEK6 activates all p38 isoforms",
              "citation": {
                "type": "PubMed",
                "name": "J Mammary Gland Biol Neoplasia 2003 Jan 8(1) 45-73",
                "id": "14587863"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8791"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "senescence-like growth arrest was accompanied by impaired activation of mitogen-activated protein kinase (MAPK) pathways, namely, extracellular-regulated protein kinase, c-jun N-terminal kinase and p38 MAPK, in response to epidermal growth factor (EGF) and insulin-like growth factor-I (IGF-I)",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2006 Jan 12 25(2) 176-85",
                "id": "16170353"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8790"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "By combining pharmacological and genetic approaches, we show here that the Ras/ERK pathway and phosphatidylinositol 3-kinase (PI3K) are both required for cortical neuron migration. By dissecting the downstream signals necessary for this event, we found that Rac1/p38 and Akt are required, whereas the c-Jun N-terminal kinase (JNK) and mTOR/p70(s6k) pathways are dispensable.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Feb 24 281(8) 4771-8",
                "id": "16361255"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad878f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "neuron",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Interestingly, although the ERK1/2, p38 and JNK MAPKs were still induced in the Mekk3 knockdown cells, their levels were consistently lower than those in the control cells with similar kinetics at early time-points",
              "citation": {
                "type": "PubMed",
                "name": "Immunology 2007 Feb 120(2) 242-50",
                "id": "17116170"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad878e"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "SWCNTs induce fibrogenesis through reactive oxygen species-regulated phosphorylation of p38 mitogen-activated protein kinase (MAPK). Activation of p38 MAPK by SWCNTs led to the induction of transforming growth factor (TGF)-??1 as well as vascular endothelial growth factor (VEGF). Both TGF-??1 and VEGF contributed significantly to the fibroproliferative and collagen-inducing effects of SWCNTs. ",
              "citation": {
                "type": "PubMed",
                "name": "Nanotoxicology 2012 Jan 20",
                "id": "22263913"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad878d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "In this paper, we present a comprehensive pathway map of EGFR signaling and other related pathways. The map reveals that the overall architecture of the pathway is a bow-tie (or hourglass) structure with several feedback loops.  See figure 2: The bow-tie architecture of the EGFR signaling pathway.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Syst Biol 2005 1 2005.0010",
                "id": "16729045"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad878c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "When HEMEC were exposed to acidic pH for various time periods, there was a rapid and significant activation of JNK which was seen as early as 1 min. Activation of p44/42 MAPK was first detected at 15 min and maximized by 30 min, while activation of p38 MAPK was delayed, appearing at 60 min (Fig. 3A).",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2006 Nov 291(5) C931-45",
                "id": "16790501"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad878b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": "vascular tissue"
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "SB203580, a p38MAPK inhibitor, blocked the stimulatory effect of BMP7",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jan 12",
                "id": "14718543"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad878a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Anthocyanins also decreased activation of JNK and p38 induced by CD40.",
              "citation": {
                "type": "PubMed",
                "name": "Atherosclerosis 2009 Jan 202(1) 41-7",
                "id": "18495129"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8789"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "umbilical vein endothelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "The results revealed that p38 MAPK was activated by IL-13 from 15 min to later stages of treatments (up to 4 h) (Fig. 4A).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2003 Jun 23(11) 3918-28",
                "id": "12748293"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8788"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Monocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "hus, suppression of p38 activity using SB203580 and siRNA transfection resulted in the significant reduction of IKK activity, DC maturation, and CXCL2 upregulation by toxin A. ",
              "citation": {
                "type": "PubMed",
                "name": "J Mol Med 2009 Feb 87(2) 169-80",
                "id": "18985311"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8787"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "dendritic cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Finally, the activation levels of extracellular signal-regulated kinase (ERK), p38, and Rac, which are important signaling molecules in angiogenesis, were all reduced in response to FGF2 when either of the Rap1 proteins was depleted. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2008 Sep 28(18) 5803-10",
                "id": "18625726"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8786"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium, Vascular"
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "IL-10-induced TNF-alpha mRNA destabilization is mediated via IL-10 suppression of p38 MAP kinase activation and inhibition of HuR expression",
              "citation": {
                "type": "PubMed",
                "name": "FASEB J 2006 Oct 20(12) 2112-4",
                "id": "16935932"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8785"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Monocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "The effects of TNF-alpha on plasma apoB48 levels could be blocked by the p38 inhibitor SB203580.",
              "citation": {
                "type": "PubMed",
                "name": "Diabetes 2007 Feb 56(2) 450-61",
                "id": "17259391"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8784"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "IL-1 beta up-regulated GCLC expression (10 ng/ml IL-1 beta, 3.76 +/- 0.86; 100 ng/ml IL-1 beta, 4.22 +/- 0.68-fold control) via the p38 form of mitogen-activated protein kinase and NF kappa B and also increased reactive oxygen species levels (10 ng/ml IL-1 beta, 5.41 +/- 1.8-fold control).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Dec 24 279(52) 53988-93",
                "id": "15485876"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8783"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "p38 MAPK and its substrate, activating transcription factor (ATF)-2, in bronchoalveolar lavage fluid cells were phosphorylated by intratracheal exposure of bleomycin, and the phosphorylation of ATF-2 was inhibited by subcutaneous administration of a specific inhibitor of p38 MAPK, FR-167653.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2002 Jul 283(1) L103-12",
                "id": "12060566"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8782"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Smoke exposure of GM-Ms also resulted in the rapid activation of the MAP kinases ERK and p38 (Figure 4).",
              "citation": {
                "type": "PubMed",
                "name": "Exp Lung Res 2008 Nov 34(9) 599-629",
                "id": "19005923"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8781"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "IL-33 rapidly activated ERK1/2, JNK, p38, and NF-kB signaling cascades, as evidenced by phosphorylation of MAP kinases and phosphorylation and degradation of the NF-kB inhibitor IkB-a.",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2009 Feb 12 113(7) 1526-34",
                "id": "18955562"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8780"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "basophil",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "The effects of hCG were reduced by inhibitors of protein kinase A, MAPK kinase, or p38 kinase, indicating that Runx1 expression is regulated by the LH-initiated activation of these signaling mediators. In addition, hCG-induced Runx1 mRNA expression was inhibited by a progesterone receptor antagonist and an epidermal growth factor receptor tyrosine kinase inhibitor, whereas amphiregulin stimulated Runx1 mRNA expression",
              "citation": {
                "type": "PubMed",
                "name": "Mol Endocrinol 2006 Sep 20(9) 2156-72",
                "id": "16675540"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad877f"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Exposure of endothelial cells to matrix-bound VEGF elicits prolonged activation of VEGFR2 with differential phosphorylation of Y1214, and extended activation kinetics of p38.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2010 Feb 22 188(4) 595-609",
                "id": "20176926"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad877e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Treatment with pharmacological inhibitors of p38 MAPK or with a dominant negative form of MKK3, an upstream regulator of p38 MAPK, significantly reduced or ablated the sorbitol induction of sgk promoter activity",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Aug 18 275(33) 25262-72",
                "id": "10842172"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad877d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Cyclosporin A inhibited Fc epsilon RI-mediated JNK and p38 activation, but did not affect the activation of these kinases when stimulated through the SCFR.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 1999 Feb 15 162(4) 2087-94",
                "id": "9973482"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad877c"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "mast cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Figure 4.  T1/ST2 activates MAP kinases p42/44 and p38",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Dec 20 277(51) 49205-11",
                "id": "12368275"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad877b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Elafin prevented lipopolysaccharide-induced phosphorylation of AP-1, c-Jun, and JNK but had no effect on phosphorylation of p38. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Nov 17 281(46) 34730-5",
                "id": "16980310"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad877a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Growth plate injury-induced p38 activation is mediated by TNF-alpha",
              "citation": {
                "type": "PubMed",
                "name": "J Bone Miner Res 2006 Jul 21(7) 1075-88",
                "id": "16813528"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8779"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": "Bone and Bones"
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "The results indicate that ERK3 expression is a consequence of p38 pathway activation",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Apr 6 276(14) 10759-66",
                "id": "11148204"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8778"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "With HBP1 expression and the subsequent increase of p16(INK4A) gene expression, Ras induces premature senescence in primary cells. The data suggest a model in which Ras and p38 MAPK signaling engage HBP1 and p16(INK4A) to trigger premature senescence. In addition, we report that HBP1 knockdown is also required for Ras-induced transformation. ",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2010 Sep 9 29(36) 5083-94",
                "id": "20581871"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8777"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "However, TNF treatment did result in activation of the transcription factor, ATF-2, a primary downstream target of p38 MAP kinase. Use of the p38 MAP kinase inhibitors SB202190 and SB203580 did not interfere with the ability of TNF to activate ATF-2, suggesting that either the gamma isoform of p38 MAP kinase or a p38-independent pathway was utilized by TNF to increase the phosphorylated fraction of ATF-2.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Physiol 1999 Apr 179(1) 58-66",
                "id": "10082133"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8776"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Stimulatory doses (0.25 nM) of BMP7 increased p38MAPK activity and stimulated phosphorylation of endogenous activating transcription factor (ATF2) in a p38MAPK-dependent manner",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jan 12",
                "id": "14718543"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8775"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "kidney epithelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "These results suggest that in keratinocytes, p38 activity is crucial for the induction of SKALP gene expression.",
              "citation": {
                "type": "PubMed",
                "name": "Arch Dermatol Res 2000 Apr 292(4) 180-7",
                "id": "10836611"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8774"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "The ability of SB203580 to inhibit p38 MAPK activity in intact cells was determined by an assay for MAPKAPK-2 activity, a kinase activated by p38 MAPK [36]. Figure 8 shows that SB203580 inhibits TNF-alpha stimulation of p38 MAPK. Similar results were seen with GM-CSF-stimulated MAPKAPK-2 activity",
              "citation": {
                "type": "PubMed",
                "name": "J Leukoc Biol 1998 Oct 64(4) 537-45",
                "id": "9766635"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8773"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "positive regulatory events, such as activation of Syk, Btk, JNK, p38, Akt, and NF-kappaB, are substantially reduced in hck(-/-) mast cells. ",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2007 May 18",
                "id": "17513616"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8772"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "mast cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "We also show that overexpression of BCMA in 293 cells activates NF-kappa B, Elk-1, the c-Jun N-terminal kinase, and the p38 mitogen-activated protein kinase.  ",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2000 Aug 1 165(3) 1322-30",
                "id": "10903733"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8771"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Induction of DNA DSBs stimulates the activation of the MAPK p38 in a RhoA-dependent manner; and this is required to delay cell death in response to toxin treatment or ?-irradiation (Guerra et al., 2008a).",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 2011 Aug 15 124(Pt 16) 2735-42",
                "id": "21807938"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8770"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Selective p38 mitogen-activated protein kinase (p38 MAPK) inhibition reduces OA and IgE-mediated IL-6 production.",
              "citation": {
                "type": "PubMed",
                "name": "J Leukoc Biol 2004 Nov 76(5) 1075-81",
                "id": "15316034"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad876f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "mast cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "TAK1-induced iNOS-Luc activity was substantially inhibited by pharmacological inhibitors of the known downstream kinases, p38 MAPK and JNK (SB203580 and SP620125), and was almost completely blocked by co-expression of a phosphorylation mutant of IkappaB. TAK1/TAB1 also induced the production of NO and the expression of iNOS in microglial cells in a p38 MAPK-, JNK- and NFkappaB-dependent manner.",
              "citation": {
                "type": "PubMed",
                "name": "J Neurochem 2003 Oct 87(1) 238-47",
                "id": "12969270"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad876e"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "glial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "This mechanism requires signaling through MyD88",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2005 Sep 9 122(5) 707-21",
                "id": "16143103"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad876d"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Recent studies have shown that MEF2C is activated by MAP kinase P38 during  inflammation, resulting in an increase in c- jun gene transcription ( 19 ).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1998 Oct 2 273(40) 26123-9",
                "id": "9748293"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad876c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "These results indicate that extracellular stressors can induce caveolin-1 tyrosine phosphorylation through the activation of well established upstream elements, such as p38 MAP kinase and c-Src kinase.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Mar 16 276(11) 8094-103",
                "id": "11094059"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad876b"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "p38 MAPK has also been reported to stimulate glucose transport by means of increased MEF2 transcriptional activity through an increase of PGC-1 phosphorylation and activation",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2003 Jun 12 423(6941) 762-9",
                "id": "12802337"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad876a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Muscles"
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "BMP-2 also induced p38 mitogen-activated protein kinase (MAPK)",
              "citation": {
                "type": "PubMed",
                "name": "Nat Med 2003 Aug 9(8) 1033-8",
                "id": "12872164"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8769"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "We generated Card9(-/-) mice and found that CARD9-deficient macrophages had defects in activation of the kinases p38 and Jnk but not of transcription factor NF-kappaB after bacterial and viral infection. ",
              "citation": {
                "type": "PubMed",
                "name": "Nat Immunol 2007 Feb 8(2) 198-205",
                "id": "17187069"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8768"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Collagen I did not affect p38 phosphorylation compared with control (data not shown); however, thrombin led to a modest increase in activated p38 between 30 min and 2 h.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2007 Apr 292(4) L1030-8",
                "id": "17189319"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8767"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Muscle, Smooth"
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "As shown in Fig. 1A, the phosphorylation of p38 and ERK was decreased in Traf2-/- cells, indicating that TRAF2 also functions in the TNF-induced activation of p38 and ERK. Consistent with a previous study (Yeh et al., 1997), JNK activation by TNF in Traf2-/- cells was also decreased.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO Rep 2003 Jun 4(6) 623-7",
                "id": "12776182"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8766"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Other inducers of the UPR, such as the protein glycosylation inhibitor, tunicamycin, and the sarcoendoplasmic reticulum calcium ATPase inhibitor, thapsigargin, are known to activate p38 (Hung et al., 2004; Li and Holbrook, 2004).",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2005 Oct 10 171(1) 61-73",
                "id": "16203857"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8765"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "This betaPix-induced p38 activation was blocked by coexpression of dominant-negative Cdc42/Rac or kinase-inactive PAK, indicating that the effect of betaPix on p38 is exerted through the Cdc42/Rac-PAK pathway and requires PAK kinase activity",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Jul 6 276(27) 25066-72",
                "id": "11309380"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8764"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "The phosphorylation of MAPKs including ERK1/2, p38, and JNK was measured by immunoblot analysis using specific Abs. LPS-induced phosphorylation of ERK1/2, p38, and JNK was inhibited by EGCG (Fig. 4A?C). However, in 67LR-ablated cells, the inhibitory effect of EGCG on LPSinduced upregulation of phosphorylation was attenuated (Fig. 4A?C).",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2010 Jul 1 185(1) 33-45",
                "id": "20511545"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8763"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "leukemia",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "the IL-16-mediated activation of SAPKs and p38 MAPK in macrophages alone induces no detectable apoptotic cell death.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 1998 Jun 15 160(12) 5874-9",
                "id": "9637499"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8762"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "MEKK1 also activated SKK2/MKK3 and SKK3/MKK6, the direct upstream activators of SAPK2a/p38 (MEKK1 = MAP3K1, MKK3 = MAP2K3, MKK6 = MAP2K6)",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 1998 Jul 1 333 ( Pt 1) 11-5",
                "id": "9639556"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8761"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Reduced SCF-induced activation of Rac1 and Rac2 GTPases, p38 mitogen-activated protein kinase, and filamentous actin polymerization was observed in fyn(-/-) mast cells compared to wild-type mast cells.",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2007 May 1 109(9) 3679-86",
                "id": "17213284"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8760"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "mast cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "AG 1478 (EGF receptor tyrosine kinase inhibitor), PD 98059 (ERK1/2 inhibitor), and SB 203580 (p38 inhibitor) significantly inhibited EGF-induced p11 expression.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Oct 11 277(41) 38431-40",
                "id": "12163506"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad875f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Other protein synthesis inhibitors, such as anisomycin and emetine, also enhanced CD40 mRNA expression, which was significantly blocked by a NF-kappaB antagonist and a p38 MAP kinase antagonist",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biochem 2004 Feb 1 91(2) 410-22",
                "id": "14743399"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad875e"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Interestingly, araA, an AMPK inhibitor, prevented the activation of p38 MAPK, whereas SB203580, a p38 MAPK inhibitor, did not affect AMPK activation, suggesting that p38 MAPK is a downstream signaling factor of AMPK. ",
              "citation": {
                "type": "PubMed",
                "name": "Diabetes 2006 Sep 55(9) 2562-70",
                "id": "16936205"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad875d"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "In C3H/HeOuJ mice treated with ETX, activation of p38 MAP kinase was also evident in macrophages and endothelial cells, and JNK kinase in macrophages. In contrast, reduced protein kinase B (AKT) was noted in macrophages.",
              "citation": {
                "type": "PubMed",
                "name": "Exp Mol Pathol 2007 Dec 83(3) 311-26",
                "id": "17996232"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad875c"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium"
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Instead, GCs inhibit GATA-3 activity by inhibition of p38 mitogen-activated protein kinase induced GATA-3 phosphorylation. GCs also inhibit GATA-3 mRNA and protein expression.",
              "citation": {
                "type": "PubMed",
                "name": "FASEB J 2009 May 23(5) 1558-71",
                "id": "19124555"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad875b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "In addition, a recent report demonstrated that exposure of SK-N-MC cells to FGF induces the p38 MAPK pathway, which then leads to CREB Ser-133 phosphorylation (66).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1998 Apr 18(4) 1946-55",
                "id": "9528766"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad875a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "neuroblastoma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Chemical inhibition of p38 MAPK and SAPK/JNK activation blocks TNF  -alpha-induced ephrin A1 expression.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Apr 27 276(17) 13771-7",
                "id": "11278471"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8759"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "The induction of Lox-1 and Nox1 by CpG ODN was regulated via the TLR9-p38 MAPK signaling pathway",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2008 Dec 20(12) 2266-75",
                "id": "18817866"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8758"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "peritoneal macrophage",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Heparin-DOCA inhibited capillary-like tubular structures of endothelial cells and bFGF-induced neovascularizations in Matrigel plug assays. Signaling experiments showed that heparin-DOCA significantly inhibited angiogenesis by suppressing the phosphorylation of FGFR and its downstream signal pathways (ERK and p38 MAPK activities)",
              "citation": {
                "type": "PubMed",
                "name": "Pharm Res 2007 Jan 24(1) 176-85",
                "id": "17109210"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8757"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "We found that IL-17 increased the transmigration of neutrophils through the endothelium and that this could be reversed by a p38 MAPK inhibitor",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2010 Apr 15 184(8) 4531-7",
                "id": "20228195"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8756"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "umbilical vein endothelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Activation of c-Jun N-terminal kinase (JNK) by TNF-? was also diminished by depletion of SphK1 (Fig. 1a) or its inhibition (Supplementary Fig. 3b). Likewise, SK1-I reduced activation of p38 (Supplementary Fig. 3a).",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2010 Jun 24 465(7301) 1084-8",
                "id": "20577214"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8755"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "We find that although pretreatment of BMMs with IL-4 does not alter M-CSF signaling, it reversibly blocks RANKL-dependent activation of the NF-kappa B, JNK, p38, and ERK signals.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Feb 22 277(8) 6622-30",
                "id": "11719504"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8754"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "At this time point only polyI:C and polyI:C+R848 stimulated cells showed enhanced IFN gene expression (Fig. 7). SB202190 and LY294002, the inhibitors of MAPK p38 and PI3K, respectively, completely blocked TLR ligand-induced IFN-B and IFN-L1 gene expression.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Immunol 2011 Jan 48(4) 505-15",
                "id": "21040977"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8753"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "dendritic cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "The decrease in eNOS expression was signaled in large part through a p38 MAPK-dependent mechanism.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Sep 6 277(36) 32498-504",
                "id": "12082097"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8752"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "The PDE4 inhibitor Rp, but not the PDE3 inhibitor lixazinone, significantly suppressed TGF-b1-induced ERK and p38 activity (Fig. 6B).",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2005 Oct 289(4) C959-70",
                "id": "15930146"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8751"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "mesangial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "SB203580 (20 or 40 um) effectively enhanced cell survival (3.1- or 4.0-fold) (Fig. 4A)",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Jun 17 280(24) 23122-9",
                "id": "15826945"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8750"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "The activation of p38 MAPK activates C/EBP?, a transcription factor that has a critical role in adipogenesis . ",
              "citation": {
                "type": "PubMed",
                "name": "PLoS One 2010 5(5) e10493",
                "id": "20463961"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad874f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Fig. 2B demonstrates that stimulation of cells with IL-1b leads to the activation of p38 as previously reported (44). Interestingly, this activation requires functional Akt because concomitant expression of a dominant negative mutant of Akt (DN-Akt) effectively abolished the ability of IL-1b to activate p38.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Jun 1 276(22) 18934-40",
                "id": "11259436"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad874e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Since Txnip is involved in ceramide-induced ASK1 activation, the regulation of ASK1 on ceramide-activated p38 MAPK and JNK was subsequently determined. In ASK1 siRNA-transfected EGFP+ Jurkat T cells, ceramide-induced phosphorylation of p38 MAPK and JNK was inhibited (Figures 6B,S4E,F).",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2008 Apr 15 111(8) 4365-74",
                "id": "18270325"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad874d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Activation of c-Jun N-terminal kinase (JNK) by TNF-? was also diminished by depletion of SphK1 (Fig. 1a) or its inhibition (Supplementary Fig. 3b). Likewise, SK1-I reduced activation of p38 (Supplementary Fig. 3a).",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2010 Jun 24 465(7301) 1084-8",
                "id": "20577214"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad874c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "We demonstrate that induction of IL-23 p19 gene expression by LPS depends on the TLR4 and MyD88 pathways. All three MAPK pathways (ERK, JNK, and p38) that are activated by lipopolysaccharide (LPS) stimulation were shown to exert a positive effect on p19 expression.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2009 Sep 4 284(36) 24006-16",
                "id": "19592489"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad874b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Angiotensin II (Ang II), a proinflammatory mediator implicated in atherosclerosis, restenosis, and hypertension,13 leads to the hypertrophic response in SMCs via the production of both superoxide and H2O2 and activation of p38 MAPK.14,15",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 2000 Aug 4 87(3) 179-83",
                "id": "10926866"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad874a"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": "vascular tissue"
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "It is known that LPS stimulation leads to increased activation of three subgroups of MAPKs, i.e., ERK, JNK, and p38, in murine macrophages and human monocytes (38, 39).",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2002 Aug 1 169(3) 1401-9",
                "id": "12133965"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8749"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Monocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "IGFBP-5-induced phosphorylation of p38 MAP kinase, which was abolished by SB203580, or expression of a dominant negative Ras mutant, Ras(S17N), and phosphorylation of Erk1/2, which was abolished by a Raf1 kinase inhibitor, U1026, or expression of Ras(S17N).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Jun 7 277(23) 20563-71",
                "id": "11923300"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8748"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Inhibitors of p38 (SB203580) and PKC (calphostin C) reduced significantly the mRNA expression stimulated by IL-17 of IL-8, GRO-alpha and GRO-beta in SFC, indicating IL-8, GRO-alpha, GRO-beta mRNA expression is mediated through p38 and PKC when stimulated with IL-17.",
              "citation": {
                "type": "PubMed",
                "name": "Clin Exp Immunol 2002 Mar 127(3) 539-46",
                "id": "11966773"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8747"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "many cytokines activate the transcriptional PPAR gamma coactivator-1 (PGC-1) through phosphorylation by p38 kinase, resulting in stabilization and activation of PGC-1 protein.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2001 Nov 8(5) 971-82",
                "id": "11741533"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8746"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Inhibition of protein kinase C delta, geranyl transferase 1, or stress-activated protein kinase p38 eliminates the expression of collagen I and III in scleroderma cells.62,63",
              "citation": {
                "type": "PubMed",
                "name": "N Engl J Med 2009 May 7 360(19) 1989-2003",
                "id": "19420368"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8745"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "The increase in the level of the p38 MAPK substrate HSP27 was less pronounced and there was no change in the level of ERK1/2 substrate p90RSK upon IL-33 stimulation.",
              "citation": {
                "type": "PubMed",
                "name": "Exp Cell Res 2010 Sep 10 316(15) 2527-37",
                "id": "20406635"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8744"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Inhibition of NF-kappaB activation and p38 MAPK activity decreased the TNF-induced release of eotaxin from eosinophils.",
              "citation": {
                "type": "PubMed",
                "name": "Clin Exp Immunol 2002 Jun 128(3) 483-9",
                "id": "12067303"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8743"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "eosinophil",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "cells exposed to 10 J/m2 of UV showed phosphorylation of not only ERK1 and ERK2 but also JNK1/2 and p38 (Fig. 3).",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2001 Jul 15 61(14) 5396-401",
                "id": "11454682"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8742"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Table S3 - TNF-inducible endothelial genes that are increased by and requiring p38 MAPK kinase, as they are repressed by SB202190 - bw",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2004 May 1 103(9) 3365-73",
                "id": "14715628"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8741"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "umbilical vein endothelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "The molecular signature response to perceived hyperoxia included (1) induction of p21, cyclin D1, cyclin D2, cyclin G1, Fos-related antigen-2, and transforming growth factor-beta1, (2) lowered telomerase activity, and (3) activation of transforming growth factor-beta1 and p38 mitogen-activated protein kinase.",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 2003 Feb 21 92(3) 264-71",
                "id": "12595337"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8740"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "The treatment of NCI-N87 cells with EGF resulted in increases in phosphorylation of Erk1/2, Akt, and P38. Blockade of the Erk, phosphatidylinositol-3 kinase/Akt, or P38 pathways in this cell line",
              "citation": {
                "type": "PubMed",
                "name": "Br J Cancer 2003 Mar 10 88(5) 796-802",
                "id": "12618892"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad873f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "stimulation of p38 MAPK isoforms phosphorylated purified Nrf2 protein and caused an increase in the interaction between Nrf2 and Keap1 in vitro and the suppression of Nrf2 translocation into the nucleus.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2006 Sep 1 66(17) 8804-13",
                "id": "16951197"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad873e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "VES treatment induced nuclear translocation and activation of p38 kinase. Pretreatment with p38 kinase inhibitor blocked the VES-induced increase in NAG-1 protein and mRNA levels, whereas an inhibition of protein kinase C, Akt, c-Jun NH(2)-terminal kinase, or MEK activity had no effect on VES-induced NAG-1 levels.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cancer Ther 2008 Apr 7(4) 961-71",
                "id": "18413810"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad873d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Katz et al. (2000) presented evidence that overexpression of mammalian tensin activates both the JNK (601158) and p38 MAPK (600289) pathways. Tensin-mediated JNK activation was independent of the activities of Rac (602048) and Cdc42 (116952), but did depend on Sek (601335).",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2002 Jan 22 99(2) 733-8",
                "id": "11792844"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad873c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "In the case of TNF-alpha-treated cells, activation of ERK1/2 was transient, with a maximum at 10-20 min and decreasing to the baseline at 30 min, whereas strong activation of p38 kinase was sustained up to 60 min. Activation of JNK was transient, with maximum levels detected at 10 min. ",
              "citation": {
                "type": "PubMed",
                "name": "FASEB J 2001 Jan 15(1) 230-242",
                "id": "11149911"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad873b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "In the absence of p38 activity, EGF fails to stimulate the ubiquitin ligase Cbl or ubiquitinylation of EGFR, and internalized EGFR accumulates in intracellular vesicles containing caveolin-1. These effects are accompanied by loss of EGFR phosphorylation on Y1045, a phosphorylation site required for Cbl activation.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2006 Dec 13 25(24) 5683-92",
                "id": "17139251"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad873a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Science 1996 May 31 272(5266) 1347-9",
                "id": "8650547"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8739"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "BMP-2 and TGF-beta stimulated Ras, MAPK, and AP-1 activities (note: Ras is upstream of the otehr two)",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 May 3 277(18) 15514-22",
                "id": "11854297"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8738"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "osteoblast",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "These effects of IL-1alpha were prevented by pretreatment of the cells with the specific inhibitors of the p38 MAP kinase, SB203580 and PD169316, suggesting that this kinase is an important part of IL-1alpha signaling in the immature Leydig cell.",
              "citation": {
                "type": "PubMed",
                "name": "J Mol Endocrinol 2003 Feb 30(1) 59-67",
                "id": "12580761"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8737"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Leydig Cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Duan et al. reported that these mice develop cardiac hypertrophy through elevated NF-KB activity [75], and unexpectedly, rosiglitazone-induced cardiac hypertrophy in both the WT mice and cardiomyocyt specific PPARG knockout mice through activation of p38 MAP kinase independent of PPARG.",
              "citation": {
                "type": "PubMed",
                "name": "PPAR Res 2010 2010",
                "id": "20814542"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8736"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "TNFa (10 ng/ml) also increased p38-MAPK phosphorylation [Fig. 2(b) and (c)].",
              "citation": {
                "type": "PubMed",
                "name": "J Mol Cell Cardiol 1999 Dec 31(12) 2087-99",
                "id": "10640438"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8735"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "myocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "sLRP1, which was purified from human plasma, and full-length LRP1, purified from mouse liver, activated cell signaling when added to cultures of RAW 264.7 cells and BMMs. Robust activation of p38 MAPK and JNK was observed. The IKK-NF-??B pathway was transiently activated.",
              "citation": {
                "type": "PubMed",
                "name": "J Leukoc Biol 2010 Oct 88(4) 769-78",
                "id": "20610799"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8734"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "inhibition of extracellular signal regulated kinase (ERK) phosphorylation and p38 mitogen-activated protein kinase (MAPK) activation in response to fMLP by CYL-26z up to 30microM was obtained",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Pharmacol 2006 Sep 14 72(6) 749-60",
                "id": "16887102"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8733"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "These demonstrate that Ang II is capable of inducing CRP generation in macrophages via AT(1)-ROS-ERK1/2/p38MAPK-NF-kB signal pathway, which contributes to better understanding of the proinflammatory and proatherosclerotic actions of Ang II.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Physiol Biochem 2011 27(1) 63-70",
                "id": "21325823"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8732"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "A signaling cascade from the Fas receptor via ceramide, Ras, Rac1, and JNK/p38-K to GADD153 is demonstrated employing transfection of transdominant inhibitory N17Ras, N17Rac1, c-Jun, or treatment with a specific p38-K inhibitor. The critical function of this signaling cascade is indicated by prevention of Fas- or C6-ceramide-induced apoptosis after inhibition of Ras, Rac1, or JNK/p38-K.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1997 Aug 29 272(35) 22173-81",
                "id": "9268362"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8731"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "To further assess the role of p38 MAPK and JNK1 in VILI, we ventilated mice genetically deficient either in mkk3 (mkk3-/-), the major upstream activating kinase of p38 MAPK",
              "citation": {
                "type": "PubMed",
                "name": "PLoS One 2008 3(2) e1601",
                "id": "18270588"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8730"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "suppression of AdipoR2 expression by siRNA in hepatocytes significantly reduced full-length adiponectin binding (Supplementary Fig. 3h) as well as increases in PPAR-a ligand activity by full-length adiponectin In mock-transfected C2C12 myocytes both globular and fulllength adiponectin increased the amount of phosphorylation of AMP kinase (AMPK), acetyl coenzyme A carboxylase (ACC)10,11 and p38 mitogen-activated protein kinase (MAPK)",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2003 Jun 12 423(6941) 762-9",
                "id": "12802337"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad872f"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "p38 MAPK inhibition affects the expression of MAPKAP-2, the direct molecular target of p38 MAPK (Figure 3)",
              "citation": {
                "type": "PubMed",
                "name": "Arthritis Rheum 2006 Feb 54(2) 463-72",
                "id": "16447221"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad872e"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "Rheumatoid Arthritis",
                "cell": "",
                "tissue": "synovium"
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "We found that CCR7 induced a Gi-dependent activation of MAPK members ERK1/2, JNK, and p38, with ERK1/2 and p38 controlling JNK. MAPK members regulated chemotaxis, but not the migratory speed, of DCs.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2005 Apr 1 174(7) 4070-80",
                "id": "15778365"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad872d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "dendritic cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Further results showed that VEGFA induced the activation of JNK/SAPK, p38 kinase and extracellular signal-regulated kinases 1 and 2 (ERK1/2), while JNK/SAPK inhibitor SP600125 and specific siRNA both blocked all those angiogenic effects induced by VEGFA. ",
              "citation": {
                "type": "PubMed",
                "name": "Cell Biochem Biophys 2012 May 17",
                "id": "22592917"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad872c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "TNF activates NFKB transcriptional activity in macrophages and epithelial cells . TNF similarly activates p38 MAPK.",
              "citation": {
                "type": "PubMed",
                "name": "Pharmacol Rev 2004 Dec 56(4) 515-48",
                "id": "15602009"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad872b"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Figure 1. Pathways to MUC5AC expression in COPD",
              "citation": {
                "type": "PubMed",
                "name": "Physiol Rev 2007 Jul 87(3) 1047-82",
                "id": "17615396"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad872a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Moreover, uPAR is known to take part in the release of both inflammatory cytokines TNF-a, IL-1b, and IL-6 and chemokines IL-8 and monocyte chemoattractant protein (MCP)-1 from human blood mononuclear cells through p38, c-Jun N-terminal kinases (JNKs), and NF-kB activation (Khan et al. 2006; Del Rosso et al. 2008).",
              "citation": {
                "type": "PubMed",
                "name": "J Lipid Res 2009 Apr 50 Suppl S189-94",
                "id": "19064999"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8729"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "peripheral blood mononuclear cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "We show that initially exposure of fibroblasts to Cr (III) induced membrane-dependent signaling including activation of Rac1 GTPase, Src and apoptosis signal-regulating kinase 1 (ASK-1) kinases leading to increased activities of p38 and particularly Jun N-terminal kinase (JNK) and subsequent activation of caspase-3. ",
              "citation": {
                "type": "PubMed",
                "name": "Toxicol Lett 2009 Aug 10 188(3) 236-42",
                "id": "19406221"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8728"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "UA strikingly induced both Raf-1 and MEK1/2 activation within 2 min and that of ERK1/2 within 5 min, as compared with the nontreated cells (Fig. 2). Similarly, both MKK3/6 and p38 MAPK were activated within 2 min, whereas phosphorylation of JNK1/2 was not observed.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2007 Apr 15 178(8) 4854-64",
                "id": "17404266"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8727"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "We found that 20% CSE caused significant increases in the phosphorylation of all three MAPK members (ERK1/2, p38, and JNK) within from 10 min to 1hr of exposure (Fig. 2).",
              "citation": {
                "type": "PubMed",
                "name": "J Toxicol Sci 2010 35(1) 33-9",
                "id": "20118622"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8726"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Neutrophils stimulated with FMLP exhibited phosphorylation of the cAMP response element binding protein (CREB), and this reaction was inhibited by SB 203580 and PD 98059.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 1999 Oct 15 163(8) 4527-36",
                "id": "10510396"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8725"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "p38MAPK inhibition markedly reduced the secretion of most SASP factors, constitutive p38MAPK activation was sufficient to induce an SASP, and p53 restrained p38MAPK activation.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2011 Apr 20 30(8) 1536-48",
                "id": "21399611"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8724"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "RANKL stimulated the phosphorylation of Ser727 of STAT1, which required p38 activity.",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2005 Apr 1 105(7) 2963-9",
                "id": "15585657"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8723"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "TNF-alpha , added alone, significantly increased the phosphorylation of p38 MAPK (Fig. 4, A and C). ",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2002 Aug 283(2) L418-27",
                "id": "12114204"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8722"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "The human beta-defensins (-1, -2, -3, -4) and cathelicidin LL-37 induce IL-18 secretion through p38 and ERK MAPK activation in primary human keratinocytes.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2005 Aug 1 175(3) 1776-84",
                "id": "16034119"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8721"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "For instance, stress-activated protein kinases, such as p38, which are activated by cellular stress and involved in the acute-phase reaction, cause C/EBPB phosphorylation on Ser105, inducing the transactivation potential (23).",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2003 Oct 285(4) L773-81",
                "id": "12959923"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8720"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "The present study demonstrates that p38 MAPK negatively regulates AngII-induced ERK1/2 activity, Rb phosphorylation, cyclin D1 expression, and DNA-synthesis in human CASMC.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2003 Jun 6 305(3) 552-6",
                "id": "12763029"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad871f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Stable over-expression of Smad7 in K562 cells (K562/7) prevented activation of Smad2/3 and MAPK (ERK1/2, p38 and JNK1/2) proteins by activin-A/TGF-beta1 and subsequent induction of erythroid differentiation.",
              "citation": {
                "type": "PubMed",
                "name": "Platelets 2007 Dec 18(8) 566-78",
                "id": "18041647"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad871e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Stem Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "In prostate DU145 cells, both FGF1 and FGF2 activated ERK1/2 potently and p38 moderately.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2001 Aug 30 20(38) 5359-65",
                "id": "11536048"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad871d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Reduction in p38 phosphorylation following 24-hours of atheroprone flow in the presence of blocking antibody R28C8, but not the control 12F1  ",
              "citation": {
                "type": "PubMed",
                "name": "Arterioscler Thromb Vasc Biol 2008 Aug 28(8) 1534-41",
                "id": "18556570"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad871c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2001 Nov 8(5) 971-82",
                "id": "11741533"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad871b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Additionally, Mig and SDF-1alpha activated MAPKs p44/42 and p38 on melanoma cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Nov 30 276(48) 45098-105",
                "id": "11571298"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad871a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "blocking p38 MAPK decreased C-reactive protein release.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2002 Apr 15 168(8) 4070-7",
                "id": "11937566"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8719"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "leukocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Interleukin-17 stimulates C-reactive protein expression in hepatocytes and smooth muscle cells via p38 MAPK and ERK1/2-dependent NF-kappaB and C/EBPbeta activation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 Sep 14 282(37) 27229-38",
                "id": "17652082"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8718"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "hepatocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "It has been demonstrated that IL-1alpha activates p38 MAPK and that this event is associated with StAR expression and testosterone synthesis in immature rat Leydig cells",
              "citation": {
                "type": "PubMed",
                "name": "J Signal Transduct 2011 2011 821615",
                "id": "21637381"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8717"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Leydig Cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "The amounts of IL-1Ra stimulated by WPE or beta-LG + alpha-LA significantly reduced the IL-1 activity in EL4 cells. Inhibitors of p38 and extracellular signal-regulated kinases (ERK)1/2 mitogen-activated protein kinase, and nuclear factor-kappaB cascades reduced neutrophil production of IL-1Ra.",
              "citation": {
                "type": "PubMed",
                "name": "J Nutr 2010 Feb 140(2) 382-91",
                "id": "20032479"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8716"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "AGTR2 inhibition with PD diminished p38 and p42/44 phosphorylation in fibroblast isolated from bleomycin-, but not saline-treated mouse lungs (Figures 6A?6D).",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2007 Dec 37(6) 640-50",
                "id": "17630322"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8715"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Treatment with roflumilast significantly suppressed LPS-induced activation of JNK and p38 MAP kinase concentration dependently (Fig. 6)",
              "citation": {
                "type": "PubMed",
                "name": "J Pharmacol Exp Ther 2005 Dec 315(3) 1188-95",
                "id": "16126838"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8714"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "the MAPKp38 inhibitors \\\"SB-202190\\\"/SB203580 enhanced the magnitude of insulin inhibition and significantly increased the level of activated ERK1/2.",
              "citation": {
                "type": "PubMed",
                "name": "Diabetes 2003 May 52(5) 1073-80",
                "id": "12716735"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8713"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Phosphorylated ERK1/2, JNK, p38 and ERK5 were significantly increased by exposure to TS, indicating the activation of these MAPK pathways.",
              "citation": {
                "type": "PubMed",
                "name": "Carcinogenesis 2005 Dec 26(12) 2187-95",
                "id": "16051644"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8712"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "In contrast, the p38 inhibitor SB 20358 (36) completely abrogated I-TAC-induced chemotaxis in a concentration-dependent manner (0.033 M) (P 0.05 by ANOVA) (Fig. 5B).",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2006 Jul 291(1) C34-9",
                "id": "16467404"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8711"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "PD98059, a selective MEK inhibitor and SB202190, a p38 MAPK inhibitor, attenuated the MMP-1 mRNA expression enhanced by NO.",
              "citation": {
                "type": "PubMed",
                "name": "Int J Cancer 2003 Jan 10 103(2) 161-8",
                "id": "12455029"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8710"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Hypoxia and PDGF-BB induced synthesis of soluble collagen type I via Erk1/2 and p38 MAP kinase",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 Jan 12 282(2) 908-15",
                "id": "17099219"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad870f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "We found increased Erk-1/2 and p38 MAP kinase activities to be important components of ROS-mediated signaling. The pro-oxidant state also contributed to constitutive elevation of AP-1, NFkappaB and cAMP response element transactivation in the malignant phenotype. ",
              "citation": {
                "type": "PubMed",
                "name": "Carcinogenesis 1999 Nov 20(11) 2063-73",
                "id": "10545407"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad870e"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "expression of MKK6b(E), a constitutive activator of p38(MAPK), significantly reduced LDL receptor promoter activity.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Jul 9 274(28) 19593-600",
                "id": "10391894"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad870d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "The ATF2 transcription factor is phosphorylated by the stress-activated mitogen-activated protein kinases (MAPKs) JNK and p38. We show that this phosphorylation is essential for ATF2 function in vivo, since a mouse carrying mutations in the critical phosphorylation sites has a strong phenotype identical to that seen upon deletion of the DNA-binding domain",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2007 Aug 15 21(16) 2069-82",
                "id": "17699753"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad870c"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Rapid activation of mitogen-activated protein kinases (Erk1/2, p38, and JNK MAPK) were observed in CSE-treated NL cells.  ",
              "citation": {
                "type": "PubMed",
                "name": "Proc Am Thorac Soc 2006 Aug 3(6) 466",
                "id": "16921106"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad870b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "We found that the activation of JNK and p38 MAPK by UV, anisomycin and TNF-a was very similar between Perk+/+ and Perk-/- MEFs (Figure 5).",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2006 Jan 1 393(Pt 1) 201-9",
                "id": "16124869"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad870a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Figure 1A shows that IL-1{beta} induces the phosphorylation of p38 in renal mesangial cells at 15 min (lane 2),",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2004 Jan 286(1) C145-52",
                "id": "14522818"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8709"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "mesangial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "We conclude that in neutrophils, proapoptotic pathways after TNFR1 stimulation are initiated by p38 and PI3K, but not by caspase-8, a finding that should be considered in anti-inflammatory drug-development strategies.",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2011 Jun 2 117(22) 5953-62",
                "id": "21478427"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8708"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Exposure of rats to the smoke from 5 to 15 cigarettes produced a marked increase in phosphorylation of p38, JNK and ERK2 (maximal inductions of ~2.4-fold, ~2.5-fold and ~1.6-fold, respectively).",
              "citation": {
                "type": "PubMed",
                "name": "Chem Biol Interact 2005 Jun 30 155(1-2) 31-42",
                "id": "15970277"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8707"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Exposure to SB202190 (p38 MAPK), U0126 (ERK1/2) and NF-kB III inhibitor revealed that OA induced MMP-9 activity through p38 MAPK.",
              "citation": {
                "type": "PubMed",
                "name": "Br J Pharmacol 2012 Jan 165(1) 274-88",
                "id": "21718298"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8706"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Furthermore, GA treatment induces MAPKs activation (SAPK/JNK and p38) and Hsp70 expression in ROS dependent manner, suggesting that GA turns on the signaling pathway by generation of ROS through Rac1.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biochem 2004 Apr 259(1-2) 23-33",
                "id": "15124904"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8705"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Therefore, TetaR signaling appears to be involved in NTHi-induced MKP-1  expression, which in turn leads to down-regulation of p38-dependent MUC5AC  transcription.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Jul 25 278(30) 27811-9",
                "id": "12734193"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8704"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Nicotine-induced calcium influx was mediated by protein kinase C (PKC) and p38 MAPK in HBEC and activated ERK1/2 in airway fibroblasts",
              "citation": {
                "type": "PubMed",
                "name": "Physiol Rev 2007 Jul 87(3) 1047-82",
                "id": "17615396"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8703"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "bronchial epithelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Two distinct inhibitors of p38MAPK, SB 203580 (10 microm) and SB 202190 (10 microm), prevented bFGF (0.3-3 nm)-stimulated cell proliferation",
              "citation": {
                "type": "PubMed",
                "name": "Br J Pharmacol 2004 Aug 142(7) 1182-90",
                "id": "15249425"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8702"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Muscle, Smooth"
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "In the present study, we demonstrate that 5'-AMP-activated protein kinase (AMPK) and p38 mitogen-activated protein kinase (MAPK) are involved in the activation of peroxisome proliferator-activated receptor (PPAR)alpha by adiponectin in muscle cells.",
              "citation": {
                "type": "PubMed",
                "name": "Diabetes 2006 Sep 55(9) 2562-70",
                "id": "16936205"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8701"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": "Muscle, Skeletal"
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Pre-incubation with U0126, SB203580, SP600125, cyclosporin A and FK506 attenuated the A 1242-induced respiratory burst, measured by DCF-fluorescence, and luminol-amplified chemiluminescence.....Our results show that the Erk1/2 kinases and p38MAPK/JNK are involved in ROS formation in neutrophils exposed to A 1242.",
              "citation": {
                "type": "PubMed",
                "name": "Toxicol Lett 2009 Jun 22 187(3) 144-8",
                "id": "19429257"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8700"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "The blockade of p38 with the pharmacologic inhibitor SB203580 abrogated IL-8 production by cell stretching",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2002 Jul 27(1) 107-14",
                "id": "12091253"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86ff"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "The astroglial-derived S100beta protein stimulates the expression of nitric oxide synthase in rodent macrophages through p38 MAP kinase activation",
              "citation": {
                "type": "PubMed",
                "name": "Life Sci 2006 May 1 78(23) 2707-15",
                "id": "16376947"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86fe"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "In addition, nickel-induced activation of p38 MAPK was attenuated by a small interference of RNA specific to ASK1 (siRNA ASK1), implying that p38 MAPK was downstream of ASK1, ",
              "citation": {
                "type": "PubMed",
                "name": "Chem Res Toxicol 2010 Mar 15 23(3) 568-77",
                "id": "20112989"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86fd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "However, addition of the p38 MAPK inhibitor SB202190 abrogates the enhancement of ERbeta activity by Brx, showing that p38 MAPK activity is required for the enhancement of ERbeta function by Brx.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Dec 14 276(50) 46792-7",
                "id": "11579095"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86fc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Results showed a time-dependent response of increased Txnip expression and p38 MAPK and JNK phosphorylation by ceramide in both Jurkat T cells (Figure 6A) and 10I cells (Figure S4A). ",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2008 Apr 15 111(8) 4365-74",
                "id": "18270325"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86fb"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "In addition, CRH treatment induced rapid phosphorylation of p38 MAPK. SB203580 were able to inhibit CRH-induced p38 MAPK phosphorylation.",
              "citation": {
                "type": "PubMed",
                "name": "J Invest Dermatol 2005 Apr 124(4) 751-5",
                "id": "15816833"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86fa"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "These results suggest a role for MEK2 and p38 in IFN-gamma-mediated signal transduction and induction of C/EBP beta expression and activity associated with interleukin-6 (IL-6) secretion in colon epithelial cells.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2003 May 284(5) C1133-9",
                "id": "12505790"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86f9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "proliferate in response to TGF-beta1 indirectly by the release of FGF-2, which induces phosphorylation of p38 MAPK and JNK.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Dec 30 280(52) 43000-9",
                "id": "16246848"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86f8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "In pilot experiments we found that both TGF1-induced Smad3 and p38 MAPK phosphorylation was still detectable after 18 h and correlated with the increased levels of3 and5 integrins (supplemental Fig. 4S and Fig. 1C).....Smad3 phosphorylation was determined using rabbit mAb against phospho-Src (Tyr-416)...p38MAPKphosphorylation was determined using mousemAb against human phosphorylated p38MAPK(Thr180/Tyr182)",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2008 May 9 283(19) 12898-908",
                "id": "18353785"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86f7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "when the cells were incubated with two structurally unrelated p38 MAPK inhibitors prestimulation with IL-17, namely SB203580 and BIRB0796 (26, 27), this upregulation was essentially abolished",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2010 Apr 15 184(8) 4531-7",
                "id": "20228195"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86f6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "exercise leads to the activation of at least three MAPK signalling pathways, i.e. ERK1/2, p38 MAPK and JNK, in skeletal muscle (Zierath, 2002).",
              "citation": {
                "type": "PubMed",
                "name": "Proc Nutr Soc 2004 May 63(2) 227-32",
                "id": "15294035"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86f5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Muscle, Skeletal"
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Phosphorylation of p38 in response to HNE was also significantly increased (Fig. 6);",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2005 Aug 1 39(3) 355-64",
                "id": "15993334"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86f4"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "In T cells CD137-induced signals lead to the recruitment of TRAF family members and activation of several kinases, including ASK-1, MKK, MAPK3/ MAPK4, p38, and JNK/SAPK  CD137 = TNFRSF9 ASK1 = MAP3K5",
              "citation": {
                "type": "PubMed",
                "name": "Immunol Res 2004 29(1-3) 197-208",
                "id": "15181282"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86f3"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "These results suggest that inhibin/activin beta(A) gene activation is achieved by the JNK and p38 kinase activation through the calmodulin pathway in mast cells.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2003 Jun 15(6) 605-13",
                "id": "12681448"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad86f2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:CSNK2A1)",
        "relation": "actsIn",
        "target": "kin(p(HGNC:CSNK2A1))",
        "directed": false,
        "label": "p(HGNC:CSNK2A1) actsIn kin(p(HGNC:CSNK2A1))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8dcb",
          "evidences": [
            {
              "bel_statement": "p(HGNC:CSNK2A1) actsIn kin(p(HGNC:CSNK2A1))",
              "summary_text": "Phosphorylation of the S100A6-binding domain of Sgt1 by casein kinase II was inhibited by S100A6, a result suggesting that the role of S100A6 binding is to regulate the phosphorylation of Sgt1. These findings suggest that protein ubiquitination via Sgt1-dependent pathway can be regulated by S100 proteins. Because S100A6 and some other S100 proteins can interact with CacyBP/SIP and Sgt1, these S100 proteins could regulate both pathways in a similar fashion. The defects in ubiquitination and degradation of -catenin",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Jul 18 278(29) 26923-8",
                "id": "12746458"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8ca9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CSNK2A1) actsIn kin(p(HGNC:CSNK2A1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Biochemistry 1998 Apr 28 37(17) 5961-7",
                "id": "9558331"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad883b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CSNK2A1) actsIn kin(p(HGNC:CSNK2A1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Eur J Biochem 1992 Nov 1 209(3) 945-50",
                "id": "1425701"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad883a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CSNK2A1) actsIn kin(p(HGNC:CSNK2A1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2000 Nov 15 352 Pt 1 145-54",
                "id": "11062067"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8839"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CSNK2A1) actsIn kin(p(HGNC:CSNK2A1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 1990 Sep 15 270(3) 621-5",
                "id": "2122883"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8838"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CSNK2A1) actsIn kin(p(HGNC:CSNK2A1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2003 Feb 14 301(3) 650-6",
                "id": "12565829"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8837"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CSNK2A1) actsIn kin(p(HGNC:CSNK2A1))",
              "summary_text": "we demonstrate that overexpression of CKII increases the transcriptional activities of MRF4 and MyoD in vivo.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1996 Apr 16(4) 1604-13",
                "id": "8657135"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8836"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CSNK2A1) actsIn kin(p(HGNC:CSNK2A1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2000 Sep 1 350 Pt 2 453-61",
                "id": "10947959"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8835"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CSNK2A1) actsIn kin(p(HGNC:CSNK2A1))",
              "summary_text": "Phosphorylation by CK-2 takes place with a Km of 12 microM calmodulin, leading to the incorporation of more than 1.5 mol P/mol substrate. Ser81 and Thr79 are among the residues affected.",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 1987 May 11 215(2) 241-6",
                "id": "3472906"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8834"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CSNK2A1) actsIn kin(p(HGNC:CSNK2A1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1997 Feb 21 272(8) 5183-6",
                "id": "9030586"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8833"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CSNK2A1) actsIn kin(p(HGNC:CSNK2A1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 May 7 279(19) 19987-95",
                "id": "14742446"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8832"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CSNK2A1) actsIn kin(p(HGNC:CSNK2A1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2004 Dec 8 23(24) 4835-46",
                "id": "15549133"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8831"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CSNK2A1) actsIn kin(p(HGNC:CSNK2A1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Oct 20 275(42) 32592-7",
                "id": "10938077"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8830"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CSNK2A1) actsIn kin(p(HGNC:CSNK2A1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Curr Biol 1999 Sep 9 9(17) 983-6",
                "id": "10508590"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad882f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CSNK2A1) actsIn kin(p(HGNC:CSNK2A1))",
              "summary_text": "Results demonstrate that SSAT is phosphorylated by CK1, in sites distinct from those phosphorylated by CK2. Moreover, both phosphorylation processes are involved in the uptake of SSAT into rat liver mitochondria.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2002 Jan 11 290(1) 463-8",
                "id": "11779193"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad882e"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CSNK2A1) actsIn kin(p(HGNC:CSNK2A1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1994 Dec 9 269(49) 31034-40",
                "id": "7983041"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad882d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CSNK2A1) actsIn kin(p(HGNC:CSNK2A1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Mar 25 280(12) 11869-75",
                "id": "15659405"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad882c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CSNK2A1) actsIn kin(p(HGNC:CSNK2A1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2002 Sep 22(17) 6079-88",
                "id": "12167702"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad882b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CSNK2A1) actsIn kin(p(HGNC:CSNK2A1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Mol Med 1996 Nov 2(6) 673-91",
                "id": "8972483"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad882a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CSNK2A1) actsIn kin(p(HGNC:CSNK2A1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Cell Death Differ 2005 Jun 12(6) 668-77",
                "id": "15818404"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8829"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CSNK2A1) actsIn kin(p(HGNC:CSNK2A1))",
              "summary_text": "The biochemical consequences of SNARE protein phosphorylation included a reduced interaction between SNAP-25 and phosphorylated syntaxin 4 and an enhanced interaction between phosphorylated syntaxin 1A and the synaptic vesicle protein synaptotagmin I, a potential Ca2+ sensor in triggering synaptic vesicle exocytosis. ",
              "citation": {
                "type": "PubMed",
                "name": "J Neurochem 1999 Feb 72(2) 614-24",
                "id": "9930733"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8828"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CSNK2A1) actsIn kin(p(HGNC:CSNK2A1))",
              "summary_text": " PTEN is phosphorylated in vitro on Thr366 and Ser370 by GSK3 (glycogen synthase kinase 3) and CK2 (casein kinase 2) respectively, and specific inhibitors of these kinases block these phosphorylation events in cultured cells.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2007 Aug 1 405(3) 439-44",
                "id": "17444818"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8827"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CSNK2A1) actsIn kin(p(HGNC:CSNK2A1))",
              "summary_text": "Here we show that upregulation of NRF2 by OxPLs depends on the activity of protein kinase CK2. Inactivation of CK2 by chemical inhibitors or gene silencing resulted in diminished accumulation of NRF2 and its downstream genes GCLM, HO-1 and NQO1 in response to OxPLs. Furthermore, inhibition of CK2 suppressed NRF2-dependent induction of ATF4 and its downstream gene VEGF. ",
              "citation": {
                "type": "PubMed",
                "name": "J Lipid Res 2010 Oct 8",
                "id": "20934988"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8826"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CSNK2A1) actsIn kin(p(HGNC:CSNK2A1))",
              "summary_text": "DEK is phosphorylated by the protein kinase CK2",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Jul 24(13) 6011-20",
                "id": "15199154"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8825"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CSNK2A1) actsIn kin(p(HGNC:CSNK2A1))",
              "summary_text": "five putative sites of phosphorylation by casein kinase II (CKII). Site-specific mutagenesis of MAZ revealed that the serine residue at position 480 was the major site of phosphorylation by CKII both in vitro and in vivo. Phosphorylation of MAZ by CKII at this serine residue was required for maximum binding of MAZ to the pyrimidine-rich DNA of the nuclease-hypersensitive element (NHE) in the 5'-end promoter region of the c-myc gene.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 1999 Aug 19 262(1) 198-205",
                "id": "10448092"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8824"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CSNK2A1) actsIn kin(p(HGNC:CSNK2A1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Feb 16 276(7) 4671-6",
                "id": "11084041"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8823"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CSNK2A1) actsIn kin(p(HGNC:CSNK2A1))",
              "summary_text": "In intact cells, CK II seems to be solely responsible for the phosphorylation of HASPP28.",
              "citation": {
                "type": "PubMed",
                "name": "Arch Biochem Biophys 1996 Mar 1 327(1) 131-41",
                "id": "8615683"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8822"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CSNK2A1) actsIn kin(p(HGNC:CSNK2A1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Oct 17 278(42) 40514-20",
                "id": "12876286"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8821"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CSNK2A1) actsIn kin(p(HGNC:CSNK2A1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2003 May 11(5) 1229-39",
                "id": "12769847"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8820"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CSNK2A1) actsIn kin(p(HGNC:CSNK2A1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 1998 Dec 1 161(11) 6022-9",
                "id": "9834084"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad881f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CSNK2A1) actsIn kin(p(HGNC:CSNK2A1))",
              "summary_text": "Grp94-CT conferred protection against aggregation on the catalytic subunit of protein kinase CK2 (CK2alpha)",
              "citation": {
                "type": "PubMed",
                "name": "Eur J Biochem 2001 Jan 268(2) 429-36",
                "id": "11168379"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad881e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CSNK2A1) actsIn kin(p(HGNC:CSNK2A1))",
              "summary_text": "Serine 59 of MEF2C is also constitutively phosphorylated in vivo, probably by casein kinase II, and this phosphorylation enhances DNA binding activity (32).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1999 Jan 19(1) 21-30",
                "id": "9858528"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad881d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CSNK2A1) actsIn kin(p(HGNC:CSNK2A1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Mar 12 274(11) 7454-61",
                "id": "10066810"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad881c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CSNK2A1) actsIn kin(p(HGNC:CSNK2A1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2003 Jan 16 22(2) 220-32",
                "id": "12527891"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad881b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CSNK2A1) actsIn kin(p(HGNC:CSNK2A1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Nucleic Acids Res 1993 Feb 25 21(4) 949-55",
                "id": "8451194"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad881a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CSNK2A1) actsIn kin(p(HGNC:CSNK2A1))",
              "summary_text": "Inhibition of CKII mediated phosphorylation of APE/Ref-1 blocked mutagen-stimulated increase in AP-1 binding. It also abrogated the induction of c-Jun protein and rendered cells more sensitive to induced DNA damage",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1999 Jan 28 18(4) 1033-40",
                "id": "10023679"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8819"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CSNK2A1) actsIn kin(p(HGNC:CSNK2A1))",
              "summary_text": "The S100A4-binding region contains two putative phosphorylation sites by protein kinase C and protein kinase CK2. S100A4-liprin beta1 interaction resulted in the inhibition of liprin beta1 phosphorylation by both kinases in vitro.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Feb 15 277(7) 5229-35",
                "id": "11836260"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8818"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CSNK2A1) actsIn kin(p(HGNC:CSNK2A1))",
              "summary_text": "In the absence of phosphorylation, only trace amounts of cytosol protein were bound and eluted. When the fusion protein was phosphorylated, a heterocomplex of potential sorting proteins was recovered. Mass spectrometer and immunoblot analysis identified five of these proteins as gp96, HSP70, HSP90, cyclophilin-A, and FKBP18.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Oct 4 277(40) 37798-803",
                "id": "12167617"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8817"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "hepatocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CSNK2A1) actsIn kin(p(HGNC:CSNK2A1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biochem 2004 Apr 1 91(5) 865-79",
                "id": "15034923"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8816"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CSNK2A1) actsIn kin(p(HGNC:CSNK2A1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1998 Sep 18 273(38) 24805-13",
                "id": "9733784"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8815"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CSNK2A1) actsIn kin(p(HGNC:CSNK2A1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2001 Jan 1 353(Pt 1) 69-77",
                "id": "11115400"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8814"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CSNK2A1) actsIn kin(p(HGNC:CSNK2A1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Aug 1 278(31) 28462-9",
                "id": "12748192"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8813"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CSNK2A1) actsIn kin(p(HGNC:CSNK2A1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Apr 25 278(17) 15297-303",
                "id": "12586839"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8812"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CSNK2A1) actsIn kin(p(HGNC:CSNK2A1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Oct 24(19) 8395-407",
                "id": "15367661"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8811"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CSNK2A1) actsIn kin(p(HGNC:CSNK2A1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Nucleic Acids Res 2002 Mar 1 30(5) 1154-62",
                "id": "11861906"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8810"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CSNK2A1) actsIn kin(p(HGNC:CSNK2A1))",
              "summary_text": "Pharmacologic inhibition of CK2 activity in cell lines established from CK2alpha transgenic T cell lymphomas reduces their proliferation and concomitantly with this, the steady state levels of c-myc protein decline. This is caused by accelerated c-myc protein turnover, which occurs in a proteasome-dependent manner.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2002 Aug 8 21(34) 5280-8",
                "id": "12149649"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad880f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CSNK2A1) actsIn kin(p(HGNC:CSNK2A1))",
              "summary_text": "-catenin is also upregulated in transgenic tumors induced by CK2{alpha}",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 2002 Oct 15 115(Pt 20) 3873-8",
                "id": "12244125"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad880e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CSNK2A1) actsIn kin(p(HGNC:CSNK2A1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1996 Mar 16(3) 899-906",
                "id": "8622692"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad880d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CSNK2A1) actsIn kin(p(HGNC:CSNK2A1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2004 Apr 2 117(1) 17-28",
                "id": "15066279"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad880c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CSNK2A1) actsIn kin(p(HGNC:CSNK2A1))",
              "summary_text": "9990034;9558331",
              "citation": {
                "type": "PubMed",
                "name": "BMC Bioinformatics 2004 Jun 22 5 79",
                "id": "15212693"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad880b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CSNK2A1) actsIn kin(p(HGNC:CSNK2A1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Jan 18 277(3) 1884-91",
                "id": "11711551"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad880a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CSNK2A1) actsIn kin(p(HGNC:CSNK2A1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 May 10 277(19) 16837-46",
                "id": "11877451"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8809"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CSNK2A1) actsIn kin(p(HGNC:CSNK2A1))",
              "summary_text": "In a gel shift analysis, this bacterially expressed splice variant binds to the TNFalpha promoter site after in vitro phosphorylation by casein kinase II (CKII). In addition, cotransfection studies demonstrate that this splice variant mediates induced transcription at the TNFalpha promoter after stimulation/activation in a heterologous system.",
              "citation": {
                "type": "PubMed",
                "name": "Nucleic Acids Res 1998 May 15 26(10) 2291-7",
                "id": "9580677"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8808"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CSNK2A1) actsIn kin(p(HGNC:CSNK2A1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1992 Oct 5 267(28) 20317-25",
                "id": "1400350"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8807"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CSNK2A1) actsIn kin(p(HGNC:CSNK2A1))",
              "summary_text": "CK2 phosphorylates CSN2 and CSN7, and PKD modifies CSN7.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2003 Mar 17 22(6) 1302-12",
                "id": "12628923"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8806"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CSNK2A1) actsIn kin(p(HGNC:CSNK2A1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2005 Feb 25(4) 1446-57",
                "id": "15684395"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8805"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CSNK2A1) actsIn kin(p(HGNC:CSNK2A1))",
              "summary_text": "Here we present evidence of a direct phosphorylation of IkappaBalpha at both S32 and S36 by purified or immunoprecipitated protein kinase CKII (PK-CKII) and a specific in vivo association between IkappaBalpha and PK-CKII.",
              "citation": {
                "type": "PubMed",
                "name": "J Mol Biol 1999 Jul 23 290(4) 839-50",
                "id": "10398585"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8804"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CSNK2A1) actsIn kin(p(HGNC:CSNK2A1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2002 Jun 6 21(25) 3978-87",
                "id": "12037680"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8803"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:PRKCI))",
        "relation": "increases",
        "target": "tloc(p(HGNC:NFE2L2),GOCC:cytoplasm,GOCC:nucleus)",
        "directed": false,
        "label": "kin(p(HGNC:PRKCI)) increases tloc(p(HGNC:NFE2L2),GOCC:cytoplasm,GOCC:nucleus)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8dcc",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:PRKCI)) increases tloc(p(HGNC:NFE2L2),GOCC:cytoplasm,GOCC:nucleus)",
              "summary_text": "Coexpression of aPKC{iota} with Nrf2-GFP and Keap1 induced the nuclear  accumulation of the fusion protein; however, the kinase inactive mutant aPKC{iota}(K274W) did not affect the cytoplasmic localization of Nrf2-GFP (Fig. 5A).",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2003 Aug 285(2) C334-42",
                "id": "12700136"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad883c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "tscript(p(HGNC:NFE2L2))",
        "relation": "directlyIncreases",
        "target": "p(HGNC:HMOX1)",
        "directed": false,
        "label": "tscript(p(HGNC:NFE2L2)) directlyIncreases p(HGNC:HMOX1)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8dcd",
          "evidences": [
            {
              "bel_statement": "tscript(p(HGNC:NFE2L2)) directlyIncreases p(HGNC:HMOX1)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad883d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "tscript(p(HGNC:NFE2L2))",
        "relation": "directlyIncreases",
        "target": "p(HGNC:NQO1)",
        "directed": false,
        "label": "tscript(p(HGNC:NFE2L2)) directlyIncreases p(HGNC:NQO1)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8dce",
          "evidences": [
            {
              "bel_statement": "tscript(p(HGNC:NFE2L2)) directlyIncreases p(HGNC:NQO1)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad883e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "tscript(p(HGNC:NFE2L2))",
        "relation": "increases",
        "target": "p(HGNC:GSTA5)",
        "directed": false,
        "label": "tscript(p(HGNC:NFE2L2)) increases p(HGNC:GSTA5)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8dcf",
          "evidences": [
            {
              "bel_statement": "tscript(p(HGNC:NFE2L2)) increases p(HGNC:GSTA5)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad883f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "tscript(p(HGNC:NFE2L2))",
        "relation": "increases",
        "target": "p(HGNC:SRXN1)",
        "directed": false,
        "label": "tscript(p(HGNC:NFE2L2)) increases p(HGNC:SRXN1)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8dd0",
          "evidences": [
            {
              "bel_statement": "tscript(p(HGNC:NFE2L2)) increases p(HGNC:SRXN1)",
              "summary_text": "Western blot analysis of lung proteins showed that Srx1 proteinwas present constitutively, and its level increased significantly on exposure to CS in Nrf2+/+ mice. By contrast, expression of Srx1 protein was low in Nrf2?/? mice and did not change significantly with CS exposure (Figs. 1B and C).",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2009 Feb 1 46(3) 376-86",
                "id": "19027064"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8840"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "tscript(p(HGNC:NFE2L2))",
        "relation": "increases",
        "target": "p(HGNC:GCLC)",
        "directed": false,
        "label": "tscript(p(HGNC:NFE2L2)) increases p(HGNC:GCLC)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8dd1",
          "evidences": [
            {
              "bel_statement": "tscript(p(HGNC:NFE2L2)) increases p(HGNC:GCLC)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8841"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "tscript(p(HGNC:NFE2L2))",
        "relation": "increases",
        "target": "p(HGNC:GSTP1)",
        "directed": false,
        "label": "tscript(p(HGNC:NFE2L2)) increases p(HGNC:GSTP1)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8dd2",
          "evidences": [
            {
              "bel_statement": "tscript(p(HGNC:NFE2L2)) increases p(HGNC:GSTP1)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8842"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "tscript(p(HGNC:NFE2L2))",
        "relation": "increases",
        "target": "p(HGNC:GCLM)",
        "directed": false,
        "label": "tscript(p(HGNC:NFE2L2)) increases p(HGNC:GCLM)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8dd3",
          "evidences": [
            {
              "bel_statement": "tscript(p(HGNC:NFE2L2)) increases p(HGNC:GCLM)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8843"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "tscript(p(HGNC:NFE2L2))",
        "relation": "directlyIncreases",
        "target": "p(HGNC:ATF4)",
        "directed": false,
        "label": "tscript(p(HGNC:NFE2L2)) directlyIncreases p(HGNC:ATF4)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8dd4",
          "evidences": [
            {
              "bel_statement": "tscript(p(HGNC:NFE2L2)) directlyIncreases p(HGNC:ATF4)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8844"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "tscript(p(HGNC:NFE2L2))",
        "relation": "increases",
        "target": "kin(p(HGNC:MAPK1))",
        "directed": false,
        "label": "tscript(p(HGNC:NFE2L2)) increases kin(p(HGNC:MAPK1))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8dd5",
          "evidences": [
            {
              "bel_statement": "tscript(p(HGNC:NFE2L2)) increases kin(p(HGNC:MAPK1))",
              "summary_text": "Subsequently, to understand the mechanism of nanoparticles-induced oxidative stress, the involvement of oxidative stress-responding transcription factors, such as, nuclear factor-kappaB (NF-kappaB) and nuclear factor-E2-related factor-2 (Nrf-2), as well as the mitogen-activated protein (MAP) kinase signal transduction pathway were investigated. From the overall results, silica nanoparticles exerted toxicity via oxidative stress, which lead to the induction of HO-1 via the Nrf-2-ERK MAP kinase signaling pathway",
              "citation": {
                "type": "PubMed",
                "name": "Toxicol In Vitro 2009 Oct 23(7) 1326-32",
                "id": "19602432"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8caa"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "tscript(p(HGNC:NFE2L2))",
        "relation": "increases",
        "target": "p(HGNC:PRDX1)",
        "directed": false,
        "label": "tscript(p(HGNC:NFE2L2)) increases p(HGNC:PRDX1)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8dd6",
          "evidences": [
            {
              "bel_statement": "tscript(p(HGNC:NFE2L2)) increases p(HGNC:PRDX1)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8845"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "tscript(p(HGNC:NFE2L2))",
        "relation": "directlyIncreases",
        "target": "p(HGNC:TXNRD1)",
        "directed": false,
        "label": "tscript(p(HGNC:NFE2L2)) directlyIncreases p(HGNC:TXNRD1)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8dd7",
          "evidences": [
            {
              "bel_statement": "tscript(p(HGNC:NFE2L2)) directlyIncreases p(HGNC:TXNRD1)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8846"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "tscript(p(HGNC:NFE2L2))",
        "relation": "increases",
        "target": "p(HGNC:HSPA1B)",
        "directed": false,
        "label": "tscript(p(HGNC:NFE2L2)) increases p(HGNC:HSPA1B)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8dd8",
          "evidences": [
            {
              "bel_statement": "tscript(p(HGNC:NFE2L2)) increases p(HGNC:HSPA1B)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8847"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "tscript(p(HGNC:NFE2L2))",
        "relation": "directlyIncreases",
        "target": "p(HGNC:GPX2)",
        "directed": false,
        "label": "tscript(p(HGNC:NFE2L2)) directlyIncreases p(HGNC:GPX2)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8dd9",
          "evidences": [
            {
              "bel_statement": "tscript(p(HGNC:NFE2L2)) directlyIncreases p(HGNC:GPX2)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8848"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "tscript(p(HGNC:NFE2L2))",
        "relation": "directlyIncreases",
        "target": "p(HGNC:SQSTM1)",
        "directed": false,
        "label": "tscript(p(HGNC:NFE2L2)) directlyIncreases p(HGNC:SQSTM1)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8dda",
          "evidences": [
            {
              "bel_statement": "tscript(p(HGNC:NFE2L2)) directlyIncreases p(HGNC:SQSTM1)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8849"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "tscript(p(HGNC:NFE2L2))",
        "relation": "increases",
        "target": "p(HGNC:GSS)",
        "directed": false,
        "label": "tscript(p(HGNC:NFE2L2)) increases p(HGNC:GSS)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8ddb",
          "evidences": [
            {
              "bel_statement": "tscript(p(HGNC:NFE2L2)) increases p(HGNC:GSS)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad884a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:GSK3B)",
        "relation": "actsIn",
        "target": "kin(p(HGNC:GSK3B))",
        "directed": false,
        "label": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8ddc",
          "evidences": [
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "Furthermore, serum starvation-induced apoptosis caused a twofold increase in caspase 3 activity in C1-TEN-overexpressing cells vs. mock cells. In addition, C1-TEN-overexpressing cells showed a markedly reduced phosphorylation of Akt/PKB kinase and its substrate GSK3, as well as reduced Akt enzymatic activity.  Equal amounts of total cell lysates were subjected to 10% SDSPAGE. The membrane was then probed with polyclonal antibody against GSK3 specifically phosphorylated at Ser21/9 (pGSK3?/?, CST), after which the membrane was stripped (stripping buffer, Pierce) and reprobed with polyclonal anti-total Akt antibody (CST). and Western blotting for detection of either Akt kinase specifically phosphorylated at Ser473 (pAkt) or both 42 and 44 kDa isoforms of phosphorylated ERK (pERK) using specific antibodies (Santa Cruz Biotechnology, Santa Cruz, CA).",
              "citation": {
                "type": "PubMed",
                "name": "FASEB J 2005 Jun 19(8) 971-3",
                "id": "15817639"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8cbf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "Insulin Stimulated phosphorylation cascade This pathway involves the tyrosine phosphorylation of IRS proteins and/or Shc, which in turn interact with the adapter protein Grb2, recruiting the Son-of-sevenless (SOS) exchange protein to the plasma membrane for activation of Ras. The activation of Ras also requires stimulation of the tyrosine phosphatase SHP2, through its interaction with receptor substrates such as Gab-1 or IRS1/2. Activated ERK can translocate into the nucleus, where it catalyses the phosphorylation of transcription factors such as p62TCF, Blockade of the pathway with dominant negative mutants or pharmacological inhibitors prevents the stimulation of cell growth by insulin, but has no effect on the metabolic actions of the hormone54. Insulin increases synthesis and blocks the degradation of proteins through activation of mTOR. The stimulation of this protein kinase involves PI(3)K activation, although another signal may also be required56. mTOR can control the mammalian translation machinery by direct phosphorylation and activation of p70 ribosomal S6 kinase (p70rsk)57, as well as phosphorylation of the initiation factor 4E for eukaryotic translation (eIF-4E) inhibitor, PHAS1 or 4E-binding protein 1 (ref. 58). P70rsk activates ribosome biosynthesis by phosphorylating the ribosomal S6 protein, producing increased translation of mRNAs with a 58-terminal oligopyrimidine tract. P70rsk also requires a second PtdIns(3,4,5)P3-dependent phosphorylation, presumably catalysed by PDK1. Phosphorylation of PHAS-1 by mTOR results in its dissociation from eIF-2, allowing capdependent translation of mRNAs with a highly structured 58-untranslated region. Although the mechanism of activation of mTOR remains unclear, it seems to require the presence of amino acids in the media for full activation by growth factors, and thus may also represent a nutrient sensor55. Glucose and lipid regulation Regulation of glycogen synthesis Insulin stimulates glycogen accumulation through a coordinated increase in glucose transport and glycogen synthesis. The hormone activates glycogen synthase by promoting its dephosphorylation, through the inhibition of kinases such as PKA or GSK-3 (ref. 59), and activation of protein phosphatase 1 (PP1)60.",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2001 Dec 13 414(6865) 799-806",
                "id": "11742412"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8cbe"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Muscles"
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "In primary rat neuronal and HT22 cells, FGF1 promoted a time-dependent inactivation of GSK3beta by phosphorylation at serine 9. Blocking FGF1 receptors with heparinase reduced this effect. The effects of FGF1 on GSK3beta were dependent on phosphatidylinositol 3-kinase (PI3K)-protein kinase B (Akt) because inhibitors of this pathway or infection with dominant negative Akt adenovirus blocked inactivation. Furthermore, treatment of neuronal cells with FGF1 resulted in ERK-independent Akt phosphorylation",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Sep 6 277(36) 32985-91",
                "id": "12095987"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8cbd"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "We demonstrate that p90rsk-1, p90rsk-2, gsk-3, ERK-2, and p70S6K kinases are components of the protein translation complex.  gsk-3b is a constitutively active kinase and phosphorylation by p90rsk inhibits its kinase activity (47). One of the known gsk-3 substrates is the translation initiation factor eIF2B. Phosphorylation of this translation initiation factor decreases translation (49, 50). Thus, inhibition of gsk-3b by p90rsk phosphorylation would result in a rapid increase in translation. ",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 1998 Dec 8 95(25) 15078-83",
                "id": "9844018"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8cbc"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "we have confirmed that GSK-3 is able to inhibit Notch-mediated transcription of the Hes-1 promoter, and this is in agreement with the up-regulation of Notch target genes by the GSK-3 inhibitor LiCl. Because Wnt glycoproteins signal through Frizzled receptors resulting in the inhibition of GSK-3, we hypothesized that Wnt signaling could up-regulate Notch transcriptional activity in our system. To test this, we transfected NIH-3T3 with N2-IC in the presence of increasing amounts of Wnt1-hFc (26) along with the Hes1-luc reporter. Consistent with our hypothesis, coexpression of Wnt1 with N2-IC resulted in up-regulation of the Hes1 promoter in a dose-dependent manner (Fig. 7A), whereas no effect was observed when Wnt1 was expressed in the absence of N2-IC (Fig 7A).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Aug 22 278(34) 32227-35",
                "id": "12794074"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8cbb"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "In unstimulated cells, GSK3 is active and contributes significantly towards the phosphorylation and inhibition of glycogen synthase [12]. Insulin stimulates glycogen synthesis both by inactivating GSK3 and also by promoting the dephosphorylation of glycogen synthase. The inactivation of GSK3 and GSK3 is achieved through phosphorylation of Ser21 and Ser9, respectively [12], and this is mediated by PKB in a PI3K-dependent fashion. Thus PI3K, PDK, PKB and GSK3 constitute one important arm of the insulin signalling cascade regulating glycogen synthesis. In addition to inducing an increase in glucose transport, over-expression of PKB elicited an inhibition of GSK3 and a concomitant increase in glycogen and protein synthesis a decrease in insulin-stimulated GLUT4 translocation, glucose transport and membrane ruffling, which coincided with reduced phosphorylation of PKB and p70S6K but normal phosphorylation of p42/44 MAPK observed an inhibition of PKB phosphorylation and downstream p70S6K activation, which was attributable to a PP2A-type phosphatase activity Akt phosphorylates and inactivates GSK-3, decreasing the rate of phosphorylation of glycogen synthase",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 2001 Mar 16 492(3) 199-203",
                "id": "11257494"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8cba"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "Mitogen-activated protein kinases (MAPKs) of the ERK family phosphorylate HSF1 and represses transcriptional function. The mechanism of repression involves initial phosphorylation by MAP kinase on serine 307, which primes HSF1 for secondary phosphorylation by glycogen synthase kinase 3 on a key residue in repression (serine 303). In vivo expression of glycogen synthase kinase 3 alpha or beta thus represses HSF1 through phosphorylation of serine 303.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1998 Jul 17 273(29) 18640-6",
                "id": "9660838"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8cb9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "Dexamethasone treatment decreased the ability of insulin to stimulate glucose uptake, glycogen synthesis and glycogen synthase fractional activity. In addition, the dephosphorylation of glycogen synthase by insulin was blocked. These defects were paralleled by reduced insulin-stimulated protein kinase B (PKB) and GSK-3 phosphorylation. We demonstrated that chronic dexamethasone treatment impairs insulin-stimulated PKB and GSK-3 phosphorylation, which may contribute to insulin resistance in skeletal muscles.",
              "citation": {
                "type": "PubMed",
                "name": "Diabetologia 2005 Oct 48(10) 2119-30",
                "id": "16078016"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8cb8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Muscle, Skeletal"
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "This observation, together with the very rapid kinetics of GSK3-beta phosphorylation in response to aortic coarctaction, supports the hypothesis that melusin selectively senses the biomechanical stimuli. In contrast to other kinases, GSK3-beta is highly active in unstimulated cells and becomes inactivated by phosphorylation of serine 9 in response to several stimuli28. Recent studies have shown that this inactivation is required for cardiac hypertrophy. In cardiomyocytes, active GSK3-beta phosphorylates the transcription factors NF-AT and GATA4, inducing their translocation from the nucleus to the cytoplasm and thus inhibiting their transcriptional activity25-27. In addition, active GSK3-beta also induces inhibition of elF2B, a principal initiation factor regulating protein synthesis.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Med 2003 Jan 9(1) 68-75",
                "id": "12496958"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8cb7"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "cardiomyocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "coexpression of betaarr1 with either Dvl1 or Dvl2 leads to a synergistic activation of LEF (up to 16-fold). Additional experiments with LiCl as an inhibitor of GSK-3beta kinase activity indicate that the step affected by betaarr1 is upstream of GSK-3beta and most likely at the level of Dvl. These results identify betaarr1 as a regulator of Dvl-dependent LEF transcription and suggest that betaarr1 might serve as an adapter molecule that can couple Frizzled receptors and perhaps other GPCRs to these important transcription pathways.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2001 Dec 18 98(26) 14889-94",
                "id": "11742073"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8cb6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "glycogen synthase kinase GSK3 which itself is a target of protein kinase B (PKB) and the serum and glucocorticoid inducible kinase SGK1. Phosphorylation of GSK3 by PKB or SGK1 inhibits GSK3 activity an the present study explored whether mineralocorticoid excess had any effect on the phosphorylation status of the a and beta isoforms of GSK3. Western blotting using an antibody specific for the PKB/SGK1 consensus phosphorylation site in GSK3a/beta (serine 21 and 9 respectively) revealed an increase in GSK3a/beta phosphorylation in human embryonic kidney 293 (HEK293) cells overexpressing wild type SGK1, constitutively active SGK1, but not catalytically inactive SGK1. The effect of SGK1 was mimicked by PKB and SGK3.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Physiol Biochem 2006 17(3-4) 137-44",
                "id": "16543730"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8cb5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "In the present study, primary human bone marrow cells were cultured for 12 days in megakaryocyte lineage induction (MKLI) media to induce their differentiation into megakaryocyte (MK) lineage cells, in the presence or absence (+/-) of TWS119, a GSK-3beta inhibitor, during MK differentiation from stem cells and subsequent platelet production. MK maturation, MK production, and subsequent platelet production were markedly enhanced in cells cultured in TWS119 (+) compared with cells cultured in TWS119 (-).",
              "citation": {
                "type": "PubMed",
                "name": "Platelets 2011 22(3) 196-203",
                "id": "21231855"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8cb4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "megakaryocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "Inhibition of PI3-kinase activity using a dominant negative mutant (30), or pharmacological agents such as wortmannin or LY294002 (31), abolishes insulin stimulated glucose uptake and inhibits GLUT4 vesicle translocation to the plasma membrane. Many other cellular effects of insulin, such as antilipolysis, activation of fatty acid synthesis, acetyl CoA-carboxylase, glycogen synthase, Akt phosphorylation, glycogen synthase kinase 3b inactivation, and stimulation of protein synthesis and DNA synthesis, are also inhibited by PI3- kinase suppression PIP3, rather than PIP2, is the major mediator of PI3- kinase dependent biological actions of insulin",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Invest 1999 Apr 103(7) 931-43",
                "id": "10194465"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8cb3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "Moreover, we show that the repression of AR activity by LY294002 is mediated through phosphorylation and inactivation of GSK3beta, a downstream substrate of PI3K/Akt, which results in the nuclear accumulation of beta-catenin The activation of Akt results in the phosphorylation of a number of downstream substrates such as glycogen synthase kinase (GSK3) It has been shown that GSK3 plays an important role in the Wnt pathway by regulating the degradation of -catenin Recently, a specific protein-protein interaction between -catenin and AR was identified by us and others (22, 23). Through this interaction, -catenin augments the ligand-dependent activity of AR in prostate cancer cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Aug 23 277(34) 30935-41",
                "id": "12063252"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8cb2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "These findings suggest that different signal transduction pathways as well as cell cycle-specific regulation are controlling the phosphorylation of Ser-62. Indeed RAS signaling that results in the activation of MAP kinases has been suggested to enhance MYC phosphorylation at Ser-62 (31, 32). Phosphorylation at this site appears to affect the stability of MYC at the G0 to G1 transition and to regulate MYC DNA binding (see below). Together these findings promote an attractive model because the RAS signaling pathway is activated by many growth factors and coincides with a strong increase in MYC protein levels upon reentry of cells into the cell cycle. However, because the evidence was derived from cells that overexpressed MYC from recombinant adenoviruses (31, 32), some caution is indicated. The massive overexpression of MYC in resting cells should stimulate cell cycle entry and apoptosis. Also it is not clear whether enough MAXis present in cells to build faithful MYC/MAX complexes. These artificial conditions may severely affect protein behavior, including stability and the response to RAS signaling. It should also be considered that MYC mRNA expression is strongly enhanced upon growth factor treatment of resting cells (6), and the analysis of de novo MYC protein synthesis has revealed a substantial increase in different cell types, including primary cells (33, 34). Thus the contribution of RAS signaling to MYC expression levels at the G0 to G1 transition will need further studying. It should also be noted that the role of MAPK in phosphorylating Ser-62 has been disputed (29). Once Ser-62 is phosphorylated, Thr-58 of MYC becomes a substrate for GSK3 (24). Most substrates of this enzyme must first be phosphorylated by another kinase at a Ser or Thr amino acid four residues C-terminal of the GSK3 site (35). This \\\"priming phosphate\\\" binds specifically into a pocket of the substrate recognition domain of GSK3 and explains why MYC and other substrates require this phosphorylation for the precise positioning of the phosphorylation site. Thus phosphorylation of Thr-58 appears to be strictly dependent on prior phosphorylation of Ser-62. Similar findings were made for MYCN (36). Phosphorylation at Ser-54 by CDK1 leads to Thr-50 phosphorylation by GSK3, the two sites correspond to Ser-62 and Thr-58 in MYC, respectively, which enhances MYCN turnover during mitosis in neuronal cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Nov 17 281(46) 34725-9",
                "id": "16987807"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8cb1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "Moreover, protein-DNA array studies identified two novel GSK-3-regulated transcription factors, early growth response 1 and Smad3/4, which were oppositely affected by GSK-3alpha or GSK-3beta silencing or inhibition Binding activity of EGR-1-responsive element with EGR-1 was down-regulated by transfection with siRNA for GSK-3{alpha} but up-regulated by siRNA for GSK-3beta compared with the non-targeting siRNA control. Luciferase reporter assays confirmed that the transcriptional activity of EGR-1 was decreased by GSK-3{alpha} siRNA and its dominant negative mutant but increased by GSK-3beta siRNA and its dominant negative mutants (Fig. 4A).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Oct 13 281(41) 30479-84",
                "id": "16912034"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8cb0"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "neuron",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "The insulin receptor and some of its substrates are also subject to serine/threonine phosphorylation. Data from some experimental models suggest that this might represent a mechanism by which signaling is terminated, or perhaps attenuated in states of insulin resistance. Numerous in vitro studies have shown that the tyrosine kinase activity of the receptor decreases as a consequence of serine/threonine phosphorylation. This might occur via  feedback \\\"retrophosphorylation\\\" events in which the receptor or IRS proteins are serine phosphorylated by GSK3 or mTOR, both of which are activated downstream of IRS phosphorylation.",
              "citation": {
                "type": "PubMed",
                "name": "Trends Cell Biol 2002 Feb 12(2) 65-71",
                "id": "11849969"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8caf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "PI3K-Akt-GSK3b pathway Glycogen-synthase kinase 3b (GSK3b) is a distinct substrate of Akt1 that has been shown to modulate hypertrophy. GSK3b activity is inhibited by Akt1 phosphorylation [65] (Fig. 1). Expression of a dominantnegative, kinase-inactive form of GSK3b induces dramatic hypertrophy in skeletal myotubes [6]. In cardiac hypertrophy, GSK3b phosphorylation is also evident [66], and expression of a dominant-negative form of GSK3b can induce cardiac hypertrophy [66].",
              "citation": {
                "type": "PubMed",
                "name": "Trends Mol Med 2003 Aug 9(8) 344-50",
                "id": "12928036"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8cae"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "Insulin is the most-potent physiological anabolic agent known, promoting the synthesis and storage of carbohydrates and lipids and inhibiting their degradation and release into the circulation. This action of the hormone is due in part to the acute regulation of metabolic enzymes through changes in their phosphorylation state. In fat, liver, and muscle, insulin stimulates the dephosphorylation of a number of enzymes involved in glycogen and lipid metabolism via activation of protein phosphatases. Numerous studies have indicated that protein phosphatase-1 (PP1) is the primary phosphatase involved in insulin action. Although PP1 is a cytosolic protein, the phosphatase is compartmentalized in cells by discrete targeting subunits. These proteins confer substrate specificity to PP1 and mediate the specific regulation of intracellular pools of PP1 by a variety of extracellular signals. Four proteins have been described that target the phosphatase to the glycogen particle. G(M) and GL are expressed exclusively in striated muscle and liver, while protein targeting to glycogen (PTG) and R6 are more widely expressed. Despite a common targeting function, these four proteins are not highly conserved, suggesting profound differences in the mechanisms by which they contribute to the hormonal regulation of PP1 activity. Overexpression studies in cell lines or animals have revealed major differences among these proteins regarding basal glycogen levels and hormonal responsiveness. Furthermore, alterations in the expression or function of PP1 glycogen-targeting subunits may contribute to the onset of insulin resistance and type 2 diabetes.",
              "citation": {
                "type": "PubMed",
                "name": "Recent Prog Horm Res 2001 56 157-73",
                "id": "11237211"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8cad"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "Dexamethasone treatment decreased the ability of insulin to stimulate glucose uptake, glycogen synthesis and glycogen synthase fractional activity. In addition, the dephosphorylation of glycogen synthase by insulin was blocked. These defects were paralleled by reduced insulin-stimulated protein kinase B (PKB) and GSK-3 phosphorylation. We demonstrated that chronic dexamethasone treatment impairs insulin-stimulated PKB and GSK-3 phosphorylation, which may contribute to insulin resistance in skeletal muscles.",
              "citation": {
                "type": "PubMed",
                "name": "Diabetologia 2005 Oct 48(10) 2119-30",
                "id": "16078016"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8cac"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "The life history of cancer cells encompasses a series of genetic missteps in which normal cells are progressively transformed into tumor cells that invade surrounding tissues and become malignant. Most prominent among the regulators disrupted in cancer cells are two tumor suppressors, the retinoblastoma protein (RB) and the p53 transcription factor. Here, we discuss interconnecting signaling pathways controlled by RB and p53, attempting to explain their potentially universal involvement in the etiology of cancer. Pinpointing the various ways by which the functions of RB and p53 are subverted in individual tumors should provide a rational basis for developing more refined tumor-specific therapies.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Cell 2002 Aug 2(2) 103-12",
                "id": "12204530"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8cab"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "GSK3 requires tyrosine phosphorylation on Y279 (a isoform) or Y216 (b isoform), a residue in the activation loop of the catalytic domain, for kinase activity",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2001 Sep 1 98(5) 1374-81",
                "id": "11520785"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88fd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "GSK-3beta phosphorylates MARK2 on Ser-212, one of the two reported phosphorylation sites (Thr-208 and Ser-212) found in the activation loop of MARK2. Down-regulation of either GSK-3beta or MARK2 by small interfering RNAs suppressed the level of phosphorylation on Ser-262. GSK-3beta is responsible for phosphorylating Ser-262 of tau through phosphorylation and activation of MARK2",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Dec 30 280(52) 42715-22",
                "id": "16257959"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88fc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "The activity of glycogen-synthase kinase-3 can be down-regulated in response to insulin or insulin-like growth factor-1 through the activation of the phosphatidylinositol 3-kinase pathway.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1997 Aug 1 272(31) 19547-53",
                "id": "9235959"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88fb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "Kit and other RTKs will activate the MAP kinase signaling pathway and has been reported both to increase the transcriptional activity of Mitf as well as down-regulate Mitf protein levels.",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2000 Jul 15 14(14) 1712-28",
                "id": "10898786"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88fa"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "Glucose and HGF treatments reduced glycogen synthase kinase 3 (GSK3) activity and increased c-Jun DNA binding.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 1998 Mar 9(3) 561-73",
                "id": "9487126"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88f9"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "The activation of MLK3 by GSK-3beta occurred via phosphorylation of MLK3 on two amino acid residues, Ser(789) and Ser(793), that are located within the C-terminal regulatory domain of MLK3. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 Oct 19 282(42) 30393-405",
                "id": "17711861"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88f8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "p53-mediated regulation of mPTP might be suppressed by inhibition of GSK-3b activity. Activation of p53 by GSK-3b enhances its functional activity and translocation to the nucleus and mitochondria.52",
              "citation": {
                "type": "PubMed",
                "name": "Circ J 2009 Jul 73(7) 1184-92",
                "id": "19506320"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88f7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2001 Feb 21(3) 902-15",
                "id": "11154277"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88f6"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "In addition, hAxin dramatically facilitated the phosphorylation of APC and beta-catenin by GSK3 beta in vitro.",
              "citation": {
                "type": "PubMed",
                "name": "Curr Biol 1998 May 7 8(10) 573-81",
                "id": "9601641"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88f5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Mar 9 276(10) 7366-75",
                "id": "11104755"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88f4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "These results suggest that Axin regulates the stability of plakoglobin by enhancing its phosphorylation by GSK-3beta and that Axin may act on beta-catenin and plakoglobin in similar manners.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Sep 24 274(39) 27682-8",
                "id": "10488109"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88f3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "Consistent with the inhibitory effect of phosphorylation of the serine residues on GSK-3 activity (10, 56), LPA treatment inhibited GSK-3beta kinase activity as determined by in vitro kinase assays (see Fig. 3).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2002 Apr 22(7) 2099-110",
                "id": "11884598"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88f2"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "Inhibition of glycogen synthase kinase-3beta by a dominant negative mutant (Rommel et al. 2001) or by LiCl (Vyas et al. 2002) is associated with an enlargement of C2C12 myotubes in culture.",
              "citation": {
                "type": "PubMed",
                "name": "J Physiol 2002 Sep 1 543(Pt 2) 399-411",
                "id": "12205177"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88f1"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "GSK-3beta modulates the early mitotic Aurora-A level through binding and phosphorylating AIP......Treatment of the cells with a GSK-3beta inhibitor reduced the protein level of Aurora-A and this reduction was suppressed by AIP knockdown. AIP was phosphorylated by GSK-3beta, and an AIP mutant in which the GSK-3beta phosphorylation site was mutated could bind and downregulate Aurora-A more efficiently.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2008 Jul 24 27(32) 4478-87",
                "id": "18391981"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88f0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "The dn-AKT used in this study was also able to inhibit the phosphorylation of GSK-3beta by endogenous AKT after stimulation with TNF-alpha",
              "citation": {
                "type": "PubMed",
                "name": "FASEB J 2002 Nov 16(13) 1732-7",
                "id": "12409315"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88ef"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "cardiomyocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "GSK3 inhibitors enhanced a transcriptional activity of ADD1/SREBP1c and expression of ADD1/SREBP1c target genes including fatty acid synthase (FAS), acetyl-CoA carboxylase 1 (ACC1), and steroyl-CoA desaturase 1 (SCD1) in adipocytes and hepatocytes",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Dec 10 279(50) 51999-2006",
                "id": "15466874"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88ee"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "hepatocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "whereas the phosphorylation at of Myc at Thr58 by GSK-3b targets Myc for ubiquitination and degradation [26,27]. Importantly, Ser62 must be phosphorylated before GSK-3b can phosphorylate Thr58, and phosphorylated Ser62 is dephosphorylated by phosphatase- 2A (PP2A) [11]. Dephosphorylation at Ser62 allows degradation to proceed by removing the stabilizing phosphate at Ser62.",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 2006 Oct 16 580(24) 5647-52",
                "id": "16996503"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88ed"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "Wnt-7a induces axonal remodelling by inhibiting glycogen synthase kinase-3 beta (GSK-3 beta), a serine/threonine kinase Inhibition of GSK-3 beta leads to a decrease in a phosphorylated form of microtubule-associated protein-1B (MAP-1B), a protein involved in microtubule assembly, and a concomitant decrease in the level of stable microtubules",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Soc Symp 1999 65 101-9",
                "id": "10320935"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88ec"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "other studies have indicated that Lkb1 downregulates the b-catenin pathway through either activation of GSK3a negative regulator of b-cateninor through diverting MARK2/ Par1a from its capacity to activate the pathway (Spicer et al., 2003; Lin-Marq et al., 2005).",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2008 Nov 24 27(55) 6908-19",
                "id": "19029933"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88eb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasm",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "Receptor-induced inhibition of GSK-3 allows beta-catenin to accumulate in the cytoplasm and then translocate to the nucleus where it promotes the transcription of genes such as c-myc and cyclin D1",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2002 Jul 15 169(2) 758-69",
                "id": "12097378"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88ea"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "Glycogen synthase kinase-3beta (GSK-3beta) regulates the Snail1 level by degrading Snail1 protein. ",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2007 Oct 12 362(1) 63-8",
                "id": "17692821"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88e9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "Our results support a simple model whereby PKA triggers a cascade of Gli3 phosphorylation by GSK3beta and CK1 that leads to direct betaTrCP binding and ubiquitination by SCFbetaTrCP.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2006 Jun 26(11) 4316-26",
                "id": "16705181"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88e8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": ", whereas no significant changes were observed in the total amount of this protein (Fig. 5, D and E). Therefore, the phosphorylation of p90rsk may be the link between ERK activation and GSK3{beta} phosphorylation. The stimulation of glycogen synthesis by insulin is triggered by the phosphorylation of GSK3{beta} at serine 9 and its concomitant inactivation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Oct 31 278(44) 42785-94",
                "id": "12925525"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88e7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "We report that phosphorylation-induced turnover of endogenous N-myc protein in CGNPs increases during mitosis, due to increased priming phosphorylation of N-myc for GSK-3beta. The priming phosphorylation requires the Cdk1 complex, whose cyclin subunits are indirect Sonic hedgehog targets",
              "citation": {
                "type": "PubMed",
                "name": "Dev Cell 2005 Sep 9(3) 327-38",
                "id": "16139224"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88e6"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "Cdk2 activity is required for cyclin E turnover in vivo because it phosphorylates S384; that phosphorylation of T380 in vivo does not require Cdk2 and is mediated primarily by GSK3; and that two additional phosphorylation sites, T62 and S372, are also required for turnover",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2003 Aug 12(2) 381-92",
                "id": "14536078"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88e5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "Both methacholine and PDGF induced significant GSK-3beta phosphorylation, but with different kinetics, since only the PDGF response was sustained after 4 h of treatment (Fig. 2).",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2007 Nov 293(5) L1348-58",
                "id": "17873004"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88e4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "Glycogen synthase kinase-3 phosphorylates Ser-434, and the phosphorylation of this residue is attenuated in response to insulin signaling. Interestingly, phosphorylation of Ser-434 promotes the glycogen synthase kinase-3-dependent phosphorylation of Thr-426 and Ser-430 and destabilizes SREBP1. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2009 Feb 27 284(9) 5885-95",
                "id": "19126544"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88e3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "Phosphorylation of MCL-1 by GSK3b induces ubiquitinylation and subsequent degradation of this anti-apoptotic Bcl-2 protein,92,9",
              "citation": {
                "type": "PubMed",
                "name": "Circ J 2009 Jul 73(7) 1184-92",
                "id": "19506320"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88e2"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "AKT was shown to phosphorylate and inactivate GSK3, thereby activating the nuclear translocation of NFAT",
              "citation": {
                "type": "PubMed",
                "name": "Mol Immunol 2002 Jun 38(15) 1087-99",
                "id": "12044776"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88e1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "beta-catenin degradation is initiated upon amino-terminal serine/threonine phosphorylation, which is believed to be performed by glycogen synthase kinase-3 (GSK-3) in complex with tumor suppressor proteins Axin and adnomatous polyposis coli (APC)",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2002 Mar 22 108(6) 837-47",
                "id": "11955436"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88e0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "8861947;14536078",
              "citation": {
                "type": "PubMed",
                "name": "BMC Bioinformatics 2004 Jun 22 5 79",
                "id": "15212693"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88df"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "engagement of CC chemokine receptor 9 (CCR9) with thymus-expressed CC chemokine leads to phosphorylation of AKT, GSK3 and FKHR, thereby blocking CHX induced apoptosis",
              "citation": {
                "type": "PubMed",
                "name": "Mol Immunol 2002 Jun 38(15) 1087-99",
                "id": "12044776"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88de"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 2003 Feb 15 116(Pt 4) 637-46",
                "id": "12538764"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88dd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Dec 26 278(52) 52432-6",
                "id": "14561750"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88dc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "down-regulation of the sarcoplasmic reticulum calcium ATPase (SERCA2a) by GSK-3beta, acting at the level of the SERCA2 promoter",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 May 14 279(20) 21383-93",
                "id": "15020584"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88db"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "AKTactivates cell proliferation by inactivating p27 (Fujita et al., 2002) and inhibiting glycogen synthase kinase 3 (GSK3)- mediated Myc and cyclin D1 inhibition (Vivanco and Sawyers, 2002).",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2008 Sep 18 27(41) 5527-41",
                "id": "18794886"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88da"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasm",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "showed that CK2 does not phosphorylate all sites in PTEN and that glycogen synthase kinase 3beta (GSK3beta) also participates in PTEN phosphorylation. Although CK2 mainly phosphorylated PTEN at Ser-370 and Ser-385, GSK3beta phosphorylated Ser-362 and Thr-366.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Oct 21 280(42) 35195-202",
                "id": "16107342"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88d9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "The central player in the canonical WNTpathway is ?-catenin (?-Cat). In the absence of secreted WNT proteins (which are ligands), ?-Cat is found in a complex with the tumour-suppressor molecule adenomatous polyposis coli (APC), the scaffold protein axin and glycogen-synthase kinase-3? (GSK3?). ?he latter phosphorylates ?-Cat, targeting it for degradation.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2003 Oct 3(10) 756-67",
                "id": "14570040"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88d8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "Indeed, GSK-3beta phosphorylated Nrf2 in vitro and in vivo",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 May 26 281(21) 14841-51",
                "id": "16551619"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88d7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "kaof(WNT)^kaof(Frizzled Family Hs); subprocessOf; Wnt_receptor_signaling_pathway kaof(Frizzled Family Hs)^kaof(Dishevelled Family Hs); subprocessOf; Wnt_receptor_signaling_pathway kaof(Dishevelled Family Hs)^kaof(GSK3B); subprocessOf; Wnt_receptor_signaling_pathway",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2002 May 2(5) 331-41",
                "id": "12044009"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88d6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "Analyses of Cdc42 signaling in microvascular ECs indicated that active Cdc42 also inhibits glycogen synthase kinase-3b (GSK-3b), a multi-functional serine/threonine protein kinase. ",
              "citation": {
                "type": "PubMed",
                "name": "Microvasc Res 2011 Jan 81(1) 34-43",
                "id": "20849862"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88d5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium"
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Feb 24(4) 1493-504",
                "id": "14749367"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88d4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "Differential transcriptional regulation of EGR-1 and Smad3/4 by GSK-3 isoforms was also confirmed using isoform-specific siRNA and dominant negative mutants in human neuroblastoma SH-SY5Y cells (Fig. 4C) and further suggests that the opposite effects of these two isoforms in regulating transcription factors are not unique to cortical neurons.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Oct 13 281(41) 30479-84",
                "id": "16912034"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88d3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "neuroblastoma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "The DYRK isoforms also phosphorylate human microtubule-associated protein tau at Thr(212) in vitro, a residue that is phosphorylated in foetal tau and hyperphosphorylated in filamentous tau from Alzheimer's-disease brain. Phosphorylation of Thr(212) primes tau for phosphorylation by GSK3 at Ser(208) in vitro, suggesting a more general role for DYRK isoforms in priming phosphorylation of GSK3 substrates.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2001 May 1 355(Pt 3) 609-15",
                "id": "11311121"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88d2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "Furthermore, Wnt-3A overexpression results in decreases in both N-cadherin and GSK-3beta protein levels, whereas Wnt-3A as well as kinase-dead GSK-3beta overexpression increase total and nuclear levels of both beta-catenin and LEF-1.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Aug 23 277(34) 30870-8",
                "id": "12077113"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88d1"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "The phosphatidylinositol 3-kinase (PI 3-kinase)/Akt signaling pathway is an important mediator of growth factor-dependent survival of mammalian cells. A variety of targets of the Akt protein kinase have been implicated in cell survival, including the protein kinase glycogen synthase kinase 3beta (GSK-3beta).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2002 Jan 22(2) 578-86",
                "id": "11756553"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88d0"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "14-3-3 enhances the binding of tau with Ser(9)-phosphorylated GSK3beta by approximately 3-fold but not with GSK3beta (S9A). Similarly, 14-3-3 stimulates phosphorylation of tau by Ser(9)-phosphorylated GSK3beta but not by GSK3beta (S9A).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jun 18 279(25) 26105-14",
                "id": "15073173"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88cf"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "NGF-mediated regulation of MAP1B phosphorylation in growing neurites by the induction of a novel isoform of GSK3beta.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 2001 Dec 114(Pt 23) 4273-84",
                "id": "11739659"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88ce"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "Axam inhibited the complex formation of Dvl with Axin and the activity of Dvl to suppress GSK-3beta-dependent phosphorylation of Axin.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Nov 24 275(47) 37030-7",
                "id": "10944533"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88cd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "In the absence of GSK3beta-mediated phosphorylation, BMAL1 becomes stabilized and BMAL1 dependent circadian gene expression is dampened. ",
              "citation": {
                "type": "PubMed",
                "name": "PLoS One 2010 5(1) e8561",
                "id": "20049328"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88cc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "Here, we demonstrate that these two proteins and the fruit fly protein are phosphorylated on tyrosine in vivo. Moreover, GSK-3 beta activity and function are shown to be dependent on tyrosine phosphorylation.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1993 Feb 12(2) 803-8",
                "id": "8382613"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88cb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "The recruitment of Axin to the plasma membrane- associated LRP5/6 co-receptor of Fz1 has been shown to be mediated by a rapid phosphorylation of LRP5/6 by CK1y as well as by GSK3b  ",
              "citation": {
                "type": "PubMed",
                "name": "J Mol Signal 2007 2 11",
                "id": "17961224"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88ca"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "We demonstrate that Fyn-Cdk5 complex acts as a downstream mediator of Sema3A signaling cascades that induce growth cone collapse. In addition, the sequential phosphorylation of CRMP2 by Cdk5 and GSK3beta is an important process of Sema3A signaling.",
              "citation": {
                "type": "PubMed",
                "name": "Nihon Shinkei Seishin Yakurigaku Zasshi 2006 Jun 26(3) 135-40",
                "id": "16866215"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88c9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2004 Nov 11 23(53) 8571-80",
                "id": "15467756"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88c8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "##from text## p70S6Ks down-regulates the activity of GSK3beta by phosphorylating Ser9 residue [33].",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cancer 2009 8 44",
                "id": "19575820"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88c7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "In addition, we observed that GSK-3beta binds exclusively to GATA-6 and inhibits its promoter activity but not to GATA-2 neither IRF-1 (Fig. 5C and D). ",
              "citation": {
                "type": "PubMed",
                "name": "Atherosclerosis 2010 Nov 213(1) 115-21",
                "id": "20864106"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88c6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "Furthermore, the expression levels of GSK-3 beta, the kinase that phosphorylates beta-catenin and signals its degradation, were up-regulated in WT1-transfected cells.",
              "citation": {
                "type": "PubMed",
                "name": "Anticancer Res 23(5A) 3575-84",
                "id": "14666652"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88c5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "Analysis of the effects of inhibitors of the protein kinase glycogen synthase kinase-3beta and in vitro phosphorylation/dephosphorylation analysis of Ets1 suggest that glycogen synthase kinase-3beta-phosphorylated Ets1 is a target of AML1-recruited CN phosphatase at the GM-CSF promoter.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jul 9 279(28) 29398-408",
                "id": "15123671"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88c4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "Epidermal growth factor (EGF), insulin-like growth factor 1 (IGF1) and phorbol myristate acetate (PMA) induce the inhibition of glycogen synthase kinase 3 (GSK3) by stimulating the phosphorylation of an N-terminal serine",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 1999 Nov 12 461(1-2) 120-4",
                "id": "10561508"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88c3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "In the Wnt-induced Fz-Lrp6 receptor complex Fz recruits Dvl through the PDZ domain, and Dvl, via its DIX domain and possibly multimerization (Schwarz-Romond et al., 2007a) recruits the axin-Gsk3 complex, thereby promoting Gsk3 phosphorylation of Lrp6 to initiate downstream signaling (Fig. 6).",
              "citation": {
                "type": "PubMed",
                "name": "Development 2008 Jan 135(2) 367-75",
                "id": "18077588"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88c2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "glycogen synthase kinase (GSK)-3beta is known to increase tau phosphorylation",
              "citation": {
                "type": "PubMed",
                "name": "J Neurosci 2001 Jul 15 21(14) 4987-95",
                "id": "11438574"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88c1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "GSK3 is inhibited by serine phosphorylation in response to insulin or growth factors and in vitro by either MAP kinase-activated protein (MAPKAP) kinase-1 (also known as p90rsk) or p70 ribosomal S6 kinase (p70S6k).",
              "citation": {
                "type": "PubMed",
                "name": "Nature 378(6559) 785-9",
                "id": "8524413"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88c0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "Figure 3A  regulation of B-catenin activity and TCF4 transcriptional activity.",
              "citation": {
                "type": "PubMed",
                "name": "Exp Mol Med 2006 Feb 28 38(1) 1-10",
                "id": "16520547"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88bf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "lithium chloride treatment or Wnt-1 overexpression that results in GSK-3 beta inhibition leads to the up-regulation of the Hes-1 promoter.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Aug 22 278(34) 32227-35",
                "id": "12794074"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88be"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "phosphorylation of GSK3beta  at Ser9, which results in its inactivation (10), was higher in [wnt3a overexpressing] than in control cells (Fig. 1, A and B).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 May 18 276(20) 17479-83",
                "id": "11278246"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88bd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "Phosphorylation of glycogen synthase kinase 3? (GSK3?), a downstream target of AKT, was also reduced in the cells treated with leflunomide.",
              "citation": {
                "type": "PubMed",
                "name": "Trends Immunol 2008 Oct 29(10) 493-501",
                "id": "18775670"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88bc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "mast cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "we found that caspase-2 activation and the subsequent apoptotic events were abolished by the GSK-3beta inhibitors lithium chloride and SB216763, and by GSK-3beta knockdown using short interfering RNA. ",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 2007 Aug 15 120(Pt 16) 2935-43",
                "id": "17666435"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88bb"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "results show that direct physical association with ceramide and PAR-4 regulates the activity of PKCzeta. They also indicate that this interaction regulates the activity of glycogen synthase kinase-3beta and NF-kappaB.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Jul 15 280(28) 26415-24",
                "id": "15901738"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88ba"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "Here it is shown that when beta-catenin is present in excess, APC binds to another component of the WINGLESS pathway, glycogen synthase kinase 3beta (GSK3beta), a mammalian homolog of Drosophila ZESTE WHITE 3.APC was a good substrate for GSK3 beta in vitro, and the phosphorylation sites were mapped to the central region of APC. Binding of beta-catenin to this region was dependent on phosphorylation by GSK3 beta.",
              "citation": {
                "type": "PubMed",
                "name": "Science 1996 May 17 272(5264) 1023-6",
                "id": "8638126"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88b9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "mall inhibitory RNA-induced silencing of GSK3beta prevents phosphorylation of MYC on T58, thereby inhibiting recognition of MYC by the E3 ubiquitin ligase component FBW7.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2005 Oct 18 102(42) 15195-200",
                "id": "16210249"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88b8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 1999 May 17 145(4) 699-711",
                "id": "10330400"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88b7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "colon epithelium",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "The phosphorylation of cyclin D1 at threonine 286 by glycogen synthase kinase 3beta (GSK3beta) has been shown to be required for the ubiquitination and nuclear export of cyclin D1 and its subsequent degradation in the proteasome",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jun 25 279(26) 27790-27798",
                "id": "15075324"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88b6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "Among these, the new natural product 6-bromoindirubin and its synthetic, cell-permeable derivative, 6-bromoindirubin-3'-oxime (BIO), display remarkable selective inhibition of glycogen synthase kinase-3 (GSK-3).  Cocrystal structure of GSK-3beta/BIO and CDK5/p25/indirubin-3'-oxime were resolved, providing a detailed view of indirubins' interactions within the ATP binding pocket of these kinases. ",
              "citation": {
                "type": "PubMed",
                "name": "Chem Biol 2003 Dec 10(12) 1255-66",
                "id": "14700633"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88b5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "Accordingly, transient transfection of HEK-293T cells by the canonical Wnt activators Dvl-2 and Axin 501-560 increased activity of the Topflash reporter 3- and 4- fold, as well as addition of LiCl, acting through GSK-3B inhibition (4.1 -fold activation of the TopFlash reporter, P<0.004).",
              "citation": {
                "type": "PubMed",
                "name": "FASEB J 2005 Jan 19(1) 144-6",
                "id": "15507471"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88b4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "Consistent with the inhibitory effect of phosphorylation at serine 21 and 9 on GSK-3 activation (9?12), 8-Br-cAMP, forskolin, or isoproterenol dramatically inhibited GSK-3 kinase activity as shown in in vitro kinase assays in Rat1 (Fig. 1A) and HEK293 cells (data not shown).",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2000 Oct 24 97(22) 11960-5",
                "id": "11035810"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88b3"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "However, NF-kappaB DNA binding activity is reduced in GSK-3beta null cells and in cells treated with a pharmacological inhibitor of GSK-3.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2005 Oct 25(19) 8444-55",
                "id": "16166627"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88b2"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "The phosphorylation of serine 9 results in autoinhibition of GSK3B",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Nov 1 277(44) 41888-96",
                "id": "12167628"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88b1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Nov 26 279(48) 50176-80",
                "id": "15466863"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88b0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "One such substrate is the epsilon-subunit of rat eukaryotic protein-synthesis initiation factor 2B (eIF2Bepsilon), which is inhibited by the GSK3-catalysed phosphorylation of Ser(535).",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2001 May 1 355(Pt 3) 609-15",
                "id": "11311121"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88af"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "PDK1 then activates protein kinase B (PKB) which, in turn, inactivates glycogen synthase kinase-3 (GSK3), leading to the dephosphorylation and activation of glycogen synthase and hence to an acceleration of glycogen synthesis",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 1997 Jun 23 410(1) 3-10",
                "id": "9247112"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88ae"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "Pretreatment with lithium, a selective inhibitor of GSK3? (2124), or a structurally dissimilar inhibitor of GSK3?, sodium valproate (25), reduced the camptothecin-induced increases in p21,",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2002 Jun 11 99(12) 7951-5",
                "id": "12048243"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88ad"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "Nevertheless, these findings support the notion that inactivation of GSK-3? by phosphorylation at Ser9 is a common mechanism of protection of cardiomyocytes against necrosis",
              "citation": {
                "type": "PubMed",
                "name": "Circ J 2009 Jul 73(7) 1184-92",
                "id": "19506320"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88ac"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "cardiomyocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Nat Struct Mol Biol 2005 Nov 12(11) 987-93",
                "id": "16244663"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88ab"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "once Akt1 is activated, it initiates a cascade of phosphorylation events targeting mammalian target of rapamycin, mTOR, which in turn phosphorylates the p70S6 kinase and GSK3B",
              "citation": {
                "type": "PubMed",
                "name": "Sci STKE 2004 Aug 3 2004(244) re11",
                "id": "15292521"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88aa"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1998 Dec 18(12) 7216-24",
                "id": "9819408"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88a9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "The ability of glycogen synthase kinase-3 (GSK-3) to phosphorylate insulin receptor substrate-1 (IRS-1) is a potential inhibitory mechanism for insulin resistance in type 2 diabetes.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Feb 11 280(6) 4422-8",
                "id": "15574412"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88a8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 May 12 275(19) 14466-75",
                "id": "10799529"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88a7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "These data suggest that stimulation of glycogen synthase by insulin in HepG2 cells is mediated through the PI-3 kinase pathway by activating PKB and PP-1G and inactivating GSK-3beta.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biochem 2000 Aug 211(1-2) 123-36",
                "id": "11055555"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88a6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "PKB also plays an important role in the stimulaiton of glycogen synthase by insulin via the phosphoryaltion and inactivation of glycogen synthase kinase-3",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Sep 13 277(37) 33895-900",
                "id": "12107176"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88a5"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Adipocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Nat Genet 2004 Feb 36(2) 131-7",
                "id": "14745448"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88a4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "Here we report that glycogen synthase kinase 3 (GSK-3) is capable of phosphorylating IRS-1 and that this modification converts IRS-1 into an inhibitor of IR tyrosine kinase activity in vitro.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 1997 Sep 2 94(18) 9660-4",
                "id": "9275179"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88a3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2001 Jun 1 61(11) 4329-32",
                "id": "11389054"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88a2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": " As shown in Figure 4D, the inhibitory phosphorylation of GSK-3B at Ser9 and Akt was reduced in SW620-NDRG2 cell line, which activated the kinase activity of GSK-3B and induced the degradation of B-catenin protein. The effect of NDRG2 on TCF/B-catenin signaling was verified by RT-PCR analysis of TCF/LEF target genes. Cyclin D1 and fibronectin are known to have TCF-/LEF-binding sites in their promoter regions and their transcription was decreased by NDRG2 expression",
              "citation": {
                "type": "PubMed",
                "name": "Carcinogenesis 2009 Apr 30(4) 598-605",
                "id": "19237607"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88a1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "beta-catenin ubiquitination is preceded by phosphorylation of its N-terminal region by the glycogen synthase kinase-3beta (GSK-3beta)/Axin kinase complex.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1999 May 4 18(9) 2401-10",
                "id": "10228155"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88a0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "from full text Results - From the data of Figure 5G, it is apparent that the lack of Par-4 leads to increased levels of phospho- Akt-Thr308, phospho-GSK3b and phospho-FOXO3",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2008 Jul 24",
                "id": "18650932"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad889f"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "# Pubmed:gene: A-kinase anchoring protein AKAP220 binds to glycogen synthase kinase-3beta (GSK-3beta ) and mediates protein kinase A-dependent inhibition of GSK-3beta. # Ariadne: Therefore, AKAP220 may associate with  PKA selectively among the GSK-3eta upstream molecules and enhance the signaling  between PKA and GSK-3eta. [Regulation]",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Oct 4 277(40) 36955-61",
                "id": "12147701"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad889e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "Serine-33 and -37 of beta-catenin are GSK3 phosphorylation sites that serve as recognition sites for the beta-TRCP-ubiquitin ligase complex, which ultimately triggers beta-catenin degradation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biochem (Tokyo) 2002 Nov 132(5) 697-703",
                "id": "12417018"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad889d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "Non-sequestered, free beta-catenin and gamma-catenin are rapidly phosphorylated by glycogen synthase kinase 3beta (GSK-3beta) in the adenomatous polyposis coli (APC)-axin-GSK-3beta complex and are subsequently degraded by the ubiquitin-proteasome pathway.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2004 Feb 4(2) 118-32",
                "id": "14964308"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad889c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "We show that GSK3beta autophosphorylates Y216 as a chaperone-dependent transitional intermediate possessing intramolecular tyrosine kinase activity and displaying different sensitivity to small-molecule inhibitors compared to mature GSK3beta.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2006 Nov 17 24(4) 627-33",
                "id": "17188038"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad889b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2005 Jul 12 102(28) 9766-71",
                "id": "15985551"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad889a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Sep 13 277(37) 33690-7",
                "id": "12093801"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8899"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "Axin, a negative regulator of Wnt, forms a complex with glycogen synthase kinase 3beta, beta-catenin, and adenomatous polyposis coli and promotes GSK3beta-dependent phosphorylation of beta-catenin, thereby stimulating degradation of the beta-catenin",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2004 Apr 30 317(2) 478-83",
                "id": "15063782"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8898"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 1999 Nov 12 461(1-2) 120-4",
                "id": "10561508"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8897"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "down-regulation of the sarcoplasmic reticulum calcium ATPase (SERCA2a) by GSK-3beta",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 May 14 279(20) 21383-93",
                "id": "15020584"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8896"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "Here we show by using small interfering technology in combination with immunoblot, gene expression analysis, and luciferase reporter assays that silencing of GSK-3alpha or GSK-3beta results in the reduction of ERalpha levels and transcriptional activity in ERalpha-positive breast cancer cells. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Endocrinol 2007 Oct 21(10) 2427-39",
                "id": "17609434"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8895"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "Here, we show that serine 21 in GSK-3 alpha and serine 9 in GSK-3 beta are also physiological substrates of cAMP-dependent protein kinase A. Protein kinase A physically associates with, phosphorylates, and inactivates both isoforms of GSK-3",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2000 Oct 24 97(22) 11960-5",
                "id": "11035810"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8894"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "PKB triggers a network that positively regulates G1/S cell cycle progression through inactivation of GSK3-beta, leading to increased cyclin D1, and inhibition of Forkhead family transcription factors and the tumor suppressor tuberin (TSC2), leading to reduction of p27Kip1.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2(4) 339-45",
                "id": "12851486"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8893"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "Inactivation of glycogen synthase kinase-3 was seen in response to both NGF and EGF and this coincided with activation of eIF2B.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1998 Mar 6 273(10) 5536-41",
                "id": "9488678"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8892"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2005 Jul 12 102(28) 9907-12",
                "id": "15985552"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8891"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "Here, we show that serine 21 in GSK-3 alpha and serine 9 in GSK-3 beta are also physiological substrates of cAMP-dependent protein kinase A. Protein kinase A physically associates with, phosphorylates, and inactivates both isoforms of GSK-3",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2000 Oct 24 97(22) 11960-5",
                "id": "11035810"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8890"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2002 Jan 22 99(2) 907-12",
                "id": "11782539"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad888f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "Upon its activation downstream of PI(3)K, Akt phosphorylates and inactivates GSK-3, decreasing the rate of phosphorylation of glycogen synthase, thus increasing its activity state59.",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2001 Dec 13 414(6865) 799-806",
                "id": "11742412"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad888e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "Normally, cytoplasmic beta-catenin  associates with APC and axin and is continuously phosphorylated by GSK-3beta, marking it for proteasomal degradation. Wnt signaling is considered to prevent GSK-3beta from phosphorylating beta-catenin, thus causing its stabilization",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2002 May 1 16(9) 1066-76",
                "id": "12000790"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad888d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "Furthermore, inhibition of glycogen synthase kinase-3beta (GSK-3beta) by SB415286 induced expression of COX-2 mRNA and protein as well as the enzyme activity in the gastric cancer cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Feb 24 281(8) 4564-9",
                "id": "16371352"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad888c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Carcinoma of stomach",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "Our analysis of the signaling events occurring in response to mechanical stress indicated that phosphorylation of p38 and ERK1/2 MAP kinases, as well as GSK3-beta, is strongly stimulated within 5 minutes of induction of the stress in wild-type mice. The absence of melusin expression specifically reduced phosphorylation of GSK3-beta serine 9, but did not substantially affect phosphorylation of p38 and ERK 1/2.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Med 2003 Jan 9(1) 68-75",
                "id": "12496958"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad888b"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "GSK3 beta-binding protein blocked the activation of MEKK1 by GSK3 beta in human embryonic kidney 293 (HEK293) cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Apr 18 278(16) 13995-4001",
                "id": "12584189"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad888a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "Kinase activities of ERK1/2 and Akt as observed by the phosphorylation of Elk-1 (Fig. 1E) and GSK-3/ (Fig. 1F), respectively, were also enhanced strongly by silibinin pre-treatment as compared with UVB alone.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 May 27 280(21) 20375-83",
                "id": "15792956"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8889"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "The concomitant phosphatidylinositol 3-kinase/Akt activation and glycogen synthase kinase 3-beta phosphorylation induced the inhibition of the proteasomal degradation of beta-catenin.",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 2008 Sep 26 103(7) 694-701",
                "id": "18703780"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8888"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "We then investigated the convergence point of PTH/cAMP signaling and the canonical Wnt pathway. Western blotting demonstrated that GSK-3beta was rapidly phosphorylated at Ser(9) on treatment with PTH or forskolin, leading to its inactivation. Moreover, overexpression of a constitutively active mutant of GSK-3beta abolished the TCF-dependent transactivation induced by forskolin. ",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biochem 2008 May 1 104(1) 304-17",
                "id": "17990294"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8887"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Eur J Biochem 1980 Jun 107(2) 529-37",
                "id": "6772446"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8886"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Aug 15 278(33) 31277-85",
                "id": "12764143"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8885"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "Site-directed mutagenesis revealed that GSK-3 in vitro phosphorylated p21(Cip1) specifically at Thr-57 within the Cdk binding domain.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Mar 22 277(12) 9684-9",
                "id": "11779850"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8884"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Biochemistry 2004 Mar 16 43(10) 2906-14",
                "id": "15005626"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8883"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "recombinant GSK3b was capable of phosphorylating this residue in vitro, either with recombinant purified p52 as a substrate (Figure 5D) or with an immunoprecipitated GFP-p52 protein (Figure 5E).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2010 May 28 38(4) 524-38",
                "id": "20513428"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8882"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "We report here that a synthetic GSK-3 inhibitor, 6-bromoindirubin-3'-oxime (BIO)",
              "citation": {
                "type": "PubMed",
                "name": "Biomed Pharmacother 2010 Mar 4",
                "id": "20359857"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8881"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "Phosphorylation of GSK-3b on Ser9 results in its inactivation, an event that leads to dephosphorylation, and thereby activation, of eukaryotic initiation factor (eIF) 2B (Welsh et al. 1998).",
              "citation": {
                "type": "PubMed",
                "name": "Proc Nutr Soc 2004 May 63(2) 351-6",
                "id": "15294054"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8880"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Muscle, Skeletal"
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Oct 13 275(41) 32046-51",
                "id": "10884377"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad887f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "Additional studies using pharmacologic, biochemical, and genetic approaches reveal that GSK3 beta is a bona fide PRLr kinase that phosphorylates PRLr on Ser(349) and is required for the recognition of PRLr by beta Trcp, as well as for PRLr ubiquitination and degradation.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2008 Mar 1 68(5) 1354-61",
                "id": "18316598"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad887e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "carcinoma of breast",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "once Akt1 is activated, it initiates a cascade of phosphorylation events targeting mammalian target of rapamycin, mTOR, which in turn phosphorylates the p70S6 kinase and GSK3B",
              "citation": {
                "type": "PubMed",
                "name": "Sci STKE 2004 Aug 3 2004(244) re11",
                "id": "15292521"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad887d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Muscle, Skeletal"
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "We now demonstrate that the glycogen synthase kinase (GSK)-3beta-dependent phosphorylation of these residues in SREBP1 is enhanced in response to specific DNA binding.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Sep 1 281(35) 25278-86",
                "id": "16825193"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad887c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "Through a yeast two-hybrid screen, we identified the Wnt canonical pathway co-receptor protein low density lipoprotein receptor-related protein 6 (LRP6) as a GSK3-binding protein. The interaction between the C terminus of LRP6 and GSK3 was also confirmed by in vitro GST pull-down assays and in situ coimmunoprecipitation assays.  In vitro assays using immunoprecipitated proteins demonstrated that the C terminus of LRP6 significantly attenuated the activity of GSK3beta",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Feb 24 281(8) 4787-94",
                "id": "16365045"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad887b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 1999 Dec 9 266(1) 28-35",
                "id": "10581160"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad887a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "We show that Gadd45a not only directly associates with two components of the APC complex, namely protein phosphatase 2A (PP2A) and glycogen synthase kinase 3beta (GSK3beta) but also promotes GSK3beta dephosphorylation at Ser9, which is essential for GSK3beta activation, and resultant activation of the APC destruction complex.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2004 Mar 11 23(10) 1829-37",
                "id": "14647429"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8879"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "Moreover we show that HFz6 repressed Wnt-3a-induced canonical signaling when co-expressed with HFz1. HFz6 repressed the canonical Wnt cascade activated also by various Wnt signaling intracellular mediators such as Dishevelled-1, a stabilized beta-catenin(S33Y) mutant, and LiCl-mediated repression of glycogen synthase kinase-3beta activity.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Apr 9 279(15) 14879-88",
                "id": "14747478"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8878"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Sep 27 277(39) 36602-10",
                "id": "12140294"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8877"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "We show that Wnt induces sequential phosphorylation of LRP6 by GSK3 and casein kinase 1, and this dual phosphorylation promotes the engagement of LRP6 with the scaffolding protein Axin",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2005 Dec 8 438(7069) 873-7",
                "id": "16341017"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8876"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2000 Nov 16 19(48) 5444-52",
                "id": "11114721"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8875"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "b-catenin can be oncogenically activated not only by direct mutation but also by inactivation of APC. Alterations of the APC gene occur in 80% of the human colon cancers. In the absence of APC, b-catenin cannot be phosphorylated by Gsk3b, and it consequently accumulates and translocates into the nucleus",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2004 Mar 15 23(11) 2037-49",
                "id": "15021891"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8874"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Virol 2003 May 77(10) 5759-73",
                "id": "12719569"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8873"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "# Ariadne: In vivo inhibition of  GSK-3eta can be followed by examining phosphorylation of the microtubule- associated protein tau, which is phosphorylated by GSK-3eta in vivo at specific  sites recognized by the PHF-1 antibody ( 34 , 41 ). [Regulation]",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Sep 28 276(39) 36734-41",
                "id": "11473107"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8872"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "In mammals GSK3 is present in two isoforms, alpha and beta regulated by phosphorylation: phosphorylation of Ser9 in GSK3beta or Ser21 in GSK3alpha leads to inactivation while phosphorylation of Tyr216 in GSK3beta or Tyr279 in GSK3alpha leads to activation.",
              "citation": {
                "type": "PubMed",
                "name": "Neurosci Lett 2004 Aug 5 366(1) 67-70",
                "id": "15265592"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8871"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "GSK3 inhibitors enhanced a transcriptional activity of ADD1/SREBP1c and expression of ADD1/SREBP1c target genes including fatty acid synthase (FAS), acetyl-CoA carboxylase 1 (ACC1), and steroyl-CoA desaturase 1 (SCD1) in adipocytes and hepatocytes",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Dec 10 279(50) 51999-2006",
                "id": "15466874"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8870"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Adipocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "We report here that the remaining GR phosphorylation site, Thr171, is a target for glycogen synthase kinase-3 (GSK-3) in vitro and in cultured mammalian cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1998 Jun 5 273(23) 14315-21",
                "id": "9603939"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad886f"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "GSK-3beta inhibition reduced the Ser536 phosphorylation of nuclear factor (NF)-kappaB subunit p65",
              "citation": {
                "type": "PubMed",
                "name": "Novartis Found Symp 2007 280 128-42; discussion 142-6, 160-4",
                "id": "17380792"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad886e"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "GSK-3 also phosphorylates cyclin D1 to promote its nuclear export and subsequent degradation.",
              "citation": {
                "type": "PubMed",
                "name": "Prog Cell Cycle Res 2003 5 489-95",
                "id": "14593744"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad886d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "valproate directly inhibits the glycogen synthase kinases (GSK)-3alpha/beta. The ability of lithium, another inhibitor of GSK3alpha/beta to protect cells from ER stress-induced lipid accumulation suggests that GSK3 plays a central role in signaling downstream effects of ER stress",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 2005 Jan 1 118(Pt 1) 89-99",
                "id": "15585578"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad886c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2004 Nov 11 23(53) 8659-72",
                "id": "15467757"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad886b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "In these cells, insulin inhibition of GSK3 alpha and -beta requires dual phosphorylation by both Akt/PKB and PKC zeta",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Oct 5 276(40) 37109-19",
                "id": "11481324"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad886a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "FASEB J 2002 Dec 16(14) 1982-4",
                "id": "12397090"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8869"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "Taken together, the translocation of PDK-1 from cytosol to the plasma membrane is critical for Akt and GSK-3 activation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Oct 11 277(41) 38863-9",
                "id": "12147684"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8868"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "ILK overexpression can also inhibit GSK-3 activity (Delcommenne et al., 1998; Troussard et al., 1999) and also results in nuclear accumulation of beta-catenin (Novak et al., 1998). ",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2001 Jan 4 20(1) 133-40",
                "id": "11244511"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8867"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Jan 21 280(3) 2388-94",
                "id": "15537647"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8866"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "ANKRD6, NKD1 and NKD2 induce class switch from the WNT/GSK3beta signaling pathway to the WNT/PCP signaling pathway.",
              "citation": {
                "type": "PubMed",
                "name": "Oncol Rep 2005 Dec 14(6) 1583-8",
                "id": "16273260"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8865"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Dec 10 279(50) 51999-2006",
                "id": "15466874"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8864"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2002 Apr 18 21(17) 2721-8",
                "id": "11965545"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8863"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Neurochem 1996 Aug 67(2) 699-707",
                "id": "8764598"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8862"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "We further demonstrate that hydrogen peroxide phosphorylates tyrosine 216 of GSK-3beta. This leads to activation of GSK-3beta.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 Jun 1 282(22) 16502-10",
                "id": "17403689"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8861"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Feb 13 279(7) 5501-7",
                "id": "14660640"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8860"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "The accumulation of beta-catenin results from the inhibition of the GSK3b kinase, which normally would phosphorylate beta-catenin as a degradation signal.",
              "citation": {
                "type": "PubMed",
                "name": "Gene 2004 Jul 7 336(1) 1-13",
                "id": "15225871"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad885f"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "T212 and S214, two sites previously shown to be phosphorylated by glycogen synthase kinase 3beta (GSK3beta)",
              "citation": {
                "type": "PubMed",
                "name": "Neuroscience 2004 127(3) 649-58",
                "id": "15283964"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad885e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Oct 10 278(41) 39583-90",
                "id": "12871932"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad885d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "b-catenin can be oncogenically activated not only by direct mutation but also by inactivation of APC. Alterations of the APC gene occur in 80% of the human colon cancers. In the absence of APC, b-catenin cannot be phosphorylated by Gsk3b, and it consequently accumulates and translocates into the nucleus",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2004 Mar 15 23(11) 2037-49",
                "id": "15021891"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad885c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "Gli2 degradation is dependent on the phosphorylation of a cluster of four PKA sites as well as the PKA-primed phosphorylation of multiple adjacent CK1 and GSK3 sites within the Gli2 C-terminal region. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2006 May 26(9) 3365-77",
                "id": "16611981"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad885b"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "Additional studies using pharmacologic, biochemical, and genetic approaches reveal that GSK3 beta is a bona fide PRLr kinase that phosphorylates PRLr on Ser(349) and is required for the recognition of PRLr by beta Trcp, as well as for PRLr ubiquitination and degradation.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2008 Mar 1 68(5) 1354-61",
                "id": "18316598"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad885a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "GSK-3 is also inhibited when it is phosphorylated by Akt, a downstream target of phosphatidylinositol 3-kinase (PI3K)",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2002 Jul 15 169(2) 758-69",
                "id": "12097378"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8859"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "b-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "Consistent with the inhibitory effect of phosphorylation at serine 21 and 9 on GSK-3 activation (9?12), 8-Br-cAMP, forskolin, or isoproterenol dramatically inhibited GSK-3 kinase activity as shown in in vitro kinase assays in Rat1 (Fig. 1A) and HEK293 cells (data not shown).",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2000 Oct 24 97(22) 11960-5",
                "id": "11035810"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8858"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "Indeed, hamartin and tuberin co-immunoprecipitated with glycogen synthase kinase 3 beta and Axin, components of this complex in a Wnt-1-dependent manner. Our data suggest that hamartin and tuberin negatively regulate beta-catenin stability and activity by participating in the beta-catenin degradation complex.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Feb 21 278(8) 5947-51",
                "id": "12511557"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8857"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Mar 25 280(12) 11740-8",
                "id": "15647282"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8856"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Jul 18 278(29) 26970-5",
                "id": "12714590"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8855"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "Inhibition of GSK-3 activity by its known inhibitor LiCl rapidly induced GSK-3 phosphorylation and decreased -catenin phosphorylation, resulting in increased translocation of -catenin to the nucleus (Fig. 6B, C) and increased COX-2 expression (Fig. 6D).",
              "citation": {
                "type": "PubMed",
                "name": "FASEB J 2007 Jun 21(8) 1831-43",
                "id": "17317723"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8854"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "UV transiently increased GSK-3beta activity, and this increase could be blocked by caffeine or by ATR small interfering RNA, indicating ATR-dependent activation of GSK-3beta.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2007 Apr 27(8) 3187-98",
                "id": "17283049"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8853"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "Phosphorylation of Thr-308 correlates with the activation of PKB, whereas phosphorylation of GSK3b on Ser-9, GSK3a on Ser-21 and FKHR-L1 on Thr-32 is indicative of inhibition of these PKB substrates",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2002 Jul 15 365(Pt 2) 537-45",
                "id": "11942857"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8852"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "Carcinoma of liver",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "phosphorylated tau is a strong candidate for a toxic molecule, particularly those isoforms phosphorylated by the kinases glycogen synthase kinase 3beta and Cdk5. Here we show that Alzheimer tau binds to Hsc70, and its phosphorylation is a recognition requirement for the addition of ubiquitin (Ub) by the E3 Ub ligase CHIP (carboxyl terminus of the Hsc70-interacting protein) and the E2 conjugating enzyme UbcH5B.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Feb 6 279(6) 4869-76",
                "id": "14612456"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8851"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "beta-Catenin is efficiently phosphorylated by glycogen synthase kinase-3beta in the Axin complex in the cytoplasm, resulting in the down-regulation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Oct 20 275(42) 32871-8",
                "id": "10921920"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8850"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Sep 23 280(38) 33006-14",
                "id": "16076840"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad884f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "Here we show that physiological concentrations of zinc ions directly inhibit GSK-3beta in vitro in an uncompetitive manner. ",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2002 Jul 5 295(1) 102-6",
                "id": "12083774"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad884e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "Analysis of the human gal-3 sequence reveled a structural similarity to beta-catenin as it also contains the consensus sequence (S92XXXS96) for glycogen synthase kinase-3beta (GSK-3beta) phosphorylation and can serve as its substrate.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2005 May 1 65(9) 3535-7",
                "id": "15867344"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad884d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "from full text - Figure 1 ",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2006 Jul 35(1) 3-9",
                "id": "16484682"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad884c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:GSK3B) actsIn kin(p(HGNC:GSK3B))",
              "summary_text": "Its activity is inhibited by phosphorylation of the Ser9 residue and up-regulated by Tyr216 phosphorylation. Activated GSK-3beta increases phosphorylation of tau protein and induces cell death in a variety of cultured neurons, whereas phosphorylation of phosphatidylinositol-3 (PI-3) kinase-dependent protein kinase B (Akt), which inhibits GSK-3beta activity, is one of the best characterized cell survival signaling pathways",
              "citation": {
                "type": "PubMed",
                "name": "J Neurochem 2005 Oct 95(1) 263-72",
                "id": "16181430"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad884b"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "neuron",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:MAPK13))",
        "relation": "directlyIncreases",
        "target": "p(HGNC:NFE2L2,pmod(P,S))",
        "directed": false,
        "label": "kin(p(HGNC:MAPK13)) directlyIncreases p(HGNC:NFE2L2,pmod(P,S))",
        "metadata": {
          "casual": true,
          "createdBy": "Jamboree2014",
          "edgeId": "55775dd92f9e241f18ad8ddd",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:MAPK13)) directlyIncreases p(HGNC:NFE2L2,pmod(P,S))",
              "summary_text": "As shown in Fig. 6A , stimulation of all p38 MAPK isoforms by anisomycin strongly phosphorylated Nrf2 protein (lanes 2-5), whereas no phosphorylation was detected in the control immunoprecipitates (lane 1)...HeLa cells were stimulated with anisomycin (10 _g/mL) for 30 minutes and FLAG-p38 MAPK isoforms were immunoprecipitated using agarose-conjugated anti-FLAG M2 monoclonal antibody. Purified GST-Nrf2 protein was immunoprecipitated with FLAG-p38 MAPK isoforms and was incubated with 32P-labeled ATP in the presence of the precipitated p38 MAPK isoforms. Phosphorylation of Nrf2 protein by activated p38 MAPK isoforms was visualized by autoradiography.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "16951197"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8cc0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "HeLa",
                "tissue": ""
              }
            },
            {
              "bel_statement": "kin(p(HGNC:MAPK13)) directlyIncreases p(HGNC:NFE2L2,pmod(P,S))",
              "summary_text": "As shown in Fig. 6A , stimulation of all p38 MAPK isoforms by anisomycin strongly phosphorylated Nrf2 protein (lanes 2-5), whereas no phosphorylation was detected in the control immunoprecipitates (lane 1)...HeLa cells were stimulated with anisomycin (10",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "16951197"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88ff"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "kin(p(HGNC:MAPK13)) directlyIncreases p(HGNC:NFE2L2,pmod(P,S))",
              "summary_text": "As shown in Fig. 6A  , stimulation of all p38 MAPK isoforms by anisomycin strongly phosphorylated Nrf2 protein (lanes 2-5), whereas no phosphorylation was detected in the control immunoprecipitates (lane 1). ",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2006 Sep 1 66(17) 8804-13",
                "id": "16951197"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad88fe"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:NFE2L2)",
        "relation": "hasModification",
        "target": "p(HGNC:NFE2L2,pmod(P,S))",
        "directed": false,
        "label": "p(HGNC:NFE2L2) hasModification p(HGNC:NFE2L2,pmod(P,S))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8dde",
          "evidences": [
            {
              "bel_statement": "p(HGNC:NFE2L2) hasModification p(HGNC:NFE2L2,pmod(P,S))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8900"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "a(CHEBI:heme)",
        "relation": "directlyDecreases",
        "target": "tscript(p(HGNC:BACH1))",
        "directed": false,
        "label": "a(CHEBI:heme) directlyDecreases tscript(p(HGNC:BACH1))",
        "metadata": {
          "casual": true,
          "createdBy": "Jamboree2014",
          "edgeId": "55775dd92f9e241f18ad8ddf",
          "evidences": [
            {
              "bel_statement": "a(CHEBI:heme) directlyDecreases tscript(p(HGNC:BACH1))",
              "summary_text": "Using chromatin immunoprecipitation assays in NIH 3T3 cells, we show that heme, an inducer of ho-1, promotes displacement of Bach1 from the MafK-occupied ho-1 enhancers, which is followed by Nrf2 binding to these elements. ",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2004 Feb 10 101(6) 1461-6",
                "id": "14747657"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8904"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "a(CHEBI:heme) directlyDecreases tscript(p(HGNC:BACH1))",
              "summary_text": "Using chromatin immunoprecipitation assays in NIH 3T3 cells, we show that heme, an inducer of ho-1, promotes displacement of Bach1 from the MafK-occupied ho-1 enhancers, which is followed by Nrf2 binding to these elements.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "14747657"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8903"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "NIH 3T3 cell line",
                "tissue": ""
              }
            },
            {
              "bel_statement": "a(CHEBI:heme) directlyDecreases tscript(p(HGNC:BACH1))",
              "summary_text": "The DNA-binding activity of Bach1 as a MafK hetero-oligomer was markedly inhibited by heme in gel mobility shift assays. The repressor activity of Bach1 was lost upon addition of hemin in transfected cells. These results suggest that increased levels of heme inactivate the repressor Bach1, resulting in induction of a host of genes with MARES:",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2001 Jun 1 20(11) 2835-43",
                "id": "11387216"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8902"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "a(CHEBI:heme) directlyDecreases tscript(p(HGNC:BACH1))",
              "summary_text": "Using chromatin immunoprecipitation assays in NIH 3T3 cells, we show that heme, an inducer of ho-1, promotes displacement of Bach1 from the MafK-occupied ho-1 enhancers, which is followed by Nrf2 binding to these elements.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "14747657"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8901"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:MAPK14))",
        "relation": "directlyIncreases",
        "target": "p(HGNC:NFE2L2,pmod(P,S))",
        "directed": false,
        "label": "kin(p(HGNC:MAPK14)) directlyIncreases p(HGNC:NFE2L2,pmod(P,S))",
        "metadata": {
          "casual": true,
          "createdBy": "Jamboree2014",
          "edgeId": "55775dd92f9e241f18ad8de0",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:MAPK14)) directlyIncreases p(HGNC:NFE2L2,pmod(P,S))",
              "summary_text": "As shown in Fig. 6A , stimulation of all p38 MAPK isoforms by anisomycin strongly phosphorylated Nrf2 protein (lanes 2-5), whereas no phosphorylation was detected in the control immunoprecipitates (lane 1)...HeLa cells were stimulated with anisomycin (10 _g/mL) for 30 minutes and FLAG-p38 MAPK isoforms were immunoprecipitated using agarose-conjugated anti-FLAG M2 monoclonal antibody. Purified GST-Nrf2 protein was immunoprecipitated with FLAG-p38 MAPK isoforms and was incubated with 32P-labeled ATP in the presence of the precipitated p38 MAPK isoforms. Phosphorylation of Nrf2 protein by activated p38 MAPK isoforms was visualized by autoradiography.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "16951197"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8cc1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "HeLa",
                "tissue": ""
              }
            },
            {
              "bel_statement": "kin(p(HGNC:MAPK14)) directlyIncreases p(HGNC:NFE2L2,pmod(P,S))",
              "summary_text": "As shown in Fig. 6A , stimulation of all p38 MAPK isoforms by anisomycin strongly phosphorylated Nrf2 protein (lanes 2-5), whereas no phosphorylation was detected in the control immunoprecipitates (lane 1)...HeLa cells were stimulated with anisomycin (10",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "16951197"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8906"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "kin(p(HGNC:MAPK14)) directlyIncreases p(HGNC:NFE2L2,pmod(P,S))",
              "summary_text": "As shown in Fig. 6A  , stimulation of all p38 MAPK isoforms by anisomycin strongly phosphorylated Nrf2 protein (lanes 2-5), whereas no phosphorylation was detected in the control immunoprecipitates (lane 1). ",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2006 Sep 1 66(17) 8804-13",
                "id": "16951197"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8905"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:MAPK14)",
        "relation": "actsIn",
        "target": "kin(p(HGNC:MAPK14))",
        "directed": false,
        "label": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8de1",
          "evidences": [
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "o clarify the intracellular downstream signaling cascades of alpha -synuclein, we measured the activity of endogenous mitogen-activated protein kinases, such as extracellular signal-regulated protein kinase (ERK), c-Jun N-terminal kinase (JNK), and p38 kinase. When 10 M alpha -synuclein was added, a significant increase of JNK (Fig. 1B) and a lower but marked activation of ERK and p38 activity (data not shown) were observed using anti-phospho-ERK, anti-phospho-JNK, and anti-active p38 antibodies. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Jul 20 276(29) 27441-8",
                "id": "11316809"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8cec"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "However, SB203580 pretreatment only inhibited p38 MAPK activation and had no effect on Akt activation (Fig. 2C, lane 5). These data indicated that the activation of p38 MAPK by CO is PI3K/Akt-dependent. We next tested whether CO modulated STAT1 and STAT3 via PI3K/Akt and p38 MAPK pathways. We pretreated PAEC with SB203580 and observed that CO can no longer modulate STAT1 or STAT3 activation (Fig. 2D, lane 5). Consistent with our data that PI3K/Akt activation is upstream of p38 MAPK activation by CO during A-R (Fig. 2C), when we blocked the PI3K/Akt pathway with LY294002, CO lost its ability to decrease STAT1 and increase STAT3 activation during A-R (Fig. 2D, lane 4). These data demonstrated that the opposing effect of CO on STAT1 and STAT3 activation is dependent upon PI3K/Akt and p38 MAPK pathways. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Mar 11 280(10) 8714-21",
                "id": "15590660"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8ceb"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Hsp27 effectively protected the cells from cisplatin-induced DNA fragmentation. The p38 inhibitors obviously decreased whereas Akt inhibitors markedly increased the apoptotic fraction in cisplatin-treated cells. Overexpression of Hsp27 doubly enhanced the drug-induced Akt activation while substantially depressing the drug-induced activation of ASK1 and p38. Hsp27 endues cells with cisplatin resistance via depression of the drug-induced ASK1/p38 activation and enhancement of the drug-induced Akt activation.",
              "citation": {
                "type": "PubMed",
                "name": "Clin Cancer Res 2007 May 15 13(10) 2855-64",
                "id": "17504983"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8cea"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Extracellular signal-regulated kinase (ERK) is critical for the expression of immediate-early genes in the striatum in response to cocaine and Delta9-tetrahydrocannabinol and for the rewarding properties of these drugs. Here we show that in mice a single injection of cocaine (10 mg/kg) activates mitogen- and stress-activated protein kinase 1 (MSK1) in dorsal striatum and nucleus accumbens. Cocaine-induced phosphorylation of MSK1 threonine 581 and cAMP response element-binding protein (CREB) serine 133 (Ser133) were blocked by SL327, a drug that prevents ERK activation. C",
              "citation": {
                "type": "PubMed",
                "name": "J Neurosci 2005 Dec 7 25(49) 11444-54",
                "id": "16339038"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8ce9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "3-Phosphoinositide- dependent protein kinase (PDK) 1 has been identified as a primary kinase that will phosphorylate Akt at Thr308. Kinases that activate Ser473 are known as PDK2, which include mitogen-activated protein kinase (MAPK)-activated protein kinase (PK)-2, integrin-linked kinase, p38 MAPK, PKCa, PKCbII, rictor-mTOR complex (mTORC2), double-stranded DNA-dependent PK, autophosphorylation, and ataxia telangiectasia- mutated gene product (Brazil et al., 2004; Manning and Cantley, 2007).",
              "citation": {
                "type": "PubMed",
                "name": "Dev Cell 2009 Dec 17(6) 800-10",
                "id": "20059950"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8ce8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Activation of RET, either by ligand or through specific mutations, results in phosphorylation of multiple tyrosine residues that, in turn, interact with specific adaptor molecules to trigger downstream signaling. Four of the tyrosines phosphorylated on RET activation, tyrosines 905, 1015, 1062, and 1096, have been well characterized, and are known to interact with a number of adaptor molecules to stimulate signaling through phosphatidylinositol kinase (PI3K)/AKT, PLC-gamma, RAS/extracellular signal-regulated kinase (ERK), p38MAPK, JNK and ERK5.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2004 Jul 1 64(13) 4453-63",
                "id": "15231654"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8ce7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "We next examined whether p38 was required for serine phosphorylation. MAEC were treated with LPS and/or IFN?, and SB202190 or PD98059 (50 ?M, 30 min) and extracts were analyzed by blotting with a phospho-Ser727-specific antibody. SB202190 (Fig. 7, A and B), but not PD98059 (data not shown), greatly attenuated STAT1? serine phosphorylation in response to IFN? alone and more dramatically in response to the combination of LPS and IFN?. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Pharmacol 2004 Aug 66(2) 302-11",
                "id": "15266021"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8ce6"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "To see the phosphorylation of MAPK by ETS, the control and ETS-exposed brain tissues were extracted and 100 mg proteins were analyzed by 10% SDS-PAGE and phosphorylated form of MAPK was detected by Western blot using anti-phospho-MAPK antibody. The result shown in Fig. 4B indicates that phosphorylated MAPK was increased in all the regions of the brain exposed to ETS as compared to control brain tissue. The same extracts were probed with anti- ERK antibody and the level of ERK was unchanged in all the lanes indicating equal loading of proteins as well as specificity of the phosphorylation of the MAPK because ERK also undergoes phoshorylation but through different signaling pathway [31]. These results therefore strongly suggest that ETS induces MAPK phosphorylation and that the level of phosphorylation was similar across all the regions of the brain. We next examined the effect of ETS on p38MAP kinase in various regions of the brain. We found that ETS induced the phosphorylation of the p38MAP kinase in all the regions of the brain examined without altering the levels of the p38 MAP kinase protein expression (Fig. 4C).",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Pharmacol 2006 May 28 71(11) 1602-9",
                "id": "16569398"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8ce5"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": "striatum"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Different agents activated the 5-LO kinase activities, including stimuli for cellular leukotriene biosynthesis (A23187, thapsigargin, N-formyl-leucyl-phenylalanine), compounds that up-regulate the capacity for leukotriene biosynthesis (phorbol 12-myristate 13-acetate, tumor necrosis factor alpha, granulocyte/macrophage colony-stimulating factor), and well known p38 stimuli as sodium arsenite and sorbitol. For all stimuli, 5-LO kinase activation was counteracted by SB203580 (3 microM or less), an inhibitor of p38 kinase",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2000 May 9 97(10) 5261-6",
                "id": "10779545"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8ce4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "leukocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Simultaneous overexpression of selenophosphate synthetase and phospholipid-hydroperoxide GSH peroxidase (PHGPx) [250] blocks activation of NF-kB by IL-1. Overexpression of SOD [84] or GSH peroxidase [81, 211] abolished NF-kB activation by preventing degradation of IkB after stimulation with TNF-a. The precise mechanism(s) through which oxidants and reductants influence activation of NF-kB is presently unknown; however, there is evidence that antioxidant enzyme (AOE372), a redox-sensitive thioredoxin peroxidase, regulates IkB phosphorylation [246]. Phosphatases The phosphatases are an important component of most signal transduction pathways, because failure to reverse kinase actions can disrupt normal cellular functions. For example, transfection of human fibroblasts with constitutively active ras (hRasV12) inhibits cell growth and ultimately results in a senescentlike phenotype [441]. Similarly, constitutive ERK activation has an inhibitory effect on cell cycle progression [442,443]. Both the serine/threonine phosphatases and the PTPs are known to be redox-sensitive [82,144,153,156,271,281, 444-449]. The mechanism of redox effects on activity is probably best understood for the PTPs. Without exception, the PTPs contain a highly conserved region of 11 amino acid residues in their catalytic domain; specifi- cally, (Ile/Val)-His-Cys-X-Ala-Gly-X-X-Arg-(Ser/Thr)- Gly, where X is a nonconserved amino acid [17]. Either oxidation or mutation of the cysteine renders these molecules inactive [17,281]. H2O2 is a potent inhibitor of PTPs. As in the case of other oxidants, H2O2 probably oxidizes the thiolate anion at the catalytic site [280]. Because formation of a phosphorylcysteine intermediate seems to be critical to PTP activity [450-452], blocking it through oxidation of the cysteine inactivates the molecules. In many cases, treatment of cells with H2O2 stimulates increases in protein phosphorylation by inhibiting phosphatase-catalyzed removal of phosphate groups. Furthermore, mitogens that increase cellular ox- idant production may stimulate phosphorylation indirectly by decreasing phosphatase activity. Additional mechanisms are involved in stimulation of pathways activated by growth factors that increase oxidant production, however, because there are known instances in which the oxidants they produce have no effect on protein phosphorylation. For example, TGF-b1 stimulates phosphorylation of numerous proteins and has been shown to cause a large increase in H2O2 production; however, its effects on protein phosphorylation are not blocked by catalase [453]. Furthermore, H2O2 is effective in promoting phosphorylation of phospholipase D, the PDGF receptor, and PKC-a even after pretreatment of Swiss 3T3 fibroblasts with orthovanadate to inhibit phosphatases [454]. Thus, although diminished phosphatase activity may partially account for increased phosphorylation in some cases, it cannot totally account for oxidation effects on phosphorylation in every case. SPECIFICITY In general, there is good agreement between studies on redox effects on any given gene; albeit, not all oxidizing or reducing treatments exert equivalent effects. This is clearly demonstrated in studies of pag , which encodes a protein associated with cellular proliferation. Pag protein inhibits the tyrosine kinase activity of the Abelson (abl ) protein by binding to its SH3-binding domain [455]. BSO, menadione, sodium arsenate, and diethyl maleate all stimulate pag expression, but H2O2 does not [269]. Conversely, H2O2 stimulates c-fos expression (Table 1), although 4-hydroynonenal (a product of v-6-polyunsaturated fatty acid peroxidation) not only fails to induce c-fos expression but is actually inhibitory to c-fos induction by EGF and PDGF [185]. Similarly, some oxidants such as diamide decrease hypoxia-induced signals [201], although others such as H2O2 increase them [124]. As might be expected, the effects of any stimu...",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2000 Feb 1 28(3) 463-99",
                "id": "10699758"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8ce3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "deliberate activation of endogenous p38 stimulates muscle differentiation even in the presence of antimyogenic cues. Much evidence indicates that p38 is an activator of MyoD: (i) p38 kinase activity is required for the expression of MyoD-responsive genes, (ii) enforced induction of p38 stimulates the transcriptional activity of a Gal4-MyoD fusion protein and allows efficient activation of chromatin-integrated reporters by MyoD, and (iii) MyoD-dependent myogenic conversion is reduced in mouse embryonic fibroblasts derived from p38alpha(-/-) embryos.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2000 Jun 20(11) 3951-64",
                "id": "10805738"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8ce2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Simultaneous overexpression of selenophosphate synthetase and phospholipid-hydroperoxide GSH peroxidase (PHGPx) [250] blocks activation of NF-kB by IL-1. Overexpression of SOD [84] or GSH peroxidase [81, 211] abolished NF-kB activation by preventing degradation of IkB after stimulation with TNF-a. The precise mechanism(s) through which oxidants and reductants influence activation of NF-kB is presently unknown; however, there is evidence that antioxidant enzyme (AOE372), a redox-sensitive thioredoxin peroxidase, regulates IkB phosphorylation [246]. Phosphatases The phosphatases are an important component of most signal transduction pathways, because failure to reverse kinase actions can disrupt normal cellular functions. For example, transfection of human fibroblasts with constitutively active ras (hRasV12) inhibits cell growth and ultimately results in a senescentlike phenotype [441]. Similarly, constitutive ERK activation has an inhibitory effect on cell cycle progression [442,443]. Both the serine/threonine phosphatases and the PTPs are known to be redox-sensitive [82,144,153,156,271,281, 444-449]. The mechanism of redox effects on activity is probably best understood for the PTPs. Without exception, the PTPs contain a highly conserved region of 11 amino acid residues in their catalytic domain; specifi- cally, (Ile/Val)-His-Cys-X-Ala-Gly-X-X-Arg-(Ser/Thr)- Gly, where X is a nonconserved amino acid [17]. Either oxidation or mutation of the cysteine renders these molecules inactive [17,281]. H2O2 is a potent inhibitor of PTPs. As in the case of other oxidants, H2O2 probably oxidizes the thiolate anion at the catalytic site [280]. Because formation of a phosphorylcysteine intermediate seems to be critical to PTP activity [450-452], blocking it through oxidation of the cysteine inactivates the molecules. In many cases, treatment of cells with H2O2 stimulates increases in protein phosphorylation by inhibiting phosphatase-catalyzed removal of phosphate groups. Furthermore, mitogens that increase cellular ox- idant production may stimulate phosphorylation indirectly by decreasing phosphatase activity. Additional mechanisms are involved in stimulation of pathways activated by growth factors that increase oxidant production, however, because there are known instances in which the oxidants they produce have no effect on protein phosphorylation. For example, TGF-b1 stimulates phosphorylation of numerous proteins and has been shown to cause a large increase in H2O2 production; however, its effects on protein phosphorylation are not blocked by catalase [453]. Furthermore, H2O2 is effective in promoting phosphorylation of phospholipase D, the PDGF receptor, and PKC-a even after pretreatment of Swiss 3T3 fibroblasts with orthovanadate to inhibit phosphatases [454]. Thus, although diminished phosphatase activity may partially account for increased phosphorylation in some cases, it cannot totally account for oxidation effects on phosphorylation in every case. SPECIFICITY In general, there is good agreement between studies on redox effects on any given gene; albeit, not all oxidizing or reducing treatments exert equivalent effects. This is clearly demonstrated in studies of pag , which encodes a protein associated with cellular proliferation. Pag protein inhibits the tyrosine kinase activity of the Abelson (abl ) protein by binding to its SH3-binding domain [455]. BSO, menadione, sodium arsenate, and diethyl maleate all stimulate pag expression, but H2O2 does not [269]. Conversely, H2O2 stimulates c-fos expression (Table 1), although 4-hydroynonenal (a product of v-6-polyunsaturated fatty acid peroxidation) not only fails to induce c-fos expression but is actually inhibitory to c-fos induction by EGF and PDGF [185]. Similarly, some oxidants such as diamide decrease hypoxia-induced signals [201], although others such as H2O2 increase them [124]. As might be expected, the effects of any stimu...",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2000 Feb 1 28(3) 463-99",
                "id": "10699758"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8ce1"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Simultaneous overexpression of selenophosphate synthetase and phospholipid-hydroperoxide GSH peroxidase (PHGPx) [250] blocks activation of NF-kB by IL-1. Overexpression of SOD [84] or GSH peroxidase [81, 211] abolished NF-kB activation by preventing degradation of IkB after stimulation with TNF-a. The precise mechanism(s) through which oxidants and reductants influence activation of NF-kB is presently unknown; however, there is evidence that antioxidant enzyme (AOE372), a redox-sensitive thioredoxin peroxidase, regulates IkB phosphorylation [246]. Phosphatases The phosphatases are an important component of most signal transduction pathways, because failure to reverse kinase actions can disrupt normal cellular functions. For example, transfection of human fibroblasts with constitutively active ras (hRasV12) inhibits cell growth and ultimately results in a senescentlike phenotype [441]. Similarly, constitutive ERK activation has an inhibitory effect on cell cycle progression [442,443]. Both the serine/threonine phosphatases and the PTPs are known to be redox-sensitive [82,144,153,156,271,281, 444-449]. The mechanism of redox effects on activity is probably best understood for the PTPs. Without exception, the PTPs contain a highly conserved region of 11 amino acid residues in their catalytic domain; specifi- cally, (Ile/Val)-His-Cys-X-Ala-Gly-X-X-Arg-(Ser/Thr)- Gly, where X is a nonconserved amino acid [17]. Either oxidation or mutation of the cysteine renders these molecules inactive [17,281]. H2O2 is a potent inhibitor of PTPs. As in the case of other oxidants, H2O2 probably oxidizes the thiolate anion at the catalytic site [280]. Because formation of a phosphorylcysteine intermediate seems to be critical to PTP activity [450-452], blocking it through oxidation of the cysteine inactivates the molecules. In many cases, treatment of cells with H2O2 stimulates increases in protein phosphorylation by inhibiting phosphatase-catalyzed removal of phosphate groups. Furthermore, mitogens that increase cellular ox- idant production may stimulate phosphorylation indirectly by decreasing phosphatase activity. Additional mechanisms are involved in stimulation of pathways activated by growth factors that increase oxidant production, however, because there are known instances in which the oxidants they produce have no effect on protein phosphorylation. For example, TGF-b1 stimulates phosphorylation of numerous proteins and has been shown to cause a large increase in H2O2 production; however, its effects on protein phosphorylation are not blocked by catalase [453]. Furthermore, H2O2 is effective in promoting phosphorylation of phospholipase D, the PDGF receptor, and PKC-a even after pretreatment of Swiss 3T3 fibroblasts with orthovanadate to inhibit phosphatases [454]. Thus, although diminished phosphatase activity may partially account for increased phosphorylation in some cases, it cannot totally account for oxidation effects on phosphorylation in every case. SPECIFICITY In general, there is good agreement between studies on redox effects on any given gene; albeit, not all oxidizing or reducing treatments exert equivalent effects. This is clearly demonstrated in studies of pag , which encodes a protein associated with cellular proliferation. Pag protein inhibits the tyrosine kinase activity of the Abelson (abl ) protein by binding to its SH3-binding domain [455]. BSO, menadione, sodium arsenate, and diethyl maleate all stimulate pag expression, but H2O2 does not [269]. Conversely, H2O2 stimulates c-fos expression (Table 1), although 4-hydroynonenal (a product of v-6-polyunsaturated fatty acid peroxidation) not only fails to induce c-fos expression but is actually inhibitory to c-fos induction by EGF and PDGF [185]. Similarly, some oxidants such as diamide decrease hypoxia-induced signals [201], although others such as H2O2 increase them [124]. As might be expected, the effects of any stimu...",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2000 Feb 1 28(3) 463-99",
                "id": "10699758"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8ce0"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "PKB/ Akt-dependent signaling controls many essential cellular processes such as cellular metabolism, transcription, cell proliferation, migration and survival [37,73,74]. PKB/Akt is believed to promote endothelial cell survival and angiogenesis via the phosphorylation and inactivation of the pro-apoptotic molecules Bad, Bax, caspase 9, and the Forkhead (FRKH) transcription factor [75], the stimulation of nitric oxide (NO) production [76,77], and the inhibition of the stressactivated kinases p38 and JNK [78].",
              "citation": {
                "type": "PubMed",
                "name": "Biochim Biophys Acta 2004 Mar 4 1654(1) 51-67",
                "id": "14984767"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8cdf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "When HEMEC were exposed to acidic pH for various time periods, there was a rapid and significant activation of JNK which was seen as early as 1 min. Activation of p44/42 MAPK was first detected at 15 min and maximized by 30 min, while activation of p38 MAPK was delayed, appearing at 60 min (Fig. 3A).",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2006 Nov 291(5) C931-45",
                "id": "16790501"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8cde"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": "vascular tissue"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "We showed previously that the transactivation activity of MEF2C is stimulated by p38 mitogen-activated protein (MAP) kinase. In this study, we examined the potential role of the p38 MAP kinase pathway in regulating the other MEF2 family members. We found that MEF2A, but not MEF2B or MEF2D, is a substrate for p38. Among the four p38 group members, p38 is the most potent kinase for MEF2A. Threonines 312 and 319 within the transcription activation domain of MEF2A are the regulatory sites phosphorylated by p38.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1999 Jan 19(1) 21-30",
                "id": "9858528"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8cdd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "We studied the response of porcine vascular smooth muscle cells (PVSMCs) to cyclic sinusoidal stretch at a frequency of 1 Hz. Cyclic stretch with an area change of 25% caused an increase in PVSMC apoptosis, which was accompanied by sustained activation of c-Jun NH(2)-terminal kinases (JNK) and the mitogen-activated protein kinase p38.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Heart Circ Physiol 2002 May 282(5) H1709-16",
                "id": "11959635"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8cdc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "vascular smooth muscle"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "As shown in Figure 2A, NECA-stimulated Akt, pan PKC, ERK, p38, JNK MAPKs, and NF-kB phosphorylation. Moreover, Cx43 phosphorylation was blocked by targeted inhibitors of PI3K (LY 294002), Akt (Akt inhibitor), PKC (bisindolylmaleimide I, staurosporine), p38 MAPK (SB 203580), ERK (PD 98059), c-Jun N-terminal kinase (JNK) (SP 600125), and NF-kB (Bay 11-7082, SN50) pathways, respectively (Fig. 2B?E).",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Physiol 2010 Jul 224(1) 187-94",
                "id": "20232318"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8cdb"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "embryonic stem cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "TAK1, a member of the mitogen-activated kinase kinase kinase family, is activated in vivo by various cytokines, including interleukin-1 (IL-1), or when ectopically expressed together with the TAK1-binding protein TAB1. However, this molecular mechanism of activation is not yet understood. We show here that endogenous TAK1 is constitutively associated with TAB1 and phosphorylated following IL-1 stimulation. Furthermore, TAK1 is constitutively phosphorylated when ectopically overexpressed with TAB1. In both cases, dephosphorylation of TAK1 renders it inactive, but it can be reactivated by preincubation with ATP. A mutant of TAK1 that lacks kinase activity is not phosphorylated either following IL-1 treatment or when coexpressed with TAB1, indicating that TAK1 phosphorylation is due to autophosphorylation. Furthermore, mutation to alanine of a conserved serine residue (Ser-192) in the activation loop between kinase domains VII and VIII abolishes both phosphorylation and activation of TAK1. These results suggest that IL-1 and ectopic expression of TAB1 both activate TAK1 via autophosphorylation of Ser-192.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Mar 10 275(10) 7359-64",
                "id": "10702308"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8cda"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Overexpression of JNK1 or p38 was sufficient to induce HIF-1alpha and VEGF expression Hypoxia rapidly induced both JNK1 and p38 activity in these cells. This activation correlated with induction of HIF-1alpha expression and DNA binding activity which was blocked by the p38 inhibitor SB203580. Hypoxia also increased VEGF production by SCC lines, which was inhibited by treatment with SB203580. Overexpression of JNK1 or p38 was sufficient to induce HIF-1alpha and VEGF expression.",
              "citation": {
                "type": "PubMed",
                "name": "Oral Oncol 2002 Apr 38(3) 251-7",
                "id": "11978547"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8cd9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Simultaneous overexpression of selenophosphate synthetase and phospholipid-hydroperoxide GSH peroxidase (PHGPx) [250] blocks activation of NF-kB by IL-1. Overexpression of SOD [84] or GSH peroxidase [81, 211] abolished NF-kB activation by preventing degradation of IkB after stimulation with TNF-a. The precise mechanism(s) through which oxidants and reductants influence activation of NF-kB is presently unknown; however, there is evidence that antioxidant enzyme (AOE372), a redox-sensitive thioredoxin peroxidase, regulates IkB phosphorylation [246]. Phosphatases The phosphatases are an important component of most signal transduction pathways, because failure to reverse kinase actions can disrupt normal cellular functions. For example, transfection of human fibroblasts with constitutively active ras (hRasV12) inhibits cell growth and ultimately results in a senescentlike phenotype [441]. Similarly, constitutive ERK activation has an inhibitory effect on cell cycle progression [442,443]. Both the serine/threonine phosphatases and the PTPs are known to be redox-sensitive [82,144,153,156,271,281, 444-449]. The mechanism of redox effects on activity is probably best understood for the PTPs. Without exception, the PTPs contain a highly conserved region of 11 amino acid residues in their catalytic domain; specifi- cally, (Ile/Val)-His-Cys-X-Ala-Gly-X-X-Arg-(Ser/Thr)- Gly, where X is a nonconserved amino acid [17]. Either oxidation or mutation of the cysteine renders these molecules inactive [17,281]. H2O2 is a potent inhibitor of PTPs. As in the case of other oxidants, H2O2 probably oxidizes the thiolate anion at the catalytic site [280]. Because formation of a phosphorylcysteine intermediate seems to be critical to PTP activity [450-452], blocking it through oxidation of the cysteine inactivates the molecules. In many cases, treatment of cells with H2O2 stimulates increases in protein phosphorylation by inhibiting phosphatase-catalyzed removal of phosphate groups. Furthermore, mitogens that increase cellular ox- idant production may stimulate phosphorylation indirectly by decreasing phosphatase activity. Additional mechanisms are involved in stimulation of pathways activated by growth factors that increase oxidant production, however, because there are known instances in which the oxidants they produce have no effect on protein phosphorylation. For example, TGF-b1 stimulates phosphorylation of numerous proteins and has been shown to cause a large increase in H2O2 production; however, its effects on protein phosphorylation are not blocked by catalase [453]. Furthermore, H2O2 is effective in promoting phosphorylation of phospholipase D, the PDGF receptor, and PKC-a even after pretreatment of Swiss 3T3 fibroblasts with orthovanadate to inhibit phosphatases [454]. Thus, although diminished phosphatase activity may partially account for increased phosphorylation in some cases, it cannot totally account for oxidation effects on phosphorylation in every case. SPECIFICITY In general, there is good agreement between studies on redox effects on any given gene; albeit, not all oxidizing or reducing treatments exert equivalent effects. This is clearly demonstrated in studies of pag , which encodes a protein associated with cellular proliferation. Pag protein inhibits the tyrosine kinase activity of the Abelson (abl ) protein by binding to its SH3-binding domain [455]. BSO, menadione, sodium arsenate, and diethyl maleate all stimulate pag expression, but H2O2 does not [269]. Conversely, H2O2 stimulates c-fos expression (Table 1), although 4-hydroynonenal (a product of v-6-polyunsaturated fatty acid peroxidation) not only fails to induce c-fos expression but is actually inhibitory to c-fos induction by EGF and PDGF [185]. Similarly, some oxidants such as diamide decrease hypoxia-induced signals [201], although others such as H2O2 increase them [124]. As might be expected, the effects of any stimu...",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2000 Feb 1 28(3) 463-99",
                "id": "10699758"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8cd8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "The insulin/IGF-I signalling cascade in brown adipocytes differentiation Insulin and IGF-I initiate the biological effects in target cells by binding to, and activating its endogenous Tyr kinase receptors. These receptors are believed to transduce signals by phosphorylation on Tyr residues of several cellular substrates including insulin receptor substrate (IRS) proteins 1, 2, 3 and 4 (White 2003). A number of signalling pathways can be activated downstream of IRS proteins. Molecules containing Src homology 2 domain, including the regulatory subunits of phosphatidylinositol 3-kinase (PI3K), Grb-2, SHP2 and others, are recruited to the Tyr phosphorylated IRSs and transmit a cascade of signals, which consists in two major elements, i.e. Ras/Raf/p44-p42MAPK and PI3K/ Akt/p70S6K pathways (Virkamaki et al. 1999). More recently, p38MAPK, a parallel MAPK signal transduction pathway that becomes activated in response to cellular stresses (Nebreda & Porras 2000), has been shown to be stimulated by insulin in several cell systems including skeletal muscle (Conejo & Lorenzo 2001).",
              "citation": {
                "type": "PubMed",
                "name": "Mini Rev Med Chem 2005 Mar 5(3) 269-78",
                "id": "15777261"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8cd7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "After establishing the role of p53 in cardiomyocyte apoptosis, we examined whether or not p53 activation was dependent on p38alpha MAPK, inhibition of which was essential in cytoprotection by E2.4 In order to block endogenous p38alpha MAPK, we expressed dominant negative p38alphaDN, via adenovirus infection, carrying a TGY180182 ? AGF mutation in the phosphorylation site of the kinase.9 This mutant prevents hypoxia-induced activation of endogenous p38alpha MAPK.4 We predicted that inactivating p38alpha MAPK would diminish the subsequent phosphorylation and activation of p53. Accordingly, little p-p53(S15) was observed in the presence of p38alphaDN during H/R, corrected for modest change in total p53 protein concentration (Figure 2). Similarly, the use of a chemical inhibitor of p38alpha MAPK, SB203580 (SB), also attenuated p-p53(S15). Although SB inhibits both p38alpha and p38beta MAPKs, the latter is not activated by H/R stress alone, whereas the former is significantly up-regulated by the same stimulus.4 Therefore, SB is likely to inhibit p38alpha MAPK to a much greater degree than p38beta in H/R. Overall, these results indicate that H/R-induced p53 depends on p38alpha MAPK. ",
              "citation": {
                "type": "PubMed",
                "name": "Cardiovasc Res 2011 Jan 1 89(1) 119-28",
                "id": "20724307"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8cd6"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "cardiomyocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Inhibition of AR by sorbinil or tolrestat prevented TNF-alpha-induced increase in Bax and Bak and the downregulation of Bcl-2. Inhibition of AR abrogated AP-1 DNA binding activity and prevented the activation of caspase-3, JNK, and p38 MAPK in cells stimulated by TNF-alpha. Exposure to TNF-alpha also induced apoptotic cell death, which was attenuated by AR inhibition or antisense ablation",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 2004 Jul 16 570(1-3) 189-94",
                "id": "15251463"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8cd5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Treating TMK-1 cells with IL-1beta increased VEGF mRNA levels and activated extracellular signal-regulated kinases 1 and 2 (Erk 1/2) and p38, but not Akt. Inhibitors of the Erk and p38 pathways blocked IL-1beta induction of VEGF mRNA. Treating TMK-1 cells with IL-1beta also increased VEGF promoter activity. VEGF transcriptional activity was found to depend on a 120-bp region just proximal to the transcription start site.",
              "citation": {
                "type": "PubMed",
                "name": "Surgery 2004 Sep 136(3) 686-92",
                "id": "15349119"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8cd4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Carcinoma of gastrointestinal tract",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "LPS-induced IL-8 production also depends on CS-induced phosphorylation and activation of ERK-1, ERK-2 and P38MAPK. CS has been found to have a profound modulatory effect on ERK-1 and ERK-2. Both basal and LPS induced phosphorylation of ERK-2 was higher in AM from healthy smokers than those from non-smokers. CS has been shown to enhance mitogenactivated protein-kinase activation more than NF-kB activation to increase LPS-induced IL-8 production in AM [76].",
              "citation": {
                "type": "PubMed",
                "name": "Exp Lung Res 2009 Aug 35(6) 439-85",
                "id": "19842832"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8cd3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "MAP kinase kinases are activated by dual phosphorylation within subdomain VIII (3, 9, 12, 29, 38, 52, 64). These phosphorylation sites are conserved in MKK6 (Ser-207 and Thr- 211)....To test this hypothesis, we examined the effect of introducing a constitutive negative charge by replacing Ser-207 and Thr-211 with Glu....MKK6(Glu) caused activation of wild-type (Thr-Gly-Tyr) p38 MAP kinase but not activation of the phosphorylation-defective (Ala-Gly-Phe) mutant (Fig. 7B). In contrast, kinase-negative MKK6 did not activate p38 MAP kinase (Fig. 7B). Together, these data demonstrate that MKK6(Glu) is an activator of p38 MAP kinase in vivo.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1996 Mar 16(3) 1247-55",
                "id": "8622669"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8cd2"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "For these experiments, p38{alpha} (wt and mt) and p38{beta}2 (wt and mt) were transiently transfected into rat mesangial cells and the effects on the expression of Il-1{beta}-induced iNOS expression were assessed. It shows that transfection of p38{alpha} wt had virtually no effect on IL-1{beta}-induced iNOS expression, whereas the mutant p38{alpha} inhibited IL-1{beta}-induced iNOS expression. the p38{beta}2 mt was without effect, whereas the wt p38{beta}2 inhibited IL-1{beta}-induced iNOS expression. ",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2004 Jan 286(1) C145-52",
                "id": "14522818"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8cd1"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "mesangial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Simultaneous overexpression of selenophosphate synthetase and phospholipid-hydroperoxide GSH peroxidase (PHGPx) [250] blocks activation of NF-kB by IL-1. Overexpression of SOD [84] or GSH peroxidase [81, 211] abolished NF-kB activation by preventing degradation of IkB after stimulation with TNF-a. The precise mechanism(s) through which oxidants and reductants influence activation of NF-kB is presently unknown; however, there is evidence that antioxidant enzyme (AOE372), a redox-sensitive thioredoxin peroxidase, regulates IkB phosphorylation [246]. Phosphatases The phosphatases are an important component of most signal transduction pathways, because failure to reverse kinase actions can disrupt normal cellular functions. For example, transfection of human fibroblasts with constitutively active ras (hRasV12) inhibits cell growth and ultimately results in a senescentlike phenotype [441]. Similarly, constitutive ERK activation has an inhibitory effect on cell cycle progression [442,443]. Both the serine/threonine phosphatases and the PTPs are known to be redox-sensitive [82,144,153,156,271,281, 444-449]. The mechanism of redox effects on activity is probably best understood for the PTPs. Without exception, the PTPs contain a highly conserved region of 11 amino acid residues in their catalytic domain; specifi- cally, (Ile/Val)-His-Cys-X-Ala-Gly-X-X-Arg-(Ser/Thr)- Gly, where X is a nonconserved amino acid [17]. Either oxidation or mutation of the cysteine renders these molecules inactive [17,281]. H2O2 is a potent inhibitor of PTPs. As in the case of other oxidants, H2O2 probably oxidizes the thiolate anion at the catalytic site [280]. Because formation of a phosphorylcysteine intermediate seems to be critical to PTP activity [450-452], blocking it through oxidation of the cysteine inactivates the molecules. In many cases, treatment of cells with H2O2 stimulates increases in protein phosphorylation by inhibiting phosphatase-catalyzed removal of phosphate groups. Furthermore, mitogens that increase cellular ox- idant production may stimulate phosphorylation indirectly by decreasing phosphatase activity. Additional mechanisms are involved in stimulation of pathways activated by growth factors that increase oxidant production, however, because there are known instances in which the oxidants they produce have no effect on protein phosphorylation. For example, TGF-b1 stimulates phosphorylation of numerous proteins and has been shown to cause a large increase in H2O2 production; however, its effects on protein phosphorylation are not blocked by catalase [453]. Furthermore, H2O2 is effective in promoting phosphorylation of phospholipase D, the PDGF receptor, and PKC-a even after pretreatment of Swiss 3T3 fibroblasts with orthovanadate to inhibit phosphatases [454]. Thus, although diminished phosphatase activity may partially account for increased phosphorylation in some cases, it cannot totally account for oxidation effects on phosphorylation in every case. SPECIFICITY In general, there is good agreement between studies on redox effects on any given gene; albeit, not all oxidizing or reducing treatments exert equivalent effects. This is clearly demonstrated in studies of pag , which encodes a protein associated with cellular proliferation. Pag protein inhibits the tyrosine kinase activity of the Abelson (abl ) protein by binding to its SH3-binding domain [455]. BSO, menadione, sodium arsenate, and diethyl maleate all stimulate pag expression, but H2O2 does not [269]. Conversely, H2O2 stimulates c-fos expression (Table 1), although 4-hydroynonenal (a product of v-6-polyunsaturated fatty acid peroxidation) not only fails to induce c-fos expression but is actually inhibitory to c-fos induction by EGF and PDGF [185]. Similarly, some oxidants such as diamide decrease hypoxia-induced signals [201], although others such as H2O2 increase them [124]. As might be expected, the effects of any stimu...",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2000 Feb 1 28(3) 463-99",
                "id": "10699758"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8cd0"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "cardiomyocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "All five cell lines did not express FADD by immunoblot analysis and were completely resistant to Fas-induced death. Complementation of the FADD mutant cell lines with wild-type FADD restored Fas-mediated apoptosis. Fas activation of caspase-2, caspase-3, caspase-7, and caspase-8 and the proteolytic cleavage of substrates such as BID, protein kinase Cdelta, and poly(ADP-ribose) polymerase were completely defective in the FADD mutant cell lines. In addition, Fas activation of the stress kinases p38 and c-Jun NH2 kinase and the generation of ceramide in response to Fas ligation were blocked in the FADD mutant cell lines",
              "citation": {
                "type": "PubMed",
                "name": "Cell Growth Differ 1999 Dec 10(12) 797-804",
                "id": "10616904"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8ccf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "p38MAPK inhibitor SB203580 could remarkably promote the apoptosis of A2780/Taxol cells, and the cell apoptosis was in a time-dependent manner. SB203580 down-regulated the activity of p38MAPK pathway, but up-regulated EGR-1 expression. SB203580 significantly increased the level of cellular phosphorylated p53 protein, but decreased the p-gp protein level and MDR1 mRNA level in A2780/Taxol cells. There existed a close relationship between p38MAPK pathway and the paclitaxel resistance of ovarian carcinoma cells. The expression of EGR-1 mediated by p38MAPK pathway plays a critical role in paclitaxel resistance of ovarian carcinoma cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Huazhong Univ Sci Technolog Med Sci 2008 Aug 28(4) 451-5",
                "id": "18704310"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8cce"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "It has recently been shown that inflammatory stimuli result in the activation of p38 MAPK, which may be responsible for the subsequent specific phosphorylation of serine 10 on H3 seen in vitro (12). To determine if this was the case in vivo in the rat smoking model, Western blot analysis was performed to assess p38 MAPK phosphorylation (activation). p38 MAPK phosphorylation remained unchanged in the lungs after 3 d of cigarette smoke exposure, but was increased significantly after 8 wk of smoke exposure (Figure 3). The increased p38 MAPK phosphorylation was positively correlated with the observed elevation in H3 phosphorylation. ",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2004 Dec 31(6) 633-42",
                "id": "15333327"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8ccd"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "In addition, we found that MCP-1 has a novel function in airway epithelium, increasing the two major airway mucins MUC5AC and MUC5B, an effect mediated, at least in part, by a cascade of events initiated by interaction of its receptor CCR2B with G(q) subunits in caveolae, followed by PLC??, PKC, and (44/42)MAPK activation. We also have shown that MCP-1 is able to induce its own expression using the same receptor but through a different pathway that involves RhoA GTPase.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2011 Feb 300(2) L204-15",
                "id": "21097527"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8ccc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "In this study, we showed that c-Abl-PKCdelta-Rac1-p38 MAPK signaling is required for the conformational changes of Bak and Bax during ionizing radiation-induced apoptotic cell death in human non-small cell lung cancer cells. Ionizing radiation induced conformational changes and subsequent oligomerizations of Bak and Bax, dissipation of mitochondrial membrane potential, and cytochrome c release from mitochondria.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Mar 17 281(11) 7049-59",
                "id": "16410245"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8ccb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Lung Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "HBECs were stimulated with pro-inflammatory cytokines tumor necrosis factor-alpha and interleukin (IL)-1beta or, because of their critical role in allergic diseases, IL-4 and IL-13. Each of these stimuli induced MIP-3alpha/CCL20 gene and protein expression. Moreover, these agents upregulated mitogen-activated protein kinase pathways in HBECs. Inhibition of the ERK1/2 pathway or p38 reduced cytokine-induced MIP-3alpha/CCL20 expression. These data suggest a mechanism by which AEC may facilitate recruitment of DC subsets to the airway.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2003 Jun 28(6) 648-54",
                "id": "12760962"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8cca"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "the mechanism by which P2RX5 receptor activation produced effects on satellite cell activity was also investigated we were able to demonstrate that ATP application to satellite cells produced a significant and rapid increase in the phosphorylation of p38 and to a lesser extent ERK1/2 however, only inhibition of p38 blocked the P2x-dependent effects on cell number these results are consistent with previous studies demonstrating the importance of the p38 MAPK signaling pathway in myogenesis",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2002 Jul 22 158(2) 345-55",
                "id": "12135987"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8cc9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "EGF stimulates the phosphorylation (activation) of the signaling intermediate p38 (MAPK11/14), and blocking phosphorylation pharmacologically with either SB203580 or SB202190 strongly inhibited spontaneous and EGF-stimulated secretion of CGB.  --From Materials and Methods: Primary antibodies to cyclin D1/CCND1and p21/CDKN1A (catalog numbers 2926 and 2946; mouse monoclonal) and phosphorylated (p)-MAPK11/14 (catalog number 9211; rabbit polyclonal) were obtained from Cell Signaling Technology (Beverley, MA) and used at a dilution of 1:500.  -- From Cell Signaling Technologies: Phospho-p38 MAP Kinase (Thr180/Tyr182) Antibody detects endogenous levels of p38 MAP kinase only when activated by phosphorylation at threonine 180 and tyrosine 182.",
              "citation": {
                "type": "PubMed",
                "name": "Biol Reprod 2005 Dec 73(6) 1282-8",
                "id": "16120828"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8cc8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "trophoblast",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "To see the phosphorylation of MAPK by ETS, the control and ETS-exposed brain tissues were extracted and 100 mg proteins were analyzed by 10% SDS-PAGE and phosphorylated form of MAPK was detected by Western blot using anti-phospho-MAPK antibody. The result shown in Fig. 4B indicates that phosphorylated MAPK was increased in all the regions of the brain exposed to ETS as compared to control brain tissue. The same extracts were probed with anti- ERK antibody and the level of ERK was unchanged in all the lanes indicating equal loading of proteins as well as specificity of the phosphorylation of the MAPK because ERK also undergoes phoshorylation but through different signaling pathway [31]. These results therefore strongly suggest that ETS induces MAPK phosphorylation and that the level of phosphorylation was similar across all the regions of the brain. We next examined the effect of ETS on p38MAP kinase in various regions of the brain. We found that ETS induced the phosphorylation of the p38MAP kinase in all the regions of the brain examined without altering the levels of the p38 MAP kinase protein expression (Fig. 4C).",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Pharmacol 2006 May 28 71(11) 1602-9",
                "id": "16569398"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8cc7"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "increase in LDL oxidation enhances platelet activation via 2 independent pathways, 1 signaling via p38(MAPK) phosphorylation and 1 via Ca(2+) mobilization. Between 0% and 15% oxidation, the p38(MAPK) route enhances fibrinogen binding induced by thrombin receptor (PAR-1)-activating peptide (TRAP), and signaling via Ca(2+) is absent. At 30% oxidation, p38(MAPK) signaling increases further and is accompanied by Ca(2+) mobilization and platelet aggregation in the absence of a second agonist",
              "citation": {
                "type": "PubMed",
                "name": "Arterioscler Thromb Vasc Biol 2005 Feb 3",
                "id": "15692097"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8cc6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Blood Platelets",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Simultaneous overexpression of selenophosphate synthetase and phospholipid-hydroperoxide GSH peroxidase (PHGPx) [250] blocks activation of NF-kB by IL-1. Overexpression of SOD [84] or GSH peroxidase [81, 211] abolished NF-kB activation by preventing degradation of IkB after stimulation with TNF-a. The precise mechanism(s) through which oxidants and reductants influence activation of NF-kB is presently unknown; however, there is evidence that antioxidant enzyme (AOE372), a redox-sensitive thioredoxin peroxidase, regulates IkB phosphorylation [246]. Phosphatases The phosphatases are an important component of most signal transduction pathways, because failure to reverse kinase actions can disrupt normal cellular functions. For example, transfection of human fibroblasts with constitutively active ras (hRasV12) inhibits cell growth and ultimately results in a senescentlike phenotype [441]. Similarly, constitutive ERK activation has an inhibitory effect on cell cycle progression [442,443]. Both the serine/threonine phosphatases and the PTPs are known to be redox-sensitive [82,144,153,156,271,281, 444-449]. The mechanism of redox effects on activity is probably best understood for the PTPs. Without exception, the PTPs contain a highly conserved region of 11 amino acid residues in their catalytic domain; specifi- cally, (Ile/Val)-His-Cys-X-Ala-Gly-X-X-Arg-(Ser/Thr)- Gly, where X is a nonconserved amino acid [17]. Either oxidation or mutation of the cysteine renders these molecules inactive [17,281]. H2O2 is a potent inhibitor of PTPs. As in the case of other oxidants, H2O2 probably oxidizes the thiolate anion at the catalytic site [280]. Because formation of a phosphorylcysteine intermediate seems to be critical to PTP activity [450-452], blocking it through oxidation of the cysteine inactivates the molecules. In many cases, treatment of cells with H2O2 stimulates increases in protein phosphorylation by inhibiting phosphatase-catalyzed removal of phosphate groups. Furthermore, mitogens that increase cellular ox- idant production may stimulate phosphorylation indirectly by decreasing phosphatase activity. Additional mechanisms are involved in stimulation of pathways activated by growth factors that increase oxidant production, however, because there are known instances in which the oxidants they produce have no effect on protein phosphorylation. For example, TGF-b1 stimulates phosphorylation of numerous proteins and has been shown to cause a large increase in H2O2 production; however, its effects on protein phosphorylation are not blocked by catalase [453]. Furthermore, H2O2 is effective in promoting phosphorylation of phospholipase D, the PDGF receptor, and PKC-a even after pretreatment of Swiss 3T3 fibroblasts with orthovanadate to inhibit phosphatases [454]. Thus, although diminished phosphatase activity may partially account for increased phosphorylation in some cases, it cannot totally account for oxidation effects on phosphorylation in every case. SPECIFICITY In general, there is good agreement between studies on redox effects on any given gene; albeit, not all oxidizing or reducing treatments exert equivalent effects. This is clearly demonstrated in studies of pag , which encodes a protein associated with cellular proliferation. Pag protein inhibits the tyrosine kinase activity of the Abelson (abl ) protein by binding to its SH3-binding domain [455]. BSO, menadione, sodium arsenate, and diethyl maleate all stimulate pag expression, but H2O2 does not [269]. Conversely, H2O2 stimulates c-fos expression (Table 1), although 4-hydroynonenal (a product of v-6-polyunsaturated fatty acid peroxidation) not only fails to induce c-fos expression but is actually inhibitory to c-fos induction by EGF and PDGF [185]. Similarly, some oxidants such as diamide decrease hypoxia-induced signals [201], although others such as H2O2 increase them [124]. As might be expected, the effects of any stimu...",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2000 Feb 1 28(3) 463-99",
                "id": "10699758"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8cc5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Although alpha2-ARs (alpha2C >> alpha2A) were detected in aortas, alpha2C-ARs were localized by immunohistochemistry to VSMs of adventitial arterioles and not aortic media. In contrast with aortas, aortic arterioles constricted in response to alpha2-AR stimulation. Reporter constructs demonstrated higher activities for alpha2A- and alpha2C-AR gene promoters in arteriolar compared with aortic VSMs. Serum induction of alpha2C-ARs was reduced by inhibition of p38 mitogen-activated protein kinase (MAPK) with 2 microM SB-202190 or dominant-negative p38 MAPK.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Heart Circ Physiol 2004 Jan 286(1) H59-67",
                "id": "12946937"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8cc4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "vascular smooth muscle"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "We show that exposure of NIH-3T3 and SV-40 transformed green monkey kidney (COS) cells to stress stimuli such as osmotic shock or UVC irradiation, but not to mitogenic activators such as PDGF or EGF, results in a marked cytoplasmic accumulation of hnRNP A1, concomitant with an increase in its phosphorylation. These effects are mediated by the MKK(3/6)-p38 pathway, and moreover, p38 activation is necessary and sufficient for the induction of hnRNP A1 cytoplasmic accumulation.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2000 Apr 17 149(2) 307-16",
                "id": "10769024"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8cc3"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "MAP kinases help to mediate diverse processes ranging from transcription of protooncogenes to programmed cell death. More than a dozen mammalian MAP kinase family members have been discovered and include, among others, the well studied ERKs and several stress-sensitive enzymes. MAP kinases lie within protein kinase cascades. Each cascade consists of no fewer than three enzymes that are activated in series. Cascades convey information to effectors, coordinates incoming information from other signaling pathways, amplify signals, and allow for a variety of response patterns. Subcellular localization of enzymes in the cascades is an important aspect of their mechanisms of action and contributes to cell-type and ligand-specific responses. Recent findings on these properties of MAP kinase cascades are the major focus of this review.",
              "citation": {
                "type": "PubMed",
                "name": "Prog Biophys Mol Biol 1999 71(3-4) 479-500",
                "id": "10354710"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8cc2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Next, we incubated the cells with p38 MAP kinase inhibitor SB 203580. SB 203580 at concentration of 5 ?M inhibited the IL-8 generation by macrophages. The amounts of IL-8 produced and released by the cells were diminished by 42% (from ~52.5  7 ng/ml to ~22.0  5.1 ng/ml).",
              "citation": {
                "type": "PubMed",
                "name": "Respir Res 2006 7 66",
                "id": "16620395"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a78"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Macrophages, Alveolar",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "ASK1 and Daxx act upstream of p38 in the Fas signaling pathway",
              "citation": {
                "type": "PubMed",
                "name": "Neuron 2002 Sep 12 35(6) 1067-83",
                "id": "12354397"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a77"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "While inhibition of extracellular signal-related kinase and NF-kappaB activation suppressed the up-regulation of the expression of TLR2, TLR4 and TLR9 mRNA, inhibition of p38 kinase prevented the up-regulation of TLR2 and TLR4 mRNA expression but enhanced the up-regulation of TLR9 expression.",
              "citation": {
                "type": "PubMed",
                "name": "Immunology 2002 May 106(1) 38-45",
                "id": "11972630"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a76"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "dendritic cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "# Ariadne: Activation of both JNK and p38 MAPK pathways was necessary for AVP-mediated induction of SM22 alpha promoter. [Regulation]",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Heart Circ Physiol 2003 Oct 285(4) H1444-52",
                "id": "12829429"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a75"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Muscle, Smooth"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "p38 kinase, a stress-activated kinase, becomes activated in response to hypoxia",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Apr 27 276(17) 14359-65",
                "id": "11278616"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a74"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "By contrast, TNF primarily induces gene transcription through the inhibitor of kappaB kinase (IKK), c-Jun N-terminal kinase (JNK), and p38 mitogen-activated protein kinase pathways.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Dec 9 280(49) 40599-608",
                "id": "16227629"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a73"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Calcimycin also activates p38 kinase and JNK2, which are not involved in calcium-induced apoptosis",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 2005 Sep 16(9) 4437-53",
                "id": "16000378"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a72"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Activated p38(MAPK) phosphorylated endogenous p53 at Ser(33) in living cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Oct 19 276(42) 39115-22",
                "id": "11495913"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a71"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "nhibition of the p38MAPK pathway, which in turn inhibits the transcription of IL-10 via Sp1. Inhibition of the IL-10 autocrine/paracrine loop results in the inhibition of STAT3 activity",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2004 Apr 29 23(20) 3530-40",
                "id": "15077178"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a70"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "b-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Moreover, in addition to JNK, ERK5, p38alpha, and p38gamma were found to stimulate the c-jun promoter by acting on distinct responsive elements.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1999 Jun 19(6) 4289-301",
                "id": "10330170"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a6f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Nephrol Dial Transplant 2003 Apr 18(4) 670-6",
                "id": "12637634"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a6e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Eur J Immunol 2001 Nov 31(11) 3218-27",
                "id": "11745338"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a6d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "reversed by suppressing p38 mitogen-activated protein kinase activity.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cancer Ther 2006 May 5(5) 1126-35",
                "id": "16731744"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a6c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Dec 13 277(50) 48764-70",
                "id": "12351630"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a6b"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "An inhibition of p38 with PD169316 impairs the upregulation of involucrin mRNAs by a treatment with MbetaCD, but not by a p38delta-activating TPA treatment, which might suggest that cholesterol depletion alters involucrin gene expression through activation of p38alpha/beta.",
              "citation": {
                "type": "PubMed",
                "name": "J Invest Dermatol 2004 Sep 123(3) 564-73",
                "id": "15304097"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a6a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Thrombin induced the phosphorylation of HSP27 and the phosphorylation was suppressed by SB-203580. These results indicate that thrombin stimulates not only the dissociation of HSP27 but also the induction of HSP27 via p38 MAPK activation in aortic smooth muscle cells.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Heart Circ Physiol 2002 Sep 283(3) H941-8",
                "id": "12181122"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a69"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Antioxid Redox Signal 2002 Aug 4(4) 587-92",
                "id": "12230870"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a68"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "We demonstrate that p38 MAPK is able to not only enhance CK2 kinase activity but also suppress PKA kinase activity.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Apr 29 280(17) 17221-6",
                "id": "15649893"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a67"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "TGF-beta1 failed to induce phosphorylation of either MKK3 or p38 MAPK in MKK3-deficient (Mkk3-/-) mouse mesangial cells, indicating that MKK3 is required for TGF-beta1-induced p38 MAPK activation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Dec 6 277(49) 47257-62",
                "id": "12374793"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a66"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "mesangial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2002 Jul 15 21(14) 3749-59",
                "id": "12110587"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a65"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "TNF-activated p38alpha kinase promotes the interaction between YY1 and PRC2, via threonine 372 phosphorylation of EZH2, the enzymatic subunit of the complex, leading to the formation of repressive chromatin on Pax7 promoter. ",
              "citation": {
                "type": "PubMed",
                "name": "Cell Stem Cell 2010 Oct 8 7(4) 455-69",
                "id": "20887952"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a64"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Acta Pharmacol Sin 2004 Apr 25(4) 485-9",
                "id": "15066218"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a63"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Furthermore, inhibitors of p38 MAPK and cPLA2, but not NF-kB and JAK2, signaling pathways inhibited ADAM-9-induced IL-6 production by hOBs (p<0.01).",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2005 Dec 22",
                "id": "16373656"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a62"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Consistent with this finding, SB203580 and overexpression of a dominant-negative mutant of p38alpha or p38beta also inhibited NTHi-induced MUC5AC transcription as assessed using a human MUC5AC promoter-luciferase reporter construct ( Fig. 1 C ), thus confirming the requirement for p38 MAPK in MUC5AC induction.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Jul 25 278(30) 27811-9",
                "id": "12734193"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a61"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "TNF activated p38 MAPK which peaked at 15 min and then returned to basal levels.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2002 May 15 168(10) 5342-51",
                "id": "11994493"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a60"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Silencing of p38alpha by isoform-specific small interfering RNAs increased claudin-4 and -8 mRNAs, whereas silencing of p38beta only increased claudin-4 mRNA.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2009 Sep 297(3) C775-87",
                "id": "19605737"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a5f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Aug 9 277(32) 29294-303",
                "id": "12034736"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a5e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Consistent with recent reports demonstrating the antagonistic actions of NF-kappaB and c-Jun amino-terminal kinase (JNK) signalling, we have found that Par4(-/-) cells show a reduced activation of the sustained phase of JNK and p38 stimulation by TNF-alpha and interleukin 1.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO Rep 2003 Mar 4(3) 307-12",
                "id": "12634851"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a5d"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Table 1 Cluster B: mRNA transcripts stabilized by NO through p38 MAPK activation",
              "citation": {
                "type": "PubMed",
                "name": "Nucleic Acids Res 2006 34(10) 3044-56",
                "id": "16757573"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a5c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Monocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Although p38 phosphorylated LIMK1 at Ser-310, it failed to activate LIMK1 directly; however, MK2 activated LIMK1 by phosphorylation at Ser-323.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2006 Feb 22 25(4) 713-26",
                "id": "16456544"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a5b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "PKA-phosphorylated GMF strongly enhances the activity of a related but distinct subfamily of MAP kinase, the p38 MAP kinase, showing an increase of 60-fold over baseline and an EC50 of 7 nM.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1996 Sep 20 271(38) 22953-6",
                "id": "8798479"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a5a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "astrocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Similarly, the p150Glued siRNA could also specifically reduce the tumor necrosis factor -induced phosphorylation of MKK3/6 and p38 MAPK.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Oct 29 279(44) 45308-11",
                "id": "15375157"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a59"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "These results suggest that Fas-mediated inactivation of Rb is mediated via the p38 kinase, independent of cdks",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1999 Mar 15 18(6) 1559-70",
                "id": "10075927"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a58"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "peroxynitrite. Indeed, the later is a powerful trigger of p38 phosphorylation and activation in a wide number of cell types, notably from cardiac (63), vascular (48,73,80) and neural origin (31,8185).",
              "citation": {
                "type": "PubMed",
                "name": "Front Biosci 2009 14 4809-14",
                "id": "19273391"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a57"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "cardiomyocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Stimulation of TLRs leads to activation of NF-?B, MAPKs, JuN N-terminal kinases (JNKs), p38 and ERKs, and interferon regulatory factor (IRF3, IRF5 and IRF7) signalling pathways5.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2009 Jan 9(1) 57-63",
                "id": "19052556"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a56"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Surprisingly, SB203580, an inhibitor of p38 MAPK, and PD98059, an inhibitor of mitogen-activated protein kinase kinase (MEK1), strongly enhanced hypoxia-induced HO-1 mRNA expression in PAEC.",
              "citation": {
                "type": "PubMed",
                "name": "Antioxid Redox Signal 2002 Aug 4(4) 587-92",
                "id": "12230870"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a55"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium, Vascular"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "IFN-dependent activation of the downstream effectors of p38, MAPKAPK-2 and MAPKAPK-3, is not detectable in cells lacking Mkk3 and Mkk6",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Mar 18 280(11) 10001-10",
                "id": "15644321"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a54"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "PMNs treated with NFA, DPI (not shown), or N-Ac all displayed significantly enhanced levels of phosphorylated p38 in the absence of any other treatment and did not further increase p38 phosphorylation in response to LOS (Fig. 8).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 Nov 23 282(47) 33958-67",
                "id": "17908687"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a53"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "p38 protein interacts with MAX protein p38 phosphorylates MAX in both in vitro and in vivo",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 1995 Nov 7 92(23) 10531-4",
                "id": "7479834"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a52"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "a part of the phosphorylation of Sap-1a upon stimulation with H2O2 is due to p38 MAPK, while the rest can most likely be attributed to JNKs that are also inducible by H2O2.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1997 Apr 1 16(7) 1620-7",
                "id": "9130707"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a51"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2005 Apr 15 387(Pt 2) 507-17",
                "id": "15568999"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a50"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Co-transfection of the MAO B promoter with dominant negative forms of Ras, Raf-1, MEKK1, MEK1, MEK3, MEK7, ERK2, JNK1, and p38/RK inhibit the PMA-dependent activation of the MAO B promoter",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Jun 21 277(25) 22222-30",
                "id": "11956220"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a4f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "As shown in Fig. 1a, p38 MAPK was strongly phosphorylated by E. coli DNA stimulation.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2006 Sep 15 177(6) 4037-46",
                "id": "16951367"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a4e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "MSK1 induction requires simultaneous activation of both ERK and p38 MAPK. Other downstream targets of p38 MAPK include transcription factors such as Elk1 and myocyte-enhancing factor (MEF) 2, whereby p38 MAPK directly phosphorylates nuclear substrates and augments their activity (Chen et al. 2001).",
              "citation": {
                "type": "PubMed",
                "name": "Proc Nutr Soc 2004 May 63(2) 227-32",
                "id": "15294035"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a4d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2001 Apr 1 61(7) 3084-91",
                "id": "11306491"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a4c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Over-expression of Hsp105alpha enhanced hydrogen peroxide-induced apoptosis by enhancing the activation of caspase-3, poly(ADP-ribose)polymerase cleavage, cytochrome c release and activation of p38 mitogen-activated protein kinase (p38).",
              "citation": {
                "type": "PubMed",
                "name": "Eur J Biochem 2002 Aug 269(16) 4143-51",
                "id": "12180991"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a4b"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2001 Aug 30 20(38) 5359-65",
                "id": "11536048"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a4a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2002 Jul 23 99(15) 10054-9",
                "id": "12114539"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a49"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "p38 phosphorylates and activates MAPKAPK5",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1998 Jun 15 17(12) 3372-84",
                "id": "9628874"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a48"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Treatment of cortical neurons with sodium arsenite activated p38 and JNK3 but not JNK1 or JNK2",
              "citation": {
                "type": "PubMed",
                "name": "J Neurosci 2000 Sep 1 20(17) 6442-51",
                "id": "10964950"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a47"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "pp60(v-src) induction of CREB was blocked by the p38 inhibitor SB203580 or by mutation of CREB at Ser133.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Mar 12 274(11) 7341-50",
                "id": "10066798"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a46"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "CK1-a, which has been shown to rephosphorylate and deactivate NFAT4 transcription factor (18, 19), and p38 MAPK.",
              "citation": {
                "type": "PubMed",
                "name": "FASEB J 2004 Jun 18(9) 1025-7",
                "id": "15084522"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a45"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Eur J Endocrinol 2003 Sep 149(3) 239-45",
                "id": "12943527"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a44"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "SB203580, a specific p38 MAPK inhibitor, attenuated these effects, further confirming that both MMK6 and MMK3 act via p38 MAPK, whereas they had no effect on the increase in glucose transport induced by a constitutively active MAPK kinase 1 (MEK1) mutant or by myristoylated Akt.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Jun 8 276(23) 19800-6",
                "id": "11279172"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a43"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "coexpression of TAB1 and p38 enhanced autophosphorylation of p38",
              "citation": {
                "type": "PubMed",
                "name": "Science 2002 Feb 15 295(5558) 1291-4",
                "id": "11847341"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a42"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Transfection of HeLa cells with MKK6b(E), a constitutively active specific upstream activator of p38, led to a potent inhibition of GR activation of the MMTV promoter-driven luciferase construct.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Oct 15 279(42) 43708-15",
                "id": "15292225"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a41"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Thus, p38alpha-induced re-localization of PP2A to caveolae can lead to dephosphorylation and inhibition of Akt, which in turn would contribute to the decreased survival observed in wild type cells",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2007 Jan 19(1) 62-74",
                "id": "16844343"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a40"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "cardiomyocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "The specific p38 MAP kinase inhibitor, SB202190, significantly decreased the cytotoxicity and increased the survivin levels in NO donor-treated and inducible NOS-transfected cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 May 7 279(19) 20267-76",
                "id": "14988404"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a3f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "VEGF also stimulated the mitogen activated protein (MAP) kinases ERK (extracellular signal-regulated kinase) and p38 (stress activated protein kinase-2)",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1997 Oct 15(18) 2169-77",
                "id": "9393975"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a3e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "these statements are all true for murine cells as well",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2001 May 3 411(6833) 102-7",
                "id": "11333986"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a3d"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Here we demonstrate that cAMP- and protein kinase A-dependent activation of p38 mitogen-activated protein kinase (MAPK) in brown adipocytes is an indispensable step in the transcription of the UCP1 gene in mice.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Apr 24(7) 3057-67",
                "id": "15024092"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a3c"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "stimulation ofalpha(2)-adrenoceptor by their agonists triggered the activation of the p38 mitogen-activated protein kinase (MAPK) signaling pathway",
              "citation": {
                "type": "PubMed",
                "name": "Eur J Pharmacol 2003 Apr 25 467(1-3) 223-31",
                "id": "12706479"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a3b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Interestingly, treatment with specific p38 mitogen-activated protein kinase inhibitors blocks both myotube formation and caveolin-3 expression,",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Oct 15 274(42) 30315-21",
                "id": "10514527"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a3a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Most surprisingly, although Rin was unable to stimulate MAP kinase activity in NIH 3T3 cells, it potently activated isoform-specific p38alpha MAP kinase signaling and weakly stimulated ERK signaling in pheochromocytoma (PC6) cells. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Nov 11 280(45) 37599-609",
                "id": "16157584"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a39"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "MEKK3-dependent activation of an NF-kappaB reporter gene as well as ERK, JNK, and p38 MAP kinases correlated with a requirement for serine at position 526. Constitutively active mutants of MEKK3, consisting of S526D and S526E, were capable of activating a NF-kappaB luciferase reporter gene as well as ERK and MEK, suggesting that a negative charge at Ser526 was necessary for MEKK3 activity and implicating Ser526 as a phosphorylation site.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Mar 10 281(10) 6236-45",
                "id": "16407301"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a38"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "In T cells CD137-induced signals lead to the recruitment of TRAF family members and activation of several kinases, including ASK-1, MKK, MAPK3/ MAPK4, p38, and JNK/SAPK  CD137 = TNFRSF9 ASK1 = MAP3K5",
              "citation": {
                "type": "PubMed",
                "name": "Immunol Res 2004 29(1-3) 197-208",
                "id": "15181282"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a37"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Activation of the tyrosine kinase receptor vascular endothelial growth factor receptor 2 (VEGFR2) by VEGF leads to the activation of stress-activated protein kinase (SAPK)2/p38 and then to actin polymerization and reorganization into stress fibers in endothelial cells.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2004 Jan 15 23(2) 434-45",
                "id": "14724572"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a36"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": "Endothelium, Vascular"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "We recently revealed that p38 MAPK-mediated serine phosphorylation of both Stat1 and Stat3 is required for the induction of 15-lipoxygenase (15-LO) expression by IL-13",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Apr 16 279(16) 15954-60",
                "id": "14757756"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a35"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Monocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2002 Mar 1 62(5) 1549-54",
                "id": "11888934"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a34"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "In the present study, we show that Fas receptor ligation or cellular treatment with synthetic C6-ceramide results in activation or phosphorylation, respectively, of the small G-protein Rac1, Jun N-terminal kinase (JNK)/p38 kinases (p38-K), and the transcription factor GADD153",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1997 Aug 29 272(35) 22173-81",
                "id": "9268362"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a33"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "inhibition of TNF-induced IkappaB alpha phosphorylation and degradation by NaSal is prevented by treatment of cells with SB203580, a highly specific p38 MAPK inhibitor.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1998 Jan 18(1) 78-84",
                "id": "9418855"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a32"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Co-exposure to C75 and Taxol induced a remarkable nuclear accumulation of activated p38 mitogen-activated protein kinase (p38 MAPK), which was accompanied by a synergistic nuclear accumulation of the p53 tumor-suppressor protein that was phosphorylated at Ser46, a p38 MAPK-regulated pro-apoptotic modification of p53",
              "citation": {
                "type": "PubMed",
                "name": "Int J Cancer 2005 May 20 115(1) 19-35",
                "id": "15657900"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a31"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "When MK2delta3B is expressed in E. coli with active p38alpha produced from this bicistronic plasmid, the kinase cascade was reconstituted. MK2delta3B was phosphorylated, demonstrated by reduced mobility of the protein in SDS-PAGE analysis (Fig. 1, A  and B) and increased peptide kinase activity (Fig. 1C). ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Mar 12 279(11) 10176-84",
                "id": "14688255"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a30"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "In contrast, p38 activation by PPARalpha and gamma ligands occurred independently of Src, oxidative stress, the EGFR, and Ras.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Nov 21 278(47) 46261-9",
                "id": "12966092"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a2f"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": "Epithelium"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "aldosterone induces CTGF expression via both p38 MAPK cascade and mineralocorticoid receptor and that cross-talk exists between the two pathways",
              "citation": {
                "type": "PubMed",
                "name": "J Korean Med Sci 2004 Dec 19(6) 805-11",
                "id": "15608389"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a2e"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "p38alpha, rather than p38beta, MAPK activity is essential for uPA/uPAR expression.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Apr 21 275(16) 12266-72",
                "id": "10766865"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a2d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "peroxynitrite. Indeed, the later is a powerful trigger of p38 phosphorylation and activation in a wide number of cell types, notably from cardiac (63), vascular (48,73,80) and neural origin (31,8185).",
              "citation": {
                "type": "PubMed",
                "name": "Front Biosci 2009 14 4809-14",
                "id": "19273391"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a2c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "vascular tissue"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Of interest, activation of PAR1 resulted in the phosphorylation of caveolin-1, a principal component of caveolae, on tyrosine 14 by a Gi-linked Src kinase pathway and p38 mitogen-activated protein kinase.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2006 Nov 18(11) 1977-87",
                "id": "16678999"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a2b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Inhibition of p160 rho kinase or p38 MAP kinase prevented the loss of epithelial morphology in response to TGFbeta, whereas only inhibition of p160 rho kinase blocked TGFbeta-stimulated caldesmon expression.",
              "citation": {
                "type": "PubMed",
                "name": "Dev Dyn 2006 Jan 235(1) 82-93",
                "id": "16258965"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a2a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "cardiac muscle"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Thus, Fer is required for maximal p38 kinase activation to promote the chemotaxis of activated mast cells.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2002 Sep 22(18) 6363-74",
                "id": "12192036"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a29"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "mast cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Recently, caveolin-1 was elucidated to be phosphorylated on tyrosine 14. However, it is not known how phosphorylation of caveolin-1 is controlled in endothelium. In this study, we found that caveolin-1 is phosphorylated by p38 mitogen-activated protein kinase (MAPK) under a static condition. ",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2006 Jan 20 339(3) 737-41",
                "id": "16325778"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a28"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "CREB-1 expression is dramatically up-regulated during macrophage differentiation and phosphorylation of CREB-1 and the related factor CREM-1 are stimulated by M-CSF in a SAPK2/p38-dependent manner.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Apr 23 279(17) 17772-84",
                "id": "14754893"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a27"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "inhibition of p38 blocks the rapid initiation of the G2 checkpoint in both human and murine cells p38 binds and phosphorylates CDC25B at serines 309 and 361 and CDC25C at serine216, phosphorylation of these residues is required for binding to 14-3-3 proteins inhibition of p38 prevents both phosphorylation of CDC25B at serine 309 and 14-3-3 binding after ultraviolet radiation",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2001 May 3 411(6833) 102-7",
                "id": "11333986"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a26"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Ang II and H2O2 induced marked activation of extracellular signal-responsive kinase1/2 (ERK1/2), which was blocked by NAC. Ang II and H2O2 also activated p38MAPK, and they were blocked by pre-treatment with NAC. However, the level of activated p38MAPK was quite low in comparison with ERK1/2. Ang II- or H2O2 -induced Gax down-regulation was significantly inhibited by PD98059, an ERK1/2 inhibitor but not SB203580, a p38MAPK inhibitor",
              "citation": {
                "type": "PubMed",
                "name": "Regul Pept 2005 Apr 15 127(1-3) 159-67",
                "id": "15680482"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a25"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Muscle, Smooth"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2000 Apr 1 60(7) 2007-17",
                "id": "10766192"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a24"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "p38 mitogen activating protein kinase (MAPK) can be activated by stressors such as hypoxia, hypertonicity, UV light, oxidative radicals and protein synthesis inhibitors, some hormones and growth factors (e.g. insulin, IGF-1 and FGF), and by muscle contraction.",
              "citation": {
                "type": "PubMed",
                "name": "Acta Physiol Scand 2003 Aug 178(4) 287-96",
                "id": "12864733"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a23"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "p38 and MK2 were phosphorylated in CD-cholesterol-loaded macrophages. Early activation of p38 by CD-cholesterol (i.e., at 5?8 h) was observed independently of ACAT inhibition.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2005 Oct 10 171(1) 61-73",
                "id": "16203857"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a22"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "In an effort to support this hypothesis, we studied the effects of P38 pharmacologic inhibition on cell growth in the epidermal growth factor receptor mutant (delE746_A750) adenocarcinoma cell line HCC827, which is derived from a nonsmoking patient and does not harbor K-Ras mutations (20). We showed that P38 activity does not inhibit, but rather, contributes to cell growth in the HCC827 model.",
              "citation": {
                "type": "PubMed",
                "name": "Clin Cancer Res 2008 Jul 1 14(13) 4096-102",
                "id": "18593986"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a21"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasm",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Inhibition of heat shock protein (HSP) 27 activity by p38 mitogen-activated protein kinase (MAPK)-catalyzed phosphorylation induces actin stress fiber formation,",
              "citation": {
                "type": "PubMed",
                "name": "J Appl Physiol 2001 Oct 91(4) 1487-500",
                "id": "11568129"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a20"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "p38 inhibitor SB 202190",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Crit Care Med 2002 Apr 15 165(8) 1161-71",
                "id": "11956062"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a1f"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Ang II also induced the rapid formation of ROS, which could be inhibited by a specific antibody as well as by antisense against the p22phox subunit of the NAD(P)H oxidase. JNK and p38 MAPK, but not ERK, activation was inhibited by an inhibitor of NAD(P)H oxidase. Antisense against p22phox also solely inhibited p38 MAPK but did not affect ERK.",
              "citation": {
                "type": "PubMed",
                "name": "Arterioscler Thromb Vasc Biol 2000 Apr 20(4) 940-8",
                "id": "10764657"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a1e"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "# Ariadne: Collectively, these results support the concept that p38 kinase targets MEF2C  at a unique site (Thr293), whose phosphorylation is required to stimulate MEF2- dependent transcription during muscle differentiation. [MolTransport]",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2000 Jun 20(11) 3942-50",
                "id": "10805737"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a1d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "cAMP- and protein kinase A-dependent activation of p38 mitogen-activated protein kinase (MAPK) in brown adipocytes is an indispensable step in the transcription of the UCP1 gene in mice.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Apr 24(7) 3057-67",
                "id": "15024092"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a1c"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "brown adipocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "The p38 mitogen-activated protein kinase (MAPK) inhibitors SB202190 and SB203580 suppressed IL-4-induced TIMP-2 expression, suggesting the involvement of p38 MAP kinase in the signaling of IL-4 leading to TIMP-2 expression.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2002 Feb 15 168(4) 1895-902",
                "id": "11823524"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a1b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Recombinant human (rh) CyPA activated ERK1/2, p38MAPK, SAPKs, and Akt in cultured cardiac myocytes. Furthermore, CyPA significantly increased Bcl-2 in cardiac myocytes.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2004 Apr 23 317(1) 162-8",
                "id": "15047162"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a1a"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "cardiomyocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Specific inhibitors for p38 kinase inhibited BMP2-induced adipocytic differentiation and transcriptional activation of PPARgamma, whereas overexpression of Smad6 had no effect on transcriptional activity of PPARgamma.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 2003 Feb 14(2) 545-55",
                "id": "12589053"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a19"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Adipocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Glucose stimulates nuclear USF2 protein accumulation through protein kinase C, p38 MAPK, and extracellular signal-regulated kinase pathways. Increased PKG activity down-regulates USF2 protein levels and its DNA binding activity under high glucose conditions, resulting in inhibition of glucose-induced TSP1 transcription and TGF-beta",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Aug 13 279(33) 34311-22",
                "id": "15184388"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a18"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "We demonstrate that BMP2 induces activation of TGF-beta-activated kinase (TAK1) and subsequent phosphorylation of p38 stress-activated protein kinase.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Jun 9 275(23) 17647-52",
                "id": "10748100"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a17"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "In both dietary and genetically (ob/ob) obese mice, adipose tissues displayed a marked decrease in p38MAPK activity compared with the same tissues from lean mice.",
              "citation": {
                "type": "PubMed",
                "name": "Diabetes 2006 Feb 55(2) 281-9",
                "id": "16443758"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a16"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Here we demonstrate that NFATc4 is phosphorylated by p38 mitogen-activated protein (MAP) kinase but not by JNK. The p38 MAP kinase phosphorylates multiple residues, including Ser(168) and Ser(170), in the NFAT homology domain of NFATc4.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2002 Jun 22(11) 3892-904",
                "id": "11997522"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a15"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "preadipocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "N6-cyclopentyladenosine (CPA; an adenosine A1 receptor agonist)-induced PP2a translocation was blocked by p38 MAPK inhibition but not by JNK inhibition. CPA increased phosphorylation of p38 MAPK, and this effect was abolished by pertussis toxin and inhibitors of the cGMP pathway",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Heart Circ Physiol 2003 Jul 285(1) H97-103",
                "id": "12649078"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a14"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "The association between HBP1 and p38 MAPK was initially defined by a two-hybrid interaction. Like the p21 results, the apparent mechanism was that p38 MAPK-mediated phosphorylation of the HBP1 led to increased protein stability and a G1 arrest.",
              "citation": {
                "type": "PubMed",
                "name": "Gene 2004 Jul 7 336(1) 1-13",
                "id": "15225871"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a13"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "blocking TGF-beta-induced p38 activity with SB202190",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Mar 28 278(13) 11041-9",
                "id": "12538652"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a12"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Jpn J Pharmacol 2000 Aug 83(4) 351-4",
                "id": "11001183"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a11"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "NMuMg mammary epithelial cells exposed to hyperosmotic stress induced by the organic osmolyte sorbitol, heat shock, ultraviolet irradiation, oxidative stress induced by hydrogen peroxide... The environmental stresses, but not dexamethasone, stimulatedSgk expression through a p38/MAPK-dependent pathway.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Feb 21 278(8) 5871-82",
                "id": "12488318"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a10"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "In these cells, FGF-BP was up-regulated by treatment with epidermal growth factor (EGF), dependent on protein kinase C and p38 mitogen-activated protein kinase signaling.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2003 Apr 1 63(7) 1696-705",
                "id": "12670924"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a0f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "The vegf gene encodes a multifunctional cytokine that is crucial in angiogenesis during the development of cancer and activates p38 Kinase, which in turn, mediates actin reorganization and cell migration in human endothelial cells. p38 may thus also be an important regulator of angiogenesis [70]. ",
              "citation": {
                "type": "PubMed",
                "name": "Curr Genomics 2007 Sep 8(6) 379-97",
                "id": "19412438"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a0e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Carcinoma of gastrointestinal tract",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "the protein kinase TAO2 activates MAP/ERK kinases (MEKs) 3, 4, and 6 toward their substrates p38 MAP kinase and c-Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 May 11 276(19) 16070-5",
                "id": "11279118"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a0d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "IFN-dependent activation of the downstream effectors of p38, MAPKAPK-2 and MAPKAPK-3, is not detectable in cells lacking Mkk3 and Mkk6",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Mar 18 280(11) 10001-10",
                "id": "15644321"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a0c"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Pretreatment of VSMC with IL-19 results in a significant reduction in fetal calf stimulated p44/42 and p38 MAPK activation in cultured human VSMC [38]. It was found that this inhibition was mediated by SOCS5 interaction with these MAP kinases, suggesting that in other cell types, other interleukins could inhibit MAPKs by induction of SOCS proteins.",
              "citation": {
                "type": "PubMed",
                "name": "Curr Vasc Pharmacol 2009 Jul 7(3) 267-76",
                "id": "19601851"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a0b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": "vascular tissue"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cell Res 2001 Jun 11(2) 89-94",
                "id": "11453551"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a0a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Ezrin, a member of the ezrin/radixin/moesin (ERM) family, seems to be involved in the formation and stabilization of the apical microvilli. We found that phosphorylation of ezrin caused elongation of microvilli via a p38 MAP-kinase signaling pathway in an immortalized mouse hepatic cell line.",
              "citation": {
                "type": "PubMed",
                "name": "Exp Cell Res 2006 Jan 15 312(2) 111-20",
                "id": "16274688"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a09"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "S100-A9 binds the transcription factors NF-kB and P53, and activates the P38 and ERK MAPK kinases and the receptor for advanced glycated end products (RAGE) (50).",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2008 May 38(5) 541-50",
                "id": "18079489"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a08"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2003 Jul 1 171(1) 106-14",
                "id": "12816988"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a07"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2001 Nov 8(5) 971-82",
                "id": "11741533"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a06"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Sodium salicylate activated p38MAPK through phosphorylation at Thr 180/Tyr 182 and Akt/PKB at Ser 473, whereas it partially activated ERK1/2 through its phosphorylation at Thr 202/Tyr 204.",
              "citation": {
                "type": "PubMed",
                "name": "Int J Oncol 2003 Aug 23(2) 503-8",
                "id": "12851702"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a05"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "...p38 MAPK alpha and beta are rapidly activated by insulin in both L6 myotubes and mature skeletal muscle...",
              "citation": {
                "type": "PubMed",
                "name": "Acta Physiol Scand 2003 Aug 178(4) 287-96",
                "id": "12864733"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a04"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": "Muscle, Skeletal"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Results show that stimulation of the CB2 receptor leads to p38 MAPK activation and that inhibition of this kinase attenuates CB2 receptor-induced caspase activation and apoptosis.",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 2005 Sep 12 579(22) 5084-8",
                "id": "16139274"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a03"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "However, inhibition of the p38 pathway prevented the insulin-stimulated decrease in GLUT4 protein levels.",
              "citation": {
                "type": "PubMed",
                "name": "Diabetes 2003 Mar 52(3) 634-41",
                "id": "12606502"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a02"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "The sentence (ResnetDB) CREB and ATF-1 were phosphorylated upon UVB treatment, and SB202190, a p38 MAPK inhibitor, decreased the phosphorylation of CREB/ATF-1 and suppressed COX-2 promoter activity.  is translated to Activation of ATF1 (Homo sapiens) Gene Expression by MAPK14 (Homo sapiens) Protein  The following edits have been made already none  Links Doc Sourcerer for 11526505 ATF1 (Homo sapiens) Gene Expression MAPK14 (Homo sapiens) Protein",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2001 Mar 1 61(5) 1862-8",
                "id": "11280739"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a01"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Table 1 Cluster B: mRNA transcripts stabilized by NO through p38 MAPK activation",
              "citation": {
                "type": "PubMed",
                "name": "Nucleic Acids Res 2006 34(10) 3044-56",
                "id": "16757573"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a00"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "p38 alpha and JNK1 phosphorylated p21 in vivo, and both p38 alpha and JNK1 phosphorylated p21 at Ser(130) in vitro.Peptide mapping demonstrated that both TGF-beta 1 and p38 alpha induced phosphorylation of p21 at Ser(130) in vivo, and mutation of Ser(130) to alanine rendered p21 less stable than wild-type p21. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Aug 16 277(33) 29792-802",
                "id": "12058028"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89ff"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Inhibition of AR also attenuated the increase in p38 mitogen-activated protein kinase and c-Jun N-terminal kinase phosphorylation",
              "citation": {
                "type": "PubMed",
                "name": "FASEB J 2003 Feb 17(2) 315-7",
                "id": "12490536"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89fe"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Epithelium"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "These were prohibitin (PHB), protein disulfide isomerase 3 (PDIA3), focal adhesion kinase 2 (FAK2), c-GMP dependent protein kinase 2 (KGP2), NADH-ubiquinone oxidoreductase 30 kDa subunit (NUGM) and translationally controlled tumor protein (TCTP). All these proteins were up-regulated in the membranes of H-RasV12-transformed p38alpha-/-cells, except for prohibitin, which was down-regulated",
              "citation": {
                "type": "PubMed",
                "name": "Proteomics 2006 Apr 6 Suppl 1 S262-71",
                "id": "16534743"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89fd"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "In addition, a p38 MAPK inhibitor, but not ERK and JNK inhibitors, suppressed their expression in cultured astrocytes.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Nov 7 278(45) 44525-34",
                "id": "12944406"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89fc"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "astrocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "We also show that p38 MAPK is able to directly associate with and modulate both casein kinase 2 (CK2) and protein kinase A (PKA)",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Apr 29 280(17) 17221-6",
                "id": "15649893"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89fb"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "In human DLD-1 cells, inhibition of p38 MAPK by the compound 4-(4-fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)1H-imidazole (SB203580) or by overexpression of a dominant-negative p38 MAPKalpha protein resulted in a reduction of human iNOS mRNA and protein expression",
              "citation": {
                "type": "PubMed",
                "name": "Mol Pharmacol 2005 Jun 67(6) 2148-61",
                "id": "15778452"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89fa"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Arch Biochem Biophys 2003 Jul 1 415(1) 117-25",
                "id": "12801520"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89f9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "deletion of p38alpha mitogen-activated protein (MAP) kinase in adult mice results in increased proliferation",
              "citation": {
                "type": "PubMed",
                "name": "Nat Genet 2007 Jun 39(6) 750-8",
                "id": "17468755"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89f8"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Thapsigargin-induced mPer1 and mPer2 mRNA expressions took distinct signaling pathways from protein kinase C and cAMP, but were partially inhibited by inhibitors of MEK1 and p38 mitogen-activated protein kinase, respectively",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 2002 Apr 10 516(1-3) 101-5",
                "id": "11959112"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89f7"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "PD98059 (MAPK/ERK1 inhibitor) and SB203580 (p38 MAPK inhibitor) respectively. In isolated rat skeletal muscle specific inhibition of ERK1/2 by PD98059 completely abolishes contraction-mediated p90rsk activity (Ryder et al. 2000).",
              "citation": {
                "type": "PubMed",
                "name": "Proc Nutr Soc 2004 May 63(2) 227-32",
                "id": "15294035"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89f6"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Bacteria induced activation of p38 mitogen-activated protein kinase (MAPK) in keratinocytes, which was required for the induction of PGLYRP2 expression, because induction of PGLYRP2 transcription by bacteria was inhibited by SB203580 (a specific inhibitor of p38 MAPK) and by a dominant-negative p38 construct.",
              "citation": {
                "type": "PubMed",
                "name": "Infect Immun 2005 Nov 73(11) 7216-25",
                "id": "16239516"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89f5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Further analysis reveals that expression of beta-arrestin2 strengthened CXCR4-mediated activation of both p38 MAPK and ERK, and the suppression of beta-arrestin2 expression blocked the activation of two kinases",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Dec 20 277(51) 49212-9",
                "id": "12370187"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89f4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Neurosci 2003 Jul 2 23(13) 5877-86",
                "id": "12843292"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89f3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "SB203580, a specific inhibitor of p38 MAP kinase, significantly inhibited IL-1beta-induced IL-6 and stromelysin-1 production by both parental FLSs and MH7A cells",
              "citation": {
                "type": "PubMed",
                "name": "J Biochem (Tokyo) 1998 Dec 1 124(6) 1153-62",
                "id": "9832620"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89f2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "These data indicate that phosphorylation of PPARalpha by p38 kinase on one or more of the serines at position 6, 12, or 21 is responsible for p38-mediated enhancement of PPARalpha transactivation function.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Nov 30 276(48) 44495-501",
                "id": "11577087"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89f1"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Endocrinol 2006 Mar 20(3) 503-15",
                "id": "16282370"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89f0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "exercise leads to the activation of at least three MAPK signalling pathways, i.e. ERK1/2, p38 MAPK and JNK, in skeletal muscle (Zierath, 2002).",
              "citation": {
                "type": "PubMed",
                "name": "Proc Nutr Soc 2004 May 63(2) 227-32",
                "id": "15294035"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89ef"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Muscle, Skeletal"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Addition of SB203580, transforming growth factor-beta1 (TGF-beta1) monoclonal antibody, p38 small interfering RNA (siRNA), and c-myc siRNA 30 minutes before stretch inhibited the induction of DDR2 protein and abolished the DNA-protein binding activity induced by cyclic stretch.",
              "citation": {
                "type": "PubMed",
                "name": "Hypertension 2005 Sep 46(3) 614-21",
                "id": "16087782"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89ee"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": "vascular smooth muscle"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "There was no significant increase in expression of p38 during H alone and early Re (1-2 h of Re). Enhanced p38 expression was detected after 4 h of Re. Postcon significantly reduced the p38 band density at 4 and 6 h of Re. Addition of anisomysin 5 min before Re also reversed inhibition of p38 with Postcon. Same patterns in change and modulation of p38 activity after H/Re with and without Postcon were also demonstrated as shown in Fig. 4. ",
              "citation": {
                "type": "PubMed",
                "name": "Apoptosis 2006 Sep 11(9) 1583-93",
                "id": "16820962"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89ed"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "cardiomyocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Figure 4A illustrates that CSE induces phosphorylation of both ERK and p38, although the magnitude of the early response was significantly less than that occurring with control DCs activated by Lps. We observed that LPS induces rapid phosphorylation of both ERK and p38 within 5-15 minutes of activation. CSE similarly induced phosphorylation of both ERK and p38 within 5-15 minutes of incubation (Figure 4A). ",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2008 Jul 15 181(2) 1536-47",
                "id": "18606709"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89ec"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "dendritic cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "At a high glucose concentration, O-glycosylation of p53 occurred between 10 and 20 min, reached its peak at 1 h, and then decreased with time. Angiotensin II synthesis increased at 45 min and 1 h, resulting in p38 mitogen-activated protein (MAP) kinase-driven p53 phosphorylation at Ser 390.",
              "citation": {
                "type": "PubMed",
                "name": "Diabetes 2001 Oct 50(10) 2363-75",
                "id": "11574421"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89eb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Muscles"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Jun 27 278(26) 23432-40",
                "id": "12697749"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89ea"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Therefore, once recruited at the promoter, active p38 is able to induce gene expression. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2010 Oct 8 285(41) 31819-28",
                "id": "20682780"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89e9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "NMuMg mammary epithelial cells exposed to hyperosmotic stress induced by the organic osmolyte sorbitol, heat shock, ultraviolet irradiation, oxidative stress induced by hydrogen peroxide... The environmental stresses, but not dexamethasone, stimulatedSgk expression through a p38/MAPK-dependent pathway.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Feb 21 278(8) 5871-82",
                "id": "12488318"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89e8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "MGSA/GROalpha in immortalized melanocytes enhances NF-kappaB activation, as well as mitogen-activated protein (MAP) kinase kinase kinase (MEKK) 1, MAP kinase kinase (MEK) 3/6, and p38 MAP kinase activation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Feb 2 276(5) 3650-9",
                "id": "11062239"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89e7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "melanocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Treatment of cells with cisplatin induces a sustained activation of the stress activated protein kinase SAPK/JNK and the mitogen-activated protein kinase p38.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2000 Oct 26 19(45) 5142-52",
                "id": "11064451"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89e6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Unexpectedly, SB-203580, a p38 kinase antagonist, was found to block HSP60-induced expression of COX-2, but not NOS-2.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2002 Oct 283(4) C1267-77",
                "id": "12225989"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89e5"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2001 Nov 21(22) 7545-57",
                "id": "11604491"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89e4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 1999 Jul 15 163(2) 844-53",
                "id": "10395678"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89e3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "The p38 kinase inhibitor, SB 203580, and the NF-kappaB inhibitor, MG-132, inhibited the induction of mob-1 mRNA",
              "citation": {
                "type": "PubMed",
                "name": "Cytokine 2003 Aug 7 23(3) 64-75",
                "id": "12906869"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89e2"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "hepatocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2001 Jan 1 166(1) 466-72",
                "id": "11123325"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89e1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Mar 26 279(13) 12300-11",
                "id": "14711826"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89e0"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": "vascular smooth muscle"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Treatment with the p38 MAPK inhibitor, SB202190, decreased interleukin-1beta stimulated MAPKAP-K2 activity, GIIa PLA(2) mRNA expression, GIIa PLA(2) protein synthesis, and the release of extracellular PLA(2) activity.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Nov 23 276(47) 43842-9",
                "id": "11571275"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89df"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2001 Feb 15 166(4) 2342-7",
                "id": "11160291"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89de"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "N6-cyclopentyladenosine (CPA; an adenosine A1 receptor agonist)-induced PP2a translocation was blocked by p38 MAPK inhibition but not by JNK inhibition. CPA increased phosphorylation of p38 MAPK, and this effect was abolished by pertussis toxin and inhibitors of the cGMP pathway",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Heart Circ Physiol 2003 Jul 285(1) H97-103",
                "id": "12649078"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89dd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "myocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2002 Dec 15 368(Pt 3) 939-45",
                "id": "12225289"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89dc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "p38 is one of the substrates of MEKs. MEK3 and MEK6 both strongly activate p38 kinase, however MEK3 is more active on p38?, while MEK6 activates all p38 isoforms",
              "citation": {
                "type": "PubMed",
                "name": "J Mammary Gland Biol Neoplasia 2003 Jan 8(1) 45-73",
                "id": "14587863"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89db"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "We show that p38alpha MAP kinase, in a phosphorylation-dependent manner, can directly interact with the alpha and beta subunits of CK2 to activate the holoenzyme through what appears to be an allosteric mechanism.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Jun 2 275(22) 16569-73",
                "id": "10747897"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89da"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "intracellular interaction of PKA, GMF, and p38 is supported by the phosphorylation of GMF upon cellular stimulation by forskolin (blocked by PKA inhibitor) and by the co-immunoprecipitation of p38 with GMF from cell lysates. Withdrawal of nerve growth factor from PC12 leads to increased GMF phosphorylation with a time course similar to that reported for p38 activation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1996 Sep 20 271(38) 22953-6",
                "id": "8798479"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89d9"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "UV-induced activation of p38 MAP kinase, which suppressed the caspase-3 activity in NHK, was blocked by dominant negative PKC eta.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2003 Mar 28 303(1) 350-6",
                "id": "12646210"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89d8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Nov 3 275(44) 34424-32",
                "id": "10896679"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89d7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "In monocytic cells, mutation of these residues to alanine prevents MEF2C activation in response to either lipopolysaccharide stimulation or constitutive activation of the p38 kinase pathway [25].",
              "citation": {
                "type": "PubMed",
                "name": "Curr Biol 1999 May 6 9(9) 449-59",
                "id": "10322110"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89d6"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Inhibition of p38 MAP kinase, which blocks ezrin phosphorylation, also prevents Akt activation",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Jan 14 280(2) 1688-95",
                "id": "15531580"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89d5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "This induction was in part dependent on the MEK1/2 and p38 components of the MAPK signal transduction pathway. Addition of either U0126, a specific and potent inhibitor of MEK1/2, or SB203580, a specific and potent inhibitor of p38, nearly abolished induction of ESE-3 mRNA (Figure 6B). Addition of both reagents inhibited induction at lower doses.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2002 Dec 27(6) 697-704",
                "id": "12444029"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89d4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "In this study, we identify, by using mass spectrometry techniques and specific anti-phosphopeptide antibodies, Ser(87) and Thr(56) as the Bcl-2 residues phosphorylated by p38 MAPK and show that phosphorylation of these residues is always associated with a decrease in the antiapoptotic potential of Bcl-2 protein.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Jul 28 281(30) 21353-61",
                "id": "16714293"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89d3"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "TGF-beta1 failed to induce phosphorylation of either MKK3 or p38 MAPK in MKK3-deficient (Mkk3-/-) mouse mesangial cells, indicating that MKK3 is required for TGF-beta1-induced p38 MAPK activation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Dec 6 277(49) 47257-62",
                "id": "12374793"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89d2"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "The alkylating agent methylmethanesulfonate (MMS) activates the c-jun N-terminal kinase (JNK)/stress-activated protein kinase (SAPK) and the p38 mitogen-activated protein kinase (p38MAPK) pathways via different mechanisms of action.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Carcinog 2001 Jun 31(2) 63-7",
                "id": "11429782"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89d1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "PPARgamma ligands not only activated calcium/calmodulin-dependent kinase II (CaMKII) 2-fold over control, but the selective CaMKII inhibitor, KN-93, attenuated MKK3/6 and p38 as well as PKR and eIF2alpha phosphorylation. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Mar 18 280(11) 10109-18",
                "id": "15649892"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89d0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Epithelium"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "CD40 lacks intrinsic catalytic activity, but the cytoplasmic domain of CD40 has two binding sites for TRAF...TRAFs 1, 2, 3, 5, and 6 have been found in association with CD40, and these adaptors couple CD40 to the phosphoinositide 3-kinase (PI3K), phospholipase C (PLC-), mitogen-activated protein kinase (MAPK-ERK, p38, and JNK), and nuclear factor B (NF-B) signaling pathways",
              "citation": {
                "type": "PubMed",
                "name": "Sci STKE 2004 Jun 15 2004(237) pe25",
                "id": "15199223"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89cf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Jan 12 276(2) 999-1004",
                "id": "11029458"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89ce"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Transforming growth factor-beta-activated kinase 1 (TAK1) is a member of the MAPK kinase kinase (MAPKKK) family and can activate JNK and p38.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Sep 29 281(39) 28802-10",
                "id": "16893890"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89cd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "# Ariadne: Activation of both JNK and p38 MAPK pathways was necessary for AVP-mediated induction of SM22 alpha promoter. [Regulation]",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Heart Circ Physiol 2003 Oct 285(4) H1444-52",
                "id": "12829429"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89cc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "ERK and p38 activities are essential for maximal c-Jun and Fra-2 expression, and AP-1 DNA binding activity.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 May 3 277(18) 15992-6001",
                "id": "11884386"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89cb"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Exposure of cells to alpha2M* (50 pM) induced phosphatidylinositol 3-kinase-dependent activation of Akt by phosphorylation at Thr-308 and Ser-473 with a concomitant 60-80% increase in Akt-associated kinase activity. ERK1/2 and p38 MAPK were also activated",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 May 12 281(19) 13694-707",
                "id": "16543232"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89ca"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Prostatic Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Furthermore, glucosamine inhibited the release of granule enzyme lysozyme from phagocytosing neutrophils and suppressed neutrophil chemotaxis toward zymosan-activated serum. In addition, glucosamine inhibited fMLP-induced up-regulation of CD11b significantly, polymerization of actin, and phosphorylation of p38 mitogen-activated protein kinase (MAPK)",
              "citation": {
                "type": "PubMed",
                "name": "J Leukoc Biol 2002 Apr 71(4) 632-40",
                "id": "11927650"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89c9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "# Ariadne: Thus, our findings provide support for a signaling pathway in which Mekk3  activity leads to the activation of p38 MAPK, which in turn regulates MEF2C. [Regulation]",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2000 Sep 12 97(19) 10454-9",
                "id": "10973481"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89c8"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "The mTOR inhibitor rapamycin reversed the dephosphorylation of eEF2 induced by CCK, as did treatment with the p38 MAPK inhibitor SB202190, the MEK inhibitor PD98059, and the phosphatase [PP2A] inhibitor calyculin A.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2004 Jun 18 319(1) 144-51",
                "id": "15158453"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89c7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "treatment of human mononuclear cells with leptin increased p38 MAP kinase phosphorylation Another study in L6 muscle cells suggested that leptin did not itself alter p38 MAP kinase phosphorylation but reduced insulin-stimulated p38 MAP kinase phosphorylation",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2002 Aug 14(8) 655-63",
                "id": "12020765"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89c6"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2000 Sep 1 96(5) 1844-52",
                "id": "10961885"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89c5"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2003 Nov 3 22(21) 5793-805",
                "id": "14592977"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89c4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "In contrast, p38 activation by PPARalpha and gamma ligands occurred independently of Src, oxidative stress, the EGFR, and Ras.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Nov 21 278(47) 46261-9",
                "id": "12966092"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89c3"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "These results imply that PPARb/d phosphorylation by p38 MAPK inhibits the transcriptional activity of the former.",
              "citation": {
                "type": "PubMed",
                "name": "Cardiovasc Res 2009 Mar 1 81(4) 703-12",
                "id": "19038972"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89c2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "cardiomyocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "although all of these effects are far less substantial than those of the accepted activators AMP kinase kinase, phosphoinositide-dependent kinase 1, and CaMKK, respectively (24-26). Finally, Ras-independent activation of the mitogen-activated protein kinases ERK2, p38, and JNK1 was observed in cells transfected with constitutively active CaMKIV and further enhanced by cotransfection with CaMKK (27).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Feb 2 276(5) 2975-8",
                "id": "11096122"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89c1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "JNK and p38 can be activated by phosphorylation at Thr183/Tyr185 and Thr180/Tyr182, respectively. As shown in Fig. 5A, palmitic acid induced both JNK and p38 phosphorylation, which were paralleled by a dose-dependent decrease in eNOS phosphorylation. ",
              "citation": {
                "type": "PubMed",
                "name": "Diabetes 2006 Aug 55(8) 2301-10",
                "id": "16873694"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89c0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "RNA interference (RNAi) demonstrates that MEKK3 and the scaffold protein are required for p38 activation in response to sorbitol-induced hyperosmolarity.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2003 Dec 5(12) 1104-10",
                "id": "14634666"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89bf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "We find that although pretreatment of BMMs with IL-4 does not alter M-CSF signaling, it reversibly blocks RANKL-dependent activation of the NF-kappa B, JNK, p38, and ERK signals.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Feb 22 277(8) 6622-30",
                "id": "11719504"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89be"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Studies with specific inhibitors and evaluation of protein phosphorylation indicated the involvement in PAF synthesis of two intracellular signaling pathways leading to cytosolic phospholipase A(2) activation: a phospholipase Cgamma-protein kinase C-Raf-p42/p44-mitogen-activated protein kinase (MAPK) and a MAPK kinase-3/6-dependent activation of p38 MAPK.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2003 Nov 15 171(10) 5489-97",
                "id": "14607955"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89bd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "However, K8/19 tyrosine phosphorylation is independent of EGF signaling or ERK activation while inhibition of p38 kinase activity blocks pervanadate-induced K8/19 tyrosine phosphorylation",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 1999 Jul 112 ( Pt 13) 2081-90",
                "id": "10362538"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89bc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "The activation of the p38-MAPK was dependent on protein kinase-C.",
              "citation": {
                "type": "PubMed",
                "name": "Diabetologia 2003 Apr 46(4) 531-7",
                "id": "12679868"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89bb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Interestingly, each of the individual MAPKs evaluated was found to promote Lox-1 expression to varying degrees. As we expected, CpG ODN treatment of macrophages increased three MAPKs phosphorylation, and each inhibitor of three MAPKs significantly attenuated the CpG ODN-induced phosphorylation of the MAPKs (Fig. 7A). ",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2008 Dec 20(12) 2266-75",
                "id": "18817866"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89ba"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Furthermore, CK2 activity toward IkappaB is UV inducible through a mechanism that depends on activation of p38 MAP kinase.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2003 Oct 12(4) 829-39",
                "id": "14580335"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89b9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Oct 22 279(43) 44294-302",
                "id": "15308641"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89b8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Jun 6 278(23) 20593-602",
                "id": "12663665"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89b7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Using specific inhibitors of MAPK pathways, we demonstrate that, in our experimental system, p38 signals survival, while ERK activity is required for apoptosis.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2000 May 11 19(20) 2377-85",
                "id": "10828879"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89b6"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "p38 MAPK has been associated with reduced GR function",
              "citation": {
                "type": "PubMed",
                "name": "Mol Psychiatry 2004 9(1) 65-75",
                "id": "14699442"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89b5"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "In addition to NF-?B, among the known pathways that can be activated by RAGE are phosphoinositide 3-kinases (PI3K)/Akt (also termed as protein kinase B), and mitogen-activated protein kinase members (MAPKs) (52,53). The latter group includes Jun-N-terminal kinase (JNK), p38, and extracellular signal-regulated kinases (ERK) (54,55) (Figure 2).",
              "citation": {
                "type": "PubMed",
                "name": "Front Biosci 2009 14 1403-13",
                "id": "19273137"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89b4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "vascular tissue"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2001 Feb 15 61(4) 1727-32",
                "id": "11245489"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89b3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "rac2-/- neutrophils displayed significant defects in... and p38 and, unexpectedly, p42/p44 MAP kinase activation",
              "citation": {
                "type": "PubMed",
                "name": "Immunity 1999 Feb 10(2) 183-96",
                "id": "10072071"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89b2"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "The transfection of the TOPK gene to COS-7 cells up-regulated a phosphorylation of p38 MAPK but not ERK1/2 or SAPK/JNK.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Jul 14 275(28) 21525-31",
                "id": "10781613"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89b1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "TNF-alpha represses the promoter activity of the 250-bp region, and the repression is mediated by p38 MAP kinase independent of NF-kappaB",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 1998 Jun 139(6) 3030-3",
                "id": "9607817"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89b0"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "p38, but not ERK or JNK, was found in a complex with Gadd45 proteins. The region of interaction was mapped to amino acids 71 to 96, and the central portion (amino acids 71 to 124) of Gadd45a was required for p38 MAPK activation in the presence of H-ras.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2003 Jun 23(11) 3859-71",
                "id": "12748288"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89af"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Nov 12 279(46) 47912-28",
                "id": "15310753"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89ae"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "In vitro kinase assays using the combined STAT1 proteins as substrates from immunoprecipitation and glutathione S-transferase pull down show that active ERK1, JNK1, p38 kinase, MEK1 and MSK1 stimulated phosphorylation of STAT1 (Ser727) indirectly through an unidentified factor or a downstream kinase.",
              "citation": {
                "type": "PubMed",
                "name": "Carcinogenesis 2004 Jul 25(7) 1165-75",
                "id": "14963018"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89ad"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Thus, both p38 and SAPK/Jun N-terminal kinase mitogen-activated protein kinases (MAPKs) are activated on stimulation of these cells with either T- or M-tropic gp120, as well as with SDF-1alpha or MIP-1beta.",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2001 Aug 1 98(3) 541-7",
                "id": "11468147"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89ac"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Nature 1997 Mar 20 386(6622) 296-9",
                "id": "9069290"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89ab"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "beta 2 receptors can also couple to Gi proteins, resulting in stimulation of of the ERK and p38 MAPK pathways.  Activation of this pathway by the beta 2 receptor requires that the receptor be phosphorylated by PKA",
              "citation": {
                "type": "PubMed",
                "name": "J Allergy Clin Immunol 2006 Jan 117(1) 18-24; quiz 25",
                "id": "16387578"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89aa"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1998 Jun 4 16(22) 2915-26",
                "id": "9671412"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89a9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "stimulation of p38 MAPK isoforms phosphorylated purified Nrf2 protein and caused an increase in the interaction between Nrf2 and Keap1 in vitro and the suppression of Nrf2 translocation into the nucleus.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2006 Sep 1 66(17) 8804-13",
                "id": "16951197"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89a8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Wy-L4,643 increases phosphorylation of ERK and p38",
              "citation": {
                "type": "PubMed",
                "name": "Thromb Haemost 2003 Oct 90(4) 611-9",
                "id": "14515181"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89a7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Invest Dermatol 2002 Apr 118(4) 704-11",
                "id": "11918720"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89a6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Figure 1. Pathways to MUC5AC expression in COPD",
              "citation": {
                "type": "PubMed",
                "name": "Physiol Rev 2007 Jul 87(3) 1047-82",
                "id": "17615396"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89a5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Finally, either inhibition or disruption of p38MAPK increased peroxisome proliferator-activated receptor (PPAR)gamma expression and transactivation.",
              "citation": {
                "type": "PubMed",
                "name": "Diabetes 2006 Feb 55(2) 281-9",
                "id": "16443758"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89a4"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "preadipocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 1999 Oct 1 85(7) 565-74",
                "id": "10506481"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89a3"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "The p38 MAP kinase kinase MKK6 is identified as a common activator of p38 alpha, p38 beta 2, and p38 gamma MAP kinase isoforms, while MKK3 activates only p38 alpha and p38 gamma MAP kinase isoforms.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1998 Jan 16 273(3) 1741-8",
                "id": "9430721"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89a2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "PDGF-BB induces phosphorylation of alphaB-crystallin via p38 MAP kinase during myocardial infarction",
              "citation": {
                "type": "PubMed",
                "name": "Arch Biochem Biophys 2005 Jun 15 438(2) 111-8",
                "id": "15907784"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89a1"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": "cardiac muscle"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "U0126 also completely abolished the insulin-stimulated increase of the activated (phosphorylated) ERK1/2. it was shown that MAPKp38 inhibits MEK1/2",
              "citation": {
                "type": "PubMed",
                "name": "Diabetes 2003 May 52(5) 1073-80",
                "id": "12716735"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad89a0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "In ClC-3- deficient PMNs there was enhanced phosphorylation in ~27% of cells (Fig. 9B and D), but phosphorylation was diminished as compared with wild-type PMNs (Fig. 9C).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 Nov 23 282(47) 33958-67",
                "id": "17908687"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad899f"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "At the gene transcriptional level, both IL-6 and Stat3 mRNA levelswere up-regulated in response to MMP12 overexpression (Fig. 4C). Other intracellular oncogenic moleculeswere also analyzed (Supplementary Fig. S2). NFnB, extracellular signal-regulated kinase (ERK), p38, and AKT were all significantly activated in doxycycline-treated bitransgenic mice compared with untreated bitransgenic mice.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2009 Sep 15 69(18) 7252-61",
                "id": "19706765"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad899e"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Alveolar type II cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Immunology 2002 May 106(1) 38-45",
                "id": "11972630"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad899d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "In cells stably transfected with empty vector, AVP rapidly stimulated ERK, JNK, and p38 activity (Fig. 7A), similar to what we have previously reported (11). ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Oct 10 278(41) 39830-8",
                "id": "12882977"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad899c"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jun 11 279(24) 25898-904",
                "id": "15037619"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad899b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Pyrrolidine dithiocarbamate (PDTC) induction of the human glutamate cysteine ligase modulatory (GCLM) gene is dependent on activation of the mitogen-activated protein kinases (MAPKs) extracellular regulated kinase (Erk) and p38",
              "citation": {
                "type": "PubMed",
                "name": "Toxicol Sci 2003 May 73(1) 124-34",
                "id": "12657749"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad899a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Id3 is induced by X/XO via superoxide, calcium, p38, and p42/44 MAP kinase.",
              "citation": {
                "type": "PubMed",
                "name": "FASEB J 2002 Jul 16(9) 1077-86",
                "id": "12087069"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8999"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Ask1 constitutes the converging point of the heat shock and oxidative stress-sensing pathways that lead to p38 activation",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Aug 23 277(34) 30792-7",
                "id": "12077134"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8998"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "inhibition of MAPK14 activity also interfered with stabilization of EPO mRNA in human hepatoma cells undergoing hypoxic stress",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2000 Jul 21 102(2) 221-31",
                "id": "10943842"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8997"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "hepatocellular carcinoma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "It was observed that p38 MAP kinase (MAPK) was activated soon after the treatment followed by over-expression of Bax protein in cells undergoing apoptosis",
              "citation": {
                "type": "PubMed",
                "name": "Apoptosis 2003 Jan 8(1) 91-100",
                "id": "12510156"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8996"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "The knockdown resulted in a significant decrease in the expression of phosphorylated p38 MAPK (p-p38), but the expression of total p38, ERK1/2, JNK, phosphorylated ERK1/2 (p-ERK1/2), and phosphorylated JNK (p-JNK) remained unchanged (Fig. 4).",
              "citation": {
                "type": "PubMed",
                "name": "Basic Res Cardiol 2009 Nov 104(6) 631-42",
                "id": "19377854"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8995"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "cardiomyocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "contraction increases both GLUT4 translocation to the cell surface and p38 mitogen-activated protein kinase (p38 MAPK) activity.",
              "citation": {
                "type": "PubMed",
                "name": "FASEB J 2003 Sep 17(12) 1658-65",
                "id": "12958172"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8994"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": "Muscle, Skeletal"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "To examine directly the role of MKP-1 in the regulation of these protein kinases in vivo, we established a U937 cell line that conditionally expresses MKP-1 from the human metallothionein IIa promoter. Conditional expression of MKP-1 inhibited PMA-induced ERK2, SAPK, and p38 MAPK activity.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1997 Jul 4 272(27) 16917-23",
                "id": "9202001"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8993"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "activation of p38MAPK by IL-6",
              "citation": {
                "type": "PubMed",
                "name": "Biol Chem 2001 Oct 382(10) 1447-53",
                "id": "11727828"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8992"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "These effects were markedly attenuated in Rat2-Rac(N17) cells expressing a dominant negative Rac1 mutant. Pretreatment with SB203580, a specific inhibitor of p38 MAP kinase",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2001 Jun 1 284(1) 126-32",
                "id": "11374881"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8991"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2002 Aug 22(16) 5835-45",
                "id": "12138194"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8990"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "TPA stimulates increased generation of ROS and initiates the stress-activated protein kinase (SAPK) pathway via protein kinase C (PKC) bII activation (Datta et al., 2000), representing typical characteristics of STASIS...Activation of stress kinases (JNK, MAPK, p38) (Day 2008;  Gao et al., 2008; Kirkham and Rahman, 2006;  Kliment et al., 2008; Koli et al., 2008) ",
              "citation": {
                "type": "PubMed",
                "name": "Biol Chem 2008 Mar 389(3) 211-20",
                "id": "18208352"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad898f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Physiol 2004 Feb 198(2) 310-23",
                "id": "14603533"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad898e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "MAPK-activated protein kinase 2 (MAPKAPK2), one of several kinases directly phosphorylated and activated by p38 MAPK, plays a central role in the inflammatory response.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Oct 4 277(40) 37401-5",
                "id": "12171911"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad898d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 1999 Feb 15 162(4) 2087-94",
                "id": "9973482"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad898c"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 May 9 278(19) 16713-9",
                "id": "12609980"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad898b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": " Knockdown of Brk by stable expression of short hairpin RNA (shRNA) in T47D breast cancer cells decreases proliferation and blocks epidermal growth factor (EGF)- and heregulin-induced activation of Rac GTPase, extracellular signal-regulated kinase (ERK) 5, and p38 mitogen-activated protein kinase (MAPK)",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2007 May 1 67(9) 4199-209",
                "id": "17483331"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad898a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "insulin-dependent p38 alpha and p38 beta MAPK activities were also markedly reduced by wortmannin",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Dec 7 276(49) 46079-87",
                "id": "11598141"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8989"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "peroxynitrite. Indeed, the later is a powerful trigger of p38 phosphorylation and activation in a wide number of cell types, notably from cardiac (63), vascular (48,73,80) and neural origin (31,8185).",
              "citation": {
                "type": "PubMed",
                "name": "Front Biosci 2009 14 4809-14",
                "id": "19273391"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8988"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "neuron",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "DUSP8, DUSP10 and DUSP16 make up the third subgroup as they preferentially recognize JNK, p38 or both, respectively",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Drug Discov 2007 May 6(5) 391-403",
                "id": "17473844"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8987"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Production of interleukin-1 and tumour necrosis factor from stimulated human monocytes is inhibited by a new series of pyridinyl-imidazole compounds. Using radiolabelled and radio-photoaffinity-labelled chemical probes, the target of these compounds was identified as a pair of closely related mitogen-activated protein kinase homologues, termed CSBPs.",
              "citation": {
                "type": "PubMed",
                "name": "Nature 372(6508) 739-46",
                "id": "7997261"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8986"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Monocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "In human fibroblasts cultivated in floating collagen gels, the induction of MMP1 is mediated by PKC-zeta and p38 MAPK [96-98].",
              "citation": {
                "type": "PubMed",
                "name": "Eur J Dermatol 11(6) 506-14",
                "id": "11701397"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8985"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Here we demonstrate that NFATc4 is phosphorylated by p38 mitogen-activated protein (MAP) kinase but not by JNK. The p38 MAP kinase phosphorylates multiple residues, including Ser(168) and Ser(170), in the NFAT homology domain of NFATc4.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2002 Jun 22(11) 3892-904",
                "id": "11997522"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8984"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Rac2D57N also inhibited lipopolysaccharide-stimulated p38 kinase activation. # Rac2D57N described as dominant inhibitory",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 2004 Jan 15 117(Pt 2) 243-55",
                "id": "14676277"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8983"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Transfection of MLK-3 increased the MBP kinase activity of endogenous p38/RK by >6- fold over control (Figure 5).",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1996 Dec 16 15(24) 7026-35",
                "id": "9003778"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8982"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "8-isoprostane significantly (P=0.03) activated ERK 1/2 and the peak of phosphorylation was reached after 15 min of stimulation (Fig. 4A). Similarly, 8-isoprostane induced significantly (P=0.03) p38 MAPK phosphorylation, but with a peak of phosphorylation after 30 min (Fig. 4B) and the 8-isoprostane induced phosphorylation of both MAP kinases sustained for up to 60 min. ",
              "citation": {
                "type": "PubMed",
                "name": "Cardiovasc Res 2003 Oct 1 59(4) 945-54",
                "id": "14553834"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8981"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Thus with a GST fusion protein of MAPKAP kinase-2 that lacks the N-terminal proline-rich domain both RK and p42 MAP kinase phosphorylate Thr222 and Ser272, but only p42 MAP kinase phosphorylates Thr334 efficiently.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1995 Dec 1 14(23) 5920-30",
                "id": "8846784"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8980"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Insulin-induced VEGF expression requires p38 MAPK and PI 3-kinase, whereas hyperglycemia-induced VEGF expression is HIF-1alpha-independent and requires PKC and p42/p44 MAPK.",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Invest 2002 Mar 109(6) 805-15",
                "id": "11901189"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad897f"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Treatment with palmitate rapidly induced the association of myeloid differentiation factor 88 (MyD88) with the TLR2 receptor, activated the stress-linked kinases p38, JNK, and protein kinase C, induced degradation of IkappaBalpha, and increased NF-kappaB DNA binding...TLR2 mediates the initial events of fatty acid-induced insulin resistance in muscle",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Sep 15 281(37) 26865-75",
                "id": "16798732"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad897e"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "These data indicate that phosphorylation of PPARalpha by p38 kinase on one or more of the serines at position 6, 12, or 21 is responsible for p38-mediated enhancement of PPARalpha transactivation function.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Nov 30 276(48) 44495-501",
                "id": "11577087"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad897d"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "cardiomyocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Moreover, the phosphatidylinositol 3 (PI3)-kinase inhibitor (wortmannin) and p38(MAPK) inhibitor (SB203580) inhibited the EGF-induced CREB phosphorylation and the expression of NF-IL6beta gene in cells.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 2005 Jul 16(7) 3365-76",
                "id": "15901830"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad897c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "SB203580, a specific inhibitor of p38MAPK, blocked arsenite-induced growth inhibition as well as the arsenite-induced p21(CIP1/WAF1) expression.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Physiol 2002 Jan 190(1) 29-37",
                "id": "11807808"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad897b"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Nat Immunol 2002 Apr 3(4) 392-8",
                "id": "11896392"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad897a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2001 Apr 21(7) 2373-83",
                "id": "11259586"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8979"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "cross-talk and activation between the PI 3-kinase/Akt and p38 MAPK pathways that is essential for efficient myoblast differentiation. During myoblast differentiation, Akt kinase activity correlated with S473 but not T308 phosphorylation and occurred 24 h after p38 activation Akt2 promoter activity and protein levels were regulated by p38 activation, thus providing a mechanism for communication.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 May 24(9) 3607-22",
                "id": "15082758"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8978"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "activation of AKT2 inhibits UV- and TNF alpha-induced c-Jun N-terminal kinase and p38 activities that have been shown to be required for stress- and TNF alpha-induced programmed cell death",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Aug 16 277(33) 29973-82",
                "id": "12048203"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8977"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "S100A8/A9 complexes, as well as S100A9 homodimers, stimulated the production of proinflammatory cytokines, such as tumor necrosis factor alpha, by purified monocytes and in vitro-differentiated macrophages.",
              "citation": {
                "type": "PubMed",
                "name": "Arthritis Res Ther 2006 Apr 13 8(3) R69",
                "id": "16613612"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8976"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Ectopic expression of PP2Cbeta-1 inhibited the TAK1-mediated mitogen-activated protein kinase kinase 4-c-Jun amino-terminal kinase and mitogen-activated protein kinase kinase 6-p38 signaling pathways.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Feb 23 276(8) 5753-9",
                "id": "11104763"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8975"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Interestingly, VSMC lines stably expressing dominant negative Ras (Ras N17) or Rac (Rac N17) exhibited a marked decrease in MKP-1 expression; the inhibition of ERK kinases (MEK1/2) by PD 98059 or of p38 MAPKs by SB 202190 resulted in a down-regulation of MKP-1 induction.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Sep 3 274(36) 25273-80",
                "id": "10464250"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8974"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": "vascular smooth muscle"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Kit and other RTKs will activate the MAP kinase signaling pathway and has been reported both to increase the transcriptional activity of Mitf as well as down-regulate Mitf protein levels.",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2000 Jul 15 14(14) 1712-28",
                "id": "10898786"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8973"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "IL-1beta rapidly activates the c-Jun NH2-terminal/stress-activated protein kinases (JNK/SAPK) and p38 mitogen-activated protein kinase (MAPK) and also induces Cox-2 expression and prostaglandin E2 (PGE2) production.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1998 Oct 30 273(44) 28670-6",
                "id": "9786861"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8972"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "mesangial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "In addition, Tiam1 or Ras-GRF1 binding to IB2/JIP2 increases the association of the components of the p38 MAP kinase signaling cassette with IB2/JIP2 in cells and activates scaffold-associated p38. # note complex contains RAC,MAP3K11,MAP2K3,MAPK14 # IB2/JIP2 = mapk8ip2",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2002 Jun 22(12) 4073-85",
                "id": "12024021"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8971"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Gal-9 induced phosphorylation of the MAPK p38 and ERK1/2 in DCs, and an inhibitor of p38 signaling, but not inhibitors of signaling by either ERK1/2 or PI3K, blocked Gal-9-induced up-regulation of costimulatory molecule expression and IL-12 production.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2005 Sep 1 175(5) 2974-81",
                "id": "16116184"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8970"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "dendritic cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Phosphorylation of mitogen-activated protein kinases (MAPKs) such as p38 MAPK and ERK was markedly increased by the heat shock, and SB203580 (a p38 MAPK kinase inhibitor) and/or PD098059 (a MEK inhibitor) inhibited the phosphorylation of HSP25, indicating that p38 MAPK and ERK are upstream regulators of HSP25 phosphorylation in the heat shock condition",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 May 31 277(22) 19913-21",
                "id": "11912188"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad896f"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Inhibition of p38 MAPK by SB203580 in differentiating C2C12 myoblasts blocks MyoD expression, SHPS-1 tyrosyl phosphorylation and the association of SHPS-1 with SHP-2.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 2001 Jun 114(Pt 11) 2187-98",
                "id": "11493654"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad896e"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2001 Mar 1 61(5) 1855-61",
                "id": "11280738"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad896d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2003 Apr 3 22(13) 2034-44",
                "id": "12673208"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad896c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Treatment of melanoma cells with SB203580, a selective inhibitor of the p38 mitogen-activated protein kinase (MAPK) pathway, effectively inhibited Ad.mda-7-induced apoptosis. Additional support for an involvement of the p38 MAPK pathway in Ad.mda-7-mediated apoptosis was documented by using an adenovirus expressing a dominant negative mutant of p38 MAPK.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2002 Jul 23 99(15) 10054-9",
                "id": "12114539"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad896b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "melanoma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "treatment of human mononuclear cells with leptin increased p38 MAP kinase phosphorylation Another study in L6 muscle cells suggested that leptin did not itself alter p38 MAP kinase phosphorylation but reduced insulin-stimulated p38 MAP kinase phosphorylation",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2002 Aug 14(8) 655-63",
                "id": "12020765"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad896a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Monocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "we have cloned GAPR-1 from the human neutrophil, and confirmed that it is also LPS-responsive at the transcriptional level, as it undergoes LPS-induced, p38 MAPK-dependent downregulation",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2004 Aug 31(2 Suppl) S1-81",
                "id": "15269003"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8969"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Active mutants of p38alpha induced AP-1-driven reporter genes, as well as the c-jun and c-fos promoters. An active variant of p38gamma suppressed AP-1-mediated transcription",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 Jan 5 282(1) 91-9",
                "id": "17088247"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8968"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2000 Jun 15 19(26) 3003-12",
                "id": "10871852"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8967"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "In addition, we present the evidence that Snn overexpression results in reduced extracellular regulated kinase activation and increased p38 activation.",
              "citation": {
                "type": "PubMed",
                "name": "Brain Res Mol Brain Res 2005 Aug 18 138(2) 256-63",
                "id": "15923056"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8966"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Treatment with SP600125, an inhibitor of JNK1, 2 and 3 Group 1 includes two transcripts, whose expression levels are increased at least twofold when compared with baseline by either of the SB203580 and SP600125 treatments.",
              "citation": {
                "type": "PubMed",
                "name": "Development 2005 Apr 132(8) 1773-83",
                "id": "15772134"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8965"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": "embryo"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "We show that in CGCs, cAMP can activate Epac1 and Epac2, which in turn stimulates Rap and p38MAPK, but not p42/p44MAPK or JNK. This effect results in mobilization of ryanodine- and IP3- sensitive intracellular Ca2 stores and BK channel opening.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2007 Feb 13 104(7) 2519-24",
                "id": "17284589"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8964"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "granulocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "We find that RanBPM is phosphorylated on serine residues; phosphorylation of RanBPM is increased by stress stimuli and decreased by treatment with the p38 kinase inhibitor SB203580.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Mar 26 279(13) 13027-34",
                "id": "14722085"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8963"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "In the present study, we investigated possible involvement of mitogen-activated protein (MAP) kinases; extracellular signal-regulated kinase (ERK), c-Jun amino-terminal kinase (JNK), and p38, in the chymase-induced eosinophil migration. Human chymase induced a rapid phosphorylation of ERK1/2 and p38 in human eosinophilic leukemia EoL-1 cells, while no phosphorylation was detected in JNK.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2005 Jul 15 332(4) 969-75",
                "id": "15919053"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8962"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "As shown in Fig. 3A, in the control experiment where NIH 3T3 cells were co-transfected with ORE-SVLuc and pCMV-Script, hypertonicity resulted in a 19-fold increase in ORE reporter activity. Co-transfection with ORE-SVLuc and the p38DN (FLAG-p38alphaAF) resulted in a reduction in hypertonic induction of ORE reporter activity to 3.5-fold, confirming the results obtained by SB203580 to inhibit p38.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Nov 29 277(48) 46085-92",
                "id": "12359721"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8961"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "In Rac2(-/-) T cells, proliferation was reduced upon stimulation with either plate-bound anti-CD3 or T cell receptor-specific antigen. This defect is accompanied with decreased activation of mitogen activated protein kinase extracellular signal-regulated kinase (ERK)1/2 and p38, and reduced Ca(2)+ mobilization. TCR stimulation-induced actin polymerization is also reduced",
              "citation": {
                "type": "PubMed",
                "name": "J Exp Med 2001 Oct 1 194(7) 915-26",
                "id": "11581314"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8960"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "basal PAK6 kinase activity was repressed by a p38 mitogen-activated protein (MAP) kinase antagonist and could be strongly stimulated by constitutively active MAP kinase kinase 6 (MKK6), an upstream activator of p38 MAP kinases.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Feb 4 280(5) 3323-30",
                "id": "15550393"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad895f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Circulation 2002 Apr 30 105(17) 2030-6",
                "id": "11980681"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad895e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Here we show that hyperglycemia inhibits thioredoxin ROS-scavenging function through p38 MAPK-mediated induction of Txnip.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jul 16 279(29) 30369-74",
                "id": "15128745"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad895d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "We report here that inhibition of the p38alpha isoform suppressed the ability of Smad3 to mediate TGF-beta-induced transcriptional responses. The inhibition of p38 activity blocked TGF-beta-mediated phosphorylation of the MSK1 kinase, a substrate of p38 that plays an important role in the remodeling of chromatin.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jul 16 279(29) 30474-9",
                "id": "15133024"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad895c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Our data demonstrate that increased intracellular cAMP concentration in endothelial cells prevents thrombin-induced ICAM-1 expression by inhibiting p38 MAPK activation, which in turn prevents phosphorylation of RelA/p65 and transcriptional activity of the bound NF-kappaB.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2004 Nov 287(5) L1017-24",
                "id": "15246972"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad895b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2003 Jun 1 372(Pt 2) 631-41",
                "id": "12646044"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad895a"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "9829964;7958915;11969286;8887554;15733869;12356771;9687510;9528766",
              "citation": {
                "type": "PubMed",
                "name": "BMC Bioinformatics 2004 Jun 22 5 79",
                "id": "15212693"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8959"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "We demonstrate that purified SCG10 can be phosphorylated by two subclasses of mitogen-activated protein (MAP) kinases, c-Jun N-terminal/stress-activated protein kinase (JNK/SAPK) and p38 MAP kinase. Moreover, SCG10 was found to bind tightly and specifically to JNK3/SAPKbeta. JNK3/SAPKbeta phosphorylation occurs at Ser-62 and Ser-73, residues that result in reduced microtubule-destabilizing activity for SCG10",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 2001 Nov 16 508(2) 259-64",
                "id": "11718727"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8958"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "PMA and granulocyte/macrophage colony-stimulating factor induce Egr-1 expression through ERK and p38 activation, respectively.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 May 23 278(21) 18859-67",
                "id": "12618431"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8957"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Stem Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cancer 2003 Aug 15 98(4) 720-9",
                "id": "12910515"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8956"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Haematologica 2004 May 89(5) 578-85",
                "id": "15136221"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8955"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Blockade of p38 activity did not affect inducible nuclear translocation and recruitment of NF-kappaB/RelA to the IL-8 promotor but did reduce the level of phosphorylated RelA (serine 536)",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Dec 17 279(51) 53241-7",
                "id": "15485852"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8954"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Chemical p38 inhibitors and a dominant negative allele of p38 decrease fat cell differentiation, and overexpression of constitutively active MKK6, an activator of p38, enhance the process.35,36",
              "citation": {
                "type": "PubMed",
                "name": "Ann N Y Acad Sci 2002 Dec 979 143-58; discussion 188-96",
                "id": "12543724"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8953"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Adipocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "The p38 mitogen-activated protein kinase (MAPK) inhibitor SB203580 diminished Ang II-induced Smad2 phosphorylation. ",
              "citation": {
                "type": "PubMed",
                "name": "Exp Dermatol 2009 Nov 18(11) 947-53",
                "id": "19397700"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8952"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2002 Dec 12 420(6916) 691-5",
                "id": "12478298"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8951"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "a p38 MAP kinase phosphorylation site (serine 401) were identified in the HBP1 protein. Furthermore, the docking and phosphorylation sites on HBP1 were specific for p38 MAP kinase",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2003 Dec 23(23) 8890-901",
                "id": "14612426"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8950"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "IL-1beta rapidly activates the c-Jun NH2-terminal/stress-activated protein kinases (JNK/SAPK) and p38 mitogen-activated protein kinase (MAPK) and also induces Cox-2 expression and prostaglandin E2 (PGE2) production.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1998 Oct 30 273(44) 28670-6",
                "id": "9786861"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad894f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Perfusion of hearts with 100 microM PE caused a rapid (maximal at 10 min) 12-fold activation of twop38-MAPK isoforms",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 1998 Jun 1 332 ( Pt 2) 459-65",
                "id": "9601075"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad894e"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "human endostatin binding to alpha 5 beta 1 integrin leads to the inhibition of focal adhesion kinase/c-Raf/MEK1/2/p38/ERK1 mitogen-activated protein kinase pathway",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2003 Apr 15 100(8) 4766-71",
                "id": "12682293"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad894d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "We show that TTP mRNA is expressed in a biphasic manner following stimulation of cells with lipopolysaccharide and that the second phase of expression, like the first, is dependent on mitogen-activated protein kinase (MAPK) p38",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jul 30 279(31) 32393-400",
                "id": "15187092"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad894c"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Neurochem 2001 Jul 78(2) 374-83",
                "id": "11461973"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad894b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "p38 can directly activate the MEF2 transcription factors in skeletal muscle and together with the myod family, mef2 transcription factors are necessary for the differentiation of myoblasts",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2002 Jul 22 158(2) 345-55",
                "id": "12135987"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad894a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Muscle, Skeletal"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "MKNK1 was phosphorylated and activated by ERK1 and p38 MAP kinases but not by JNK/SAPK MNK1 was activated upon stimulation of HeLa cells with 12-o-tetradecanoylphorbol-13-acetate",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1997 Apr 15 16(8) 1921-33",
                "id": "9155018"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8949"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Arthritis Res Ther 2003 5(4) R186-92",
                "id": "12823853"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8948"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": "synovium"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "In contrast, USF1/2 activates the hTERT promoter exclusively in hTERT-positive cells in a manner that is enhanced by the coactivator p300 and attenuated upon inhibiting p38-MAP kinase, a known modulator of USF activity.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2003 Sep 11 22(39) 8042-7",
                "id": "12970752"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8947"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2002 Jun 22(11) 3892-904",
                "id": "11997522"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8946"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Recent in vitro studies by Saccani and colleagues (12) showed that specific phosphorylation of H3 at serine 10, indirectly resulting from activation of p38 mitogen-activated protein kinase (MAPK),",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2004 Dec 31(6) 633-42",
                "id": "15333327"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8945"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Interestingly, phospho-acceptor site mutations of MEF2 that render it unresponsive to p38 MAP kinase signalling abrogate the cooperativity with the Smads suggesting that p38 MAP Kinase-catalysed phosphorylation of MEF2 is a prerequisite for the Smad-MEF2 interaction.",
              "citation": {
                "type": "PubMed",
                "name": "Nucleic Acids Res 2001 Feb 1 29(3) 732-42",
                "id": "11160896"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8944"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Western analysis demonstrated that phospho-p38, but not phospho-ERK or phospho-JNK (data not shown), was activated after stimulation with both IL-1 and NE in bronchial epithelial cells (Fig. 2C).  ",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2005 Dec 1 175(11) 7594-601",
                "id": "16301669"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8943"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "bronchial epithelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "As shown in Fig. 2A, THP-1 cells transfected with siRNAs for p38 MAPK and p47phox showed complete inhibition in ET-1?mediated MIP-1b mRNA expression, whereas control scRNA had no effect.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2010 Oct 15",
                "id": "20952681"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8942"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "IL13 in combination with IL1beta, caused synergistic increase in eotaxin release. There was 16 fold increase in eotaxin production when 100 ng/ml of IL13 and IL1beta were used. Treatment of cells with inhibitors of p38, ERK1/2 attenuated the eotaxin release.",
              "citation": {
                "type": "PubMed",
                "name": "J Neurochem 2000 Nov 75(5) 2020-8",
                "id": "11032891"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8941"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Histamine induced a time-dependent, H1 receptor-mediated activation of p38 MAP kinase (p38), p44/42 MAP kinase (ERK), and c-jun terminal NH2 kinase (JNK).",
              "citation": {
                "type": "PubMed",
                "name": "Circulation 2005 Jul 19 112(3) 341-9",
                "id": "16009787"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8940"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Substitution of either YY239/240 or Y317 also results in a defective activation of Rac and the coupled stress kinases JNK and p38. ",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2005 Mar 24 24(13) 2218-28",
                "id": "15688026"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad893f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "the p38 inhibitor SB203580 (SB) produced additive increases in StAR expression",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Endocrinol 2005 Feb 28 231(1-2) 95-107",
                "id": "15713539"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad893e"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Hypertension 1998 Oct 32(4) 661-7",
                "id": "9774360"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad893d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "These  results indicated that p38 MAPK regulates IL-12 p40 transcriptionally, at least  in part.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1999 Apr 1 18(7) 1845-57",
                "id": "10202148"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad893c"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "SOCS6 reduced SCF-induced activation of ERK1/2 and p38",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jan 5",
                "id": "14707129"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad893b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Western blot analysis of phospho-p38 MAPK gave similar results: combination treatment markedly increased phosphorylation of p38 compared with either IGF-I or TGF-beta1 treatment alone (Figure 7b).",
              "citation": {
                "type": "PubMed",
                "name": "J Invest Dermatol 2003 Jun 120(6) 956-62",
                "id": "12787120"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad893a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2003 Jul 285(1) C39-47",
                "id": "12606313"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8939"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2002 Oct 1 62(19) 5611-7",
                "id": "12359775"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8938"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Here, we demonstrate that p38alpha-/- cells fail to activate HIF-1 under hypoxic conditions.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2005 Jun 25(12) 4853-62",
                "id": "15923604"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8937"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "In this report we demonstrate that IL-12 activates mitogen-activated protein kinase kinase 3/6 (MKK) and p38 mitogen-activated protein kinase (MAPK), but not p44/42 (ERK) or stress-activated protein kinase/c-Jun N-terminal kinase MAPK. The activation of p38 MAPK is required for normal induction of IFN-gamma mRNA and IFN-gamma secretion by IL-12 in activated T cells and Th1 cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2000 Aug 1 165(3) 1374-80",
                "id": "10903740"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8936"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Phorbol ester-dependent activation of peroxiredoxin I gene expression via a protein kinase C, Ras, p38 mitogen-activated protein kinase signaling pathway. The data indicate that a protein kinase C, Ras, MEKK1, p38 MAPK signaling pathway plays a major role for the transcriptional up-regulation of Prx I gene expression.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Nov 14 278(46) 45419-34",
                "id": "12960165"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8935"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "In addition, JDP2 induced p38 activity in both C2 and RD cells programmed to differentiate.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Oct 18 277(42) 40043-54",
                "id": "12171923"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8934"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "the in vitro phosphorylation of GSTElk and GSTSap by immunoprecipitated p38 MAPK was abolished in the presence of the inhibitor SB202190, whereas the ability of the MAPK ERK-1 to phosphorylate these two TCFs was unaffected (Figure 1B).",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1997 Apr 1 16(7) 1620-7",
                "id": "9130707"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8933"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 2000 Dec 141(12) 4637-46",
                "id": "11108278"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8932"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "jubilant",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Crit Care Med 2002 Apr 15 165(8) 1161-71",
                "id": "11956062"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8931"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "As shown in Fig. 1A, the phosphorylation level of type 1 and type 2 JNKs was significantly increased within 60 min after H2O2 treatment, peaking (?5.5-fold, compared with the no treatment sample) at 2 h. The p38 and ERK proteins were also phosphorylated and activated in response to oxidative stress but to a substantially lesser than was JNK (Fig. 1B).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 Sep 28 282(39) 28395-407",
                "id": "17681939"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8930"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "MEHP also induced phosphorylation of MAPK p38, while the p38 inhibitor SB 202190 reduced MEHP-induced TNF-alpha, suggesting a p38-dependent cytokine production.",
              "citation": {
                "type": "PubMed",
                "name": "Inhal Toxicol 2010 Feb 22(2) 140-50",
                "id": "19938896"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad892f"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "From Cell Signaling Technologies Pathway Maps for p38 and JNK signaling.",
              "citation": {
                "type": "PubMed",
                "name": "Physiol Rev 2001 Apr 81(2) 807-69",
                "id": "11274345"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad892e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "We show that both HSP60s activate the stress-activated protein kinases p38 and JNK1/2, the mitogen-activated protein kinases ERK1/2, and the I-kappaB kinase (IKK).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Aug 17 276(33) 31332-9",
                "id": "11402040"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad892d"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Furthermore, TGF-beta1 rapidly activated the p38 mitogen-activated protein kinase (p38 MAPK) pathway in A549 cells.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2002 Nov 283(5) L1094-102",
                "id": "12376363"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad892c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "calcineurin promotes down-regulation of p38 MAPK activity and enhances expression of the dual specificity phosphatase MAPK phosphatase-1 (MKP-1).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 May 11 276(19) 15913-9",
                "id": "11279073"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad892b"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": "cardiac muscle"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Pretreatment of LNCaP cells with SB202190, PD98059, or tyrphostin AG879 [p38 mitogen-activated protein kinase (MAPK), MAP/extracellular signal-regulated protein kinase kinase 1/2, and ErbB2 MAPK inhibitors, respectively) but not wortmannin (PI3-kinase inhibitor) blocked IL-6-mediated induction of the PSA promoter, which demonstrates that IL-6 activity is dependent on a MAPK pathway.",
              "citation": {
                "type": "PubMed",
                "name": "Clin Cancer Res 2001 Jun 7(6) 1773-81",
                "id": "11410519"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad892a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "In the present study, we found that blocking alpha(v) integrin functionality with a function-blocking monoclonal antibody or down-regulating alpha(v) integrin expression with alpha(v)-specific antisense oligonucleotides significantly decreased the levels of active p38 MAPK and inhibited cell-associated uPA expression in invasive breast cancer MDA-MB-231 cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Dec 21 276(51) 47901-5",
                "id": "11606583"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8929"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "We found upregulation of several genes, including CYR6 (IGFBP10), FGF2, IGF1, IGFBP7, PDGFA, and PTHLH. The induction of these genes was suppressed by SD-208, but not by SD-282. In addition, down-regulation of several antiproliferative genes, such as BTG1, CD164, and GAS1, was observed. The regulation of these genes was strongly suppressed by SD-208, and not by SD-282, except for GAS1, which showed modest reversal by SD-282",
              "citation": {
                "type": "PubMed",
                "name": "Mol Pharmacol 2006 Aug 70(2) 518-31",
                "id": "16707625"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8928"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Thus, we conclude that RELT does not rely on the canonical TRAF pathways for its function, but instead uses a kinase, SPAK, to mediate p38 and JNK activation  RELT = TNFRSF19L SPAK = STK39",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2006 Apr 28 343(1) 125-34",
                "id": "16530727"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8927"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2002 Nov 283(5) L1094-102",
                "id": "12376363"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8926"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Fig. 7C and D shows that CSC at 0.1, 10 and 50 lg/ml concentration significantly induced the p38 kinase activity by 3.0, 3.78- and 4.92-fold, respectively. Effect of CSC on SAPK activity is shown in Fig. 7C and D. SAPK activity was significantly increased by 50 lg/ml of CSC concentration and this increase was found to be 5.0-fold with respect to control.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Lett 2008 Oct 18 270(1) 120-31",
                "id": "18550274"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8925"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "nhibition of p38 MAPK signaling with the specific SB203580 inhibitor totally prevented the H2O2-mediated activation of the two Sp1 binding sites of the caveolin-1 promoter (?244/?222 and ?124/?101; Fig. 3B)",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2006 Nov 15 66(22) 10805-14",
                "id": "17108117"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8924"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Overexpression of LAX in Jurkat cells specifically inhibits T cell receptor-mediated p38 MAPK activation and NFAT/AP-1 transcriptional activation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Nov 29 277(48) 46151-8",
                "id": "12359715"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8923"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "% We previously showed that MKP-7 suppresses MAPK activation in COS-7 cells in the order of selectivity, JNK >> p38 > ERK, but interacts with ERK as well as JNK and p38.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Aug 22 278(34) 32448-56",
                "id": "12794087"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8922"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Furthermore, anisomycin, a potent stimulus of SAPK and p38 MAP kinase, also induced MKP-1 mRNA expression.",
              "citation": {
                "type": "PubMed",
                "name": "Hypertension 1998 Oct 32(4) 661-7",
                "id": "9774360"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8921"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Furthermore, we demonstrate that anisomycin- and tumor necrosis factor-alpha-induced phosphorylation of p53 at Ser-392, which is important for the transcriptional activity of this growth suppressor protein, requires p38 MAP kinase and CK2 activities.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Jun 2 275(22) 16569-73",
                "id": "10747897"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8920"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Oxidative stress induces in endothelial cells a quick and transient coactivation of both stress-activated protein kinase-2/p38 and extracellular signal-regulated kinase (ERK) mitogen-activated protein kinases. We found that inhibiting the ERK pathway resulted, within 5 min of oxidative stress, in a misassembly of focal adhesions characterized by mislocalization of key proteins such as paxillin.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 2003 Apr 14(4) 1418-32",
                "id": "12686598"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad891f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Investigation into the downstream targets and mechanisms involved in ALK7-induced apoptosis revealed that the TGF-beta signaling intermediates, Smad2 and -3, were activated, as well as the MAPKs JNK and p38. In addition, caspase-3 and -9 were also activated, and cytochrome c release from the mitochondria was observed",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jul 2 279(27) 28458-65",
                "id": "15107418"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad891e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "PMA-induced galectin-3 overexpression was blocked by: protein kinase C inhibitors staurosporine, calphostin C, and apigenin; tyrosine-specific protein kinase inhibitors genistein and tyrphostin A25; PD 98059, a selective inhibitor of mitogen-activated protein kinase (MAPK) kinase 1 (MEK1 or MKK1); and SB 203580, a specific inhibitor of p38 MAPK",
              "citation": {
                "type": "PubMed",
                "name": "Biochim Biophys Acta 2003 Jun 17 1641(1) 13-23",
                "id": "12788225"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad891d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "In the absence of p38 activity, EGF fails to stimulate the ubiquitin ligase Cbl or ubiquitinylation of EGFR, and internalized EGFR accumulates in intracellular vesicles containing caveolin-1. These effects are accompanied by loss of EGFR phosphorylation on Y1045, a phosphorylation site required for Cbl activation.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2006 Dec 13 25(24) 5683-92",
                "id": "17139251"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad891c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "m1 muscarinic acetylcholine receptor induces p38 MAPK activation mediated by MKK3 and MKK6",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Jun 29 276(26) 23362-72",
                "id": "11304531"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad891b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "It has been shown recently that sole activation of the p38 pathway can lead to hypertrophy of cultured cardiomyocytes (43, 47).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1999 Jan 19(1) 21-30",
                "id": "9858528"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad891a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "cardiomyocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "PPM1A inhibited the activation of the p38 and JNK cascades induced by environmental stresses PPM1A dephosphorylated and inactivates MAPKKs (MKK6 and SEK1) and p38 in the stress-responsive MAPK cascades",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1998 Aug 17 17(16) 4744-52",
                "id": "9707433"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8919"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "We found that BPDE transiently increased the phosphorylation of p38 and Hdm2, and increased total p53 protein levels after 4 h of BPDE exposure (Figure 2A).",
              "citation": {
                "type": "PubMed",
                "name": "Carcinogenesis 2006 Nov 27(11) 2331-40",
                "id": "16774943"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8918"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Erk and p38 phosphorylate MNK1 and MNK2, which stimulates their in vitro kinase activity towards a substrate, EIF-4E",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1997 Apr 15 16(8) 1909-20",
                "id": "9155017"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8917"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Unexpectedly, in tumors induced by the K12D oncogene, the K-Ras mutant protein does not interact with Raf-1 nor activates the Erk canonical pathway. Instead, it transduces signals through the PI3K/Akt, JNK, p38 and FAK pathways.",
              "citation": {
                "type": "PubMed",
                "name": "Carcinogenesis 2006 Nov 27(11) 2190-200",
                "id": "16679305"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8916"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "treatment with SB203580, a specific inhibitor of p38 alpha and beta MAPKs",
              "citation": {
                "type": "PubMed",
                "name": "Development 2005 Apr 132(8) 1773-83",
                "id": "15772134"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8915"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Inhibition of p38 MAP kinase by SB203580 also partially suppressed the H2O2-initiated AR induction",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2001 Jul 15 31(2) 205-16",
                "id": "11440832"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8914"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": "Muscle, Smooth"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "We also show that p38 mitogen-activated protein kinase is activated within 10 min of DA treatment, which precedes the onset of apoptosis because the potent p38 kinase inhibitor SB203580 protects against DA-induced cell death as well as against caspase-9 and caspase-3 activation.",
              "citation": {
                "type": "PubMed",
                "name": "J Neurochem 2001 Jul 78(2) 374-83",
                "id": "11461973"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8913"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Carcinoma of brain",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Here, we have shown that MKK7, but not SEK1/ MKK4, is activated by Fas as an activator for JNK/ SAPK and that MKK6 is a major activator for p38 in Fas signaling",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 1997 Nov 17 139(4) 1005-15",
                "id": "9362518"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8912"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Here we show that CXCL12, complement factor 5a (C5a), hepatocyte growth factor (HGF) and platelet-derived growth factor (PDGF)-BB, which stimulate cell migration, also activate p38alpha MAPK. ",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2006 Nov 18(11) 1897-905",
                "id": "16574378"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8911"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Besides binding to specific elements in the ucp-1 enhancer, rosiglitazone has extragenic effects activating p38 mitogen-activated protein kinase (MAPK), a necessary signal for UCP-1 induction (Teruel et al. 2003).",
              "citation": {
                "type": "PubMed",
                "name": "Mini Rev Med Chem 2005 Mar 5(3) 269-78",
                "id": "15777261"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8910"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Adipocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Exp Med 2004 Feb 16 199(4) 449-58",
                "id": "14970175"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad890f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Aug 4 275(31) 23549-58",
                "id": "10806207"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad890e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "inhibitor of p38-MAPK reversed the influence of IL-1beta on tau phosphorylation and synaptophysin",
              "citation": {
                "type": "PubMed",
                "name": "J Neurosci 2003 Mar 1 23(5) 1605-11",
                "id": "12629164"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad890d"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "FGF-1-induced PN expression was blocked by the FGF-1 receptor antagonist PD-166866 and by inhibitors of phosphatidylinositol 3-kinase (PI3K) (LY-294002, wortmannin), p70S6K (rapamycin), MEK1/2 (U-0126, PD-98059), and p38MAPK (SB-203580) but not of JNK (SP-600125)",
              "citation": {
                "type": "PubMed",
                "name": "J Appl Physiol 2004 Oct 97(4) 1550-8; discussion 1549",
                "id": "15121739"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad890c"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": "Muscle, Smooth"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Both PD98059 and SB203580, inhibitors of ERK1/ERK2 and p38 strongly suppressed IL-1beta induced COX-2 expression in a dose dependent manner, indicating that they mediate IL-1beta induced COX-2 expression.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Pharmacol 2002 Nov 62(5) 1112-8",
                "id": "12391274"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad890b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "In addition, JDP2 induced p38 activity in both C2 and RD cells programmed to differentiate.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Oct 18 277(42) 40043-54",
                "id": "12171923"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad890a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "rhabdomyosarcoma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Ang II dramatically increased the phosphorylation of ERK1/2, JNK1/2 and p38 (Figure 2 A-C).",
              "citation": {
                "type": "PubMed",
                "name": "Exp Mol Med 2006 Oct 31 38(5) 525-34",
                "id": "17079869"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8909"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "minimally modified LDL (mmLDL) mainly activated components involved in stress response and apoptotic cell death including p38 mitogen-activated protein kinase (MAPK) and c-Jun N-terminal kinase/stress-activated protein kinase (JNK) as well as neutral and acid sphingomyelinase",
              "citation": {
                "type": "PubMed",
                "name": "Biochim Biophys Acta 2004 Oct 14 1690(2) 150-8",
                "id": "15469904"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8908"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Yet, nothing is known about the molecular mechanisms that couple VEGFR2 to SAPK2/p38. Here, we found that VEGF increased by twofold the activity of the small GTPase Cdc42 and that the expression of two different constitutively active forms of Cdc42 (Cdc42 V12 and Cdc42 L61) led to a marked increase in the formation of stress fibers that was sensitive to SAPK2/p38 inhibition by SB203580.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2004 Jan 15 23(2) 434-45",
                "id": "14724572"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8907"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium, Vascular"
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:FYN)",
        "relation": "actsIn",
        "target": "kin(p(HGNC:FYN))",
        "directed": false,
        "label": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8de2",
          "evidences": [
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "We observed that overexpression of active Src and Fyn resulted in tyrosine phosphorylation of RSK2....We identified that RSK2 was tyrosinephosphorylated at a group of tyrosine sites (Table 1), including Tyr-529 (spectra presented in Fig. 4B), due to expression of the constitutively activated Src and Fyn....As shown in Fig. 7, wild-type RSK2 CTD domain was highly tyrosine-phosphorylated at Tyr-529 by rSrc or rFyn, whereas Tyr-529 phosphorylation was abolished in the RSK2 CTD Y529F mutant (in vitro)",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2008 Feb 22 283(8) 4652-7",
                "id": "18156174"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8cf9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "In the present study, we identified a Rho GTPase-activating protein (GAP), TCGAP (Tc10/Cdc42 GTPase-activating protein), as a novel Fyn substrate. TCGAP interacted with Fyn and was phosphorylated by Fyn, with Tyr-406 in the GAP domain as a major Fyn-mediated phosphorylation site. Fyn suppressed the GAP activity of wild-type TCGAP but not the Y406F mutant of TCGAP in a phosphorylation-dependent manner, suggesting that Fyn-mediated Tyr-406 phosphorylation negatively regulated the TCGAP activity.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Aug 18 281(33) 23611-9",
                "id": "16777849"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8cf8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "We have studied the phosphorylation of the closely related lck, fyn, and c-src tyrosine protein kinases in leukemic murine T-cell lines that have lost the expression of CD45. The phosphorylation of the lck kinase at an inhibitory site of tyrosine phosphorylation, Tyr-505, was increased by two-, six-, and eightfold in three different cell lines. Phosphorylation of the fyn kinase at the homologous site, Tyr-531, was unaltered in one of these cell lines, but increased by 2.5-fold in the two others.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1993 Mar 13(3) 1651-6",
                "id": "8441403"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8cf7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "Here we have examined the role of p62(dok) in CD2-dependent signaling in Jurkat T cells. As previously reported, we find that ligation of the CD2 molecule by mitogenic pairs of anti-CD2 mAbs led to phosphorylation of p62(dok). While CD2-induced p62(dok) tyrosine phosphorylation was independent of both the p36/38 membrane adapter protein linker of activated T cells (LAT) and the ZAP70/Syk family of kinases, it was dependent upon the Src family of kinases including Lck and Fyn. We find further that CD2 engagement induced the association of tyrosine-phosphorylated p62(dok) to Crk-L. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Dec 7 276(49) 45654-61",
                "id": "11553620"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8cf6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "Significant tyrosine phosphorylation of cortactin, stable complex formation between activated Fyn and cortactin, and co-localization of cortactin with Fyn at cell membranes were all observed only in cells with high metastatic potential. Both integrin-mediated Fyn activation and hyperphosphorylation of cortactin were observed 2-5 h after stimulation in highly metastatic cells, and they required de novo protein synthesis. We demonstrate that cortactin is a specific substrate and cooperative effector of Fyn in integrin-mediated signaling processes regulating metastatic potential.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Nov 28 278(48) 48367-76",
                "id": "13129922"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8cf5"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "In this study, we provide evidence that the VEGF-dependent tyrosine phosphorylation of caveolin-1 induces interaction of the protein with the membrane-type 1 matrix metalloproteinase (MT1-MMP). This interaction requires the phosphorylation of caveolin-1 on tyrosine 14 by members of the Src family of protein kinases, such as Src and Fyn, because it is completely abolished by expression of a catalytically inactive Src mutant or by site-directed mutagenesis of tyrosine 14 of caveolin-1. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Dec 10 279(50) 52132-40",
                "id": "15466865"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8cf4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "A caveolin peptide derived from this region (residues 82-101) functionally suppressed the auto-activation of purified recombinant c-Src tyrosine kinase and Fyn, a related Src family tyrosine kinase. We further analyzed the effect of caveolin on c-Src activity in vivo by transiently co-expressing full-length caveolin and c-Src tyrosine kinase in 293T cells. Co-expression with caveolin dramatically suppressed the tyrosine kinase activity of c-Src as measured via an immune complex kinase assay. Thus, it appears that caveolin structurally and functionally interacts with wild-type c-Src via caveolin residues 82-101. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1996 Nov 15 271(46) 29182-90",
                "id": "8910575"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8cf3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "To determine if Src family kinases (SFKs) are involved, we demonstrated that CSF-1 activated Fyn and Lyn in cells expressing wild-type (WT) or DeltaKI receptors. Moreover, CSF-1-induced Akt activity in cells expressing DeltaKI is SFK dependent since Akt activation was prevented by pharmacological or genetic inhibition of SFK activity. The docking protein Gab2 may link SFK to PI3-kinase. CSF-1 induced Gab2 tyrosyl phosphorylation and association with PI3-kinase in cells expressing WT or DeltaKI receptors. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2000 Sep 20(18) 6779-98",
                "id": "10958675"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8cf2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "Given that the three ubiquitously expressed SFK members c-Src, Fyn, and Yes have been previously identified in 3T3-L1 cells (34) , we immunoprecipitated Src, Fyn, and Yes from IGF-I-stimulated proliferating cells and measured kinase activity with an in vitro assay using enolase as a substrate (35) . IGF-I stimulated c-Src kinase activity in proliferating cells at a peak stimulation time of 1 min (Fig. 5A)Citation . The kinetics of IGF-I-stimulated c-Src and MAPK are consistent with SFK activation occurring upstream of MAPK: both activities are back to baseline by 10 min, and our previous studies demonstrated peak MAPK activation was at 5 min (15) . IGF-I stimulation of c-Src and Fyn activity was comparable, ~3-fold more than baseline, and dependent on immunoprecipitation with specific antibodies (Fig. 5B)Citation . IGF-I activation of both c-Src and Fyn is not surprising,",
              "citation": {
                "type": "PubMed",
                "name": "Cell Growth Differ 2001 Jul 12(7) 379-86",
                "id": "11457735"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8cf1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "Basic fibroblast growth factor (FGF)-2 induced a specific signaling response within the caveolae-like domain of LAN-1 cells, characterized by the tyrosine phosphorylation of a 75-80-kDa protein. This protein present in the caveolae-like domains has properties suggesting that it is a member of the SNT family of adapter proteins. The signaling event originating in the caveolae-like domains in response to FGF-2 appeared to require the activation of at least Fyn and Lyn, two members of the Src family of tyrosine kinases.",
              "citation": {
                "type": "PubMed",
                "name": "J Neurochem 2000 Feb 74(2) 676-83",
                "id": "10646519"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8cf0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "Using Fyn as bait, p190 RhoGAP was isolated in the screen of an oligodendrocyte cDNA library. Coimmunoprecipitation and in vitro binding assays verified that p190 RhoGAP bound to the Fyn SH2 domain. These findings define a pathway in which Fyn activity regulates the phosphorylation of p190, leading to an increase in RhoGAP activity with a subsequent increase in RhoGDP, which in turn, regulates the morphological changes that accompany oligodendrocyte differentiation.   ",
              "citation": {
                "type": "PubMed",
                "name": "J Neurobiol 2001 Oct 49(1) 62-78",
                "id": "11536198"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8cef"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "oligodendrocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "Caveolin-1 functions as a membrane adaptor to link the integrin alpha subunit to the tyrosine kinase Fyn. Upon integrin ligation, Fyn is activated and binds, via its SH3 domain, to Shc. Shc is subsequently phosphorylated at tyrosine 317 and recruits Grb2. This sequence of events is necessary to couple integrins to the Ras-ERK pathway and promote cell cycle progression. These findings reveal an unexpected function of caveolin-1 and Fyn in integrin signaling and anchorage-dependent cell growth.",
              "citation": {
                "type": "PubMed",
                "name": "Cell 1998 Sep 4 94(5) 625-34",
                "id": "9741627"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8cee"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "TNF-alpha activated multiple PTKs, including src family PTKs.To identify which src family kinase(s) was required for TNF-alpha-induced vascular permeability, small interfering RNA (siRNA) targeting each of the three src family PTKs expressed in human EC, c-src, fyn, and yes, were introduced into the barrier function assay. Only fyn siRNA protected against the TNF-alpha effect, whereas the c-src and yes siRNAs did not. ",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2006 Dec 291(6) L1232-45",
                "id": "16891393"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8ced"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium, Vascular"
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "Caveolin-1 is a substrate for nonreceptor tyrosine kinases including Src, Fyn, and Abl.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Mar 15 277(11) 8771-4",
                "id": "11805080"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8afa"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "Furthermore, dominant negative Fyn decreases the ability of squamous carcinoma cells to invade through Matrigel in vitro and to form lung metastases following intravenous injection in nude mice. ",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2001 Oct 29 155(3) 447-58",
                "id": "11684709"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8af9"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "squamous cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "Transient expression of mSKAP55R in COS cells demonstrated that tyrosine 260 was the predominant site of phosphorylation by FYN kinase. Furthermore, this phosphotyrosine was essential for coimmunoprecipitation of FYN with mSKAP55R",
              "citation": {
                "type": "PubMed",
                "name": "Exp Hematol 2000 Nov 28(11) 1250-9",
                "id": "11063873"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8af8"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "IL-6 induced the activation and tyrosine phosphorylation of p59Fyn, p56/59Hck, and p56Lyn.",
              "citation": {
                "type": "PubMed",
                "name": "Exp Hematol 1997 Dec 25(13) 1367-77",
                "id": "9406996"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8af7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Multiple Myeloma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "In a human embryonic kidney (HEK) 293 cell expression system, PTPalpha enhanced fyn-mediated NR2A and NR2B tyrosine phosphorylation by several-fold.",
              "citation": {
                "type": "PubMed",
                "name": "J Neurochem 2006 Sep 98(6) 1798-809",
                "id": "16899073"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8af6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "Carlos Ibanez and collaborators demonstrated that neural cell adhesion molecule (NCAM) functions as an alternative signaling receptor for GFLs (fig. 2). In the presence of GFR-a, GDNF binds with high affinity to p140-NCAM and intracellularly activates the Src-like kinase c-Fyn and the focal adhesion kinase FAK [29].",
              "citation": {
                "type": "PubMed",
                "name": "Cell Mol Life Sci 2004 Dec 61(23) 2954-64",
                "id": "15583857"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8af5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "Fyn, by phosphorylating a residue located in the regulatory domain of p120-catenin (Tyr112), inhibits the interaction of this protein with RhoA",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2007 Mar 27(5) 1745-57",
                "id": "17194753"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8af4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "Further experiments with small interfering RNA revealed that Fyn phosphorylated Nrf 2Y568 leading to nuclear export and degradation of Nrf 2.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Apr 28 281(17) 12132-42",
                "id": "16513647"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8af3"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "exposure to PDGF resulted in a marked increase in c-Src, Fyn, and Yes kinase activities",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 2005 Nov 16(11) 5418-32",
                "id": "16135530"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8af2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "Yes tyrosine kinase also binds to p120 catenin but only upon activation, and stimulates Fer and Fyn tyrosine kinases. p120 catenin acts as a docking protein facilitating the activation of Fer/Fyn tyrosine kinases by Yes",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2003 Apr 23(7) 2287-97",
                "id": "12640114"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8af1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "Recently, it was shown that Fyn is one of the kinases responsible for the phosphorylation of caveolin",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Invest 1999 Apr 103(7) 931-43",
                "id": "10194465"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8af0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "These observations collectively suggest that Fyn plays critical roles in promoting accelerated MBP expression during myelinogenesis in a MBP isoform-preferential manner, and QKI may act in the same pathway downstream of Fyn for MBP mRNA homeostasis.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Jan 7 280(1) 389-95",
                "id": "15528192"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8aef"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "oligodendrocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "Lyn-deficient Mast Cells Show Increased Fyn Kinase Activity.",
              "citation": {
                "type": "PubMed",
                "name": "J Exp Med 2004 Jun 7 199(11) 1491-502",
                "id": "15173205"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8aee"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "Mutational analysis revealed that tyrosine 271 in SKAP55 played a pivotal role for interaction with both Fyn kinase and adapter protein Grb-2, indicating that the Fyn-phosphorylated SKAP55 transiently associates with adapter Grb-2 to mediate mitogen-activated protein kinase activation. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Oct 25 277(43) 40420-7",
                "id": "12171928"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8aed"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "p250GAP is tyrosine phosphorylated by Fyn",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2003 Jun 20 306(1) 151-5",
                "id": "12788081"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8aec"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Jan 5 276(1) 693-9",
                "id": "11024032"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8aeb"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "Recombinant PSD-93 was phosphorylated by Fyn in vitro, and Tyr-384 was identified as a major phosphorylation site",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Nov 28 278(48) 47610-21",
                "id": "13129934"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8aea"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "We found that UVB only stimulated ERKs (Thr-202/Tyr-204) and Akt (serine 473) phosphorylation (Fig. 8, E and G) but not p38 MAP kinase or JNKs (Fig. 8, A and C) in WT-Fyn cells. ERKs and Akt were not affected by UVB in DNM-Fyn cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Jan 28 280(4) 2446-54",
                "id": "15537652"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8ae9"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "and dominant-negative and constitutively active Fyn mutants rescue and recapitulate the Sca-1 antisense phenotype, respectively.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 2004 Dec 1 117(Pt 25) 6185-95",
                "id": "15546912"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8ae8"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": "Muscle, Skeletal"
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "The phosphorylation generated a consensus sequence for the binding of the SH2 domain of Grb2 (pYSN). Pull-down assays with SH2-Grb2 from human fetal brain homogenates, and co-immunoprecipitation of Grb2 and MAP-2 confirmed the interaction in vivo, and demonstrated that MAP-2c is tyrosine-phosphorylated in human fetal brain. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Jan 21 280(3) 1962-70",
                "id": "15536091"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8ae7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "Depletion of Sam68 by RNA interference caused accumulation of antiapoptotic Bcl-x(L), whereas its up-regulation increased the levels of proapoptotic Bcl-x(s). Tyrosine phosphorylation of Sam68 by Fyn inverted this effect and favored the Bcl-x(L) splice site selection. ",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2007 Mar 26 176(7) 929-39",
                "id": "17371836"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8ae6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "We also provide evidence that upon CD43 cross-linking, Fyn is tyrosine-phosphorylated in a time-dependent manner. Our results suggest that CD43 cross-linking on the T cell surface induces the interaction between CD43 and Fyn, presumably through the Fyn SH3 domain and a putative SH3 binding site in CD43, leading to Fyn tyrosine phosphorylation and signal propagation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1996 Nov 1 271(44) 27564-8",
                "id": "8910342"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8ae5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "lymphocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "However, Fyn-deficient mast cells showed a significant reduction in phosphorylation of Shp2 phosphatase and p38 mitogen-activated protein kinase. ",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2006 Sep 18(9) 1447-54",
                "id": "16442778"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8ae4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "mast cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2002 Apr 22(8) 2673-86",
                "id": "11909961"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8ae3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "Both SKAP55 and SKAP55R were found to bind FYB through their SH3 domains and to act as substrates for the FYN kinase in T cells",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 1998 Jul 21 95(15) 8779-84",
                "id": "9671755"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8ae2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "ROS activate Fyn, which phosphorylates JAK2",
              "citation": {
                "type": "PubMed",
                "name": "Arterioscler Thromb Vasc Biol 2002 Dec 1 22(12) 1962-71",
                "id": "12482820"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8ae1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "TCR mediated activation of protein tyrosine kinases, such as lck (LCK), fyn (FYN), and ZAP-70 occurs, resulting in the phosphorylation of a number of substrates, including the transmembrane adaptor proteins LAT and TRIM, which can both bind, and therefore recruit PI3K",
              "citation": {
                "type": "PubMed",
                "name": "Mol Immunol 2002 Jun 38(15) 1087-99",
                "id": "12044776"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8ae0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "JAK2 tyrosine kinase and the Src family p59 Fyn tyrosine kinase are required for Ang II-induced STAT1 tyrosine phosphorylation in VSMCs.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Jul 9 274(28) 19846-51",
                "id": "10391929"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8adf"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": "vascular smooth muscle"
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "Because Fyn is the kinase primarily responsible for the phosphorylation of PAG (the phosphoprotein associated with glycosphingolipid-enriched microdomains), which negatively regulates Src-kinase activity by recruiting Csk (the C-terminal Src kinase) to the membrane, we investigated whether anergy induction also affects PAG.",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2007 Jul 15 110(2) 596-625",
                "id": "17389760"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8ade"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "lymphocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "Activation of tyrosine kinases Fyn and Lyn, but not Lck, also occurred within 2 min after PAF stimulation in the cells",
              "citation": {
                "type": "PubMed",
                "name": "Prog Lipid Res 2000 Jan 39(1) 41-82",
                "id": "10729607"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8add"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Apr 16 279(16) 16311-6",
                "id": "14761954"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8adc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "This phosphorylation was mediated by Src family tyrosine kinases (STKs), with Fyn appearing to be the dominant kinase. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Nov 11 280(45) 37974-87",
                "id": "16144838"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8adb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "In Fyn-/- fibroblasts, activation of Ras by H(2)O(2) was significantly attenuated.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Jan 21 275(3) 1739-48",
                "id": "10636870"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8ada"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "The activated GSK-3beta phosphorylates Fyn at threonine residue(s). Phosphorylated Fyn accumulates in the nucleus and phosphorylates Nrf2 at tyrosine 568. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 Jun 1 282(22) 16502-10",
                "id": "17403689"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8ad9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "We examined the effect of PEDF on kinase activity of Fyn and found that PEDF downregulated FGF-2-promoted Fyn activity by tyrosine phosphorylation at the C-terminus in a Fes-dependent manner. ",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 2005 Mar 1 118(Pt 5) 961-70",
                "id": "15713745"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8ad8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "Sema3A promotes Cdk5 activity through phosphorylation of Tyr15, a phosphorylation site with Fyn.",
              "citation": {
                "type": "PubMed",
                "name": "Neuron 2002 Aug 29 35(5) 907-20",
                "id": "12372285"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8ad7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "neuron",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "These data suggest that Fyn prefers Y731 to other tyrosines in the C-terminus of c-Cbl.",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 2004 Nov 19 577(3) 555-62",
                "id": "15556646"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8ad6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "PTP? is required for SCF-induced c-Kit and Fyn activation, and in this way regulates a Fyn-based c-Kit signaling axis (Fyn/Gab2/Shp2/Vav/PAK/Rac/JNK) that mediates mast cell migration.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2010 Nov 15 185(10) 5993-6002",
                "id": "20944008"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8ad5"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "mast cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "RESULTS: Immunoprecipitation experiments showed that Crk-associated substrate (Cas) was tyrosine-phosphorylated in response to ethanol administration. Fyn kinase was shown to be activated by ethanol administration and to phosphorylate Cas on tyrosine residue in vitro. CONCLUSIONS: Cas was tyrosine-phosphorylated in rat brain by ethanol administration, and Fyn kinase was most likely involved in the process.",
              "citation": {
                "type": "PubMed",
                "name": "Alcohol Clin Exp Res 2002 Aug 26(8 Suppl) 38S-43S",
                "id": "12198373"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8ad4"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "96108162;12522270;16094384;15659558",
              "citation": {
                "type": "PubMed",
                "name": "BMC Bioinformatics 2004 Jun 22 5 79",
                "id": "15212693"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8ad3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "\\\"Ly-6A is required for T cell receptor expression and protein tyrosine kinase fyn activity.\\\"",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1994 May 1 13(9) 2167-76",
                "id": "8187770"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8ad2"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "We conclude that p59(fyn) and p56(lck) differently participate in regulating the phosphorylation state of Sam68 in T cells and that ZAP-70 may contribute to Sam68 tyrosine phosphorylation and to the specific recruitment of this molecule after CD3 stimulation.",
              "citation": {
                "type": "PubMed",
                "name": "Eur J Immunol 1997 Dec 27(12) 3360-7",
                "id": "9464824"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8ad1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "Caveolin-1 is phosphorylated on Tyr(14) in response to both oxidative and hyperosmotic stress. In the present paper, we show that this phosphorylation requires activation of the Src family kinase Fyn. ",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2003 Nov 15 376(Pt 1) 159-68",
                "id": "12921535"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8ad0"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "Increased PRK2 expression induces catenin tyrosine phosphorylation and Fyn activation Tyrosine phosphorylation of beta and gamma catenin and p120ctn was also induced by PRK2 overexpression",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2002 Jan 7 156(1) 137-48",
                "id": "11777936"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8acf"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "CD146 cross-linking induces the tyrosine phosphorylation of the protein tyrosine kinase p125(FAK) as well as p125(FAK) association with paxillin, both events being inhibited by cytochalasin D. No direct association of CD146 with p125(FAK) was observed. Consistent with these data, CD146 associates with p59(fyn), a Src family kinase known to phosphorylate p125(FAK).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1998 Oct 9 273(41) 26852-6",
                "id": "9756930"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8ace"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "we found that PP2, a Fyn kinase inhibitor (33), and leflunomide, an Src kinase inhibitor (34), markedly inhibited the UVB-induced phosphorylation of histone H3 at serine 10 in a dose-dependent manner (Fig. 4, A and C, respectively) but did not change the total histone H3 protein level (Fig. 4, B and D).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Jan 28 280(4) 2446-54",
                "id": "15537652"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8acd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "Transient expression of actively mutated Fyn, having Phe-528 instead of Tyr-528, in Jurkat T cells stimulated the fos promoter and serum response element (SRE), suggesting that the Fyn kinase stimulates c-fos expression through SRE.",
              "citation": {
                "type": "PubMed",
                "name": "Princess Takamatsu Symp 1991 22 293-305",
                "id": "1668889"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8acc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "Exogenous Fyn kinase was shown to phosphorylate on tyrosine residue(s) of Cbl from the cerebellum in vitro.",
              "citation": {
                "type": "PubMed",
                "name": "Brain Res 2002 Sep 20 950(1-2) 203-9",
                "id": "12231245"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8acb"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "upon ligation of the integrin beta6 with fibronectin, beta6 complexed with Fyn and activated it.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Oct 24 278(43) 41646-53",
                "id": "12917446"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8aca"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "PTPalpha-null thymocytes develop normally, but unstimulated PTPalpha-/- cells exhibit increased tyrosine phosphorylation of specific proteins, increased Fyn activity, and hyperphosphorylation of Cbp/PAG that promotes its association with C-terminal Src kinase. Elevated Fyn activity in the absence of PTPalpha is due to enhanced phosphorylation of Fyn tyrosines 528 and 417. ",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2005 Dec 15 175(12) 7947-56",
                "id": "16339530"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8ac9"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "lymphocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "However, purified EGFR did not phosphorylate recombinant PKC delta in vitro, whereas members of the Src family (c-Src, c-Fyn) and membrane preparations from keratinocytes did. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1996 Mar 8 271(10) 5325-31",
                "id": "8621384"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8ac8"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "Hck negatively regulates Lyn, and Lyn negatively regulates Fyn",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2007 May 18",
                "id": "17513616"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8ac7"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "mast cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "Fyn but not JAK2 is the major kinase that phosphorylates Cbl",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Jan 22 274(4) 2097-106",
                "id": "9890970"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8ac6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 1997 Dec 18 241(2) 355-62",
                "id": "9425276"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8ac5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "Srcasm itself exerts a negative feedback, as it inhibits its activator, the Src kinase Fyn (Li et al., 2007).",
              "citation": {
                "type": "PubMed",
                "name": "J Invest Dermatol 2008 Mar 128(3) 501-16",
                "id": "18268536"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8ac4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "As shown in Fig. 2A, whereas hypertonic induction for 4 h greatly stimulated the ORE-SVLuc activity in mock-transfected cells, co-transfection with increasing amounts of pCMV-FynDN resulted in an incremental reduction in the hypertonicity-induced ORE-Luc activity.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Nov 29 277(48) 46085-92",
                "id": "12359721"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8ac3"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "PKCh is a direct upstream activator of Fyn; PKCh associates with, and activates Fyn, leading to keratinocyte growth arrest and differentiation",
              "citation": {
                "type": "PubMed",
                "name": "J Biochem (Tokyo) 2002 Dec 132(6) 853-7",
                "id": "12473186"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8ac2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "The LHR-mediated phosphorylation of the EGFR and Shc, the activation of Ras, and the phosphorylation of ERK1/2 are inhibited by expression of a dominant-negative mutant of Fyn, a member of the Src family kinases (SFKs) expressed in MA-10 cells and by PP2, a pharmacological inhibitor of the SFKs. ",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 2006 Jul 147(7) 3419-27",
                "id": "16614081"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8ac1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "In heterogeneous COS-1 cells, Cbl-b was phosphorylated on tyrosine residues by both Syk- (Syk/Zap-70) and Src- (Fyn/Lck) family kinases",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1999 Feb 4 18(5) 1147-56",
                "id": "10022120"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8ac0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "Importantly, tyrosine phosphorylation of Itch appears to reduce its interaction with its substrate JunB. The turnover of JunB is accelerated in Fyn-deficient T cells, which is further reconstituted by Itch Tyr371 mutation. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2006 Jan 6 21(1) 135-41",
                "id": "16387660"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8abf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "lymphocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "PRAP was found to function as a substrate for Src family kinases, such as c-Src or Fyn, but not for Pyk2/RAFTK",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Oct 24 278(43) 42225-33",
                "id": "12893833"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8abe"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "In Fyn-/- fibroblasts, activation of Ras by H(2)O(2) was significantly attenuated.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Jan 21 275(3) 1739-48",
                "id": "10636870"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8abd"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "Upon integrin binding to ECM, Fyn becomes activated, and its SH3 domain interacts with a proline-rich site in Shc. Shc is then phosphorylated by Fyn at Tyr317 and combines with the Grb2-mSOS complex (4) (Fig. 3B).",
              "citation": {
                "type": "PubMed",
                "name": "Science 1999 Aug 13 285(5430) 1028-32",
                "id": "10446041"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8abc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Virol 1991 Jan 65(1) 170-9",
                "id": "1985196"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8abb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "Reconstitution of complexes containing p62 and the src family kinase p59fyn in HeLa cells demonstrated that complex formation resulted in tyrosine phosphorylation of p62 and was mediated by both the SH3 and SH2 domains of p59fyn.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1995 Jan 15(1) 186-97",
                "id": "7799925"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8aba"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "Data presented here demonstrate that epidermal growth factor (EGF) receptor ligands promote the tyrosine phosphorylation of endogenous and adenovirally transduced Srcasm in keratinocytes, and that increased levels of Srcasm activate endogenous SFKs, with a preference for Fyn and Src. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Feb 18 280(7) 6036-46",
                "id": "15579470"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8ab9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Nov 28 278(48) 47610-21",
                "id": "13129934"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8ab8"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "The Csk tyrosine kinase negatively regulates the Src family kinases Lck and Fyn in T cells.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2005 Mar 25(6) 2227-41",
                "id": "15743820"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8ab7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "Cotransfection of tau and kinases showed that Tyr-18 was the major site for Fyn phosphorylation, but Tyr-394 was the main residue for Abl.",
              "citation": {
                "type": "PubMed",
                "name": "J Neurosci 2005 Jul 13 25(28) 6584-93",
                "id": "16014719"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8ab6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "Interaction with DAF also activates Fyn kinase, an event that is required for the phosphorylation of caveolin and transport of virus into the cell within caveolar vesicles.",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2006 Jan 13 124(1) 119-31",
                "id": "16413486"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8ab5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "We found previously that a Src type tyrosine kinase Fyn and cyclin-dependent kinase 5 (Cdk5) mediate Sema3A-signaling.",
              "citation": {
                "type": "PubMed",
                "name": "J Neurosci 2004 Jul 7 24(27) 6161-70",
                "id": "15240808"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8ab4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "nterestingly, we also observed that APOBEC3G can be phosphorylated on tyrosine in the presence of Fyn or Hck, suggesting that both kinases may regulate APOBEC3G function. ",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2005 Apr 15 329(3) 917-24",
                "id": "15752743"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8ab3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "lymphocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 1998 Apr 1 160(7) 3305-14",
                "id": "9531288"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8ab2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "Employing fyn-deficient mouse embryonic fibroblast cells and tissues, we demonstrate that fyn is essential for phosphorylating PIKE-A and protects it from apoptotic cleavage. Active but not kinase-dead fyn interacts with PIKE-A and phosphorylates it on both Y682 and Y774 residues. ",
              "citation": {
                "type": "PubMed",
                "name": "Cell Death Differ 2007 Feb 14(2) 368-77",
                "id": "16841086"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8ab1"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2002 Feb 1 99(3) 957-65",
                "id": "11806999"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8ab0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "The CD45 tyrosine phosphatase has been reported to activate the src family tyrosine kinases Lck and Fyn by dephosphorylating regulatory COOH-terminal tyrosine residues 505 and 528, respectively. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1996 Sep 16(9) 4996-5003",
                "id": "8756658"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8aaf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "lymphocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "Fyn plays an essential role by positive regulation of Lck activity.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2004 Oct 12 101(41) 14859-64",
                "id": "15465914"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8aae"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "naive T-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "2) both Fyn and Lck are capable of phosphorylating DAP12; and 3) both kinases coimmunoprecipitate with the Ly-49D/DAP12 complex in NK cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2006 Jun 1 176(11) 6615-23",
                "id": "16709819"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8aad"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "Moreover, activation of the LHR in MA-10 cells results in the stimulation of the activity of Fyn and Yes, and overexpression of either of these two tyrosine kinases enhances the LHR-mediated phosphorylation of FAK-Tyr576. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Endocrinol 2006 Mar 20(3) 619-30",
                "id": "16293639"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8aac"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "Here we show that 3BP2 is tyrosine phosphorylated following BCR aggregation on B lymphoma cells, and that 3BP2 is a substrate for Syk and Fyn, but not Btk. ",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2005 Feb 1 105(3) 1106-13",
                "id": "15345594"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8aab"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "PKC-eta activity is both necessary and sufficient for Fyn activation, PKC-eta and Fyn are found in association, and recombinant PKC-eta directly activates Fyn. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2000 Nov 6(5) 1121-9",
                "id": "11106751"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8aaa"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "p90RSK activation by H(2)O(2) was significantly reduced in fibroblasts derived from transgenic mice deficient in Fyn, but not c-Src. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Jan 21 275(3) 1739-48",
                "id": "10636870"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8aa9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "Immunoprecipitation experiments showed that the amount of coimmunoprecipitated Fyn kinase with an anti-Cbl antibody increased in extracts from ethanol-administered rats compared to those from saline-administered rats. Exogenous Fyn kinase was shown to phosphorylate on tyrosine residue(s) of Cbl from the cerebellum in vitro.",
              "citation": {
                "type": "PubMed",
                "name": "Brain Res 2002 Sep 20 950(1-2) 203-9",
                "id": "12231245"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8aa8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1996 Sep 16(9) 4735-43",
                "id": "8756631"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8aa7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "alpha PTP phosphorylation occurred at Tyr789 and required SFKs (Src or Fyn/Yes), FAK, and an intact cytoskeleton.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Apr 28 281(17) 11972-80",
                "id": "16507567"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8aa6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "Hypertonicity provoked Fyn-dependent tyrosine phosphorylation in beta-catenin, alpha-catenin, and p120(Cas) and caused the dissociation of beta-catenin from the contacts.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Oct 13 275(41) 32289-98",
                "id": "10921917"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8aa5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "In transfected COS cells, Dok-4 was a substrate for the cytosolic tyrosine kinases Src and Fyn as well as for Jak2. Dok-4 could also be phosphorylated by the receptor tyrosine kinase Ret ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Apr 30 279(18) 19335-49",
                "id": "14963042"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8aa4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "In response to PDGF, Fyn associated with PKCdelta via tyrosine 187. Finally, overexpression of dominant negative Fyn abrogated the decrease in GS expression and reduced the tyrosine phosphorylation of PKCdelta induced by PDGF. We conclude that the tyrosine phosphorylation of PKCdelta and its association with tyrosine kinases may be an important point of divergence in PKC signaling.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Nov 10 275(45) 35491-8",
                "id": "10945993"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8aa3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2001 Oct 19 288(1) 233-9",
                "id": "11594778"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8aa2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "Following the anti-PrPc antibody-mediated stimulation of live GN11 cells, we observed that PrPc clustered on plasma membrane domains rich in Cav-1 in which Fyn kinase converged to be activated. After these events, a signaling cascade through p42/44 MAP kinase (Erk 1/2) was triggered, suggesting that following translocations from rafts to caveolae or caveolae-like domains PrPc could interact with Cav-1 and induce signal transduction events.",
              "citation": {
                "type": "PubMed",
                "name": "J Biomed Biotechnol 2006 2006(5) 69469",
                "id": "17489019"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8aa1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "neuron",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "This hypothesis is supported by the findings that shear stress activation of ERK is inhibited by a polyclonal antiCav-158 and that shear stress can activate Fyn (S. Jalali, S. Chien, unpublished data, 1998).",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 2002 Nov 1 91(9) 769-75",
                "id": "12411390"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8aa0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "N.N.;12374739",
              "citation": {
                "type": "PubMed",
                "name": "BMC Bioinformatics 2004 Jun 22 5 79",
                "id": "15212693"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a9f"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "EGF-R causes disassembly of hemidesmosomes by activating Fyn, which in turn phosphorylates the beta4 cytoplasmic domain. Neoplastic cells expressing dominant negative Fyn display increased hemidesmosomes and migrate poorly in vitro in response to EGF.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2001 Oct 29 155(3) 447-58",
                "id": "11684709"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a9e"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "Hence, we identified p59fyn and p53/56lyn to be stimulated by IL-7.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 1994 Jul 1 153(1) 97-109",
                "id": "7515933"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a9d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "The functional significance of pp115 association with p59fyn is suggested by the ability of alpha 4 integrin stimulation to activate Fyn tyrosine kinase activity. ",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 1997 Nov 15 159(10) 4806-14",
                "id": "9366405"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a9c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "lymphocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Feb 9 276(6) 3879-84",
                "id": "11078745"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a9b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "and dominant-negative and constitutively active Fyn mutants rescue and recapitulate the Sca-1 antisense phenotype, respectively.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 2004 Dec 1 117(Pt 25) 6185-95",
                "id": "15546912"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a9a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "Consistent with an involvement of this kinase, fyn-deficient keratinocytes have strongly decreased tyrosine phosphorylation levels of beta- and gamma-catenins and p120-Cas, and structural and functional abnormalities in cell adhesion similar to those caused by tyrosine kinase inhibitors.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 1998 Jun 15 141(6) 1449-65",
                "id": "9628900"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a99"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "In cells lacking RET, GDNF binds with high affinity to the NCAM and GFRalpha1 complex, which activates Fyn and FAK.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 2003 Oct 1 116(Pt 19) 3855-62",
                "id": "12953054"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a98"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "Using dominant-negative mutants of c-Src and Fyn and Src-deficient SYF cells as well as by co-immunoprecipitation studies, we can demonstrate that the M2R-mediated transactivation of EGFR specifically involves Fyn but not c-Src or Yes. ",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2006 Aug 18(8) 1338-49",
                "id": "16337776"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a97"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "Biochemical and in vitro experiments implicate Src and Fyn in the Reelin-dependent tyrosine phosphorylation of Dab1, which controls the positioning of radially migrating neurons in many brain regions. ",
              "citation": {
                "type": "PubMed",
                "name": "J Neurosci 2005 Sep 14 25(37) 8578-86",
                "id": "16162939"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a96"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "Kinase-active Lck complexes with and activates Fyn",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2008 Sep 26 283(39) 26409-22",
                "id": "18660530"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a95"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "Furthermore, we show that NRG1 signaling, through activation of Fyn and Pyk2 kinases, stimulates phosphorylation of Y1472 on the NR2B subunit of the NMDA receptor (NMDAR), a key regulatory site that modulates channel properties. ",
              "citation": {
                "type": "PubMed",
                "name": "J Neurosci 2007 Apr 25 27(17) 4519-29",
                "id": "17460065"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a94"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "SK is activated following FcepsilonRI aggregation at the surface of mast cells in a LYN- and FYN-dependent manner78, and this results in the phosphorylation of lipid-raft associated sphingosine to form S1P 79,80.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Immunol 2006 Mar 6(3) 218-30",
                "id": "16470226"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a93"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "mast cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "Src is associated with c-Cbl, and we have previously demonstrated that the Src-like kinase Fyn can phosphorylate c-Cbl at a preferred binding site for the p85 subunit of phosphatidylinositol 3'-kinase. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Jul 12 277(28) 24967-75",
                "id": "11994282"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a92"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Mol Pharmacol 2002 Sep 62(3) 672-9",
                "id": "12181444"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a91"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "We show that the overactive FGFR2 S252W mutation induced decreased Src family kinase tyrosine phosphorylation and activity associated with decreased Lyn and Fyn protein expression in human osteoblasts. Thus, constitutive FGFR2 activation induces c-Cbl-dependent Lyn and Fyn proteasome degradation, resulting in reduced Lyn and Fyn kinase activity, increased ALP expression, and FGFR2 down-regulation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Aug 27 279(35) 36259-67",
                "id": "15190072"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a90"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "Pleiotrophin (PTN the protein, Ptn the gene) signals downstream targets through inactivation of its receptor, the transmembrane receptor protein tyrosine phosphatase (RPTP)beta zeta We further demonstrate that Fyn is a substrate of RPTPbeta zeta, and that tyrosine phosphorylation of Fyn is sharply increased in PTN-stimulated cells.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2005 Jul 8 332(3) 664-9",
                "id": "15925565"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a8f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "Cdk5 phosphorylates p80 Dab1 at multiple sites in its carboxyl-terminal region, and tyrosine phosphorylation of p80 Dab1 by Fyn tyrosine kinase is attenuated by this Cdk5-mediated phosphorylation in vitro. ",
              "citation": {
                "type": "PubMed",
                "name": "Brain Res 2007 Apr 6 1140 84-95",
                "id": "16529723"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a8e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Aug 24(16) 6980-92",
                "id": "15282299"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a8d"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "We identify Tyr-131 as the major phosphorylation site and Tyr-132 as a minor site and the Src family PTKs Lck and Fyn as enzymes capable of phosphorylating these sites in vivo and in vitro. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1997 Feb 28 272(9) 5371-4",
                "id": "9038134"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a8c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Dec 6 277(49) 47373-9",
                "id": "12239221"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a8b"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "To unravel the cellular functions of magicin, we used a yeast two-hybrid system and identified Fyn tyrosine kinase as a specific binding partner for magicin. Fyn phosphorylates magicin in vitro. In addition to Fyn, Src and Lck also interact with magicin. ",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2006 Sep 29 348(3) 826-31",
                "id": "16899217"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a8a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "We show herethat RPTP is a physiological activator of two additional Src family kinases, Yes and Fyn.",
              "citation": {
                "type": "PubMed",
                "name": "Exp Cell Res 2004 Mar 10 294(1) 236-43",
                "id": "14980517"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a89"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "On the contrary, the Cas-associated kinase activity was remarkably decreased in Fyn-/- cells.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1997 Mar 27 14(12) 1419-26",
                "id": "9136985"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a88"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "SHP2 KO BMMCs displayed several phenotypes associated with reduced Fyn activity, including elevated phosphorylation of the inhibitory pY531 site in Fyn, impaired signaling to Grb2-associated binder 2, Akt/PKB, and IkappaB kinase, and decreased TNF-alpha release compared with control cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2009 Oct 15 183(8) 4940-7",
                "id": "19786542"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a87"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "mast cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "Thus, in contrast to the activation pathway mediated by serine/threonine phosphorylation, tyrosine phosphorylation of Itch plays a negative role in modulating Itch-promoted ubiquitination.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2006 Jan 6 21(1) 135-41",
                "id": "16387660"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a86"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "SKAP-HOM is a cytosolic adaptor protein representing a specific substrate for the Src family protein tyrosine kinase Fyn",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2005 Sep 25(18) 8052-63",
                "id": "16135797"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a85"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "CD146 engagement initiates an outside-in signaling pathway involving the protein tyrosine kinases FYN and FAK as well as paxillin.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Jan 12 276(2) 1564-9",
                "id": "11036077"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a84"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "The protein-tyrosine kinase Csk is one of the main down-regulators of the Src family of kinases. Csk may be involved in the down-regulation of T cell receptor (TCR) signaling by C-terminal tyrosine phosphorylation of Lck and Fyn; however, it is not known how Csk activity is regulated or how it targets these Src family members.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1996 Apr 19 271(16) 9698-703",
                "id": "8621646"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a83"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "lymphocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "Collectively, our results suggest that BDNF enhances phosphorylation of NR2B tyrosine 1472 through activation of Fyn, leading to alteration of NMDA receptor activity and increased synaptic transmission.",
              "citation": {
                "type": "PubMed",
                "name": "Brain Res 2006 Nov 22 1121(1) 22-34",
                "id": "17045972"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a82"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "The binding of beta-catenin to these partners is regulated by phosphorylation of at least three critical tyrosine residues. Each of these residues is targeted by one or more specific kinases: Y142 by Fyn, Fer and cMet; Y489 by Abl; and Y654 by Src and the epidermal growth factor receptor.",
              "citation": {
                "type": "PubMed",
                "name": "Curr Opin Cell Biol 2005 Oct 17(5) 459-65",
                "id": "16099633"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a81"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "Moreover, expression of a constitutive active form of Fyn also promoted the recruitment of Tom1L1 to enlarged endosomes.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Mar 11 280(10) 9258-64",
                "id": "15611048"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a80"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "IL-6-treatment of INA-6 cells induced the kinase activities of Fyn, Lyn and Hck",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2007 Jul 26 26(34) 4987-98",
                "id": "17310994"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a7f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "Using chemical and genetic inhibitors, we show that Fyn activity is required for SAPK2/p38 but not for FAK activation in response to VEGF. In contrast, c-Src permits activation of FAK, but not that of SAPK2/p38. In addition, Fyn is required for stress fiber formation and endothelial cell migration. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Nov 10 281(45) 34009-20",
                "id": "16966330"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a7e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 2000 Jun 2 474(2-3) 179-83",
                "id": "10838081"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a7d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "MAPK. Stimulation of ERK by endothelial-cell integrins is mediated by either FAK, or the Src-family kinases Fyn and Yes.",
              "citation": {
                "type": "PubMed",
                "name": "Biochim Biophys Acta 2004 Mar 4 1654(1) 51-67",
                "id": "14984767"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a7c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "Several lipid signaling pathways are activated downstream of Fc?RI via Fyn, including pathways mediated by PI3K, SphK, and PLD",
              "citation": {
                "type": "PubMed",
                "name": "Immunol Rev 2007 Jun 217 255-68",
                "id": "17498064"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a7b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "mast cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2000 Jun 8 19(25) 2895-903",
                "id": "10871840"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a7a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FYN) actsIn kin(p(HGNC:FYN))",
              "summary_text": "Through its phosphorylated tyrosine residues, the activated VEGFR-2 associates with the adapter molecules Shc, Grb2 and Nck, to Ras GTPase activating protein, p59fyn, pp62yes and phospholipase Cg, and to the tyrosine phosphatases SHP-1 and SHP-2",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1999 Feb 15 18(4) 882-92",
                "id": "10022831"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8a79"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:MAPK11))",
        "relation": "directlyIncreases",
        "target": "p(HGNC:NFE2L2,pmod(P,S))",
        "directed": false,
        "label": "kin(p(HGNC:MAPK11)) directlyIncreases p(HGNC:NFE2L2,pmod(P,S))",
        "metadata": {
          "casual": true,
          "createdBy": "Jamboree2014",
          "edgeId": "55775dd92f9e241f18ad8de3",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:MAPK11)) directlyIncreases p(HGNC:NFE2L2,pmod(P,S))",
              "summary_text": "As shown in Fig. 6A , stimulation of all p38 MAPK isoforms by anisomycin strongly phosphorylated Nrf2 protein (lanes 2-5), whereas no phosphorylation was detected in the control immunoprecipitates (lane 1)...HeLa cells were stimulated with anisomycin (10 _g/mL) for 30 minutes and FLAG-p38 MAPK isoforms were immunoprecipitated using agarose-conjugated anti-FLAG M2 monoclonal antibody. Purified GST-Nrf2 protein was immunoprecipitated with FLAG-p38 MAPK isoforms and was incubated with 32P-labeled ATP in the presence of the precipitated p38 MAPK isoforms. Phosphorylation of Nrf2 protein by activated p38 MAPK isoforms was visualized by autoradiography.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "16951197"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8cfa"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "HeLa",
                "tissue": ""
              }
            },
            {
              "bel_statement": "kin(p(HGNC:MAPK11)) directlyIncreases p(HGNC:NFE2L2,pmod(P,S))",
              "summary_text": "As shown in Fig. 6A  , stimulation of all p38 MAPK isoforms by anisomycin strongly phosphorylated Nrf2 protein (lanes 2-5), whereas no phosphorylation was detected in the control immunoprecipitates (lane 1). ",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2006 Sep 1 66(17) 8804-13",
                "id": "16951197"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8afc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "kin(p(HGNC:MAPK11)) directlyIncreases p(HGNC:NFE2L2,pmod(P,S))",
              "summary_text": "As shown in Fig. 6A , stimulation of all p38 MAPK isoforms by anisomycin strongly phosphorylated Nrf2 protein (lanes 2-5), whereas no phosphorylation was detected in the control immunoprecipitates (lane 1)...HeLa cells were stimulated with anisomycin (10",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "16951197"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8afb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "a(CHEBI:curcumin)",
        "relation": "increases",
        "target": "tloc(p(HGNC:NFE2L2),GOCC:cytoplasm,GOCC:nucleus)",
        "directed": false,
        "label": "a(CHEBI:curcumin) increases tloc(p(HGNC:NFE2L2),GOCC:cytoplasm,GOCC:nucleus)",
        "metadata": {
          "casual": true,
          "createdBy": "Jamboree2014",
          "edgeId": "55775dd92f9e241f18ad8de4",
          "evidences": [
            {
              "bel_statement": "a(CHEBI:curcumin) increases tloc(p(HGNC:NFE2L2),GOCC:cytoplasm,GOCC:nucleus)",
              "summary_text": "Dietary curcumin led to increase in NF-E2-related factor-2 (Nrf2) protein levels and enhanced its nuclear translocation in liver and lungs of mice as compared with controls.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "18321868"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8afd"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": "Lung"
              }
            }
          ]
        }
      },
      {
        "source": "a(CHEBI:curcumin)",
        "relation": "increases",
        "target": "p(HGNC:NFE2L2)",
        "directed": false,
        "label": "a(CHEBI:curcumin) increases p(HGNC:NFE2L2)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8de5",
          "evidences": [
            {
              "bel_statement": "a(CHEBI:curcumin) increases p(HGNC:NFE2L2)",
              "summary_text": "Dietary curcumin led to increase in NF-E2-related factor-2 (Nrf2) protein levels and enhanced its nuclear translocation in liver and lungs of mice as compared with controls.",
              "citation": {
                "type": "PubMed",
                "name": "Carcinogenesis 2008 May 29(5) 1022-32",
                "id": "18321868"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b00"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "a(CHEBI:curcumin) increases p(HGNC:NFE2L2)",
              "summary_text": "Also, studies in renal epithelial and MDA-MB468 breast cells showed the parallel increase in Nrf2 nuclear protein and hemoxygenase-1 in response to curcumin (18,19).",
              "citation": {
                "type": "PubMed",
                "name": "Carcinogenesis 2008 May 29(5) 1022-32",
                "id": "18321868"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8aff"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Renal Epithelial Cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "a(CHEBI:curcumin) increases p(HGNC:NFE2L2)",
              "summary_text": "Also, studies in renal epithelial and MDA-MB468 breast cells showed the parallel increase in Nrf2 nuclear protein and hemoxygenase-1 in response to curcumin (18,19).",
              "citation": {
                "type": "PubMed",
                "name": "Carcinogenesis 2008 May 29(5) 1022-32",
                "id": "18321868"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8afe"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:GSK3B))",
        "relation": "increases",
        "target": "p(HGNC:FYN,pmod(P,T))",
        "directed": false,
        "label": "kin(p(HGNC:GSK3B)) increases p(HGNC:FYN,pmod(P,T))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8de6",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:GSK3B)) increases p(HGNC:FYN,pmod(P,T))",
              "summary_text": "The activated GSK-3beta phosphorylates Fyn at threonine residue(s). Phosphorylated Fyn accumulates in the nucleus and phosphorylates Nrf2 at tyrosine 568. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 Jun 1 282(22) 16502-10",
                "id": "17403689"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b01"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:NFE2L2)",
        "relation": "hasModification",
        "target": "p(HGNC:NFE2L2,pmod(P))",
        "directed": false,
        "label": "p(HGNC:NFE2L2) hasModification p(HGNC:NFE2L2,pmod(P))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8de7",
          "evidences": [
            {
              "bel_statement": "p(HGNC:NFE2L2) hasModification p(HGNC:NFE2L2,pmod(P))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b02"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:NFE2L2,pmod(P))",
        "relation": "decreases",
        "target": "complex(p(HGNC:NFE2L2),p(HGNC:KEAP1),p(HGNC:RBX1),p(HGNC:CUL3))",
        "directed": false,
        "label": "p(HGNC:NFE2L2,pmod(P)) decreases complex(p(HGNC:NFE2L2),p(HGNC:KEAP1),p(HGNC:RBX1),p(HGNC:CUL3))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8de8",
          "evidences": [
            {
              "bel_statement": "p(HGNC:NFE2L2,pmod(P)) decreases complex(p(HGNC:NFE2L2),p(HGNC:KEAP1),p(HGNC:RBX1),p(HGNC:CUL3))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b03"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:NFE2L2),p(HGNC:EIF2AK3))",
        "relation": "hasComponent",
        "target": "p(HGNC:NFE2L2)",
        "directed": false,
        "label": "complex(p(HGNC:NFE2L2),p(HGNC:EIF2AK3)) hasComponent p(HGNC:NFE2L2)",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8de9",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:NFE2L2),p(HGNC:EIF2AK3)) hasComponent p(HGNC:NFE2L2)",
              "summary_text": "Biochemical Activity; Two-hybrid",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2003 Oct 23(20) 7198-209",
                "id": "14517290"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b04"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:NFE2L2),p(HGNC:EIF2AK3))",
        "relation": "hasComponent",
        "target": "p(HGNC:EIF2AK3)",
        "directed": false,
        "label": "complex(p(HGNC:NFE2L2),p(HGNC:EIF2AK3)) hasComponent p(HGNC:EIF2AK3)",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8dea",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:NFE2L2),p(HGNC:EIF2AK3)) hasComponent p(HGNC:EIF2AK3)",
              "summary_text": "Biochemical Activity; Two-hybrid",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2003 Oct 23(20) 7198-209",
                "id": "14517290"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b05"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:NFE2L1)",
        "relation": "actsIn",
        "target": "tscript(p(HGNC:NFE2L1))",
        "directed": false,
        "label": "p(HGNC:NFE2L1) actsIn tscript(p(HGNC:NFE2L1))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8deb",
          "evidences": [
            {
              "bel_statement": "p(HGNC:NFE2L1) actsIn tscript(p(HGNC:NFE2L1))",
              "summary_text": "A chromatin immunoprecipitation assay with Nrf1 antibody confirmed the interaction of Nrf1 with the mouse osterix promoter. A reporter assay demonstrated that the promoter activity of mouse osterix containing an ARE was stimulated 4-fold by a 48-h treatment with AA in spontaneous fracture BMS cells. Treatment of mutant BMS cells with AA resulted in a 3.9-fold increase in the nuclear accumulation of Nrf1. Transfection of mutant BMS cells with Nrf1 small interfering RNA decreased Nrf1 protein by 4.5-fold, blocked AA induction of osterix expression, and impaired BMS cell differentiation. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 Jul 27 282(30) 22052-61",
                "id": "17510056"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8d00"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L1) actsIn tscript(p(HGNC:NFE2L1))",
              "summary_text": "PGC-1{alpha} can also interact directly with and coactivate NRF-1 on the Tfam gene promoter. Third, studies in primary cardiac myocytes in culture and in the hearts of transgenic mice have demonstrated that overexpression of PGC-1{alpha} up-regulates the expression of genes involved in mitochondrial fatty acid oxidation, most of which are PPAR{alpha} targets, in addition to NRF-1 targets (Lehman et al. 2000Go). Cardiac-specific overexpression of PGC-1{alpha} in transgenic mice leads to massive mitochondrial proliferation, ultimately resulting in cardiomyopathy and death (Lehman et al. 2000Go). Interestingly, in neonatal cardiac myocytes in culture, PGC-1{alpha} induces mitochondria that support largely coupled respiration consistent with the known ATP-generating function of this organelle in heart (Lehman et al. 2000Go). Lastly, forced expression of PGC-1{alpha} in skeletal muscle of transgenic mice triggers mitochondrial proliferation and the formation of mitochondrial-rich type I, oxidative (\\\"slow-twitch\\\") muscle fibers (Lin et al. 2002bGo). Collectively, these results indicate that PGC-1{alpha} is capable of promoting mitochondrial biogenesis through its coactivating effects on key factors such as NRF-1.",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2004 Feb 15 18(4) 357-68",
                "id": "15004004"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8cff"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "cardiomyocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L1) actsIn tscript(p(HGNC:NFE2L1))",
              "summary_text": "We show here that the TCF11 protein interacts to form heterodimers with small Maf proteins, previously shown to dimerize with p45 NF-E2, ECH and Fos. Such heterodimerization significantly alters the DNA binding characteristics of TCF11. While TCF11 alone binds in vitro to the tandem NF-E2 site derived from 5' DNase hypersensitive site 2 in the beta-globin locus control region and to the single NF-E2 site in the porphobilinogen deaminase gene promoter, stronger binding is detected in the presence of small Maf proteins.",
              "citation": {
                "type": "PubMed",
                "name": "Nucleic Acids Res 1996 Nov 1 24(21) 4289-97",
                "id": "8932385"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8cfe"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L1) actsIn tscript(p(HGNC:NFE2L1))",
              "summary_text": "The various AREs bind to a complex of nuclear proteins from cells of different origins (15-23, 25). Analysis of ARE-nuclear protein complexes have identified several nuclear transcription factors including c-Jun, Jun-B, Jun-D, c-Fos, Fra1, Nrf1, Nrf2, YABP, ARE-BP1, MafK, Ah (aromatic hydrocarbon) receptor, and the estrogen receptor (15-32). Among these transcription factors, Nrf1 and Nrf2 have been shown to heterodimerize with c-Jun and up-regulate the ARE-mediated expression and induction of NQO1 in response to antioxidants and xenobiotics (26, 31). ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Dec 22 275(51) 40134-41",
                "id": "11013233"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8cfd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L1) actsIn tscript(p(HGNC:NFE2L1))",
              "summary_text": "Nrf1 and Nrf2 Regulate a Similar Subset of Antioxidant Genes: Expression of Gclm was reduced to the same extent in both Nrf1 and Nrf2 mutant cells. NQO1 was down-regulated to a similar extent in both single mutant cells, whereas mRNA levels of heme-oxygenase-1 (HO-1), ferritin-H (FtH), and metallothionein-1 (MT-1) was lower in nrf2/ cells compared with nrf1/ cells (Fig. 6a). In all cases, however, expression in double knockout cells was abolished compared with single knockout cells, indicating a dependence on both Nrf1 and Nrf2",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Nov 28 278(48) 48021-9",
                "id": "12968018"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8cfc"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L1) actsIn tscript(p(HGNC:NFE2L1))",
              "summary_text": "hepatic nuclear factor 3 (HNF3) and nuclear factor 1 (NF1) are necessary for an appropriate expression of the ALAS gene. Insulin overrides the HNF3beta or HNF3beta plus NF1-mediated stimulation of ALAS transcriptional activity. Electrophoretic mobility shift assay and Southwestern blotting indicate that HNF3 binds to the ALAS promoter We propose a model in which insulin exerts its negative effect through the disturbance of HNF3beta binding or transactivation potential",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jul 2 279(27) 28082-92",
                "id": "15123725"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8cfb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L1) actsIn tscript(p(HGNC:NFE2L1))",
              "summary_text": "Transcripts for GSTM3, GSTM6, and GSTP2 were clearly reduced in Nrf1LKO samples. ",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2005 Mar 15 102(11) 4120-5",
                "id": "15738389"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b1a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L1) actsIn tscript(p(HGNC:NFE2L1))",
              "summary_text": "Figure 2. TCF11 transactivates expression through the PBGD erythroid-specific promoter in a variety of cell lines as indicated",
              "citation": {
                "type": "PubMed",
                "name": "Nucleic Acids Res 1998 Jan 15 26(2) 512-20",
                "id": "9421508"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b19"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L1) actsIn tscript(p(HGNC:NFE2L1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1997 Jun 27 272(26) 16490-7",
                "id": "9195958"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b18"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L1) actsIn tscript(p(HGNC:NFE2L1))",
              "summary_text": "Fibroblasts derived from Nrf1 null embryos showed reduced expression of GCLM and GSS, and Nrf1 has been shown to bind and activate the GCLM promoter",
              "citation": {
                "type": "PubMed",
                "name": "Toxicol Appl Pharmacol 2010 Apr 1 244(1) 16-20",
                "id": "19665035"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b17"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L1) actsIn tscript(p(HGNC:NFE2L1))",
              "summary_text": "These results indicated that hARE-mediated expression of the NQO1 gene and its induction by xenobiotics and antioxidants are mediated by Nrf1 and Nrf2. The hARE-mediated basal expression, however, is repressed by overexpression of c-Fos and Fra1",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 1996 Dec 10 93(25) 14960-5",
                "id": "8962164"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b16"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L1) actsIn tscript(p(HGNC:NFE2L1))",
              "summary_text": "Supershift analyses revealed that oxLDL stimulates binding of the transcription factors Nrf1, Nrf2, and c-jun to the AREs",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 2003 Mar 7 92(4) 386-93",
                "id": "12600891"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b15"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L1) actsIn tscript(p(HGNC:NFE2L1))",
              "summary_text": "Nrf1 has also been reported to function as a repressor of transcription. The dentin sialophosphoprotein (DSPP) gene encodes DSP and DPP, which are expressed in terminally differentiated odontoblast. In undifferentiated odontoblast, Nrf1 interacts with C/EBP-? to repress DSPP expression.",
              "citation": {
                "type": "PubMed",
                "name": "Toxicol Appl Pharmacol 2010 Apr 1 244(1) 16-20",
                "id": "19665035"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b14"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L1) actsIn tscript(p(HGNC:NFE2L1))",
              "summary_text": "Figure 2. TCF11 transactivates expression through the PBGD erythroid-specific promoter in a variety of cell lines as indicated",
              "citation": {
                "type": "PubMed",
                "name": "Nucleic Acids Res 1998 Jan 15 26(2) 512-20",
                "id": "9421508"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b13"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L1) actsIn tscript(p(HGNC:NFE2L1))",
              "summary_text": "Overexpression of Smad6-short, which enhances TGF-? signaling, resulted in an increase in TCF11/MafG binding (Fig. 4B). In contrast, overexpression of Smad7, the negative regulator of TGF signaling, blocked the induction by Smad6-short. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 Dec 21 282(51) 36837-44",
                "id": "17928287"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b12"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L1) actsIn tscript(p(HGNC:NFE2L1))",
              "summary_text": "Using peritoneal macrophages from Nrf2-deficient mice, we show here that Nrf2 also controls the expression of a group of electrophile- and oxidative stress-inducible proteins and activities, which includes heme oxygenase-1, A170, peroxiredoxin MSP23, and cystine membrane transport (system x(c)(-)) activity.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 May 26 275(21) 16023-9",
                "id": "10821856"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b11"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L1) actsIn tscript(p(HGNC:NFE2L1))",
              "summary_text": "TABLE 1. Changes in gene expression identified by quantitative RT-PCR in nrf1-/- fetal livers and erythroid progenitorsa",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2003 Jul 23(13) 4673-86",
                "id": "12808106"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b10"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L1) actsIn tscript(p(HGNC:NFE2L1))",
              "summary_text": "In the present report, we demonstrate that nuclear transcription factors Nrf2 and Nrf1 associate with Jun (c-Jun, Jun-B and Jun-D) proteins to upregulate ARE-mediated expression and coordinated induction of detoxifying enzymes in response to antioxidants and xenobiotics.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1998 Dec 17 17(24) 3145-56",
                "id": "9872330"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b0f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L1) actsIn tscript(p(HGNC:NFE2L1))",
              "summary_text": "Table 1 shows that genes regulating oxidative phosphorylation, rat and human cytochrome c genes, contain NRF-1 recognition sites.",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2004 Feb 15 18(4) 357-68",
                "id": "15004004"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b0e"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L1) actsIn tscript(p(HGNC:NFE2L1))",
              "summary_text": "The basal protein and mRNA levels and nuclear binding activities of c-Jun, c-Fos, p50, and p65 were lower in F1 (Nrf1/Nfe2l1 null) and F2 (Nrf2/Nfe2l2 null) cells and exhibited a blunted response to TBH. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2005 Jul 25(14) 5933-46",
                "id": "15988009"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b0d"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L1) actsIn tscript(p(HGNC:NFE2L1))",
              "summary_text": "Microarray analysis of bones from a mutant mouse strain (sfx) that develops spontaneous fractures has identified osterix as another Nrf1 target gene...The promoter region of osterix has a well-conserved ARE that mediates ascorbic acid-induced expression and is bound by Nrf1 as indicated by gel shift and chromatin immunoprecipitation assays ",
              "citation": {
                "type": "PubMed",
                "name": "Toxicol Appl Pharmacol 2010 Apr 1 244(1) 16-20",
                "id": "19665035"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b0c"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": "Bone and Bones"
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L1) actsIn tscript(p(HGNC:NFE2L1))",
              "summary_text": "Down-regulation of NRF-1 target gene transcription on expression of DNRF-1 (dominant negative)",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2003 Jan 15 17(2) 240-55",
                "id": "12533512"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b0b"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L1) actsIn tscript(p(HGNC:NFE2L1))",
              "summary_text": "Cell-based studies also implicate GCLC and GSS as targets of Nrf1. Enforced expression of Nrf1 in cells up-regulates luciferase gene expression driven by GCLC or GSS promoter, and these promoters have been shown to bind Nrf1 by gel shift and chromatin immunoprecipitation experiments ",
              "citation": {
                "type": "PubMed",
                "name": "Toxicol Appl Pharmacol 2010 Apr 1 244(1) 16-20",
                "id": "19665035"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b0a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L1) actsIn tscript(p(HGNC:NFE2L1))",
              "summary_text": "In a gel shift analysis, this bacterially expressed splice variant binds to the TNFalpha promoter site after in vitro phosphorylation by casein kinase II (CKII). In addition, cotransfection studies demonstrate that this splice variant mediates induced transcription at the TNFalpha promoter after stimulation/activation in a heterologous system.",
              "citation": {
                "type": "PubMed",
                "name": "Nucleic Acids Res 1998 May 15 26(10) 2291-7",
                "id": "9580677"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b09"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L1) actsIn tscript(p(HGNC:NFE2L1))",
              "summary_text": "TGF-? treatment of human smooth muscle cells leads to increased expression and binding of Nrf1/MafG heterodimers to an ARE-like site in the iNOS promoter (Berg et al., 2007). The knockdown of Nrf1 blocks the suppression of iNOS expression by TGF-?.",
              "citation": {
                "type": "PubMed",
                "name": "Toxicol Appl Pharmacol 2010 Apr 1 244(1) 16-20",
                "id": "19665035"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b08"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L1) actsIn tscript(p(HGNC:NFE2L1))",
              "summary_text": "We have identified a binding site in the iNOS promoter that interacts with the nuclear heterodimer TCF11/MafG using chromatin immunoprecipitation and mutation analyses. We demonstrate that binding at this site acts to repress the induction of iNOS gene expression by cytokines.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 Dec 21 282(51) 36837-44",
                "id": "17928287"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b07"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Muscle, Smooth"
              }
            },
            {
              "bel_statement": "p(HGNC:NFE2L1) actsIn tscript(p(HGNC:NFE2L1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Dec 24 274(52) 37491-8",
                "id": "10601325"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b06"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:NFE2L2),p(HGNC:KEAP1),p(HGNC:RBX1),p(HGNC:CUL3))",
        "relation": "hasComponent",
        "target": "p(HGNC:CUL3)",
        "directed": false,
        "label": "complex(p(HGNC:NFE2L2),p(HGNC:KEAP1),p(HGNC:RBX1),p(HGNC:CUL3)) hasComponent p(HGNC:CUL3)",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8dec",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:NFE2L2),p(HGNC:KEAP1),p(HGNC:RBX1),p(HGNC:CUL3)) hasComponent p(HGNC:CUL3)",
              "summary_text": "Cul3 connects the RING H2 finger protein Ring-box (Rbx) 1 or 2 and a substrate-binding subunit containing a BTB (Bric-a-brac, Tramtrack, Broad-complex) domain [22]. BPOZ-2 contains two BTB domains, through which BPOZ-2 binds to Cul3.  Nrf2, which is a substrate of the Keap1/Cul3 E3 complex,",
              "citation": {
                "type": "Other",
                "name": "",
                "id": "22808041"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b1c"
              },
              "experiment_context": {
                "species_common_name": "human",
                "disease": "",
                "cell": "hek293",
                "tissue": "kidney"
              }
            },
            {
              "bel_statement": "complex(p(HGNC:NFE2L2),p(HGNC:KEAP1),p(HGNC:RBX1),p(HGNC:CUL3)) hasComponent p(HGNC:CUL3)",
              "summary_text": "We propose that exposure of cells to sulforaphane or oxidative stress, by altering the redox state of Cys 151, reduces the ability of Nrf2-bound Keap1 proteins to associate with the Cul3-Rbx1 core complex. As a result, fewer Nrf2 molecules will be targeted for ubiquitination and subsequent degradation, leading to increased accumulation of Nrf2.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Dec 24(24) 10941-53",
                "id": "15572695"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b1b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:NFE2L2),p(HGNC:KEAP1),p(HGNC:RBX1),p(HGNC:CUL3))",
        "relation": "decreases",
        "target": "tscript(p(HGNC:NFE2L2))",
        "directed": false,
        "label": "complex(p(HGNC:NFE2L2),p(HGNC:KEAP1),p(HGNC:RBX1),p(HGNC:CUL3)) decreases tscript(p(HGNC:NFE2L2))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8ded",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:NFE2L2),p(HGNC:KEAP1),p(HGNC:RBX1),p(HGNC:CUL3)) decreases tscript(p(HGNC:NFE2L2))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b1d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:NFE2L2),p(HGNC:KEAP1),p(HGNC:RBX1),p(HGNC:CUL3))",
        "relation": "hasComponent",
        "target": "p(HGNC:KEAP1)",
        "directed": false,
        "label": "complex(p(HGNC:NFE2L2),p(HGNC:KEAP1),p(HGNC:RBX1),p(HGNC:CUL3)) hasComponent p(HGNC:KEAP1)",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8dee",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:NFE2L2),p(HGNC:KEAP1),p(HGNC:RBX1),p(HGNC:CUL3)) hasComponent p(HGNC:KEAP1)",
              "summary_text": "We propose that exposure of cells to sulforaphane or oxidative stress, by altering the redox state of Cys 151, reduces the ability of Nrf2-bound Keap1 proteins to associate with the Cul3-Rbx1 core complex. As a result, fewer Nrf2 molecules will be targeted for ubiquitination and subsequent degradation, leading to increased accumulation of Nrf2.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Dec 24(24) 10941-53",
                "id": "15572695"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b1e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:NFE2L2),p(HGNC:KEAP1),p(HGNC:RBX1),p(HGNC:CUL3))",
        "relation": "hasComponent",
        "target": "p(HGNC:RBX1)",
        "directed": false,
        "label": "complex(p(HGNC:NFE2L2),p(HGNC:KEAP1),p(HGNC:RBX1),p(HGNC:CUL3)) hasComponent p(HGNC:RBX1)",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8def",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:NFE2L2),p(HGNC:KEAP1),p(HGNC:RBX1),p(HGNC:CUL3)) hasComponent p(HGNC:RBX1)",
              "summary_text": "We propose that exposure of cells to sulforaphane or oxidative stress, by altering the redox state of Cys 151, reduces the ability of Nrf2-bound Keap1 proteins to associate with the Cul3-Rbx1 core complex. As a result, fewer Nrf2 molecules will be targeted for ubiquitination and subsequent degradation, leading to increased accumulation of Nrf2.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Dec 24(24) 10941-53",
                "id": "15572695"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b1f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:NFE2L2),p(HGNC:KEAP1),p(HGNC:RBX1),p(HGNC:CUL3))",
        "relation": "increases",
        "target": "p(HGNC:NFE2L2,pmod(U,K))",
        "directed": false,
        "label": "complex(p(HGNC:NFE2L2),p(HGNC:KEAP1),p(HGNC:RBX1),p(HGNC:CUL3)) increases p(HGNC:NFE2L2,pmod(U,K))",
        "metadata": {
          "casual": true,
          "createdBy": "Jamboree2014",
          "edgeId": "55775dd92f9e241f18ad8df0",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:NFE2L2),p(HGNC:KEAP1),p(HGNC:RBX1),p(HGNC:CUL3)) increases p(HGNC:NFE2L2,pmod(U,K))",
              "summary_text": "We propose that exposure of cells to sulforaphane or oxidative stress, by altering the redox state of Cys 151, reduces the ability of Nrf2-bound Keap1 proteins to associate with the Cul3-Rbx1 core complex. As a result, fewer Nrf2 molecules will be targeted for ubiquitination and subsequent degradation, leading to increased accumulation of Nrf2.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "15572695"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b20"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "COS cell line",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:NFE2L2),p(HGNC:KEAP1),p(HGNC:RBX1),p(HGNC:CUL3))",
        "relation": "hasComponent",
        "target": "p(HGNC:NFE2L2)",
        "directed": false,
        "label": "complex(p(HGNC:NFE2L2),p(HGNC:KEAP1),p(HGNC:RBX1),p(HGNC:CUL3)) hasComponent p(HGNC:NFE2L2)",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8df1",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:NFE2L2),p(HGNC:KEAP1),p(HGNC:RBX1),p(HGNC:CUL3)) hasComponent p(HGNC:NFE2L2)",
              "summary_text": "We propose that exposure of cells to sulforaphane or oxidative stress, by altering the redox state of Cys 151, reduces the ability of Nrf2-bound Keap1 proteins to associate with the Cul3-Rbx1 core complex. As a result, fewer Nrf2 molecules will be targeted for ubiquitination and subsequent degradation, leading to increased accumulation of Nrf2.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Dec 24(24) 10941-53",
                "id": "15572695"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b21"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:KEAP1),p(HGNC:NFE2L2))",
        "relation": "isA",
        "target": "complex(p(HGNC:NFE2L2),p(HGNC:KEAP1),p(HGNC:RBX1),p(HGNC:CUL3))",
        "directed": false,
        "label": "complex(p(HGNC:KEAP1),p(HGNC:NFE2L2)) isA complex(p(HGNC:NFE2L2),p(HGNC:KEAP1),p(HGNC:RBX1),p(HGNC:CUL3))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8df2",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:KEAP1),p(HGNC:NFE2L2)) isA complex(p(HGNC:NFE2L2),p(HGNC:KEAP1),p(HGNC:RBX1),p(HGNC:CUL3))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b22"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "cat(p(HGNC:PTGS2))",
        "relation": "increases",
        "target": "a(SCHEM:\"15-deoxy-D12,14-prostaglandin J2\")",
        "directed": false,
        "label": "cat(p(HGNC:PTGS2)) increases a(SCHEM:\"15-deoxy-D12,14-prostaglandin J2\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8df3",
          "evidences": [
            {
              "bel_statement": "cat(p(HGNC:PTGS2)) increases a(SCHEM:\"15-deoxy-D12,14-prostaglandin J2\")",
              "summary_text": "COX-2-dependent generation of 15d-PGJ2 is essential for the activation of Nrf2 in endothelial cells after exposure to L-flow. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Jul 22 280(29) 27244-50",
                "id": "15917255"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b25"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "cat(p(HGNC:PTGS2)) increases a(SCHEM:\"15-deoxy-D12,14-prostaglandin J2\")",
              "summary_text": "Administration of the cyclooxygenase 2 inhibitor NS-398 to mice with carrageenan-induced pleurisy caused persistence of neutrophil recruitment and, in macrophages, attenuated the 15d-PGJ(2) accumulation and PrxI expression.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Jan 24(1) 36-45",
                "id": "14673141"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b24"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "cat(p(HGNC:PTGS2)) increases a(SCHEM:\"15-deoxy-D12,14-prostaglandin J2\")",
              "summary_text": "COX-2 inhibitors...in the vasculature prevents the accumulation of COX-2- derived 15d-PGJ2, which is associated with the atheroprotective nature of laminar flow.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2005 Sep 27 102(39) 14010-5",
                "id": "16172382"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b23"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium, Vascular"
              }
            }
          ]
        }
      },
      {
        "source": "cat(p(HGNC:PTGS2))",
        "relation": "decreases",
        "target": "kin(p(SFAM:\"PIK3C Class IA Family\"))",
        "directed": false,
        "label": "cat(p(HGNC:PTGS2)) decreases kin(p(SFAM:\"PIK3C Class IA Family\"))",
        "metadata": {
          "casual": true,
          "createdBy": "Jamboree2014",
          "edgeId": "55775dd92f9e241f18ad8df4",
          "evidences": [
            {
              "bel_statement": "cat(p(HGNC:PTGS2)) decreases kin(p(SFAM:\"PIK3C Class IA Family\"))",
              "summary_text": "We demonstrate that shear-induced cyclooxygenase (COX)-2 suppresses phosphatidylinositol 3-kinase (PI3-K) activity, which represses antioxidant response element (ARE)/NF-E2 related factor 2 (Nrf2)-mediated transcriptional response in human chondrocytes.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "16172382"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b27"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "chondrocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "cat(p(HGNC:PTGS2)) decreases kin(p(SFAM:\"PIK3C Class IA Family\"))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b26"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:NFE2L2),p(HGNC:MAFF))",
        "relation": "increases",
        "target": "p(HGNC:HMOX1)",
        "directed": false,
        "label": "complex(p(HGNC:NFE2L2),p(HGNC:MAFF)) increases p(HGNC:HMOX1)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8df5",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:NFE2L2),p(HGNC:MAFF)) increases p(HGNC:HMOX1)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b28"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:NFE2L2),p(HGNC:MAFF))",
        "relation": "hasComponent",
        "target": "p(HGNC:NFE2L2)",
        "directed": false,
        "label": "complex(p(HGNC:NFE2L2),p(HGNC:MAFF)) hasComponent p(HGNC:NFE2L2)",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8df6",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:NFE2L2),p(HGNC:MAFF)) hasComponent p(HGNC:NFE2L2)",
              "summary_text": "in vitro",
              "citation": {
                "type": "PubMed",
                "name": "Blood Cells Mol Dis 29(2) 145-58",
                "id": "12490281"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b29"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:NFE2L2),p(HGNC:MAFF))",
        "relation": "hasComponent",
        "target": "p(HGNC:MAFF)",
        "directed": false,
        "label": "complex(p(HGNC:NFE2L2),p(HGNC:MAFF)) hasComponent p(HGNC:MAFF)",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8df7",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:NFE2L2),p(HGNC:MAFF)) hasComponent p(HGNC:MAFF)",
              "summary_text": "in vitro",
              "citation": {
                "type": "PubMed",
                "name": "Blood Cells Mol Dis 29(2) 145-58",
                "id": "12490281"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b2a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:MAPK12))",
        "relation": "isA",
        "target": "kin(p(SFAM:\"MAPK p38 Family\"))",
        "directed": false,
        "label": "kin(p(HGNC:MAPK12)) isA kin(p(SFAM:\"MAPK p38 Family\"))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8df8",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:MAPK12)) isA kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b2b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:MAPK14))",
        "relation": "isA",
        "target": "kin(p(SFAM:\"MAPK p38 Family\"))",
        "directed": false,
        "label": "kin(p(HGNC:MAPK14)) isA kin(p(SFAM:\"MAPK p38 Family\"))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8df9",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:MAPK14)) isA kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b2c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:MAPK11))",
        "relation": "isA",
        "target": "kin(p(SFAM:\"MAPK p38 Family\"))",
        "directed": false,
        "label": "kin(p(HGNC:MAPK11)) isA kin(p(SFAM:\"MAPK p38 Family\"))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8dfa",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:MAPK11)) isA kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b2d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:MAPK13))",
        "relation": "isA",
        "target": "kin(p(SFAM:\"MAPK p38 Family\"))",
        "directed": false,
        "label": "kin(p(HGNC:MAPK13)) isA kin(p(SFAM:\"MAPK p38 Family\"))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8dfb",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:MAPK13)) isA kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b2e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(SFAM:\"MAPK p38 Family\"))",
        "relation": "directlyIncreases",
        "target": "complex(p(HGNC:KEAP1),p(HGNC:NFE2L2))",
        "directed": false,
        "label": "kin(p(SFAM:\"MAPK p38 Family\")) directlyIncreases complex(p(HGNC:KEAP1),p(HGNC:NFE2L2))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775dd92f9e241f18ad8dfc",
          "evidences": [
            {
              "bel_statement": "kin(p(SFAM:\"MAPK p38 Family\")) directlyIncreases complex(p(HGNC:KEAP1),p(HGNC:NFE2L2))",
              "summary_text": "stimulation of p38 MAPK isoforms phosphorylated purified Nrf2 protein and caused an increase in the interaction between Nrf2 and Keap1 in vitro and the suppression of Nrf2 translocation into the nucleus.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2006 Sep 1 66(17) 8804-13",
                "id": "16951197"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775dd92f9e241f18ad8b2f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "tscript(p(HGNC:AHR))",
        "relation": "increases",
        "target": "p(HGNC:NFE2L2)",
        "directed": false,
        "label": "tscript(p(HGNC:AHR)) increases p(HGNC:NFE2L2)",
        "metadata": {
          "casual": false,
          "createdBy": "alejandroferreiromorales.cr",
          "edgeId": "55775dd92f9e241f18ad8dfd",
          "evidences": [
            {
              "bel_statement": "tscript(p(HGNC:AHR)) increases p(HGNC:NFE2L2)",
              "summary_text": "There may be bidirectional regulation; recent studies suggest that Nrf2 is an AhR target gene, and the Nrf2 expression is directly modulated by AhR activation.",
              "citation": {
                "type": "Other",
                "name": "Lung Cancer. 2009 Aug;65(2):129-37. doi: 10.1016/j.lungcan.2009.01.002. Epub 2009 Jan 31.",
                "id": "19185948"
              },
              "metadata": {
                "created_by": "alejandroferreiromorales.cr",
                "id": "55775dd92f9e241f18ad8d01"
              },
              "experiment_context": {
                "species_common_name": "human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:NFE2L2)",
        "relation": "increases",
        "target": "p(HGNC:SOD1)",
        "directed": false,
        "label": "p(HGNC:NFE2L2) increases p(HGNC:SOD1)",
        "metadata": {
          "casual": false,
          "createdBy": "alejandroferreiromorales.cr",
          "edgeId": "55775dd92f9e241f18ad8dfe",
          "evidences": [
            {
              "bel_statement": "p(HGNC:NFE2L2) increases p(HGNC:SOD1)",
              "summary_text": "nfr2 also enhanced the activity of SOD and HO-1",
              "citation": {
                "type": "Other",
                "name": "Cell Stress Chaperones. 2012 Sep;17(5):553-65. doi: 10.1007/s12192-012-0331-9. Epub 2012 Feb 24.",
                "id": "22362068"
              },
              "metadata": {
                "created_by": "alejandroferreiromorales.cr",
                "id": "55775dd92f9e241f18ad8d02"
              },
              "experiment_context": {
                "species_common_name": "human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:TXNRD1)",
        "relation": "increases",
        "target": "cat(p(HGNC:TXNRD1))",
        "directed": false,
        "label": "p(HGNC:TXNRD1) increases cat(p(HGNC:TXNRD1))",
        "metadata": {
          "casual": false,
          "createdBy": "alejandroferreiromorales.cr",
          "edgeId": "55775dd92f9e241f18ad8dff",
          "evidences": [
            {
              "bel_statement": "p(HGNC:TXNRD1) increases cat(p(HGNC:TXNRD1))",
              "summary_text": "Mammalian thioredoxin reductase is one selenoprotein that shows increased activity with Se supplementation",
              "citation": {
                "type": "Other",
                "name": "Carcinogenesis. 1999 Sep;20(9):1657-66.",
                "id": "10469608"
              },
              "metadata": {
                "created_by": "alejandroferreiromorales.cr",
                "id": "55775dd92f9e241f18ad8d03"
              },
              "experiment_context": {
                "species_common_name": "mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:JUN)",
        "relation": "hasComponent",
        "target": "complex(SCOMP:\"AP-1 Complex\")",
        "directed": false,
        "label": "p(HGNC:JUN) hasComponent complex(SCOMP:\"AP-1 Complex\")",
        "metadata": {
          "casual": false,
          "createdBy": "alejandroferreiromorales.cr",
          "edgeId": "55775dd92f9e241f18ad8e00",
          "evidences": [
            {
              "bel_statement": "p(HGNC:JUN) hasComponent complex(SCOMP:\"AP-1 Complex\")",
              "summary_text": "The principal substrate for JNK phosphorylation is the AP-1 subunit c-Jun. Phosphorylation by JNK increases the ability of c-Jun to activate AP-1-dependent transcription. To determine whether the sustained JNK activation that occurred in response to TNF and NF-kappaB inhibition resulted in increased c-Jun activation, AP-1-dependent transcriptional activity was measured in untreated and TNF treated cells. RALA hepatocytes were transiently transfected with the AP-1-driven firefly luciferase reporter construct Coll73-Luc, and the constitutively expressing Renilla luciferase reporter pRL-TK for normalization. No significant increase in AP-1 transcriptional activity occurred in Ad5LacZ-infected cells at 4 hours after TNF treatment (Fig. 1B). AP-1 transcriptional activity in Ad5IkappaB-infected cells was increased slightly in untreated cells and almost 3-fold in cells treated with TNF (Fig. 1B). JNK overactivation resulting from NF-kappaB inactivation therefore led to increased AP-1-dependent transcription.",
              "citation": {
                "type": "Other",
                "name": "Hepatology. 2002 Apr;35(4):772-8.",
                "id": "11915022"
              },
              "metadata": {
                "created_by": "alejandroferreiromorales.cr",
                "id": "55775dd92f9e241f18ad8d04"
              },
              "experiment_context": {
                "species_common_name": "rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "gtp(p(HGNC:KRAS))",
        "relation": "increases",
        "target": "cat(p(HGNC:PTGS2))",
        "directed": false,
        "label": "gtp(p(HGNC:KRAS)) increases cat(p(HGNC:PTGS2))",
        "metadata": {
          "casual": false,
          "createdBy": "alejandroferreiromorales.cr",
          "edgeId": "55775dd92f9e241f18ad8e01",
          "evidences": [
            {
              "bel_statement": "gtp(p(HGNC:KRAS)) increases cat(p(HGNC:PTGS2))",
              "summary_text": "COX-2 protein and activity measured as prostaglandin E(2) level were up-regulated in cells expressing mutant K-ras(V12);",
              "citation": {
                "type": "Other",
                "name": "Carcinogenesis. 2004 Nov;25(11):2231-7. Epub 2004 Jul 29.",
                "id": "15284181"
              },
              "metadata": {
                "created_by": "alejandroferreiromorales.cr",
                "id": "55775dd92f9e241f18ad8d05"
              },
              "experiment_context": {
                "species_common_name": "mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      }
    ]
  }
}
